data_6uyj_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6uyj _Structure_validation_residue.Date_analyzed 2020-03-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -63.2 158.77 19.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.558 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.27 149.76 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.166 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -91.82 124.31 35.86 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.697 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -108.64 114.09 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -91.55 123.86 35.28 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.308 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 67.3 p . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 111.101 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.99 0.424 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.25 106.37 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.402 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 22.0 m -74.92 129.17 37.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.094 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.3 126.31 47.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.473 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.11 112.97 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -134.22 161.68 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.72 154.26 38.67 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.079 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.65 -36.74 98.39 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.151 1.901 . . . . 0.0 112.272 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.01 0.13 55.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -62.36 136.64 58.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 63.2 p -78.59 163.47 25.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.96 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.66 -37.7 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tm-20 -59.03 -42.17 89.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.914 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.89 -41.33 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 110.736 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.68 -42.99 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -60.87 -39.4 89.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.11 93.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.099 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.42 -39.95 89.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.69 -42.18 94.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.138 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.71 -39.73 89.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.85 7.34 15.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.412 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -115.83 -44.42 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.87 1.18 13.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.419 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.47 20.11 78.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 17.9 mm -79.83 120.87 81.35 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.05 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.1 150.7 54.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.72 1.614 . . . . 0.0 111.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -24.51 29.58 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -93.26 22.27 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.222 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -152.92 52.14 0.75 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 111.062 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -172.71 140.65 1.01 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.084 0.469 . . . . 0.0 110.856 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.93 128.47 43.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.254 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 64.0 mt -104.38 119.68 39.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.944 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.98 128.45 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.416 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -129.78 130.25 45.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.004 0.431 . . . . 0.0 111.002 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.36 16.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.603 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 2.17 89.87 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.64 125.78 51.09 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.88 0.34 . . . . 0.0 110.227 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -72.16 132.16 43.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -83.07 95.43 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.106 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.62 148.13 41.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.858 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -62.83 138.62 58.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 -18.31 54.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -84.24 177.5 8.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.14 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 64.7 p -126.3 165.76 18.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.38 -40.03 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.275 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -63.52 -28.28 69.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.55 -29.99 70.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.044 0.45 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.08 15.21 29.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 55.54 43.22 28.78 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.906 0.384 . . . . 0.0 110.251 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.38 109.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.045 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -97.55 -175.5 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.403 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -64.54 149.77 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.052 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 56.71 42.22 27.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.88 0.372 . . . . 0.0 110.903 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 53.6 m -100.02 127.53 46.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.099 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 89.1 m -77.24 127.67 33.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.68 142.24 47.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -85.99 117.77 25.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.27 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.46 123.56 48.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.01 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.69 131.97 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.55 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 31.2 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 -179.169 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -62.93 161.4 12.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.435 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -143.93 139.13 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.061 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -85.66 120.16 26.79 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.948 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.78 108.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.65 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.51 120.43 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -80.78 170.76 15.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.635 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.78 -22.5 66.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.154 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -87.58 -0.54 56.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.72 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.86 79.12 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -68.7 115.85 8.54 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -92.69 137.79 32.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.022 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.75 105.72 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 12.9 m -80.92 125.62 30.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 66.9 mt -122.32 123.47 41.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.17 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -65.79 108.84 2.25 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.45 163.66 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.717 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -108.98 149.79 40.08 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.01 -0.366 . . . . 0.0 110.01 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -42.47 65.26 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.851 1.701 . . . . 0.0 112.368 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -68.72 -19.77 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.245 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -58.0 136.7 57.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.384 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -79.62 166.2 22.12 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.849 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.25 -37.13 79.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.8 -44.27 86.22 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.65 -41.09 98.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 110.651 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.0 -41.87 94.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -60.3 -40.64 91.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.18 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.305 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.82 -38.77 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.8 -39.4 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.859 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' D' ' 35' ' ' GLY . 64.8 tt0 -59.83 -44.81 93.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.261 0.553 . . . . 0.0 109.946 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -65.99 -35.05 79.53 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.815 -0.553 . . . . 0.0 111.159 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -88.94 -4.02 58.57 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -147.61 -53.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.277 0.561 . . . . 0.0 110.467 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 117.22 13.51 7.59 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mt -83.69 119.88 74.36 Favored Pre-proline 0 N--CA 1.447 -0.606 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.346 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.88 164.03 34.32 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.865 1.71 . . . . 0.0 111.338 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.25 -34.15 94.1 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.466 2.111 . . . . 0.0 112.666 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -92.52 -17.29 24.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.955 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -96.05 131.17 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.467 . . . . 0.0 111.522 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -133.9 103.18 5.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.83 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 81.3 mt -83.6 129.85 34.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.054 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 66.4 mt -129.33 130.94 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.68 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -150.59 155.62 39.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.741 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.45 20.62 7.17 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.545 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.91 -3.19 77.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -129.21 147.68 51.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.083 0.468 . . . . 0.0 110.73 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -69.86 140.67 53.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.351 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.48 144.91 46.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.392 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.33 -82.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.268 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 177.38 -72.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 110.572 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.14 -18.51 69.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -59.46 155.05 15.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.986 0.422 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -96.44 164.97 12.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.153 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.517 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -63.05 -23.91 67.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.405 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.47 -38.26 86.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.026 0.441 . . . . 0.0 110.354 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -97.49 15.25 23.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.192 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 56.34 39.11 30.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.247 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.68 103.7 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.786 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.32 178.76 5.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.0 110.824 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -61.8 150.04 38.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.906 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 59.67 17.94 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.172 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -67.59 129.08 38.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -85.49 105.42 16.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -93.35 142.6 27.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 123.1 34.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.272 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 28.3 tp -100.09 119.19 37.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.181 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 69.1 t -109.84 129.71 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 -179.074 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 pttp . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.642 0.258 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.05 126.43 37.14 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.41 0.624 . . . . 0.0 109.998 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -66.96 -38.53 86.26 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.942 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.15 161.42 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.898 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.67 122.88 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -153.5 157.51 39.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.486 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.71 120.6 19.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.603 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.33 145.4 23.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.72 154.66 16.63 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -87.21 156.89 19.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.812 0.339 . . . . 0.0 110.811 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 28.3 mtp -125.23 174.1 8.33 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.8 m -127.7 122.05 31.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 tp -107.86 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.96 0.409 . . . . 0.0 110.247 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.63 120.25 31.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.809 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.41 -90.19 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -144.32 21.85 1.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.506 0.193 . . . . 0.0 110.765 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.9 m -123.45 130.71 53.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.14 120.28 58.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.694 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.6 p -118.82 124.01 28.65 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.202 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 141.76 42.08 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.817 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -91.88 132.31 36.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.533 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -67.74 -7.6 28.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -74.42 75.24 1.91 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -53.1 136.14 36.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.211 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -161.17 9.86 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.357 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 tp -137.72 124.92 21.64 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -98.45 108.67 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -132.29 154.57 49.56 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.922 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.8 mt -121.52 141.11 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.786 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -142.9 141.9 31.62 Favored 'General case' 0 C--O 1.219 -0.505 0 O-C-N 123.716 0.635 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -104.99 129.17 53.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.188 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.1 p -89.01 173.57 8.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.73 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.16 -10.84 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.717 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.32 -1.07 57.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.445 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 t 70.12 20.9 6.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.284 0.564 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.2 mt -103.13 126.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.408 HG23 HD11 ' A' ' 57' ' ' ILE . 51.7 mm -80.54 127.83 39.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -104.41 117.91 35.34 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.709 0.631 . . . . 0.0 110.933 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -94.35 107.82 19.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 90.4 m -119.35 142.81 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.82 0.819 . . . . 0.0 112.978 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.38 114.17 19.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.2 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -105.91 145.22 31.56 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.566 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -80.74 131.54 35.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.33 -19.35 62.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.969 0.414 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.5 m -59.58 -45.58 91.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.719 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.3 m -117.1 -11.82 10.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.2 23.39 78.03 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.36 148.21 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 110.662 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.88 102.7 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.039 0.447 . . . . 0.0 110.691 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -75.5 -36.32 60.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -125.89 148.18 49.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.624 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.81 96.38 1.36 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.5 mt -125.48 132.53 52.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.98 129.03 36.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 mm -116.61 120.18 64.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.277 0.561 . . . . 0.0 110.62 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -84.37 160.51 56.75 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.244 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 140.09 92.53 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.679 1.586 . . . . 0.0 111.041 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.37 11.15 3.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.032 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -85.07 -27.67 26.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.653 0.263 . . . . 0.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.9 p -145.1 164.75 30.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.235 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -132.02 121.86 24.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.111 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -97.11 119.33 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -148.12 166.88 26.5 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.788 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -83.85 159.79 21.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.162 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.39 95.82 20.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.093 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.77 60.25 7.61 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.99 1.793 . . . . 0.0 112.428 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.51 -41.68 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.24 81.14 71.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.56 130.76 27.45 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.874 1.716 . . . . 0.0 111.646 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 169.68 -41.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.94 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.31 -150.06 6.43 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.99 105.74 13.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.814 0.34 . . . . 0.0 110.517 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.26 127.49 72.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 110.71 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.57 152.63 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.367 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.8 p -129.62 139.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.615 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.1 tp -99.95 116.7 32.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -103.31 106.74 17.32 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.24 -37.37 82.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.72 -22.92 12.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.726 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.66 81.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.639 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.7 m 58.6 18.04 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 110.992 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -117.15 152.0 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.504 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -128.56 135.5 49.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.858 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.5 mt -118.53 148.19 42.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -117.2 134.49 54.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.844 0.354 . . . . 0.0 111.097 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 156.44 46.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.219 0.533 . . . . 0.0 111.152 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -135.37 136.55 41.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.601 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.2 ttm -73.56 132.57 42.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.168 0.509 . . . . 0.0 111.372 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 3.14 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.969 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.12 142.31 92.77 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.84 -28.45 36.31 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.903 1.735 . . . . 0.0 112.674 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.41 141.92 51.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.267 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -98.28 10.64 40.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.45 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -54.27 -24.16 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.296 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -119.41 6.39 11.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.241 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.71 -46.16 90.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.919 0.39 . . . . 0.0 110.748 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.66 -41.08 98.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.76 -43.34 96.68 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.551 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -64.06 -41.09 97.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.79 -41.14 97.99 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.122 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.05 -42.84 79.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.494 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.26 -40.48 96.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.68 -49.06 81.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.766 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -65.33 -39.2 92.09 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.126 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -72.34 -26.18 61.83 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.496 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -88.12 -26.27 22.57 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.796 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.4 mt -94.21 -17.56 22.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.06 -22.39 9.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.202 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -134.44 72.18 70.64 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.053 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.81 151.47 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.806 2.337 . . . . 0.0 112.123 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.494 1.503 0 C-N-CA 122.451 2.101 . . . . 0.0 112.127 -179.799 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.24 152.19 79.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.773 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.7 147.81 25.12 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.798 2.332 . . . . 0.0 112.024 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -82.42 154.02 68.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.228 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.17 150.95 82.02 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.141 1.894 . . . . 0.0 112.086 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.07 163.71 36.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -81.75 156.33 70.32 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.31 151.39 82.75 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.471 2.114 . . . . 0.0 112.124 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -151.76 164.04 37.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 111.087 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -85.65 134.68 33.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -117.94 132.48 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.536 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.1 mt -132.26 128.68 58.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.52 85.35 3.22 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.913 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.349 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.63 158.7 14.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.9 148.92 23.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.242 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -92.66 120.87 33.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.605 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -106.69 110.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.372 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -88.66 126.39 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.76 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 111.196 179.778 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.792 0.329 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.89 116.61 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.46 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -84.05 130.32 34.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 94.0 mt -123.76 123.1 39.76 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.656 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.17 112.42 5.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.769 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.26 162.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -104.72 153.83 38.98 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.635 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.62 -35.64 93.22 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.056 1.837 . . . . 0.0 112.102 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -84.89 -5.74 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.105 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -59.56 136.96 58.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.012 0.434 . . . . 0.0 110.823 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -76.98 160.84 28.83 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -64.41 -39.38 85.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.232 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.56 -40.78 88.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.89 -41.71 98.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.23 -42.78 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.544 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -59.02 -40.93 86.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.69 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.31 91.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.265 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.05 -38.85 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.85 -39.54 83.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.266 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.71 -38.86 82.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -68.81 -50.85 46.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.108 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -63.77 -42.74 97.73 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.02 150.42 49.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.964 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.13 55.7 2.73 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 27.7 mm -109.86 114.97 55.93 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.17 153.99 66.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.639 1.559 . . . . 0.0 112.056 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.77 -38.01 66.25 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.143 1.895 . . . . 0.0 112.385 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.13 -39.92 94.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.378 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -87.27 -9.44 54.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -80.9 88.95 5.85 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -99.11 105.27 17.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 mt -97.51 122.28 40.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.6 mt -128.72 123.09 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -112.48 114.51 27.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.447 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.97 49.94 20.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.4 27.84 73.58 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -127.75 102.96 7.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.393 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.09 132.07 51.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 41.9 mt -85.3 87.65 7.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.395 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.16 144.85 42.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -59.63 165.68 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.95 8.09 87.85 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.03 173.56 9.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.572 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -123.52 170.5 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.838 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.5 -39.95 92.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.354 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.1 -30.59 71.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.87 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.05 -28.68 69.76 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.008 0.432 . . . . 0.0 110.422 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -101.61 12.63 36.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.073 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.06 40.33 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -91.77 118.88 38.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.37 -179.25 3.9 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -63.58 149.67 45.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.733 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 59.86 18.73 7.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.216 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -74.44 129.15 37.23 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.29 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -80.46 129.85 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.225 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -119.26 144.48 46.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.367 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -90.39 114.18 26.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.284 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 65.6 tp -101.88 120.5 40.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.896 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -118.6 132.9 67.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.955 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 -179.055 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -59.68 158.72 9.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -138.31 144.32 30.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.112 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.36 124.62 33.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.2 t -108.89 105.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.329 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 128.63 34.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.647 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -87.49 171.39 10.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.8 -29.15 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.303 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -78.09 -10.94 59.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 -12.66 56.08 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.48 125.55 26.05 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.232 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -98.11 135.27 40.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.291 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.47 109.93 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.565 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -84.9 129.3 34.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.45 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 89.0 mt -124.7 126.62 45.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.883 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -65.81 113.26 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.454 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.75 167.26 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 O-C-N 121.933 -0.479 . . . . 0.0 110.056 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -111.77 154.17 44.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.613 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.36 -26.58 83.03 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.116 1.877 . . . . 0.0 112.045 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.1 p -89.97 -12.04 39.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.03 142.83 57.3 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.144 0.497 . . . . 0.0 111.043 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -81.96 164.24 21.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.056 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.02 -37.79 79.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.2 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -58.5 -40.32 82.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.37 -41.41 97.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 110.242 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.02 -42.51 95.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.574 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.83 -41.04 90.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.84 89.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.331 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -60.45 -40.11 89.96 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 79.6 mt -63.8 -41.48 92.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.699 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.82 -50.96 71.76 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.888 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -57.26 -24.05 52.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -96.9 -61.32 1.43 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.62 -25.39 22.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.907 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.27 11.54 64.48 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.385 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.09 121.49 80.67 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.908 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 149.36 55.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.519 1.48 . . . . 0.0 111.709 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.42 -41.75 65.25 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.889 1.726 . . . . 0.0 112.64 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.06 -40.59 74.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.98 -39.18 93.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.788 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.24 147.25 24.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.781 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -131.79 125.85 32.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 72.9 mt -91.41 122.67 34.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.482 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 81.9 mt -128.3 126.8 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.255 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.86 149.72 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 110.805 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.58 20.12 11.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.37 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.38 86.22 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -114.23 140.7 48.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -75.48 119.39 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.716 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.42 95.64 2.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.865 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.9 163.61 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 159.38 32.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.5 18.78 63.39 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -128.01 162.21 27.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.618 0.246 . . . . 0.0 110.576 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -113.43 160.81 18.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.399 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 78.2 mt -61.32 -40.11 92.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.688 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -63.34 -24.7 67.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 0.0 110.394 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -62.87 -37.46 86.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.091 0.472 . . . . 0.0 110.281 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -96.12 12.74 29.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.077 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.6 t30 57.15 40.37 28.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.005 0.431 . . . . 0.0 110.446 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.98 108.91 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.055 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -94.58 -179.43 4.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -61.66 145.37 52.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 61.75 36.28 16.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.9 t -87.28 123.78 32.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.226 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -78.44 124.22 27.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -117.8 143.31 46.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.187 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -87.97 123.03 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 48.6 tp -103.42 109.6 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 52.5 t -98.31 134.28 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 81.9 mt . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.642 -179.16 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -90.58 110.83 21.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.126 0.489 . . . . 0.0 109.694 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.3 mt -65.58 -38.45 89.58 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.649 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.19 162.51 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.08 122.35 0.31 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.01 156.69 36.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.92 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -71.89 123.81 23.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.53 143.71 18.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.188 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.89 153.11 16.92 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -91.73 170.98 9.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.87 0.367 . . . . 0.0 111.416 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.4 mtp -136.83 175.27 9.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.14 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.08 124.44 41.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.6 tp -106.08 117.89 35.21 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.446 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -121.46 110.48 16.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.057 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 -87.89 0.58 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 p -143.32 22.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.2 m -125.59 131.49 52.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.428 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.3 t -109.66 122.34 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.008 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.0 p -113.35 132.33 22.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.315 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.05 144.25 46.73 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.147 1.898 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.27 121.93 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.507 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -64.52 -12.52 45.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.851 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -73.17 74.48 1.27 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -54.99 135.32 48.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.08 -154.3 7.45 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tp -142.52 125.54 16.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.3 t -95.87 108.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.64 154.36 47.98 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.068 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 23' ' ' LEU . 91.4 mt -121.67 140.55 45.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.582 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -142.74 142.65 31.99 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 123.48 0.488 . . . . 0.0 110.191 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -105.84 128.28 53.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.285 0.564 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.3 p -87.84 172.06 9.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.606 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.89 -10.68 22.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.72 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.51 -1.1 56.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.452 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t 70.14 20.43 6.36 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.132 0.491 . . . . 0.0 110.962 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -104.15 127.54 51.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 57' ' ' ILE . 43.4 mm -80.18 128.17 38.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -105.08 116.62 32.26 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.551 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -98.02 107.27 19.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 147.2 47.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.822 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -119.94 111.64 18.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.899 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -102.03 134.45 45.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.279 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.7 137.57 40.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.864 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -78.49 -16.8 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -60.97 -45.62 94.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.501 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.3 m -117.07 -16.63 10.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.065 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.24 70.32 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -101.07 152.86 20.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.4 102.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -75.87 -37.53 58.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -126.65 145.58 50.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -159.17 100.71 1.55 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.328 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.7 mt -127.25 139.4 52.94 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.386 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.7 mt -77.72 127.23 38.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.6 mm -113.86 125.81 71.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.924 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -96.28 159.48 31.93 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.939 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.32 140.25 93.69 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.016 1.811 . . . . 0.0 111.348 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 62.34 13.18 5.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.031 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -95.44 -35.75 11.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 110.778 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 147.12 47.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -121.49 128.91 52.57 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.194 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -104.16 116.78 32.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -139.87 168.25 20.26 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -85.12 160.97 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.41 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.15 88.97 18.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.458 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.19 59.81 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.266 1.977 . . . . 0.0 112.005 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -114.5 -45.44 3.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.2 t -120.74 95.56 48.94 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.442 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.87 130.08 18.58 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.758 1.638 . . . . 0.0 111.658 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 167.93 -29.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.612 0.57 . . . . 0.0 110.315 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.7 -171.42 24.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.06 111.92 22.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 110.485 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.24 130.3 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.87 155.55 45.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 p -129.68 133.36 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.5 tp -100.74 119.83 39.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -119.01 129.6 55.22 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.474 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -87.66 116.5 25.84 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.62 -33.43 72.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.474 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.93 -19.04 10.55 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.191 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.61 -18.75 79.64 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 m 58.75 27.69 16.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -121.72 149.7 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -133.19 130.91 39.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.267 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 mt -120.99 148.87 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -119.8 135.32 54.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.4 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.47 153.26 48.82 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -128.46 134.7 48.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.561 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.0 mtp -77.62 139.01 39.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.967 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -100.82 7.76 43.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.043 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.38 134.21 86.93 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.522 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.2 -25.9 36.57 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.029 1.819 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.05 143.13 49.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 110.328 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.6 p -89.38 -1.05 57.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.97 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.22 -18.53 37.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -116.86 -17.38 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.42 -41.76 97.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.64 -40.61 95.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.082 0.467 . . . . 0.0 111.047 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -66.04 -41.67 90.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -62.41 -40.85 97.85 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.94 -43.26 99.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.04 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -67.73 -42.6 81.61 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.545 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.88 -43.02 97.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.656 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.38 -47.64 84.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.822 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.98 -39.46 93.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.048 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -72.69 -22.13 60.95 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.423 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.91 -26.87 19.1 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.809 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.8 mt -96.94 -16.22 20.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -118.04 -19.5 9.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -135.77 67.2 64.42 Favored Pre-proline 0 CA--C 1.519 -0.224 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.73 153.79 72.48 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 C-N-CA 122.459 2.106 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--N 1.312 -1.342 0 C-N-CA 122.545 2.163 . . . . 0.0 112.174 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -130.26 150.58 76.55 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.32 145.27 26.93 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.54 154.96 85.69 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.478 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 158.98 52.92 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.159 1.906 . . . . 0.0 112.451 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.54 -178.69 3.53 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.882 2.388 . . . . 0.0 111.935 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -115.33 158.89 40.2 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.67 141.79 83.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.069 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -153.68 164.11 38.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.2 139.48 31.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.972 0.415 . . . . 0.0 110.566 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.82 130.24 51.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.48 126.71 58.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -74.58 83.65 2.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.116 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.539 179.644 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -62.48 160.96 12.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.59 153.9 31.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.277 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -96.61 124.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.681 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.12 113.56 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.532 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -86.93 131.46 34.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.719 179.533 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.193 0.52 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.87 108.59 23.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.342 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 9.6 m -77.0 129.62 36.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.229 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.1 mt -124.28 123.9 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.619 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -69.57 115.48 8.87 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -137.67 164.79 27.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.619 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -106.77 154.28 40.23 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.97 -35.74 94.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.786 1.657 . . . . 0.0 111.968 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -82.78 -6.6 59.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.6 135.23 57.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.864 0.364 . . . . 0.0 110.803 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -78.61 163.34 25.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.966 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -63.48 -38.65 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.267 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -59.17 -42.79 91.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.041 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -62.15 -41.15 98.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.561 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -63.44 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.789 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -61.24 -39.39 90.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.271 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.15 -40.73 94.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.259 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.66 -39.68 89.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.19 -40.01 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.98 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.41 -39.57 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.305 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.21 -43.36 86.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.393 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -71.4 -40.25 70.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -132.76 155.76 48.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.002 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.58 64.75 1.78 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.36 98.75 51.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 150.76 74.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.624 1.55 . . . . 0.0 112.016 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.23 -25.19 12.84 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.392 2.061 . . . . 0.0 112.39 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -90.08 31.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -167.23 31.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.814 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.36 97.81 5.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.64 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -97.08 107.16 19.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.497 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -102.9 120.87 41.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.222 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 95.1 mt -128.78 129.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.705 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -120.43 118.66 30.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.53 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.68 88.1 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptt -95.81 112.87 24.49 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -66.44 129.48 39.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.03 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.9 88.0 3.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.333 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.25 138.34 51.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.13 145.52 46.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.328 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.72 60.49 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -93.1 170.31 9.74 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 65.2 p -113.39 167.12 10.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.389 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.14 -39.86 94.0 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.3 p -63.09 -27.29 69.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.245 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.93 -35.96 79.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.009 0.433 . . . . 0.0 110.074 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -95.5 14.45 22.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.089 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.03 40.28 30.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.218 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.16 110.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.541 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -99.25 -170.26 1.89 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.029 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -65.03 145.78 55.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.513 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 57.24 41.02 27.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.035 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -91.7 122.19 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.103 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 63.8 m -72.61 127.13 31.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.204 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -118.79 147.25 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.23 113.18 25.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.271 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.7 tp -102.5 119.84 39.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.683 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.15 133.75 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.376 -178.707 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.04 159.31 14.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.095 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -139.31 148.49 23.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.808 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -91.95 113.92 26.31 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.898 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 64.1 t -97.88 108.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.641 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -94.92 121.87 36.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.752 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -81.02 172.99 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.99 -36.14 76.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.819 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.77 -10.96 60.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 -9.84 66.47 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.61 126.83 29.12 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -100.68 132.2 46.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.556 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.65 109.16 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.904 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -78.95 128.37 33.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.486 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -124.32 121.83 36.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.389 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -67.03 113.71 5.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.306 0.574 . . . . 0.0 111.146 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 25.7 m -136.63 162.01 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.8 153.39 38.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.57 -39.34 91.64 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.873 1.715 . . . . 0.0 111.955 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -79.59 -8.75 59.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.083 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -58.24 135.6 57.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -76.15 161.78 28.54 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.3 -38.43 82.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.929 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.77 90.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.046 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.28 -42.04 99.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.131 0.491 . . . . 0.0 110.838 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.13 -43.5 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.23 -38.75 87.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.54 93.52 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.411 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mttp -59.68 -39.12 83.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.88 -39.98 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.336 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.26 -39.41 82.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.953 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -68.49 -51.04 47.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.759 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -65.17 -40.85 94.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -128.77 147.47 50.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.18 60.53 2.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -110.73 106.31 57.65 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.99 154.88 41.99 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.062 1.842 . . . . 0.0 111.766 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.29 -28.46 79.91 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.365 2.043 . . . . 0.0 112.781 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.84 -10.21 58.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.981 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.74 -52.93 3.44 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.24 116.36 7.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.356 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -116.23 103.65 10.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.56 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.79 129.06 34.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 55.0 mt -133.83 130.55 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.615 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -151.14 157.19 42.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.47 20.34 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.668 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.73 -6.09 75.61 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -129.16 150.06 50.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.128 0.49 . . . . 0.0 111.04 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -69.89 142.47 53.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.455 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.55 112.95 19.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.31 138.23 41.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.947 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -58.46 150.12 23.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.251 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.71 64.62 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -84.85 -178.59 6.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.936 0.398 . . . . 0.0 110.758 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -126.54 162.29 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.099 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.72 -39.56 94.45 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.68 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -63.75 -28.34 69.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.48 -34.59 75.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.029 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -97.84 12.37 34.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.432 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 m120 55.73 39.78 30.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.888 0.375 . . . . 0.0 110.23 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -86.59 106.8 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.35 177.19 6.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.629 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -61.33 150.26 35.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.347 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 61.73 13.07 5.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.935 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m -70.75 136.3 48.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -86.31 119.94 27.12 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.83 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -110.4 125.31 53.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.285 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -75.22 133.06 41.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 69.2 tp -112.56 115.84 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -103.94 129.08 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 C--N 1.324 -0.52 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.309 -179.069 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -91.67 112.36 24.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.155 0.502 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.4 mt -66.64 -37.43 84.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.7 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.29 162.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.743 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.58 122.92 0.36 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.816 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.7 159.81 42.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.253 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -75.89 118.82 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.675 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.37 22.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.23 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.48 158.51 14.7 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -92.97 156.4 16.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.6 mtp -122.65 171.05 9.43 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.1 m -122.95 120.33 33.1 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.263 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -106.57 117.72 34.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.202 0.525 . . . . 0.0 110.337 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -123.45 118.21 26.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.521 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.68 -98.27 0.6 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.7 p -135.0 22.58 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.52 0.2 . . . . 0.0 111.074 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -124.37 130.76 53.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.802 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.15 124.46 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.7 p -124.03 118.21 26.88 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.09 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.5 148.38 66.64 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.541 1.494 . . . . 0.0 113.122 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.55 140.94 34.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.975 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -71.26 -7.37 46.51 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.947 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -70.01 78.52 0.49 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.24 133.76 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -162.7 10.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.216 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 tp -136.08 124.27 23.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.18 110.59 24.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -132.55 154.13 50.29 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.388 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.9 mt -119.42 136.5 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.918 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.47 130.99 33.43 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.509 0.506 . . . . 0.0 110.288 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -100.37 125.18 46.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.124 0.488 . . . . 0.0 109.986 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 p -84.78 172.17 11.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.575 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.54 -10.63 27.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.21 0.11 56.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.452 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t 70.66 21.32 5.38 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.148 0.499 . . . . 0.0 110.41 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.1 mt -99.28 123.67 43.75 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 57' ' ' ILE . 50.9 mm -81.17 122.2 35.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -99.01 114.56 27.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.719 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -96.54 109.08 21.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 142.99 51.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.229 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.71 116.53 28.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.458 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -106.42 133.25 51.4 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.04 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.489 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -72.03 -19.86 61.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.029 0.442 . . . . 0.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.2 m -60.09 -44.82 94.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.044 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -115.37 -15.49 11.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.74 20.31 79.77 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.08 146.78 27.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.62 102.32 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.187 0.518 . . . . 0.0 109.824 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.17 -38.26 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -126.63 144.91 50.75 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.087 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -157.78 101.56 1.81 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.246 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.2 mt -127.9 136.31 51.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.01 123.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 mm -110.77 131.6 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.234 0.54 . . . . 0.0 111.169 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -95.7 159.62 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.928 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.72 139.95 91.96 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.686 1.591 . . . . 0.0 111.23 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 61.68 11.2 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.334 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -88.25 -22.53 23.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.178 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.5 p -147.93 164.91 32.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.519 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -137.7 127.27 25.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.58 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -97.05 121.39 38.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -144.93 163.47 34.06 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.544 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 -88.41 157.03 18.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.225 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.95 88.78 10.51 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.45 60.97 8.03 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.995 1.797 . . . . 0.0 112.028 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -112.99 -48.87 2.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.136 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.22 102.2 54.64 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.165 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.64 130.75 16.32 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.435 1.424 . . . . 0.0 111.691 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 168.22 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.74 -179.06 33.32 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.01 109.68 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.91 127.58 75.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.301 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.62 152.35 43.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.03 140.48 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.21 122.49 40.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -109.34 110.08 21.14 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -73.62 105.1 4.8 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -60.99 -37.78 83.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.611 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.66 -20.49 17.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.633 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.82 140.8 15.14 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -83.78 52.84 2.37 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.169 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -140.22 144.32 36.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -130.94 138.45 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.181 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.5 mt -116.24 149.4 39.23 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.92 134.82 54.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.766 0.317 . . . . 0.0 111.133 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.93 155.97 47.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.326 0.584 . . . . 0.0 111.259 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -133.28 138.48 46.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.492 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.3 tpp -73.17 129.04 37.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.331 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -5.7 19.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.482 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.84 146.35 97.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.34 -25.82 15.12 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.091 1.861 . . . . 0.0 112.882 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -119.7 141.96 48.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.9 p -96.98 10.81 38.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.492 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.36 -20.43 59.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -125.92 6.75 7.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.423 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.63 -50.23 73.38 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.164 0.507 . . . . 0.0 110.769 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -65.22 -40.47 94.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.225 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.65 -44.64 96.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.89 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -64.59 -40.09 94.9 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.648 0.737 . . . . 0.0 109.498 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.0 m -64.2 -41.58 97.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.141 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -67.18 -41.79 85.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -64.97 -35.77 82.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.364 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.54 -48.26 87.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.111 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.15 -30.23 38.92 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.859 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -67.68 -37.92 83.0 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -81.03 -33.8 33.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.57 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.4 mt -77.79 -27.0 50.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -106.98 -23.3 12.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.386 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -140.08 67.74 33.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.132 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.68 160.86 46.96 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.997 2.465 . . . . 0.0 112.391 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.31 -1.496 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 -179.494 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -71.37 149.15 93.85 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.65 146.03 53.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.598 2.199 . . . . 0.0 112.675 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.74 161.78 62.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.94 149.82 81.77 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.554 2.17 . . . . 0.0 112.238 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.33 163.08 39.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.443 2.095 . . . . 0.0 112.151 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -74.74 156.79 86.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.52 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.86 147.09 83.3 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.62 162.57 41.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -86.22 137.79 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -115.72 127.64 55.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.92 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.39 121.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -81.45 85.21 6.51 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.078 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.296 179.714 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -58.76 159.33 6.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.7 pt -140.22 141.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.274 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -85.28 124.06 31.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.75 112.26 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -96.82 119.73 35.85 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.876 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.172 -178.836 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.955 0.407 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.62 113.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.271 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -85.8 131.96 34.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 25.9 mt -124.19 125.64 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.343 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.41 112.79 4.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 110.907 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.18 162.89 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.323 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -104.19 154.5 38.19 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.55 -37.22 95.31 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.947 1.765 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -79.56 -7.88 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.13 135.35 53.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.981 0.419 . . . . 0.0 110.865 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -78.25 161.58 27.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.76 -41.38 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.066 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.93 -36.17 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.083 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.02 -41.28 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.32 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.81 -42.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.468 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -60.81 -40.93 94.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.603 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -40.11 94.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.958 0.409 . . . . 0.0 110.478 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -60.21 -39.07 85.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.341 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.92 -39.07 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.165 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.7 -40.96 85.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.22 -41.92 72.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -66.09 -42.34 89.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.924 0.392 . . . . 0.0 112.039 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -136.83 154.98 50.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.992 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 57.07 3.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mm -109.8 106.26 58.12 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.81 153.41 56.78 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.707 1.605 . . . . 0.0 111.672 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.74 -39.56 76.52 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.015 1.81 . . . . 0.0 112.366 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -39.09 91.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 0.0 110.322 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -86.58 -6.48 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.204 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -88.24 77.43 8.25 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.978 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -84.11 107.81 16.67 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 mt -99.16 119.26 37.57 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.009 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -126.51 127.75 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.354 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -130.41 129.65 43.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.86 25.59 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.66 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.14 2.69 90.59 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -108.14 126.17 52.46 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 122.538 -0.39 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -72.08 133.58 45.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.209 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.23 102.91 6.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 110.287 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.22 139.96 42.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.946 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -61.56 137.08 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.241 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -17.37 55.64 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -83.4 -179.96 7.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.828 0.346 . . . . 0.0 110.359 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -127.32 165.41 19.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.0 -40.09 94.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.308 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -63.45 -27.6 69.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.007 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.53 -35.23 77.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 109.894 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.68 12.88 32.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.244 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.68 41.46 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.26 109.17 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.06 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.28 -176.08 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.504 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -66.05 148.14 52.27 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.34 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 58.21 41.11 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 42.8 m -93.68 125.07 38.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.258 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 41.7 m -75.76 128.83 36.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.831 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.64 152.05 33.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -101.83 112.62 25.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.91 128.61 53.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.448 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -124.46 136.12 61.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.151 0.501 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--N 1.332 -0.156 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.366 -179.309 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -62.26 160.0 13.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 pt -142.83 146.93 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -95.34 123.27 38.78 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.755 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 83.8 t -104.96 110.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.44 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -97.8 132.69 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.524 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -88.27 -178.32 5.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.081 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.92 -37.02 83.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.302 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.9 p -73.72 -9.6 58.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.71 -6.45 67.47 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.654 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -59.07 121.79 12.16 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -100.66 133.11 45.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.046 0.45 . . . . 0.0 110.902 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.76 108.44 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 129.47 34.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.092 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 66.9 mt -127.35 126.3 42.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.541 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.1 114.63 10.41 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.35 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.71 164.14 33.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.716 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -110.68 155.62 41.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.051 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.02 -36.59 96.26 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.087 1.858 . . . . 0.0 111.763 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -77.45 -10.06 59.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.046 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -57.76 137.2 56.78 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -78.84 160.97 27.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.3 -43.02 98.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.185 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -59.93 -34.51 73.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.257 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -64.92 -42.71 94.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.138 0.494 . . . . 0.0 110.71 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.36 -43.22 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.549 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.24 -38.85 88.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.56 87.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.059 0.457 . . . . 0.0 109.796 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -60.03 -37.18 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.85 -39.46 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.89 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.2 -45.27 93.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.512 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.82 -38.22 90.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.783 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -90.19 -4.4 57.26 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -148.1 -47.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 8.41 32.79 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -80.42 120.69 80.12 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.43 156.98 62.68 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.259 1.306 . . . . 0.0 111.419 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -51.85 -36.04 61.73 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.163 1.908 . . . . 0.0 112.429 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -67.37 -46.02 74.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.54 -40.32 95.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -98.68 151.03 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.37 0.605 . . . . 0.0 111.424 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -133.34 118.05 18.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.499 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 66.2 mt -86.15 122.29 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -125.19 130.24 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.745 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -153.45 156.22 37.77 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.32 19.03 9.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.719 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -6.74 74.22 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -126.79 149.76 49.49 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 110.598 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -73.71 137.07 43.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.474 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -83.53 112.2 19.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.841 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -75.23 175.93 7.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.734 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.28 162.89 21.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.454 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.17 -151.08 41.61 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 51.69 179.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.334 0.588 . . . . 0.0 111.462 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 71.8 p -131.69 170.31 14.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.68 -39.63 92.13 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.401 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -65.37 -27.36 68.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.01 -28.08 69.85 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.137 0.494 . . . . 0.0 110.067 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -103.49 14.73 30.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.326 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 57.02 39.46 29.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.597 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.2 mt -88.69 117.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.078 0.466 . . . . 0.0 110.136 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -101.18 176.51 5.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.387 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -60.43 150.74 30.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.902 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 60.11 14.87 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.185 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -63.47 136.39 57.56 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -95.38 107.13 19.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.93 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.34 155.81 17.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.254 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -106.69 124.12 49.14 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.76 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -99.89 92.88 5.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.36 129.81 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.011 -179.424 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.808 0.337 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -93.74 126.27 38.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.249 0.547 . . . . 0.0 109.913 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.99 -37.33 78.67 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.973 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.99 160.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.802 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -173.87 122.22 0.32 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -152.77 157.24 40.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -76.31 121.82 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.09 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.88 143.95 22.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.648 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.42 151.47 17.45 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -95.12 157.14 16.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.916 0.389 . . . . 0.0 110.974 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 43.0 mtp -121.84 172.77 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.1 m -122.44 122.43 38.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.211 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.7 tp -106.45 118.99 38.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.729 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -121.25 111.54 17.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.437 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -102.11 1.0 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.5 p -127.62 20.38 6.64 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.359 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.7 m -122.32 129.88 52.6 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.74 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.01 123.88 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.705 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 p -115.59 134.88 22.59 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.58 143.85 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.72 1.613 . . . . 0.0 112.305 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -106.57 131.49 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -72.35 -7.18 48.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.153 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -73.14 75.96 1.26 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -57.42 131.06 48.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.18 -160.25 10.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.523 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 tp -136.42 124.67 23.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.2 t -98.03 111.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.304 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -133.86 155.7 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.917 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.94 140.24 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.389 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -141.38 141.64 33.79 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.096 0.474 . . . . 0.0 110.136 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -106.1 127.58 53.29 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 p -88.48 172.46 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.477 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.53 -10.73 19.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.073 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.14 0.18 55.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.262 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t 68.46 21.76 8.07 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 110.482 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.2 mt -101.7 124.69 47.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 57' ' ' ILE . 50.9 mm -80.84 125.73 39.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -102.79 116.42 32.53 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.571 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -92.5 109.35 20.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.4 m -120.69 144.84 48.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.877 0.846 . . . . 0.0 112.904 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.98 114.08 18.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.183 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -107.53 131.31 54.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.295 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -73.03 131.98 42.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -72.51 -19.12 61.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 110.415 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -60.24 -45.07 94.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.15 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.8 p -116.0 -15.18 11.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 20.59 79.48 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -101.62 145.49 28.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.4 t -73.98 103.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.261 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -78.44 -31.55 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -126.77 145.89 50.44 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.641 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -157.53 98.73 1.7 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.332 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.9 mt -128.07 134.47 49.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.563 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.6 127.29 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.3 mm -113.77 123.55 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.905 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -90.33 163.23 32.04 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.114 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.62 140.66 90.65 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.072 1.848 . . . . 0.0 111.309 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 59.89 13.61 3.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.246 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -90.15 -32.34 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.502 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.4 m -134.95 152.37 51.67 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.331 0.586 . . . . 0.0 111.93 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.29 129.11 48.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.58 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.94 118.73 37.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -144.35 166.58 24.7 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.9 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -88.69 159.69 17.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.956 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 t -114.83 89.76 20.29 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.47 59.98 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.015 1.81 . . . . 0.0 111.972 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -47.43 2.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.8 t -114.27 99.33 50.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.96 130.03 16.13 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.559 1.506 . . . . 0.0 111.488 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.6 -35.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.682 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.37 176.67 36.13 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -81.12 113.82 19.55 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.916 0.389 . . . . 0.0 110.783 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.97 125.16 67.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.969 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.79 152.34 35.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.307 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 p -131.23 135.95 58.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.0 110.125 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.6 tp -102.53 118.11 36.16 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -113.83 132.6 55.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.616 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -85.17 116.07 23.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.244 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.48 -37.1 82.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.03 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.19 -24.13 8.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.104 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.13 72.14 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 p 81.57 -6.11 1.52 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 124.128 0.546 . . . . 0.0 110.721 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -79.7 148.19 31.66 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.259 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -133.76 133.43 41.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.795 0.331 . . . . 0.0 110.479 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.7 mt -121.74 152.8 39.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.033 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.05 137.69 54.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.912 0.386 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.98 159.93 41.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -136.99 139.83 41.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.013 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.13 131.04 49.85 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 111.282 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.42 0.89 10.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.73 147.82 81.68 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.27 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.77 -40.07 67.14 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.814 1.676 . . . . 0.0 112.299 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.92 144.54 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.7 p -100.28 12.01 38.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.633 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -55.76 -20.76 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.965 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -124.06 17.48 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.702 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.54 -45.48 93.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -71.63 -34.82 70.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.432 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -44.43 88.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -64.14 -39.78 94.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.8 -46.03 91.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.749 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -65.64 -43.15 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.262 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -62.72 -39.82 95.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.544 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.51 -47.77 89.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.408 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -79.87 -24.93 40.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.936 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -69.59 -42.38 74.54 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.866 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -79.0 -35.45 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.674 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.34 -36.05 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -98.84 -27.79 13.76 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.497 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -132.89 76.25 70.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.353 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.58 155.57 36.09 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.819 2.346 . . . . 0.0 112.037 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.492 1.429 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 -179.406 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.62 149.24 90.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.12 148.04 38.97 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.29 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -73.89 151.7 88.72 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.35 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.97 156.44 47.7 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.021 . . . . 0.0 112.372 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.71 -169.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.439 2.093 . . . . 0.0 112.023 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.09 157.24 77.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 140.01 82.59 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.42 2.08 . . . . 0.0 112.338 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -157.59 164.73 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.621 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -86.32 136.73 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -118.05 129.7 55.72 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.723 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.19 132.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.15 84.64 0.74 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.326 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.472 179.578 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -64.23 161.48 16.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.489 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -142.1 145.22 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.045 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -87.87 122.77 31.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.826 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.86 108.73 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.169 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -89.63 124.23 34.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.651 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.347 -179.921 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.834 0.35 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 111.94 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.496 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 37.4 m -83.05 129.77 35.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.691 -0.404 . . . . 0.0 109.911 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.56 131.76 53.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.57 114.14 10.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.941 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -136.1 165.43 29.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -107.13 152.36 41.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.1 -37.43 94.04 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.054 1.836 . . . . 0.0 112.096 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -82.27 -8.34 59.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.237 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -58.39 137.35 57.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 50.0 p -79.08 163.52 25.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.88 -37.39 80.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.804 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -43.4 90.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.46 -41.9 99.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.025 0.44 . . . . 0.0 110.81 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.18 -43.07 98.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.812 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.89 -39.48 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.71 91.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.058 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.61 -40.08 90.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.18 -40.39 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.111 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.96 -44.31 94.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.201 0.524 . . . . 0.0 110.206 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -74.24 -17.86 60.82 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -101.02 -4.62 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -149.56 -46.01 0.14 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 110.456 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 3.26 26.62 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.072 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . 0.428 HD13 HG22 ' C' ' 36' ' ' ILE . 32.7 mm -65.99 117.22 40.3 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.863 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.39 150.17 86.21 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.108 1.872 . . . . 0.0 112.089 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.88 -38.05 67.54 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.996 1.798 . . . . 0.0 112.482 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.26 -40.22 96.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.819 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.44 -4.61 59.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -84.68 103.1 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.53 103.2 12.46 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.0 mt -100.34 119.91 39.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -127.46 128.22 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.138 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -129.33 126.75 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 110.798 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.03 27.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.727 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.86 2.08 89.99 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -106.38 117.59 34.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -69.28 127.78 34.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.82 98.17 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.121 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.07 146.58 47.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.136 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.03 137.7 58.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.482 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.96 -17.0 57.86 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -83.44 175.27 9.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.706 0.289 . . . . 0.0 110.263 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -121.58 164.61 16.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.68 -40.14 96.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.469 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.0 p -64.1 -26.26 68.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.989 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.864 0.364 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -104.02 14.03 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.346 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 57.06 40.2 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.401 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -90.66 107.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.157 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.81 -173.48 3.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.285 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -67.0 150.2 49.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.059 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 55.44 39.86 31.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.024 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -93.46 126.64 38.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.097 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 43.8 m -76.18 129.18 36.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.157 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.11 146.55 45.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.395 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.33 112.58 24.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.551 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.3 tp -104.46 121.57 43.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.666 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -121.51 138.06 53.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.893 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 22.7 mt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.114 -178.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -62.65 161.57 12.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.093 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.7 pt -139.55 139.32 38.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.013 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -83.4 121.38 27.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.465 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -110.26 98.76 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -84.59 123.81 30.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 110.917 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 80.9 p -86.66 173.45 9.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.981 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 70.6 mt -63.14 -24.67 68.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -71.89 -14.78 62.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.68 -15.54 59.64 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -70.92 141.8 51.12 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 95.6 m -104.88 132.61 50.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.083 0.468 . . . . 0.0 110.96 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.67 101.52 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.174 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -83.53 122.7 28.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 79.2 mt -121.98 129.13 52.22 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.823 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.59 115.49 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.654 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.93 177.07 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.614 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.99 156.22 69.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.392 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.27 -43.55 54.95 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.935 1.757 . . . . 0.0 112.073 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 82.7 p -72.35 -14.66 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -57.8 138.82 55.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.963 0.411 . . . . 0.0 110.638 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -80.97 161.66 24.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.785 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.7 mm -64.24 -41.29 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.081 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -58.3 -35.78 72.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.322 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -65.14 -43.48 91.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.483 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.41 -41.81 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.168 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -60.55 -39.03 86.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.227 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.4 90.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 0.0 110.136 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -60.44 -39.08 86.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.81 -40.75 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.096 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.06 -41.38 92.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.23 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.59 -41.4 97.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -78.38 -76.73 0.18 Allowed 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.779 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.58 152.9 24.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.86 53.02 4.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mm -107.92 113.9 60.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.967 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.61 155.78 62.46 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.94 1.76 . . . . 0.0 112.147 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.72 -27.05 49.96 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.337 2.025 . . . . 0.0 112.603 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -83.36 -1.66 53.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.447 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -114.47 -49.18 2.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.557 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.12 128.1 35.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.037 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mmt-85 -126.99 102.51 7.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.13 125.55 29.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -130.59 130.76 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -151.77 155.29 37.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.23 21.6 5.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 0.04 85.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -136.08 149.74 48.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.505 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -68.48 148.28 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.473 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -83.01 117.11 22.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.691 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -76.12 137.99 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.1 142.81 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 0.0 110.345 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.98 -15.84 62.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -83.11 163.8 20.65 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.699 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -104.77 171.09 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.222 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 mp -71.27 -38.81 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.071 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -62.77 -25.82 68.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.54 -37.73 87.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.113 0.482 . . . . 0.0 110.374 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.19 11.3 34.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.274 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 56.14 40.19 30.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 110.435 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -85.56 109.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -94.22 178.1 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.673 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.25 146.09 49.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 63.61 14.71 8.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.331 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -63.37 135.11 56.76 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -91.1 121.97 33.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.93 0.395 . . . . 0.0 110.313 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.07 144.85 45.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.333 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -90.48 129.75 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.515 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tt -104.24 101.53 11.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.798 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.74 132.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 C--N 1.326 -0.442 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.628 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm . . . . . 0 C--O 1.237 0.421 0 CA-C-O 120.998 0.427 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.17 115.26 27.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.87 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' ILE . 98.0 mt -66.81 -36.7 82.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.361 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -151.22 163.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.419 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.77 122.84 0.34 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.224 0.535 . . . . 0.0 110.988 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -156.21 159.54 39.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.034 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -77.9 118.79 20.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.636 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.45 139.87 20.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.955 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.17 151.53 17.55 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -88.06 154.77 20.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.968 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.6 mtp -122.33 171.75 8.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -121.94 125.84 47.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.472 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.5 tp -107.29 119.2 38.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.443 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -119.11 107.83 13.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.805 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 -94.28 0.63 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.0 p -133.98 21.54 3.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.459 0.171 . . . . 0.0 110.79 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.8 m -124.46 131.23 53.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.41 125.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.107 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.7 p -119.8 138.07 26.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.623 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.55 142.84 29.9 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.84 1.693 . . . . 0.0 112.405 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.66 135.73 44.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.614 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.84 -6.78 47.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.934 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -77.72 62.2 2.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -56.02 133.8 52.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.62 -152.08 7.81 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tp -138.2 125.01 21.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.67 107.02 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -131.08 152.72 50.08 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.791 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.4 mt -120.57 140.52 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -140.66 143.49 35.16 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.624 0.577 . . . . 0.0 109.831 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -107.23 127.44 53.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.309 0.576 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 p -86.58 172.1 10.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.952 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -11.34 22.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.662 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.52 3.45 47.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.46 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.6 m 64.79 22.89 12.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.154 0.502 . . . . 0.0 111.065 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.9 mt -102.5 126.08 49.43 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.424 HG21 HD12 ' A' ' 57' ' ' ILE . 46.7 mm -80.56 126.87 39.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -103.78 117.74 35.07 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.489 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -94.34 107.97 19.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.9 m -120.87 144.04 48.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.708 0.766 . . . . 0.0 112.681 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -125.09 112.09 16.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.616 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -105.34 133.09 50.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.345 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.51 138.55 47.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.053 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.8 -18.55 50.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.607 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.4 m -60.53 -45.79 92.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.5 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.6 m -116.84 -13.93 10.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.5 23.66 76.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -102.56 144.15 31.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.383 . . . . 0.0 110.987 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.7 t -73.79 108.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -89.56 -25.97 21.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.751 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -127.76 143.4 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.566 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -158.11 94.62 1.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.544 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.6 mt -126.43 134.19 51.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.822 0.344 . . . . 0.0 110.872 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.3 mt -77.23 127.15 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.306 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.2 mm -111.53 121.79 64.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.746 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -94.77 163.48 22.26 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.055 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.04 137.85 77.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.0 1.8 . . . . 0.0 111.755 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.34 12.44 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.584 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -89.85 -34.01 16.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 120.764 0.316 . . . . 0.0 110.428 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -141.52 145.44 35.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.103 0.478 . . . . 0.0 111.341 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -123.95 131.97 53.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.344 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.8 118.43 36.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -142.61 167.31 22.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.084 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -89.74 160.63 16.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 t -113.75 89.25 15.49 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.381 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.67 60.35 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.946 1.764 . . . . 0.0 111.642 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -114.85 -39.88 3.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.118 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.1 t -121.21 87.95 44.88 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.237 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.14 130.72 24.87 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.656 1.571 . . . . 0.0 111.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 168.81 -40.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.67 -149.04 5.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.286 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.48 105.79 12.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.347 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.2 t -121.66 126.62 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.704 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.61 154.02 33.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.06 133.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.126 0.489 . . . . 0.0 110.283 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.2 tp -102.92 122.88 45.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -119.73 133.52 55.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.032 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.61 115.09 25.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.87 -32.65 72.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.507 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.24 -23.7 9.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.967 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.91 -25.84 68.35 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.997 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.81 7.3 5.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -96.54 148.75 22.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.857 0.36 . . . . 0.0 110.732 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -129.37 133.15 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.918 0.389 . . . . 0.0 110.601 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.9 mt -120.42 148.0 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.711 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.6 136.74 54.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.769 0.319 . . . . 0.0 111.394 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.02 154.07 48.19 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.378 0.609 . . . . 0.0 111.554 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -130.45 135.8 48.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.351 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 141.81 50.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.256 0.55 . . . . 0.0 110.925 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.62 2.94 4.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.463 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -77.08 155.22 82.58 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.104 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.52 -41.67 38.6 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.251 1.967 . . . . 0.0 113.162 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.89 146.87 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.91 -1.76 56.43 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.46 -18.37 28.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -117.02 -17.67 10.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.695 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.24 -41.21 96.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.819 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.03 -40.66 96.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.03 0.443 . . . . 0.0 111.167 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.32 -40.04 85.91 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.253 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -61.33 -39.73 91.61 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.59 -45.78 92.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.367 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -64.98 -41.59 95.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.383 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -66.47 -37.05 84.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.45 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.19 -48.35 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.248 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -78.24 -27.28 47.59 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.008 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.7 -37.61 76.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.885 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -80.99 -31.55 34.67 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.804 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.7 mt -81.58 -27.11 34.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -104.83 -27.66 11.61 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.243 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -133.83 73.2 71.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.76 152.52 62.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.935 2.423 . . . . 0.0 112.345 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 122.384 2.056 . . . . 0.0 112.025 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -128.46 153.42 79.24 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.597 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.64 150.0 68.36 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.374 2.049 . . . . 0.0 112.299 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.46 153.66 91.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.81 161.82 44.73 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.345 2.03 . . . . 0.0 112.301 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.2 -170.26 0.48 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.881 2.388 . . . . 0.0 111.816 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -116.67 158.71 42.87 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.553 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.14 142.66 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.564 2.176 . . . . 0.0 112.105 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.48 165.58 36.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.69 139.57 31.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.37 122.21 37.07 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.821 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 64.3 mt -131.88 122.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.597 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -67.61 83.92 0.18 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.584 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 31.2 t0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.59 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -151.29 170.54 19.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.127 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.41 147.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.861 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.75 111.96 24.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -93.47 110.86 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.357 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.83 122.1 31.06 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.086 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 58.1 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 83.3 m . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.712 0.291 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.62 111.08 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.759 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.33 128.8 34.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.705 0.288 . . . . 0.0 110.265 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -125.66 133.86 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.15 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.99 120.63 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.972 0.415 . . . . 0.0 110.293 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.49 177.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.965 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -122.71 155.19 63.5 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.327 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.63 -27.61 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.945 . . . . 0.0 112.312 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -91.83 -9.84 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.516 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -60.69 141.18 57.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.815 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -79.09 160.21 27.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.49 -37.65 80.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.34 -41.99 85.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.017 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.14 -40.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 110.185 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.04 -42.87 96.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.798 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -60.01 -39.73 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.97 93.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.497 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -60.35 -39.09 85.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.227 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.69 -37.99 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.071 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.09 -38.85 80.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.071 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.31 -50.35 47.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -63.28 -40.85 98.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.682 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -133.21 148.9 52.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.174 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.02 59.57 2.67 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . 0.408 HG22 HD12 ' C' ' 36' ' ' ILE . 28.9 mm -111.16 103.69 55.22 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.81 150.61 70.11 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.227 1.952 . . . . 0.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.61 -37.97 54.19 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.174 1.916 . . . . 0.0 112.278 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.76 -38.58 91.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.556 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.84 -2.88 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.189 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -89.44 94.14 9.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.07 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.29 109.47 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 33.9 mt -104.11 119.98 40.12 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.622 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.86 120.55 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.228 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -66.87 -46.68 74.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.55 79.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.936 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.88 88.86 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -126.69 126.63 43.83 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.961 0.41 . . . . 0.0 110.733 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -76.75 146.09 38.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.36 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 59.8 mt -95.7 112.64 24.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.611 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.07 148.35 36.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.17 -40.15 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.105 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.67 -12.05 66.61 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 166.48 13.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.079 0.466 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 77.6 p -117.42 165.67 13.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.191 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -60.92 -40.53 93.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.905 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -64.36 -23.92 67.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.891 0.377 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.41 -34.53 75.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -99.88 16.95 22.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.036 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 57.28 37.59 28.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -84.79 117.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.19 -176.56 3.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.676 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.53 145.3 33.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.906 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 60.56 25.73 15.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.393 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -73.93 124.06 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.037 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -85.83 128.1 34.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.5 149.89 40.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.49 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -94.19 119.47 33.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.83 124.15 49.1 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.281 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.41 133.06 69.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--N 1.334 -0.099 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -178.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.04 161.67 18.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -142.07 139.82 30.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.364 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -83.27 122.86 28.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -106.52 109.19 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.318 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -80.0 114.99 19.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.843 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 59.9 p -70.66 176.29 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -26.16 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -108.46 -175.96 2.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.906 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.58 -20.66 59.47 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -53.77 133.38 42.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 110.494 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -124.2 137.39 54.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.54 112.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.404 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 28.8 m -84.11 127.2 33.76 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.296 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 87.4 mt -120.86 130.7 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.572 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.87 115.22 10.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 m -135.61 164.32 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.66 153.71 39.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.453 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -37.01 91.43 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.236 1.957 . . . . 0.0 112.026 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.1 p -82.26 -7.4 59.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.185 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.73 136.51 58.02 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.915 0.388 . . . . 0.0 110.904 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -80.04 162.88 24.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.761 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.06 -37.67 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.614 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.35 -43.22 92.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.274 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.24 -40.4 96.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.184 0.516 . . . . 0.0 110.59 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.94 -42.39 96.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.469 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -60.25 -39.81 88.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.115 0.484 . . . . 0.0 110.362 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -39.71 91.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.332 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -60.48 -38.79 85.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.37 -41.05 91.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.035 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.5 -40.36 96.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -78.03 -64.81 1.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.286 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -97.81 161.25 13.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.235 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.99 53.68 3.77 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.8 mm -109.28 107.56 59.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.63 150.94 69.66 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.081 1.854 . . . . 0.0 112.03 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.27 -20.63 8.35 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.297 1.998 . . . . 0.0 112.612 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -92.75 19.85 7.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.606 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -152.49 26.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.624 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.86 95.86 5.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.415 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -96.19 100.17 11.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.672 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.66 122.33 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.28 131.48 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.546 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -153.25 157.55 40.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.772 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.68 18.89 7.47 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.796 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.27 -5.9 78.43 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -130.94 149.11 52.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.562 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.79 140.53 57.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.37 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 69.2 mt -81.68 123.51 28.78 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.621 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.67 139.39 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.177 0.513 . . . . 0.0 110.612 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -63.41 138.99 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.316 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.89 -12.52 64.12 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -80.22 172.07 14.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -115.29 157.53 23.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.226 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.99 -40.82 96.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.542 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -63.33 -24.14 67.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.456 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -62.54 -37.66 86.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.117 0.484 . . . . 0.0 110.424 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -98.68 14.64 27.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 m120 56.46 38.77 29.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.454 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.87 104.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.91 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.56 179.05 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.39 151.64 27.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 57.87 42.09 23.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.967 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -90.22 122.73 33.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.268 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -79.69 85.68 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.045 0.45 . . . . 0.0 110.589 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.19 154.36 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.891 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -102.64 122.67 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.256 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -104.59 121.49 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.225 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -115.62 132.34 65.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.009 -178.837 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.847 0.356 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -85.44 127.12 34.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.287 0.565 . . . . 0.0 110.293 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 86.3 mt -67.53 -36.17 80.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.88 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.74 161.71 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.01 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.99 122.47 0.31 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.165 0.507 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.36 156.16 34.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.857 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.62 119.2 18.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.474 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.86 144.86 25.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.222 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.75 149.12 16.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -91.98 163.47 13.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.3 mtp -124.9 175.96 6.95 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -121.62 121.22 36.9 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.354 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.4 tp -107.68 117.93 35.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.58 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -121.14 114.41 21.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.986 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 -86.68 0.56 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -146.46 22.16 1.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.558 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.3 m -124.36 129.5 50.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.431 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.2 t -106.33 121.63 59.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.957 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.4 m -116.05 122.52 32.24 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.515 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -55.41 142.31 80.35 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.178 1.919 . . . . 0.0 112.23 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -108.13 132.66 53.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.879 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -70.63 -6.69 38.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.153 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -72.37 73.17 0.98 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -59.67 135.17 57.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.713 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.15 -154.99 7.02 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -140.64 124.93 17.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.34 108.27 21.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.84 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -131.24 153.23 49.73 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.661 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 94.9 mt -121.17 141.21 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.933 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -141.86 140.73 32.98 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.786 0.679 . . . . 0.0 110.269 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -104.35 128.82 52.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.08 0.467 . . . . 0.0 110.399 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 p -88.09 172.74 9.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.673 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.72 -10.37 19.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -86.15 -0.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.343 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t 69.4 19.65 7.56 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.05 0.452 . . . . 0.0 110.698 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.1 mt -103.34 126.95 50.77 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 57' ' ' ILE . 45.5 mm -79.26 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.485 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -104.95 116.65 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.691 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -92.81 107.25 19.07 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 94.9 m -118.53 144.79 45.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.653 0.739 . . . . 0.0 112.805 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -125.76 111.18 14.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.745 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -103.3 136.29 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.989 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -76.12 139.58 41.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -79.17 -18.97 52.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.614 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -61.08 -46.29 91.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -117.04 -12.47 10.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.328 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.95 77.16 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.78 147.66 26.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.32 . . . . 0.0 111.028 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.5 103.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.103 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -83.15 -28.74 29.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.28 143.46 51.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.057 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -158.11 99.98 1.68 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.769 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -132.09 130.13 40.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.0 mt -74.32 129.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 mm -117.26 120.24 64.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -86.02 163.55 42.67 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.191 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.8 136.27 75.39 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.023 1.815 . . . . 0.0 111.525 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t0 61.4 12.06 4.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.44 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.85 -25.32 30.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.889 -0.142 . . . . 0.0 110.778 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.2 p -147.04 169.17 19.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.253 0.549 . . . . 0.0 110.672 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.93 132.42 30.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.448 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -102.29 117.77 35.47 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -141.74 164.8 29.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.072 0.463 . . . . 0.0 111.461 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -83.81 160.71 21.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.383 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.7 88.43 20.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.45 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.96 59.86 7.64 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.298 1.999 . . . . 0.0 112.038 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -48.83 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.42 102.77 54.79 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.828 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.73 129.6 14.72 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 121.516 1.478 . . . . 0.0 111.478 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 p 167.46 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.7 0.625 . . . . 0.0 110.416 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.35 -179.26 33.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -88.09 114.7 24.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.655 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.12 129.81 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.199 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -119.83 157.3 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 p -134.21 136.94 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.5 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.6 tp -102.55 121.79 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -118.53 134.37 55.14 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.242 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -85.75 114.16 22.49 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -37.13 84.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.8 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.06 -22.52 22.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.454 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.44 -169.78 20.39 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.6 p -121.42 13.2 10.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.626 0.251 . . . . 0.0 110.572 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -85.87 142.6 28.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.847 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -135.33 129.22 33.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.314 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.2 mt -112.48 150.7 30.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.889 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -123.65 135.62 54.02 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.654 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -137.49 152.1 49.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.26 0.552 . . . . 0.0 111.425 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -128.87 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.475 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.25 134.62 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.83 -6.53 11.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.363 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -75.06 150.57 85.76 Favored Pre-proline 0 C--O 1.231 0.119 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.703 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.38 -40.41 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.022 1.814 . . . . 0.0 112.393 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.93 147.67 45.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.8 p -95.99 8.53 43.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.234 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.38 -20.43 43.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -121.45 -15.71 7.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.823 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.79 -40.04 93.81 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.663 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.02 -40.98 99.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.14 -40.02 86.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.174 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -60.57 -39.67 88.84 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.1 m -62.05 -41.98 98.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.718 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -66.83 -40.91 88.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.192 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -67.22 -36.72 82.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.32 -48.49 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.083 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -78.56 -25.49 45.4 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.026 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.22 -37.68 75.09 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.452 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -82.05 -31.7 30.77 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.727 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.4 mt -81.33 -20.67 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.038 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -114.97 -18.23 11.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.279 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -146.42 73.83 12.84 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.848 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 161.28 43.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.771 2.314 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.718 2.279 . . . . 0.0 112.145 -179.638 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -71.38 152.97 94.12 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.21 147.23 65.98 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.497 2.131 . . . . 0.0 111.944 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.02 154.74 77.65 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.11 150.2 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.228 1.952 . . . . 0.0 112.46 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.99 -153.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.503 2.135 . . . . 0.0 111.581 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -129.5 158.86 72.04 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.526 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.45 140.42 89.04 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.71 2.273 . . . . 0.0 111.974 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -155.69 165.6 36.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.07 138.08 32.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.864 0.364 . . . . 0.0 110.62 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -122.31 123.51 41.57 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.815 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 122.43 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -72.53 84.09 1.12 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.106 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 38.4 t0 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.797 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -62.23 157.69 18.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.794 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.73 142.04 35.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.302 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.48 125.22 32.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.561 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 62.5 t -113.44 118.32 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.848 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -90.19 121.17 31.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.205 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.867 179.85 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.964 0.411 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.04 105.5 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.422 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -73.09 128.83 36.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -120.5 124.53 45.61 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.889 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.81 108.91 2.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.062 0.458 . . . . 0.0 111.071 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.45 167.58 26.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.12 154.81 46.12 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.93 -29.12 80.93 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.701 . . . . 0.0 111.73 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.5 p -85.27 -12.82 51.54 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.856 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -64.89 142.95 58.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.021 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -83.86 164.14 19.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.491 0.662 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.9 -34.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.34 -43.44 88.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -63.01 -40.8 98.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 110.467 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.72 -42.94 97.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -62.05 -39.63 93.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.194 0.521 . . . . 0.0 110.329 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.06 89.5 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.824 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -60.11 -37.97 81.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 8.4 mm -63.41 -39.63 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.595 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -59.46 -46.75 87.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -62.09 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.772 -0.58 . . . . 0.0 111.136 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.27 -26.16 61.89 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -137.16 -53.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.238 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.0 10.35 8.28 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 62.7 mt -76.14 122.11 86.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.37 160.64 48.09 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.395 1.397 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.69 -39.89 88.46 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.538 2.159 . . . . 0.0 112.828 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.94 -37.06 83.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.246 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.24 21.53 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.725 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -109.73 -46.55 3.49 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.208 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 35.37 77.86 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.033 0.833 . . . . 0.0 110.862 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.53 132.58 35.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -130.05 130.83 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.503 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.73 129.22 43.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.46 26.36 15.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.56 90.53 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -104.49 126.65 51.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.933 0.366 . . . . 0.0 110.02 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.72 132.66 46.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 68.6 mt -81.71 97.74 8.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 110.31 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.03 139.13 42.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.8 135.87 57.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.263 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.55 -18.65 52.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -81.92 157.15 24.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.683 0.278 . . . . 0.0 110.304 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -99.69 162.21 13.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.065 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.75 -39.07 90.31 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.28 -22.6 66.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.01 -38.69 89.6 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.2 14.53 25.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 57.05 39.86 28.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.023 0.439 . . . . 0.0 110.335 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.96 117.77 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.033 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -102.58 -170.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.351 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -69.72 152.47 44.62 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.545 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 51.59 39.1 24.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.452 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -90.63 125.03 35.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 49.6 m -75.94 130.16 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.249 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.05 156.17 30.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -105.21 121.49 43.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.448 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.54 118.34 35.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.108 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.07 127.12 65.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.243 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.551 -179.002 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.84 161.37 18.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.229 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 pt -139.75 143.32 30.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.131 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -88.65 119.56 29.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -102.34 108.12 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.11 120.93 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.378 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -80.91 172.52 13.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.083 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.15 -37.77 84.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.031 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.12 -8.51 55.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.809 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.42 8.12 60.05 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -81.03 113.67 19.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.849 0.356 . . . . 0.0 110.158 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -86.14 134.2 33.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.685 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -129.59 106.7 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.398 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -79.65 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -123.77 124.02 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.661 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.04 114.5 7.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.895 0.379 . . . . 0.0 110.25 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 25.9 m -136.24 163.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.492 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -109.43 154.72 42.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.097 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.68 -28.62 86.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.79 1.66 . . . . 0.0 111.728 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 62.7 m -86.27 -10.17 55.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.707 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.7 144.4 57.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.529 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -79.12 162.6 25.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.022 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.33 -39.23 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.927 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.2 -41.46 88.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.091 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.79 -41.01 97.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.117 0.484 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.79 -43.98 99.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.789 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -61.06 -39.73 90.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.472 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.09 92.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.45 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.01 -40.71 90.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.05 -41.35 91.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.179 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.95 -40.36 88.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.515 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.94 6.98 7.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -114.39 -52.75 2.7 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.635 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -107.42 -0.79 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 18.58 78.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mm -80.25 119.23 75.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.09 154.25 52.31 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.921 1.747 . . . . 0.0 111.822 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.29 -40.01 79.2 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.314 2.009 . . . . 0.0 112.263 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.96 -39.25 91.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.546 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.69 32.2 2.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -136.9 120.14 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -124.48 114.11 19.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 mt -96.05 128.63 43.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.67 129.48 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.542 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -147.65 152.51 37.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.22 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.81 15.65 8.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.679 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.17 -15.33 58.47 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -113.78 146.52 39.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.354 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -71.35 139.23 49.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.255 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 7.7 mp -88.91 114.39 25.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.808 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -74.89 -169.12 0.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.672 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.48 -146.2 44.13 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 50.56 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.593 . . . . 0.0 111.446 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -132.6 168.43 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.236 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 79.2 mt -61.83 -39.68 92.66 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.552 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -64.98 -26.82 68.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.72 -31.12 71.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.059 0.457 . . . . 0.0 109.897 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -101.31 13.15 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.51 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.46 40.04 29.75 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.374 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -89.46 107.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.012 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.38 -177.16 4.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.423 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.93 150.56 49.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.993 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 60.44 45.97 10.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 57.5 m -94.87 123.7 38.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 31.5 m -77.77 80.23 4.23 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.179 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -71.06 140.18 50.64 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.209 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -93.89 122.96 36.91 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.259 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 40.3 tp -102.59 120.26 40.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.542 . . . . 0.0 110.26 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 91.6 t -111.9 130.87 64.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.596 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 54.8 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.86 -179.065 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 pttt . . . . . 0 C--O 1.238 0.484 0 CA-C-O 121.038 0.447 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -97.61 116.25 29.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.408 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.7 mt -67.13 -37.3 83.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.771 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -150.17 161.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.821 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -173.22 122.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.182 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.44 157.17 38.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.599 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.83 123.41 25.61 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.607 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.43 146.45 23.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.06 153.63 16.91 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -89.06 174.87 7.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.029 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.0 mtp -139.72 172.69 12.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.585 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.51 127.16 49.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.4 tp -107.58 117.19 33.45 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.49 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -120.6 111.84 18.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.813 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.17 -86.21 0.49 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -145.59 20.66 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 0.0 110.792 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.5 m -122.2 130.64 53.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.941 0.401 . . . . 0.0 110.467 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.07 123.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.1 p -112.89 133.34 21.99 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 147.32 54.51 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.871 1.714 . . . . 0.0 113.055 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -101.5 117.21 34.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.85 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -59.42 -14.6 12.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.03 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -71.78 82.83 0.89 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -59.11 136.85 58.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.102 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.12 -159.64 9.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.971 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tp -138.35 125.17 21.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.36 111.58 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -134.64 154.59 51.44 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.241 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 98.0 mt -121.11 138.03 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.14 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.42 133.62 34.95 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 123.675 0.609 . . . . 0.0 110.168 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -102.18 126.37 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.031 0.443 . . . . 0.0 110.536 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.4 p -85.72 171.48 11.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.692 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.67 -10.69 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.78 0.41 56.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.631 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t 70.78 21.04 5.34 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.171 0.51 . . . . 0.0 110.314 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.1 mt -98.54 121.7 40.81 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 57' ' ' ILE . 50.0 mm -80.5 122.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -98.92 115.64 29.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.719 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -98.59 107.83 20.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.91 143.12 51.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.551 -0.859 . . . . 0.0 112.941 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -116.95 117.19 29.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.298 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -106.72 146.05 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.355 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.9 128.49 34.58 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.41 -27.72 64.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -58.26 -36.75 73.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.853 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.9 m -116.75 -16.98 10.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.998 0.428 . . . . 0.0 110.241 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.4 21.87 79.18 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -102.4 151.1 22.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.24 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.51 102.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.5 -38.05 62.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.228 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -126.63 145.79 50.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.251 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -157.47 101.58 1.86 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.184 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.5 mt -128.34 136.73 51.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.881 0.372 . . . . 0.0 110.72 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.3 123.61 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.417 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.2 mm -108.75 123.77 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.318 0.58 . . . . 0.0 111.466 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -91.48 162.47 31.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.126 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.63 138.02 79.76 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.21 1.94 . . . . 0.0 111.778 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.1 11.81 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.452 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.37 -36.84 18.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.752 0.311 . . . . 0.0 110.492 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.41 145.12 36.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.506 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -121.73 135.24 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.616 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -106.29 120.24 41.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -143.06 166.82 23.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.831 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -84.34 160.13 20.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.087 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.23 89.74 12.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -79.84 60.12 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.799 1.666 . . . . 0.0 112.29 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -114.07 -37.45 4.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.343 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.5 t -130.51 82.77 64.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.05 130.89 26.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.791 1.661 . . . . 0.0 111.477 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p 170.25 -38.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.38 -150.09 5.48 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.47 105.85 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.777 0.323 . . . . 0.0 110.429 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.87 128.23 71.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 110.783 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.31 156.35 40.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.56 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.15 136.07 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.514 . . . . 0.0 110.232 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.56 123.36 47.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -118.08 137.7 52.75 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.081 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -91.94 108.44 19.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.359 0.599 . . . . 0.0 110.056 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.8 -38.26 87.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.694 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.61 -22.38 24.78 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.33 -177.96 30.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -121.03 30.17 6.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.76 155.82 42.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.198 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -136.75 148.25 47.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.632 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.7 mt -122.97 152.81 40.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.866 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.22 136.86 53.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.553 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.87 156.31 47.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.185 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -130.26 137.78 50.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.587 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttm -72.72 133.4 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.17 0.509 . . . . 0.0 111.887 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 4.74 21.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.437 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -71.95 139.58 82.79 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.03 -26.83 42.97 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.845 1.697 . . . . 0.0 112.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.63 141.8 48.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.471 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -98.13 10.87 39.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.588 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -54.28 -21.61 9.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -130.02 16.52 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.1 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -62.17 -47.68 83.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.2 0.524 . . . . 0.0 110.253 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -74.49 -32.98 62.73 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.461 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.04 -46.54 83.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.531 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -63.87 -40.83 97.47 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.601 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.91 -45.37 94.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.804 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -64.72 -43.85 92.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.453 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.19 -36.28 83.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.881 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.83 -48.33 86.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.077 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -77.69 -29.56 51.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.741 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.61 -36.68 76.4 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.618 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -80.02 -31.42 39.61 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.754 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.0 mt -82.45 -27.67 31.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -103.23 -27.46 12.49 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.0 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -133.23 73.75 73.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.084 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.38 156.66 34.62 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.119 2.546 . . . . 0.0 112.034 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.492 1.426 0 C-N-CA 122.486 2.124 . . . . 0.0 112.148 -179.456 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -129.56 152.02 78.97 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.83 146.94 26.83 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.68 2.253 . . . . 0.0 112.149 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.53 153.62 87.65 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.68 158.63 55.22 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.251 1.967 . . . . 0.0 112.021 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.24 -171.81 0.77 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.726 2.284 . . . . 0.0 112.056 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -119.06 159.15 46.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.04 141.91 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.503 2.136 . . . . 0.0 112.324 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.52 162.14 41.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.671 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -87.25 136.82 32.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.621 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -120.88 125.72 48.19 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.67 123.14 54.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.588 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -82.06 83.73 7.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.899 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.2 t0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.298 179.494 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.96 157.47 18.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.203 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -139.66 144.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -88.93 123.34 33.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.127 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 80.5 t -109.02 105.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -85.77 127.65 34.59 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.72 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 -179.624 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.793 0.33 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.12 109.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.653 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.9 m -84.16 132.97 34.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.271 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.0 mt -126.56 126.9 44.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.5 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.02 108.39 2.6 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 110.866 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.47 164.03 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.122 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.89 155.05 38.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.312 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.22 -33.92 92.04 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.056 1.837 . . . . 0.0 111.984 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -85.21 -3.91 58.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.152 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.12 136.87 58.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.857 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -79.07 160.53 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.29 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.769 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.85 -42.14 88.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -62.07 -42.41 99.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -61.96 -43.83 98.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.912 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.73 -39.62 89.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.285 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.02 89.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.256 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -59.89 -39.57 85.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 7.8 mm -64.52 -39.97 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.318 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.62 -39.32 83.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.05 9.61 19.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -113.26 -42.51 3.5 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.7 2.41 8.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.362 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.12 79.43 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -81.11 128.51 70.59 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.733 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.49 153.11 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.721 1.614 . . . . 0.0 111.62 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.96 -36.19 63.42 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.297 1.998 . . . . 0.0 112.594 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.96 -38.07 84.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -95.85 17.88 14.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.31 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -112.53 103.73 11.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.138 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.53 109.83 18.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 69.8 mt -101.19 123.49 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.458 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -128.9 127.99 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 128.66 48.61 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.69 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.74 27.03 16.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.41 89.72 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -102.79 126.2 49.83 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.913 0.387 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.89 130.22 42.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.425 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 mt -88.96 82.88 6.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.098 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -73.01 173.4 9.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -78.3 171.16 15.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.04 12.68 81.34 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.94 165.68 19.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.981 0.419 . . . . 0.0 110.58 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.42 167.78 11.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.95 -39.77 93.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.369 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -62.82 -28.29 69.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -62.54 -29.27 70.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.419 . . . . 0.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -102.95 13.46 34.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.29 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 56.35 40.48 29.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.239 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -89.56 108.88 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.073 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -93.09 -174.05 3.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.485 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -67.0 151.48 47.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 54.77 38.66 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -92.51 124.73 36.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.044 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -75.94 129.46 36.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.45 148.91 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.324 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -93.07 114.61 27.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -103.93 121.12 42.46 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.08 131.4 71.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.827 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.157 -179.043 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.4 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.6 157.47 17.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.18 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 pt -138.18 147.56 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.059 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -88.68 123.27 32.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.301 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 64.8 t -108.21 102.7 14.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.636 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -92.94 120.73 33.56 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.664 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.5 p -81.37 173.48 12.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.73 -26.78 68.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.147 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -72.29 -12.98 61.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 -13.6 63.06 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 132.95 49.37 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.2 m -103.64 132.58 49.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.661 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.86 108.83 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -81.04 128.65 33.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.484 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -125.17 127.76 47.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.599 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -69.33 114.77 7.88 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.716 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 23.3 m -134.88 165.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.543 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -108.64 153.83 42.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.11 -35.08 94.53 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.928 1.752 . . . . 0.0 112.243 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -86.49 -2.59 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.166 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.38 133.68 56.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.668 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.16 -38.71 83.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.39 -42.05 90.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.1 -41.75 98.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 110.904 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.6 -42.24 95.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.484 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.92 -38.83 87.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.84 90.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.064 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -59.98 -39.74 86.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.05 -40.48 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.449 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.58 -40.8 93.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -63.66 -43.48 96.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -75.24 -72.74 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.134 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -84.63 166.99 16.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.173 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.77 15.08 56.71 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -70.39 124.8 91.5 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.174 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.93 155.79 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.026 1.817 . . . . 0.0 111.585 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.67 -40.89 82.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.993 1.795 . . . . 0.0 112.971 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.89 -45.28 94.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.898 0.38 . . . . 0.0 110.966 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -69.92 -38.73 76.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.741 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -54.46 106.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.35 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -118.9 88.12 2.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.39 129.19 37.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.361 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 79.0 mt -131.0 129.75 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -150.69 154.61 37.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.65 19.58 9.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.68 80.13 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -127.38 147.55 50.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 110.45 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -71.61 141.01 49.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.068 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.9 115.85 14.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.797 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.96 139.54 41.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.87 143.92 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.17 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.67 69.23 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -83.58 179.01 7.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.765 0.317 . . . . 0.0 110.773 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -126.1 163.65 22.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.285 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.79 -39.88 95.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.543 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.07 -29.2 70.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.16 -35.14 76.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 110.122 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -97.31 14.15 27.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.246 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.65 40.81 32.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.851 0.358 . . . . 0.0 110.329 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.83 107.24 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.308 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -93.95 177.32 6.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.66 150.49 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.248 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 58.92 40.34 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -97.31 123.4 41.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.186 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 69.0 m -74.97 127.55 33.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.0 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.22 146.76 44.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.887 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -95.89 117.48 30.68 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.093 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.99 97.67 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.1 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -83.96 134.6 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.095 0.474 . . . . 0.0 110.478 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.59 -179.342 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.713 0.292 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -89.4 112.26 23.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.331 0.586 . . . . 0.0 109.898 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' ILE . 88.6 mt -65.2 -38.25 89.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.606 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -151.36 162.93 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.115 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -172.82 122.58 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.262 0.553 . . . . 0.0 110.969 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -157.51 159.89 37.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.076 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -75.62 120.64 21.3 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.45 140.81 18.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.074 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.16 150.79 17.11 Favored Glycine 0 C--O 1.226 -0.347 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -95.03 177.38 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.99 0.424 . . . . 0.0 111.068 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.3 mtp -140.35 168.44 19.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.0 m -119.03 120.94 38.7 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.6 tp -101.13 123.43 45.27 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.919 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -119.54 104.02 9.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.091 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -81.14 0.86 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 p -146.84 19.07 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.562 0.22 . . . . 0.0 110.973 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.7 m -120.85 128.97 53.33 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -103.0 123.21 56.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.144 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.6 p -110.46 114.5 55.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.54 141.04 95.09 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.121 1.88 . . . . 0.0 112.621 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.98 113.03 24.76 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.58 -18.29 39.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.541 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -75.43 73.57 2.48 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -56.04 137.21 51.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.65 -152.98 8.45 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.508 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.12 124.24 21.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.49 107.28 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -130.96 153.34 49.3 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.927 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.6 mt -119.54 140.88 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.658 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -136.6 132.93 35.77 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 123.787 0.679 . . . . 0.0 109.936 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -100.53 123.46 44.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.09 0.471 . . . . 0.0 110.182 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 p -84.26 168.86 15.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.787 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.13 -10.38 10.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.929 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -91.03 6.66 43.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.629 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 m 63.88 23.66 13.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.234 0.54 . . . . 0.0 110.93 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.8 mt -100.02 122.85 43.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.413 HG22 HD11 ' A' ' 57' ' ' ILE . 50.6 mm -81.06 121.89 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -98.77 114.17 26.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.786 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -95.18 107.83 19.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.4 m -120.62 146.61 46.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 0.0 112.648 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -125.86 112.68 16.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.583 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -105.16 128.89 53.6 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.829 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.16 136.56 48.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.21 -17.19 58.68 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.714 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.7 m -60.49 -45.25 94.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.593 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.5 m -116.58 -16.28 10.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.77 20.84 79.33 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -102.07 145.82 28.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.656 0.265 . . . . 0.0 110.388 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.6 t -73.27 103.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.091 0.472 . . . . 0.0 110.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -79.91 -32.91 40.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.766 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -126.32 145.27 50.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.202 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -160.83 98.32 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.2 mt -128.26 137.1 51.84 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.01 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.12 123.11 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 mm -111.27 121.05 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.13 0.49 . . . . 0.0 110.599 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -85.12 163.65 44.7 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.257 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.17 138.33 82.71 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.813 1.675 . . . . 0.0 111.785 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 59.58 12.68 2.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.449 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.2 -38.66 24.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.44 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.3 m -129.87 155.78 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.122 0.486 . . . . 0.0 110.99 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -126.11 130.46 51.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.59 117.64 35.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -138.56 162.98 33.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -82.08 161.35 22.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.54 88.89 14.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.331 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.24 60.41 7.38 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.145 1.897 . . . . 0.0 112.084 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -114.45 -39.53 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.44 78.09 76.27 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.59 130.43 40.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.271 1.981 . . . . 0.0 111.178 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 169.12 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.111 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.45 -165.77 12.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -96.78 105.18 17.26 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 110.18 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.3 t -126.38 128.24 71.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -124.93 160.52 28.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.009 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -135.16 135.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 110.044 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.6 tp -101.61 123.51 45.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -120.39 140.39 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.147 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -88.34 116.92 26.89 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.35 -37.38 85.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.832 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.87 -19.78 18.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.533 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.58 -178.39 23.11 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.0 m -114.89 13.46 17.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.661 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -84.98 142.81 29.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.227 0.537 . . . . 0.0 110.983 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -136.07 121.47 19.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.556 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.0 mt -111.35 152.46 27.25 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.79 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -126.18 136.63 53.08 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.443 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.62 153.77 49.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.249 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -129.66 138.6 51.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.599 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.55 136.25 49.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.82 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.94 -1.04 26.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.451 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.0 131.86 65.47 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.296 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.9 -18.6 46.83 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.081 1.854 . . . . 0.0 112.727 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -113.74 140.34 48.35 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.1 p -96.06 8.19 44.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.61 -16.97 62.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.604 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -131.98 -5.37 3.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.625 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.38 -41.69 98.81 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.942 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -74.17 -34.53 63.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.956 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.55 -42.31 92.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.156 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.9 m170 -63.6 -41.74 98.3 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.9 t -60.98 -44.23 97.68 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.299 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -66.79 -43.59 83.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.939 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -63.71 -40.09 95.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.71 -48.1 86.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.203 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.24 -22.1 42.12 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.406 -0.917 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.85 -39.86 69.42 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -79.88 -35.89 37.37 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.551 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.15 -36.7 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.079 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -98.4 -27.83 13.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.333 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -134.48 73.59 67.99 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.894 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.67 155.88 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.958 2.439 . . . . 0.0 112.286 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.544 2.163 . . . . 0.0 112.042 -179.718 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.27 80.97 69.55 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.69 141.92 91.5 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.595 2.196 . . . . 0.0 112.147 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.21 153.6 94.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.063 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.98 149.22 77.22 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.018 1.812 . . . . 0.0 112.244 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -54.96 -172.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.352 2.035 . . . . 0.0 111.851 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.15 159.55 58.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.93 138.84 78.73 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.511 2.141 . . . . 0.0 112.431 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.71 163.87 39.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -86.58 137.63 32.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.359 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -125.18 129.23 49.71 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.188 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.41 129.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -72.32 84.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.83 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.619 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -63.84 159.02 20.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.158 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -138.95 150.84 23.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.983 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -94.11 124.08 37.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.552 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.58 115.61 49.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.192 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -93.35 129.92 39.29 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.506 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 111.125 -179.891 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.946 0.403 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.94 118.21 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.527 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.9 m -85.1 130.37 34.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.303 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.0 mt -123.41 127.1 47.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.241 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.39 113.72 8.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.825 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -136.43 167.36 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.79 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -116.94 152.24 48.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.56 -43.9 51.45 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.026 1.817 . . . . 0.0 112.485 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.21 -37.13 86.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.242 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -41.65 133.07 2.77 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.106 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -82.4 167.9 18.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.307 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.03 -35.78 70.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.47 -42.53 87.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.084 0.469 . . . . 0.0 110.377 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.96 -41.38 91.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.231 0.538 . . . . 0.0 110.875 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.43 -46.41 93.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.796 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -62.81 -32.5 73.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.255 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.29 98.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 110.099 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.78 -39.4 88.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.163 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.64 -40.37 88.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.981 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.86 -42.5 93.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.488 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.15 -40.13 95.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.416 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -74.66 -60.73 2.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -106.73 155.33 19.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.83 55.23 4.21 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mm -109.64 113.26 58.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.44 150.66 58.41 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.664 1.576 . . . . 0.0 111.621 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.46 -38.35 43.66 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.193 1.929 . . . . 0.0 112.474 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.24 -39.18 89.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.353 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -89.92 -2.32 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.245 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -86.19 100.7 12.42 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.208 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -104.32 100.46 10.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 59.5 mt -96.7 117.97 32.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.469 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 93.9 mt -126.36 128.26 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -128.41 130.46 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.674 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 24.52 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.73 3.04 90.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -106.96 128.51 54.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.68 133.04 47.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 mp -80.33 95.61 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.47 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.22 139.01 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.339 0.59 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -59.43 150.74 25.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.396 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 -13.38 64.66 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -94.9 151.61 19.07 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.255 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -92.26 164.22 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.193 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.02 -39.05 90.95 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.577 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -62.48 -23.93 67.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.625 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.71 -38.25 87.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.174 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -96.86 16.21 19.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.339 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 56.28 40.38 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 84.3 mt -91.78 113.52 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.0 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -102.22 -170.83 1.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -69.62 149.08 48.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 57.27 35.54 26.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.629 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -91.28 128.23 37.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.984 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -78.97 128.19 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.986 0.422 . . . . 0.0 110.485 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -117.0 139.88 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -87.44 111.36 21.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 59.1 tp -102.55 120.6 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.997 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.9 t -119.4 137.68 52.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -178.609 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.01 161.19 24.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.829 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.1 pt -142.87 145.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.015 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -92.24 123.29 35.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.647 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -103.22 109.8 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.388 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -87.63 120.93 29.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.519 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -80.86 170.98 15.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.787 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.35 -25.16 67.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.029 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -86.52 -0.99 57.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.43 -7.32 80.27 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.78 115.66 7.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 70.0 m -92.82 135.62 33.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.252 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.2 105.6 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.11 122.89 26.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 92.0 mt -122.22 131.86 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.42 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.88 114.4 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -133.98 167.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.473 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.34 154.95 44.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.98 -37.89 95.46 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.901 1.734 . . . . 0.0 111.815 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -77.92 -9.95 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.079 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.19 134.66 57.2 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.731 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -79.11 163.08 25.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.226 0.536 . . . . 0.0 110.525 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.16 -38.27 81.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.91 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.07 -39.89 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -62.38 -41.1 98.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.273 0.559 . . . . 0.0 110.549 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.3 -42.91 98.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.461 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.89 -40.01 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.295 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.42 90.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.172 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -59.75 -38.71 82.54 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.422 HG22 HD12 ' D' ' 30' ' ' ILE . 86.6 mt -64.49 -41.34 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.068 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.51 -45.52 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.243 0.544 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -67.69 -32.01 72.37 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.855 -0.528 . . . . 0.0 111.276 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -92.25 -3.51 55.39 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -148.48 -49.91 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.06 10.46 15.79 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.208 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.5 mt -82.14 118.76 73.18 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.885 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.43 153.13 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.943 1.762 . . . . 0.0 111.47 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.36 -40.92 80.75 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.985 1.79 . . . . 0.0 112.184 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.9 -38.94 76.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -62.34 -39.7 93.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.811 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.72 144.27 31.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.273 0.559 . . . . 0.0 111.384 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -124.89 117.29 23.75 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 73.3 mt -83.78 126.93 33.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.463 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.85 131.4 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -148.47 153.11 38.03 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.916 0.388 . . . . 0.0 111.074 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.02 16.28 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.5 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -9.23 72.68 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -119.74 145.89 46.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.936 0.398 . . . . 0.0 110.277 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.33 141.34 50.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.202 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.37 111.85 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.951 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -75.32 135.88 40.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.787 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -57.75 149.95 20.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.453 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.44 -16.21 60.48 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -85.77 170.27 12.61 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.336 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -113.13 157.33 21.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.965 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mp -57.91 -39.61 78.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.625 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 88.0 p -63.14 -23.46 67.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.299 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.98 -37.56 87.63 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.131 0.491 . . . . 0.0 109.932 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.74 10.73 39.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.295 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 62.1 t30 57.34 42.54 24.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.396 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 66.8 mt -86.51 108.14 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -93.84 175.65 6.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.384 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -58.85 150.76 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 59.25 46.58 12.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.1 t -96.74 123.34 40.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.185 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -80.34 85.84 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.908 0.385 . . . . 0.0 110.347 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.2 150.06 42.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -99.83 124.87 45.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.36 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tt -101.77 117.51 35.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.918 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 90.9 t -111.29 129.55 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.134 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.344 -179.364 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -92.8 113.28 25.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.279 0.562 . . . . 0.0 109.524 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.1 mt -65.75 -38.31 88.77 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.609 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.6 162.47 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.796 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.29 122.49 0.37 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.831 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.61 157.68 37.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.877 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -75.58 121.78 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.983 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.57 144.1 22.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.256 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.58 150.65 16.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -90.47 175.16 7.18 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.002 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.4 mtp -138.96 174.17 10.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -124.05 125.71 45.0 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.58 118.58 37.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.807 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -121.37 108.88 14.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.772 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.61 0.51 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -137.5 20.19 2.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.781 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -122.55 131.73 53.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.48 123.52 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.028 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.5 p -113.5 132.01 22.71 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.147 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.25 146.2 50.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.919 1.746 . . . . 0.0 113.32 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -98.4 119.9 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.45 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -64.0 -14.92 57.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.752 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 -74.45 74.02 1.91 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 109.962 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -49.91 139.35 13.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.762 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.66 -159.09 8.88 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.651 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 tp -137.03 125.12 22.92 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.8 t -97.51 110.02 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -133.43 153.71 51.38 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.51 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.7 mt -119.64 139.3 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.093 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -136.8 132.42 34.66 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.651 0.594 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -100.77 125.1 47.22 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 p -85.34 171.99 11.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -65.16 -9.54 23.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.13 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.55 0.74 56.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t 70.4 21.02 5.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 110.351 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.7 mt -99.23 122.6 42.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.429 HG23 HD13 ' A' ' 57' ' ' ILE . 51.8 mm -80.6 122.57 36.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.463 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -98.65 114.44 26.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.763 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -97.77 107.9 20.5 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 143.96 50.89 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.687 -0.805 . . . . 0.0 113.125 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -118.9 117.12 27.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.569 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -106.34 144.76 32.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.373 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.11 131.31 35.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -72.86 -16.69 61.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.9 m -59.69 -45.16 92.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.367 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.1 m -116.63 -14.01 10.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.92 22.29 77.1 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -102.25 152.66 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.61 102.71 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.221 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -73.44 -37.38 65.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.913 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -127.24 145.18 50.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -158.08 99.76 1.67 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.1 mt -127.34 136.83 52.46 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.3 124.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.272 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.0 mm -113.46 121.77 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.121 0.486 . . . . 0.0 110.861 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -88.37 162.8 38.73 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.382 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.42 139.11 86.31 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.972 1.781 . . . . 0.0 111.585 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 59.75 12.82 3.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -86.44 -25.78 25.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.7 p -145.92 168.09 21.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.431 0.634 . . . . 0.0 110.38 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -135.24 126.56 28.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.91 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -102.14 116.77 33.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -145.18 167.26 23.19 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.012 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.53 160.02 19.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.131 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.56 89.78 13.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.148 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.74 59.76 7.55 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.925 1.75 . . . . 0.0 112.12 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -114.88 -39.07 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.627 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.4 t -124.0 86.99 53.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.479 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.15 130.0 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.593 1.528 . . . . 0.0 111.486 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p 167.37 -29.69 0.0 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.56 178.52 34.74 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.472 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.01 113.38 20.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 111.122 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.94 127.78 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.03 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -120.44 152.58 37.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.839 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.9 132.75 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.385 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.6 tp -102.24 121.35 42.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -119.76 130.81 55.14 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.47 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -79.99 115.23 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.0 -37.67 85.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.385 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.75 21.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.565 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.96 -175.65 22.88 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -116.47 12.96 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.601 0.239 . . . . 0.0 110.534 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -89.7 142.62 27.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.977 0.417 . . . . 0.0 111.101 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -134.29 133.01 40.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.55 149.44 38.19 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.716 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.31 137.86 54.75 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.608 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -138.63 156.73 47.2 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.241 0.543 . . . . 0.0 111.307 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -131.75 135.58 46.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.272 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 137.7 57.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.66 -0.19 13.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.287 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.99 149.76 73.99 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.49 -31.14 28.0 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.13 1.887 . . . . 0.0 112.765 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -123.63 142.29 51.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.125 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -94.29 5.7 50.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.763 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.04 -21.05 58.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -118.72 -15.14 9.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.0 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.95 -39.58 94.46 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.116 0.484 . . . . 0.0 110.411 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.45 -35.14 79.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.017 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.89 -40.96 83.44 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.126 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -61.36 -39.47 90.73 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.183 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -61.71 -44.83 96.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.454 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -67.96 -39.41 83.39 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.914 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -66.4 -42.2 88.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.746 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.07 -46.48 88.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.021 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -63.97 -38.57 91.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.561 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -75.55 -23.44 56.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.231 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -87.51 -29.09 21.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.568 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.8 mt -92.85 -18.3 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.614 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -116.33 -18.81 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -137.99 65.37 44.43 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.094 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.49 151.76 70.65 Favored 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.612 2.208 . . . . 0.0 112.243 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 C-N-CA 122.412 2.074 . . . . 0.0 112.147 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.85 154.71 81.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.92 147.19 49.1 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.584 2.189 . . . . 0.0 111.951 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.03 153.87 63.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.36 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.77 144.13 98.48 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.595 2.196 . . . . 0.0 112.209 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.14 -174.77 2.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.32 2.013 . . . . 0.0 111.849 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -111.58 160.27 30.09 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.581 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.75 147.23 89.23 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.687 2.258 . . . . 0.0 112.231 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.08 163.34 39.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.835 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.01 137.34 32.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.648 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -122.42 122.54 39.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.921 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 47.6 mt -132.26 125.13 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -79.23 84.25 5.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.045 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 32.7 t0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.59 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.1 ttp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -58.96 163.19 3.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.029 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 20.1 pt -143.02 139.59 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.006 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -83.86 121.91 27.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.27 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.02 106.12 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -87.88 133.84 33.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.301 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 111.742 -179.459 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.897 0.379 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.83 100.68 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.1 m -75.5 127.2 32.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -120.49 124.64 45.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.602 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.01 112.68 3.96 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.383 0.611 . . . . 0.0 110.701 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.24 164.27 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -106.37 153.88 40.17 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.49 -36.48 94.33 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.99 1.793 . . . . 0.0 112.026 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -82.08 -6.56 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -60.44 135.25 57.69 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -76.65 161.39 28.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.903 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.214 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.28 -39.55 87.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.93 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.54 -42.96 99.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.277 0.56 . . . . 0.0 110.381 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.07 -42.62 95.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.71 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.92 -38.02 84.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.33 89.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.38 -38.14 82.98 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 mm -63.55 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.927 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -61.68 -46.05 91.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.85 -13.75 60.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -104.96 -12.49 16.17 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -141.33 -37.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.77 14.42 27.17 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -89.16 117.68 68.46 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.12 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.13 146.56 94.03 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.994 . . . . 0.0 111.397 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.99 -39.5 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.049 1.833 . . . . 0.0 112.294 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.99 -31.14 70.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -83.87 -10.5 57.97 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -121.78 145.18 48.31 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.143 0.497 . . . . 0.0 111.105 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -127.66 131.03 49.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 72.7 mt -102.68 122.24 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.105 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -126.97 126.63 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -116.06 119.94 37.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.946 0.403 . . . . 0.0 110.909 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.54 39.45 30.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.99 14.79 80.04 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.94 105.7 13.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.42 132.97 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 mt -84.82 100.13 11.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.65 146.95 39.88 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.37 0.605 . . . . 0.0 111.431 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -63.53 150.43 43.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.249 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.28 -12.63 64.03 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -91.09 167.83 12.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.036 0.446 . . . . 0.0 110.471 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 59.6 p -116.45 163.77 15.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.911 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.33 -39.85 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.2 p -63.31 -24.35 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.591 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.26 -37.96 87.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.117 0.484 . . . . 0.0 110.301 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -96.57 13.35 28.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.71 42.81 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.029 0.442 . . . . 0.0 110.274 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -91.9 116.97 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -101.02 -178.76 3.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.594 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -61.52 144.67 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.185 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 63.77 17.1 10.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -66.04 131.05 45.29 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -85.26 128.31 34.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 0.0 109.996 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -117.25 146.16 43.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -91.32 116.95 29.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.849 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.01 119.58 35.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.1 t -116.65 129.78 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 0.0 110.626 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.839 -179.056 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -62.22 161.62 10.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.311 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.3 pt -143.46 142.53 25.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -90.4 116.52 28.4 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.822 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.3 102.92 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.452 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.15 124.09 31.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.184 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -77.46 -171.6 2.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.515 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.16 -18.78 50.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -115.9 -172.88 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.139 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.53 -20.25 58.87 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.79 131.27 34.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.306 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -128.02 140.48 51.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.569 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.83 102.25 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.781 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.78 128.97 34.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.585 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.64 124.17 37.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -68.24 112.49 5.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.249 0.547 . . . . 0.0 110.532 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.69 165.63 29.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.111 -0.368 . . . . 0.0 110.552 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -111.28 154.53 43.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -55.7 -41.3 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.055 1.837 . . . . 0.0 112.253 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -70.29 -15.82 62.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -57.93 136.75 57.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.32 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -81.44 163.83 22.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.159 0.505 . . . . 0.0 110.999 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.13 -38.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.933 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.78 -40.31 83.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.03 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.6 -43.36 94.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 0.0 110.417 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.49 -47.36 93.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.901 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.28 -31.46 72.05 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.89 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.4 97.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.947 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.17 -38.99 84.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.439 HG23 HD13 ' D' ' 30' ' ' ILE . 86.5 mt -64.62 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.913 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.37 -39.21 82.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.98 -45.31 67.6 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -68.39 -40.67 81.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.845 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -130.23 148.41 52.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.425 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 59.4 3.04 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 mm -111.36 106.95 57.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.02 152.44 51.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.877 1.718 . . . . 0.0 111.306 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.98 -41.49 56.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.952 1.768 . . . . 0.0 112.51 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -68.09 -40.12 82.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.856 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -63.31 -40.31 96.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.29 143.59 26.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.264 0.555 . . . . 0.0 111.461 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -131.9 120.52 22.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 86.9 mt -89.73 122.85 33.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.289 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 56.5 mt -131.42 131.14 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.788 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -144.96 152.99 41.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.981 0.419 . . . . 0.0 111.092 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.5 19.04 10.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.528 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.71 -7.68 72.64 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -123.53 144.6 49.45 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 110.764 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -62.28 150.03 40.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.194 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.21 120.46 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.124 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -75.58 130.72 39.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.76 137.21 58.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.55 -17.0 54.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -88.85 166.17 14.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.439 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -101.14 168.21 9.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.67 -38.89 90.58 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.697 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -63.45 -25.01 68.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.996 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.82 -28.8 70.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.15 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.79 14.98 28.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.552 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 55.44 39.73 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.233 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -88.32 102.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -90.43 -177.66 5.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.915 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.27 145.89 55.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.606 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 66.16 10.38 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.356 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 52.8 m -64.28 135.85 56.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -90.05 112.43 23.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -95.03 137.28 34.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.852 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -85.71 125.77 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.036 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.55 124.41 52.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.925 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.61 130.39 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.957 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.142 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.239 0.536 0 CA-C-O 121.013 0.435 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.1 114.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.683 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.4 mt -66.37 -37.78 86.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 p -149.91 162.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.802 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.49 123.13 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -154.17 159.38 41.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.981 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.96 121.61 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.631 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.29 141.65 17.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.697 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.4 157.66 15.76 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -93.16 153.52 18.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.603 0.24 . . . . 0.0 110.946 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.4 mtm -127.02 175.78 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.1 m -126.79 139.08 53.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.758 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.4 tp -117.71 119.0 33.62 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.421 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -120.03 111.01 17.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.26 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 -101.52 0.89 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -127.62 21.66 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.573 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.96 121.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 p -113.63 133.68 22.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.683 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.07 140.85 23.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.94 1.76 . . . . 0.0 112.424 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -97.97 145.25 26.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.82 -6.05 58.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.087 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -73.87 65.7 1.08 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -49.57 132.15 21.23 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.92 -157.98 8.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.139 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 tp -138.34 127.52 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.79 110.56 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.344 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -132.89 154.35 50.48 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.305 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.8 mt -117.39 137.57 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.232 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 131.98 37.34 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 123.799 0.687 . . . . 0.0 110.031 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -100.52 124.79 46.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.889 0.376 . . . . 0.0 109.997 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p -85.88 170.31 12.49 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.459 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -61.85 -13.16 21.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.0 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -84.66 0.26 50.93 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.402 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 t 68.93 20.42 7.89 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.105 0.478 . . . . 0.0 110.376 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -100.06 125.47 46.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 57' ' ' ILE . 51.7 mm -80.23 124.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.403 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -100.89 115.8 31.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.788 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -93.76 108.65 20.38 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.7 m -120.75 147.94 44.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.812 0.815 . . . . 0.0 112.778 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -126.98 114.35 17.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.289 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.49 133.03 52.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.955 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.79 133.05 43.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.447 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -74.35 -18.68 60.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 110.806 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.9 m -59.97 -46.07 90.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.723 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.4 m -116.45 -14.9 10.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.452 . . . . 0.0 110.035 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.9 22.47 78.03 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.59 144.48 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.945 0.402 . . . . 0.0 110.246 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.43 108.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -89.02 -26.34 21.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.715 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -127.91 143.7 51.1 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.211 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.34 98.58 1.57 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.378 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 mt -127.93 133.74 49.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.79 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.37 125.97 35.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.342 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.6 mm -113.06 124.79 70.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.357 0.599 . . . . 0.0 110.83 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.3 162.54 31.83 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.332 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.4 136.78 77.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.015 1.81 . . . . 0.0 111.434 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 60.79 8.45 1.81 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.609 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -72.89 -36.4 67.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.821 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.3 p -143.98 165.49 27.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.437 0.637 . . . . 0.0 110.31 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -125.95 128.17 47.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.303 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -102.87 119.85 39.57 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -148.2 166.72 27.07 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.886 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -80.1 159.84 25.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.114 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.17 89.97 13.0 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.856 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.41 60.78 7.65 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.944 1.763 . . . . 0.0 112.43 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -39.72 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.2 t -129.89 77.33 76.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.68 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.1 130.43 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.391 2.06 . . . . 0.0 111.495 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.45 -43.71 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.34 -160.65 9.05 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.92 106.38 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.79 128.58 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.775 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.12 152.42 47.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.79 138.66 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.367 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.2 tp -100.87 116.3 32.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -104.17 107.68 18.69 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -75.73 106.05 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.86 -37.79 83.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.47 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.98 -22.61 13.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.744 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.29 -14.48 82.17 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.638 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.5 m 56.15 21.19 4.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.42 153.09 35.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.351 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -131.09 136.3 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.678 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.6 mt -120.07 147.22 45.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.168 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -114.98 132.47 56.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.98 155.37 49.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.875 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -134.14 135.62 43.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.9 mtp -83.7 136.73 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.5 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -100.74 12.79 36.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.78 129.44 91.15 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.944 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.64 -37.79 94.92 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.822 1.681 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.81 144.91 46.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.83 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 p -90.84 0.7 57.4 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.04 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.9 -20.6 53.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.202 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -113.87 -16.05 12.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.786 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.62 -40.42 94.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.892 0.377 . . . . 0.0 110.703 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -41.32 99.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.004 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.04 -41.96 94.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.814 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -64.39 -40.44 95.8 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.786 0.803 . . . . 0.0 109.336 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.42 -44.82 95.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.126 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -64.19 -43.91 93.62 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.3 -40.97 98.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.984 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.1 -48.56 86.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.843 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.64 -38.77 90.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.228 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.93 -22.85 55.58 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.606 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -89.88 -28.2 19.39 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.53 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.6 mt -92.66 -18.06 23.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -117.25 -17.14 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.265 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -139.76 65.21 31.08 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.207 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.0 156.22 63.25 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 C-N-CA 122.821 2.347 . . . . 0.0 112.359 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.311 -1.417 0 C-N-CA 122.525 2.15 . . . . 0.0 112.262 -179.794 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -127.27 130.78 23.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.439 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.85 146.29 37.59 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.935 1.757 . . . . 0.0 111.968 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.79 153.4 87.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.09 158.03 56.14 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.39 2.06 . . . . 0.0 112.12 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -58.2 -172.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.279 1.986 . . . . 0.0 111.806 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -128.92 158.2 73.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.65 141.75 95.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.105 1.87 . . . . 0.0 112.326 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.53 165.47 36.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.589 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.92 135.84 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.439 . . . . 0.0 110.542 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -115.32 128.5 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.151 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.22 122.58 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.54 85.5 5.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.087 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.617 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -63.29 158.85 19.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.438 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.04 144.47 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -88.02 125.27 34.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.199 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.74 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -99.84 128.48 45.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.784 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 111.483 -179.739 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.16 105.06 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -75.04 131.09 40.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.042 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.71 129.21 51.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.448 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.16 115.94 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.068 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 m -138.73 165.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.59 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -107.89 155.65 39.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.7 -37.64 95.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.041 1.827 . . . . 0.0 112.015 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -80.93 -7.42 59.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.191 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -58.69 137.96 57.3 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.058 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.06 161.02 26.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 110.952 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.69 -39.21 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.08 -39.11 84.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.864 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.99 -42.75 99.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.396 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.76 -42.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.204 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -39.89 80.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.551 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.85 -41.29 95.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 110.063 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -59.6 -38.63 81.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 mm -65.18 -39.9 87.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.984 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.21 -41.96 89.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.823 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -69.48 -50.3 46.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -63.97 -41.2 97.63 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -131.67 148.92 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.58 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.42 63.61 2.19 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 45.0 mt -115.97 119.81 36.49 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.28 159.93 48.35 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.779 1.653 . . . . 0.0 111.457 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.05 -31.68 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.041 1.827 . . . . 0.0 112.613 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.75 -42.59 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.961 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.71 -10.8 57.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.412 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -80.62 86.55 5.86 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.799 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -96.86 103.76 15.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.9 119.36 34.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.122 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.6 127.57 71.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.084 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -129.2 130.34 46.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.521 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.67 28.04 14.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.54 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.97 15.3 81.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -119.37 132.75 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 110.371 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -72.61 131.94 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.106 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -81.34 97.74 7.84 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.968 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.17 139.83 52.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.781 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.23 143.68 52.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.43 -17.73 58.55 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -84.39 171.38 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.806 0.336 . . . . 0.0 110.105 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -119.0 165.69 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.246 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.33 -39.83 94.36 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.381 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.97 -27.02 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.248 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.78 -35.98 79.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.206 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -96.51 12.6 30.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.319 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.29 40.67 27.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.342 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -89.58 114.92 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -99.22 -175.2 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.354 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -65.3 150.12 48.79 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.946 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 54.89 42.54 31.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.947 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 45.3 m -96.25 124.46 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.032 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -75.01 128.19 34.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.906 0.384 . . . . 0.0 110.074 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.35 143.46 46.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -89.96 112.08 23.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.07 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 59.2 tp -100.51 120.42 39.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.635 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -117.45 133.83 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.793 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.007 -178.883 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -68.93 158.32 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.97 146.5 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.754 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -94.82 122.07 37.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.59 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 85.8 t -104.42 113.23 40.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.395 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -98.49 130.29 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.719 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -86.76 -177.56 6.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.203 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 52.1 mt -72.83 -17.07 61.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.365 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 56.1 p -90.87 -2.35 57.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.041 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -9.09 75.9 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.47 130.73 44.36 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -111.47 134.1 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.996 0.427 . . . . 0.0 110.979 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.91 109.8 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.351 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.94 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.34 124.86 44.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.204 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.31 114.51 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.563 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.33 168.5 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.445 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -109.86 154.86 42.37 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.294 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.57 -32.93 91.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.893 1.728 . . . . 0.0 111.893 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -83.19 -6.28 59.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.113 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -60.99 144.9 52.45 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -89.45 161.28 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.73 -38.69 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.088 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.16 -42.66 91.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.084 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -62.86 -40.63 98.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.341 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 62.4 t -61.91 -42.97 96.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.618 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -61.17 -39.4 90.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.201 0.524 . . . . 0.0 109.951 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.35 90.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.9 -38.09 81.31 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.01 -41.95 94.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.506 0.67 . . . . 0.0 109.949 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.8 -44.74 96.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.09 -20.33 62.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -101.61 -6.14 24.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -145.36 -43.63 0.22 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.28 0.562 . . . . 0.0 110.226 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.97 14.13 12.62 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . 0.413 HG22 HD13 ' D' ' 36' ' ' ILE . 57.4 mt -87.93 119.17 70.4 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.438 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.52 160.14 44.91 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.823 1.682 . . . . 0.0 111.943 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.63 -22.26 59.64 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.418 2.079 . . . . 0.0 112.215 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -87.48 1.36 53.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.443 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -126.42 21.2 7.25 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -162.42 154.97 19.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 111.214 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.23 132.38 35.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.666 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mp -91.46 122.26 33.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.547 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 70.0 mt -128.99 132.23 67.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.784 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -151.9 155.14 37.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.365 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.68 16.69 7.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.617 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.56 -12.69 62.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -119.71 146.38 45.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.138 0.494 . . . . 0.0 110.397 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -65.11 142.66 58.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.979 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -84.43 114.79 22.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.411 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.51 149.59 38.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.228 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -71.21 165.05 24.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.73 26.82 74.0 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -128.01 157.3 41.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.868 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -100.91 160.79 14.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.277 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.59 -40.47 97.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.86 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.4 p -62.62 -23.63 67.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -62.9 -38.08 89.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.112 0.482 . . . . 0.0 109.907 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.62 13.83 30.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.277 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.91 40.36 28.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.568 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.94 98.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 109.995 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -86.1 178.38 7.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.256 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -60.75 151.68 28.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.289 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 57.13 44.47 22.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 123.42 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.86 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -81.88 96.83 7.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.081 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.19 152.47 24.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.04 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -101.87 122.39 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.302 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.35 114.0 27.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 64.0 t -106.43 120.07 56.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.804 -178.879 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 C--O 1.238 0.454 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.27 115.1 26.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.682 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.1 mt -68.05 -36.86 80.58 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.682 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.09 161.9 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.818 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.0 122.23 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.295 0.569 . . . . 0.0 111.091 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.89 158.61 38.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.924 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -77.22 123.23 26.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.602 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 146.28 23.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.221 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.55 151.58 17.04 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -89.73 172.46 8.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.04 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.6 mtp -138.22 174.34 10.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.739 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.2 m -124.54 127.27 47.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.6 tp -107.72 117.2 33.49 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.184 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.97 110.33 16.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.826 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.73 -83.22 0.58 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.15 18.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.8 m -119.17 130.14 55.36 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.1 t -108.5 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.6 p -115.64 132.6 23.06 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.044 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.32 146.66 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.552 1.501 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -101.04 121.47 41.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.456 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -62.36 -14.62 41.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -71.29 80.55 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -64.27 130.58 44.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.641 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.03 -154.64 8.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.348 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -138.11 127.24 24.3 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.6 110.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -134.17 154.66 51.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.0 mt -120.36 138.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.63 132.64 37.31 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 123.772 0.67 . . . . 0.0 110.045 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -102.01 125.29 48.66 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 p -84.9 171.78 11.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.873 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.85 -10.34 27.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.566 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.31 5.42 47.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.424 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m 64.02 25.16 13.77 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.578 0.704 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.7 mt -101.55 122.77 44.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.434 HG21 HD11 ' A' ' 57' ' ' ILE . 50.7 mm -80.92 123.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.234 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -99.45 115.64 29.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.827 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -94.7 108.65 20.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.9 m -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.86 0.838 . . . . 0.0 113.108 -177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -125.67 114.85 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.113 -1.403 . . . . 0.0 107.646 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -106.51 132.74 52.17 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.582 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -74.5 134.22 42.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -75.59 -16.5 60.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.69 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 m -60.41 -44.84 95.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.754 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.9 p -116.47 -17.41 10.66 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.763 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.39 22.01 74.05 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -101.53 153.01 20.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.56 102.47 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -77.21 -32.8 56.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -125.87 144.84 50.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.589 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -157.34 99.23 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.6 mt -130.53 133.83 46.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.771 0.32 . . . . 0.0 110.877 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -78.73 125.45 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.307 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 mm -111.06 126.15 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.915 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.47 162.2 32.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.351 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.08 138.69 83.54 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.817 1.678 . . . . 0.0 111.235 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.8 t0 59.44 11.74 2.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.731 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.67 -27.05 37.2 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.616 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.5 p -151.65 166.97 29.61 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.759 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.01 132.33 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.277 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -104.5 118.51 36.78 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -142.39 166.81 23.66 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.719 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.49 159.99 19.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.967 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.03 89.46 19.96 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.8 60.44 7.56 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.829 1.686 . . . . 0.0 112.149 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -113.84 -42.8 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.329 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.1 t -120.22 96.97 49.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.042 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 131.04 18.46 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.122 1.215 . . . . 0.0 111.487 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 168.17 -31.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.985 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.58 -174.31 28.13 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.552 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.72 112.6 23.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.486 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.2 128.83 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.21 152.97 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.62 136.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.149 0.5 . . . . 0.0 110.283 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.78 120.84 41.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -116.7 120.11 37.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.147 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -79.2 113.73 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.43 -37.78 84.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.054 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.89 -23.0 12.51 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.58 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.4 -17.37 79.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.274 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m 58.32 21.19 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.627 -0.337 . . . . 0.0 111.165 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -119.1 151.4 38.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.099 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.42 138.4 49.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.0 110.852 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -123.42 153.05 40.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.146 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.76 135.76 53.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.819 0.342 . . . . 0.0 110.683 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -139.6 156.67 46.72 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.301 0.572 . . . . 0.0 111.224 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -130.43 138.91 50.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.439 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 77.6 mmm -75.07 139.15 42.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.843 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.56 2.09 33.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.894 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -73.83 146.36 85.27 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.746 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.82 -28.01 17.25 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.999 1.8 . . . . 0.0 112.601 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.77 144.13 48.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.891 0.377 . . . . 0.0 110.334 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.7 p -91.47 1.15 57.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.922 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.01 -19.51 44.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -118.52 -20.2 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.88 -41.7 98.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.273 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.51 -40.87 96.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.48 -42.44 92.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.415 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -64.44 -39.94 94.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.674 0.749 . . . . 0.0 109.314 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.0 t -61.02 -45.83 93.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.491 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -63.42 -43.1 98.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.153 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -65.62 -35.44 80.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.51 -48.35 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.987 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.32 -28.99 53.36 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.777 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.8 -34.99 74.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.97 -31.32 31.24 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -81.48 -26.94 34.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -106.39 -26.82 11.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.477 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.58 73.66 72.23 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.78 151.2 72.47 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.945 2.43 . . . . 0.0 111.964 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.49 1.318 0 C-N-CA 122.394 2.063 . . . . 0.0 112.068 -179.84 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -134.27 154.77 80.15 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.978 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.28 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.268 1.979 . . . . 0.0 111.569 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -73.63 159.0 85.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -54.92 140.77 79.09 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.411 2.074 . . . . 0.0 112.193 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.42 174.12 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.387 2.058 . . . . 0.0 111.84 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -97.11 154.49 38.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.53 147.0 88.73 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.463 2.108 . . . . 0.0 112.105 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.43 161.4 42.64 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.84 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.04 136.21 33.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 0.0 110.572 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -118.69 124.72 48.03 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.7 mp -130.46 122.69 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.477 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.26 83.97 7.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.932 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.4 p30 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.586 179.571 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.91 160.76 14.11 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -136.94 154.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.082 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -93.53 122.69 36.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.115 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.03 108.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.42 108.25 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.571 0.701 . . . . 0.0 111.08 -179.166 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 94.8 m . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -132.42 118.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -86.7 122.98 31.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.54 128.11 52.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.508 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -70.62 116.37 10.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.858 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -135.92 166.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.515 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -111.98 153.76 44.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.091 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 -38.25 93.92 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.062 1.841 . . . . 0.0 112.156 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -81.45 -8.74 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.07 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.72 134.76 57.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -78.57 163.82 25.2 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.043 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.25 -35.74 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.943 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.8 tm-20 -58.44 -40.01 81.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.2 -41.51 94.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.7 t -63.09 -47.59 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.044 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -62.82 -33.35 75.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.053 0.454 . . . . 0.0 110.17 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.05 97.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.34 -39.3 86.62 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.083 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . 0.405 HD12 HG23 ' C' ' 30' ' ' ILE . 92.1 mt -66.17 -39.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.001 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -46.53 88.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.29 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.77 -15.1 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.033 -0.417 . . . . 0.0 111.906 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -101.14 -6.34 24.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -148.61 -41.03 0.16 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.181 0.515 . . . . 0.0 110.501 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 11.17 21.02 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 73.8 mt -77.52 125.25 86.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.43 158.05 48.55 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.675 1.583 . . . . 0.0 112.05 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.18 -38.62 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.113 1.875 . . . . 0.0 112.274 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.07 -39.93 94.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.906 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.79 -3.63 58.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -80.02 96.2 6.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -96.22 85.28 3.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.578 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 86.8 mt -89.17 113.08 24.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.63 129.03 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.616 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -132.72 132.49 42.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.859 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 24.34 14.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.65 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.94 3.43 90.6 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.344 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -110.69 127.14 55.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.645 -0.326 . . . . 0.0 110.238 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -70.18 134.25 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.6 94.43 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.429 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.06 146.61 39.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.295 0.569 . . . . 0.0 111.038 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -61.44 150.6 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.07 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.85 -17.65 57.5 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -90.2 164.12 14.54 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.211 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.8 p -113.34 167.06 10.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.309 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.39 -39.41 93.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.384 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -62.96 -26.75 68.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.094 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.08 -35.91 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -95.52 14.29 23.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.213 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 55.77 40.41 30.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 0.0 110.497 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.71 121.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.977 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.18 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.598 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -58.96 145.12 42.77 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.972 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 59.18 26.17 14.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 123.37 25.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.479 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -72.63 130.07 39.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.226 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -120.57 143.11 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -93.24 109.22 20.74 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -106.66 123.62 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.11 141.32 43.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.332 -178.424 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -64.13 157.23 26.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.599 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 pt -136.72 152.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.131 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -93.46 122.02 35.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.714 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.24 107.47 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.678 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -91.88 125.56 36.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.599 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -83.32 174.53 10.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.189 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 70.7 mt -62.46 -25.95 68.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.076 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p -78.48 -9.45 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 -11.7 66.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.41 134.61 52.87 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.88 0.34 . . . . 0.0 110.124 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -104.3 133.68 48.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.719 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -122.7 113.05 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.644 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -80.96 125.24 29.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.089 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -119.58 116.56 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.716 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.98 108.89 2.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.465 0.65 . . . . 0.0 110.883 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 m -134.49 164.73 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -107.76 155.06 40.5 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.172 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.87 -37.29 96.03 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.864 1.71 . . . . 0.0 111.814 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -79.21 -9.4 59.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.78 136.28 58.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.904 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -79.74 162.94 24.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.39 -38.95 83.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.761 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.51 -41.58 90.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.947 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.89 -41.52 97.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.147 0.499 . . . . 0.0 110.578 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.43 -42.03 94.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.43 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -60.61 -39.34 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 110.245 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.15 93.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.097 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.37 -39.22 86.45 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 92.4 mt -63.59 -42.12 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.199 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 27.0 tm0? -60.57 -40.08 90.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.636 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -83.52 12.0 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -118.56 -47.89 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -112.08 2.28 16.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.246 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.15 24.8 75.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 13.6 mm -85.82 116.24 64.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.164 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.5 147.2 70.57 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 122.083 1.855 . . . . 0.0 112.32 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.69 -33.06 78.52 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.223 1.949 . . . . 0.0 112.643 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 9.85 31.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -121.14 28.61 7.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -160.53 151.27 18.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.065 0.46 . . . . 0.0 111.142 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -132.0 126.27 33.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.792 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.74 124.06 33.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.707 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.6 mt -127.38 129.11 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.736 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -148.59 151.54 35.22 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.997 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.8 17.74 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 85.49 -8.77 70.21 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -119.57 145.3 46.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.127 0.489 . . . . 0.0 110.735 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.29 132.41 47.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.967 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.64 104.94 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.71 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.97 168.29 20.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.474 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -78.39 172.66 13.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.3 21.35 77.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -130.59 157.2 43.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.876 0.37 . . . . 0.0 110.693 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -105.83 162.97 13.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.134 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.88 -39.79 93.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.393 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -63.56 -23.02 67.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.378 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.48 -38.35 86.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.012 0.434 . . . . 0.0 110.233 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -99.23 15.7 25.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.368 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.24 40.82 24.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.264 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -90.65 104.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.23 -171.55 2.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.255 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -68.78 146.4 52.94 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.07 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 63.14 42.34 7.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -99.54 125.71 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.785 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -76.11 126.01 30.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.01 139.53 51.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.627 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -88.48 118.38 28.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.57 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.48 120.0 39.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.53 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.41 127.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 70.1 mt . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.683 -179.713 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp . . . . . 0 CA--C 1.521 -0.17 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -89.11 112.87 23.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.1 mt -66.11 -38.38 88.07 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.6 162.94 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.644 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.72 122.92 0.34 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.281 0.562 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -154.47 158.95 40.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.845 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.33 122.57 23.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.415 . . . . 0.0 110.819 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.14 143.83 20.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.96 153.57 16.92 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -86.78 157.36 19.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.903 0.383 . . . . 0.0 110.871 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.8 mtp -125.53 172.95 9.28 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.44 124.64 41.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.374 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.7 tp -106.84 117.48 34.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.879 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -122.05 119.81 32.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.857 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -86.83 0.22 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -148.15 24.51 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.705 0.288 . . . . 0.0 110.722 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.9 m -126.26 131.18 51.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.285 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.99 122.18 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.646 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.8 p -121.35 122.94 27.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.53 146.41 55.35 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.269 1.313 . . . . 0.0 112.902 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -99.74 142.58 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.53 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -72.33 -6.26 42.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -73.1 74.11 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -55.42 135.68 50.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.89 -160.89 9.69 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 tp -137.26 126.97 25.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.3 t -99.69 109.58 24.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -133.19 154.49 50.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.609 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -117.89 137.89 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.236 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.91 131.3 35.02 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.549 0.531 . . . . 0.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -100.45 124.73 46.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.231 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -84.35 172.32 11.88 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.604 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.11 -10.36 30.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.533 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.48 -0.06 56.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.626 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 71.03 19.68 5.52 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.7 mt -98.62 122.62 42.07 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 57' ' ' ILE . 51.8 mm -78.97 125.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -101.07 116.69 33.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.669 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -95.96 107.48 19.76 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 71.9 m -121.41 146.99 46.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 113.041 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.6 t90 -124.79 114.27 19.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.948 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -106.13 131.53 53.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.723 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -75.89 131.04 39.41 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -72.26 -18.86 61.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 110.662 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.5 m -59.91 -44.68 94.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.964 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p -115.94 -16.01 11.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.091 0.472 . . . . 0.0 109.991 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.17 19.6 79.78 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -102.54 146.52 28.02 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.82 102.05 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 110.06 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -74.44 -36.5 63.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -126.27 145.98 50.19 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.761 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -158.08 100.61 1.72 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.83 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' D' ' 47' ' ' GLY . 31.7 mt -127.89 133.21 49.29 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.84 0.352 . . . . 0.0 110.756 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 125.55 35.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.144 0.497 . . . . 0.0 110.123 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 mm -112.09 118.18 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.897 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -82.95 161.58 57.57 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.858 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -54.59 131.98 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.676 1.584 . . . . 0.0 111.699 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 62.37 12.29 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.446 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -81.26 -26.89 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.111 0.481 . . . . 0.0 110.18 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -142.12 151.08 41.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.209 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -121.06 129.26 53.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.977 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.09 118.11 35.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -141.97 167.82 21.23 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.648 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -85.1 159.99 20.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.026 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.72 90.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.118 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.33 61.1 8.07 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.921 1.747 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -113.28 -38.04 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.6 t -131.44 77.26 74.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.697 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.13 130.33 40.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.151 1.901 . . . . 0.0 111.359 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 t 167.78 -47.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.723 0.64 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.8 -149.32 7.06 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.58 106.43 13.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.394 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -124.9 129.3 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.58 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.46 153.71 45.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.535 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -129.7 135.78 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 0.0 109.894 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.8 tp -104.73 122.3 45.4 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -120.19 130.39 54.54 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.135 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -86.24 116.41 24.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.78 -36.24 78.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.271 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.27 -20.88 12.14 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.398 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -73.23 -20.77 80.02 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.058 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 m 59.44 27.6 16.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -125.53 151.23 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.125 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -131.77 139.78 49.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.17 0.509 . . . . 0.0 110.934 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.1 mt -122.91 149.1 44.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.799 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.25 135.21 54.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.58 157.14 46.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.317 0.58 . . . . 0.0 111.318 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -135.05 137.07 42.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.523 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.4 ttm -73.7 135.22 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.238 0.542 . . . . 0.0 111.244 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.23 0.25 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.13 139.1 89.93 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.72 -25.74 33.55 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.979 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -117.51 141.68 48.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.41 . . . . 0.0 110.434 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.2 p -95.15 9.56 39.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.47 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.9 -21.0 60.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.362 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -121.05 3.16 10.47 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.476 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -62.02 -49.22 76.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.997 0.427 . . . . 0.0 110.986 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.14 -39.73 93.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.272 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.76 -42.98 99.94 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.737 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 66.2 m170 -64.26 -41.06 97.11 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.036 0.922 . . . . 0.0 109.467 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.88 -44.11 96.99 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.409 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -65.46 -43.51 90.1 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.53 -41.42 98.86 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.665 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.9 t -58.77 -49.38 83.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.014 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.501 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.87 -25.04 59.84 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.384 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.401 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.4 m-85 -87.84 -28.92 21.32 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.8 mt -91.23 -15.58 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.294 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -118.21 -17.95 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.165 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -142.1 66.74 21.07 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.255 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.4 155.0 64.76 Favored 'Trans proline' 0 C--N 1.297 -2.176 0 C-N-CA 122.604 2.203 . . . . 0.0 112.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 C-N-CA 122.559 2.173 . . . . 0.0 112.099 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -68.95 139.92 90.95 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.505 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.72 143.83 21.55 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.091 1.861 . . . . 0.0 112.079 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -79.81 155.25 75.65 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.1 150.48 72.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.933 1.755 . . . . 0.0 112.167 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.58 160.11 44.79 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.86 156.0 84.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.511 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.7 151.39 85.86 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.39 2.06 . . . . 0.0 111.883 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.91 165.77 33.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.835 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -85.47 136.91 33.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.039 0.447 . . . . 0.0 110.638 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -122.66 129.54 51.96 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.056 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.7 mp -130.72 130.08 64.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -69.99 83.09 0.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.383 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.838 179.591 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -58.65 159.27 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.005 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -137.83 154.05 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.087 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -92.43 123.7 35.94 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.426 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -111.15 106.73 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -91.25 133.18 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.383 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.28 -179.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.82 113.62 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -80.98 126.68 31.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.584 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.07 126.45 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.17 116.36 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.944 0.402 . . . . 0.0 110.301 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 m -136.71 173.06 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.366 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -125.8 155.32 72.92 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.135 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.72 -29.25 89.05 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 121.896 1.731 . . . . 0.0 111.761 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -85.19 -15.47 43.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.62 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.38 142.37 58.42 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.592 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -85.98 167.83 14.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 110.808 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . 0.407 HG23 HD11 ' C' ' 23' ' ' ILE . 25.3 mm -62.8 -35.57 71.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.95 -42.56 90.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.94 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -62.36 -42.2 99.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.9 -42.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.807 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -61.11 -41.09 96.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.272 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -59.61 -39.22 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -66.0 -41.14 89.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.157 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.76 11.05 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.62 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -120.45 -33.86 3.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -125.17 -14.91 6.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.057 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 12.52 75.87 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 28.6 mt -77.1 129.02 79.56 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.035 0.417 . . . . 0.0 110.083 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.69 154.78 59.35 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.243 1.962 . . . . 0.0 111.536 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.15 -37.77 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.927 1.751 . . . . 0.0 112.768 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.86 -43.79 98.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.625 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -83.06 -12.34 57.24 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -83.81 102.49 12.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.809 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -102.26 109.5 21.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 mp -98.41 109.62 22.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.69 128.38 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.821 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -132.93 132.45 42.01 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.842 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.35 26.67 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.37 14.19 81.02 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -119.5 133.79 55.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.782 0.325 . . . . 0.0 110.148 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -72.32 131.83 43.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.867 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -84.57 100.15 11.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.43 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.11 143.11 41.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.269 0.557 . . . . 0.0 111.171 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.0 144.44 55.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.68 -18.05 57.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.83 145.46 24.75 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.26 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -88.64 162.35 16.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.518 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.39 -38.88 88.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.803 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -62.41 -23.07 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.769 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.66 -37.42 83.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.682 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -96.42 14.28 24.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.56 39.21 25.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.925 0.393 . . . . 0.0 110.336 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.94 120.06 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.926 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.45 -179.04 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 110.902 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -60.23 145.77 46.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.934 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 59.67 23.67 12.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.8 t -74.06 124.39 26.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.05 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 37.9 m -73.54 128.43 35.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -115.35 140.07 49.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -88.17 108.01 19.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.737 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.44 120.6 40.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.688 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.59 138.96 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.155 0.502 . . . . 0.0 110.742 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.405 -178.831 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -64.79 161.98 17.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.867 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -143.67 147.41 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.95 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -94.95 121.43 36.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.053 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -103.41 111.28 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.519 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -95.6 124.53 39.67 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.739 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -83.5 172.78 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.347 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.2 -24.07 67.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.153 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 48.8 p -81.41 -8.51 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.22 63.16 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -62.67 131.06 47.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.412 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -108.15 133.3 52.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.92 108.78 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.904 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.72 124.12 28.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -122.52 129.72 52.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.405 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -74.38 114.95 13.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.52 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.28 170.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.187 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -120.88 153.95 57.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.55 -38.38 94.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.866 1.71 . . . . 0.0 112.169 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -70.52 -21.77 62.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.818 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.65 144.11 56.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -87.89 168.59 12.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.85 -36.24 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.865 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tm-20 -59.36 -41.56 89.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -62.72 -41.34 99.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.732 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.26 -42.28 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.605 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -60.76 -39.25 88.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.983 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.82 91.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.971 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -59.88 -39.32 84.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -64.57 -39.36 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.173 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.31 -39.7 83.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.863 0.363 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -68.14 -55.6 11.81 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.843 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -64.54 -40.67 96.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.096 0.474 . . . . 0.0 111.737 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.53 140.29 52.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.92 62.77 2.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.92 110.59 43.81 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.33 150.1 69.45 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.851 1.7 . . . . 0.0 110.739 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.77 -42.2 51.82 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.156 1.904 . . . . 0.0 112.87 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.63 -43.69 92.89 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.49 -41.76 99.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.046 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -84.91 142.39 29.72 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.287 0.565 . . . . 0.0 111.378 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -137.34 109.29 7.16 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.306 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -80.97 132.21 35.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.081 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 78.9 mt -131.38 128.88 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -147.78 153.93 39.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.858 0.361 . . . . 0.0 110.677 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.77 16.17 10.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.391 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.23 -7.93 76.19 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 110.8 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -67.21 133.84 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.221 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.85 104.49 4.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.291 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -75.84 153.05 37.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.75 154.43 41.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.72 20.96 64.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -130.43 140.02 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.355 . . . . 0.0 110.293 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -79.92 163.55 24.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.773 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 74.4 mt -66.03 -38.18 87.76 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.866 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.58 -23.72 67.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.132 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.96 -30.1 71.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 110.447 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -101.86 12.88 36.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.342 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.92 34.08 23.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.255 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 71.9 mt -80.16 104.57 8.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -93.09 178.84 5.62 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.73 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -62.39 142.8 57.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.001 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.07 16.06 10.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.558 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -67.64 133.8 50.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.4 m -89.57 116.08 27.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.792 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.45 129.7 34.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.288 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 64.2 tp -108.04 121.53 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.947 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.71 129.09 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 57.8 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.646 -178.942 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.822 0.344 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.6 112.44 24.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.178 0.513 . . . . 0.0 109.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.19 -37.34 83.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.793 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.55 162.07 4.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.813 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.46 122.47 0.36 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.179 0.514 . . . . 0.0 110.882 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.27 156.38 35.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.0 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -75.91 123.7 26.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.472 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 145.62 22.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.401 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.93 149.67 16.74 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -92.49 174.93 7.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.016 0.436 . . . . 0.0 111.106 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.1 mtp -135.12 173.57 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.9 m -122.52 120.98 35.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.2 tp -105.39 117.08 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.236 0.541 . . . . 0.0 110.244 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -122.05 116.9 25.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 -87.7 0.27 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.6 p -144.92 21.25 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.686 0.279 . . . . 0.0 110.799 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -123.03 131.23 53.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 110.478 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.7 t -109.75 123.31 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.045 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -116.76 137.07 23.41 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.249 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.77 146.57 54.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.776 1.651 . . . . 0.0 112.987 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -103.87 119.13 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.427 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.37 -16.2 53.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.46 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -70.25 82.72 0.54 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -62.32 136.41 57.91 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.398 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.1 -157.45 8.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.686 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tp -137.13 125.68 23.64 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.3 t -97.85 110.67 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -133.85 153.93 51.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.382 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.9 mt -119.27 137.75 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.232 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 130.35 34.61 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 123.624 0.578 . . . . 0.0 110.28 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -101.09 123.76 45.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.895 0.379 . . . . 0.0 110.013 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 p -83.2 172.17 12.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.704 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.89 -10.2 26.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.706 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.09 1.8 55.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.74 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 70.5 21.06 5.68 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 110.501 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.5 mt -97.74 120.72 38.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.433 HD13 HG22 ' A' ' 57' ' ' ILE . 50.8 mm -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -97.66 113.8 25.62 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.662 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -97.01 106.74 19.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.53 147.34 49.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.856 0.836 . . . . 0.0 112.929 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -122.02 116.21 23.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.57 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -105.39 144.32 32.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.298 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.91 131.31 35.2 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -72.61 -16.3 61.73 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.837 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.65 -45.33 92.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.04 -14.15 10.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.172 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.62 74.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -102.23 152.49 20.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.9 102.27 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.152 0.501 . . . . 0.0 110.475 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.897 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -126.75 145.01 50.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.24 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -157.5 101.46 1.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.145 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 mt -127.4 136.14 51.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.966 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.19 122.59 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.401 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.2 mm -113.2 122.55 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.777 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -87.23 162.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.518 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.95 140.61 92.67 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.006 1.804 . . . . 0.0 111.625 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t0 60.43 12.46 3.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.454 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.93 -21.85 23.38 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.039 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -148.77 169.07 21.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.396 0.617 . . . . 0.0 110.584 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -140.17 130.7 25.53 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.352 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -101.07 118.91 37.92 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -142.01 170.1 16.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.663 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.18 161.81 20.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -114.37 88.95 16.46 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.645 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.79 59.48 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.983 1.788 . . . . 0.0 112.105 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -115.41 -37.25 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.387 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 p -126.28 75.61 73.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.633 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.27 130.04 34.23 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.771 1.647 . . . . 0.0 111.196 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p 170.27 -41.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.13 -125.59 2.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.431 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -143.03 107.63 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.257 0.551 . . . . 0.0 110.384 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.62 132.49 70.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.595 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.99 155.5 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.45 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.25 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.027 0.441 . . . . 0.0 110.381 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.3 tp -101.15 121.92 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -119.19 133.05 55.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.091 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -83.43 115.48 22.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 0.0 109.678 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.77 -37.77 85.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.635 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.06 18.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.79 -179.91 26.55 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -115.25 18.03 16.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.704 0.288 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -95.28 144.41 25.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.407 . . . . 0.0 110.949 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.47 129.1 30.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.97 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -114.68 148.34 38.36 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.771 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -122.58 136.81 54.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.213 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.84 154.46 50.51 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.397 0.617 . . . . 0.0 111.246 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -126.58 136.37 52.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.056 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 139.2 57.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.272 0.558 . . . . 0.0 111.301 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -2.01 11.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.066 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.55 139.0 54.8 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.933 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.89 -39.41 91.6 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.972 1.781 . . . . 0.0 112.372 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -112.02 143.79 42.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.3 p -94.29 1.86 55.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.857 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -57.54 -20.46 32.02 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.55 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -118.76 -16.18 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.49 -41.6 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.855 0.359 . . . . 0.0 110.569 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.75 -40.88 97.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.03 -40.38 90.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.486 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -62.52 -39.54 93.87 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.728 0.775 . . . . 0.0 109.15 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.76 -45.52 93.99 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.54 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -65.94 -41.88 90.73 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.525 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -63.27 -38.34 90.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.301 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.17 -47.94 88.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.153 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -80.02 -29.75 39.4 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.714 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.17 -37.85 81.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.517 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -81.36 -31.85 33.19 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.767 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.5 mt -81.36 -24.79 36.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.75 -23.63 11.31 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -137.37 68.32 54.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.931 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.86 160.82 48.17 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 C-N-CA 122.849 2.366 . . . . 0.0 112.283 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.311 -1.431 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 -179.583 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.31 127.84 93.51 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.319 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.31 141.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.836 1.691 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.43 151.16 55.76 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.61 158.49 53.49 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.429 2.086 . . . . 0.0 112.222 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.6 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.709 2.273 . . . . 0.0 112.027 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -120.82 158.59 51.71 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.498 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.15 140.7 87.61 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.564 2.176 . . . . 0.0 112.19 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.37 162.94 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -86.96 136.81 32.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.495 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -124.06 127.65 48.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.285 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.4 mp -130.3 126.74 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.249 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -77.11 83.76 3.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.726 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.636 179.537 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -79.51 162.08 25.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.4 pt -141.91 149.88 19.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -97.42 126.94 42.97 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.817 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -110.12 116.92 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.292 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -101.27 133.52 45.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.589 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.0 110.803 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 120.863 0.363 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 105.04 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.442 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 134.81 42.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.075 0.464 . . . . 0.0 110.366 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 62.4 mt -132.21 132.91 43.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.965 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.53 117.63 18.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.52 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.09 -178.7 2.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -127.24 154.0 76.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.144 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.94 -27.83 85.78 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.016 1.811 . . . . 0.0 112.181 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.6 m -87.04 -10.04 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.692 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.69 142.94 58.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.023 0.44 . . . . 0.0 110.795 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -81.25 164.53 22.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . 0.401 HD11 HG21 ' C' ' 23' ' ' ILE . 45.3 mm -63.86 -38.83 83.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.988 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.71 -40.32 87.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.045 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.66 -42.97 99.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 0.0 110.393 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.64 -42.63 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.273 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -59.89 -38.93 83.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.597 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -41.83 96.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -59.67 -38.47 81.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.36 -39.54 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.816 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -58.66 -40.48 83.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.88 -41.62 71.1 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.417 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -65.75 -41.18 92.43 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.93 156.93 47.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.969 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.21 59.02 2.77 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 35.1 mm -112.28 114.89 50.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.53 162.31 41.73 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.825 1.683 . . . . 0.0 112.001 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.97 -36.72 96.31 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.419 2.079 . . . . 0.0 112.804 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.28 -39.6 95.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.428 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -88.49 -13.95 39.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.74 86.32 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.66 107.55 19.4 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.48 118.47 36.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.421 . . . . 0.0 110.663 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 84.7 mt -129.06 129.7 67.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.583 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -117.55 121.83 42.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.577 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.4 14.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.14 80.52 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -90.58 121.42 32.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -69.01 132.27 46.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 mt -85.01 101.73 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.124 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.3 144.8 42.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.18 143.49 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.203 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.65 -19.23 55.2 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -83.12 169.39 15.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -119.82 164.69 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.819 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.82 -40.56 93.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.501 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.6 -24.0 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.459 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.46 -37.67 84.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 110.476 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -97.99 15.41 24.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 57.51 40.45 27.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.346 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.53 107.61 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -96.52 179.09 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -58.16 149.12 24.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 57.82 40.58 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -94.67 123.13 37.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.007 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 8.3 m -76.8 131.07 38.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.24 141.1 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.578 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -91.01 108.32 19.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.989 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 64.9 tp -100.73 118.78 37.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.21 133.43 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.25 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.42 -178.506 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -58.13 159.84 5.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.169 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -139.69 141.4 34.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.349 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -83.93 123.8 30.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -109.78 103.75 15.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.5 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -94.45 122.91 37.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.841 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -82.71 179.36 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.129 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.87 -35.48 80.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.085 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -67.01 -14.92 63.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.792 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.05 59.13 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.55 131.01 47.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.275 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.7 m -104.15 132.59 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.806 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.16 107.14 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.872 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -81.85 127.67 33.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 93.4 mt -123.16 126.36 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.8 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -66.1 113.88 4.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -135.62 162.63 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.131 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.42 152.75 40.69 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.09 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.65 -37.24 91.22 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.988 1.792 . . . . 0.0 111.956 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -81.16 -8.64 59.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -57.92 138.1 56.11 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.014 0.435 . . . . 0.0 110.991 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -80.37 162.87 24.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.12 -39.34 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.071 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.5 -39.89 89.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -62.45 -42.67 99.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.112 0.482 . . . . 0.0 110.477 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.28 -42.71 96.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.655 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -60.23 -39.76 87.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.323 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.65 92.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.488 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -60.16 -38.83 84.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.71 -39.69 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.701 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.68 -40.94 93.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.17 -40.29 97.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -78.59 -71.41 0.43 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.892 0.377 . . . . 0.0 111.007 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.32 166.64 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.086 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.5 21.77 23.92 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . 0.44 HG21 HD13 ' D' ' 36' ' ' ILE . 27.1 mm -78.08 119.3 76.85 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.367 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.45 161.95 42.81 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.173 1.915 . . . . 0.0 111.538 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.12 -37.51 87.15 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.236 1.957 . . . . 0.0 112.479 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.3 -42.75 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.348 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -82.8 -12.52 57.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -80.86 80.57 7.31 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -97.8 94.59 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.15 129.67 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 49.1 mt -129.1 130.18 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.376 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -148.45 154.75 40.3 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.832 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.0 22.25 5.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.757 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 -2.24 77.62 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -132.26 150.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.08 0.467 . . . . 0.0 110.47 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -65.13 148.5 51.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.566 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -84.88 109.44 18.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.82 151.8 37.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.201 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -74.9 167.93 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.221 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.51 24.58 76.1 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -129.3 169.29 15.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.821 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.4 p -115.53 164.63 14.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.452 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.82 -39.66 95.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.7 p -62.72 -28.49 69.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.07 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.49 -35.97 79.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.025 0.441 . . . . 0.0 110.158 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -94.92 12.04 29.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.224 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 56.21 39.6 30.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.143 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.48 112.83 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -97.11 177.18 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.531 0.681 . . . . 0.0 111.133 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -61.7 142.58 57.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.121 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 65.13 18.61 11.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -70.55 130.79 42.78 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.94 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -82.32 126.3 31.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.09 142.85 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.06 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -89.19 117.67 28.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.232 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.7 100.26 11.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.31 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.68 128.83 38.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 -179.169 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -89.28 126.94 35.72 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.366 0.603 . . . . 0.0 110.208 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 83.4 mt -67.35 -38.46 84.87 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.878 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.48 161.99 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -173.06 122.14 0.39 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.048 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -153.51 153.16 31.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.68 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.51 123.38 21.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.572 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.46 145.69 23.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.266 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.15 151.74 17.69 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -89.25 172.61 8.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.419 . . . . 0.0 110.99 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.3 mtp -136.41 170.47 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.632 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.9 m -120.8 121.31 37.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 tp -104.57 118.26 36.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.639 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.55 107.23 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.743 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 -92.88 0.61 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.4 p -135.13 19.84 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.942 -0.152 . . . . 0.0 110.972 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -121.52 130.94 53.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.838 0.351 . . . . 0.0 110.369 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.8 t -112.31 124.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.194 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -116.51 136.15 23.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 147.18 45.46 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.956 1.771 . . . . 0.0 112.918 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -101.94 122.31 43.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.635 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -65.3 -11.34 40.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.762 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -73.8 78.79 1.58 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -55.47 137.36 48.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.86 -159.49 8.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.312 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tp -139.09 124.43 19.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -96.91 109.62 23.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.454 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -132.72 154.52 50.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.905 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 84.5 mt -120.8 141.77 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.625 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -142.85 140.95 31.48 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 123.75 0.657 . . . . 0.0 110.048 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -104.43 127.43 52.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.975 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 p -87.67 173.95 8.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.77 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.69 -11.08 22.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.822 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.21 -1.24 57.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.399 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.97 19.88 6.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 110.529 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.9 mt -101.96 128.79 48.22 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 57' ' ' ILE . 51.5 mm -82.21 127.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -104.99 114.82 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.112 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -89.57 107.77 19.27 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 95.0 m -119.36 140.8 49.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -121.59 114.08 20.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.187 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -105.99 147.61 28.65 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.348 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -79.8 137.19 36.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.737 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -76.55 -21.1 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.3 m -60.14 -45.17 93.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -116.48 -12.17 11.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.492 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.4 77.12 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.01 146.29 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.17 105.93 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.174 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -84.0 -31.55 25.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.832 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -128.12 147.92 50.56 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.392 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -158.7 99.14 1.55 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.7 134.53 50.66 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.645 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.3 mt -79.12 129.22 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.136 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -117.28 117.14 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.841 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -83.4 163.56 49.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.28 137.97 78.39 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.736 1.624 . . . . 0.0 111.003 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 58.25 14.29 2.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -90.02 -40.81 12.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.462 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -128.06 147.91 50.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.864 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -121.34 129.68 53.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.254 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.03 117.63 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.1 167.97 20.83 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.629 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -82.38 160.83 22.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.865 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.93 90.44 13.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.145 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.35 59.83 7.6 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.069 1.846 . . . . 0.0 112.342 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.12 -39.8 3.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.371 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 36.9 t -127.89 81.09 70.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.11 130.55 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.804 1.669 . . . . 0.0 111.528 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p 170.27 -39.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.887 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.7 -146.07 5.01 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.418 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.38 106.96 13.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.43 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -126.62 129.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.22 154.14 43.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.325 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.19 135.99 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 110.349 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.4 tp -104.65 118.29 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -117.45 131.2 56.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.194 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.84 114.81 23.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -31.6 70.93 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.449 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.93 -21.98 11.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.98 -23.25 78.26 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.827 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.79 12.24 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.563 0.22 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.81 155.81 30.52 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.797 0.332 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 143.78 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.747 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.8 mt -120.21 151.98 38.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.522 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -121.28 134.23 55.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.69 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.62 158.14 44.62 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.0 111.148 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -132.73 138.71 47.31 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.893 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 52.2 tpp -70.5 132.75 46.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.766 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.72 1.81 14.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.426 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -66.34 146.48 99.04 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.393 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.04 -40.47 84.74 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.923 1.748 . . . . 0.0 112.659 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -122.98 146.61 47.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.3 p -96.88 11.96 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -59.72 -21.46 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.368 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -116.63 6.32 13.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.95 -46.79 87.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.86 -40.88 97.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.042 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.06 -43.66 94.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.695 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -64.65 -40.97 96.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.755 0.788 . . . . 0.0 109.535 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.5 t -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.874 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 tpp85 -67.51 -42.33 83.0 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.44 -41.39 98.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.244 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.34 -47.77 86.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.15 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -63.93 -38.2 90.22 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.575 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.47 -29.46 63.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.219 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -83.01 -29.77 28.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.4 mt -89.23 -20.64 23.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.5 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -111.39 -23.99 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.154 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -134.51 72.45 69.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.83 150.83 75.24 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.744 2.296 . . . . 0.0 112.081 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 122.402 2.068 . . . . 0.0 112.088 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -71.18 149.38 94.37 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.692 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.02 150.32 29.63 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.182 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -81.91 153.47 69.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.166 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 158.96 53.65 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.413 2.075 . . . . 0.0 112.144 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.31 -169.27 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.783 2.322 . . . . 0.0 112.027 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -120.06 159.83 45.52 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.349 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.53 143.98 86.19 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.92 164.73 38.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -86.22 134.95 33.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -120.29 132.62 55.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.349 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.11 130.61 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.45 85.22 3.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.158 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.406 179.696 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.92 164.89 9.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.6 pt -144.35 141.05 24.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.193 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -86.12 123.85 31.88 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.847 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.07 116.83 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -95.08 121.74 37.01 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.757 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.22 179.859 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.66 110.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.841 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.0 m -81.31 130.15 34.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.092 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -122.32 131.41 53.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.701 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -71.94 116.03 11.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 110.729 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.08 164.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.394 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -105.33 153.22 39.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.223 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.41 -34.91 95.67 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.081 1.854 . . . . 0.0 112.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.53 -2.19 58.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.42 136.66 58.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 110.737 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 59.8 p -78.59 163.07 25.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.931 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' ILE . . . . . 0.421 HG22 HD12 ' C' ' 23' ' ' ILE . 40.3 mm -64.84 -41.27 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.429 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -58.16 -36.81 73.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.996 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.08 -41.76 94.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.382 0.611 . . . . 0.0 110.826 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.24 -42.27 94.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.588 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -60.82 -39.72 90.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.315 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.16 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.043 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.31 -39.17 86.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.15 -40.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.179 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -59.75 -41.11 90.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.326 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -40.47 96.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.153 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -63.7 1.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.47 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -107.05 159.66 16.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.893 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.23 55.25 3.99 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 33.8 mm -107.91 121.01 45.28 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.56 159.94 47.75 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.651 1.568 . . . . 0.0 111.868 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.93 -39.08 94.07 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.186 1.924 . . . . 0.0 112.47 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -61.48 -50.22 73.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -67.63 -39.69 84.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.692 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.2 96.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.279 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -104.24 110.75 23.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.68 117.91 30.49 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 92.4 mt -130.06 128.36 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.417 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -127.9 128.87 45.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.662 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 25.62 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.527 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.28 1.63 90.12 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.17 123.14 46.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -66.95 134.08 51.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.222 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.25 102.27 14.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.344 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -74.21 146.17 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.912 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.67 144.93 53.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.536 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.15 -15.38 63.3 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -83.22 168.09 17.08 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 56.9 p -116.45 161.76 18.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.74 -40.36 94.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.959 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.19 -24.68 67.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -62.78 -37.78 88.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.145 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -95.59 14.15 23.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.165 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.93 41.77 27.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.419 . . . . 0.0 110.171 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -91.87 106.16 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.667 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -92.51 -173.77 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.961 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.63 144.78 56.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.221 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 63.64 13.07 7.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.075 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -65.6 132.78 49.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -85.02 127.67 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 10.2 mp -119.39 140.38 50.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -86.15 123.72 31.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.171 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 66.5 tp -109.33 120.1 41.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.626 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.83 131.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.591 -178.711 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.02 162.59 16.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.17 146.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.942 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -90.58 101.14 13.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.686 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -87.75 101.03 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 132.65 41.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -64.45 -150.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.04 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.85 -40.01 87.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.589 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.96 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.123 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.46 -89.35 0.44 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.096 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.36 139.88 14.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.887 0.375 . . . . 0.0 110.762 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -126.43 137.78 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.833 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.65 111.7 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -85.78 125.78 33.51 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.126 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -122.63 130.42 52.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.56 115.97 13.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -133.65 166.3 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.616 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.46 152.66 44.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.893 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.7 -27.28 82.82 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.76 1.64 . . . . 0.0 111.765 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -87.36 -11.42 49.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.37 142.19 58.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 57.4 p -82.32 165.41 20.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -62.42 -38.75 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.8 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.29 -41.41 88.86 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -60.86 -42.82 98.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.569 . . . . 0.0 110.375 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -41.39 90.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.933 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -60.5 -40.09 90.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 110.485 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.36 91.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.393 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -59.78 -38.33 81.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' ILE . . . . . 0.414 HD11 HG22 ' D' ' 30' ' ' ILE . 82.4 mt -62.79 -39.73 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.371 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.66 -43.95 97.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.31 -20.15 62.23 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.985 -0.447 . . . . 0.0 111.871 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -102.9 -7.67 21.34 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -141.32 -43.8 0.37 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.252 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.16 14.92 10.3 Favored Glycine 0 C--N 1.321 -0.268 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.038 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -88.79 117.64 68.5 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.622 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.32 172.67 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.961 1.774 . . . . 0.0 111.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.67 -27.13 18.87 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.494 2.129 . . . . 0.0 111.763 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -100.24 -176.15 3.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.837 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 64.94 16.9 10.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.539 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -157.2 159.15 37.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.777 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -147.27 131.32 17.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 mt -100.49 114.52 28.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 77.0 mt -118.71 130.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.61 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -142.38 149.23 39.1 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.984 0.421 . . . . 0.0 111.192 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.25 15.78 10.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.14 64.23 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -114.62 142.34 46.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.102 0.477 . . . . 0.0 110.534 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -69.51 146.14 52.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.24 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 83.2 mt -84.32 115.66 22.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.477 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.23 138.81 42.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -60.13 147.93 37.83 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.77 68.13 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -84.08 167.77 16.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.776 0.288 . . . . 0.0 110.607 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -114.07 159.44 20.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.025 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.21 -39.89 94.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.714 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -63.61 -24.13 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -63.09 -38.1 89.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.079 0.466 . . . . 0.0 110.234 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -96.12 12.73 29.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.206 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.45 41.37 26.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.326 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.04 103.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -90.55 179.33 5.87 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.239 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -61.74 150.7 36.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.987 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 60.07 31.3 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 18.4 t -86.57 125.88 34.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.919 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 123.22 26.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.05 149.72 31.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.815 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -99.13 117.76 34.33 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.626 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 61.4 tp -100.69 112.73 25.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 66.7 t -112.6 123.52 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 61.4 mt . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.759 0.314 . . . . 0.0 110.534 -179.308 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -94.82 125.17 39.31 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.452 0.644 . . . . 0.0 110.419 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.87 -36.54 78.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.304 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.95 160.78 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.729 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -172.84 122.73 0.42 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.0 158.98 38.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -77.35 119.57 21.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.831 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.21 146.05 25.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.395 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.25 150.88 16.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -89.3 162.15 15.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.07 0.462 . . . . 0.0 111.031 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtm -133.23 168.54 18.36 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -121.75 134.24 54.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.653 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -115.42 118.96 34.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -123.8 120.76 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.926 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.0 -85.79 0.22 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.32 22.56 0.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.752 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -123.77 128.73 49.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.946 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.89 119.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 p -114.3 135.31 22.19 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.656 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.74 149.25 37.71 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.064 1.843 . . . . 0.0 112.856 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -105.53 142.91 34.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -80.61 -7.97 59.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -72.3 75.87 1.0 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -57.38 135.23 56.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.295 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.68 -159.15 8.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 tp -137.3 125.71 23.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.53 109.14 23.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.55 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 38.8 p90 -132.44 153.97 50.32 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.4 139.85 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.458 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 128.81 29.91 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 123.922 0.764 . . . . 0.0 110.736 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -99.29 124.23 44.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.7 p -85.11 170.74 12.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.414 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.03 -10.73 15.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.71 0.53 55.59 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.556 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.81 20.45 6.77 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.225 0.536 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.56 121.94 41.91 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 57' ' ' ILE . 50.5 mm -79.32 124.83 38.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.495 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -100.32 115.42 29.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.833 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.08 108.29 20.38 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -121.61 143.7 49.17 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.787 0.804 . . . . 0.0 112.836 -177.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -124.86 114.42 19.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.025 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -104.93 144.13 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.419 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -80.8 131.5 35.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -72.29 -18.43 61.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.899 0.381 . . . . 0.0 110.786 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.7 m -59.54 -45.43 91.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.649 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -117.09 -13.46 10.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.446 . . . . 0.0 110.32 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.36 23.73 74.89 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -102.15 152.16 21.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.82 102.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -76.16 -35.01 59.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.12 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -125.59 147.07 49.42 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.725 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -157.81 98.88 1.67 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.518 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.1 mt -128.9 133.04 47.76 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.901 0.382 . . . . 0.0 110.907 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.09 124.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.913 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.5 mm -111.37 128.15 68.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.076 0.465 . . . . 0.0 110.62 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -93.04 162.17 29.3 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.364 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.56 140.2 89.3 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.931 1.754 . . . . 0.0 111.362 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 59.52 13.2 3.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.249 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -87.28 -37.79 16.87 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-O 120.872 0.368 . . . . 0.0 110.415 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.8 m -131.75 153.41 50.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.261 0.553 . . . . 0.0 111.653 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -125.5 129.49 49.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -103.57 117.45 34.44 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.04 166.39 24.83 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.602 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -83.73 160.11 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.987 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.93 90.26 12.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.51 60.65 7.65 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.049 1.832 . . . . 0.0 112.31 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -114.01 -37.97 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.328 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.0 t -132.3 76.25 72.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.72 130.57 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.278 1.985 . . . . 0.0 111.435 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.83 -42.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.055 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.27 -149.72 6.18 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.408 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.26 105.68 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.0 t -125.19 127.71 72.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.13 152.23 46.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.2 p -128.35 137.85 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.457 . . . . 0.0 110.228 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 tp -102.33 120.22 40.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -118.47 134.86 54.73 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.49 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -84.36 117.03 23.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -61.24 -37.54 83.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.744 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -100.42 -10.28 21.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.728 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.83 152.92 17.15 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -93.18 22.02 5.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.331 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -118.33 144.85 45.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.912 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -139.72 152.79 46.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.958 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.1 mt -121.58 159.39 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.252 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.12 137.54 53.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.393 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.42 161.24 38.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.353 0.597 . . . . 0.0 111.088 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.76 140.56 40.7 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.637 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.9 mmm -72.77 139.1 46.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.143 0.497 . . . . 0.0 110.788 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.94 4.27 15.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.844 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.96 147.49 93.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.49 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.94 -38.93 65.25 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.812 1.674 . . . . 0.0 112.223 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -118.81 145.76 45.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.148 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.0 p -91.9 1.25 57.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.972 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.24 -19.79 48.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.364 0.415 . . . . 0.0 110.151 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.86 -17.42 10.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.29 -41.49 97.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.503 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.64 -41.06 98.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.388 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.92 -41.77 90.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.531 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -63.82 -39.91 95.36 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.698 0.761 . . . . 0.0 109.196 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m -62.41 -42.35 99.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.641 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -65.22 -43.96 89.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -61.88 -37.72 85.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.025 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.35 -48.76 84.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.24 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.54 -27.83 41.3 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.904 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.88 -37.99 79.39 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.482 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -80.91 -31.78 34.97 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.753 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.6 mt -82.16 -20.57 37.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -114.13 -17.36 11.93 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.116 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -146.56 72.88 12.82 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.753 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 160.95 45.42 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 123.03 2.487 . . . . 0.0 112.139 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.495 1.579 0 C-N-CA 122.651 2.234 . . . . 0.0 112.377 -179.556 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 50.12 71.89 1.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.83 144.09 99.51 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.913 2.408 . . . . 0.0 112.15 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.89 154.66 92.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.77 150.2 88.99 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.332 2.021 . . . . 0.0 111.824 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.5 -169.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.237 1.958 . . . . 0.0 112.319 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.04 154.86 76.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.86 143.32 85.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.252 1.968 . . . . 0.0 112.124 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -156.79 164.81 37.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.701 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -88.05 133.33 34.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -121.49 125.88 47.9 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.311 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.4 mp -129.83 120.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.506 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -81.53 83.71 6.93 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.962 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.583 179.458 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -63.2 158.77 19.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.558 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.27 149.76 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.166 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -91.82 124.31 35.86 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.697 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -108.64 114.09 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -91.55 123.86 35.28 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.308 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 67.3 p -84.28 174.86 9.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 111.101 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 86.8 mt -60.88 -38.56 86.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.35 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -72.84 -8.98 58.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.85 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.63 -10.65 64.74 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -63.58 126.5 27.74 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -98.87 133.61 42.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.99 0.424 . . . . 0.0 110.786 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.25 106.37 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.402 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 22.0 m -74.92 129.17 37.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.094 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.3 126.31 47.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.473 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.11 112.97 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -134.22 161.68 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.72 154.26 38.67 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.079 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.65 -36.74 98.39 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.151 1.901 . . . . 0.0 112.272 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.01 0.13 55.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -62.36 136.64 58.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 63.2 p -78.59 163.47 25.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.96 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.66 -37.7 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tm-20 -59.03 -42.17 89.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.914 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.89 -41.33 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 110.736 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.68 -42.99 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -60.87 -39.4 89.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.11 93.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.099 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.42 -39.95 89.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -64.69 -42.18 94.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.138 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.71 -39.73 89.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.85 7.34 15.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.412 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -115.83 -44.42 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.87 1.18 13.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.419 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.47 20.11 78.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 17.9 mm -79.83 120.87 81.35 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.05 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.1 150.7 54.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.72 1.614 . . . . 0.0 111.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -24.51 29.58 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -93.26 22.27 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.222 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -152.92 52.14 0.75 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 111.062 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -172.71 140.65 1.01 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.084 0.469 . . . . 0.0 110.856 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.93 128.47 43.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.254 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 64.0 mt -104.38 119.68 39.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.944 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.98 128.45 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.416 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -129.78 130.25 45.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.004 0.431 . . . . 0.0 111.002 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.36 16.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.603 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 2.17 89.87 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.64 125.78 51.09 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.88 0.34 . . . . 0.0 110.227 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -72.16 132.16 43.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -83.07 95.43 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.106 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.62 148.13 41.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.858 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -62.83 138.62 58.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 -18.31 54.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -84.24 177.5 8.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.14 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 64.7 p -126.3 165.76 18.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.38 -40.03 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.275 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -63.52 -28.28 69.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.55 -29.99 70.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.044 0.45 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.08 15.21 29.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 55.54 43.22 28.78 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.906 0.384 . . . . 0.0 110.251 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.38 109.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.045 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -97.55 -175.5 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.403 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -64.54 149.77 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.052 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 56.71 42.22 27.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.88 0.372 . . . . 0.0 110.903 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 53.6 m -100.02 127.53 46.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.099 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 89.1 m -77.24 127.67 33.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.68 142.24 47.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -85.99 117.77 25.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.27 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.46 123.56 48.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.01 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.69 131.97 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.55 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 31.2 mt -105.44 142.71 34.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.53 88.14 4.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.268 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 64.7 tp -64.62 -46.17 83.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.861 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -63.04 -38.86 92.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.901 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.69 13.76 80.93 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.34 -131.81 52.24 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.411 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -62.93 161.4 12.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.435 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -143.93 139.13 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.061 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -85.66 120.16 26.79 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.948 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.78 108.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.65 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.51 120.43 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -80.78 170.76 15.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.635 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.78 -22.5 66.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.154 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -87.58 -0.54 56.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.72 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.86 79.12 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -68.7 115.85 8.54 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 94.9 m -92.69 137.79 32.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.022 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.75 105.72 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 12.9 m -80.92 125.62 30.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 66.9 mt -122.32 123.47 41.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.17 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -65.79 108.84 2.25 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.45 163.66 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.717 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -108.98 149.79 40.08 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.01 -0.366 . . . . 0.0 110.01 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -42.47 65.26 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.851 1.701 . . . . 0.0 112.368 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -68.72 -19.77 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.245 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -58.0 136.7 57.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.384 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -79.62 166.2 22.12 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.849 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mm -66.25 -37.13 79.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.8 -44.27 86.22 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.65 -41.09 98.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 110.651 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.0 -41.87 94.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -60.3 -40.64 91.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.18 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.305 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.82 -38.77 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.8 -39.4 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.859 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' D' ' 35' ' ' GLY . 64.8 tt0 -59.83 -44.81 93.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.261 0.553 . . . . 0.0 109.946 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -65.99 -35.05 79.53 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.815 -0.553 . . . . 0.0 111.159 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -88.94 -4.02 58.57 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -147.61 -53.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.277 0.561 . . . . 0.0 110.467 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 117.22 13.51 7.59 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.6 mt -83.69 119.88 74.36 Favored Pre-proline 0 N--CA 1.447 -0.606 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.346 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.88 164.03 34.32 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.865 1.71 . . . . 0.0 111.338 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.25 -34.15 94.1 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.466 2.111 . . . . 0.0 112.666 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -92.52 -17.29 24.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.955 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -96.05 131.17 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.467 . . . . 0.0 111.522 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -133.9 103.18 5.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.83 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 81.3 mt -83.6 129.85 34.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.054 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 66.4 mt -129.33 130.94 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.68 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -150.59 155.62 39.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.741 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.45 20.62 7.17 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.545 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.91 -3.19 77.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -129.21 147.68 51.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.083 0.468 . . . . 0.0 110.73 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -69.86 140.67 53.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.351 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.48 144.91 46.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.392 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.33 -82.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.268 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 177.38 -72.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 110.572 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.14 -18.51 69.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -59.46 155.05 15.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.986 0.422 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -96.44 164.97 12.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.153 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.517 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -63.05 -23.91 67.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.405 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.47 -38.26 86.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.026 0.441 . . . . 0.0 110.354 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -97.49 15.25 23.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.192 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 56.34 39.11 30.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.247 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.68 103.7 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.786 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.32 178.76 5.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.0 110.824 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -61.8 150.04 38.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.906 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 59.67 17.94 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.172 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -67.59 129.08 38.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -85.49 105.42 16.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -93.35 142.6 27.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 123.1 34.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.272 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 28.3 tp -100.09 119.19 37.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.181 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 69.1 t -109.84 129.71 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 64.1 mt -110.01 137.39 47.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -78.83 -163.94 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.426 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -65.22 143.41 57.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 51.1 mmm-85 -98.25 26.82 5.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.264 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.46 7.11 72.82 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.742 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.643 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -68.36 152.98 44.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.33 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.05 126.43 37.14 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.41 0.624 . . . . 0.0 109.998 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -66.96 -38.53 86.26 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.942 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.15 161.42 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.898 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.67 122.88 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -153.5 157.51 39.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.486 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.71 120.6 19.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.603 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.33 145.4 23.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.72 154.66 16.63 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -87.21 156.89 19.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.812 0.339 . . . . 0.0 110.811 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 28.3 mtp -125.23 174.1 8.33 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.8 m -127.7 122.05 31.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 tp -107.86 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.96 0.409 . . . . 0.0 110.247 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.63 120.25 31.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.809 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.41 -90.19 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -144.32 21.85 1.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.506 0.193 . . . . 0.0 110.765 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.9 m -123.45 130.71 53.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -107.14 120.28 58.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.694 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.6 p -118.82 124.01 28.65 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.202 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 141.76 42.08 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.817 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -91.88 132.31 36.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.533 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -67.74 -7.6 28.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -74.42 75.24 1.91 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -53.1 136.14 36.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.211 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -161.17 9.86 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.357 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 tp -137.72 124.92 21.64 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.3 t -98.45 108.67 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -132.29 154.57 49.56 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.922 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 95.8 mt -121.52 141.11 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.786 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -142.9 141.9 31.62 Favored 'General case' 0 C--O 1.219 -0.505 0 O-C-N 123.716 0.635 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -104.99 129.17 53.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.188 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.1 p -89.01 173.57 8.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.73 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.16 -10.84 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.717 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.32 -1.07 57.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.445 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 t 70.12 20.9 6.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.284 0.564 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.2 mt -103.13 126.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.408 HG23 HD11 ' A' ' 57' ' ' ILE . 51.7 mm -80.54 127.83 39.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -104.41 117.91 35.34 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.709 0.631 . . . . 0.0 110.933 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -94.35 107.82 19.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 90.4 m -119.35 142.81 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.82 0.819 . . . . 0.0 112.978 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.38 114.17 19.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.2 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -105.91 145.22 31.56 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.566 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -80.74 131.54 35.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.33 -19.35 62.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.969 0.414 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.5 m -59.58 -45.58 91.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.719 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.3 m -117.1 -11.82 10.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.2 23.39 78.03 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.36 148.21 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 110.662 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.88 102.7 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.039 0.447 . . . . 0.0 110.691 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -75.5 -36.32 60.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -125.89 148.18 49.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.624 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -158.81 96.38 1.36 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.5 mt -125.48 132.53 52.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.98 129.03 36.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.9 mm -116.61 120.18 64.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.277 0.561 . . . . 0.0 110.62 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -84.37 160.51 56.75 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.244 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 140.09 92.53 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.679 1.586 . . . . 0.0 111.041 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.37 11.15 3.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.032 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -85.07 -27.67 26.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.653 0.263 . . . . 0.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.9 p -145.1 164.75 30.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.235 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -132.02 121.86 24.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.111 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -97.11 119.33 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -148.12 166.88 26.5 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.788 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -83.85 159.79 21.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.162 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.8 t -109.39 95.82 20.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.093 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.77 60.25 7.61 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.99 1.793 . . . . 0.0 112.428 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.51 -41.68 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.24 81.14 71.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.56 130.76 27.45 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.874 1.716 . . . . 0.0 111.646 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 169.68 -41.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.94 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.31 -150.06 6.43 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.99 105.74 13.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.814 0.34 . . . . 0.0 110.517 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.26 127.49 72.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 110.71 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.57 152.63 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.367 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.8 p -129.62 139.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.615 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.1 tp -99.95 116.7 32.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -103.31 106.74 17.32 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.24 -37.37 82.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.72 -22.92 12.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.726 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.66 81.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.639 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.7 m 58.6 18.04 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 110.992 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -117.15 152.0 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.504 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -128.56 135.5 49.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.858 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.5 mt -118.53 148.19 42.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -117.2 134.49 54.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.844 0.354 . . . . 0.0 111.097 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 156.44 46.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.219 0.533 . . . . 0.0 111.152 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -135.37 136.55 41.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.601 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.2 ttm -73.56 132.57 42.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.168 0.509 . . . . 0.0 111.372 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 3.14 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.969 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.12 142.31 92.77 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.84 -28.45 36.31 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.903 1.735 . . . . 0.0 112.674 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.41 141.92 51.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.267 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -98.28 10.64 40.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.45 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -54.27 -24.16 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.296 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -119.41 6.39 11.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.241 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.71 -46.16 90.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.919 0.39 . . . . 0.0 110.748 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.66 -41.08 98.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.76 -43.34 96.68 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.551 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -64.06 -41.09 97.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.79 -41.14 97.99 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.122 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.05 -42.84 79.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.494 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.26 -40.48 96.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.68 -49.06 81.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.766 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -65.33 -39.2 92.09 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.126 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -72.34 -26.18 61.83 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.496 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -88.12 -26.27 22.57 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.796 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.4 mt -94.21 -17.56 22.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.06 -22.39 9.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.202 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -134.44 72.18 70.64 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.053 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.81 151.47 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.806 2.337 . . . . 0.0 112.123 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 N--CA 1.494 1.503 0 C-N-CA 122.451 2.101 . . . . 0.0 112.127 -179.799 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.24 152.19 79.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.773 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.7 147.81 25.12 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.798 2.332 . . . . 0.0 112.024 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -82.42 154.02 68.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.228 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.17 150.95 82.02 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.141 1.894 . . . . 0.0 112.086 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.07 163.71 36.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -81.75 156.33 70.32 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -62.31 151.39 82.75 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.471 2.114 . . . . 0.0 112.124 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -151.76 164.04 37.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 111.087 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -85.65 134.68 33.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -117.94 132.48 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.536 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.1 mt -132.26 128.68 58.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.52 85.35 3.22 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.913 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.349 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.63 158.7 14.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.9 148.92 23.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.242 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -92.66 120.87 33.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.605 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -106.69 110.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.372 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -88.66 126.39 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.76 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -88.31 174.26 8.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 111.196 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.69 -37.09 85.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -69.01 -11.41 60.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.603 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.77 -12.21 62.67 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -65.66 127.77 33.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.142 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -100.77 131.05 46.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.296 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.89 116.61 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.46 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -84.05 130.32 34.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 94.0 mt -123.76 123.1 39.76 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.656 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.17 112.42 5.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.769 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.26 162.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -104.72 153.83 38.98 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.635 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.62 -35.64 93.22 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.056 1.837 . . . . 0.0 112.102 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -84.89 -5.74 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.105 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -59.56 136.96 58.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.012 0.434 . . . . 0.0 110.823 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -76.98 160.84 28.83 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.8 mm -64.41 -39.38 85.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.232 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.56 -40.78 88.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.89 -41.71 98.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 57.2 t -63.23 -42.78 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.544 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mtpt -59.02 -40.93 86.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.69 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.31 91.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.265 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -60.05 -38.85 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.85 -39.54 83.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.266 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.71 -38.86 82.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -68.81 -50.85 46.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.108 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -63.77 -42.74 97.73 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.02 150.42 49.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.964 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.13 55.7 2.73 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 27.7 mm -109.86 114.97 55.93 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.17 153.99 66.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.639 1.559 . . . . 0.0 112.056 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.77 -38.01 66.25 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.143 1.895 . . . . 0.0 112.385 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.13 -39.92 94.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.378 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -87.27 -9.44 54.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -80.9 88.95 5.85 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -99.11 105.27 17.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 21.5 mt -97.51 122.28 40.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.6 mt -128.72 123.09 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -112.48 114.51 27.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.447 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.97 49.94 20.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.4 27.84 73.58 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -127.75 102.96 7.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.393 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.09 132.07 51.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 41.9 mt -85.3 87.65 7.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.395 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.16 144.85 42.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -59.63 165.68 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.95 8.09 87.85 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.03 173.56 9.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.572 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -123.52 170.5 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.838 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.5 -39.95 92.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.354 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.1 -30.59 71.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.87 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.05 -28.68 69.76 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.008 0.432 . . . . 0.0 110.422 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -101.61 12.63 36.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.073 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.06 40.33 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -91.77 118.88 38.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.37 -179.25 3.9 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -63.58 149.67 45.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.733 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 59.86 18.73 7.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.216 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -74.44 129.15 37.23 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.29 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -80.46 129.85 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.225 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.4 mp -119.26 144.48 46.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.367 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -90.39 114.18 26.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.284 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 65.6 tp -101.88 120.5 40.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.896 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -118.6 132.9 67.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.955 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.2 mt -96.76 137.36 35.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -96.55 126.97 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.686 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -112.32 139.29 47.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.962 0.41 . . . . 0.0 110.458 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -63.18 -40.91 98.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.464 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.49 -41.41 99.78 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.57 -40.77 99.17 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.533 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -59.68 158.72 9.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -138.31 144.32 30.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.112 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.36 124.62 33.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.2 t -108.89 105.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.329 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 128.63 34.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.647 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -87.49 171.39 10.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.8 -29.15 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.303 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -78.09 -10.94 59.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 -12.66 56.08 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.48 125.55 26.05 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.232 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -98.11 135.27 40.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.291 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.47 109.93 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.565 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -84.9 129.3 34.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.45 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 89.0 mt -124.7 126.62 45.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.883 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -65.81 113.26 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.454 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.75 167.26 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 O-C-N 121.933 -0.479 . . . . 0.0 110.056 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -111.77 154.17 44.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.613 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.36 -26.58 83.03 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.116 1.877 . . . . 0.0 112.045 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.1 p -89.97 -12.04 39.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.03 142.83 57.3 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.144 0.497 . . . . 0.0 111.043 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -81.96 164.24 21.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.056 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 47.4 mm -62.02 -37.79 79.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.2 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -58.5 -40.32 82.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.37 -41.41 97.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 110.242 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 78.7 t -64.02 -42.51 95.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.574 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.83 -41.04 90.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.84 89.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.331 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -60.45 -40.11 89.96 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 79.6 mt -63.8 -41.48 92.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.699 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.82 -50.96 71.76 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.888 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -57.26 -24.05 52.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -96.9 -61.32 1.43 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.62 -25.39 22.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.907 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.27 11.54 64.48 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.385 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.09 121.49 80.67 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.908 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 149.36 55.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.519 1.48 . . . . 0.0 111.709 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.42 -41.75 65.25 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.889 1.726 . . . . 0.0 112.64 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.06 -40.59 74.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.98 -39.18 93.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.788 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.24 147.25 24.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.781 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -131.79 125.85 32.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 72.9 mt -91.41 122.67 34.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.482 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 81.9 mt -128.3 126.8 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.255 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.86 149.72 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 110.805 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.58 20.12 11.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.37 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.38 86.22 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -114.23 140.7 48.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -75.48 119.39 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.716 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.42 95.64 2.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.865 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.9 163.61 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 159.38 32.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.5 18.78 63.39 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -128.01 162.21 27.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.618 0.246 . . . . 0.0 110.576 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -113.43 160.81 18.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.399 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 78.2 mt -61.32 -40.11 92.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.688 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -63.34 -24.7 67.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 0.0 110.394 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -62.87 -37.46 86.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.091 0.472 . . . . 0.0 110.281 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -96.12 12.74 29.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.077 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.6 t30 57.15 40.37 28.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.005 0.431 . . . . 0.0 110.446 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 69.9 mt -86.98 108.91 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.055 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -94.58 -179.43 4.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -61.66 145.37 52.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 61.75 36.28 16.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.9 t -87.28 123.78 32.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.226 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -78.44 124.22 27.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -117.8 143.31 46.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.187 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -87.97 123.03 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 48.6 tp -103.42 109.6 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 52.5 t -98.31 134.28 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 81.9 mt -107.86 147.36 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.642 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -129.74 154.18 47.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.41 129.2 54.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.447 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -55.5 137.9 47.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.744 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.87 -153.41 19.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.896 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.86 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.0 m120 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.19 148.37 27.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.254 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -90.58 110.83 21.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.126 0.489 . . . . 0.0 109.694 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.3 mt -65.58 -38.45 89.58 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.649 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.19 162.51 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.163 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.08 122.35 0.31 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.01 156.69 36.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.92 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -71.89 123.81 23.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.53 143.71 18.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.188 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.89 153.11 16.92 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -91.73 170.98 9.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.87 0.367 . . . . 0.0 111.416 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 20.4 mtp -136.83 175.27 9.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.14 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.08 124.44 41.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.6 tp -106.08 117.89 35.21 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.446 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -121.46 110.48 16.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.057 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 -87.89 0.58 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 p -143.32 22.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.2 m -125.59 131.49 52.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.428 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.3 t -109.66 122.34 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.008 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.0 p -113.35 132.33 22.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.315 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.05 144.25 46.73 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.147 1.898 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.27 121.93 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.507 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -64.52 -12.52 45.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.851 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -73.17 74.48 1.27 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -54.99 135.32 48.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.08 -154.3 7.45 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tp -142.52 125.54 16.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.3 t -95.87 108.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.64 154.36 47.98 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.068 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 23' ' ' LEU . 91.4 mt -121.67 140.55 45.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.582 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -142.74 142.65 31.99 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 123.48 0.488 . . . . 0.0 110.191 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -105.84 128.28 53.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.285 0.564 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.3 p -87.84 172.06 9.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.606 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.89 -10.68 22.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.72 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.51 -1.1 56.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.452 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t 70.14 20.43 6.36 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.132 0.491 . . . . 0.0 110.962 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -104.15 127.54 51.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 57' ' ' ILE . 43.4 mm -80.18 128.17 38.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -105.08 116.62 32.26 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.551 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -98.02 107.27 19.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 147.2 47.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.822 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -119.94 111.64 18.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.899 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -102.03 134.45 45.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.279 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.7 137.57 40.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.864 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -78.49 -16.8 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -60.97 -45.62 94.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.501 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.3 m -117.07 -16.63 10.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.065 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.24 70.32 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -101.07 152.86 20.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.4 102.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -75.87 -37.53 58.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -126.65 145.58 50.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -159.17 100.71 1.55 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.328 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.7 mt -127.25 139.4 52.94 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.386 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.7 mt -77.72 127.23 38.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.6 mm -113.86 125.81 71.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.924 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -96.28 159.48 31.93 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.939 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.32 140.25 93.69 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.016 1.811 . . . . 0.0 111.348 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 62.34 13.18 5.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.031 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -95.44 -35.75 11.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 110.778 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 147.12 47.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -121.49 128.91 52.57 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.194 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -104.16 116.78 32.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -139.87 168.25 20.26 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -85.12 160.97 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.41 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.15 88.97 18.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.458 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.19 59.81 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.266 1.977 . . . . 0.0 112.005 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -114.5 -45.44 3.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.2 t -120.74 95.56 48.94 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.442 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.87 130.08 18.58 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.758 1.638 . . . . 0.0 111.658 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 167.93 -29.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.612 0.57 . . . . 0.0 110.315 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.7 -171.42 24.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.06 111.92 22.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 110.485 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.24 130.3 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.87 155.55 45.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.3 p -129.68 133.36 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.5 tp -100.74 119.83 39.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -119.01 129.6 55.22 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.474 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -87.66 116.5 25.84 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.62 -33.43 72.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.474 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.93 -19.04 10.55 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.191 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -75.61 -18.75 79.64 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 m 58.75 27.69 16.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -121.72 149.7 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.415 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -133.19 130.91 39.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.267 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 mt -120.99 148.87 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -119.8 135.32 54.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.4 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.47 153.26 48.82 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -128.46 134.7 48.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.561 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.0 mtp -77.62 139.01 39.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.967 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -100.82 7.76 43.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.043 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.38 134.21 86.93 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.522 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.2 -25.9 36.57 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.029 1.819 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.05 143.13 49.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 110.328 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.6 p -89.38 -1.05 57.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.97 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.22 -18.53 37.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -116.86 -17.38 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.42 -41.76 97.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.64 -40.61 95.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.082 0.467 . . . . 0.0 111.047 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -66.04 -41.67 90.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -62.41 -40.85 97.85 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.94 -43.26 99.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.04 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -67.73 -42.6 81.61 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.545 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.88 -43.02 97.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.656 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -57.38 -47.64 84.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.822 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.98 -39.46 93.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.048 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -72.69 -22.13 60.95 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.423 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.91 -26.87 19.1 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.809 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.8 mt -96.94 -16.22 20.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -118.04 -19.5 9.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -135.77 67.2 64.42 Favored Pre-proline 0 CA--C 1.519 -0.224 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.73 153.79 72.48 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 C-N-CA 122.459 2.106 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--N 1.312 -1.342 0 C-N-CA 122.545 2.163 . . . . 0.0 112.174 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -130.26 150.58 76.55 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.32 145.27 26.93 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.54 154.96 85.69 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.478 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 158.98 52.92 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.159 1.906 . . . . 0.0 112.451 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.54 -178.69 3.53 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.882 2.388 . . . . 0.0 111.935 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -115.33 158.89 40.2 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.67 141.79 83.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.069 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -153.68 164.11 38.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.2 139.48 31.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.972 0.415 . . . . 0.0 110.566 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.82 130.24 51.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.0 mp -131.48 126.71 58.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -74.58 83.65 2.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.116 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.539 179.644 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -62.48 160.96 12.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.59 153.9 31.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.277 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -96.61 124.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.681 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.12 113.56 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.532 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -86.93 131.46 34.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -91.13 177.39 6.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.719 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 92.6 mt -60.99 -37.59 83.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.788 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 30.8 p -76.42 -6.44 51.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.007 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.79 -8.48 73.79 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -62.08 129.26 40.02 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m -102.05 131.66 48.38 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.581 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.87 108.59 23.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.342 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 9.6 m -77.0 129.62 36.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.229 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.1 mt -124.28 123.9 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.619 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -69.57 115.48 8.87 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -137.67 164.79 27.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.619 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -106.77 154.28 40.23 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.97 -35.74 94.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.786 1.657 . . . . 0.0 111.968 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -82.78 -6.6 59.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.6 135.23 57.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.864 0.364 . . . . 0.0 110.803 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -78.61 163.34 25.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.966 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 48.1 mm -63.48 -38.65 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.267 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -59.17 -42.79 91.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.041 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -62.15 -41.15 98.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.561 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -63.44 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.789 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -61.24 -39.39 90.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.271 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.15 -40.73 94.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.259 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.66 -39.68 89.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.19 -40.01 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.98 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.41 -39.57 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.305 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.21 -43.36 86.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.393 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -71.4 -40.25 70.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -132.76 155.76 48.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.002 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.58 64.75 1.78 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.36 98.75 51.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 150.76 74.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.624 1.55 . . . . 0.0 112.016 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.23 -25.19 12.84 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.392 2.061 . . . . 0.0 112.39 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -90.08 31.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -167.23 31.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.814 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.36 97.81 5.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.64 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -97.08 107.16 19.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.497 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -102.9 120.87 41.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.222 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 95.1 mt -128.78 129.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.705 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -120.43 118.66 30.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.53 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.68 88.1 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptt -95.81 112.87 24.49 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -66.44 129.48 39.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.03 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.9 88.0 3.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.333 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.25 138.34 51.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.13 145.52 46.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.328 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.72 60.49 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -93.1 170.31 9.74 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 65.2 p -113.39 167.12 10.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.389 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.14 -39.86 94.0 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.3 p -63.09 -27.29 69.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.245 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.93 -35.96 79.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.009 0.433 . . . . 0.0 110.074 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -95.5 14.45 22.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.089 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.03 40.28 30.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.218 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.16 110.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.541 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -99.25 -170.26 1.89 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.029 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -65.03 145.78 55.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.513 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 57.24 41.02 27.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.035 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -91.7 122.19 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.103 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 63.8 m -72.61 127.13 31.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.204 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -118.79 147.25 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.23 113.18 25.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.271 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.7 tp -102.5 119.84 39.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.683 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.15 133.75 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 25.1 mt -102.68 133.84 47.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.376 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -86.93 136.7 32.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.412 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.85 118.0 35.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.395 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 54.33 39.11 30.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.403 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.31 146.24 45.59 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.55 -172.61 38.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.349 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.04 159.31 14.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.095 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -139.31 148.49 23.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.808 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-30 -91.95 113.92 26.31 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.898 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 64.1 t -97.88 108.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.641 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -94.92 121.87 36.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.752 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -81.02 172.99 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.99 -36.14 76.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.819 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.77 -10.96 60.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 -9.84 66.47 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.61 126.83 29.12 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -100.68 132.2 46.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.556 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.65 109.16 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.904 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -78.95 128.37 33.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.486 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 94.8 mt -124.32 121.83 36.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.389 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -67.03 113.71 5.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.306 0.574 . . . . 0.0 111.146 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 25.7 m -136.63 162.01 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.8 153.39 38.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.57 -39.34 91.64 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.873 1.715 . . . . 0.0 111.955 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -79.59 -8.75 59.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.083 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -58.24 135.6 57.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -76.15 161.78 28.54 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.3 -38.43 82.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.929 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.77 90.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.046 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.28 -42.04 99.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.131 0.491 . . . . 0.0 110.838 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.13 -43.5 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.23 -38.75 87.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.54 93.52 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.411 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mttp -59.68 -39.12 83.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.88 -39.98 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.336 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.26 -39.41 82.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.953 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -68.49 -51.04 47.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.759 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 65.9 mttt -65.17 -40.85 94.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -128.77 147.47 50.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.18 60.53 2.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -110.73 106.31 57.65 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.99 154.88 41.99 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.062 1.842 . . . . 0.0 111.766 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.29 -28.46 79.91 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.365 2.043 . . . . 0.0 112.781 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.84 -10.21 58.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.981 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.74 -52.93 3.44 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.24 116.36 7.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.356 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -116.23 103.65 10.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.56 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.79 129.06 34.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 55.0 mt -133.83 130.55 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.615 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -151.14 157.19 42.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.47 20.34 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.668 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.73 -6.09 75.61 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -129.16 150.06 50.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.128 0.49 . . . . 0.0 111.04 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -69.89 142.47 53.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.455 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mp -81.55 112.95 19.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.31 138.23 41.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.947 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -58.46 150.12 23.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.251 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.71 64.62 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -84.85 -178.59 6.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.936 0.398 . . . . 0.0 110.758 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -126.54 162.29 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.099 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.72 -39.56 94.45 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.68 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -63.75 -28.34 69.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.48 -34.59 75.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.029 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -97.84 12.37 34.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.432 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 m120 55.73 39.78 30.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.888 0.375 . . . . 0.0 110.23 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -86.59 106.8 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.35 177.19 6.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.629 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -61.33 150.26 35.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.347 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 61.73 13.07 5.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.935 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m -70.75 136.3 48.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -86.31 119.94 27.12 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.83 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -110.4 125.31 53.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.285 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -75.22 133.06 41.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 69.2 tp -112.56 115.84 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -103.94 129.08 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 47.8 mt -96.78 124.95 40.91 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.309 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 73.8 mtp85 -95.86 140.84 30.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.432 . . . . 0.0 110.848 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 tt -76.92 131.65 38.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.176 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 56.0 mmm-85 -64.54 137.09 57.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.878 0.371 . . . . 0.0 110.505 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.61 2.23 90.45 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.582 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.727 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -84.1 150.4 25.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.097 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -91.67 112.36 24.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.155 0.502 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.4 mt -66.64 -37.43 84.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.7 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.29 162.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.743 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.58 122.92 0.36 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.816 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.7 159.81 42.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.253 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -75.89 118.82 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.675 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.37 22.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.23 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.48 158.51 14.7 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -92.97 156.4 16.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.6 mtp -122.65 171.05 9.43 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.1 m -122.95 120.33 33.1 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.263 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -106.57 117.72 34.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.202 0.525 . . . . 0.0 110.337 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -123.45 118.21 26.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.521 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.68 -98.27 0.6 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.7 p -135.0 22.58 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.52 0.2 . . . . 0.0 111.074 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -124.37 130.76 53.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.802 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.15 124.46 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.7 p -124.03 118.21 26.88 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.09 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.5 148.38 66.64 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.541 1.494 . . . . 0.0 113.122 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.55 140.94 34.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.975 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -71.26 -7.37 46.51 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.947 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -70.01 78.52 0.49 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.24 133.76 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -162.7 10.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.216 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.0 tp -136.08 124.27 23.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.18 110.59 24.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -132.55 154.13 50.29 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.388 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.41 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.9 mt -119.42 136.5 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.918 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.47 130.99 33.43 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.509 0.506 . . . . 0.0 110.288 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -100.37 125.18 46.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.124 0.488 . . . . 0.0 109.986 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 p -84.78 172.17 11.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.575 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.54 -10.63 27.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.21 0.11 56.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.452 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t 70.66 21.32 5.38 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.148 0.499 . . . . 0.0 110.41 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.1 mt -99.28 123.67 43.75 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 57' ' ' ILE . 50.9 mm -81.17 122.2 35.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -99.01 114.56 27.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.719 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -96.54 109.08 21.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 142.99 51.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.229 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.71 116.53 28.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.458 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -106.42 133.25 51.4 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.04 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.489 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -72.03 -19.86 61.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.029 0.442 . . . . 0.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.2 m -60.09 -44.82 94.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.044 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -115.37 -15.49 11.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.74 20.31 79.77 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.08 146.78 27.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.62 102.32 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.187 0.518 . . . . 0.0 109.824 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.17 -38.26 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -126.63 144.91 50.75 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.087 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -157.78 101.56 1.81 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.246 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.2 mt -127.9 136.31 51.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.01 123.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 mm -110.77 131.6 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.234 0.54 . . . . 0.0 111.169 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -95.7 159.62 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.928 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.72 139.95 91.96 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.686 1.591 . . . . 0.0 111.23 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 61.68 11.2 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.334 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -88.25 -22.53 23.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.178 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.5 p -147.93 164.91 32.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.519 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -137.7 127.27 25.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.58 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -97.05 121.39 38.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -144.93 163.47 34.06 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.544 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 -88.41 157.03 18.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.225 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.95 88.78 10.51 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.45 60.97 8.03 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.995 1.797 . . . . 0.0 112.028 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -112.99 -48.87 2.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.136 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.22 102.2 54.64 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.165 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.64 130.75 16.32 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.435 1.424 . . . . 0.0 111.691 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 168.22 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.74 -179.06 33.32 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.01 109.68 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.91 127.58 75.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.301 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.62 152.35 43.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.03 140.48 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.21 122.49 40.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -109.34 110.08 21.14 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -73.62 105.1 4.8 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -60.99 -37.78 83.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.611 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.66 -20.49 17.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.633 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.82 140.8 15.14 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -83.78 52.84 2.37 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.169 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -140.22 144.32 36.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -130.94 138.45 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.181 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.5 mt -116.24 149.4 39.23 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -118.92 134.82 54.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.766 0.317 . . . . 0.0 111.133 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.93 155.97 47.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.326 0.584 . . . . 0.0 111.259 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -133.28 138.48 46.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.492 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.3 tpp -73.17 129.04 37.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.331 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -5.7 19.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.482 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.84 146.35 97.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.34 -25.82 15.12 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.091 1.861 . . . . 0.0 112.882 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -119.7 141.96 48.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.9 p -96.98 10.81 38.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.492 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.36 -20.43 59.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -125.92 6.75 7.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.423 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.63 -50.23 73.38 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.164 0.507 . . . . 0.0 110.769 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -65.22 -40.47 94.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.225 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.65 -44.64 96.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.89 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -64.59 -40.09 94.9 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.648 0.737 . . . . 0.0 109.498 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.0 m -64.2 -41.58 97.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.141 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -67.18 -41.79 85.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -64.97 -35.77 82.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.364 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.54 -48.26 87.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.111 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.15 -30.23 38.92 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.859 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -67.68 -37.92 83.0 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -81.03 -33.8 33.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.57 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.4 mt -77.79 -27.0 50.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -106.98 -23.3 12.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.386 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -140.08 67.74 33.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.132 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.68 160.86 46.96 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.997 2.465 . . . . 0.0 112.391 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.31 -1.496 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 -179.494 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -71.37 149.15 93.85 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.65 146.03 53.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.598 2.199 . . . . 0.0 112.675 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.74 161.78 62.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.94 149.82 81.77 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.554 2.17 . . . . 0.0 112.238 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.33 163.08 39.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.443 2.095 . . . . 0.0 112.151 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -74.74 156.79 86.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.52 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.86 147.09 83.3 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.62 162.57 41.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -86.22 137.79 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -115.72 127.64 55.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.92 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.39 121.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -81.45 85.21 6.51 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.078 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.296 179.714 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -58.76 159.33 6.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.7 pt -140.22 141.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.274 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -85.28 124.06 31.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.75 112.26 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -96.82 119.73 35.85 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.876 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -112.56 178.61 4.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.172 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -45.04 159.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.239 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p 66.11 8.49 5.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.887 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.09 29.07 73.23 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -84.98 111.34 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.783 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m -96.4 131.57 42.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.955 0.407 . . . . 0.0 110.706 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.62 113.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.271 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -85.8 131.96 34.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 25.9 mt -124.19 125.64 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.343 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.41 112.79 4.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 110.907 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.18 162.89 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.323 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -104.19 154.5 38.19 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.55 -37.22 95.31 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.947 1.765 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -79.56 -7.88 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.13 135.35 53.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.981 0.419 . . . . 0.0 110.865 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -78.25 161.58 27.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.76 -41.38 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.066 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.93 -36.17 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.083 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.02 -41.28 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.32 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.81 -42.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.468 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -60.81 -40.93 94.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.603 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -40.11 94.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.958 0.409 . . . . 0.0 110.478 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -60.21 -39.07 85.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.341 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.92 -39.07 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.165 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.7 -40.96 85.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.22 -41.92 72.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -66.09 -42.34 89.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.924 0.392 . . . . 0.0 112.039 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -136.83 154.98 50.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.992 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 57.07 3.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mm -109.8 106.26 58.12 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.81 153.41 56.78 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.707 1.605 . . . . 0.0 111.672 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.74 -39.56 76.52 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.015 1.81 . . . . 0.0 112.366 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -39.09 91.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 0.0 110.322 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -86.58 -6.48 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.204 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -88.24 77.43 8.25 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.978 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -84.11 107.81 16.67 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 17.3 mt -99.16 119.26 37.57 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.009 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -126.51 127.75 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.354 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -130.41 129.65 43.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.86 25.59 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.66 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.14 2.69 90.59 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -108.14 126.17 52.46 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 122.538 -0.39 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -72.08 133.58 45.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.209 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.23 102.91 6.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 110.287 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.22 139.96 42.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.946 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -61.56 137.08 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.241 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -17.37 55.64 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -83.4 -179.96 7.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.828 0.346 . . . . 0.0 110.359 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -127.32 165.41 19.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.0 -40.09 94.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.308 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -63.45 -27.6 69.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.007 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.53 -35.23 77.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 109.894 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.68 12.88 32.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.244 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.68 41.46 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.26 109.17 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.06 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.28 -176.08 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.504 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -66.05 148.14 52.27 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.34 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 58.21 41.11 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 42.8 m -93.68 125.07 38.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.258 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 41.7 m -75.76 128.83 36.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.831 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.64 152.05 33.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -101.83 112.62 25.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.91 128.61 53.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.448 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -124.46 136.12 61.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.151 0.501 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mt -97.78 153.5 18.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.366 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -99.0 129.8 45.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.425 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 86.6 mt -122.02 147.03 46.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.616 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -60.44 -43.88 96.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.785 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.95 173.05 45.05 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.13 -177.06 47.23 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 33.7 t0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.547 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -62.26 160.0 13.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 pt -142.83 146.93 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -95.34 123.27 38.78 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.755 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 83.8 t -104.96 110.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.44 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -97.8 132.69 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.524 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -88.27 -178.32 5.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.081 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.92 -37.02 83.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.302 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.9 p -73.72 -9.6 58.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.71 -6.45 67.47 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.654 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -59.07 121.79 12.16 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -100.66 133.11 45.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.046 0.45 . . . . 0.0 110.902 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.76 108.44 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 129.47 34.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.092 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 66.9 mt -127.35 126.3 42.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.541 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.1 114.63 10.41 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.35 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.71 164.14 33.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.716 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -110.68 155.62 41.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.051 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.02 -36.59 96.26 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.087 1.858 . . . . 0.0 111.763 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -77.45 -10.06 59.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.046 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -57.76 137.2 56.78 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -78.84 160.97 27.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.3 -43.02 98.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.185 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -59.93 -34.51 73.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.257 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -64.92 -42.71 94.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.138 0.494 . . . . 0.0 110.71 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.36 -43.22 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.549 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.24 -38.85 88.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.56 87.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.059 0.457 . . . . 0.0 109.796 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -60.03 -37.18 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 6.2 mm -62.85 -39.46 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.89 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.2 -45.27 93.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.512 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.82 -38.22 90.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.783 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -90.19 -4.4 57.26 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -148.1 -47.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 8.41 32.79 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -80.42 120.69 80.12 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.43 156.98 62.68 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.259 1.306 . . . . 0.0 111.419 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -51.85 -36.04 61.73 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.163 1.908 . . . . 0.0 112.429 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -67.37 -46.02 74.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.54 -40.32 95.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -98.68 151.03 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.37 0.605 . . . . 0.0 111.424 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -133.34 118.05 18.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.499 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 66.2 mt -86.15 122.29 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -125.19 130.24 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.745 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -153.45 156.22 37.77 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.32 19.03 9.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.719 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -6.74 74.22 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -126.79 149.76 49.49 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 110.598 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -73.71 137.07 43.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.474 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mp -83.53 112.2 19.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.841 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -75.23 175.93 7.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.734 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.28 162.89 21.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.454 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.17 -151.08 41.61 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 51.69 179.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.334 0.588 . . . . 0.0 111.462 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 71.8 p -131.69 170.31 14.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.68 -39.63 92.13 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.401 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -65.37 -27.36 68.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.01 -28.08 69.85 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.137 0.494 . . . . 0.0 110.067 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -103.49 14.73 30.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.326 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 57.02 39.46 29.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.597 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 81.2 mt -88.69 117.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.078 0.466 . . . . 0.0 110.136 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -101.18 176.51 5.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.387 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -60.43 150.74 30.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.902 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 60.11 14.87 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.185 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -63.47 136.39 57.56 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -95.38 107.13 19.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.93 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.9 mp -92.34 155.81 17.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.254 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -106.69 124.12 49.14 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.76 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -99.89 92.88 5.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.36 129.81 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 65.1 mt -95.13 134.91 37.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.011 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -63.56 -40.37 96.8 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.116 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.93 128.14 24.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 110.414 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -67.85 135.36 52.41 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.876 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.99 -14.96 62.25 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.777 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.408 179.548 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -69.65 145.97 52.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.189 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -93.74 126.27 38.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.249 0.547 . . . . 0.0 109.913 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.8 mt -68.99 -37.33 78.67 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.973 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.99 160.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.802 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -173.87 122.22 0.32 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -152.77 157.24 40.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -76.31 121.82 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.09 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.88 143.95 22.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.648 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.42 151.47 17.45 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -95.12 157.14 16.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.916 0.389 . . . . 0.0 110.974 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 43.0 mtp -121.84 172.77 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.1 m -122.44 122.43 38.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.211 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.7 tp -106.45 118.99 38.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.729 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -121.25 111.54 17.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.437 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -102.11 1.0 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.5 p -127.62 20.38 6.64 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.359 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.7 m -122.32 129.88 52.6 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.74 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.01 123.88 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.705 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 p -115.59 134.88 22.59 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.58 143.85 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.72 1.613 . . . . 0.0 112.305 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -106.57 131.49 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -72.35 -7.18 48.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.153 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -73.14 75.96 1.26 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -57.42 131.06 48.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.18 -160.25 10.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.523 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 tp -136.42 124.67 23.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.2 t -98.03 111.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.304 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -133.86 155.7 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.917 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.94 140.24 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.389 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -141.38 141.64 33.79 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.096 0.474 . . . . 0.0 110.136 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -106.1 127.58 53.29 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 p -88.48 172.46 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.477 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.53 -10.73 19.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.073 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.14 0.18 55.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.262 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t 68.46 21.76 8.07 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 110.482 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.2 mt -101.7 124.69 47.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 57' ' ' ILE . 50.9 mm -80.84 125.73 39.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -102.79 116.42 32.53 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.571 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -92.5 109.35 20.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.4 m -120.69 144.84 48.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.877 0.846 . . . . 0.0 112.904 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.98 114.08 18.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.183 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -107.53 131.31 54.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.295 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -73.03 131.98 42.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -72.51 -19.12 61.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 110.415 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -60.24 -45.07 94.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.15 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.8 p -116.0 -15.18 11.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 20.59 79.48 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -101.62 145.49 28.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.4 t -73.98 103.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.261 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -78.44 -31.55 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -126.77 145.89 50.44 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.641 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -157.53 98.73 1.7 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.332 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.9 mt -128.07 134.47 49.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.563 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.6 127.29 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.3 mm -113.77 123.55 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.905 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -90.33 163.23 32.04 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.114 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.62 140.66 90.65 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.072 1.848 . . . . 0.0 111.309 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 59.89 13.61 3.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.246 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -90.15 -32.34 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.502 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 71.4 m -134.95 152.37 51.67 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.331 0.586 . . . . 0.0 111.93 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.29 129.11 48.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.58 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.94 118.73 37.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -144.35 166.58 24.7 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.9 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -88.69 159.69 17.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.956 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 t -114.83 89.76 20.29 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.47 59.98 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.015 1.81 . . . . 0.0 111.972 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -47.43 2.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.8 t -114.27 99.33 50.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.96 130.03 16.13 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.559 1.506 . . . . 0.0 111.488 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.6 -35.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.682 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.37 176.67 36.13 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -81.12 113.82 19.55 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.916 0.389 . . . . 0.0 110.783 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.97 125.16 67.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.969 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.79 152.34 35.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.307 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 p -131.23 135.95 58.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.0 110.125 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.6 tp -102.53 118.11 36.16 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -113.83 132.6 55.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.616 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -85.17 116.07 23.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.244 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.48 -37.1 82.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.03 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.19 -24.13 8.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.104 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.13 72.14 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 p 81.57 -6.11 1.52 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 124.128 0.546 . . . . 0.0 110.721 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -79.7 148.19 31.66 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.259 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -133.76 133.43 41.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.795 0.331 . . . . 0.0 110.479 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.7 mt -121.74 152.8 39.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.033 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.05 137.69 54.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.912 0.386 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.98 159.93 41.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -136.99 139.83 41.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.013 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.13 131.04 49.85 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 111.282 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.42 0.89 10.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.73 147.82 81.68 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.27 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.77 -40.07 67.14 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.814 1.676 . . . . 0.0 112.299 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.92 144.54 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.7 p -100.28 12.01 38.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.633 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -55.76 -20.76 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.965 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -124.06 17.48 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.702 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.54 -45.48 93.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -71.63 -34.82 70.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.432 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -44.43 88.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -64.14 -39.78 94.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.8 -46.03 91.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.749 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -65.64 -43.15 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.262 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -62.72 -39.82 95.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.544 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.51 -47.77 89.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.408 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -79.87 -24.93 40.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.936 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -69.59 -42.38 74.54 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.866 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -79.0 -35.45 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.674 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 80.4 mt -71.34 -36.05 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -98.84 -27.79 13.76 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.497 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -132.89 76.25 70.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.353 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.58 155.57 36.09 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.819 2.346 . . . . 0.0 112.037 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.492 1.429 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 -179.406 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.62 149.24 90.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.12 148.04 38.97 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.29 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -73.89 151.7 88.72 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.35 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.97 156.44 47.7 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.021 . . . . 0.0 112.372 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -61.71 -169.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.439 2.093 . . . . 0.0 112.023 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.09 157.24 77.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 140.01 82.59 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.42 2.08 . . . . 0.0 112.338 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -157.59 164.73 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.621 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -86.32 136.73 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -118.05 129.7 55.72 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.723 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.19 132.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.15 84.64 0.74 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.326 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.472 179.578 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -64.23 161.48 16.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.489 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -142.1 145.22 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.045 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -87.87 122.77 31.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.826 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.86 108.73 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.169 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -89.63 124.23 34.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.651 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -75.37 -166.69 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.347 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.45 -28.17 66.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.394 . . . . 0.0 109.993 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 14.3 p -103.71 -178.38 3.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.227 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.23 -19.12 56.86 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -53.21 129.66 32.11 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.975 0.417 . . . . 0.0 110.618 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.7 m -124.48 138.82 54.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.684 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 111.94 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.496 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 37.4 m -83.05 129.77 35.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.691 -0.404 . . . . 0.0 109.911 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.56 131.76 53.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.57 114.14 10.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.941 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -136.1 165.43 29.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -107.13 152.36 41.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.1 -37.43 94.04 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.054 1.836 . . . . 0.0 112.096 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -82.27 -8.34 59.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.237 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -58.39 137.35 57.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 50.0 p -79.08 163.52 25.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.88 -37.39 80.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.804 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -43.4 90.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.46 -41.9 99.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.025 0.44 . . . . 0.0 110.81 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.18 -43.07 98.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.812 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.89 -39.48 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.71 91.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.058 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.61 -40.08 90.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.18 -40.39 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.111 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.96 -44.31 94.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.201 0.524 . . . . 0.0 110.206 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -74.24 -17.86 60.82 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -101.02 -4.62 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -149.56 -46.01 0.14 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 110.456 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 3.26 26.62 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.072 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . 0.428 HD13 HG22 ' C' ' 36' ' ' ILE . 32.7 mm -65.99 117.22 40.3 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.863 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.39 150.17 86.21 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.108 1.872 . . . . 0.0 112.089 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.88 -38.05 67.54 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.996 1.798 . . . . 0.0 112.482 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.26 -40.22 96.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.819 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.44 -4.61 59.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -84.68 103.1 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.53 103.2 12.46 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.0 mt -100.34 119.91 39.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -127.46 128.22 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.138 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -129.33 126.75 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 110.798 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.03 27.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.727 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.86 2.08 89.99 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -106.38 117.59 34.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -69.28 127.78 34.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.82 98.17 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.121 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.07 146.58 47.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.136 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.03 137.7 58.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.482 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.96 -17.0 57.86 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -83.44 175.27 9.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.706 0.289 . . . . 0.0 110.263 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -121.58 164.61 16.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.68 -40.14 96.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.469 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.0 p -64.1 -26.26 68.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.989 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.864 0.364 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -104.02 14.03 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.346 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 57.06 40.2 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.401 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.3 mt -90.66 107.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.157 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.81 -173.48 3.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.285 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -67.0 150.2 49.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.059 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 55.44 39.86 31.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.024 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -93.46 126.64 38.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.097 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 43.8 m -76.18 129.18 36.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.157 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.11 146.55 45.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.395 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.33 112.58 24.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.551 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.3 tp -104.46 121.57 43.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.666 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -121.51 138.06 53.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.893 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 22.7 mt -103.07 137.37 41.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.114 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -72.2 143.02 49.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.792 0.33 . . . . 0.0 110.86 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.19 -39.32 92.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.971 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 mmt-85 58.65 22.8 10.28 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.688 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.46 -41.36 99.53 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.05 -131.05 51.85 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 118.1 -0.953 . . . . 0.0 110.477 179.749 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -62.65 161.57 12.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.093 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.7 pt -139.55 139.32 38.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.013 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -83.4 121.38 27.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.465 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -110.26 98.76 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -84.59 123.81 30.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 110.917 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 80.9 p -86.66 173.45 9.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.981 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 70.6 mt -63.14 -24.67 68.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -71.89 -14.78 62.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.68 -15.54 59.64 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -70.92 141.8 51.12 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 95.6 m -104.88 132.61 50.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.083 0.468 . . . . 0.0 110.96 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.67 101.52 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.174 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -83.53 122.7 28.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 79.2 mt -121.98 129.13 52.22 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.823 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.59 115.49 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.654 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.93 177.07 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.614 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.99 156.22 69.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.392 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.27 -43.55 54.95 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.935 1.757 . . . . 0.0 112.073 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 82.7 p -72.35 -14.66 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -57.8 138.82 55.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.963 0.411 . . . . 0.0 110.638 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -80.97 161.66 24.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.785 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.7 mm -64.24 -41.29 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.081 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -58.3 -35.78 72.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.322 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -65.14 -43.48 91.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.483 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.41 -41.81 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.168 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -60.55 -39.03 86.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.227 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.4 90.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 0.0 110.136 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -60.44 -39.08 86.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.81 -40.75 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.096 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.06 -41.38 92.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.23 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.59 -41.4 97.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -78.38 -76.73 0.18 Allowed 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.779 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.58 152.9 24.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.86 53.02 4.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mm -107.92 113.9 60.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.967 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.61 155.78 62.46 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.94 1.76 . . . . 0.0 112.147 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.72 -27.05 49.96 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.337 2.025 . . . . 0.0 112.603 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -83.36 -1.66 53.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.447 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -114.47 -49.18 2.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.557 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.12 128.1 35.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.037 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mmt-85 -126.99 102.51 7.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -76.13 125.55 29.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -130.59 130.76 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -151.77 155.29 37.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.23 21.6 5.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 0.04 85.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -136.08 149.74 48.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.505 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -68.48 148.28 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.473 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 68.0 mt -83.01 117.11 22.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.691 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -76.12 137.99 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.1 142.81 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 0.0 110.345 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.98 -15.84 62.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -83.11 163.8 20.65 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.699 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -104.77 171.09 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.222 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 mp -71.27 -38.81 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.071 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -62.77 -25.82 68.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.54 -37.73 87.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.113 0.482 . . . . 0.0 110.374 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.19 11.3 34.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.274 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 56.14 40.19 30.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 110.435 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -85.56 109.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -94.22 178.1 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.673 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.25 146.09 49.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 63.61 14.71 8.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.331 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -63.37 135.11 56.76 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -91.1 121.97 33.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.93 0.395 . . . . 0.0 110.313 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.07 144.85 45.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.333 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -90.48 129.75 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.515 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tt -104.24 101.53 11.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.798 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.74 132.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 57.2 mt -98.51 134.59 41.26 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -135.68 168.28 19.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.762 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.91 146.0 55.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.156 0.503 . . . . 0.0 111.096 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -69.06 176.41 3.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.725 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.7 -39.76 95.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.56 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -80.88 142.77 33.27 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.166 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.17 115.26 27.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.87 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' ILE . 98.0 mt -66.81 -36.7 82.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.361 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -151.22 163.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.419 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.77 122.84 0.34 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.224 0.535 . . . . 0.0 110.988 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -156.21 159.54 39.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.034 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -77.9 118.79 20.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.636 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.45 139.87 20.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.955 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.17 151.53 17.55 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -88.06 154.77 20.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.968 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.6 mtp -122.33 171.75 8.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -121.94 125.84 47.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.472 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.5 tp -107.29 119.2 38.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.443 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -119.11 107.83 13.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.805 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 -94.28 0.63 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.0 p -133.98 21.54 3.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.459 0.171 . . . . 0.0 110.79 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.8 m -124.46 131.23 53.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.41 125.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.107 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.7 p -119.8 138.07 26.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.623 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.55 142.84 29.9 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.84 1.693 . . . . 0.0 112.405 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.66 135.73 44.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.614 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.84 -6.78 47.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.934 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -77.72 62.2 2.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -56.02 133.8 52.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.62 -152.08 7.81 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tp -138.2 125.01 21.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.67 107.02 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -131.08 152.72 50.08 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.791 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.4 mt -120.57 140.52 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -140.66 143.49 35.16 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.624 0.577 . . . . 0.0 109.831 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -107.23 127.44 53.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.309 0.576 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 p -86.58 172.1 10.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.952 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -11.34 22.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.662 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.52 3.45 47.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.46 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.6 m 64.79 22.89 12.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.154 0.502 . . . . 0.0 111.065 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.9 mt -102.5 126.08 49.43 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG21 HD12 ' A' ' 57' ' ' ILE . 46.7 mm -80.56 126.87 39.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.3 m-70 -103.78 117.74 35.07 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.489 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -94.34 107.97 19.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.9 m -120.87 144.04 48.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.708 0.766 . . . . 0.0 112.681 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -125.09 112.09 16.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.616 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -105.34 133.09 50.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.345 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.51 138.55 47.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.053 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.8 -18.55 50.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.607 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.4 m -60.53 -45.79 92.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.5 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.6 m -116.84 -13.93 10.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.5 23.66 76.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -102.56 144.15 31.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.383 . . . . 0.0 110.987 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.7 t -73.79 108.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -89.56 -25.97 21.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.751 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -127.76 143.4 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.566 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -158.11 94.62 1.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.544 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.6 mt -126.43 134.19 51.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.822 0.344 . . . . 0.0 110.872 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.3 mt -77.23 127.15 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.306 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.2 mm -111.53 121.79 64.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.746 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -94.77 163.48 22.26 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.055 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.04 137.85 77.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.0 1.8 . . . . 0.0 111.755 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.34 12.44 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.584 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -89.85 -34.01 16.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 120.764 0.316 . . . . 0.0 110.428 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -141.52 145.44 35.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.103 0.478 . . . . 0.0 111.341 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -123.95 131.97 53.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.344 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.8 118.43 36.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -142.61 167.31 22.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.084 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -89.74 160.63 16.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 t -113.75 89.25 15.49 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.381 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.67 60.35 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.946 1.764 . . . . 0.0 111.642 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -114.85 -39.88 3.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.118 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.1 t -121.21 87.95 44.88 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.237 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.14 130.72 24.87 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.656 1.571 . . . . 0.0 111.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 168.81 -40.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.67 -149.04 5.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.286 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.48 105.79 12.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.347 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.2 t -121.66 126.62 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.704 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.61 154.02 33.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.06 133.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.126 0.489 . . . . 0.0 110.283 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.2 tp -102.92 122.88 45.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -119.73 133.52 55.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.032 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -88.61 115.09 25.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.87 -32.65 72.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.507 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.24 -23.7 9.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.967 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.91 -25.84 68.35 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.997 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.81 7.3 5.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.1 ttmm -96.54 148.75 22.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.857 0.36 . . . . 0.0 110.732 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -129.37 133.15 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.918 0.389 . . . . 0.0 110.601 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 45.9 mt -120.42 148.0 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.711 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.6 136.74 54.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.769 0.319 . . . . 0.0 111.394 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.02 154.07 48.19 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.378 0.609 . . . . 0.0 111.554 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -130.45 135.8 48.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.351 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 141.81 50.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.256 0.55 . . . . 0.0 110.925 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.62 2.94 4.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.463 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -77.08 155.22 82.58 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.104 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.52 -41.67 38.6 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.251 1.967 . . . . 0.0 113.162 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.89 146.87 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.91 -1.76 56.43 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.46 -18.37 28.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -117.02 -17.67 10.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.695 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.24 -41.21 96.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.819 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.03 -40.66 96.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.03 0.443 . . . . 0.0 111.167 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.32 -40.04 85.91 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.253 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -61.33 -39.73 91.61 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.59 -45.78 92.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.367 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -64.98 -41.59 95.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.383 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -66.47 -37.05 84.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.45 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.19 -48.35 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.248 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -78.24 -27.28 47.59 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.008 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.7 -37.61 76.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.885 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -80.99 -31.55 34.67 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.804 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.7 mt -81.58 -27.11 34.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -104.83 -27.66 11.61 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.243 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -133.83 73.2 71.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.76 152.52 62.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.935 2.423 . . . . 0.0 112.345 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 122.384 2.056 . . . . 0.0 112.025 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -128.46 153.42 79.24 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.597 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.64 150.0 68.36 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.374 2.049 . . . . 0.0 112.299 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.46 153.66 91.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.81 161.82 44.73 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.345 2.03 . . . . 0.0 112.301 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.2 -170.26 0.48 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.881 2.388 . . . . 0.0 111.816 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -116.67 158.71 42.87 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.553 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.14 142.66 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.564 2.176 . . . . 0.0 112.105 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.48 165.58 36.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.69 139.57 31.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.37 122.21 37.07 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.821 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 64.3 mt -131.88 122.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.597 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -67.61 83.92 0.18 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.584 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 31.2 t0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.59 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -151.29 170.54 19.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.127 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.41 147.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.861 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.75 111.96 24.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -93.47 110.86 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.357 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.83 122.1 31.06 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.086 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 58.1 p -74.59 -170.02 0.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.26 -21.81 62.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.308 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 9.4 p -113.79 -171.63 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.379 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.83 -18.73 59.99 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.87 131.0 45.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.409 . . . . 0.0 110.402 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 83.3 m -127.75 139.33 52.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.304 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.62 111.08 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.759 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.33 128.8 34.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.705 0.288 . . . . 0.0 110.265 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.9 mt -125.66 133.86 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.15 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.99 120.63 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.972 0.415 . . . . 0.0 110.293 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.49 177.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.965 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -122.71 155.19 63.5 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.327 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.63 -27.61 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.945 . . . . 0.0 112.312 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -91.83 -9.84 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.516 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -60.69 141.18 57.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.815 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -79.09 160.21 27.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.49 -37.65 80.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.34 -41.99 85.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.017 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.14 -40.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 110.185 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.04 -42.87 96.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.798 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -60.01 -39.73 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.97 93.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.497 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -60.35 -39.09 85.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.227 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.69 -37.99 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.071 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.09 -38.85 80.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.071 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.31 -50.35 47.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -63.28 -40.85 98.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.682 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -133.21 148.9 52.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.174 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.02 59.57 2.67 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . 0.408 HG22 HD12 ' C' ' 36' ' ' ILE . 28.9 mm -111.16 103.69 55.22 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.81 150.61 70.11 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.227 1.952 . . . . 0.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.61 -37.97 54.19 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.174 1.916 . . . . 0.0 112.278 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.76 -38.58 91.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.556 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.84 -2.88 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.189 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -89.44 94.14 9.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.07 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.29 109.47 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 33.9 mt -104.11 119.98 40.12 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.622 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.86 120.55 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.228 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -66.87 -46.68 74.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.55 79.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.936 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.88 88.86 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -126.69 126.63 43.83 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.961 0.41 . . . . 0.0 110.733 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -76.75 146.09 38.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.36 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 59.8 mt -95.7 112.64 24.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.611 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.07 148.35 36.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.17 -40.15 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.105 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.67 -12.05 66.61 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 166.48 13.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.079 0.466 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 77.6 p -117.42 165.67 13.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.191 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -60.92 -40.53 93.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.905 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -64.36 -23.92 67.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.891 0.377 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.41 -34.53 75.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -99.88 16.95 22.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.036 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 57.28 37.59 28.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.6 mt -84.79 117.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.19 -176.56 3.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.676 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.53 145.3 33.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.906 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 60.56 25.73 15.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.393 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -73.93 124.06 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.037 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -85.83 128.1 34.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mp -118.5 149.89 40.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.49 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -94.19 119.47 33.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.83 124.15 49.1 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.281 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.41 133.06 69.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 17.5 mt -105.15 136.33 44.85 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -75.95 146.38 39.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 62.8 tp -114.92 128.36 56.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.372 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -88.74 117.28 27.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.124 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.96 -171.58 54.49 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.55 179.87 50.4 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 65.1 t0 . . . . . 0 C--O 1.222 -0.375 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.38 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.04 161.67 18.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -142.07 139.82 30.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.364 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -83.27 122.86 28.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -106.52 109.19 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.318 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -80.0 114.99 19.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.843 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 59.9 p -70.66 176.29 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -26.16 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -108.46 -175.96 2.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.906 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.58 -20.66 59.47 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -53.77 133.38 42.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 110.494 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -124.2 137.39 54.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.54 112.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.404 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 28.8 m -84.11 127.2 33.76 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.296 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 87.4 mt -120.86 130.7 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.572 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.87 115.22 10.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 m -135.61 164.32 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.66 153.71 39.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.453 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -37.01 91.43 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.236 1.957 . . . . 0.0 112.026 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.1 p -82.26 -7.4 59.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.185 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.73 136.51 58.02 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.915 0.388 . . . . 0.0 110.904 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -80.04 162.88 24.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.761 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.06 -37.67 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.614 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.35 -43.22 92.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.274 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.24 -40.4 96.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.184 0.516 . . . . 0.0 110.59 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.94 -42.39 96.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.469 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -60.25 -39.81 88.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.115 0.484 . . . . 0.0 110.362 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -39.71 91.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.332 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -60.48 -38.79 85.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.37 -41.05 91.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.035 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.5 -40.36 96.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -78.03 -64.81 1.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.286 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -97.81 161.25 13.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.235 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.99 53.68 3.77 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.8 mm -109.28 107.56 59.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.63 150.94 69.66 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.081 1.854 . . . . 0.0 112.03 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.27 -20.63 8.35 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.297 1.998 . . . . 0.0 112.612 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -92.75 19.85 7.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.606 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -152.49 26.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.624 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -118.86 95.86 5.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.415 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -96.19 100.17 11.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.672 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.66 122.33 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.28 131.48 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.546 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -153.25 157.55 40.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.772 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.68 18.89 7.47 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.796 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.27 -5.9 78.43 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -130.94 149.11 52.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.562 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.79 140.53 57.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.37 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 69.2 mt -81.68 123.51 28.78 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.621 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.67 139.39 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.177 0.513 . . . . 0.0 110.612 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -63.41 138.99 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.316 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.89 -12.52 64.12 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -80.22 172.07 14.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -115.29 157.53 23.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.226 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.99 -40.82 96.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.542 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -63.33 -24.14 67.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.456 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -62.54 -37.66 86.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.117 0.484 . . . . 0.0 110.424 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -98.68 14.64 27.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 m120 56.46 38.77 29.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.454 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.87 104.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.91 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.56 179.05 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.39 151.64 27.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 57.87 42.09 23.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.967 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -90.22 122.73 33.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.268 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -79.69 85.68 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.045 0.45 . . . . 0.0 110.589 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.19 154.36 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.891 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -102.64 122.67 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.256 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -104.59 121.49 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.225 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -115.62 132.34 65.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt -101.94 123.65 46.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.009 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -63.4 -39.43 94.48 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.797 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.76 80.57 1.53 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.495 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -61.02 -44.99 96.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.91 -176.52 50.09 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.56 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.628 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -70.28 146.48 50.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -85.44 127.12 34.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.287 0.565 . . . . 0.0 110.293 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 86.3 mt -67.53 -36.17 80.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.88 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.74 161.71 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.01 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.99 122.47 0.31 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.165 0.507 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.36 156.16 34.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.857 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.62 119.2 18.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.474 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.86 144.86 25.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.222 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.75 149.12 16.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -91.98 163.47 13.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.3 mtp -124.9 175.96 6.95 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -121.62 121.22 36.9 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.354 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.4 tp -107.68 117.93 35.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.58 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -121.14 114.41 21.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.986 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 -86.68 0.56 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -146.46 22.16 1.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.558 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.3 m -124.36 129.5 50.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.431 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.2 t -106.33 121.63 59.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.957 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.4 m -116.05 122.52 32.24 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.515 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -55.41 142.31 80.35 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.178 1.919 . . . . 0.0 112.23 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -108.13 132.66 53.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.879 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -70.63 -6.69 38.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.153 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -72.37 73.17 0.98 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -59.67 135.17 57.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.713 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.15 -154.99 7.02 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -140.64 124.93 17.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.34 108.27 21.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.84 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -131.24 153.23 49.73 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.661 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 94.9 mt -121.17 141.21 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.933 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -141.86 140.73 32.98 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.786 0.679 . . . . 0.0 110.269 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -104.35 128.82 52.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.08 0.467 . . . . 0.0 110.399 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.7 p -88.09 172.74 9.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.673 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.72 -10.37 19.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -86.15 -0.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.343 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t 69.4 19.65 7.56 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.05 0.452 . . . . 0.0 110.698 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.1 mt -103.34 126.95 50.77 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 57' ' ' ILE . 45.5 mm -79.26 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.485 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -104.95 116.65 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.691 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -92.81 107.25 19.07 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 94.9 m -118.53 144.79 45.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.653 0.739 . . . . 0.0 112.805 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -125.76 111.18 14.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.745 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -103.3 136.29 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.989 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -76.12 139.58 41.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -79.17 -18.97 52.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.614 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -61.08 -46.29 91.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -117.04 -12.47 10.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.328 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.95 77.16 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.78 147.66 26.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.32 . . . . 0.0 111.028 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.5 103.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.103 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -83.15 -28.74 29.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.28 143.46 51.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.057 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -158.11 99.98 1.68 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.769 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -132.09 130.13 40.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.0 mt -74.32 129.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 mm -117.26 120.24 64.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -86.02 163.55 42.67 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.191 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.8 136.27 75.39 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.023 1.815 . . . . 0.0 111.525 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t0 61.4 12.06 4.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.44 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.85 -25.32 30.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.889 -0.142 . . . . 0.0 110.778 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 10.2 p -147.04 169.17 19.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.253 0.549 . . . . 0.0 110.672 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.93 132.42 30.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.448 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -102.29 117.77 35.47 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -141.74 164.8 29.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.072 0.463 . . . . 0.0 111.461 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -83.81 160.71 21.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.383 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.7 88.43 20.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.45 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.96 59.86 7.64 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.298 1.999 . . . . 0.0 112.038 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -48.83 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.42 102.77 54.79 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.828 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.73 129.6 14.72 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 121.516 1.478 . . . . 0.0 111.478 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 p 167.46 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.7 0.625 . . . . 0.0 110.416 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.35 -179.26 33.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -88.09 114.7 24.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.655 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.12 129.81 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.199 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -119.83 157.3 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.7 p -134.21 136.94 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.5 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.6 tp -102.55 121.79 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -118.53 134.37 55.14 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.242 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -85.75 114.16 22.49 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -37.13 84.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.8 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.06 -22.52 22.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.454 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.44 -169.78 20.39 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.6 p -121.42 13.2 10.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.626 0.251 . . . . 0.0 110.572 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.3 ttmm -85.87 142.6 28.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.847 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -135.33 129.22 33.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.314 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.2 mt -112.48 150.7 30.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.889 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -123.65 135.62 54.02 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.654 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -137.49 152.1 49.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.26 0.552 . . . . 0.0 111.425 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -128.87 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.475 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.25 134.62 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.83 -6.53 11.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.363 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -75.06 150.57 85.76 Favored Pre-proline 0 C--O 1.231 0.119 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.703 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.38 -40.41 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.022 1.814 . . . . 0.0 112.393 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.93 147.67 45.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.8 p -95.99 8.53 43.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.234 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.38 -20.43 43.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -121.45 -15.71 7.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.823 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.79 -40.04 93.81 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.663 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.02 -40.98 99.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.14 -40.02 86.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.174 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -60.57 -39.67 88.84 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.1 m -62.05 -41.98 98.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.718 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -66.83 -40.91 88.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.192 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -67.22 -36.72 82.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.32 -48.49 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.083 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -78.56 -25.49 45.4 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.026 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.22 -37.68 75.09 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.452 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -82.05 -31.7 30.77 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.727 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.4 mt -81.33 -20.67 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.038 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -114.97 -18.23 11.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.279 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -146.42 73.83 12.84 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.848 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 161.28 43.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.771 2.314 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.718 2.279 . . . . 0.0 112.145 -179.638 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -71.38 152.97 94.12 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.21 147.23 65.98 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.497 2.131 . . . . 0.0 111.944 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.02 154.74 77.65 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.11 150.2 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.228 1.952 . . . . 0.0 112.46 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.99 -153.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.503 2.135 . . . . 0.0 111.581 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -129.5 158.86 72.04 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.526 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.45 140.42 89.04 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.71 2.273 . . . . 0.0 111.974 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -155.69 165.6 36.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.07 138.08 32.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.864 0.364 . . . . 0.0 110.62 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -122.31 123.51 41.57 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.815 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 122.43 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -72.53 84.09 1.12 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.106 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 38.4 t0 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.797 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -62.23 157.69 18.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.794 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.73 142.04 35.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.302 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.48 125.22 32.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.561 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 62.5 t -113.44 118.32 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.848 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -90.19 121.17 31.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.205 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -78.02 169.81 17.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.867 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.12 -41.16 92.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.218 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -72.07 -8.46 54.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.695 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.04 -12.84 60.61 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.21 123.24 18.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -98.83 132.39 44.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.964 0.411 . . . . 0.0 111.286 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.04 105.5 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.422 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -73.09 128.83 36.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 62.8 mt -120.5 124.53 45.61 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.889 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.81 108.91 2.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.062 0.458 . . . . 0.0 111.071 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.45 167.58 26.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.12 154.81 46.12 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.93 -29.12 80.93 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.701 . . . . 0.0 111.73 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.5 p -85.27 -12.82 51.54 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.856 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -64.89 142.95 58.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.021 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -83.86 164.14 19.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.491 0.662 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.9 -34.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.34 -43.44 88.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -63.01 -40.8 98.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 110.467 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.72 -42.94 97.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -62.05 -39.63 93.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.194 0.521 . . . . 0.0 110.329 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.06 89.5 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.824 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -60.11 -37.97 81.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 8.4 mm -63.41 -39.63 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.595 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -59.46 -46.75 87.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -62.09 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.772 -0.58 . . . . 0.0 111.136 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.27 -26.16 61.89 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -137.16 -53.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.238 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.0 10.35 8.28 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 62.7 mt -76.14 122.11 86.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.37 160.64 48.09 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.395 1.397 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.69 -39.89 88.46 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.538 2.159 . . . . 0.0 112.828 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.94 -37.06 83.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.246 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.24 21.53 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.725 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -109.73 -46.55 3.49 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.208 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 35.37 77.86 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.033 0.833 . . . . 0.0 110.862 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.53 132.58 35.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -130.05 130.83 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.503 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.73 129.22 43.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.46 26.36 15.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.56 90.53 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -104.49 126.65 51.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.933 0.366 . . . . 0.0 110.02 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.72 132.66 46.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 68.6 mt -81.71 97.74 8.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 110.31 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.03 139.13 42.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.8 135.87 57.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.263 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.55 -18.65 52.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -81.92 157.15 24.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.683 0.278 . . . . 0.0 110.304 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -99.69 162.21 13.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.065 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 75.8 mt -61.75 -39.07 90.31 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.28 -22.6 66.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.01 -38.69 89.6 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.2 14.53 25.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 57.05 39.86 28.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.023 0.439 . . . . 0.0 110.335 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.96 117.77 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.033 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -102.58 -170.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.351 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -69.72 152.47 44.62 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.545 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 51.59 39.1 24.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.452 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -90.63 125.03 35.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 49.6 m -75.94 130.16 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.249 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -119.05 156.17 30.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -105.21 121.49 43.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.448 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.54 118.34 35.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.108 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.07 127.12 65.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.243 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt -85.64 144.98 27.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.551 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -100.33 120.97 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.802 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 65.6 tp -122.83 130.06 52.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.281 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -67.46 146.58 53.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.476 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.8 143.79 15.74 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.02 169.6 54.8 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 54.9 p30 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.646 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.84 161.37 18.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.229 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 pt -139.75 143.32 30.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.131 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -88.65 119.56 29.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -102.34 108.12 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.11 120.93 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.378 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 80.2 p -80.91 172.52 13.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.083 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.15 -37.77 84.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.031 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.12 -8.51 55.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.809 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.42 8.12 60.05 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -81.03 113.67 19.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.849 0.356 . . . . 0.0 110.158 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -86.14 134.2 33.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.685 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -129.59 106.7 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.398 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -79.65 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -123.77 124.02 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.661 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.04 114.5 7.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.895 0.379 . . . . 0.0 110.25 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 25.9 m -136.24 163.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.492 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -109.43 154.72 42.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.097 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.68 -28.62 86.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.79 1.66 . . . . 0.0 111.728 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 62.7 m -86.27 -10.17 55.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.707 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.7 144.4 57.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.529 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -79.12 162.6 25.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.022 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 27.4 mm -63.33 -39.23 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.927 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.2 -41.46 88.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.091 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.79 -41.01 97.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.117 0.484 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.79 -43.98 99.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.789 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -61.06 -39.73 90.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.472 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.09 92.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.45 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.01 -40.71 90.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.05 -41.35 91.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.179 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.95 -40.36 88.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.515 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.94 6.98 7.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -114.39 -52.75 2.7 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.635 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -107.42 -0.79 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 18.58 78.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mm -80.25 119.23 75.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.09 154.25 52.31 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.921 1.747 . . . . 0.0 111.822 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.29 -40.01 79.2 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.314 2.009 . . . . 0.0 112.263 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.96 -39.25 91.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.546 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.69 32.2 2.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -136.9 120.14 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -124.48 114.11 19.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 mt -96.05 128.63 43.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 66.2 mt -127.67 129.48 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.542 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -147.65 152.51 37.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.22 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.81 15.65 8.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.679 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.17 -15.33 58.47 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -113.78 146.52 39.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.354 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -71.35 139.23 49.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.255 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 7.7 mp -88.91 114.39 25.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.808 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -74.89 -169.12 0.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.672 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.48 -146.2 44.13 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 50.56 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.593 . . . . 0.0 111.446 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -132.6 168.43 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.236 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 79.2 mt -61.83 -39.68 92.66 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.552 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -64.98 -26.82 68.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.72 -31.12 71.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.059 0.457 . . . . 0.0 109.897 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -101.31 13.15 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.51 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.46 40.04 29.75 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.374 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 88.6 mt -89.46 107.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.012 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.38 -177.16 4.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.423 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.93 150.56 49.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.993 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 60.44 45.97 10.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 57.5 m -94.87 123.7 38.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 31.5 m -77.77 80.23 4.23 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.179 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 mp -71.06 140.18 50.64 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.209 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -93.89 122.96 36.91 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.259 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 40.3 tp -102.59 120.26 40.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.542 . . . . 0.0 110.26 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 91.6 t -111.9 130.87 64.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.596 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 54.8 mt -105.69 142.06 36.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.86 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -62.82 -40.27 96.86 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.654 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 tt -122.9 121.16 35.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.565 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.54 140.81 58.59 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.178 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.66 -12.07 70.12 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.552 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -83.26 138.63 33.51 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.703 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -97.61 116.25 29.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.408 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.7 mt -67.13 -37.3 83.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.771 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -150.17 161.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.821 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -173.22 122.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.182 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.44 157.17 38.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.599 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.83 123.41 25.61 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.607 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.43 146.45 23.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.06 153.63 16.91 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -89.06 174.87 7.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.029 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 23.0 mtp -139.72 172.69 12.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.585 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.51 127.16 49.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 32.4 tp -107.58 117.19 33.45 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.49 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -120.6 111.84 18.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.813 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.17 -86.21 0.49 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -145.59 20.66 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 0.0 110.792 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.5 m -122.2 130.64 53.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.941 0.401 . . . . 0.0 110.467 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.07 123.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.1 p -112.89 133.34 21.99 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 147.32 54.51 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.871 1.714 . . . . 0.0 113.055 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -101.5 117.21 34.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.85 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -59.42 -14.6 12.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.03 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -71.78 82.83 0.89 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -59.11 136.85 58.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.102 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.12 -159.64 9.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.971 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tp -138.35 125.17 21.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.36 111.58 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -134.64 154.59 51.44 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.241 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 98.0 mt -121.11 138.03 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.14 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.42 133.62 34.95 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 123.675 0.609 . . . . 0.0 110.168 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -102.18 126.37 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.031 0.443 . . . . 0.0 110.536 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.4 p -85.72 171.48 11.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.692 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.67 -10.69 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.78 0.41 56.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.631 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t 70.78 21.04 5.34 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.171 0.51 . . . . 0.0 110.314 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.1 mt -98.54 121.7 40.81 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 57' ' ' ILE . 50.0 mm -80.5 122.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -98.92 115.64 29.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.719 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -98.59 107.83 20.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.91 143.12 51.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.551 -0.859 . . . . 0.0 112.941 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -116.95 117.19 29.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.298 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -106.72 146.05 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.355 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.9 128.49 34.58 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.41 -27.72 64.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -58.26 -36.75 73.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.853 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.9 m -116.75 -16.98 10.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.998 0.428 . . . . 0.0 110.241 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.4 21.87 79.18 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -102.4 151.1 22.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.24 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.51 102.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.5 -38.05 62.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.228 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -126.63 145.79 50.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.251 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -157.47 101.58 1.86 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.184 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.5 mt -128.34 136.73 51.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.881 0.372 . . . . 0.0 110.72 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.3 123.61 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.417 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.2 mm -108.75 123.77 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.318 0.58 . . . . 0.0 111.466 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -91.48 162.47 31.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.126 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.63 138.02 79.76 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.21 1.94 . . . . 0.0 111.778 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.1 11.81 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.452 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.37 -36.84 18.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.752 0.311 . . . . 0.0 110.492 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.41 145.12 36.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.506 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -121.73 135.24 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.616 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -106.29 120.24 41.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -143.06 166.82 23.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.831 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -84.34 160.13 20.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.087 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.23 89.74 12.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -79.84 60.12 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.799 1.666 . . . . 0.0 112.29 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -114.07 -37.45 4.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.343 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.5 t -130.51 82.77 64.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.05 130.89 26.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.791 1.661 . . . . 0.0 111.477 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p 170.25 -38.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.38 -150.09 5.48 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.47 105.85 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.777 0.323 . . . . 0.0 110.429 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.87 128.23 71.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 110.783 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.31 156.35 40.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.56 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.15 136.07 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.514 . . . . 0.0 110.232 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.56 123.36 47.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -118.08 137.7 52.75 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.081 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -91.94 108.44 19.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.359 0.599 . . . . 0.0 110.056 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.8 -38.26 87.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.694 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.61 -22.38 24.78 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.33 -177.96 30.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -121.03 30.17 6.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.76 155.82 42.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.198 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -136.75 148.25 47.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.632 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.7 mt -122.97 152.81 40.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.866 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.22 136.86 53.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.553 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.87 156.31 47.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.185 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -130.26 137.78 50.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.587 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttm -72.72 133.4 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.17 0.509 . . . . 0.0 111.887 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 4.74 21.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.437 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -71.95 139.58 82.79 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.03 -26.83 42.97 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.845 1.697 . . . . 0.0 112.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.63 141.8 48.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.471 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -98.13 10.87 39.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.588 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -54.28 -21.61 9.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -130.02 16.52 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.1 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -62.17 -47.68 83.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.2 0.524 . . . . 0.0 110.253 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -74.49 -32.98 62.73 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.461 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.04 -46.54 83.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.531 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.8 m170 -63.87 -40.83 97.47 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.601 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.91 -45.37 94.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.804 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -64.72 -43.85 92.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.453 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.19 -36.28 83.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.881 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.83 -48.33 86.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.077 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -77.69 -29.56 51.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.741 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.61 -36.68 76.4 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.618 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -80.02 -31.42 39.61 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.754 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.0 mt -82.45 -27.67 31.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -103.23 -27.46 12.49 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.0 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -133.23 73.75 73.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.084 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.38 156.66 34.62 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.119 2.546 . . . . 0.0 112.034 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.492 1.426 0 C-N-CA 122.486 2.124 . . . . 0.0 112.148 -179.456 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -129.56 152.02 78.97 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.83 146.94 26.83 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.68 2.253 . . . . 0.0 112.149 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.53 153.62 87.65 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.68 158.63 55.22 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.251 1.967 . . . . 0.0 112.021 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.24 -171.81 0.77 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.726 2.284 . . . . 0.0 112.056 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -119.06 159.15 46.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.04 141.91 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.503 2.136 . . . . 0.0 112.324 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.52 162.14 41.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.671 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -87.25 136.82 32.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.621 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -120.88 125.72 48.19 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.67 123.14 54.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.588 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -82.06 83.73 7.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.899 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.2 t0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.298 179.494 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.96 157.47 18.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.203 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -139.66 144.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -88.93 123.34 33.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.127 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 80.5 t -109.02 105.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -85.77 127.65 34.59 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.72 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 73.1 p -77.95 -168.64 1.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 93.0 mt -59.85 -21.94 61.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.105 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 10.0 p -111.97 -174.39 2.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.147 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.22 -20.06 57.93 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -52.41 129.48 28.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.964 0.411 . . . . 0.0 110.783 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -125.96 136.72 53.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.602 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.12 109.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.653 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.9 m -84.16 132.97 34.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.271 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 77.0 mt -126.56 126.9 44.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.5 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.02 108.39 2.6 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 110.866 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.47 164.03 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.122 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.89 155.05 38.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.312 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.22 -33.92 92.04 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.056 1.837 . . . . 0.0 111.984 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -85.21 -3.91 58.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.152 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.12 136.87 58.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.857 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -79.07 160.53 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.29 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.769 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.85 -42.14 88.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -62.07 -42.41 99.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -61.96 -43.83 98.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.912 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.73 -39.62 89.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.285 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.02 89.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.256 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -59.89 -39.57 85.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 7.8 mm -64.52 -39.97 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.318 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.62 -39.32 83.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.05 9.61 19.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -113.26 -42.51 3.5 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.7 2.41 8.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.362 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.12 79.43 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mt -81.11 128.51 70.59 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.733 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.49 153.11 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.721 1.614 . . . . 0.0 111.62 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.96 -36.19 63.42 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.297 1.998 . . . . 0.0 112.594 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.96 -38.07 84.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -95.85 17.88 14.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.31 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -112.53 103.73 11.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.138 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.53 109.83 18.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 69.8 mt -101.19 123.49 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.458 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -128.9 127.99 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 128.66 48.61 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.69 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.74 27.03 16.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.41 89.72 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -102.79 126.2 49.83 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.913 0.387 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.89 130.22 42.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.425 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 mt -88.96 82.88 6.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.098 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -73.01 173.4 9.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -78.3 171.16 15.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.04 12.68 81.34 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.94 165.68 19.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.981 0.419 . . . . 0.0 110.58 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.42 167.78 11.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.95 -39.77 93.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.369 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -62.82 -28.29 69.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -62.54 -29.27 70.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.419 . . . . 0.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -102.95 13.46 34.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.29 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 56.35 40.48 29.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.239 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -89.56 108.88 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.073 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -93.09 -174.05 3.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.485 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -67.0 151.48 47.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 54.77 38.66 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -92.51 124.73 36.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.044 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -75.94 129.46 36.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.97 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.45 148.91 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.324 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -93.07 114.61 27.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 54.3 tp -103.93 121.12 42.46 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.08 131.4 71.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.827 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 mt -101.41 80.77 2.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.157 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 55.34 179.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.707 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.22 148.44 43.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.425 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -106.96 145.28 32.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.477 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.17 -39.96 97.88 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.67 161.42 54.23 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.647 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.4 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.6 157.47 17.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.18 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 pt -138.18 147.56 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.059 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -88.68 123.27 32.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.301 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 64.8 t -108.21 102.7 14.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.636 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -92.94 120.73 33.56 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.664 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.5 p -81.37 173.48 12.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.73 -26.78 68.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.147 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -72.29 -12.98 61.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 -13.6 63.06 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 132.95 49.37 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.2 m -103.64 132.58 49.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.661 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.86 108.83 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -81.04 128.65 33.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.484 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 93.6 mt -125.17 127.76 47.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.599 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -69.33 114.77 7.88 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.716 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 23.3 m -134.88 165.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.543 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -108.64 153.83 42.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.11 -35.08 94.53 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.928 1.752 . . . . 0.0 112.243 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -86.49 -2.59 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.166 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.38 133.68 56.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.668 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.16 -38.71 83.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.39 -42.05 90.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.1 -41.75 98.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 110.904 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.6 -42.24 95.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.484 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.92 -38.83 87.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.84 90.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.064 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -59.98 -39.74 86.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.05 -40.48 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.449 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.58 -40.8 93.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -63.66 -43.48 96.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -75.24 -72.74 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.134 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -84.63 166.99 16.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.173 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.77 15.08 56.71 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.3 mm -70.39 124.8 91.5 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.174 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.93 155.79 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.026 1.817 . . . . 0.0 111.585 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.67 -40.89 82.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.993 1.795 . . . . 0.0 112.971 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.89 -45.28 94.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.898 0.38 . . . . 0.0 110.966 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -69.92 -38.73 76.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.741 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -54.46 106.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.35 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -118.9 88.12 2.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.39 129.19 37.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.361 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 79.0 mt -131.0 129.75 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.527 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -150.69 154.61 37.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.65 19.58 9.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.68 80.13 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -127.38 147.55 50.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 110.45 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -71.61 141.01 49.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.068 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 82.7 mt -74.9 115.85 14.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.797 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.96 139.54 41.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.87 143.92 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.17 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.67 69.23 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -83.58 179.01 7.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.765 0.317 . . . . 0.0 110.773 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -126.1 163.65 22.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.285 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.79 -39.88 95.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.543 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.07 -29.2 70.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.16 -35.14 76.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 110.122 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -97.31 14.15 27.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.246 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.65 40.81 32.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.851 0.358 . . . . 0.0 110.329 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.83 107.24 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.308 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -93.95 177.32 6.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.66 150.49 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.248 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 58.92 40.34 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 30.2 t -97.31 123.4 41.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.186 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 69.0 m -74.97 127.55 33.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.0 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.22 146.76 44.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.887 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -95.89 117.48 30.68 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.093 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.99 97.67 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.1 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -83.96 134.6 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.095 0.474 . . . . 0.0 110.478 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 75.3 mt -105.96 -177.49 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.59 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -127.04 165.15 20.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.571 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mp -65.75 138.68 58.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -146.55 104.18 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.493 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.0 24.57 76.4 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -74.77 147.51 41.23 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.419 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -89.4 112.26 23.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.331 0.586 . . . . 0.0 109.898 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' ILE . 88.6 mt -65.2 -38.25 89.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.606 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -151.36 162.93 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.115 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -172.82 122.58 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.262 0.553 . . . . 0.0 110.969 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -157.51 159.89 37.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.076 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -75.62 120.64 21.3 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.45 140.81 18.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.074 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.16 150.79 17.11 Favored Glycine 0 C--O 1.226 -0.347 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -95.03 177.38 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.99 0.424 . . . . 0.0 111.068 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.3 mtp -140.35 168.44 19.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.0 m -119.03 120.94 38.7 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.6 tp -101.13 123.43 45.27 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.919 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -119.54 104.02 9.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.091 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -81.14 0.86 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 p -146.84 19.07 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.562 0.22 . . . . 0.0 110.973 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.7 m -120.85 128.97 53.33 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -103.0 123.21 56.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.144 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.6 p -110.46 114.5 55.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.54 141.04 95.09 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.121 1.88 . . . . 0.0 112.621 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.98 113.03 24.76 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.58 -18.29 39.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.541 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -75.43 73.57 2.48 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -56.04 137.21 51.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.65 -152.98 8.45 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.508 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.12 124.24 21.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.49 107.28 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -130.96 153.34 49.3 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.927 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.6 mt -119.54 140.88 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.658 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -136.6 132.93 35.77 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 123.787 0.679 . . . . 0.0 109.936 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -100.53 123.46 44.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.09 0.471 . . . . 0.0 110.182 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 p -84.26 168.86 15.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.787 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.13 -10.38 10.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.929 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -91.03 6.66 43.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.629 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 m 63.88 23.66 13.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.234 0.54 . . . . 0.0 110.93 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.8 mt -100.02 122.85 43.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.413 HG22 HD11 ' A' ' 57' ' ' ILE . 50.6 mm -81.06 121.89 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -98.77 114.17 26.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.786 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -95.18 107.83 19.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.4 m -120.62 146.61 46.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 0.0 112.648 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -125.86 112.68 16.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.583 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -105.16 128.89 53.6 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.829 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.16 136.56 48.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.21 -17.19 58.68 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.714 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.7 m -60.49 -45.25 94.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.593 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.5 m -116.58 -16.28 10.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.77 20.84 79.33 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -102.07 145.82 28.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.656 0.265 . . . . 0.0 110.388 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.6 t -73.27 103.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.091 0.472 . . . . 0.0 110.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -79.91 -32.91 40.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.766 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -126.32 145.27 50.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.202 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -160.83 98.32 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.2 mt -128.26 137.1 51.84 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.01 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.12 123.11 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.4 mm -111.27 121.05 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.13 0.49 . . . . 0.0 110.599 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -85.12 163.65 44.7 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.257 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.17 138.33 82.71 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.813 1.675 . . . . 0.0 111.785 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 59.58 12.68 2.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.449 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.2 -38.66 24.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.44 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.3 m -129.87 155.78 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.122 0.486 . . . . 0.0 110.99 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -126.11 130.46 51.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.59 117.64 35.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -138.56 162.98 33.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -82.08 161.35 22.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.54 88.89 14.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.331 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.24 60.41 7.38 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.145 1.897 . . . . 0.0 112.084 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -114.45 -39.53 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.44 78.09 76.27 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.59 130.43 40.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.271 1.981 . . . . 0.0 111.178 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 169.12 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.111 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.45 -165.77 12.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -96.78 105.18 17.26 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 110.18 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.3 t -126.38 128.24 71.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -124.93 160.52 28.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.009 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.7 p -135.16 135.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 110.044 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.6 tp -101.61 123.51 45.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -120.39 140.39 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.147 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -88.34 116.92 26.89 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.35 -37.38 85.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.832 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.87 -19.78 18.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.533 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.58 -178.39 23.11 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.0 m -114.89 13.46 17.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.661 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -84.98 142.81 29.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.227 0.537 . . . . 0.0 110.983 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -136.07 121.47 19.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.556 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.0 mt -111.35 152.46 27.25 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.79 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -126.18 136.63 53.08 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.443 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.62 153.77 49.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.249 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -129.66 138.6 51.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.599 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.55 136.25 49.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.82 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.94 -1.04 26.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.451 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.0 131.86 65.47 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.296 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.9 -18.6 46.83 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.081 1.854 . . . . 0.0 112.727 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -113.74 140.34 48.35 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.1 p -96.06 8.19 44.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.61 -16.97 62.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.604 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -131.98 -5.37 3.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.625 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.38 -41.69 98.81 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.942 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -74.17 -34.53 63.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.956 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.55 -42.31 92.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.156 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.9 m170 -63.6 -41.74 98.3 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.9 t -60.98 -44.23 97.68 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.299 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -66.79 -43.59 83.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.939 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -63.71 -40.09 95.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.71 -48.1 86.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.203 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.24 -22.1 42.12 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.406 -0.917 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.85 -39.86 69.42 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -79.88 -35.89 37.37 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.551 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.15 -36.7 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.079 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -98.4 -27.83 13.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.333 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -134.48 73.59 67.99 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.894 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.67 155.88 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.958 2.439 . . . . 0.0 112.286 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.544 2.163 . . . . 0.0 112.042 -179.718 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.27 80.97 69.55 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.69 141.92 91.5 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.595 2.196 . . . . 0.0 112.147 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.21 153.6 94.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.063 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.98 149.22 77.22 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.018 1.812 . . . . 0.0 112.244 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -54.96 -172.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.352 2.035 . . . . 0.0 111.851 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.15 159.55 58.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.93 138.84 78.73 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.511 2.141 . . . . 0.0 112.431 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.71 163.87 39.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -86.58 137.63 32.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.359 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -125.18 129.23 49.71 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.188 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.41 129.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -72.32 84.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.83 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.619 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -63.84 159.02 20.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.158 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -138.95 150.84 23.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.983 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -94.11 124.08 37.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.552 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.58 115.61 49.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.192 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -93.35 129.92 39.29 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.506 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -92.9 175.42 6.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 111.125 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 81.9 mt -62.43 -37.7 86.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.295 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -70.05 -10.0 57.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.852 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.36 -11.66 65.2 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.36 130.81 45.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.749 0.309 . . . . 0.0 110.367 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -106.48 131.15 54.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.946 0.403 . . . . 0.0 110.409 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.94 118.21 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.527 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.9 m -85.1 130.37 34.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.303 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 93.0 mt -123.41 127.1 47.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.241 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.39 113.72 8.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.825 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 m -136.43 167.36 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.79 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -116.94 152.24 48.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.56 -43.9 51.45 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.026 1.817 . . . . 0.0 112.485 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.21 -37.13 86.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.242 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -41.65 133.07 2.77 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.106 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -82.4 167.9 18.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.307 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 35.8 mm -62.03 -35.78 70.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.47 -42.53 87.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.084 0.469 . . . . 0.0 110.377 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.96 -41.38 91.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.231 0.538 . . . . 0.0 110.875 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.43 -46.41 93.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.796 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -62.81 -32.5 73.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.255 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.29 98.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 110.099 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.78 -39.4 88.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.163 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 93.2 mt -64.64 -40.37 88.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.981 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.86 -42.5 93.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.488 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.15 -40.13 95.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.416 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -74.66 -60.73 2.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -106.73 155.33 19.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.83 55.23 4.21 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mm -109.64 113.26 58.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.44 150.66 58.41 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.664 1.576 . . . . 0.0 111.621 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.46 -38.35 43.66 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.193 1.929 . . . . 0.0 112.474 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.24 -39.18 89.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.353 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -89.92 -2.32 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.245 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -86.19 100.7 12.42 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.208 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -104.32 100.46 10.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 59.5 mt -96.7 117.97 32.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.469 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 93.9 mt -126.36 128.26 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -128.41 130.46 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.674 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 24.52 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.73 3.04 90.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -106.96 128.51 54.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.68 133.04 47.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 mp -80.33 95.61 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.47 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.22 139.01 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.339 0.59 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -59.43 150.74 25.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.396 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 -13.38 64.66 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -94.9 151.61 19.07 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.255 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -92.26 164.22 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.193 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.02 -39.05 90.95 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.577 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -62.48 -23.93 67.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.625 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.71 -38.25 87.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.174 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -96.86 16.21 19.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.339 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 56.28 40.38 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 84.3 mt -91.78 113.52 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.0 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -102.22 -170.83 1.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -69.62 149.08 48.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 57.27 35.54 26.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.629 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -91.28 128.23 37.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.984 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -78.97 128.19 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.986 0.422 . . . . 0.0 110.485 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -117.0 139.88 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -87.44 111.36 21.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 59.1 tp -102.55 120.6 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.997 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.9 t -119.4 137.68 52.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 24.9 mt -105.55 142.71 34.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.79 -39.71 95.09 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.593 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 67.1 tp -104.04 124.64 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 mmm-85 -73.33 146.7 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.386 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.15 179.29 53.4 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.81 -40.04 97.63 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 t0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.685 179.93 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.01 161.19 24.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.829 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.1 pt -142.87 145.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.015 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -92.24 123.29 35.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.647 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 93.9 t -103.22 109.8 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.388 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -87.63 120.93 29.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.519 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -80.86 170.98 15.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.787 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.35 -25.16 67.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.029 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -86.52 -0.99 57.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.43 -7.32 80.27 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.78 115.66 7.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 70.0 m -92.82 135.62 33.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.252 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.2 105.6 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.11 122.89 26.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 92.0 mt -122.22 131.86 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.42 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.88 114.4 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -133.98 167.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.473 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.34 154.95 44.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.98 -37.89 95.46 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.901 1.734 . . . . 0.0 111.815 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -77.92 -9.95 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.079 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.19 134.66 57.2 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.731 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -79.11 163.08 25.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.226 0.536 . . . . 0.0 110.525 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.16 -38.27 81.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.91 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.07 -39.89 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -62.38 -41.1 98.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.273 0.559 . . . . 0.0 110.549 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.3 -42.91 98.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.461 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.89 -40.01 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.295 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.42 90.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.172 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -59.75 -38.71 82.54 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.422 HG22 HD12 ' D' ' 30' ' ' ILE . 86.6 mt -64.49 -41.34 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.068 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.51 -45.52 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.243 0.544 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -67.69 -32.01 72.37 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.855 -0.528 . . . . 0.0 111.276 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -92.25 -3.51 55.39 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -148.48 -49.91 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.06 10.46 15.79 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.208 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.5 mt -82.14 118.76 73.18 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.885 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.43 153.13 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.943 1.762 . . . . 0.0 111.47 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.36 -40.92 80.75 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.985 1.79 . . . . 0.0 112.184 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.9 -38.94 76.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -62.34 -39.7 93.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.811 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.72 144.27 31.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.273 0.559 . . . . 0.0 111.384 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -124.89 117.29 23.75 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 73.3 mt -83.78 126.93 33.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.463 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.85 131.4 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -148.47 153.11 38.03 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.916 0.388 . . . . 0.0 111.074 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.02 16.28 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.5 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -9.23 72.68 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -119.74 145.89 46.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.936 0.398 . . . . 0.0 110.277 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.33 141.34 50.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.202 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.37 111.85 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.951 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -75.32 135.88 40.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.787 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -57.75 149.95 20.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.453 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.44 -16.21 60.48 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -85.77 170.27 12.61 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.336 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -113.13 157.33 21.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.965 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mp -57.91 -39.61 78.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.625 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 88.0 p -63.14 -23.46 67.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.299 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.98 -37.56 87.63 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.131 0.491 . . . . 0.0 109.932 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.74 10.73 39.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.295 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 62.1 t30 57.34 42.54 24.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.396 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 66.8 mt -86.51 108.14 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -93.84 175.65 6.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.384 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -58.85 150.76 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 59.25 46.58 12.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.1 t -96.74 123.34 40.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.185 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -80.34 85.84 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.908 0.385 . . . . 0.0 110.347 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.2 150.06 42.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -99.83 124.87 45.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.36 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 tt -101.77 117.51 35.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.918 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 90.9 t -111.29 129.55 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.134 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 66.8 mt -104.93 140.4 38.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.344 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.57 -80.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -139.43 149.06 43.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.736 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -92.65 35.93 1.02 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.379 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.72 23.77 77.3 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.8 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -82.76 138.3 34.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.783 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -92.8 113.28 25.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.279 0.562 . . . . 0.0 109.524 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.1 mt -65.75 -38.31 88.77 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.609 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.6 162.47 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.796 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.29 122.49 0.37 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.831 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.61 157.68 37.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.877 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -75.58 121.78 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.983 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.57 144.1 22.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.256 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.58 150.65 16.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -90.47 175.16 7.18 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.002 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.4 mtp -138.96 174.17 10.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -124.05 125.71 45.0 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.58 118.58 37.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.807 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -121.37 108.88 14.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.772 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.61 0.51 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -137.5 20.19 2.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.781 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.2 m -122.55 131.73 53.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -111.48 123.52 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.028 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.5 p -113.5 132.01 22.71 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.147 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.25 146.2 50.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.919 1.746 . . . . 0.0 113.32 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -98.4 119.9 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.45 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -64.0 -14.92 57.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.752 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 -74.45 74.02 1.91 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 109.962 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -49.91 139.35 13.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.762 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.66 -159.09 8.88 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.651 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 tp -137.03 125.12 22.92 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.8 t -97.51 110.02 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -133.43 153.71 51.38 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.51 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.7 mt -119.64 139.3 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.093 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -136.8 132.42 34.66 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.651 0.594 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -100.77 125.1 47.22 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 p -85.34 171.99 11.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -65.16 -9.54 23.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.13 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.55 0.74 56.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t 70.4 21.02 5.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 110.351 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.7 mt -99.23 122.6 42.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 HG23 HD13 ' A' ' 57' ' ' ILE . 51.8 mm -80.6 122.57 36.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.463 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -98.65 114.44 26.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.763 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -97.77 107.9 20.5 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 143.96 50.89 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.687 -0.805 . . . . 0.0 113.125 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -118.9 117.12 27.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.569 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -106.34 144.76 32.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.373 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.11 131.31 35.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -72.86 -16.69 61.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.9 m -59.69 -45.16 92.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.367 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.1 m -116.63 -14.01 10.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.92 22.29 77.1 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -102.25 152.66 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.61 102.71 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.221 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -73.44 -37.38 65.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.913 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -127.24 145.18 50.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -158.08 99.76 1.67 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.1 mt -127.34 136.83 52.46 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.3 124.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.272 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.0 mm -113.46 121.77 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.121 0.486 . . . . 0.0 110.861 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -88.37 162.8 38.73 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.382 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.42 139.11 86.31 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.972 1.781 . . . . 0.0 111.585 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 59.75 12.82 3.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -86.44 -25.78 25.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.7 p -145.92 168.09 21.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.431 0.634 . . . . 0.0 110.38 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -135.24 126.56 28.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.91 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -102.14 116.77 33.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -145.18 167.26 23.19 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.012 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.53 160.02 19.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.131 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.56 89.78 13.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.148 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.74 59.76 7.55 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.925 1.75 . . . . 0.0 112.12 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -114.88 -39.07 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.627 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.4 t -124.0 86.99 53.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.479 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.15 130.0 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.593 1.528 . . . . 0.0 111.486 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p 167.37 -29.69 0.0 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.56 178.52 34.74 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.472 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.01 113.38 20.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 111.122 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.94 127.78 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.03 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -120.44 152.58 37.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.839 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.9 132.75 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.385 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 65.6 tp -102.24 121.35 42.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -119.76 130.81 55.14 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.47 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -79.99 115.23 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.0 -37.67 85.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.385 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.75 21.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.565 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.96 -175.65 22.88 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -116.47 12.96 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.601 0.239 . . . . 0.0 110.534 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -89.7 142.62 27.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.977 0.417 . . . . 0.0 111.101 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -134.29 133.01 40.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.4 mt -115.55 149.44 38.19 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.716 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.31 137.86 54.75 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.608 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -138.63 156.73 47.2 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.241 0.543 . . . . 0.0 111.307 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -131.75 135.58 46.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.272 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 137.7 57.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.66 -0.19 13.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.287 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.99 149.76 73.99 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.49 -31.14 28.0 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.13 1.887 . . . . 0.0 112.765 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -123.63 142.29 51.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.125 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -94.29 5.7 50.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.763 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.04 -21.05 58.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -118.72 -15.14 9.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.0 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.95 -39.58 94.46 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.116 0.484 . . . . 0.0 110.411 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.45 -35.14 79.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.017 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.89 -40.96 83.44 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.126 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -61.36 -39.47 90.73 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.183 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -61.71 -44.83 96.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.454 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -67.96 -39.41 83.39 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.914 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -66.4 -42.2 88.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.746 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.07 -46.48 88.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.021 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -63.97 -38.57 91.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.561 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -75.55 -23.44 56.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.231 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -87.51 -29.09 21.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.568 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.8 mt -92.85 -18.3 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.614 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -116.33 -18.81 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -137.99 65.37 44.43 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.094 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.49 151.76 70.65 Favored 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.612 2.208 . . . . 0.0 112.243 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 C-N-CA 122.412 2.074 . . . . 0.0 112.147 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.85 154.71 81.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.92 147.19 49.1 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.584 2.189 . . . . 0.0 111.951 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.03 153.87 63.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.36 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.77 144.13 98.48 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.595 2.196 . . . . 0.0 112.209 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.14 -174.77 2.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.32 2.013 . . . . 0.0 111.849 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -111.58 160.27 30.09 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.581 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.75 147.23 89.23 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.687 2.258 . . . . 0.0 112.231 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.08 163.34 39.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.835 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.01 137.34 32.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.648 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -122.42 122.54 39.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.921 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 47.6 mt -132.26 125.13 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -79.23 84.25 5.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.045 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 32.7 t0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.59 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.1 ttp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -58.96 163.19 3.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.029 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 20.1 pt -143.02 139.59 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.006 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -83.86 121.91 27.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.27 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 90.6 t -107.02 106.12 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -87.88 133.84 33.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.301 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.2 p -97.18 170.93 8.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 111.742 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.35 -13.41 60.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.884 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 58.4 p -93.1 -0.5 57.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.488 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.02 -9.41 77.88 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.0 131.46 39.56 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.674 0.273 . . . . 0.0 110.412 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -107.73 132.57 53.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.897 0.379 . . . . 0.0 110.698 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.83 100.68 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.1 m -75.5 127.2 32.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -120.49 124.64 45.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.602 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.01 112.68 3.96 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.383 0.611 . . . . 0.0 110.701 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.24 164.27 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -106.37 153.88 40.17 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.49 -36.48 94.33 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.99 1.793 . . . . 0.0 112.026 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -82.08 -6.56 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -60.44 135.25 57.69 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -76.65 161.39 28.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.903 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.214 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.28 -39.55 87.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.93 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.54 -42.96 99.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.277 0.56 . . . . 0.0 110.381 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.07 -42.62 95.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.71 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.92 -38.02 84.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.33 89.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.38 -38.14 82.98 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 6.8 mm -63.55 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.927 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -61.68 -46.05 91.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.85 -13.75 60.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -104.96 -12.49 16.17 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -141.33 -37.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.77 14.42 27.17 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 34.9 mt -89.16 117.68 68.46 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.12 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.13 146.56 94.03 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.994 . . . . 0.0 111.397 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.99 -39.5 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.049 1.833 . . . . 0.0 112.294 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.99 -31.14 70.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -83.87 -10.5 57.97 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -121.78 145.18 48.31 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.143 0.497 . . . . 0.0 111.105 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -127.66 131.03 49.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 72.7 mt -102.68 122.24 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.105 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -126.97 126.63 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -116.06 119.94 37.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.946 0.403 . . . . 0.0 110.909 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.54 39.45 30.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.99 14.79 80.04 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.94 105.7 13.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.42 132.97 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 mt -84.82 100.13 11.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.65 146.95 39.88 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.37 0.605 . . . . 0.0 111.431 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -63.53 150.43 43.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.249 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.28 -12.63 64.03 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -91.09 167.83 12.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.036 0.446 . . . . 0.0 110.471 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 59.6 p -116.45 163.77 15.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.911 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.33 -39.85 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.2 p -63.31 -24.35 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.591 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.26 -37.96 87.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.117 0.484 . . . . 0.0 110.301 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -96.57 13.35 28.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.71 42.81 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.029 0.442 . . . . 0.0 110.274 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 80.8 mt -91.9 116.97 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -101.02 -178.76 3.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.594 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -61.52 144.67 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.185 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 63.77 17.1 10.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -66.04 131.05 45.29 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -85.26 128.31 34.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 0.0 109.996 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -117.25 146.16 43.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -91.32 116.95 29.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.849 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.01 119.58 35.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.1 t -116.65 129.78 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 0.0 110.626 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 29.8 mt -109.38 135.92 49.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.839 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -70.81 159.03 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.68 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.7 173.68 11.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.33 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -117.55 141.42 48.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.624 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.72 -179.49 52.1 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -137.21 157.75 24.03 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.644 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -62.22 161.62 10.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.311 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.3 pt -143.46 142.53 25.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -90.4 116.52 28.4 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.822 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.3 102.92 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.452 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.15 124.09 31.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.184 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -77.46 -171.6 2.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.515 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.16 -18.78 50.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -115.9 -172.88 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.139 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.53 -20.25 58.87 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.79 131.27 34.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.306 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -128.02 140.48 51.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.569 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.83 102.25 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.781 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.78 128.97 34.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.585 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.64 124.17 37.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -68.24 112.49 5.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.249 0.547 . . . . 0.0 110.532 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.69 165.63 29.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.111 -0.368 . . . . 0.0 110.552 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -111.28 154.53 43.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -55.7 -41.3 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.055 1.837 . . . . 0.0 112.253 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -70.29 -15.82 62.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -57.93 136.75 57.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.32 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -81.44 163.83 22.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.159 0.505 . . . . 0.0 110.999 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 46.5 mm -63.13 -38.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.933 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.78 -40.31 83.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.03 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.6 -43.36 94.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 0.0 110.417 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -62.49 -47.36 93.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.901 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.28 -31.46 72.05 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.89 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.4 97.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.947 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -60.17 -38.99 84.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.439 HG23 HD13 ' D' ' 30' ' ' ILE . 86.5 mt -64.62 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.913 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.37 -39.21 82.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.98 -45.31 67.6 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -68.39 -40.67 81.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.845 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -130.23 148.41 52.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.425 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 59.4 3.04 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 19.9 mm -111.36 106.95 57.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.02 152.44 51.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.877 1.718 . . . . 0.0 111.306 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.98 -41.49 56.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.952 1.768 . . . . 0.0 112.51 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -68.09 -40.12 82.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.856 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -63.31 -40.31 96.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.29 143.59 26.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.264 0.555 . . . . 0.0 111.461 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -131.9 120.52 22.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 86.9 mt -89.73 122.85 33.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.289 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 56.5 mt -131.42 131.14 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.788 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -144.96 152.99 41.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.981 0.419 . . . . 0.0 111.092 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.5 19.04 10.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.528 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.71 -7.68 72.64 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 32.5 ptt-85 -123.53 144.6 49.45 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 110.764 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -62.28 150.03 40.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.194 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 74.9 mt -87.21 120.46 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.124 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -75.58 130.72 39.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.76 137.21 58.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.55 -17.0 54.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -88.85 166.17 14.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.439 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -101.14 168.21 9.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.67 -38.89 90.58 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.697 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -63.45 -25.01 68.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.996 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.82 -28.8 70.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.15 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.79 14.98 28.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.552 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 55.44 39.73 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.233 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -88.32 102.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -90.43 -177.66 5.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.915 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.27 145.89 55.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.606 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 66.16 10.38 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.356 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 52.8 m -64.28 135.85 56.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -90.05 112.43 23.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -95.03 137.28 34.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.852 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -85.71 125.77 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.036 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 60.4 tp -111.55 124.41 52.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.925 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.61 130.39 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.957 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 mt -107.27 133.89 51.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.142 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -89.5 -71.01 0.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.771 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 tt -146.89 139.52 25.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.462 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -65.48 139.18 58.48 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.82 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.91 1.89 90.4 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.789 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -69.98 142.13 52.87 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.013 0.435 . . . . 0.0 110.153 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.1 114.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.683 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.4 mt -66.37 -37.78 86.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 p -149.91 162.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.802 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.49 123.13 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -154.17 159.38 41.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.981 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -74.96 121.61 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.631 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.29 141.65 17.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.697 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.4 157.66 15.76 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -93.16 153.52 18.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.603 0.24 . . . . 0.0 110.946 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.4 mtm -127.02 175.78 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.1 m -126.79 139.08 53.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.758 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.4 tp -117.71 119.0 33.62 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.421 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -120.03 111.01 17.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.26 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 -101.52 0.89 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -127.62 21.66 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.573 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.96 121.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 p -113.63 133.68 22.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.683 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.07 140.85 23.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.94 1.76 . . . . 0.0 112.424 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -97.97 145.25 26.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.82 -6.05 58.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.087 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -73.87 65.7 1.08 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -49.57 132.15 21.23 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.92 -157.98 8.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.139 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 tp -138.34 127.52 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.79 110.56 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.344 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -132.89 154.35 50.48 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.305 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.8 mt -117.39 137.57 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.232 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 131.98 37.34 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 123.799 0.687 . . . . 0.0 110.031 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -100.52 124.79 46.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.889 0.376 . . . . 0.0 109.997 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p -85.88 170.31 12.49 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.459 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -61.85 -13.16 21.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.0 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -84.66 0.26 50.93 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.402 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 t 68.93 20.42 7.89 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.105 0.478 . . . . 0.0 110.376 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -100.06 125.47 46.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 57' ' ' ILE . 51.7 mm -80.23 124.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.403 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -100.89 115.8 31.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.788 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -93.76 108.65 20.38 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.7 m -120.75 147.94 44.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.812 0.815 . . . . 0.0 112.778 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -126.98 114.35 17.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.289 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.49 133.03 52.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.955 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.79 133.05 43.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.447 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -74.35 -18.68 60.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 110.806 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.9 m -59.97 -46.07 90.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.723 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.4 m -116.45 -14.9 10.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.452 . . . . 0.0 110.035 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.9 22.47 78.03 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.59 144.48 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.945 0.402 . . . . 0.0 110.246 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.43 108.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -89.02 -26.34 21.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.715 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -127.91 143.7 51.1 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.211 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.34 98.58 1.57 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.378 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.2 mt -127.93 133.74 49.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.79 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.37 125.97 35.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.342 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.6 mm -113.06 124.79 70.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.357 0.599 . . . . 0.0 110.83 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.3 162.54 31.83 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.332 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.4 136.78 77.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.015 1.81 . . . . 0.0 111.434 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 60.79 8.45 1.81 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.609 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -72.89 -36.4 67.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.821 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.3 p -143.98 165.49 27.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.437 0.637 . . . . 0.0 110.31 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -125.95 128.17 47.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.303 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -102.87 119.85 39.57 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -148.2 166.72 27.07 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.886 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -80.1 159.84 25.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.114 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.17 89.97 13.0 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.856 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.41 60.78 7.65 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.944 1.763 . . . . 0.0 112.43 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -39.72 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.2 t -129.89 77.33 76.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.68 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.1 130.43 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.391 2.06 . . . . 0.0 111.495 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.45 -43.71 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.34 -160.65 9.05 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.92 106.38 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.79 128.58 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.775 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.12 152.42 47.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.79 138.66 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.367 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.2 tp -100.87 116.3 32.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -104.17 107.68 18.69 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -75.73 106.05 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.86 -37.79 83.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.47 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.98 -22.61 13.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.744 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.29 -14.48 82.17 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.638 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.5 m 56.15 21.19 4.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.42 153.09 35.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.351 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -131.09 136.3 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.678 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.6 mt -120.07 147.22 45.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.168 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -114.98 132.47 56.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.98 155.37 49.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.875 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -134.14 135.62 43.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.9 mtp -83.7 136.73 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.5 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -100.74 12.79 36.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.78 129.44 91.15 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.944 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.64 -37.79 94.92 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.822 1.681 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.81 144.91 46.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.83 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 p -90.84 0.7 57.4 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.04 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.9 -20.6 53.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.202 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -113.87 -16.05 12.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.786 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.62 -40.42 94.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.892 0.377 . . . . 0.0 110.703 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -41.32 99.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.004 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.04 -41.96 94.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.814 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -64.39 -40.44 95.8 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.786 0.803 . . . . 0.0 109.336 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.42 -44.82 95.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.126 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -64.19 -43.91 93.62 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.3 -40.97 98.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.984 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.1 -48.56 86.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.843 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.64 -38.77 90.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.228 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.93 -22.85 55.58 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.606 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -89.88 -28.2 19.39 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.53 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.6 mt -92.66 -18.06 23.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -117.25 -17.14 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.265 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -139.76 65.21 31.08 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.207 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.0 156.22 63.25 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 C-N-CA 122.821 2.347 . . . . 0.0 112.359 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.311 -1.417 0 C-N-CA 122.525 2.15 . . . . 0.0 112.262 -179.794 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -127.27 130.78 23.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.439 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.85 146.29 37.59 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.935 1.757 . . . . 0.0 111.968 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.79 153.4 87.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.09 158.03 56.14 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.39 2.06 . . . . 0.0 112.12 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -58.2 -172.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.279 1.986 . . . . 0.0 111.806 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -128.92 158.2 73.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.65 141.75 95.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.105 1.87 . . . . 0.0 112.326 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.53 165.47 36.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.589 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.92 135.84 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.439 . . . . 0.0 110.542 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -115.32 128.5 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.151 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.22 122.58 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.54 85.5 5.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.087 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.617 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -63.29 158.85 19.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.438 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.04 144.47 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -88.02 125.27 34.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.199 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.74 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -99.84 128.48 45.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.784 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -88.02 179.33 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 111.483 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.59 -36.86 84.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.254 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -69.3 -12.17 61.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.804 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.68 63.4 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.5 131.36 48.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.382 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 99.0 m -107.85 131.92 53.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.16 105.06 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -75.04 131.09 40.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.042 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.71 129.21 51.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.448 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.16 115.94 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.068 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 m -138.73 165.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.59 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -107.89 155.65 39.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.7 -37.64 95.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.041 1.827 . . . . 0.0 112.015 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -80.93 -7.42 59.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.191 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -58.69 137.96 57.3 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.058 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.06 161.02 26.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 110.952 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.69 -39.21 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.08 -39.11 84.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.864 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.99 -42.75 99.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.396 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.76 -42.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.204 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -39.89 80.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.551 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.85 -41.29 95.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 110.063 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -59.6 -38.63 81.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 mm -65.18 -39.9 87.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.984 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.21 -41.96 89.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.823 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -69.48 -50.3 46.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -63.97 -41.2 97.63 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -131.67 148.92 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.58 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.42 63.61 2.19 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 45.0 mt -115.97 119.81 36.49 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.28 159.93 48.35 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.779 1.653 . . . . 0.0 111.457 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.05 -31.68 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.041 1.827 . . . . 0.0 112.613 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.75 -42.59 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.961 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.71 -10.8 57.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.412 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -80.62 86.55 5.86 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.799 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -96.86 103.76 15.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.9 119.36 34.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.122 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.6 127.57 71.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.084 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -129.2 130.34 46.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.521 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.67 28.04 14.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.54 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.97 15.3 81.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -119.37 132.75 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 110.371 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -72.61 131.94 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.106 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 78.2 mt -81.34 97.74 7.84 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.968 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.17 139.83 52.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.781 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.23 143.68 52.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.43 -17.73 58.55 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -84.39 171.38 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.806 0.336 . . . . 0.0 110.105 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -119.0 165.69 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.246 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 82.5 mt -62.33 -39.83 94.36 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.381 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.97 -27.02 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.248 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.78 -35.98 79.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.206 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -96.51 12.6 30.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.319 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.29 40.67 27.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.342 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -89.58 114.92 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -99.22 -175.2 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.354 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -65.3 150.12 48.79 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.946 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 54.89 42.54 31.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.947 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 45.3 m -96.25 124.46 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.032 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -75.01 128.19 34.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.906 0.384 . . . . 0.0 110.074 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -118.35 143.46 46.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -89.96 112.08 23.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.07 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 59.2 tp -100.51 120.42 39.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.635 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -117.45 133.83 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.793 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -92.46 122.5 34.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.007 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -71.25 132.81 45.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.501 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -116.65 141.05 48.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.289 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -75.19 144.56 42.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.616 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.24 178.95 52.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.22 -40.26 98.33 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 61.3 t0 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.501 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -68.93 158.32 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.97 146.5 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.754 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -94.82 122.07 37.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.59 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 85.8 t -104.42 113.23 40.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.395 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -98.49 130.29 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.719 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.5 p -86.76 -177.56 6.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.203 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 52.1 mt -72.83 -17.07 61.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.365 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 56.1 p -90.87 -2.35 57.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.041 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -9.09 75.9 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.47 130.73 44.36 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -111.47 134.1 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.996 0.427 . . . . 0.0 110.979 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.91 109.8 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.351 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.94 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.34 124.86 44.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.204 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.31 114.51 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.563 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.33 168.5 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.445 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -109.86 154.86 42.37 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.294 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.57 -32.93 91.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.893 1.728 . . . . 0.0 111.893 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -83.19 -6.28 59.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.113 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -60.99 144.9 52.45 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -89.45 161.28 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.73 -38.69 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.088 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.16 -42.66 91.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.084 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -62.86 -40.63 98.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.341 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 62.4 t -61.91 -42.97 96.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.618 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -61.17 -39.4 90.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.201 0.524 . . . . 0.0 109.951 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.35 90.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -59.9 -38.09 81.31 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 mm -63.01 -41.95 94.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.506 0.67 . . . . 0.0 109.949 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.8 -44.74 96.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.09 -20.33 62.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -101.61 -6.14 24.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -145.36 -43.63 0.22 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.28 0.562 . . . . 0.0 110.226 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.97 14.13 12.62 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . 0.413 HG22 HD13 ' D' ' 36' ' ' ILE . 57.4 mt -87.93 119.17 70.4 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.438 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.52 160.14 44.91 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.823 1.682 . . . . 0.0 111.943 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.63 -22.26 59.64 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.418 2.079 . . . . 0.0 112.215 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -87.48 1.36 53.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.443 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -126.42 21.2 7.25 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -162.42 154.97 19.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 111.214 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.23 132.38 35.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.666 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mp -91.46 122.26 33.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.547 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 70.0 mt -128.99 132.23 67.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.784 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -151.9 155.14 37.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.365 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.68 16.69 7.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.617 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.56 -12.69 62.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -119.71 146.38 45.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.138 0.494 . . . . 0.0 110.397 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -65.11 142.66 58.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.979 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -84.43 114.79 22.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.411 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.51 149.59 38.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.228 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -71.21 165.05 24.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.73 26.82 74.0 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -128.01 157.3 41.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.868 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -100.91 160.79 14.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.277 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.59 -40.47 97.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.86 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.4 p -62.62 -23.63 67.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -62.9 -38.08 89.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.112 0.482 . . . . 0.0 109.907 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.62 13.83 30.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.277 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.91 40.36 28.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.568 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.94 98.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 109.995 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -86.1 178.38 7.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.256 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -60.75 151.68 28.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.289 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 57.13 44.47 22.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 123.42 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.86 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -81.88 96.83 7.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.081 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.19 152.47 24.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.04 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -101.87 122.39 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.302 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.35 114.0 27.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 64.0 t -106.43 120.07 56.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 65.3 mt -82.29 146.6 29.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.804 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -120.9 131.45 54.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 tt -93.35 125.47 37.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.139 0.495 . . . . 0.0 110.385 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -65.85 134.13 52.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.057 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.29 -17.87 43.07 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.707 179.413 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.3 m120 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -66.85 151.46 47.49 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.032 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.27 115.1 26.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.682 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ILE . 96.1 mt -68.05 -36.86 80.58 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.682 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.09 161.9 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.818 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.0 122.23 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.295 0.569 . . . . 0.0 111.091 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.89 158.61 38.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.924 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -77.22 123.23 26.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.602 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 146.28 23.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.221 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.55 151.58 17.04 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -89.73 172.46 8.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.04 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 24.6 mtp -138.22 174.34 10.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.739 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.2 m -124.54 127.27 47.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.6 tp -107.72 117.2 33.49 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.184 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.97 110.33 16.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.826 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.73 -83.22 0.58 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.15 18.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.8 m -119.17 130.14 55.36 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.1 t -108.5 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.856 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.6 p -115.64 132.6 23.06 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.044 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.32 146.66 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.552 1.501 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -101.04 121.47 41.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.456 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -62.36 -14.62 41.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -71.29 80.55 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -64.27 130.58 44.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.641 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.03 -154.64 8.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.348 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -138.11 127.24 24.3 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.6 110.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -134.17 154.66 51.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.189 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.0 mt -120.36 138.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.63 132.64 37.31 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 123.772 0.67 . . . . 0.0 110.045 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -102.01 125.29 48.66 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 p -84.9 171.78 11.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.873 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.85 -10.34 27.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.566 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.31 5.42 47.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.424 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m 64.02 25.16 13.77 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.578 0.704 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.7 mt -101.55 122.77 44.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG21 HD11 ' A' ' 57' ' ' ILE . 50.7 mm -80.92 123.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.234 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -99.45 115.64 29.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.827 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -94.7 108.65 20.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.9 m -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.86 0.838 . . . . 0.0 113.108 -177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -125.67 114.85 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.113 -1.403 . . . . 0.0 107.646 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -106.51 132.74 52.17 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.582 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -74.5 134.22 42.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -75.59 -16.5 60.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.69 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 m -60.41 -44.84 95.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.754 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.9 p -116.47 -17.41 10.66 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.763 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.39 22.01 74.05 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -101.53 153.01 20.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.56 102.47 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -77.21 -32.8 56.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -125.87 144.84 50.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.589 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -157.34 99.23 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.6 mt -130.53 133.83 46.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.771 0.32 . . . . 0.0 110.877 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -78.73 125.45 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.307 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.9 mm -111.06 126.15 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.915 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.47 162.2 32.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.351 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.08 138.69 83.54 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.817 1.678 . . . . 0.0 111.235 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.8 t0 59.44 11.74 2.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.731 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.67 -27.05 37.2 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.616 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.5 p -151.65 166.97 29.61 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.759 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.01 132.33 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.277 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -104.5 118.51 36.78 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -142.39 166.81 23.66 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.719 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.49 159.99 19.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.967 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.03 89.46 19.96 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.8 60.44 7.56 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.829 1.686 . . . . 0.0 112.149 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -113.84 -42.8 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.329 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.1 t -120.22 96.97 49.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.042 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 131.04 18.46 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.122 1.215 . . . . 0.0 111.487 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 168.17 -31.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.985 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.58 -174.31 28.13 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.552 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.72 112.6 23.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.486 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.2 128.83 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.21 152.97 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.62 136.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.149 0.5 . . . . 0.0 110.283 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.78 120.84 41.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -116.7 120.11 37.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.147 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -79.2 113.73 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.43 -37.78 84.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.054 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.89 -23.0 12.51 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.58 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.4 -17.37 79.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.274 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m 58.32 21.19 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.627 -0.337 . . . . 0.0 111.165 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -119.1 151.4 38.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.099 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -131.42 138.4 49.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.0 110.852 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.3 mt -123.42 153.05 40.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.146 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.76 135.76 53.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.819 0.342 . . . . 0.0 110.683 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -139.6 156.67 46.72 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.301 0.572 . . . . 0.0 111.224 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -130.43 138.91 50.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.439 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 77.6 mmm -75.07 139.15 42.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.843 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.56 2.09 33.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.894 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -73.83 146.36 85.27 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.746 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.82 -28.01 17.25 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.999 1.8 . . . . 0.0 112.601 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.77 144.13 48.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.891 0.377 . . . . 0.0 110.334 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.7 p -91.47 1.15 57.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.922 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.01 -19.51 44.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -118.52 -20.2 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.88 -41.7 98.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.273 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.51 -40.87 96.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.48 -42.44 92.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.415 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -64.44 -39.94 94.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.674 0.749 . . . . 0.0 109.314 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.0 t -61.02 -45.83 93.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.491 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -63.42 -43.1 98.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.153 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -65.62 -35.44 80.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.51 -48.35 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.987 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.32 -28.99 53.36 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.777 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.8 -34.99 74.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.97 -31.32 31.24 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -81.48 -26.94 34.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -106.39 -26.82 11.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.477 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.58 73.66 72.23 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.78 151.2 72.47 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.945 2.43 . . . . 0.0 111.964 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.49 1.318 0 C-N-CA 122.394 2.063 . . . . 0.0 112.068 -179.84 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -134.27 154.77 80.15 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.978 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.28 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.268 1.979 . . . . 0.0 111.569 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -73.63 159.0 85.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -54.92 140.77 79.09 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.411 2.074 . . . . 0.0 112.193 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.42 174.12 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.387 2.058 . . . . 0.0 111.84 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -97.11 154.49 38.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.53 147.0 88.73 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.463 2.108 . . . . 0.0 112.105 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.43 161.4 42.64 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.84 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.04 136.21 33.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 0.0 110.572 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -118.69 124.72 48.03 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.7 mp -130.46 122.69 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.477 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.26 83.97 7.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.932 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.4 p30 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.586 179.571 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.91 160.76 14.11 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -136.94 154.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.082 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -93.53 122.69 36.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.115 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.03 108.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.42 108.25 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 23.7 p -96.3 -173.32 2.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.571 0.701 . . . . 0.0 111.08 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 90.7 mt -55.42 159.92 2.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.311 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p 66.43 6.29 4.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.121 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.74 24.46 76.05 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.315 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -83.73 107.0 15.88 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.459 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 94.8 m -87.74 135.99 33.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.796 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -132.42 118.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 9.7 m -86.7 122.98 31.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.54 128.11 52.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.508 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -70.62 116.37 10.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.858 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 25.5 m -135.92 166.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.515 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -111.98 153.76 44.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.091 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 -38.25 93.92 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.062 1.841 . . . . 0.0 112.156 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -81.45 -8.74 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.07 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.72 134.76 57.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -78.57 163.82 25.2 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.043 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.25 -35.74 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.943 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.8 tm-20 -58.44 -40.01 81.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.2 -41.51 94.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.7 t -63.09 -47.59 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.044 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -62.82 -33.35 75.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.053 0.454 . . . . 0.0 110.17 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.05 97.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.34 -39.3 86.62 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.083 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . 0.405 HD12 HG23 ' C' ' 30' ' ' ILE . 92.1 mt -66.17 -39.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.001 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -46.53 88.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.29 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.77 -15.1 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.033 -0.417 . . . . 0.0 111.906 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -101.14 -6.34 24.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -148.61 -41.03 0.16 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.181 0.515 . . . . 0.0 110.501 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 11.17 21.02 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 73.8 mt -77.52 125.25 86.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.43 158.05 48.55 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.675 1.583 . . . . 0.0 112.05 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.18 -38.62 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.113 1.875 . . . . 0.0 112.274 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.07 -39.93 94.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.906 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.79 -3.63 58.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -80.02 96.2 6.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -96.22 85.28 3.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.578 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 86.8 mt -89.17 113.08 24.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.63 129.03 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.616 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -132.72 132.49 42.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.859 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 24.34 14.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.65 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.94 3.43 90.6 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.344 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -110.69 127.14 55.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.645 -0.326 . . . . 0.0 110.238 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -70.18 134.25 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 59.4 mt -79.6 94.43 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.429 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.06 146.61 39.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.295 0.569 . . . . 0.0 111.038 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -61.44 150.6 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.07 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.85 -17.65 57.5 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -90.2 164.12 14.54 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.211 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.8 p -113.34 167.06 10.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.309 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -62.39 -39.41 93.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.384 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -62.96 -26.75 68.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.094 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.08 -35.91 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -95.52 14.29 23.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.213 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 55.77 40.41 30.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 0.0 110.497 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.71 121.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.977 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.18 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.598 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -58.96 145.12 42.77 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.972 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 59.18 26.17 14.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 123.37 25.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.479 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 91.3 m -72.63 130.07 39.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.226 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -120.57 143.11 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -93.24 109.22 20.74 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -106.66 123.62 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -123.11 141.32 43.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -109.25 142.59 39.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.332 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -71.94 143.37 49.31 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.708 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 8.7 mp -112.92 124.03 51.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.327 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.73 -38.78 91.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.655 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.38 95.98 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.08 -131.48 50.17 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.657 -179.898 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -64.13 157.23 26.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.599 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 pt -136.72 152.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.131 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -93.46 122.02 35.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.714 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.24 107.47 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.678 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -91.88 125.56 36.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.599 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -83.32 174.53 10.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.189 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 70.7 mt -62.46 -25.95 68.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.076 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p -78.48 -9.45 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 -11.7 66.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.41 134.61 52.87 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.88 0.34 . . . . 0.0 110.124 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -104.3 133.68 48.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.719 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -122.7 113.05 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.644 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -80.96 125.24 29.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.089 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -119.58 116.56 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.716 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.98 108.89 2.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.465 0.65 . . . . 0.0 110.883 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 22.8 m -134.49 164.73 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -107.76 155.06 40.5 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.172 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.87 -37.29 96.03 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.864 1.71 . . . . 0.0 111.814 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -79.21 -9.4 59.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.78 136.28 58.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.904 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -79.74 162.94 24.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.39 -38.95 83.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.761 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.51 -41.58 90.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.947 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.89 -41.52 97.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.147 0.499 . . . . 0.0 110.578 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 68.5 t -63.43 -42.03 94.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.43 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -60.61 -39.34 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 110.245 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.15 93.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.097 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -60.37 -39.22 86.45 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 92.4 mt -63.59 -42.12 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.199 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 27.0 tm0? -60.57 -40.08 90.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.636 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -83.52 12.0 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -118.56 -47.89 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -112.08 2.28 16.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.246 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.15 24.8 75.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 13.6 mm -85.82 116.24 64.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.164 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.5 147.2 70.57 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 122.083 1.855 . . . . 0.0 112.32 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.69 -33.06 78.52 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.223 1.949 . . . . 0.0 112.643 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 9.85 31.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -121.14 28.61 7.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -160.53 151.27 18.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.065 0.46 . . . . 0.0 111.142 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -132.0 126.27 33.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.792 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.74 124.06 33.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.707 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 83.6 mt -127.38 129.11 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.736 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -148.59 151.54 35.22 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.997 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.8 17.74 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 85.49 -8.77 70.21 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -119.57 145.3 46.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.127 0.489 . . . . 0.0 110.735 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.29 132.41 47.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.967 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 55.0 mt -81.64 104.94 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.71 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.97 168.29 20.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.474 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -78.39 172.66 13.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.3 21.35 77.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -130.59 157.2 43.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.876 0.37 . . . . 0.0 110.693 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -105.83 162.97 13.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.134 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.88 -39.79 93.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.393 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -63.56 -23.02 67.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.378 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.48 -38.35 86.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.012 0.434 . . . . 0.0 110.233 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -99.23 15.7 25.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.368 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.24 40.82 24.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.264 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -90.65 104.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.23 -171.55 2.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.255 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -68.78 146.4 52.94 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.07 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 63.14 42.34 7.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -99.54 125.71 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.785 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -76.11 126.01 30.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.01 139.53 51.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.627 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -88.48 118.38 28.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.57 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.48 120.0 39.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.53 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.41 127.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 70.1 mt -107.75 126.82 53.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.683 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.99 -42.98 99.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.669 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 26.4 mt -145.62 147.08 31.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.734 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -113.59 116.83 30.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.252 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.75 2.32 88.1 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.675 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -76.96 152.3 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.176 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -89.11 112.87 23.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 49' ' ' ILE . 97.1 mt -66.11 -38.38 88.07 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.6 162.94 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.644 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.72 122.92 0.34 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.281 0.562 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -154.47 158.95 40.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.845 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.33 122.57 23.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.415 . . . . 0.0 110.819 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.14 143.83 20.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.96 153.57 16.92 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -86.78 157.36 19.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.903 0.383 . . . . 0.0 110.871 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.8 mtp -125.53 172.95 9.28 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.44 124.64 41.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.374 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.7 tp -106.84 117.48 34.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.879 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -122.05 119.81 32.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.857 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -86.83 0.22 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -148.15 24.51 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.705 0.288 . . . . 0.0 110.722 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 86.9 m -126.26 131.18 51.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.285 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.99 122.18 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.646 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.8 p -121.35 122.94 27.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.53 146.41 55.35 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.269 1.313 . . . . 0.0 112.902 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -99.74 142.58 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.53 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -72.33 -6.26 42.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -73.1 74.11 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -55.42 135.68 50.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.89 -160.89 9.69 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 tp -137.26 126.97 25.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.3 t -99.69 109.58 24.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -133.19 154.49 50.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.609 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -117.89 137.89 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.236 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.91 131.3 35.02 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.549 0.531 . . . . 0.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -100.45 124.73 46.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.231 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.0 p -84.35 172.32 11.88 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.604 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.11 -10.36 30.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.533 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.48 -0.06 56.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.626 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 71.03 19.68 5.52 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.7 mt -98.62 122.62 42.07 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 57' ' ' ILE . 51.8 mm -78.97 125.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -101.07 116.69 33.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.669 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -95.96 107.48 19.76 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 71.9 m -121.41 146.99 46.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 113.041 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.6 t90 -124.79 114.27 19.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.948 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -106.13 131.53 53.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.723 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -75.89 131.04 39.41 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -72.26 -18.86 61.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 110.662 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.5 m -59.91 -44.68 94.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.964 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p -115.94 -16.01 11.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.091 0.472 . . . . 0.0 109.991 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.17 19.6 79.78 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -102.54 146.52 28.02 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.82 102.05 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 110.06 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -74.44 -36.5 63.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -126.27 145.98 50.19 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.761 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -158.08 100.61 1.72 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.83 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' D' ' 47' ' ' GLY . 31.7 mt -127.89 133.21 49.29 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.84 0.352 . . . . 0.0 110.756 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 125.55 35.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.144 0.497 . . . . 0.0 110.123 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 mm -112.09 118.18 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.897 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -82.95 161.58 57.57 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.858 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -54.59 131.98 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.676 1.584 . . . . 0.0 111.699 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 62.37 12.29 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.446 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -81.26 -26.89 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.111 0.481 . . . . 0.0 110.18 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -142.12 151.08 41.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.209 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -121.06 129.26 53.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.977 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.09 118.11 35.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -141.97 167.82 21.23 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.648 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -85.1 159.99 20.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.026 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.72 90.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.118 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.33 61.1 8.07 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.921 1.747 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -113.28 -38.04 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.6 t -131.44 77.26 74.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.697 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.13 130.33 40.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.151 1.901 . . . . 0.0 111.359 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 t 167.78 -47.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.723 0.64 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.8 -149.32 7.06 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.58 106.43 13.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.394 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -124.9 129.3 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.58 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.46 153.71 45.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.535 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -129.7 135.78 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 0.0 109.894 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 60.8 tp -104.73 122.3 45.4 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -120.19 130.39 54.54 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.135 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -86.24 116.41 24.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.78 -36.24 78.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.271 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.27 -20.88 12.14 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.398 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -73.23 -20.77 80.02 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.058 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 m 59.44 27.6 16.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -125.53 151.23 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.125 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -131.77 139.78 49.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.17 0.509 . . . . 0.0 110.934 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.1 mt -122.91 149.1 44.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.799 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -119.25 135.21 54.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.58 157.14 46.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.317 0.58 . . . . 0.0 111.318 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -135.05 137.07 42.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.523 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.4 ttm -73.7 135.22 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.238 0.542 . . . . 0.0 111.244 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.23 0.25 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.13 139.1 89.93 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.72 -25.74 33.55 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.979 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -117.51 141.68 48.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.41 . . . . 0.0 110.434 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.2 p -95.15 9.56 39.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.47 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.9 -21.0 60.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.362 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -121.05 3.16 10.47 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.476 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -62.02 -49.22 76.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.997 0.427 . . . . 0.0 110.986 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.14 -39.73 93.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.272 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.76 -42.98 99.94 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.737 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 66.2 m170 -64.26 -41.06 97.11 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.036 0.922 . . . . 0.0 109.467 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.88 -44.11 96.99 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.409 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -65.46 -43.51 90.1 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.53 -41.42 98.86 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.665 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 55.9 t -58.77 -49.38 83.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.014 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.501 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.87 -25.04 59.84 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.384 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.401 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.4 m-85 -87.84 -28.92 21.32 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 73.8 mt -91.23 -15.58 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.294 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -118.21 -17.95 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.165 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -142.1 66.74 21.07 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.255 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.4 155.0 64.76 Favored 'Trans proline' 0 C--N 1.297 -2.176 0 C-N-CA 122.604 2.203 . . . . 0.0 112.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 C-N-CA 122.559 2.173 . . . . 0.0 112.099 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -68.95 139.92 90.95 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.505 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.72 143.83 21.55 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.091 1.861 . . . . 0.0 112.079 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -79.81 155.25 75.65 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.1 150.48 72.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.933 1.755 . . . . 0.0 112.167 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.58 160.11 44.79 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.86 156.0 84.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.511 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.7 151.39 85.86 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.39 2.06 . . . . 0.0 111.883 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.91 165.77 33.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.835 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -85.47 136.91 33.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.039 0.447 . . . . 0.0 110.638 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -122.66 129.54 51.96 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.056 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.7 mp -130.72 130.08 64.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -69.99 83.09 0.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.383 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.838 179.591 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -58.65 159.27 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.005 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -137.83 154.05 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.087 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -92.43 123.7 35.94 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.426 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -111.15 106.73 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -91.25 133.18 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.383 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 49.2 p -81.16 -162.47 0.5 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.28 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.47 -20.86 58.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -113.8 -176.28 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.811 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.43 -14.58 54.79 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -50.53 128.05 19.24 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.16 137.28 54.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.761 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.82 113.62 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -80.98 126.68 31.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.584 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.07 126.45 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.17 116.36 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.944 0.402 . . . . 0.0 110.301 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 m -136.71 173.06 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.366 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -125.8 155.32 72.92 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.135 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.72 -29.25 89.05 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 121.896 1.731 . . . . 0.0 111.761 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -85.19 -15.47 43.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.62 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.38 142.37 58.42 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.592 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -85.98 167.83 14.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 110.808 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . 0.407 HG23 HD11 ' C' ' 23' ' ' ILE . 25.3 mm -62.8 -35.57 71.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.95 -42.56 90.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.94 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -62.36 -42.2 99.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 79.1 t -62.9 -42.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.807 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -61.11 -41.09 96.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.272 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -59.61 -39.22 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -66.0 -41.14 89.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.157 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.76 11.05 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.62 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -120.45 -33.86 3.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -125.17 -14.91 6.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.057 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 12.52 75.87 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 28.6 mt -77.1 129.02 79.56 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.035 0.417 . . . . 0.0 110.083 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.69 154.78 59.35 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.243 1.962 . . . . 0.0 111.536 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.15 -37.77 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.927 1.751 . . . . 0.0 112.768 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.86 -43.79 98.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.625 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -83.06 -12.34 57.24 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -83.81 102.49 12.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.809 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -102.26 109.5 21.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 mp -98.41 109.62 22.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.69 128.38 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.821 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -132.93 132.45 42.01 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.842 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.35 26.67 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.37 14.19 81.02 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -119.5 133.79 55.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.782 0.325 . . . . 0.0 110.148 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -72.32 131.83 43.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.867 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 70.8 mt -84.57 100.15 11.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.43 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.11 143.11 41.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.269 0.557 . . . . 0.0 111.171 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.0 144.44 55.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.68 -18.05 57.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.83 145.46 24.75 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.26 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -88.64 162.35 16.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.518 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.39 -38.88 88.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.803 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -62.41 -23.07 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.769 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.66 -37.42 83.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.682 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -96.42 14.28 24.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.56 39.21 25.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.925 0.393 . . . . 0.0 110.336 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.94 120.06 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.926 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.45 -179.04 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 110.902 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -60.23 145.77 46.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.934 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 59.67 23.67 12.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.8 t -74.06 124.39 26.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.05 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 37.9 m -73.54 128.43 35.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -115.35 140.07 49.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -88.17 108.01 19.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.737 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.44 120.6 40.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.688 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.2 t -120.59 138.96 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.155 0.502 . . . . 0.0 110.742 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 22.0 mt -109.1 142.21 40.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.405 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -62.85 -39.5 94.58 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.371 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.94 136.59 39.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.493 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.13 26.08 5.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.655 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.76 18.39 77.34 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.13 175.07 43.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.606 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -64.79 161.98 17.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.867 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -143.67 147.41 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.95 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -94.95 121.43 36.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.053 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -103.41 111.28 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.519 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -95.6 124.53 39.67 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.739 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p -83.5 172.78 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.347 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 58.8 mt -63.2 -24.07 67.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.153 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 48.8 p -81.41 -8.51 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.22 63.16 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -62.67 131.06 47.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.412 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -108.15 133.3 52.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.92 108.78 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.904 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.72 124.12 28.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 80.5 mt -122.52 129.72 52.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.405 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -74.38 114.95 13.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.52 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.28 170.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.187 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -120.88 153.95 57.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.55 -38.38 94.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.866 1.71 . . . . 0.0 112.169 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -70.52 -21.77 62.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.818 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.65 144.11 56.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -87.89 168.59 12.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.85 -36.24 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.865 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tm-20 -59.36 -41.56 89.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -62.72 -41.34 99.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.732 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.26 -42.28 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.605 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -60.76 -39.25 88.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.983 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.82 91.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.971 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -59.88 -39.32 84.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -64.57 -39.36 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.173 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.31 -39.7 83.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.863 0.363 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -68.14 -55.6 11.81 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.843 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -64.54 -40.67 96.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.096 0.474 . . . . 0.0 111.737 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.53 140.29 52.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.92 62.77 2.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.92 110.59 43.81 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.33 150.1 69.45 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.851 1.7 . . . . 0.0 110.739 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.77 -42.2 51.82 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.156 1.904 . . . . 0.0 112.87 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.63 -43.69 92.89 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.49 -41.76 99.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.046 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -84.91 142.39 29.72 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.287 0.565 . . . . 0.0 111.378 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -137.34 109.29 7.16 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.306 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -80.97 132.21 35.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.081 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 78.9 mt -131.38 128.88 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -147.78 153.93 39.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.858 0.361 . . . . 0.0 110.677 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.77 16.17 10.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.391 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.23 -7.93 76.19 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 110.8 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -67.21 133.84 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.221 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 74.4 mt -73.85 104.49 4.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.291 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -75.84 153.05 37.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.75 154.43 41.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.72 20.96 64.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -130.43 140.02 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.355 . . . . 0.0 110.293 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -79.92 163.55 24.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.773 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 74.4 mt -66.03 -38.18 87.76 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.866 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.58 -23.72 67.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.132 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.96 -30.1 71.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 110.447 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -101.86 12.88 36.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.342 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.92 34.08 23.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.255 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 71.9 mt -80.16 104.57 8.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -93.09 178.84 5.62 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.73 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -62.39 142.8 57.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.001 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.07 16.06 10.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.558 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -67.64 133.8 50.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.4 m -89.57 116.08 27.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.792 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.45 129.7 34.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.288 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 64.2 tp -108.04 121.53 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.947 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.71 129.09 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 57.8 mt -111.83 117.15 32.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.646 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -62.83 -44.56 95.83 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.612 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.48 137.93 23.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -68.77 120.2 14.34 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.239 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.56 24.51 75.22 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.351 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.9 m120 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.01 147.02 47.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.175 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.6 112.44 24.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.178 0.513 . . . . 0.0 109.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.2 mt -67.19 -37.34 83.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.793 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.55 162.07 4.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.813 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.46 122.47 0.36 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.179 0.514 . . . . 0.0 110.882 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.27 156.38 35.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.0 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -75.91 123.7 26.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.472 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 145.62 22.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.401 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.93 149.67 16.74 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -92.49 174.93 7.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.016 0.436 . . . . 0.0 111.106 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 31.1 mtp -135.12 173.57 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.9 m -122.52 120.98 35.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.2 tp -105.39 117.08 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.236 0.541 . . . . 0.0 110.244 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -122.05 116.9 25.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 -87.7 0.27 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.6 p -144.92 21.25 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.686 0.279 . . . . 0.0 110.799 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -123.03 131.23 53.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 110.478 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.7 t -109.75 123.31 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.045 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -116.76 137.07 23.41 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.249 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.77 146.57 54.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.776 1.651 . . . . 0.0 112.987 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -103.87 119.13 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.427 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.37 -16.2 53.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.46 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -70.25 82.72 0.54 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -62.32 136.41 57.91 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.398 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.1 -157.45 8.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.686 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.3 tp -137.13 125.68 23.64 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.3 t -97.85 110.67 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -133.85 153.93 51.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.382 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.9 mt -119.27 137.75 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.232 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 130.35 34.61 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 123.624 0.578 . . . . 0.0 110.28 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -101.09 123.76 45.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.895 0.379 . . . . 0.0 110.013 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 p -83.2 172.17 12.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.704 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.89 -10.2 26.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.706 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.09 1.8 55.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.74 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 70.5 21.06 5.68 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 110.501 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.5 mt -97.74 120.72 38.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.433 HD13 HG22 ' A' ' 57' ' ' ILE . 50.8 mm -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -97.66 113.8 25.62 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.662 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -97.01 106.74 19.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.53 147.34 49.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.856 0.836 . . . . 0.0 112.929 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -122.02 116.21 23.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.57 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -105.39 144.32 32.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.298 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.91 131.31 35.2 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -72.61 -16.3 61.73 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.837 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.65 -45.33 92.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.04 -14.15 10.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.172 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.62 74.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -102.23 152.49 20.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.9 102.27 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.152 0.501 . . . . 0.0 110.475 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.897 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -126.75 145.01 50.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.24 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -157.5 101.46 1.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.145 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.6 mt -127.4 136.14 51.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.966 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.19 122.59 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.401 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.2 mm -113.2 122.55 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.777 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -87.23 162.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.518 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.95 140.61 92.67 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.006 1.804 . . . . 0.0 111.625 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t0 60.43 12.46 3.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.454 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.93 -21.85 23.38 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.039 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -148.77 169.07 21.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.396 0.617 . . . . 0.0 110.584 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -140.17 130.7 25.53 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.352 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -101.07 118.91 37.92 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -142.01 170.1 16.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.663 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.18 161.81 20.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -114.37 88.95 16.46 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.645 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.79 59.48 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.983 1.788 . . . . 0.0 112.105 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -115.41 -37.25 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.387 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 p -126.28 75.61 73.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.633 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.27 130.04 34.23 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.771 1.647 . . . . 0.0 111.196 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p 170.27 -41.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.13 -125.59 2.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.431 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -143.03 107.63 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.257 0.551 . . . . 0.0 110.384 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.62 132.49 70.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.595 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.99 155.5 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.45 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.25 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.027 0.441 . . . . 0.0 110.381 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.3 tp -101.15 121.92 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -119.19 133.05 55.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.091 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -83.43 115.48 22.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 0.0 109.678 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.77 -37.77 85.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.635 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.06 18.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.79 -179.91 26.55 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -115.25 18.03 16.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.704 0.288 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -95.28 144.41 25.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.407 . . . . 0.0 110.949 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.47 129.1 30.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.97 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -114.68 148.34 38.36 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.771 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -122.58 136.81 54.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.213 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.84 154.46 50.51 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.397 0.617 . . . . 0.0 111.246 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -126.58 136.37 52.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.056 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 139.2 57.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.272 0.558 . . . . 0.0 111.301 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -2.01 11.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.066 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.55 139.0 54.8 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.933 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.89 -39.41 91.6 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.972 1.781 . . . . 0.0 112.372 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -112.02 143.79 42.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.3 p -94.29 1.86 55.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.857 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -57.54 -20.46 32.02 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.55 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -118.76 -16.18 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.49 -41.6 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.855 0.359 . . . . 0.0 110.569 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.75 -40.88 97.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.03 -40.38 90.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.486 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -62.52 -39.54 93.87 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.728 0.775 . . . . 0.0 109.15 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.76 -45.52 93.99 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.54 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -65.94 -41.88 90.73 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.525 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -63.27 -38.34 90.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.301 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.17 -47.94 88.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.153 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -80.02 -29.75 39.4 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.714 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.17 -37.85 81.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.517 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -81.36 -31.85 33.19 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.767 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.5 mt -81.36 -24.79 36.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.75 -23.63 11.31 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -137.37 68.32 54.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.931 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.86 160.82 48.17 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 C-N-CA 122.849 2.366 . . . . 0.0 112.283 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.311 -1.431 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 -179.583 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.31 127.84 93.51 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.319 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.31 141.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.836 1.691 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.43 151.16 55.76 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.61 158.49 53.49 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.429 2.086 . . . . 0.0 112.222 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.6 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.709 2.273 . . . . 0.0 112.027 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -120.82 158.59 51.71 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.498 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.15 140.7 87.61 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.564 2.176 . . . . 0.0 112.19 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.37 162.94 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -86.96 136.81 32.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.495 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -124.06 127.65 48.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.285 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.4 mp -130.3 126.74 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.249 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -77.11 83.76 3.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.726 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.636 179.537 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -79.51 162.08 25.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.4 pt -141.91 149.88 19.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -97.42 126.94 42.97 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.817 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -110.12 116.92 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.292 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -101.27 133.52 45.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.589 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 67.6 p -90.33 -175.19 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.49 -38.9 91.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.238 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 38.3 p -72.58 -9.49 58.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.434 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.84 -7.07 70.27 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -57.36 125.73 24.12 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -104.9 131.93 51.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.863 0.363 . . . . 0.0 110.592 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 105.04 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.442 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 134.81 42.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.075 0.464 . . . . 0.0 110.366 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 62.4 mt -132.21 132.91 43.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.965 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.53 117.63 18.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.52 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.09 -178.7 2.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -127.24 154.0 76.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.144 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.94 -27.83 85.78 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.016 1.811 . . . . 0.0 112.181 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.6 m -87.04 -10.04 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.692 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.69 142.94 58.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.023 0.44 . . . . 0.0 110.795 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -81.25 164.53 22.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . 0.401 HD11 HG21 ' C' ' 23' ' ' ILE . 45.3 mm -63.86 -38.83 83.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.988 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.71 -40.32 87.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.045 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.66 -42.97 99.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 0.0 110.393 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.64 -42.63 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.273 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -59.89 -38.93 83.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.597 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -41.83 96.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -59.67 -38.47 81.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.36 -39.54 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.816 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -58.66 -40.48 83.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.88 -41.62 71.1 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.417 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -65.75 -41.18 92.43 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.93 156.93 47.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.969 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.21 59.02 2.77 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 35.1 mm -112.28 114.89 50.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.53 162.31 41.73 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.825 1.683 . . . . 0.0 112.001 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.97 -36.72 96.31 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.419 2.079 . . . . 0.0 112.804 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.28 -39.6 95.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.428 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -88.49 -13.95 39.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.74 86.32 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.66 107.55 19.4 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.48 118.47 36.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.421 . . . . 0.0 110.663 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 84.7 mt -129.06 129.7 67.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.583 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -117.55 121.83 42.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.577 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.4 14.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.14 80.52 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -90.58 121.42 32.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -69.01 132.27 46.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 56.2 mt -85.01 101.73 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.124 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.3 144.8 42.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.18 143.49 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.203 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.65 -19.23 55.2 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -83.12 169.39 15.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -119.82 164.69 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.819 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.82 -40.56 93.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.501 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.6 -24.0 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.459 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.46 -37.67 84.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 110.476 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -97.99 15.41 24.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 57.51 40.45 27.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.346 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.53 107.61 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -96.52 179.09 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -58.16 149.12 24.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 57.82 40.58 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -94.67 123.13 37.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.007 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 8.3 m -76.8 131.07 38.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -115.24 141.1 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.578 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -91.01 108.32 19.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.989 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 64.9 tp -100.73 118.78 37.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.21 133.43 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.25 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 mt -109.58 149.09 30.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.42 -178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -93.62 155.66 17.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.555 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 67.0 tp -101.15 122.78 44.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.556 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -63.06 -39.69 95.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.763 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.19 -163.0 54.45 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.32 166.27 54.71 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.606 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -58.13 159.84 5.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.169 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -139.69 141.4 34.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.349 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -83.93 123.8 30.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 81.4 t -109.78 103.75 15.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.5 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -94.45 122.91 37.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.841 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -82.71 179.36 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.129 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -62.87 -35.48 80.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.085 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -67.01 -14.92 63.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.792 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.05 59.13 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.55 131.01 47.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.275 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.7 m -104.15 132.59 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.806 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -127.16 107.14 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.872 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -81.85 127.67 33.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 93.4 mt -123.16 126.36 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.8 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -66.1 113.88 4.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -135.62 162.63 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.131 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.42 152.75 40.69 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.09 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.65 -37.24 91.22 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.988 1.792 . . . . 0.0 111.956 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -81.16 -8.64 59.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -57.92 138.1 56.11 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.014 0.435 . . . . 0.0 110.991 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -80.37 162.87 24.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.12 -39.34 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.071 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.5 -39.89 89.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -62.45 -42.67 99.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.112 0.482 . . . . 0.0 110.477 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.28 -42.71 96.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.655 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -60.23 -39.76 87.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.323 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.65 92.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.488 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -60.16 -38.83 84.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.71 -39.69 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.701 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.68 -40.94 93.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.17 -40.29 97.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -78.59 -71.41 0.43 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.892 0.377 . . . . 0.0 111.007 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.32 166.64 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.086 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.5 21.77 23.92 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . 0.44 HG21 HD13 ' D' ' 36' ' ' ILE . 27.1 mm -78.08 119.3 76.85 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.367 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.45 161.95 42.81 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.173 1.915 . . . . 0.0 111.538 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.12 -37.51 87.15 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.236 1.957 . . . . 0.0 112.479 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.3 -42.75 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.348 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -82.8 -12.52 57.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -80.86 80.57 7.31 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -97.8 94.59 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.15 129.67 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 49.1 mt -129.1 130.18 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.376 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -148.45 154.75 40.3 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.832 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.0 22.25 5.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.757 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 -2.24 77.62 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -132.26 150.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.08 0.467 . . . . 0.0 110.47 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -65.13 148.5 51.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.566 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 81.0 mt -84.88 109.44 18.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.82 151.8 37.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.201 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -74.9 167.93 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.221 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.51 24.58 76.1 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -129.3 169.29 15.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.821 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.4 p -115.53 164.63 14.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.452 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.82 -39.66 95.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.7 p -62.72 -28.49 69.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.07 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.49 -35.97 79.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.025 0.441 . . . . 0.0 110.158 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -94.92 12.04 29.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.224 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 56.21 39.6 30.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.143 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.48 112.83 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -97.11 177.18 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.531 0.681 . . . . 0.0 111.133 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -61.7 142.58 57.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.121 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 65.13 18.61 11.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -70.55 130.79 42.78 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.94 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -82.32 126.3 31.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.09 142.85 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.06 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -89.19 117.67 28.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.232 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.7 100.26 11.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.31 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.68 128.83 38.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 75.6 mt -104.62 148.87 26.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -128.27 129.85 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.4 . . . . 0.0 110.949 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 81.4 mt -109.2 16.51 22.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -60.08 128.07 34.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.946 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.12 -9.6 76.85 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.658 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -69.94 149.27 47.96 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.068 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -89.28 126.94 35.72 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.366 0.603 . . . . 0.0 110.208 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 83.4 mt -67.35 -38.46 84.87 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.878 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.48 161.99 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -173.06 122.14 0.39 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.048 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -153.51 153.16 31.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.68 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.51 123.38 21.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.572 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.46 145.69 23.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.266 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.15 151.74 17.69 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -89.25 172.61 8.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.419 . . . . 0.0 110.99 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 33.3 mtp -136.41 170.47 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.632 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.9 m -120.8 121.31 37.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.0 tp -104.57 118.26 36.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.639 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.55 107.23 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.743 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 -92.88 0.61 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.4 p -135.13 19.84 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.942 -0.152 . . . . 0.0 110.972 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.6 m -121.52 130.94 53.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.838 0.351 . . . . 0.0 110.369 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.8 t -112.31 124.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.194 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -116.51 136.15 23.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 147.18 45.46 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.956 1.771 . . . . 0.0 112.918 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -101.94 122.31 43.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.635 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -65.3 -11.34 40.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.762 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -73.8 78.79 1.58 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -55.47 137.36 48.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.86 -159.49 8.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.312 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tp -139.09 124.43 19.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.4 t -96.91 109.62 23.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.454 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -132.72 154.52 50.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.905 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 84.5 mt -120.8 141.77 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.625 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -142.85 140.95 31.48 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 123.75 0.657 . . . . 0.0 110.048 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -104.43 127.43 52.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.975 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.9 p -87.67 173.95 8.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.77 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.69 -11.08 22.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.822 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.21 -1.24 57.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.399 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.97 19.88 6.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 110.529 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.9 mt -101.96 128.79 48.22 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 57' ' ' ILE . 51.5 mm -82.21 127.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -104.99 114.82 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.112 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -89.57 107.77 19.27 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 95.0 m -119.36 140.8 49.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -121.59 114.08 20.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.187 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -105.99 147.61 28.65 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.348 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -79.8 137.19 36.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.737 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -76.55 -21.1 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.3 m -60.14 -45.17 93.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -116.48 -12.17 11.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.492 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.4 77.12 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.01 146.29 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.17 105.93 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.174 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -84.0 -31.55 25.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.832 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -128.12 147.92 50.56 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.392 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -158.7 99.14 1.55 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.7 134.53 50.66 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.645 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.3 mt -79.12 129.22 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.136 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -117.28 117.14 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.841 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -83.4 163.56 49.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.28 137.97 78.39 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.736 1.624 . . . . 0.0 111.003 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 58.25 14.29 2.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -90.02 -40.81 12.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.462 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -128.06 147.91 50.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.864 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -121.34 129.68 53.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.254 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.03 117.63 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.1 167.97 20.83 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.629 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -82.38 160.83 22.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.865 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.93 90.44 13.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.145 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.35 59.83 7.6 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.069 1.846 . . . . 0.0 112.342 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.12 -39.8 3.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.371 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 36.9 t -127.89 81.09 70.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.11 130.55 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.804 1.669 . . . . 0.0 111.528 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p 170.27 -39.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.887 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.7 -146.07 5.01 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.418 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.38 106.96 13.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.43 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -126.62 129.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.22 154.14 43.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.325 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.19 135.99 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 110.349 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.4 tp -104.65 118.29 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -117.45 131.2 56.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.194 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -86.84 114.81 23.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -31.6 70.93 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.449 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.93 -21.98 11.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.98 -23.25 78.26 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.827 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.79 12.24 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.563 0.22 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.81 155.81 30.52 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.797 0.332 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 143.78 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.747 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.8 mt -120.21 151.98 38.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.522 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -121.28 134.23 55.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.69 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.62 158.14 44.62 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.0 111.148 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -132.73 138.71 47.31 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.893 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 52.2 tpp -70.5 132.75 46.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.766 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.72 1.81 14.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.426 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -66.34 146.48 99.04 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.393 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.04 -40.47 84.74 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.923 1.748 . . . . 0.0 112.659 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -122.98 146.61 47.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.3 p -96.88 11.96 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -59.72 -21.46 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.368 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -116.63 6.32 13.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.95 -46.79 87.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.86 -40.88 97.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.042 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.06 -43.66 94.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.695 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -64.65 -40.97 96.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.755 0.788 . . . . 0.0 109.535 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.5 t -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.874 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 tpp85 -67.51 -42.33 83.0 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.44 -41.39 98.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.244 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.34 -47.77 86.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.15 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -63.93 -38.2 90.22 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.575 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.47 -29.46 63.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.219 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -83.01 -29.77 28.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.4 mt -89.23 -20.64 23.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.5 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -111.39 -23.99 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.154 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -134.51 72.45 69.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.83 150.83 75.24 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.744 2.296 . . . . 0.0 112.081 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 122.402 2.068 . . . . 0.0 112.088 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -71.18 149.38 94.37 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.692 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.02 150.32 29.63 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.182 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -81.91 153.47 69.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.166 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 158.96 53.65 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.413 2.075 . . . . 0.0 112.144 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.31 -169.27 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.783 2.322 . . . . 0.0 112.027 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -120.06 159.83 45.52 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.349 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.53 143.98 86.19 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.92 164.73 38.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -86.22 134.95 33.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -120.29 132.62 55.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.349 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.11 130.61 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.45 85.22 3.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.158 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.406 179.696 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.92 164.89 9.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.6 pt -144.35 141.05 24.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.193 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -86.12 123.85 31.88 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.847 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.07 116.83 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -95.08 121.74 37.01 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.757 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -83.51 172.59 12.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.22 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.94 -36.6 81.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.203 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 48.7 p -68.22 -11.62 59.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.801 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.28 -12.75 63.46 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -66.61 130.28 42.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.5 m -104.62 131.27 52.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.66 110.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.841 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.0 m -81.31 130.15 34.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.092 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -122.32 131.41 53.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.701 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -71.94 116.03 11.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 110.729 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.08 164.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.394 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -105.33 153.22 39.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.223 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.41 -34.91 95.67 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.081 1.854 . . . . 0.0 112.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.53 -2.19 58.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.42 136.66 58.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 110.737 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 59.8 p -78.59 163.07 25.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.931 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' ILE . . . . . 0.421 HG22 HD12 ' C' ' 23' ' ' ILE . 40.3 mm -64.84 -41.27 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.429 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -58.16 -36.81 73.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.996 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.08 -41.76 94.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.382 0.611 . . . . 0.0 110.826 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.24 -42.27 94.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.588 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -60.82 -39.72 90.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.315 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.16 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.043 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -60.31 -39.17 86.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.15 -40.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.179 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -59.75 -41.11 90.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.326 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -40.47 96.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.153 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -63.7 1.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.47 -178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -107.05 159.66 16.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.893 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.23 55.25 3.99 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 33.8 mm -107.91 121.01 45.28 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.56 159.94 47.75 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.651 1.568 . . . . 0.0 111.868 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.93 -39.08 94.07 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.186 1.924 . . . . 0.0 112.47 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -61.48 -50.22 73.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -67.63 -39.69 84.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.692 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.2 96.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.279 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -104.24 110.75 23.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.68 117.91 30.49 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 92.4 mt -130.06 128.36 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.417 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -127.9 128.87 45.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.662 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 25.62 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.527 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.28 1.63 90.12 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.17 123.14 46.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -66.95 134.08 51.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.222 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.7 mp -87.25 102.27 14.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.344 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -74.21 146.17 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.912 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.67 144.93 53.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.536 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.15 -15.38 63.3 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -83.22 168.09 17.08 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 56.9 p -116.45 161.76 18.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.74 -40.36 94.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.959 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.19 -24.68 67.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -62.78 -37.78 88.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.145 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -95.59 14.15 23.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.165 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.93 41.77 27.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.419 . . . . 0.0 110.171 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -91.87 106.16 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.667 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -92.51 -173.77 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.961 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.63 144.78 56.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.221 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 63.64 13.07 7.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.075 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -65.6 132.78 49.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 56.6 m -85.02 127.67 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 10.2 mp -119.39 140.38 50.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -86.15 123.72 31.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.171 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 66.5 tp -109.33 120.1 41.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.626 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.83 131.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.84 32.47 1.25 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.591 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 59.49 43.82 15.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.384 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 66.4 tp -103.01 122.98 45.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.274 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -95.42 125.59 40.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.243 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.15 -40.01 97.95 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.12 90.7 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.599 -179.748 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.02 162.59 16.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.17 146.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.942 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -90.58 101.14 13.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.686 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -87.75 101.03 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 132.65 41.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -64.45 -150.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.04 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.85 -40.01 87.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.589 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.96 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.123 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.46 -89.35 0.44 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.096 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.36 139.88 14.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.887 0.375 . . . . 0.0 110.762 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -126.43 137.78 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.833 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.65 111.7 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -85.78 125.78 33.51 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.126 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -122.63 130.42 52.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.56 115.97 13.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 m -133.65 166.3 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.616 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.46 152.66 44.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.893 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.7 -27.28 82.82 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.76 1.64 . . . . 0.0 111.765 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -87.36 -11.42 49.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.37 142.19 58.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 57.4 p -82.32 165.41 20.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -62.42 -38.75 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.8 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.29 -41.41 88.86 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -60.86 -42.82 98.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.569 . . . . 0.0 110.375 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -41.39 90.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.933 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -60.5 -40.09 90.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 110.485 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.36 91.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.393 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -59.78 -38.33 81.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' ILE . . . . . 0.414 HD11 HG22 ' D' ' 30' ' ' ILE . 82.4 mt -62.79 -39.73 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.371 178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.66 -43.95 97.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.31 -20.15 62.23 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.985 -0.447 . . . . 0.0 111.871 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -102.9 -7.67 21.34 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -141.32 -43.8 0.37 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.252 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.16 14.92 10.3 Favored Glycine 0 C--N 1.321 -0.268 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.038 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -88.79 117.64 68.5 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.622 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.32 172.67 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.961 1.774 . . . . 0.0 111.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.67 -27.13 18.87 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.494 2.129 . . . . 0.0 111.763 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -100.24 -176.15 3.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.837 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 64.94 16.9 10.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.539 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -157.2 159.15 37.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.777 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -147.27 131.32 17.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 22.4 mt -100.49 114.52 28.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 77.0 mt -118.71 130.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.61 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -142.38 149.23 39.1 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.984 0.421 . . . . 0.0 111.192 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.25 15.78 10.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.14 64.23 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -114.62 142.34 46.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.102 0.477 . . . . 0.0 110.534 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -69.51 146.14 52.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.24 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 83.2 mt -84.32 115.66 22.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.477 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.23 138.81 42.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -60.13 147.93 37.83 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.77 68.13 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -84.08 167.77 16.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.776 0.288 . . . . 0.0 110.607 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -114.07 159.44 20.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.025 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.21 -39.89 94.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.714 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -63.61 -24.13 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -63.09 -38.1 89.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.079 0.466 . . . . 0.0 110.234 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -96.12 12.73 29.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.206 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.45 41.37 26.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.326 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.04 103.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -90.55 179.33 5.87 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.239 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -61.74 150.7 36.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.987 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 60.07 31.3 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 18.4 t -86.57 125.88 34.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.919 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 123.22 26.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.05 149.72 31.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.815 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -99.13 117.76 34.33 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.626 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 61.4 tp -100.69 112.73 25.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 66.7 t -112.6 123.52 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 61.4 mt -96.76 140.67 31.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.759 0.314 . . . . 0.0 110.534 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -62.9 -40.59 98.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.738 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 15.9 tp -141.3 54.53 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.337 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 48.6 34.43 5.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 110.194 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.95 -177.54 25.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.782 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -71.06 148.17 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.127 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -94.82 125.17 39.31 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.452 0.644 . . . . 0.0 110.419 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.87 -36.54 78.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.304 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.95 160.78 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.729 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -172.84 122.73 0.42 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.0 158.98 38.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -77.35 119.57 21.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.831 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.21 146.05 25.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.395 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.25 150.88 16.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -89.3 162.15 15.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.07 0.462 . . . . 0.0 111.031 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.2 mtm -133.23 168.54 18.36 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -121.75 134.24 54.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.653 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 tp -115.42 118.96 34.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -123.8 120.76 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.926 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.0 -85.79 0.22 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.32 22.56 0.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.752 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 92.7 m -123.77 128.73 49.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.946 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.89 119.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 p -114.3 135.31 22.19 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.656 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.74 149.25 37.71 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.064 1.843 . . . . 0.0 112.856 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -105.53 142.91 34.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -80.61 -7.97 59.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -72.3 75.87 1.0 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -57.38 135.23 56.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.295 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.68 -159.15 8.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 tp -137.3 125.71 23.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.53 109.14 23.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.55 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 38.8 p90 -132.44 153.97 50.32 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.4 139.85 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.458 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 128.81 29.91 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 123.922 0.764 . . . . 0.0 110.736 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -99.29 124.23 44.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.7 p -85.11 170.74 12.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.414 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.03 -10.73 15.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.71 0.53 55.59 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.556 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.81 20.45 6.77 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.225 0.536 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.9 mt -99.56 121.94 41.91 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 57' ' ' ILE . 50.5 mm -79.32 124.83 38.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.495 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -100.32 115.42 29.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.833 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.08 108.29 20.38 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -121.61 143.7 49.17 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.787 0.804 . . . . 0.0 112.836 -177.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -124.86 114.42 19.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.025 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -104.93 144.13 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.419 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -80.8 131.5 35.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -72.29 -18.43 61.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.899 0.381 . . . . 0.0 110.786 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.7 m -59.54 -45.43 91.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.649 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -117.09 -13.46 10.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.446 . . . . 0.0 110.32 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.36 23.73 74.89 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -102.15 152.16 21.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.82 102.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -76.16 -35.01 59.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.12 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -125.59 147.07 49.42 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.725 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -157.81 98.88 1.67 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.518 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.1 mt -128.9 133.04 47.76 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.901 0.382 . . . . 0.0 110.907 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.09 124.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.913 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.5 mm -111.37 128.15 68.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.076 0.465 . . . . 0.0 110.62 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -93.04 162.17 29.3 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.364 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.56 140.2 89.3 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.931 1.754 . . . . 0.0 111.362 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 59.52 13.2 3.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.249 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -87.28 -37.79 16.87 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-O 120.872 0.368 . . . . 0.0 110.415 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.8 m -131.75 153.41 50.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.261 0.553 . . . . 0.0 111.653 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -125.5 129.49 49.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -103.57 117.45 34.44 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.04 166.39 24.83 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.602 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -83.73 160.11 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.987 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.93 90.26 12.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.51 60.65 7.65 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.049 1.832 . . . . 0.0 112.31 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -114.01 -37.97 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.328 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.0 t -132.3 76.25 72.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.72 130.57 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.278 1.985 . . . . 0.0 111.435 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.83 -42.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.055 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.27 -149.72 6.18 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.408 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.26 105.68 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.0 t -125.19 127.71 72.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.13 152.23 46.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.2 p -128.35 137.85 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.457 . . . . 0.0 110.228 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.4 tp -102.33 120.22 40.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -118.47 134.86 54.73 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.49 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -84.36 117.03 23.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -61.24 -37.54 83.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.744 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -100.42 -10.28 21.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.728 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.83 152.92 17.15 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -93.18 22.02 5.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.331 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -118.33 144.85 45.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.912 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -139.72 152.79 46.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.958 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.1 mt -121.58 159.39 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.252 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.12 137.54 53.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.393 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.42 161.24 38.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.353 0.597 . . . . 0.0 111.088 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.76 140.56 40.7 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.637 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.9 mmm -72.77 139.1 46.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.143 0.497 . . . . 0.0 110.788 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.94 4.27 15.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.844 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.96 147.49 93.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.49 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.94 -38.93 65.25 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.812 1.674 . . . . 0.0 112.223 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -118.81 145.76 45.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.148 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.0 p -91.9 1.25 57.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.972 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.24 -19.79 48.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.364 0.415 . . . . 0.0 110.151 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.86 -17.42 10.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.29 -41.49 97.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.503 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.64 -41.06 98.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.388 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.92 -41.77 90.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.531 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -63.82 -39.91 95.36 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.698 0.761 . . . . 0.0 109.196 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m -62.41 -42.35 99.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.641 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -65.22 -43.96 89.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -61.88 -37.72 85.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.025 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.35 -48.76 84.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.24 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.54 -27.83 41.3 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.904 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.88 -37.99 79.39 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.482 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -80.91 -31.78 34.97 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.753 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.6 mt -82.16 -20.57 37.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -114.13 -17.36 11.93 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.116 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -146.56 72.88 12.82 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.753 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 160.95 45.42 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 123.03 2.487 . . . . 0.0 112.139 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.495 1.579 0 C-N-CA 122.651 2.234 . . . . 0.0 112.377 -179.556 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 50.12 71.89 1.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.83 144.09 99.51 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.913 2.408 . . . . 0.0 112.15 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.89 154.66 92.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.77 150.2 88.99 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.332 2.021 . . . . 0.0 111.824 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.5 -169.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.237 1.958 . . . . 0.0 112.319 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.04 154.86 76.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.86 143.32 85.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.252 1.968 . . . . 0.0 112.124 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -156.79 164.81 37.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.701 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -88.05 133.33 34.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -121.49 125.88 47.9 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.311 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.4 mp -129.83 120.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.506 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -81.53 83.71 6.93 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.962 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.583 179.458 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -63.2 158.77 19.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.558 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.27 149.76 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.166 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' C' ' 14' ' ' THR . 13.3 m-30 -91.82 124.31 35.86 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.697 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -108.64 114.09 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -91.55 123.86 35.28 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.308 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.71 HG22 HD23 ' C' ' 69' ' ' LEU . 67.3 p . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 111.101 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.99 0.424 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.25 106.37 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.402 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' THR . . . . . 0.416 HG23 ' CD2' ' C' ' 4' ' ' PHE . 22.0 m -74.92 129.17 37.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.3 126.31 47.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.473 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.11 112.97 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.503 HG12 ' HE3' ' C' ' 29' ' ' LYS . 31.0 m -134.22 161.68 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.72 154.26 38.67 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.079 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.65 -36.74 98.39 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.151 1.901 . . . . 0.0 112.272 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.01 0.13 55.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -62.36 136.64 58.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 63.2 p -78.59 163.47 25.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.96 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.633 HD12 HD23 ' C' ' 50' ' ' LEU . 46.3 mm -64.66 -37.7 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tm-20 -59.03 -42.17 89.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.914 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.89 -41.33 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 110.736 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.68 -42.99 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -60.87 -39.4 89.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.11 93.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.099 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.503 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.6 mttm -60.42 -39.95 89.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.744 ' CD1' HD21 ' C' ' 43' ' ' LEU . 91.2 mt -64.69 -42.18 94.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.138 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.71 -39.73 89.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.85 7.34 15.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.412 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -115.83 -44.42 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.87 1.18 13.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.419 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.47 20.11 78.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.522 HG21 ' HB3' ' C' ' 41' ' ' GLN . 17.9 mm -79.83 120.87 81.35 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.05 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.1 150.7 54.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.72 1.614 . . . . 0.0 111.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -24.51 29.58 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -93.26 22.27 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.222 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -152.92 52.14 0.75 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 111.062 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.522 ' HB3' HG21 ' C' ' 36' ' ' ILE . 2.3 pt20 -172.71 140.65 1.01 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.084 0.469 . . . . 0.0 110.856 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.93 128.47 43.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.254 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.744 HD21 ' CD1' ' C' ' 30' ' ' ILE . 64.0 mt -104.38 119.68 39.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.98 128.45 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.416 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -129.78 130.25 45.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.004 0.431 . . . . 0.0 111.002 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.36 16.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.603 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 2.17 89.87 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.64 125.78 51.09 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.88 0.34 . . . . 0.0 110.227 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -72.16 132.16 43.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.633 HD23 HD12 ' C' ' 23' ' ' ILE . 8.2 mp -83.07 95.43 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.106 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.62 148.13 41.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.858 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -62.83 138.62 58.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 -18.31 54.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -84.24 177.5 8.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.14 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 64.7 p -126.3 165.76 18.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.38 -40.03 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.275 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -63.52 -28.28 69.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.55 -29.99 70.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.044 0.45 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.08 15.21 29.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 55.54 43.22 28.78 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.906 0.384 . . . . 0.0 110.251 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.38 109.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.045 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -97.55 -175.5 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.403 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -64.54 149.77 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.052 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 56.71 42.22 27.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.88 0.372 . . . . 0.0 110.903 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 53.6 m -100.02 127.53 46.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.099 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 89.1 m -77.24 127.67 33.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.68 142.24 47.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -85.99 117.77 25.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.27 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.71 HD23 HG22 ' C' ' 7' ' ' THR . 55.1 tp -106.46 123.56 48.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.69 131.97 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.55 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 31.2 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 -179.169 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -62.93 161.4 12.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.435 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.488 ' HB ' HD13 ' D' ' 67' ' ' LEU . 18.1 pt -143.93 139.13 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.061 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.529 ' HD2' HG21 ' D' ' 12' ' ' THR . 9.5 m-85 -85.66 120.16 26.79 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.948 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.78 108.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.65 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.51 120.43 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.691 HG22 HD23 ' D' ' 69' ' ' LEU . 82.0 p -80.78 170.76 15.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.774 HD11 ' H ' ' D' ' 71' ' ' LEU . 68.6 mt -65.78 -22.5 66.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.154 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -87.58 -0.54 56.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.72 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.86 79.12 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -68.7 115.85 8.54 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.529 HG21 ' HD2' ' D' ' 4' ' ' PHE . 94.9 m -92.69 137.79 32.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.022 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.75 105.72 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 12.9 m -80.92 125.62 30.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.446 HD21 ' HD2' ' D' ' 33' ' ' LYS . 66.9 mt -122.32 123.47 41.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.17 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -65.79 108.84 2.25 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.672 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 24.2 m -132.45 163.66 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.717 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' GLU . . . . . 0.461 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.4 mt-10 -108.98 149.79 40.08 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.01 -0.366 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -42.47 65.26 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.851 1.701 . . . . 0.0 112.368 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -68.72 -19.77 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.245 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -58.0 136.7 57.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.384 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -79.62 166.2 22.12 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.849 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.877 HD12 HD13 ' D' ' 50' ' ' LEU . 48.9 mm -66.25 -37.13 79.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.8 -44.27 86.22 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.65 -41.09 98.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 110.651 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.0 -41.87 94.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -60.3 -40.64 91.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.18 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.305 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.672 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 98.6 mttt -59.82 -38.77 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.777 ' CD1' HD21 ' D' ' 43' ' ' LEU . 81.3 mt -64.8 -39.4 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.859 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' D' ' 35' ' ' GLY . 64.8 tt0 -59.83 -44.81 93.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.261 0.553 . . . . 0.0 109.946 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -65.99 -35.05 79.53 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.815 -0.553 . . . . 0.0 111.159 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.446 ' HD2' HD21 ' D' ' 15' ' ' LEU . 18.4 mttt -88.94 -4.02 58.57 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -147.61 -53.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.277 0.561 . . . . 0.0 110.467 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 117.22 13.51 7.59 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.561 HD13 HD21 ' D' ' 71' ' ' LEU . 33.6 mt -83.69 119.88 74.36 Favored Pre-proline 0 N--CA 1.447 -0.606 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.346 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.88 164.03 34.32 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.865 1.71 . . . . 0.0 111.338 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.25 -34.15 94.1 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.466 2.111 . . . . 0.0 112.666 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -92.52 -17.29 24.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.955 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.642 ' OE1' HD12 ' D' ' 30' ' ' ILE . 5.1 tt0 -96.05 131.17 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.467 . . . . 0.0 111.522 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -133.9 103.18 5.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.83 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.777 HD21 ' CD1' ' D' ' 30' ' ' ILE . 81.3 mt -83.6 129.85 34.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.054 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' D' ' 49' ' ' GLN . 66.4 mt -129.33 130.94 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.68 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 78.5 t80 -150.59 155.62 39.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.741 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.45 20.62 7.17 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.545 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.91 -3.19 77.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.409 ' HB3' HD22 ' A' ' 73' ' ' LEU . 38.7 ptt180 -129.21 147.68 51.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.083 0.468 . . . . 0.0 110.73 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.491 ' HA ' HG23 ' D' ' 44' ' ' ILE . 18.7 pt20 -69.86 140.67 53.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.351 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.877 HD13 HD12 ' D' ' 23' ' ' ILE . 81.7 mt -73.48 144.91 46.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.33 -82.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.268 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 177.38 -72.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 110.572 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.14 -18.51 69.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -59.46 155.05 15.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.986 0.422 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -96.44 164.97 12.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.153 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.461 HD12 ' O ' ' D' ' 18' ' ' GLU . 81.7 mt -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -63.05 -23.91 67.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.405 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.47 -38.26 86.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.026 0.441 . . . . 0.0 110.354 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' TYR . . . . . 0.442 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.0 m-85 -97.49 15.25 23.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.192 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 56.34 39.11 30.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.247 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.68 103.7 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.786 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.32 178.76 5.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.0 110.824 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -61.8 150.04 38.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.906 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 59.67 17.94 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.172 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -67.59 129.08 38.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -85.49 105.42 16.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.488 HD13 ' HB ' ' D' ' 3' ' ' ILE . 8.5 mp -93.35 142.6 27.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 123.1 34.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.272 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.691 HD23 HG22 ' D' ' 7' ' ' THR . 28.3 tp -100.09 119.19 37.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.181 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 56' ' ' LEU . 69.1 t -109.84 129.71 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.774 ' H ' HD11 ' D' ' 8' ' ' LEU . 64.1 mt . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 pttp . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.642 0.258 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.05 126.43 37.14 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.41 0.624 . . . . 0.0 109.998 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -66.96 -38.53 86.26 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.942 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -147.15 161.42 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.898 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.67 122.88 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -153.5 157.51 39.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.486 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -73.71 120.6 19.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.603 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -153.33 145.4 23.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.72 154.66 16.63 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -87.21 156.89 19.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.812 0.339 . . . . 0.0 110.811 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 28.3 mtp -125.23 174.1 8.33 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.8 m -127.7 122.05 31.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 37' ' ' THR . 30.9 tp -107.86 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.96 0.409 . . . . 0.0 110.247 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.63 120.25 31.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.809 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.41 -90.19 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -144.32 21.85 1.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.506 0.193 . . . . 0.0 110.765 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.596 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.9 m -123.45 130.71 53.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' CG2' HD13 ' A' ' 33' ' ' LEU . 71.4 t -107.14 120.28 58.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.694 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.781 HG22 ' HB3' ' B' ' 947' ' ' PRO . 44.6 p -118.82 124.01 28.65 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.202 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 141.76 42.08 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.817 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -91.88 132.31 36.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.533 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -67.74 -7.6 28.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -74.42 75.24 1.91 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -53.1 136.14 36.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.211 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -161.17 9.86 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.357 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 27' ' ' ARG . 8.7 tp -137.72 124.92 21.64 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 28' ' ' ALA . 44.3 t -98.45 108.67 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.1 p90 -132.29 154.57 49.56 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.922 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 24' ' ' VAL . 95.8 mt -121.52 141.11 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.786 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -142.9 141.9 31.62 Favored 'General case' 0 C--O 1.219 -0.505 0 O-C-N 123.716 0.635 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -104.99 129.17 53.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.188 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.511 HG23 ' CD2' ' A' ' 58' ' ' HIS . 21.1 p -89.01 173.57 8.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.73 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.16 -10.84 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.717 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.32 -1.07 57.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.445 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 t 70.12 20.9 6.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.284 0.564 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD11 HG11 ' D' ' 70' ' ' VAL . 66.2 mt -103.13 126.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.55 HD11 ' HD2' ' A' ' 132' ' ' PRO . 51.7 mm -80.54 127.83 39.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.511 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.8 m-70 -104.41 117.91 35.34 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.709 0.631 . . . . 0.0 110.933 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -94.35 107.82 19.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 90.4 m -119.35 142.81 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.82 0.819 . . . . 0.0 112.978 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.38 114.17 19.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.2 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -105.91 145.22 31.56 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.566 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -80.74 131.54 35.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.33 -19.35 62.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.969 0.414 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.5 m -59.58 -45.58 91.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.719 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.3 m -117.1 -11.82 10.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.2 23.39 78.03 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.36 148.21 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 110.662 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.88 102.7 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.039 0.447 . . . . 0.0 110.691 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -75.5 -36.32 60.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -125.89 148.18 49.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.624 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.565 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.8 p30 -158.81 96.38 1.36 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 72' ' ' ASP . 29.5 mt -125.48 132.53 52.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.474 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -73.98 129.03 36.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.662 HG21 ' SG ' ' A' ' 80' ' ' CYS . 22.9 mm -116.61 120.18 64.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.277 0.561 . . . . 0.0 110.62 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.4 m-85 -84.37 160.51 56.75 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.244 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 140.09 92.53 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.679 1.586 . . . . 0.0 111.041 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.37 11.15 3.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.032 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -85.07 -27.67 26.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.653 0.263 . . . . 0.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.693 ' SG ' HD11 ' A' ' 96' ' ' LEU . 13.9 p -145.1 164.75 30.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.235 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 2.7 tt0 -132.02 121.86 24.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.111 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' HG11 ' A' ' 124' ' ' VAL . 44.8 t80 -97.11 119.33 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -148.12 166.88 26.5 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.788 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -83.85 159.79 21.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.162 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 87' ' ' GLN . 48.8 t -109.39 95.82 20.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.77 60.25 7.61 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.99 1.793 . . . . 0.0 112.428 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.44 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -114.51 -41.68 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 178.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.24 81.14 71.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.56 130.76 27.45 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.874 1.716 . . . . 0.0 111.646 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 169.68 -41.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.94 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.31 -150.06 6.43 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.99 105.74 13.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.814 0.34 . . . . 0.0 110.517 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.26 127.49 72.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 110.71 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.57 152.63 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.367 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.8 p -129.62 139.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.615 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.693 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.1 tp -99.95 116.7 32.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -103.31 106.74 17.32 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 103' ' ' LYS . 53.1 m-85 -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 98.8 mttt -61.24 -37.37 82.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.72 -22.92 12.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.726 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.66 81.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.639 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.7 m 58.6 18.04 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 110.992 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' CD ' HD21 ' A' ' 105' ' ' LEU . 4.0 ttmt -117.15 152.0 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.504 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -128.56 135.5 49.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.858 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 95' ' ' VAL . 59.5 mt -118.53 148.19 42.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.4 m-85 -117.2 134.49 54.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.844 0.354 . . . . 0.0 111.097 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 156.44 46.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.219 0.533 . . . . 0.0 111.152 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -135.37 136.55 41.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.601 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.2 ttm -73.56 132.57 42.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.168 0.509 . . . . 0.0 111.372 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 3.14 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.969 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.12 142.31 92.77 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.84 -28.45 36.31 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.903 1.735 . . . . 0.0 112.674 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.41 141.92 51.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.267 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -98.28 10.64 40.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.45 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -54.27 -24.16 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.296 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.435 ' NE2' ' OE1' ' A' ' 119' ' ' GLU . 26.1 mm100 -119.41 6.39 11.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.241 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.71 -46.16 90.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.919 0.39 . . . . 0.0 110.748 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.66 -41.08 98.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.435 ' OE1' ' NE2' ' A' ' 116' ' ' GLN . 88.7 tt0 -63.76 -43.34 96.68 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.551 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.732 ' O ' HG23 ' A' ' 124' ' ' VAL . 61.4 m170 -64.06 -41.09 97.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.79 -41.14 97.99 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.122 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.05 -42.84 79.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.494 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.26 -40.48 96.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -57.68 -49.06 81.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.766 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -65.33 -39.2 92.09 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.126 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -72.34 -26.18 61.83 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.496 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -88.12 -26.27 22.57 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.796 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.4 mt -94.21 -17.56 22.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -115.06 -22.39 9.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.202 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -134.44 72.18 70.64 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.053 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.81 151.47 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.806 2.337 . . . . 0.0 112.123 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.55 ' HD2' HD11 ' A' ' 57' ' ' ILE . 51.1 Cg_exo . . . . . 0 N--CA 1.494 1.503 0 C-N-CA 122.451 2.101 . . . . 0.0 112.127 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.24 152.19 79.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.773 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.7 147.81 25.12 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.798 2.332 . . . . 0.0 112.024 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -82.42 154.02 68.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.228 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.17 150.95 82.02 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.141 1.894 . . . . 0.0 112.086 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.07 163.71 36.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -81.75 156.33 70.32 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.781 ' HB3' HG22 ' A' ' 39' ' ' THR . 21.4 Cg_endo -62.31 151.39 82.75 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.471 2.114 . . . . 0.0 112.124 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -151.76 164.04 37.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 111.087 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -85.65 134.68 33.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -117.94 132.48 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.536 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.1 mt -132.26 128.68 58.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.52 85.35 3.22 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.913 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.349 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -61.63 158.7 14.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.9 148.92 23.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.242 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -92.66 120.87 33.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.605 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -106.69 110.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.372 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -88.66 126.39 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.76 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.83 HG22 HD23 ' C' ' 69' ' ' LEU . 82.0 p . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 111.196 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.792 0.329 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.439 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -122.89 116.61 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.46 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -84.05 130.32 34.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' C' ' 33' ' ' LYS . 94.0 mt -123.76 123.1 39.76 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.656 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.17 112.42 5.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.769 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.444 HG12 ' HE3' ' C' ' 29' ' ' LYS . 30.8 m -135.26 162.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.728 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -104.72 153.83 38.98 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.635 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.62 -35.64 93.22 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.056 1.837 . . . . 0.0 112.102 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -84.89 -5.74 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.105 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -59.56 136.96 58.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.012 0.434 . . . . 0.0 110.823 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -76.98 160.84 28.83 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' C' ' 50' ' ' LEU . 46.8 mm -64.41 -39.38 85.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.232 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.56 -40.78 88.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.89 -41.71 98.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.418 HG22 HG11 ' C' ' 17' ' ' VAL . 57.2 t -63.23 -42.78 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.544 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.632 ' HG3' HD11 ' C' ' 43' ' ' LEU . 4.1 mtpt -59.02 -40.93 86.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.69 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.31 91.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.265 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.4 mttm -60.05 -38.85 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.85 -39.54 83.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.266 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.71 -38.86 82.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -68.81 -50.85 46.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.108 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.439 ' HD2' HG22 ' C' ' 13' ' ' ILE . 21.7 mttt -63.77 -42.74 97.73 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.02 150.42 49.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.964 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.13 55.7 2.73 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.468 HG22 ' HG3' ' C' ' 41' ' ' GLN . 27.7 mm -109.86 114.97 55.93 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.17 153.99 66.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.639 1.559 . . . . 0.0 112.056 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.77 -38.01 66.25 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.143 1.895 . . . . 0.0 112.385 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.13 -39.92 94.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.378 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -87.27 -9.44 54.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.468 ' HG3' HG22 ' C' ' 36' ' ' ILE . 85.1 mt-30 -80.9 88.95 5.85 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -99.11 105.27 17.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.689 ' CB ' HD12 ' C' ' 50' ' ' LEU . 21.5 mt -97.51 122.28 40.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.6 mt -128.72 123.09 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -112.48 114.51 27.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.447 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.97 49.94 20.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.4 27.84 73.58 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -127.75 102.96 7.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.393 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.09 132.07 51.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.689 HD12 ' CB ' ' C' ' 43' ' ' LEU . 41.9 mt -85.3 87.65 7.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.395 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.16 144.85 42.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -59.63 165.68 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.95 8.09 87.85 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.03 173.56 9.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.572 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -123.52 170.5 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.838 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.5 -39.95 92.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.354 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.1 -30.59 71.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.87 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.05 -28.68 69.76 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.008 0.432 . . . . 0.0 110.422 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.415 ' CD2' HD23 ' C' ' 50' ' ' LEU . 57.7 m-85 -101.61 12.63 36.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.073 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.06 40.33 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -91.77 118.88 38.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.37 -179.25 3.9 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -63.58 149.67 45.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.733 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 59.86 18.73 7.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.216 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -74.44 129.15 37.23 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.29 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.545 ' C ' HD12 ' C' ' 67' ' ' LEU . 90.5 m -80.46 129.85 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.225 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.545 HD12 ' C ' ' C' ' 66' ' ' THR . 8.4 mp -119.26 144.48 46.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.367 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -90.39 114.18 26.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.284 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.83 HD23 HG22 ' C' ' 7' ' ' THR . 65.6 tp -101.88 120.5 40.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.896 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -118.6 132.9 67.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.955 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.449 HD22 HG23 ' C' ' 36' ' ' ILE . 24.2 mt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -59.68 158.72 9.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -138.31 144.32 30.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.112 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.36 124.62 33.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.2 t -108.89 105.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.329 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 128.63 34.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.647 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -87.49 171.39 10.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.757 HD11 ' H ' ' D' ' 71' ' ' LEU . 83.9 mt -66.8 -29.15 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.303 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -78.09 -10.94 59.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 -12.66 56.08 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.48 125.55 26.05 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.232 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -98.11 135.27 40.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.291 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.47 109.93 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.565 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -84.9 129.3 34.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.45 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.643 HD21 ' HD2' ' D' ' 33' ' ' LYS . 89.0 mt -124.7 126.62 45.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.883 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -65.81 113.26 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.454 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.698 HG12 ' HE3' ' D' ' 29' ' ' LYS . 15.3 m -134.75 167.26 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 O-C-N 121.933 -0.479 . . . . 0.0 110.056 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' GLU . . . . . 0.425 ' O ' HD12 ' D' ' 56' ' ' LEU . 79.2 mm-40 -111.77 154.17 44.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.613 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.36 -26.58 83.03 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.116 1.877 . . . . 0.0 112.045 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.1 p -89.97 -12.04 39.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.03 142.83 57.3 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.144 0.497 . . . . 0.0 111.043 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -81.96 164.24 21.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.056 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.784 HD12 HD23 ' D' ' 50' ' ' LEU . 47.4 mm -62.02 -37.79 79.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.2 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -58.5 -40.32 82.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.37 -41.41 97.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 110.242 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.437 HG21 HD21 ' D' ' 56' ' ' LEU . 78.7 t -64.02 -42.51 95.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.574 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.83 -41.04 90.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.84 89.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.331 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.698 ' HE3' HG12 ' D' ' 17' ' ' VAL . 64.6 mttm -60.45 -40.11 89.96 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.785 ' CD1' HD21 ' D' ' 43' ' ' LEU . 79.6 mt -63.8 -41.48 92.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.699 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.82 -50.96 71.76 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.888 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -57.26 -24.05 52.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.643 ' HD2' HD21 ' D' ' 15' ' ' LEU . 11.6 mttm -96.9 -61.32 1.43 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.62 -25.39 22.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.907 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.27 11.54 64.48 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.385 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.09 121.49 80.67 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.908 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 149.36 55.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.519 1.48 . . . . 0.0 111.709 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.42 -41.75 65.25 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.889 1.726 . . . . 0.0 112.64 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.06 -40.59 74.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.98 -39.18 93.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.788 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.84 ' HB2' HD11 ' D' ' 69' ' ' LEU . 0.0 OUTLIER -97.24 147.25 24.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.781 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -131.79 125.85 32.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.785 HD21 ' CD1' ' D' ' 30' ' ' ILE . 72.9 mt -91.41 122.67 34.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.482 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.431 HG21 ' HE1' ' A' ' 76' ' ' PHE . 81.9 mt -128.3 126.8 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.255 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.86 149.72 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 110.805 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.58 20.12 11.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.37 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.38 86.22 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.807 ' HG2' HD22 ' A' ' 73' ' ' LEU . 99.0 mtt180 -114.23 140.7 48.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -75.48 119.39 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.716 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.813 HD21 HD11 ' D' ' 61' ' ' ILE . 9.6 mp -74.42 95.64 2.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.865 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.9 163.61 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 159.38 32.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.5 18.78 63.39 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -128.01 162.21 27.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.618 0.246 . . . . 0.0 110.576 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -113.43 160.81 18.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.399 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.437 HD21 HG21 ' D' ' 26' ' ' VAL . 78.2 mt -61.32 -40.11 92.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.688 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -63.34 -24.7 67.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 0.0 110.394 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -62.87 -37.46 86.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.091 0.472 . . . . 0.0 110.281 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -96.12 12.74 29.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.077 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.6 t30 57.15 40.37 28.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.005 0.431 . . . . 0.0 110.446 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ILE . . . . . 0.813 HD11 HD21 ' D' ' 50' ' ' LEU . 69.9 mt -86.98 108.91 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.055 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -94.58 -179.43 4.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -61.66 145.37 52.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 61.75 36.28 16.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' SER . . . . . 0.562 ' O ' HD12 ' D' ' 67' ' ' LEU . 28.9 t -87.28 123.78 32.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.226 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -78.44 124.22 27.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.562 HD12 ' O ' ' D' ' 65' ' ' SER . 4.9 mp -117.8 143.31 46.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.187 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -87.97 123.03 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.84 HD11 ' HB2' ' D' ' 41' ' ' GLN . 48.6 tp -103.42 109.6 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.706 HG11 HD11 ' A' ' 56' ' ' LEU . 52.5 t -98.31 134.28 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.757 ' H ' HD11 ' D' ' 8' ' ' LEU . 81.9 mt . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.642 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -90.58 110.83 21.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.126 0.489 . . . . 0.0 109.694 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.416 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.3 mt -65.58 -38.45 89.58 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.649 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -149.19 162.51 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.163 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.08 122.35 0.31 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.01 156.69 36.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.92 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.62 ' HA ' HD12 ' A' ' 46' ' ' LEU . 89.7 mtm180 -71.89 123.81 23.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.53 143.71 18.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.188 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.89 153.11 16.92 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -91.73 170.98 9.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.87 0.367 . . . . 0.0 111.416 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 20.4 mtp -136.83 175.27 9.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.14 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.08 124.44 41.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 37' ' ' THR . 28.6 tp -106.08 117.89 35.21 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.446 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -121.46 110.48 16.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.057 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 -87.89 0.58 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 p -143.32 22.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.54 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.2 m -125.59 131.49 52.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.428 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' CG2' HD13 ' A' ' 33' ' ' LEU . 80.3 t -109.66 122.34 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.008 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.0 p -113.35 132.33 22.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.315 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.05 144.25 46.73 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.147 1.898 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.27 121.93 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.507 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -64.52 -12.52 45.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.851 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -73.17 74.48 1.27 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -54.99 135.32 48.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.08 -154.3 7.45 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' ARG . 1.8 tp -142.52 125.54 16.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.3 t -95.87 108.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.64 154.36 47.98 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.068 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HB ' HG12 ' A' ' 24' ' ' VAL . 91.4 mt -121.67 140.55 45.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.582 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -142.74 142.65 31.99 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 123.48 0.488 . . . . 0.0 110.191 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -105.84 128.28 53.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.285 0.564 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 58' ' ' HIS . 23.3 p -87.84 172.06 9.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.606 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.89 -10.68 22.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.72 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.51 -1.1 56.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.452 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t 70.14 20.43 6.36 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.132 0.491 . . . . 0.0 110.962 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.706 HD11 HG11 ' D' ' 70' ' ' VAL . 63.8 mt -104.15 127.54 51.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 23' ' ' LEU . 43.4 mm -80.18 128.17 38.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.8 m-70 -105.08 116.62 32.26 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.551 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -98.02 107.27 19.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 147.2 47.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.822 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -119.94 111.64 18.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.899 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -102.03 134.45 45.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.279 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.7 137.57 40.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.864 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -78.49 -16.8 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -60.97 -45.62 94.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.501 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.3 m -117.07 -16.63 10.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.065 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.24 70.32 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -101.07 152.86 20.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.4 102.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -75.87 -37.53 58.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -126.65 145.58 50.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.3 t0 -159.17 100.71 1.55 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.328 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.807 HD22 ' HG2' ' D' ' 48' ' ' ARG . 23.7 mt -127.25 139.4 52.94 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.386 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.7 mt -77.72 127.23 38.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 80' ' ' CYS . 29.6 mm -113.86 125.81 71.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.924 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.567 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 72.6 m-85 -96.28 159.48 31.93 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.939 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.32 140.25 93.69 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.016 1.811 . . . . 0.0 111.348 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 62.34 13.18 5.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.031 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -95.44 -35.75 11.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 110.778 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -136.46 147.12 47.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -121.49 128.91 52.57 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.194 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -104.16 116.78 32.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -139.87 168.25 20.26 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -85.12 160.97 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.41 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.15 88.97 18.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.458 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.19 59.81 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.266 1.977 . . . . 0.0 112.005 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -114.5 -45.44 3.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.2 t -120.74 95.56 48.94 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.442 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.87 130.08 18.58 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.758 1.638 . . . . 0.0 111.658 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 167.93 -29.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.612 0.57 . . . . 0.0 110.315 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.7 -171.42 24.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.06 111.92 22.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 110.485 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.24 130.3 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.87 155.55 45.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.3 p -129.68 133.36 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.471 HD11 ' SG ' ' A' ' 80' ' ' CYS . 68.5 tp -100.74 119.83 39.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -119.01 129.6 55.22 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.474 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.468 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 54.3 m-85 -87.66 116.5 25.84 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.62 -33.43 72.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.474 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.93 -19.04 10.55 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.191 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -75.61 -18.75 79.64 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 m 58.75 27.69 16.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.62 ' HD3' HD21 ' A' ' 105' ' ' LEU . 15.7 ttmt -121.72 149.7 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.415 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.416 ' O ' HD23 ' A' ' 105' ' ' LEU . 94.5 mtt-85 -133.19 130.91 39.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.267 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.62 HD21 ' HD3' ' A' ' 103' ' ' LYS . 43.8 mt -120.99 148.87 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CE1' HD22 ' A' ' 33' ' ' LEU . 93.8 m-85 -119.8 135.32 54.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.4 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.47 153.26 48.82 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -128.46 134.7 48.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.561 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.0 mtp -77.62 139.01 39.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.967 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -100.82 7.76 43.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.043 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.38 134.21 86.93 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.522 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.2 -25.9 36.57 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.029 1.819 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.05 143.13 49.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 110.328 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.6 p -89.38 -1.05 57.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.97 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.22 -18.53 37.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -116.86 -17.38 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.42 -41.76 97.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.64 -40.61 95.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.082 0.467 . . . . 0.0 111.047 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -66.04 -41.67 90.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.5 m170 -62.41 -40.85 97.85 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.94 -43.26 99.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.04 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -67.73 -42.6 81.61 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.545 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.88 -43.02 97.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.656 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.7 t -57.38 -47.64 84.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.822 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.98 -39.46 93.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.048 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -72.69 -22.13 60.95 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.423 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.91 -26.87 19.1 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.809 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.8 mt -96.94 -16.22 20.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -118.04 -19.5 9.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -135.77 67.2 64.42 Favored Pre-proline 0 CA--C 1.519 -0.224 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.73 153.79 72.48 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 C-N-CA 122.459 2.106 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--N 1.312 -1.342 0 C-N-CA 122.545 2.163 . . . . 0.0 112.174 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -130.26 150.58 76.55 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.32 145.27 26.93 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.54 154.96 85.69 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.478 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 158.98 52.92 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.159 1.906 . . . . 0.0 112.451 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.54 -178.69 3.53 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.882 2.388 . . . . 0.0 111.935 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -115.33 158.89 40.2 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.67 141.79 83.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.069 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -153.68 164.11 38.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.2 139.48 31.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.972 0.415 . . . . 0.0 110.566 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.82 130.24 51.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 951' ' ' ILE . 3.0 mp -131.48 126.71 58.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -74.58 83.65 2.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.116 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.539 179.644 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 2' ' ' GLN . . . . . 0.416 ' OE1' HG21 ' C' ' 14' ' ' THR . 12.8 pt20 -62.48 160.96 12.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.59 153.9 31.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.277 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.461 ' CD1' HG23 ' C' ' 14' ' ' THR . 11.2 m-30 -96.61 124.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.681 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.12 113.56 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.532 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -86.93 131.46 34.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.719 179.533 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.193 0.52 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -120.87 108.59 23.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.342 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 14' ' ' THR . . . . . 0.461 HG23 ' CD1' ' C' ' 4' ' ' PHE . 9.6 m -77.0 129.62 36.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.229 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.1 mt -124.28 123.9 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.619 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -69.57 115.48 8.87 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.416 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.2 m -137.67 164.79 27.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.619 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -106.77 154.28 40.23 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.97 -35.74 94.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.786 1.657 . . . . 0.0 111.968 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -82.78 -6.6 59.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.6 135.23 57.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.864 0.364 . . . . 0.0 110.803 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -78.61 163.34 25.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.966 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.498 HD12 HD23 ' C' ' 50' ' ' LEU . 48.1 mm -63.48 -38.65 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.267 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -59.17 -42.79 91.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.041 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -62.15 -41.15 98.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.561 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.435 HG21 HD21 ' C' ' 56' ' ' LEU . 58.4 t -63.44 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.789 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.418 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.6 mtmt -61.24 -39.39 90.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.271 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.15 -40.73 94.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.259 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.484 ' HB3' HD22 ' C' ' 15' ' ' LEU . 67.3 mttm -60.66 -39.68 89.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.19 -40.01 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.98 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.41 -39.57 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.305 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.21 -43.36 86.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.393 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.553 ' HG3' HD21 ' C' ' 15' ' ' LEU . 11.5 mttm -71.4 -40.25 70.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -132.76 155.76 48.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.002 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.58 64.75 1.78 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.746 HG22 ' HG2' ' C' ' 41' ' ' GLN . 33.0 mm -116.36 98.75 51.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 150.76 74.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.624 1.55 . . . . 0.0 112.016 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.23 -25.19 12.84 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.392 2.061 . . . . 0.0 112.39 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -90.08 31.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -167.23 31.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.814 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' C' ' 36' ' ' ILE . 0.9 OUTLIER -123.36 97.81 5.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.64 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -97.08 107.16 19.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.497 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.418 HD11 ' HG2' ' C' ' 27' ' ' LYS . 60.6 mt -102.9 120.87 41.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.222 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 95.1 mt -128.78 129.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.705 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -120.43 118.66 30.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.53 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.68 88.1 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptt -95.81 112.87 24.49 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -66.44 129.48 39.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.03 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.498 HD23 HD12 ' C' ' 23' ' ' ILE . 7.3 mp -76.9 88.0 3.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.333 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.25 138.34 51.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.13 145.52 46.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.328 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.72 60.49 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -93.1 170.31 9.74 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 65.2 p -113.39 167.12 10.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.389 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.435 HD21 HG21 ' C' ' 26' ' ' VAL . 84.7 mt -62.14 -39.86 94.0 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.3 p -63.09 -27.29 69.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.245 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.93 -35.96 79.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.009 0.433 . . . . 0.0 110.074 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -95.5 14.45 22.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.089 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.03 40.28 30.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.218 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.16 110.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.541 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -99.25 -170.26 1.89 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.029 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -65.03 145.78 55.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.513 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 57.24 41.02 27.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.035 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -91.7 122.19 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.103 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 63.8 m -72.61 127.13 31.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.204 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -118.79 147.25 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.23 113.18 25.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.271 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.7 tp -102.5 119.84 39.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.683 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.15 133.75 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.376 -178.707 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.04 159.31 14.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.095 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' D' ' 67' ' ' LEU . 10.5 pt -139.31 148.49 23.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.808 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.412 ' CD2' HG23 ' D' ' 14' ' ' THR . 13.7 m-30 -91.95 113.92 26.31 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.898 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 64.1 t -97.88 108.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.641 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -94.92 121.87 36.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.752 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.766 HG22 HD23 ' D' ' 69' ' ' LEU . 82.1 p -81.02 172.99 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.649 HD11 ' H ' ' D' ' 71' ' ' LEU . 87.9 mt -59.99 -36.14 76.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.819 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.77 -10.96 60.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 -9.84 66.47 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.61 126.83 29.12 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -100.68 132.2 46.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.556 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.65 109.16 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.904 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.412 HG23 ' CD2' ' D' ' 4' ' ' PHE . 22.3 m -78.95 128.37 33.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' D' ' 33' ' ' LYS . 94.8 mt -124.32 121.83 36.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.389 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -67.03 113.71 5.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.306 0.574 . . . . 0.0 111.146 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' D' ' 29' ' ' LYS . 25.7 m -136.63 162.01 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.8 153.39 38.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.57 -39.34 91.64 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.873 1.715 . . . . 0.0 111.955 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -79.59 -8.75 59.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.083 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -58.24 135.6 57.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -76.15 161.78 28.54 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.879 HD12 HD23 ' D' ' 50' ' ' LEU . 46.3 mm -64.3 -38.43 82.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.929 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.77 90.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.046 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.28 -42.04 99.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.131 0.491 . . . . 0.0 110.838 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.13 -43.5 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.23 -38.75 87.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.54 93.52 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.411 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.517 ' HB3' HD22 ' D' ' 15' ' ' LEU . 13.7 mttp -59.68 -39.12 83.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.856 ' CD1' HD21 ' D' ' 43' ' ' LEU . 93.1 mt -65.88 -39.98 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.336 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.26 -39.41 82.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.953 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -68.49 -51.04 47.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.759 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.551 ' HD2' HD21 ' D' ' 15' ' ' LEU . 65.9 mttt -65.17 -40.85 94.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -128.77 147.47 50.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.18 60.53 2.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -110.73 106.31 57.65 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.99 154.88 41.99 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.062 1.842 . . . . 0.0 111.766 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.29 -28.46 79.91 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.365 2.043 . . . . 0.0 112.781 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.84 -10.21 58.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.981 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.74 -52.93 3.44 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.558 ' CB ' HD11 ' D' ' 69' ' ' LEU . 0.6 OUTLIER -66.24 116.36 7.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.356 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -116.23 103.65 10.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.56 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.856 HD21 ' CD1' ' D' ' 30' ' ' ILE . 80.3 mt -78.79 129.06 34.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' D' ' 49' ' ' GLN . 55.0 mt -133.83 130.55 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.615 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 55.3 t80 -151.14 157.19 42.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.47 20.34 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.668 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.73 -6.09 75.61 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -129.16 150.06 50.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.128 0.49 . . . . 0.0 111.04 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.6 ' HA ' HG23 ' D' ' 44' ' ' ILE . 24.0 pt20 -69.89 142.47 53.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.455 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.879 HD23 HD12 ' D' ' 23' ' ' ILE . 8.1 mp -81.55 112.95 19.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.31 138.23 41.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.947 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -58.46 150.12 23.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.251 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.71 64.62 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -84.85 -178.59 6.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.936 0.398 . . . . 0.0 110.758 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -126.54 162.29 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.099 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.72 -39.56 94.45 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.68 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -63.75 -28.34 69.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.48 -34.59 75.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.029 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -97.84 12.37 34.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.432 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 m120 55.73 39.78 30.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.888 0.375 . . . . 0.0 110.23 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ILE . . . . . 0.715 HD11 HD21 ' D' ' 50' ' ' LEU . 75.9 mt -86.59 106.8 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.35 177.19 6.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.629 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -61.33 150.26 35.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.347 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 61.73 13.07 5.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.935 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m -70.75 136.3 48.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -86.31 119.94 27.12 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.83 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.52 HD21 HD13 ' D' ' 61' ' ' ILE . 7.6 mp -110.4 125.31 53.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.285 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -75.22 133.06 41.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.766 HD23 HG22 ' D' ' 7' ' ' THR . 69.2 tp -112.56 115.84 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -103.94 129.08 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.649 ' H ' HD11 ' D' ' 8' ' ' LEU . 47.8 mt . . . . . 0 C--N 1.324 -0.52 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.309 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -91.67 112.36 24.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.155 0.502 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.4 mt -66.64 -37.43 84.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.7 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.3 p -150.29 162.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.58 122.92 0.36 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.816 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.7 159.81 42.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.253 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.472 ' HA ' HD12 ' A' ' 46' ' ' LEU . 77.3 mtp180 -75.89 118.82 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.675 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.37 22.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.23 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.48 158.51 14.7 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -92.97 156.4 16.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.6 mtp -122.65 171.05 9.43 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.1 m -122.95 120.33 33.1 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.263 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 38' ' ' VAL . 28.1 tp -106.57 117.72 34.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.202 0.525 . . . . 0.0 110.337 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -123.45 118.21 26.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.521 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.68 -98.27 0.6 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.7 p -135.0 22.58 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.52 0.2 . . . . 0.0 111.074 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 33' ' ' LEU . 87.1 m -124.37 130.76 53.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.802 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 33' ' ' LEU . 59.9 t -109.15 124.46 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.644 HG22 ' HB3' ' B' ' 947' ' ' PRO . 21.7 p -124.03 118.21 26.88 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.09 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.5 148.38 66.64 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.541 1.494 . . . . 0.0 113.122 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.55 140.94 34.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.975 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -71.26 -7.37 46.51 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.947 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -70.01 78.52 0.49 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.24 133.76 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -162.7 10.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.216 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.0 tp -136.08 124.27 23.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.18 110.59 24.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -132.55 154.13 50.29 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.388 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.9 mt -119.42 136.5 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.918 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.47 130.99 33.43 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.509 0.506 . . . . 0.0 110.288 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.462 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.9 tt0 -100.37 125.18 46.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.124 0.488 . . . . 0.0 109.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 58' ' ' HIS . 15.1 p -84.78 172.17 11.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.575 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.54 -10.63 27.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.21 0.11 56.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.452 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t 70.66 21.32 5.38 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.148 0.499 . . . . 0.0 110.41 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD22 ' HE2' ' A' ' 76' ' ' PHE . 70.1 mt -99.28 123.67 43.75 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.9 mm -81.17 122.2 35.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.501 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.9 m-70 -99.01 114.56 27.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.719 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -96.54 109.08 21.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 142.99 51.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.229 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.71 116.53 28.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.458 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -106.42 133.25 51.4 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.04 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.489 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -72.03 -19.86 61.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.029 0.442 . . . . 0.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.2 m -60.09 -44.82 94.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.044 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -115.37 -15.49 11.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.74 20.31 79.77 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.08 146.78 27.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.62 102.32 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.187 0.518 . . . . 0.0 109.824 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.17 -38.26 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -126.63 144.91 50.75 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.087 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.0 t0 -157.78 101.56 1.81 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.246 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 72' ' ' ASP . 37.2 mt -127.9 136.31 51.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.01 123.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.9 mm -110.77 131.6 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.234 0.54 . . . . 0.0 111.169 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.537 ' HE2' HD22 ' A' ' 56' ' ' LEU . 57.2 m-85 -95.7 159.62 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.928 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.72 139.95 91.96 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.686 1.591 . . . . 0.0 111.23 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 61.68 11.2 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.334 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 100' ' ' ALA . 17.1 t70 -88.25 -22.53 23.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.178 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.703 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.5 p -147.93 164.91 32.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 7.5 tt0 -137.7 127.27 25.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.58 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -97.05 121.39 38.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -144.93 163.47 34.06 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.544 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 -88.41 157.03 18.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.225 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.95 88.78 10.51 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.45 60.97 8.03 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.995 1.797 . . . . 0.0 112.028 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -112.99 -48.87 2.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.136 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.22 102.2 54.64 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.165 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.64 130.75 16.32 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.435 1.424 . . . . 0.0 111.691 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 168.22 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.74 -179.06 33.32 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.566 ' NE ' HG22 ' A' ' 114' ' ' THR . 0.5 OUTLIER -88.01 109.68 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.91 127.58 75.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.301 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.62 152.35 43.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.6 p -130.03 140.48 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.21 122.49 40.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -109.34 110.08 21.14 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -73.62 105.1 4.8 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 81' ' ' GLU . 57.8 mttm -60.99 -37.78 83.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.611 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.621 ' HB3' ' OD1' ' A' ' 79' ' ' ASP . . . -97.66 -20.49 17.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.633 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.82 140.8 15.14 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -83.78 52.84 2.37 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.169 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.629 ' HD3' HD21 ' A' ' 105' ' ' LEU . 8.7 ttmt -140.22 144.32 36.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -130.94 138.45 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.181 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD21 ' HD3' ' A' ' 103' ' ' LYS . 55.5 mt -116.24 149.4 39.23 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.2 m-85 -118.92 134.82 54.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.766 0.317 . . . . 0.0 111.133 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.93 155.97 47.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.326 0.584 . . . . 0.0 111.259 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -133.28 138.48 46.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.492 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.3 tpp -73.17 129.04 37.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.331 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -5.7 19.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.482 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.84 146.35 97.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.34 -25.82 15.12 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.091 1.861 . . . . 0.0 112.882 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -119.7 141.96 48.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.566 HG22 ' NE ' ' A' ' 92' ' ' ARG . 73.9 p -96.98 10.81 38.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.492 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.36 -20.43 59.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -125.92 6.75 7.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.423 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.63 -50.23 73.38 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.164 0.507 . . . . 0.0 110.769 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -65.22 -40.47 94.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.225 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.65 -44.64 96.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.89 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.79 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.5 m170 -64.59 -40.09 94.9 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.648 0.737 . . . . 0.0 109.498 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.0 m -64.2 -41.58 97.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.141 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -67.18 -41.79 85.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -64.97 -35.77 82.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.364 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 120' ' ' HIS . 61.3 t -59.54 -48.26 87.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.111 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.15 -30.23 38.92 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.859 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -67.68 -37.92 83.0 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -81.03 -33.8 33.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.57 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.539 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.4 mt -77.79 -27.0 50.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -106.98 -23.3 12.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.386 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -140.08 67.74 33.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.132 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.68 160.86 46.96 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.997 2.465 . . . . 0.0 112.391 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.31 -1.496 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 -179.494 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -71.37 149.15 93.85 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.65 146.03 53.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.598 2.199 . . . . 0.0 112.675 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.74 161.78 62.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.94 149.82 81.77 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.554 2.17 . . . . 0.0 112.238 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.33 163.08 39.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.443 2.095 . . . . 0.0 112.151 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -74.74 156.79 86.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.52 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.644 ' HB3' HG22 ' A' ' 39' ' ' THR . 44.8 Cg_exo -57.86 147.09 83.3 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.62 162.57 41.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -86.22 137.79 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -115.72 127.64 55.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.92 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.39 121.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -81.45 85.21 6.51 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.078 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.296 179.714 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -58.76 159.33 6.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.7 pt -140.22 141.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.274 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -85.28 124.06 31.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.75 112.26 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -96.82 119.73 35.85 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.876 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.656 HG22 ' CB ' ' C' ' 69' ' ' LEU . 29.9 p . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.172 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.955 0.407 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.421 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -134.62 113.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.271 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -85.8 131.96 34.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' C' ' 33' ' ' LYS . 25.9 mt -124.19 125.64 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.343 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.41 112.79 4.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 110.907 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.697 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.5 m -136.18 162.89 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.323 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -104.19 154.5 38.19 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.55 -37.22 95.31 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.947 1.765 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -79.56 -7.88 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.13 135.35 53.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.981 0.419 . . . . 0.0 110.865 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -78.25 161.58 27.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.9 mm -64.76 -41.38 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.93 -36.17 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.083 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ASN . . . . . 0.419 ' HA ' HD21 ' C' ' 25' ' ' ASN . 9.1 m120 -65.02 -41.28 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.32 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 56' ' ' LEU . 58.9 t -63.81 -42.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.468 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.589 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.3 mtmt -60.81 -40.93 94.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.603 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -40.11 94.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.958 0.409 . . . . 0.0 110.478 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.697 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.0 mttm -60.21 -39.07 85.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.341 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.73 HD13 ' CD1' ' C' ' 69' ' ' LEU . 96.6 mt -66.92 -39.07 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.7 -40.96 85.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.22 -41.92 72.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.726 ' HG3' HD21 ' C' ' 15' ' ' LEU . 11.6 mmtt -66.09 -42.34 89.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.924 0.392 . . . . 0.0 112.039 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -136.83 154.98 50.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.992 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 57.07 3.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.631 HG22 ' HG3' ' C' ' 41' ' ' GLN . 28.8 mm -109.8 106.26 58.12 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.81 153.41 56.78 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.707 1.605 . . . . 0.0 111.672 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.74 -39.56 76.52 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.015 1.81 . . . . 0.0 112.366 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -39.09 91.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 0.0 110.322 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -86.58 -6.48 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.204 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.631 ' HG3' HG22 ' C' ' 36' ' ' ILE . 19.2 mt-30 -88.24 77.43 8.25 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.978 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -84.11 107.81 16.67 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.632 ' CB ' HD12 ' C' ' 50' ' ' LEU . 17.3 mt -99.16 119.26 37.57 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.009 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -126.51 127.75 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.354 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -130.41 129.65 43.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.86 25.59 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.66 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.14 2.69 90.59 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -108.14 126.17 52.46 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 122.538 -0.39 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -72.08 133.58 45.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.209 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' C' ' 43' ' ' LEU . 69.1 mt -77.23 102.91 6.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 110.287 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.22 139.96 42.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.946 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -61.56 137.08 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.241 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -17.37 55.64 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -83.4 -179.96 7.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.828 0.346 . . . . 0.0 110.359 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -127.32 165.41 19.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 26' ' ' VAL . 84.3 mt -62.0 -40.09 94.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -63.45 -27.6 69.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.007 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.53 -35.23 77.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 109.894 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.68 12.88 32.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.244 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.68 41.46 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.26 109.17 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.06 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.28 -176.08 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.504 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -66.05 148.14 52.27 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.34 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 58.21 41.11 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 42.8 m -93.68 125.07 38.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.258 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.47 ' C ' HD12 ' C' ' 67' ' ' LEU . 41.7 m -75.76 128.83 36.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.831 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.47 HD12 ' C ' ' C' ' 66' ' ' THR . 9.1 mp -115.64 152.05 33.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -101.83 112.62 25.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.73 ' CD1' HD13 ' C' ' 30' ' ' ILE . 0.7 OUTLIER -104.91 128.61 53.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.448 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -124.46 136.12 61.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.151 0.501 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--N 1.332 -0.156 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.366 -179.309 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -62.26 160.0 13.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.442 HD12 HD22 ' D' ' 67' ' ' LEU . 15.2 pt -142.83 146.93 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -95.34 123.27 38.78 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.755 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.747 HG11 HD11 ' D' ' 30' ' ' ILE . 83.8 t -104.96 110.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.44 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -97.8 132.69 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.524 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -88.27 -178.32 5.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.081 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.617 HD11 ' H ' ' D' ' 71' ' ' LEU . 83.8 mt -61.92 -37.02 83.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.302 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.9 p -73.72 -9.6 58.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.71 -6.45 67.47 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.654 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -59.07 121.79 12.16 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -100.66 133.11 45.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.046 0.45 . . . . 0.0 110.902 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.76 108.44 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 129.47 34.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.092 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' D' ' 29' ' ' LYS . 66.9 mt -127.35 126.3 42.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.541 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.1 114.63 10.41 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.35 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.652 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.0 m -135.71 164.14 33.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.716 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -110.68 155.62 41.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.051 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.02 -36.59 96.26 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.087 1.858 . . . . 0.0 111.763 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -77.45 -10.06 59.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.046 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -57.76 137.2 56.78 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -78.84 160.97 27.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.753 HD12 HD23 ' D' ' 50' ' ' LEU . 43.6 mm -63.3 -43.02 98.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.185 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -59.93 -34.51 73.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.257 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -64.92 -42.71 94.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.138 0.494 . . . . 0.0 110.71 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.553 HG21 HD21 ' D' ' 56' ' ' LEU . 69.1 t -62.36 -43.22 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.549 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.24 -38.85 88.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.56 87.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.059 0.457 . . . . 0.0 109.796 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.652 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -60.03 -37.18 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.747 HD11 HG11 ' D' ' 5' ' ' VAL . 6.2 mm -62.85 -39.46 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.89 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.2 -45.27 93.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.512 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.82 -38.22 90.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.783 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.416 ' HG3' HD21 ' D' ' 15' ' ' LEU . 23.5 mttm -90.19 -4.4 57.26 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -148.1 -47.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 8.41 32.79 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -80.42 120.69 80.12 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.43 156.98 62.68 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.259 1.306 . . . . 0.0 111.419 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -51.85 -36.04 61.73 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.163 1.908 . . . . 0.0 112.429 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -67.37 -46.02 74.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.54 -40.32 95.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.4 ' HB2' HD11 ' D' ' 69' ' ' LEU . 2.0 pt20 -98.68 151.03 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.37 0.605 . . . . 0.0 111.424 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -133.34 118.05 18.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.499 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.652 HD23 HD12 ' D' ' 69' ' ' LEU . 66.2 mt -86.15 122.29 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.587 HD12 HG21 ' D' ' 70' ' ' VAL . 83.9 mt -125.19 130.24 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.745 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 71.4 t80 -153.45 156.22 37.77 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.32 19.03 9.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.719 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -6.74 74.22 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -126.79 149.76 49.49 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 110.598 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -73.71 137.07 43.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.474 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.766 HD21 HD11 ' D' ' 61' ' ' ILE . 8.2 mp -83.53 112.2 19.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.841 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -75.23 175.93 7.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.734 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.28 162.89 21.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.454 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.17 -151.08 41.61 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 51.69 179.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.334 0.588 . . . . 0.0 111.462 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 71.8 p -131.69 170.31 14.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.553 HD21 HG21 ' D' ' 26' ' ' VAL . 84.8 mt -61.68 -39.63 92.13 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.401 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -65.37 -27.36 68.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.01 -28.08 69.85 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.137 0.494 . . . . 0.0 110.067 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -103.49 14.73 30.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.326 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 57.02 39.46 29.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.597 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ILE . . . . . 0.766 HD11 HD21 ' D' ' 50' ' ' LEU . 81.2 mt -88.69 117.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.078 0.466 . . . . 0.0 110.136 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -101.18 176.51 5.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.387 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -60.43 150.74 30.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.902 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 60.11 14.87 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.185 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -63.47 136.39 57.56 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -95.38 107.13 19.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.93 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.442 HD22 HD12 ' D' ' 3' ' ' ILE . 8.9 mp -92.34 155.81 17.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.254 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -106.69 124.12 49.14 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.76 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.652 HD12 HD23 ' D' ' 43' ' ' LEU . 7.7 tp -99.89 92.88 5.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.815 HG11 HD11 ' A' ' 56' ' ' LEU . 58.3 t -87.36 129.81 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.617 ' H ' HD11 ' D' ' 8' ' ' LEU . 65.1 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.011 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.808 0.337 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -93.74 126.27 38.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.249 0.547 . . . . 0.0 109.913 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 51' ' ' GLN . 90.8 mt -68.99 -37.33 78.67 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.973 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.99 160.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.802 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -173.87 122.22 0.32 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -152.77 157.24 40.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HA ' HD12 ' A' ' 46' ' ' LEU . 72.9 mtp180 -76.31 121.82 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.09 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.88 143.95 22.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.648 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.42 151.47 17.45 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -95.12 157.14 16.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.916 0.389 . . . . 0.0 110.974 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 43.0 mtp -121.84 172.77 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.1 m -122.44 122.43 38.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.211 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 37' ' ' THR . 25.7 tp -106.45 118.99 38.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.729 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -121.25 111.54 17.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.437 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -102.11 1.0 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.5 p -127.62 20.38 6.64 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.359 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.61 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.7 m -122.32 129.88 52.6 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 33' ' ' LEU . 62.1 t -109.01 123.88 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.705 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 p -115.59 134.88 22.59 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.58 143.85 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.72 1.613 . . . . 0.0 112.305 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -106.57 131.49 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -72.35 -7.18 48.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.153 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -73.14 75.96 1.26 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -57.42 131.06 48.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.18 -160.25 10.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.523 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.9 tp -136.42 124.67 23.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.2 t -98.03 111.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.304 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -133.86 155.7 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.917 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.6 mt -123.94 140.24 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.389 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -141.38 141.64 33.79 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.096 0.474 . . . . 0.0 110.136 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.508 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.9 tt0 -106.1 127.58 53.29 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.535 HG23 ' CD2' ' A' ' 58' ' ' HIS . 27.0 p -88.48 172.46 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.477 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.53 -10.73 19.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.073 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.14 0.18 55.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.262 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t 68.46 21.76 8.07 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 110.482 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.815 HD11 HG11 ' D' ' 70' ' ' VAL . 70.2 mt -101.7 124.69 47.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 131' ' ' PRO . 50.9 mm -80.84 125.73 39.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.0 m-70 -102.79 116.42 32.53 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.571 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -92.5 109.35 20.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.4 m -120.69 144.84 48.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.877 0.846 . . . . 0.0 112.904 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.98 114.08 18.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.183 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -107.53 131.31 54.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.295 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -73.03 131.98 42.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -72.51 -19.12 61.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 110.415 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -60.24 -45.07 94.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.15 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.8 p -116.0 -15.18 11.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 20.59 79.48 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -101.62 145.49 28.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.4 t -73.98 103.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.261 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -78.44 -31.55 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -126.77 145.89 50.44 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.641 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.599 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.5 t0 -157.53 98.73 1.7 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.332 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 72' ' ' ASP . 35.9 mt -128.07 134.47 49.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.563 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.6 127.29 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.55 HG23 ' SG ' ' A' ' 80' ' ' CYS . 31.3 mm -113.77 123.55 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.905 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.462 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 64.6 m-85 -90.33 163.23 32.04 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.114 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.62 140.66 90.65 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.072 1.848 . . . . 0.0 111.309 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 59.89 13.61 3.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.246 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -90.15 -32.34 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.502 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.598 ' HB3' HD11 ' A' ' 96' ' ' LEU . 71.4 m -134.95 152.37 51.67 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.331 0.586 . . . . 0.0 111.93 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.29 129.11 48.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.58 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.94 118.73 37.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -144.35 166.58 24.7 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.9 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -88.69 159.69 17.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.956 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 t -114.83 89.76 20.29 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.47 59.98 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.015 1.81 . . . . 0.0 111.972 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -47.43 2.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.8 t -114.27 99.33 50.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.96 130.03 16.13 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.559 1.506 . . . . 0.0 111.488 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.6 -35.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.682 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.37 176.67 36.13 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.697 ' HE ' HG21 ' A' ' 114' ' ' THR . 94.6 mtt-85 -81.12 113.82 19.55 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.916 0.389 . . . . 0.0 110.783 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.97 125.16 67.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.969 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.79 152.34 35.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.307 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 105' ' ' LEU . 15.0 p -131.23 135.95 58.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.0 110.125 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 80' ' ' CYS . 63.6 tp -102.53 118.11 36.16 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -113.83 132.6 55.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.616 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -85.17 116.07 23.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.244 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.48 -37.1 82.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.03 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.19 -24.13 8.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.104 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.13 72.14 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 p 81.57 -6.11 1.52 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 124.128 0.546 . . . . 0.0 110.721 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.707 ' HD3' HD21 ' A' ' 105' ' ' LEU . 9.1 ttmm -79.7 148.19 31.66 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.259 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.4 mtt180 -133.76 133.43 41.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.795 0.331 . . . . 0.0 110.479 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.707 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.7 mt -121.74 152.8 39.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.033 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.05 137.69 54.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.912 0.386 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.98 159.93 41.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -136.99 139.83 41.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.013 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.13 131.04 49.85 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 111.282 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.42 0.89 10.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.73 147.82 81.68 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.27 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.77 -40.07 67.14 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.814 1.676 . . . . 0.0 112.299 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.92 144.54 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.697 HG21 ' HE ' ' A' ' 92' ' ' ARG . 74.7 p -100.28 12.01 38.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -55.76 -20.76 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.965 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -124.06 17.48 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.702 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.54 -45.48 93.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -71.63 -34.82 70.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.432 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -44.43 88.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.736 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.1 m170 -64.14 -39.78 94.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.8 -46.03 91.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.749 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -65.64 -43.15 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.262 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -62.72 -39.82 95.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.544 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 120' ' ' HIS . 59.3 t -59.51 -47.77 89.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.408 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -79.87 -24.93 40.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.936 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -69.59 -42.38 74.54 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.866 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -79.0 -35.45 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.674 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 124' ' ' VAL . 80.4 mt -71.34 -36.05 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -98.84 -27.79 13.76 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.497 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -132.89 76.25 70.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.353 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.491 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.2 Cg_exo -58.58 155.57 36.09 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.819 2.346 . . . . 0.0 112.037 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.492 1.429 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 -179.406 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.62 149.24 90.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.12 148.04 38.97 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.29 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -73.89 151.7 88.72 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.35 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 944' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' B' ' 945' ' ' PRO . 73.6 Cg_endo -73.97 156.44 47.7 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.021 . . . . 0.0 112.372 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 945' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 944' ' ' PRO . 22.5 Cg_exo -61.71 -169.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.439 2.093 . . . . 0.0 112.023 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.09 157.24 77.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 140.01 82.59 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.42 2.08 . . . . 0.0 112.338 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -157.59 164.73 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.621 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -86.32 136.73 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -118.05 129.7 55.72 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.723 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.19 132.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.15 84.64 0.74 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.326 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.472 179.578 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -64.23 161.48 16.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.489 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -142.1 145.22 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.045 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -87.87 122.77 31.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.826 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.86 108.73 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.169 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -89.63 124.23 34.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.651 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.49 HG22 HD23 ' C' ' 69' ' ' LEU . 72.8 p . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.347 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.834 0.35 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 111.94 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.496 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 37.4 m -83.05 129.77 35.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.691 -0.404 . . . . 0.0 109.911 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.56 131.76 53.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.57 114.14 10.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.941 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.439 HG12 ' HD2' ' C' ' 29' ' ' LYS . 24.5 m -136.1 165.43 29.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -107.13 152.36 41.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.1 -37.43 94.04 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.054 1.836 . . . . 0.0 112.096 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -82.27 -8.34 59.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.237 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -58.39 137.35 57.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 50.0 p -79.08 163.52 25.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.786 HD12 HD23 ' C' ' 50' ' ' LEU . 41.3 mm -64.88 -37.39 80.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.804 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -43.4 90.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.46 -41.9 99.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.025 0.44 . . . . 0.0 110.81 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.18 -43.07 98.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.812 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.43 ' HG2' HD11 ' C' ' 43' ' ' LEU . 58.4 mtmt -60.89 -39.48 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.71 91.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.058 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.439 ' HD2' HG12 ' C' ' 17' ' ' VAL . 68.0 mttm -60.61 -40.08 90.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.18 -40.39 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.111 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.96 -44.31 94.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.201 0.524 . . . . 0.0 110.206 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -74.24 -17.86 60.82 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -101.02 -4.62 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -149.56 -46.01 0.14 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 110.456 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 3.26 26.62 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.072 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.48 HG22 ' HG3' ' C' ' 41' ' ' GLN . 32.7 mm -65.99 117.22 40.3 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.863 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.39 150.17 86.21 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.108 1.872 . . . . 0.0 112.089 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.88 -38.05 67.54 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.996 1.798 . . . . 0.0 112.482 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.26 -40.22 96.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.819 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.44 -4.61 59.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.48 ' HG3' HG22 ' C' ' 36' ' ' ILE . 45.3 mt-30 -84.68 103.1 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.166 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.53 103.2 12.46 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.43 HD11 ' HG2' ' C' ' 27' ' ' LYS . 58.0 mt -100.34 119.91 39.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -127.46 128.22 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.138 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -129.33 126.75 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 110.798 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.03 27.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.727 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.86 2.08 89.99 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -106.38 117.59 34.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -69.28 127.78 34.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.786 HD23 HD12 ' C' ' 23' ' ' ILE . 7.8 mp -74.82 98.17 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.121 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.07 146.58 47.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.136 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.03 137.7 58.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.482 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.96 -17.0 57.86 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -83.44 175.27 9.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.706 0.289 . . . . 0.0 110.263 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -121.58 164.61 16.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.68 -40.14 96.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.469 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.0 p -64.1 -26.26 68.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.989 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.864 0.364 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -104.02 14.03 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.346 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 57.06 40.2 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.401 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.506 ' CD1' HD21 ' C' ' 50' ' ' LEU . 83.3 mt -90.66 107.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.157 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.81 -173.48 3.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.285 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -67.0 150.2 49.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.059 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 55.44 39.86 31.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.024 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -93.46 126.64 38.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.097 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.528 ' C ' HD12 ' C' ' 67' ' ' LEU . 43.8 m -76.18 129.18 36.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.157 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.528 HD12 ' C ' ' C' ' 66' ' ' THR . 8.7 mp -119.11 146.55 45.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.395 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.33 112.58 24.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.551 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.49 HD23 HG22 ' C' ' 7' ' ' THR . 51.3 tp -104.46 121.57 43.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.666 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -121.51 138.06 53.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.893 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.455 HD22 ' CG2' ' C' ' 36' ' ' ILE . 22.7 mt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.114 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -62.65 161.57 12.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.093 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.602 HD13 HD21 ' D' ' 56' ' ' LEU . 12.7 pt -139.55 139.32 38.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.013 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.653 ' HD2' HG21 ' D' ' 12' ' ' THR . 3.9 m-85 -83.4 121.38 27.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.465 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -110.26 98.76 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -84.59 123.81 30.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 110.917 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.428 HG22 HD13 ' D' ' 69' ' ' LEU . 80.9 p -86.66 173.45 9.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.981 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.519 HD11 ' H ' ' D' ' 71' ' ' LEU . 70.6 mt -63.14 -24.67 68.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -71.89 -14.78 62.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.68 -15.54 59.64 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -70.92 141.8 51.12 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.653 HG21 ' HD2' ' D' ' 4' ' ' PHE . 95.6 m -104.88 132.61 50.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.083 0.468 . . . . 0.0 110.96 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.67 101.52 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.174 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -83.53 122.7 28.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.634 HD21 ' HD2' ' D' ' 33' ' ' LYS . 79.2 mt -121.98 129.13 52.22 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.823 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.59 115.49 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.654 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.422 HG12 ' HE3' ' D' ' 29' ' ' LYS . 16.2 m -136.93 177.07 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.99 156.22 69.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.392 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.27 -43.55 54.95 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.935 1.757 . . . . 0.0 112.073 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 82.7 p -72.35 -14.66 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -57.8 138.82 55.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.963 0.411 . . . . 0.0 110.638 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -80.97 161.66 24.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.785 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.645 HD12 HD13 ' D' ' 50' ' ' LEU . 49.7 mm -64.24 -41.29 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.081 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -58.3 -35.78 72.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.322 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -65.14 -43.48 91.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.483 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.621 HG21 HD11 ' D' ' 56' ' ' LEU . 78.1 t -62.41 -41.81 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -60.55 -39.03 86.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.227 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.4 90.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 0.0 110.136 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.501 ' CB ' HD13 ' D' ' 15' ' ' LEU . 66.7 mttm -60.44 -39.08 86.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.928 HD11 HD21 ' D' ' 43' ' ' LEU . 91.1 mt -63.81 -40.75 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.096 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.06 -41.38 92.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.23 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.59 -41.4 97.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.634 ' HD2' HD21 ' D' ' 15' ' ' LEU . 76.6 mttt -78.38 -76.73 0.18 Allowed 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.779 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.58 152.9 24.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.86 53.02 4.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mm -107.92 113.9 60.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.967 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.61 155.78 62.46 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.94 1.76 . . . . 0.0 112.147 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.72 -27.05 49.96 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.337 2.025 . . . . 0.0 112.603 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -83.36 -1.66 53.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.447 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -114.47 -49.18 2.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.557 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.485 ' HA ' HD21 ' D' ' 69' ' ' LEU . 0.8 OUTLIER -70.12 128.1 35.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.037 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mmt-85 -126.99 102.51 7.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.928 HD21 HD11 ' D' ' 30' ' ' ILE . 91.3 mt -76.13 125.55 29.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' D' ' 49' ' ' GLN . 72.3 mt -130.59 130.76 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.0 t80 -151.77 155.29 37.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 70.23 21.6 5.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 0.04 85.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.511 ' HB3' HD22 ' A' ' 73' ' ' LEU . 3.0 ptm180 -136.08 149.74 48.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.505 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.415 ' HA ' HG23 ' D' ' 44' ' ' ILE . 20.3 pt20 -68.48 148.28 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.473 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.645 HD13 HD12 ' D' ' 23' ' ' ILE . 68.0 mt -83.01 117.11 22.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.691 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -76.12 137.99 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.1 142.81 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 0.0 110.345 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.98 -15.84 62.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -83.11 163.8 20.65 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.699 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -104.77 171.09 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.222 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.621 HD11 HG21 ' D' ' 26' ' ' VAL . 5.1 mp -71.27 -38.81 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.071 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -62.77 -25.82 68.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.54 -37.73 87.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.113 0.482 . . . . 0.0 110.374 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.19 11.3 34.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.274 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 56.14 40.19 30.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 110.435 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -85.56 109.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -94.22 178.1 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.673 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.25 146.09 49.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 63.61 14.71 8.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.331 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -63.37 135.11 56.76 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -91.1 121.97 33.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.93 0.395 . . . . 0.0 110.313 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.521 HD23 HD11 ' D' ' 50' ' ' LEU . 5.4 mp -118.07 144.85 45.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.333 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -90.48 129.75 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.515 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.615 HD11 HG21 ' D' ' 30' ' ' ILE . 3.2 tt -104.24 101.53 11.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.798 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 56' ' ' LEU . 60.0 t -87.74 132.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.519 ' H ' HD11 ' D' ' 8' ' ' LEU . 57.2 mt . . . . . 0 C--N 1.326 -0.442 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm . . . . . 0 C--O 1.237 0.421 0 CA-C-O 120.998 0.427 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.17 115.26 27.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.87 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' HD12 ' A' ' 57' ' ' ILE . 98.0 mt -66.81 -36.7 82.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.361 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -151.22 163.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.419 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.77 122.84 0.34 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.224 0.535 . . . . 0.0 110.988 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -156.21 159.54 39.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.034 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -77.9 118.79 20.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.636 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.45 139.87 20.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.955 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.17 151.53 17.55 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -88.06 154.77 20.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.968 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.6 mtp -122.33 171.75 8.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -121.94 125.84 47.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.472 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 37' ' ' THR . 22.5 tp -107.29 119.2 38.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.443 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -119.11 107.83 13.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.805 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 -94.28 0.63 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.0 p -133.98 21.54 3.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.459 0.171 . . . . 0.0 110.79 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.634 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.8 m -124.46 131.23 53.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.533 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' CG2' HD13 ' A' ' 33' ' ' LEU . 76.6 t -110.41 125.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.107 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.442 HG22 ' HB3' ' B' ' 947' ' ' PRO . 21.7 p -119.8 138.07 26.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.623 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.55 142.84 29.9 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.84 1.693 . . . . 0.0 112.405 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.66 135.73 44.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.614 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.84 -6.78 47.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.934 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -77.72 62.2 2.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -56.02 133.8 52.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.62 -152.08 7.81 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -138.2 125.01 21.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.67 107.02 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.4 p90 -131.08 152.72 50.08 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.791 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.4 mt -120.57 140.52 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -140.66 143.49 35.16 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.624 0.577 . . . . 0.0 109.831 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -107.23 127.44 53.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.309 0.576 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' CD2' ' A' ' 58' ' ' HIS . 22.7 p -86.58 172.1 10.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.952 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -11.34 22.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.662 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.52 3.45 47.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.46 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.6 m 64.79 22.89 12.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.154 0.502 . . . . 0.0 111.065 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.75 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 65.9 mt -102.5 126.08 49.43 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.577 HD12 ' CD1' ' A' ' 23' ' ' LEU . 46.7 mm -80.56 126.87 39.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.3 m-70 -103.78 117.74 35.07 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.489 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -94.34 107.97 19.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -120.87 144.04 48.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.708 0.766 . . . . 0.0 112.681 -177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -125.09 112.09 16.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.616 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -105.34 133.09 50.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.345 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.51 138.55 47.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.053 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.8 -18.55 50.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.607 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.4 m -60.53 -45.79 92.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.5 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.6 m -116.84 -13.93 10.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.5 23.66 76.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -102.56 144.15 31.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.383 . . . . 0.0 110.987 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.7 t -73.79 108.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -89.56 -25.97 21.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.751 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -127.76 143.4 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.566 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 73' ' ' LEU . 66.8 t0 -158.11 94.62 1.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.544 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 72' ' ' ASP . 30.6 mt -126.43 134.19 51.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.822 0.344 . . . . 0.0 110.872 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.3 mt -77.23 127.15 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.306 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.521 ' HB ' HD22 ' A' ' 128' ' ' LEU . 27.2 mm -111.53 121.79 64.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.746 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.75 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 59.7 m-85 -94.77 163.48 22.26 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.055 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.04 137.85 77.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.0 1.8 . . . . 0.0 111.755 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.34 12.44 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.584 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -89.85 -34.01 16.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 120.764 0.316 . . . . 0.0 110.428 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -141.52 145.44 35.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.103 0.478 . . . . 0.0 111.341 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.8 tt0 -123.95 131.97 53.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.344 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.8 118.43 36.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -142.61 167.31 22.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.084 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -89.74 160.63 16.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 t -113.75 89.25 15.49 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.381 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.67 60.35 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.946 1.764 . . . . 0.0 111.642 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -114.85 -39.88 3.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.118 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.1 t -121.21 87.95 44.88 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.237 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.14 130.72 24.87 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.656 1.571 . . . . 0.0 111.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 168.81 -40.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.67 -149.04 5.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.286 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.48 105.79 12.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.347 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.2 t -121.66 126.62 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.704 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.61 154.02 33.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.06 133.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.126 0.489 . . . . 0.0 110.283 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 81' ' ' GLU . 57.2 tp -102.92 122.88 45.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -119.73 133.52 55.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.032 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 51.7 m-85 -88.61 115.09 25.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.87 -32.65 72.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.507 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.24 -23.7 9.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.967 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.91 -25.84 68.35 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.997 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.81 7.3 5.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HD3' HD21 ' A' ' 105' ' ' LEU . 9.1 ttmm -96.54 148.75 22.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.857 0.36 . . . . 0.0 110.732 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -129.37 133.15 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.918 0.389 . . . . 0.0 110.601 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.453 HD21 ' HD3' ' A' ' 103' ' ' LYS . 45.9 mt -120.42 148.0 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.711 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.6 136.74 54.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.769 0.319 . . . . 0.0 111.394 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.02 154.07 48.19 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.378 0.609 . . . . 0.0 111.554 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -130.45 135.8 48.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.351 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 141.81 50.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.256 0.55 . . . . 0.0 110.925 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.62 2.94 4.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.463 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -77.08 155.22 82.58 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.104 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.52 -41.67 38.6 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.251 1.967 . . . . 0.0 113.162 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.89 146.87 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.91 -1.76 56.43 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.46 -18.37 28.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -117.02 -17.67 10.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.695 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.24 -41.21 96.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.819 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.03 -40.66 96.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.03 0.443 . . . . 0.0 111.167 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.32 -40.04 85.91 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.253 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.738 ' O ' HG23 ' A' ' 124' ' ' VAL . 65.0 m170 -61.33 -39.73 91.61 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.59 -45.78 92.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.367 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -64.98 -41.59 95.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.383 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -66.47 -37.05 84.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.45 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.9 t -58.19 -48.35 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.248 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -78.24 -27.28 47.59 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.008 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.7 -37.61 76.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.885 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -80.99 -31.55 34.67 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.804 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 75' ' ' ILE . 51.7 mt -81.58 -27.11 34.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -104.83 -27.66 11.61 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.243 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -133.83 73.2 71.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.76 152.52 62.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.935 2.423 . . . . 0.0 112.345 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 122.384 2.056 . . . . 0.0 112.025 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -128.46 153.42 79.24 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.597 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.64 150.0 68.36 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.374 2.049 . . . . 0.0 112.299 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.46 153.66 91.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.81 161.82 44.73 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.345 2.03 . . . . 0.0 112.301 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.2 -170.26 0.48 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.881 2.388 . . . . 0.0 111.816 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -116.67 158.71 42.87 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.553 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.442 ' HB3' HG22 ' A' ' 39' ' ' THR . 51.0 Cg_exo -56.14 142.66 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.564 2.176 . . . . 0.0 112.105 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.48 165.58 36.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.69 139.57 31.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.37 122.21 37.07 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.821 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 64.3 mt -131.88 122.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.597 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -67.61 83.92 0.18 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.584 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 31.2 t0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.59 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -151.29 170.54 19.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.127 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.614 HG22 ' HB3' ' C' ' 65' ' ' SER . 5.2 pt -143.41 147.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.861 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.75 111.96 24.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -93.47 110.86 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.357 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.83 122.1 31.06 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.086 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 58.1 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 83.3 m . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.712 0.291 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.427 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -122.62 111.08 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.759 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.33 128.8 34.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.705 0.288 . . . . 0.0 110.265 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.773 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.9 mt -125.66 133.86 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.15 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.99 120.63 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.972 0.415 . . . . 0.0 110.293 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.749 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 32.8 m -138.49 177.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.965 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.415 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.7 mt-10 -122.71 155.19 63.5 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.327 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.63 -27.61 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.945 . . . . 0.0 112.312 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -91.83 -9.84 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.516 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -60.69 141.18 57.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.815 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -79.09 160.21 27.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.49 -37.65 80.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.34 -41.99 85.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.017 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.14 -40.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 110.185 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.458 HG21 HD21 ' C' ' 56' ' ' LEU . 54.9 t -62.04 -42.87 96.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.798 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.492 ' HG2' HD11 ' C' ' 43' ' ' LEU . 54.6 mtmt -60.01 -39.73 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.97 93.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.497 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.749 ' NZ ' HG12 ' C' ' 17' ' ' VAL . 75.4 mttt -60.35 -39.09 85.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.227 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.69 -37.99 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.071 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.09 -38.85 80.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.071 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.31 -50.35 47.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.773 ' HG3' HD21 ' C' ' 15' ' ' LEU . 5.0 mttt -63.28 -40.85 98.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.682 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -133.21 148.9 52.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.174 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.02 59.57 2.67 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.591 ' CG2' HD22 ' C' ' 71' ' ' LEU . 28.9 mm -111.16 103.69 55.22 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.81 150.61 70.11 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.227 1.952 . . . . 0.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.61 -37.97 54.19 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.174 1.916 . . . . 0.0 112.278 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.76 -38.58 91.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.556 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.84 -2.88 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.189 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.576 ' HG3' HG22 ' C' ' 36' ' ' ILE . 91.1 mt-30 -89.44 94.14 9.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.29 109.47 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' C' ' 27' ' ' LYS . 33.9 mt -104.11 119.98 40.12 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.622 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.86 120.55 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.228 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -66.87 -46.68 74.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.55 79.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.936 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.88 88.86 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -126.69 126.63 43.83 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.961 0.41 . . . . 0.0 110.733 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -76.75 146.09 38.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.36 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.558 HD11 HD23 ' C' ' 67' ' ' LEU . 59.8 mt -95.7 112.64 24.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.611 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.07 148.35 36.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.17 -40.15 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.105 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.67 -12.05 66.61 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 166.48 13.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.079 0.466 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 77.6 p -117.42 165.67 13.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.191 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.458 HD21 HG21 ' C' ' 26' ' ' VAL . 77.2 mt -60.92 -40.53 93.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.905 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -64.36 -23.92 67.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.891 0.377 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.41 -34.53 75.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.517 ' CE2' HD23 ' C' ' 50' ' ' LEU . 69.5 m-85 -99.88 16.95 22.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.036 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 57.28 37.59 28.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.632 HG23 ' OG ' ' C' ' 65' ' ' SER . 86.6 mt -84.79 117.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.19 -176.56 3.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.676 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.53 145.3 33.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.906 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 60.56 25.73 15.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.393 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' SER . . . . . 0.632 ' OG ' HG23 ' C' ' 61' ' ' ILE . 2.4 t -73.93 124.06 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.037 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -85.83 128.1 34.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.558 HD23 HD11 ' C' ' 50' ' ' LEU . 1.5 mp -118.5 149.89 40.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.49 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -94.19 119.47 33.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.83 124.15 49.1 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.281 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.41 133.06 69.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.591 HD22 ' CG2' ' C' ' 36' ' ' ILE . 17.5 mt . . . . . 0 C--N 1.334 -0.099 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.04 161.67 18.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -142.07 139.82 30.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.364 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -83.27 122.86 28.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -106.52 109.19 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.318 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -80.0 114.99 19.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.843 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.58 ' CG2' HD11 ' D' ' 13' ' ' ILE . 59.9 p -70.66 176.29 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -26.16 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -108.46 -175.96 2.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.906 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.58 -20.66 59.47 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -53.77 133.38 42.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 110.494 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -124.2 137.39 54.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.58 HD11 ' CG2' ' D' ' 7' ' ' THR . 0.1 OUTLIER -123.54 112.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.404 -179.022 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 28.8 m -84.11 127.2 33.76 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.296 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.626 HD21 ' HD2' ' D' ' 33' ' ' LYS . 87.4 mt -120.86 130.7 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.572 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.87 115.22 10.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.486 HG12 ' HE3' ' D' ' 29' ' ' LYS . 21.4 m -135.61 164.32 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.66 153.71 39.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.453 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -37.01 91.43 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.236 1.957 . . . . 0.0 112.026 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.1 p -82.26 -7.4 59.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.185 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.73 136.51 58.02 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.915 0.388 . . . . 0.0 110.904 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -80.04 162.88 24.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.761 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.06 -37.67 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.614 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.35 -43.22 92.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.274 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.24 -40.4 96.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.184 0.516 . . . . 0.0 110.59 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.503 HG12 HD21 ' D' ' 43' ' ' LEU . 69.6 t -62.94 -42.39 96.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.469 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.507 ' HG2' HD13 ' D' ' 43' ' ' LEU . 57.3 mtmt -60.25 -39.81 88.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.115 0.484 . . . . 0.0 110.362 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -39.71 91.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.332 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.486 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.9 mttm -60.48 -38.79 85.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.428 ' CD1' HD11 ' D' ' 43' ' ' LEU . 90.2 mt -63.37 -41.05 91.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.035 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.5 -40.36 96.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.626 ' HD2' HD21 ' D' ' 15' ' ' LEU . 52.3 mttt -78.03 -64.81 1.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.286 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -97.81 161.25 13.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.235 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.99 53.68 3.77 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.727 HG22 ' HG2' ' D' ' 41' ' ' GLN . 33.8 mm -109.28 107.56 59.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.63 150.94 69.66 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.081 1.854 . . . . 0.0 112.03 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.27 -20.63 8.35 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.297 1.998 . . . . 0.0 112.612 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -92.75 19.85 7.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.606 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -152.49 26.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.624 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.727 ' HG2' HG22 ' D' ' 36' ' ' ILE . 1.3 mt-30 -118.86 95.86 5.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' D' ' 70' ' ' VAL . 82.6 mtp180 -96.19 100.17 11.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.672 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.566 ' HB3' HD12 ' D' ' 50' ' ' LEU . 7.5 mp -85.66 122.33 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' D' ' 49' ' ' GLN . 67.1 mt -128.28 131.48 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.546 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.492 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 72.2 t80 -153.25 157.55 40.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.68 18.89 7.47 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.796 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.27 -5.9 78.43 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -130.94 149.11 52.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.562 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.522 ' HA ' HG23 ' D' ' 44' ' ' ILE . 18.5 pt20 -66.79 140.53 57.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.37 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.566 HD12 ' HB3' ' D' ' 43' ' ' LEU . 69.2 mt -81.68 123.51 28.78 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.621 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.67 139.39 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.177 0.513 . . . . 0.0 110.612 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -63.41 138.99 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.316 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.89 -12.52 64.12 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -80.22 172.07 14.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -115.29 157.53 23.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.226 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.99 -40.82 96.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.542 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -63.33 -24.14 67.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.456 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -62.54 -37.66 86.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.117 0.484 . . . . 0.0 110.424 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -98.68 14.64 27.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 m120 56.46 38.77 29.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.454 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.87 104.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.91 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.56 179.05 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.39 151.64 27.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 57.87 42.09 23.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.967 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 65' ' ' SER . . . . . 0.421 ' O ' HD12 ' D' ' 67' ' ' LEU . 30.2 t -90.22 122.73 33.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.268 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -79.69 85.68 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.045 0.45 . . . . 0.0 110.589 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.438 ' N ' HD12 ' D' ' 67' ' ' LEU . 7.1 mp -77.19 154.36 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.891 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -102.64 122.67 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.256 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -104.59 121.49 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.225 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 56' ' ' LEU . 61.3 t -115.62 132.34 65.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.009 -178.837 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.847 0.356 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -85.44 127.12 34.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.287 0.565 . . . . 0.0 110.293 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' CD1' HD12 ' A' ' 57' ' ' ILE . 86.3 mt -67.53 -36.17 80.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.88 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.74 161.71 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.01 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.99 122.47 0.31 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.165 0.507 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 120' ' ' HIS . 50.6 p90 -155.36 156.16 34.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.857 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.663 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -74.62 119.2 18.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.474 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.86 144.86 25.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.222 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.75 149.12 16.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -91.98 163.47 13.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.3 mtp -124.9 175.96 6.95 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -121.62 121.22 36.9 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.354 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 37' ' ' THR . 30.4 tp -107.68 117.93 35.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.58 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -121.14 114.41 21.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.986 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 -86.68 0.56 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -146.46 22.16 1.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.558 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.603 ' O ' HD12 ' A' ' 33' ' ' LEU . 93.3 m -124.36 129.5 50.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.431 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' HD13 ' A' ' 33' ' ' LEU . 64.2 t -106.33 121.63 59.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.74 HG23 ' HG3' ' B' ' 947' ' ' PRO . 98.4 m -116.05 122.52 32.24 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.515 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -55.41 142.31 80.35 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.178 1.919 . . . . 0.0 112.23 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -108.13 132.66 53.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.879 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -70.63 -6.69 38.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.153 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -72.37 73.17 0.98 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -59.67 135.17 57.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.713 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.15 -154.99 7.02 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.0 tp -140.64 124.93 17.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.34 108.27 21.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.84 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.8 p90 -131.24 153.23 49.73 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.661 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 94.9 mt -121.17 141.21 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.933 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -141.86 140.73 32.98 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.786 0.679 . . . . 0.0 110.269 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -104.35 128.82 52.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.08 0.467 . . . . 0.0 110.399 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.52 HG23 ' CD2' ' A' ' 58' ' ' HIS . 22.7 p -88.09 172.74 9.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.673 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.72 -10.37 19.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -86.15 -0.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.343 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t 69.4 19.65 7.56 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.05 0.452 . . . . 0.0 110.698 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 60.1 mt -103.34 126.95 50.77 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 23' ' ' LEU . 45.5 mm -79.26 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.485 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.7 m-70 -104.95 116.65 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.691 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -92.81 107.25 19.07 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.9 m -118.53 144.79 45.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.653 0.739 . . . . 0.0 112.805 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -125.76 111.18 14.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.745 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -103.3 136.29 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.989 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -76.12 139.58 41.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -79.17 -18.97 52.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.614 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -61.08 -46.29 91.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -117.04 -12.47 10.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.328 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.95 77.16 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.78 147.66 26.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.32 . . . . 0.0 111.028 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.5 103.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.103 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -83.15 -28.74 29.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.28 143.46 51.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.057 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.798 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.5 t0 -158.11 99.98 1.68 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.769 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 72' ' ' ASP . 6.2 mt -132.09 130.13 40.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.0 mt -74.32 129.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.687 HG21 ' SG ' ' A' ' 80' ' ' CYS . 21.4 mm -117.26 120.24 64.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.647 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.6 m-85 -86.02 163.55 42.67 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.191 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.8 136.27 75.39 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.023 1.815 . . . . 0.0 111.525 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t0 61.4 12.06 4.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.44 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.85 -25.32 30.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.889 -0.142 . . . . 0.0 110.778 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 75' ' ' ILE . 10.2 p -147.04 169.17 19.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.253 0.549 . . . . 0.0 110.672 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.93 132.42 30.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.448 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -102.29 117.77 35.47 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -141.74 164.8 29.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.072 0.463 . . . . 0.0 111.461 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -83.81 160.71 21.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.383 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.7 88.43 20.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.45 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.96 59.86 7.64 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.298 1.999 . . . . 0.0 112.038 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -48.83 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.42 102.77 54.79 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.828 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.73 129.6 14.72 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 121.516 1.478 . . . . 0.0 111.478 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 p 167.46 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.7 0.625 . . . . 0.0 110.416 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.35 -179.26 33.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -88.09 114.7 24.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.655 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.12 129.81 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.199 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -119.83 157.3 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.7 p -134.21 136.94 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.5 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.609 HD11 ' SG ' ' A' ' 80' ' ' CYS . 67.6 tp -102.55 121.79 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -118.53 134.37 55.14 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.242 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CE2' HD12 ' A' ' 75' ' ' ILE . 40.1 m-85 -85.75 114.16 22.49 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -37.13 84.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.8 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.06 -22.52 22.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.454 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.44 -169.78 20.39 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.6 p -121.42 13.2 10.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.626 0.251 . . . . 0.0 110.572 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.467 ' HD3' HD21 ' A' ' 105' ' ' LEU . 14.3 ttmm -85.87 142.6 28.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.847 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -135.33 129.22 33.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.314 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' VAL . 46.2 mt -112.48 150.7 30.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.889 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.466 ' CE1' HD22 ' A' ' 33' ' ' LEU . 93.2 m-85 -123.65 135.62 54.02 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.654 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -137.49 152.1 49.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.26 0.552 . . . . 0.0 111.425 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -128.87 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.475 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.25 134.62 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.83 -6.53 11.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.363 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -75.06 150.57 85.76 Favored Pre-proline 0 C--O 1.231 0.119 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.703 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.38 -40.41 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.022 1.814 . . . . 0.0 112.393 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.93 147.67 45.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.8 p -95.99 8.53 43.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.234 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.38 -20.43 43.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -121.45 -15.71 7.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.823 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.79 -40.04 93.81 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.663 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.02 -40.98 99.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.14 -40.02 86.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.174 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.74 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.3 m170 -60.57 -39.67 88.84 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.1 m -62.05 -41.98 98.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.718 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -66.83 -40.91 88.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.192 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -67.22 -36.72 82.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.8 t -58.32 -48.49 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.083 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -78.56 -25.49 45.4 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.026 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.22 -37.68 75.09 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.452 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -82.05 -31.7 30.77 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.727 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.4 mt -81.33 -20.67 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.038 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -114.97 -18.23 11.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.279 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -146.42 73.83 12.84 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.848 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 161.28 43.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.771 2.314 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.718 2.279 . . . . 0.0 112.145 -179.638 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -71.38 152.97 94.12 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.21 147.23 65.98 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.497 2.131 . . . . 0.0 111.944 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.02 154.74 77.65 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.11 150.2 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.228 1.952 . . . . 0.0 112.46 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.99 -153.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.503 2.135 . . . . 0.0 111.581 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -129.5 158.86 72.04 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.526 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.74 ' HG3' HG23 ' A' ' 39' ' ' THR . 50.8 Cg_exo -56.45 140.42 89.04 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.71 2.273 . . . . 0.0 111.974 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -155.69 165.6 36.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.07 138.08 32.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.864 0.364 . . . . 0.0 110.62 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -122.31 123.51 41.57 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.815 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 122.43 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -72.53 84.09 1.12 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.106 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 38.4 t0 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.797 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -62.23 157.69 18.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.794 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.73 142.04 35.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.302 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.48 125.22 32.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.561 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.885 HG11 HD11 ' C' ' 30' ' ' ILE . 62.5 t -113.44 118.32 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.848 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -90.19 121.17 31.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.205 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.867 179.85 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.964 0.411 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.416 HD12 HD13 ' C' ' 30' ' ' ILE . 0.0 OUTLIER -128.04 105.5 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.422 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -73.09 128.83 36.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.659 HD13 ' CB ' ' C' ' 29' ' ' LYS . 62.8 mt -120.5 124.53 45.61 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.889 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.81 108.91 2.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.062 0.458 . . . . 0.0 111.071 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.586 HG12 ' HE3' ' C' ' 29' ' ' LYS . 20.5 m -132.45 167.58 26.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.442 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.4 mt-10 -114.12 154.81 46.12 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.93 -29.12 80.93 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.701 . . . . 0.0 111.73 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.5 p -85.27 -12.82 51.54 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.856 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -64.89 142.95 58.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.021 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -83.86 164.14 19.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.491 0.662 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.9 -34.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.34 -43.44 88.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -63.01 -40.8 98.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 110.467 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.565 HG22 HG11 ' C' ' 17' ' ' VAL . 55.6 t -63.72 -42.94 97.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -62.05 -39.63 93.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.194 0.521 . . . . 0.0 110.329 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.06 89.5 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.824 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.659 ' CB ' HD13 ' C' ' 15' ' ' LEU . 66.9 mttm -60.11 -37.97 81.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.885 HD11 HG11 ' C' ' 5' ' ' VAL . 8.4 mm -63.41 -39.63 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.595 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -59.46 -46.75 87.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -62.09 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.772 -0.58 . . . . 0.0 111.136 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.27 -26.16 61.89 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -137.16 -53.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.238 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.0 10.35 8.28 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.55 HG22 ' HG3' ' C' ' 41' ' ' GLN . 62.7 mt -76.14 122.11 86.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.37 160.64 48.09 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.395 1.397 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.69 -39.89 88.46 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.538 2.159 . . . . 0.0 112.828 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.94 -37.06 83.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.246 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.24 21.53 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.725 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.55 ' HG3' HG22 ' C' ' 36' ' ' ILE . 14.0 mt-30 -109.73 -46.55 3.49 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 35.37 77.86 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.033 0.833 . . . . 0.0 110.862 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.684 ' CB ' HD12 ' C' ' 50' ' ' LEU . 84.3 mt -80.53 132.58 35.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -130.05 130.83 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.503 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.73 129.22 43.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.46 26.36 15.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.56 90.53 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -104.49 126.65 51.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.933 0.366 . . . . 0.0 110.02 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.72 132.66 46.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' C' ' 43' ' ' LEU . 68.6 mt -81.71 97.74 8.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 110.31 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.03 139.13 42.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.8 135.87 57.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.263 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.55 -18.65 52.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -81.92 157.15 24.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.683 0.278 . . . . 0.0 110.304 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -99.69 162.21 13.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.065 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.463 HD21 HG21 ' C' ' 26' ' ' VAL . 75.8 mt -61.75 -39.07 90.31 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.28 -22.6 66.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.01 -38.69 89.6 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.2 14.53 25.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 57.05 39.86 28.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.023 0.439 . . . . 0.0 110.335 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.96 117.77 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.033 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -102.58 -170.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.351 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -69.72 152.47 44.62 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.545 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 51.59 39.1 24.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.452 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -90.63 125.03 35.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.515 ' C ' HD12 ' C' ' 67' ' ' LEU . 49.6 m -75.94 130.16 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.249 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.515 HD12 ' C ' ' C' ' 66' ' ' THR . 8.2 mp -119.05 156.17 30.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -105.21 121.49 43.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.448 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.425 HD11 HG21 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -98.54 118.34 35.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.108 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.07 127.12 65.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.243 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.551 -179.002 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.84 161.37 18.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.229 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.473 HD12 HD22 ' D' ' 67' ' ' LEU . 9.3 pt -139.75 143.32 30.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.131 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -88.65 119.56 29.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -102.34 108.12 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.11 120.93 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.378 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.464 HG22 HD23 ' D' ' 69' ' ' LEU . 80.2 p -80.91 172.52 13.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.774 HD11 ' H ' ' D' ' 71' ' ' LEU . 87.7 mt -61.15 -37.77 84.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.031 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.12 -8.51 55.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.809 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.42 8.12 60.05 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -81.03 113.67 19.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.849 0.356 . . . . 0.0 110.158 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -86.14 134.2 33.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.685 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.4 mt -129.59 106.7 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.398 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -79.65 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' D' ' 33' ' ' LYS . 75.5 mt -123.77 124.02 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.661 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.04 114.5 7.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.895 0.379 . . . . 0.0 110.25 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.53 HG12 ' CD ' ' D' ' 29' ' ' LYS . 25.9 m -136.24 163.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.492 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' GLU . . . . . 0.43 ' O ' HD12 ' D' ' 56' ' ' LEU . 73.8 mm-40 -109.43 154.72 42.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.097 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.68 -28.62 86.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.79 1.66 . . . . 0.0 111.728 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 62.7 m -86.27 -10.17 55.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.707 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.7 144.4 57.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.529 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -79.12 162.6 25.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.022 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.602 HD12 HD23 ' D' ' 50' ' ' LEU . 27.4 mm -63.33 -39.23 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.2 -41.46 88.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.091 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.79 -41.01 97.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.117 0.484 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.462 HG21 HD21 ' D' ' 56' ' ' LEU . 58.0 t -62.79 -43.98 99.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.789 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.429 ' HG2' HD11 ' D' ' 43' ' ' LEU . 58.6 mtmt -61.06 -39.73 90.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.09 92.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.45 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.53 ' CD ' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -60.01 -40.71 90.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.558 HD12 ' OE1' ' D' ' 41' ' ' GLN . 91.7 mt -65.05 -41.35 91.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.179 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.95 -40.36 88.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.515 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.94 6.98 7.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.714 ' HG3' HD21 ' D' ' 15' ' ' LEU . 5.3 mttt -114.39 -52.75 2.7 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.635 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -107.42 -0.79 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 18.58 78.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mm -80.25 119.23 75.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.09 154.25 52.31 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.921 1.747 . . . . 0.0 111.822 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.29 -40.01 79.2 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.314 2.009 . . . . 0.0 112.263 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.96 -39.25 91.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.546 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.69 32.2 2.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.558 ' OE1' HD12 ' D' ' 30' ' ' ILE . 8.2 tt0 -136.9 120.14 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -124.48 114.11 19.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.429 HD11 ' HG2' ' D' ' 27' ' ' LYS . 27.1 mt -96.05 128.63 43.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' D' ' 49' ' ' GLN . 66.2 mt -127.67 129.48 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.542 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.7 t80 -147.65 152.51 37.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.22 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.81 15.65 8.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.679 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 47' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 89.17 -15.33 58.47 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.649 ' HB3' HD22 ' A' ' 73' ' ' LEU . 41.2 ptt180 -113.78 146.52 39.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.354 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.448 ' HA ' HG23 ' D' ' 44' ' ' ILE . 22.9 pt20 -71.35 139.23 49.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.255 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.829 HD21 HD11 ' D' ' 61' ' ' ILE . 7.7 mp -88.91 114.39 25.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.808 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 51' ' ' GLU . . . . . 0.443 ' O ' HG21 ' D' ' 23' ' ' ILE . 24.1 pt-20 -74.89 -169.12 0.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.672 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.48 -146.2 44.13 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 50.56 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.593 . . . . 0.0 111.446 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -132.6 168.43 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.236 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.462 HD21 HG21 ' D' ' 26' ' ' VAL . 79.2 mt -61.83 -39.68 92.66 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.552 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -64.98 -26.82 68.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.72 -31.12 71.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.059 0.457 . . . . 0.0 109.897 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -101.31 13.15 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.51 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.46 40.04 29.75 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.374 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ILE . . . . . 0.829 HD11 HD21 ' D' ' 50' ' ' LEU . 88.6 mt -89.46 107.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.012 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.38 -177.16 4.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.423 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.93 150.56 49.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.993 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 60.44 45.97 10.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 57.5 m -94.87 123.7 38.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 31.5 m -77.77 80.23 4.23 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.179 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.473 HD22 HD12 ' D' ' 3' ' ' ILE . 10.7 mp -71.06 140.18 50.64 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.209 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -93.89 122.96 36.91 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.259 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.464 HD23 HG22 ' D' ' 7' ' ' THR . 40.3 tp -102.59 120.26 40.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.542 . . . . 0.0 110.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.54 HG11 HD11 ' A' ' 56' ' ' LEU . 91.6 t -111.9 130.87 64.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.596 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.774 ' H ' HD11 ' D' ' 8' ' ' LEU . 54.8 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.86 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 pttt . . . . . 0 C--O 1.238 0.484 0 CA-C-O 121.038 0.447 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -97.61 116.25 29.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.408 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.7 mt -67.13 -37.3 83.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.771 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.431 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.1 p -150.17 161.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.821 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -173.22 122.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.182 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.44 157.17 38.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.599 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -75.83 123.41 25.61 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.607 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -154.43 146.45 23.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.06 153.63 16.91 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -89.06 174.87 7.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.029 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 23.0 mtp -139.72 172.69 12.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.585 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.51 127.16 49.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 37' ' ' THR . 32.4 tp -107.58 117.19 33.45 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.49 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -120.6 111.84 18.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.813 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.17 -86.21 0.49 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -145.59 20.66 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 0.0 110.792 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.5 m -122.2 130.64 53.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.941 0.401 . . . . 0.0 110.467 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 33' ' ' LEU . 57.5 t -109.07 123.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.1 p -112.89 133.34 21.99 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 147.32 54.51 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.871 1.714 . . . . 0.0 113.055 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -101.5 117.21 34.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.85 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -59.42 -14.6 12.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.03 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -71.78 82.83 0.89 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -59.11 136.85 58.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.102 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.12 -159.64 9.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.971 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.4 tp -138.35 125.17 21.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' A' ' 28' ' ' ALA . 46.1 t -98.36 111.58 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -134.64 154.59 51.44 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.241 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 24' ' ' VAL . 98.0 mt -121.11 138.03 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.14 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.42 133.62 34.95 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 123.675 0.609 . . . . 0.0 110.168 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.424 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.1 tt0 -102.18 126.37 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.031 0.443 . . . . 0.0 110.536 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' CD2' ' A' ' 58' ' ' HIS . 16.4 p -85.72 171.48 11.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.692 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.67 -10.69 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.78 0.41 56.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.631 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t 70.78 21.04 5.34 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.171 0.51 . . . . 0.0 110.314 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD11 HG11 ' D' ' 70' ' ' VAL . 85.1 mt -98.54 121.7 40.81 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.547 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.0 mm -80.5 122.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.497 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.0 m-70 -98.92 115.64 29.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -98.59 107.83 20.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.91 143.12 51.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.551 -0.859 . . . . 0.0 112.941 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -116.95 117.19 29.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.298 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -106.72 146.05 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.355 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.9 128.49 34.58 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.41 -27.72 64.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -58.26 -36.75 73.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.853 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.9 m -116.75 -16.98 10.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.998 0.428 . . . . 0.0 110.241 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.4 21.87 79.18 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -102.4 151.1 22.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.24 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.51 102.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.5 -38.05 62.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.228 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -126.63 145.79 50.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.251 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.578 ' O ' HD23 ' A' ' 73' ' ' LEU . 17.8 t70 -157.47 101.58 1.86 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.184 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' D' ' 48' ' ' ARG . 37.5 mt -128.34 136.73 51.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.881 0.372 . . . . 0.0 110.72 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.3 123.61 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.417 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.522 ' HB ' HD22 ' A' ' 128' ' ' LEU . 26.2 mm -108.75 123.77 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.318 0.58 . . . . 0.0 111.466 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 56.5 m-85 -91.48 162.47 31.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.126 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.63 138.02 79.76 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.21 1.94 . . . . 0.0 111.778 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.1 11.81 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.452 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.37 -36.84 18.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.752 0.311 . . . . 0.0 110.492 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.468 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -140.41 145.12 36.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.506 -178.604 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.615 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.5 tt0 -121.73 135.24 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.616 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -106.29 120.24 41.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -143.06 166.82 23.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.831 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -84.34 160.13 20.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.087 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.23 89.74 12.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -79.84 60.12 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.799 1.666 . . . . 0.0 112.29 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -114.07 -37.45 4.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.343 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.5 t -130.51 82.77 64.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.05 130.89 26.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.791 1.661 . . . . 0.0 111.477 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p 170.25 -38.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.38 -150.09 5.48 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.47 105.85 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.777 0.323 . . . . 0.0 110.429 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.87 128.23 71.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 110.783 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.31 156.35 40.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.56 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 105' ' ' LEU . 12.4 p -133.15 136.07 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.514 . . . . 0.0 110.232 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 81' ' ' GLU . 57.3 tp -104.56 123.36 47.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -118.08 137.7 52.75 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.081 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -91.94 108.44 19.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.359 0.599 . . . . 0.0 110.056 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.8 -38.26 87.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.694 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.61 -22.38 24.78 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.33 -177.96 30.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -121.03 30.17 6.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.76 155.82 42.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.198 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.477 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.8 mtt180 -136.75 148.25 47.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.632 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 104' ' ' ARG . 36.7 mt -122.97 152.81 40.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.866 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.454 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 97.3 m-85 -125.22 136.86 53.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.87 156.31 47.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.185 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -130.26 137.78 50.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.587 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttm -72.72 133.4 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.17 0.509 . . . . 0.0 111.887 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 4.74 21.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.437 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -71.95 139.58 82.79 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.03 -26.83 42.97 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.845 1.697 . . . . 0.0 112.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.63 141.8 48.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.471 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -98.13 10.87 39.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.588 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -54.28 -21.61 9.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -130.02 16.52 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.1 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -62.17 -47.68 83.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.2 0.524 . . . . 0.0 110.253 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -74.49 -32.98 62.73 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.461 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.04 -46.54 83.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.531 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.791 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.8 m170 -63.87 -40.83 97.47 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.601 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.91 -45.37 94.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.804 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -64.72 -43.85 92.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.453 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.19 -36.28 83.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.881 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.5 t -58.83 -48.33 86.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -77.69 -29.56 51.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.741 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.61 -36.68 76.4 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.618 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -80.02 -31.42 39.61 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.754 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.522 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.0 mt -82.45 -27.67 31.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -103.23 -27.46 12.49 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.0 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -133.23 73.75 73.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.084 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.6 Cg_exo -59.38 156.66 34.62 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.119 2.546 . . . . 0.0 112.034 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.492 1.426 0 C-N-CA 122.486 2.124 . . . . 0.0 112.148 -179.456 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -129.56 152.02 78.97 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.83 146.94 26.83 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.68 2.253 . . . . 0.0 112.149 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.53 153.62 87.65 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.68 158.63 55.22 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.251 1.967 . . . . 0.0 112.021 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.24 -171.81 0.77 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.726 2.284 . . . . 0.0 112.056 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -119.06 159.15 46.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.04 141.91 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.503 2.136 . . . . 0.0 112.324 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.52 162.14 41.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.671 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -87.25 136.82 32.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.621 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -120.88 125.72 48.19 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.415 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.0 mp -130.67 123.14 54.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.588 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -82.06 83.73 7.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.899 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.2 t0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.298 179.494 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.96 157.47 18.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.203 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -139.66 144.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.451 ' HD2' HG21 ' C' ' 12' ' ' THR . 8.1 m-85 -88.93 123.34 33.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.127 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.585 HG11 HD11 ' C' ' 30' ' ' ILE . 80.5 t -109.02 105.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -85.77 127.65 34.59 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.72 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.458 HG22 HD23 ' C' ' 69' ' ' LEU . 73.1 p . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' THR . . . . . 0.451 HG21 ' HD2' ' C' ' 4' ' ' PHE . 88.1 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.793 0.33 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -123.12 109.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.653 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.9 m -84.16 132.97 34.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.271 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.766 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.0 mt -126.56 126.9 44.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.5 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.02 108.39 2.6 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 110.866 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.789 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.6 m -131.47 164.03 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.122 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.89 155.05 38.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.312 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.22 -33.92 92.04 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.056 1.837 . . . . 0.0 111.984 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -85.21 -3.91 58.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.152 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.12 136.87 58.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.857 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -79.07 160.53 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.564 HG21 ' O ' ' C' ' 50' ' ' LEU . 47.1 mm -64.29 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.769 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.85 -42.14 88.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -62.07 -42.41 99.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -61.96 -43.83 98.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.912 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.73 -39.62 89.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.285 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.02 89.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.256 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.789 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.7 mttm -59.89 -39.57 85.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.585 HD11 HG11 ' C' ' 5' ' ' VAL . 7.8 mm -64.52 -39.97 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.318 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.62 -39.32 83.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.05 9.61 19.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.766 ' HG3' HD21 ' C' ' 15' ' ' LEU . 2.8 mmtt -113.26 -42.51 3.5 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.7 2.41 8.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.362 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.12 79.43 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.588 HG22 ' HG3' ' C' ' 41' ' ' GLN . 51.5 mt -81.11 128.51 70.59 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.733 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.49 153.11 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.721 1.614 . . . . 0.0 111.62 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.96 -36.19 63.42 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.297 1.998 . . . . 0.0 112.594 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.96 -38.07 84.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -95.85 17.88 14.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.31 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.588 ' HG3' HG22 ' C' ' 36' ' ' ILE . 90.6 mt-30 -112.53 103.73 11.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.138 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.53 109.83 18.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' C' ' 50' ' ' LEU . 69.8 mt -101.19 123.49 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -128.9 127.99 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 128.66 48.61 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.69 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.74 27.03 16.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.41 89.72 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -102.79 126.2 49.83 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.913 0.387 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.89 130.22 42.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.425 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' C' ' 43' ' ' LEU . 55.7 mt -88.96 82.88 6.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -73.01 173.4 9.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -78.3 171.16 15.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.04 12.68 81.34 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.94 165.68 19.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.981 0.419 . . . . 0.0 110.58 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.42 167.78 11.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' C' ' 56' ' ' LEU . 82.7 mt -61.95 -39.77 93.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -62.82 -28.29 69.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -62.54 -29.27 70.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.419 . . . . 0.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' C' ' 50' ' ' LEU . 68.4 m-85 -102.95 13.46 34.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.29 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 56.35 40.48 29.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.239 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -89.56 108.88 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.073 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -93.09 -174.05 3.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.485 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -67.0 151.48 47.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 54.77 38.66 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -92.51 124.73 36.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.044 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.416 ' C ' HD12 ' C' ' 67' ' ' LEU . 28.0 m -75.94 129.46 36.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.97 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.416 HD12 ' C ' ' C' ' 66' ' ' THR . 6.3 mp -120.45 148.91 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.324 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -93.07 114.61 27.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.458 HD23 HG22 ' C' ' 7' ' ' THR . 54.3 tp -103.93 121.12 42.46 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.08 131.4 71.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.827 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.472 ' CD2' HD13 ' C' ' 36' ' ' ILE . 13.3 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.157 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.4 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.6 157.47 17.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.18 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 pt -138.18 147.56 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.059 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -88.68 123.27 32.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.301 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' D' ' 69' ' ' LEU . 64.8 t -108.21 102.7 14.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.636 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -92.94 120.73 33.56 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.664 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.5 p -81.37 173.48 12.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.623 HD11 ' H ' ' D' ' 71' ' ' LEU . 74.6 mt -61.73 -26.78 68.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.147 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -72.29 -12.98 61.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 -13.6 63.06 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 132.95 49.37 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.2 m -103.64 132.58 49.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.661 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.86 108.83 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -81.04 128.65 33.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.484 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.647 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.6 mt -125.17 127.76 47.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.599 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -69.33 114.77 7.88 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.716 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.579 HG12 ' HE2' ' D' ' 29' ' ' LYS . 23.3 m -134.88 165.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.543 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -108.64 153.83 42.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.11 -35.08 94.53 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.928 1.752 . . . . 0.0 112.243 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -86.49 -2.59 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.166 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' D' ' 26' ' ' VAL . 18.8 t70 -61.38 133.68 56.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.668 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.434 HD12 HD13 ' D' ' 50' ' ' LEU . 48.7 mm -64.16 -38.71 83.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.39 -42.05 90.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.1 -41.75 98.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 110.904 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.549 HG23 ' OD1' ' D' ' 21' ' ' ASP . 57.5 t -63.6 -42.24 95.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.484 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.92 -38.83 87.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.84 90.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.064 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.579 ' HE2' HG12 ' D' ' 17' ' ' VAL . 61.4 mttp -59.98 -39.74 86.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.805 ' CD1' HD21 ' D' ' 43' ' ' LEU . 88.9 mt -65.05 -40.48 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.449 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.58 -40.8 93.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -63.66 -43.48 96.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.647 ' HD2' HD21 ' D' ' 15' ' ' LEU . 62.4 mttt -75.24 -72.74 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.134 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -84.63 166.99 16.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.173 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.77 15.08 56.71 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.578 HG22 ' HG3' ' D' ' 41' ' ' GLN . 33.3 mm -70.39 124.8 91.5 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.174 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.93 155.79 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.026 1.817 . . . . 0.0 111.585 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.67 -40.89 82.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.993 1.795 . . . . 0.0 112.971 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.89 -45.28 94.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.898 0.38 . . . . 0.0 110.966 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -69.92 -38.73 76.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.741 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.578 ' HG3' HG22 ' D' ' 36' ' ' ILE . 59.9 mt-30 -54.46 106.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.35 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -118.9 88.12 2.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.805 HD21 ' CD1' ' D' ' 30' ' ' ILE . 77.3 mt -74.39 129.19 37.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.361 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.536 HD12 HG21 ' D' ' 70' ' ' VAL . 79.0 mt -131.0 129.75 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 73.2 t80 -150.69 154.61 37.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.65 19.58 9.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.68 80.13 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -127.38 147.55 50.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 110.45 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -71.61 141.01 49.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.068 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' D' ' 43' ' ' LEU . 82.7 mt -74.9 115.85 14.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.797 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.96 139.54 41.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.87 143.92 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.17 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.67 69.23 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -83.58 179.01 7.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.765 0.317 . . . . 0.0 110.773 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -126.1 163.65 22.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.285 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.79 -39.88 95.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.543 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.07 -29.2 70.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.16 -35.14 76.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 110.122 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' TYR . . . . . 0.474 ' CE2' HD23 ' D' ' 50' ' ' LEU . 59.2 m-85 -97.31 14.15 27.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.246 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.65 40.81 32.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.851 0.358 . . . . 0.0 110.329 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.83 107.24 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.308 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -93.95 177.32 6.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.66 150.49 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.248 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 58.92 40.34 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' SER . . . . . 0.434 ' O ' HD12 ' D' ' 67' ' ' LEU . 30.2 t -97.31 123.4 41.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.186 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 69.0 m -74.97 127.55 33.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.0 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.434 HD12 ' O ' ' D' ' 65' ' ' SER . 5.3 mp -118.22 146.76 44.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.887 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -95.89 117.48 30.68 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.093 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.607 HD11 HD13 ' D' ' 30' ' ' ILE . 0.6 OUTLIER -93.99 97.67 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.1 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.536 HG21 HD12 ' D' ' 44' ' ' ILE . 46.1 t -83.96 134.6 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.095 0.474 . . . . 0.0 110.478 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.623 ' H ' HD11 ' D' ' 8' ' ' LEU . 75.3 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.59 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.713 0.292 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -89.4 112.26 23.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.331 0.586 . . . . 0.0 109.898 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 51' ' ' GLN . 88.6 mt -65.2 -38.25 89.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.606 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -151.36 162.93 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.115 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -172.82 122.58 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.262 0.553 . . . . 0.0 110.969 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -157.51 159.89 37.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.076 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -75.62 120.64 21.3 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.45 140.81 18.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.074 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.16 150.79 17.11 Favored Glycine 0 C--O 1.226 -0.347 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -95.03 177.38 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.99 0.424 . . . . 0.0 111.068 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.3 mtp -140.35 168.44 19.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.0 m -119.03 120.94 38.7 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 37' ' ' THR . 52.6 tp -101.13 123.43 45.27 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.919 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -119.54 104.02 9.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.091 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -81.14 0.86 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 p -146.84 19.07 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.562 0.22 . . . . 0.0 110.973 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.745 ' O ' HD12 ' A' ' 33' ' ' LEU . 94.7 m -120.85 128.97 53.33 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.535 HG22 HD13 ' A' ' 33' ' ' LEU . 63.5 t -103.0 123.21 56.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.144 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.6 p -110.46 114.5 55.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.54 141.04 95.09 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.121 1.88 . . . . 0.0 112.621 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.98 113.03 24.76 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.58 -18.29 39.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.541 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -75.43 73.57 2.48 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -56.04 137.21 51.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.65 -152.98 8.45 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.508 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.12 124.24 21.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.49 107.28 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.2 p90 -130.96 153.34 49.3 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.927 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 23' ' ' LEU . 96.6 mt -119.54 140.88 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.658 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -136.6 132.93 35.77 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 123.787 0.679 . . . . 0.0 109.936 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.689 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.1 tt0 -100.53 123.46 44.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.09 0.471 . . . . 0.0 110.182 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.449 HG23 ' CD2' ' A' ' 58' ' ' HIS . 7.6 p -84.26 168.86 15.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.787 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.13 -10.38 10.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.929 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -91.03 6.66 43.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.629 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 m 63.88 23.66 13.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.234 0.54 . . . . 0.0 110.93 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 76.8 mt -100.02 122.85 43.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.658 HG21 HD23 ' A' ' 128' ' ' LEU . 50.6 mm -81.06 121.89 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.449 ' CD2' HG23 ' A' ' 52' ' ' THR . 75.6 m-70 -98.77 114.17 26.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.786 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -95.18 107.83 19.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 72.4 m -120.62 146.61 46.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 0.0 112.648 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -125.86 112.68 16.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.583 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -105.16 128.89 53.6 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.829 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.16 136.56 48.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.21 -17.19 58.68 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.714 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.7 m -60.49 -45.25 94.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.593 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.5 m -116.58 -16.28 10.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.77 20.84 79.33 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -102.07 145.82 28.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.656 0.265 . . . . 0.0 110.388 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.6 t -73.27 103.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.091 0.472 . . . . 0.0 110.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -79.91 -32.91 40.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.766 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -126.32 145.27 50.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.202 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.593 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.2 p-10 -160.83 98.32 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 72' ' ' ASP . 34.2 mt -128.26 137.1 51.84 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.12 123.11 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.672 ' HB ' HD22 ' A' ' 128' ' ' LEU . 29.4 mm -111.27 121.05 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.13 0.49 . . . . 0.0 110.599 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.539 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 50.7 m-85 -85.12 163.65 44.7 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.257 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.17 138.33 82.71 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.813 1.675 . . . . 0.0 111.785 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 59.58 12.68 2.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.449 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.2 -38.66 24.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.44 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB3' HD11 ' A' ' 96' ' ' LEU . 85.3 m -129.87 155.78 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.122 0.486 . . . . 0.0 110.99 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 2.1 tt0 -126.11 130.46 51.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.59 117.64 35.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -138.56 162.98 33.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -82.08 161.35 22.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.54 88.89 14.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.331 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.24 60.41 7.38 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.145 1.897 . . . . 0.0 112.084 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -114.45 -39.53 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.44 78.09 76.27 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.59 130.43 40.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.271 1.981 . . . . 0.0 111.178 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 169.12 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.111 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.45 -165.77 12.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.508 ' HD3' HG22 ' A' ' 114' ' ' THR . 4.2 mtt-85 -96.78 105.18 17.26 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.3 t -126.38 128.24 71.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -124.93 160.52 28.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.009 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 105' ' ' LEU . 9.7 p -135.16 135.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 110.044 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 80' ' ' CYS . 58.6 tp -101.61 123.51 45.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -120.39 140.39 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.147 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.413 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 21.6 m-85 -88.34 116.92 26.89 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 98.5 mttt -62.35 -37.38 85.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.832 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.87 -19.78 18.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.533 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -106.58 -178.39 23.11 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.0 m -114.89 13.46 17.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.661 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.611 ' HD3' HD21 ' A' ' 105' ' ' LEU . 25.5 ttmt -84.98 142.81 29.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.227 0.537 . . . . 0.0 110.983 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -136.07 121.47 19.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.556 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.611 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.0 mt -111.35 152.46 27.25 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.79 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CE1' HD22 ' A' ' 33' ' ' LEU . 91.8 m-85 -126.18 136.63 53.08 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.443 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.62 153.77 49.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.249 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -129.66 138.6 51.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.599 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.55 136.25 49.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.82 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -104.94 -1.04 26.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.451 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.0 131.86 65.47 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.296 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.9 -18.6 46.83 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.081 1.854 . . . . 0.0 112.727 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -113.74 140.34 48.35 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.508 HG22 ' HD3' ' A' ' 92' ' ' ARG . 79.1 p -96.06 8.19 44.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.61 -16.97 62.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.604 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -131.98 -5.37 3.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.625 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.38 -41.69 98.81 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.942 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -74.17 -34.53 63.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.956 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.55 -42.31 92.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.156 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.701 ' O ' HG23 ' A' ' 124' ' ' VAL . 67.9 m170 -63.6 -41.74 98.3 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.9 t -60.98 -44.23 97.68 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.299 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -66.79 -43.59 83.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.939 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -63.71 -40.09 95.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 120' ' ' HIS . 47.3 t -58.71 -48.1 86.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.203 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.24 -22.1 42.12 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.406 -0.917 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.85 -39.86 69.42 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' A' ' 23' ' ' LEU . 31.1 m-85 -79.88 -35.89 37.37 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.551 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 75' ' ' ILE . 70.9 mt -71.15 -36.7 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.079 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -98.4 -27.83 13.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.333 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -134.48 73.59 67.99 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.894 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' A' ' 57' ' ' ILE . 35.2 Cg_exo -59.67 155.88 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.958 2.439 . . . . 0.0 112.286 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.544 2.163 . . . . 0.0 112.042 -179.718 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.27 80.97 69.55 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.69 141.92 91.5 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.595 2.196 . . . . 0.0 112.147 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.21 153.6 94.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.063 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.98 149.22 77.22 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.018 1.812 . . . . 0.0 112.244 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -54.96 -172.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.352 2.035 . . . . 0.0 111.851 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.15 159.55 58.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.93 138.84 78.73 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.511 2.141 . . . . 0.0 112.431 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.71 163.87 39.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -86.58 137.63 32.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.359 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -125.18 129.23 49.71 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.188 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.41 129.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -72.32 84.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.83 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.619 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -63.84 159.02 20.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.158 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -138.95 150.84 23.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.983 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -94.11 124.08 37.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.552 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.58 115.61 49.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.192 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -93.35 129.92 39.29 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.506 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.469 HG22 HD23 ' C' ' 69' ' ' LEU . 76.8 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 111.125 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.946 0.403 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.94 118.21 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.527 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.9 m -85.1 130.37 34.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.303 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.561 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.0 mt -123.41 127.1 47.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.241 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.39 113.72 8.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.825 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.471 HG12 ' CD ' ' C' ' 29' ' ' LYS . 21.3 m -136.43 167.36 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.79 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.601 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.8 mt-10 -116.94 152.24 48.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.56 -43.9 51.45 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.026 1.817 . . . . 0.0 112.485 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.21 -37.13 86.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.242 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -41.65 133.07 2.77 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.106 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -82.4 167.9 18.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.307 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.678 HD12 HD23 ' C' ' 50' ' ' LEU . 35.8 mm -62.03 -35.78 70.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.47 -42.53 87.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.084 0.469 . . . . 0.0 110.377 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.96 -41.38 91.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.231 0.538 . . . . 0.0 110.875 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.541 HG21 HD21 ' C' ' 56' ' ' LEU . 62.9 t -64.43 -46.41 93.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.796 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -62.81 -32.5 73.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.255 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.29 98.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 110.099 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.471 ' CD ' HG12 ' C' ' 17' ' ' VAL . 66.8 mttm -60.78 -39.4 88.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.163 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.745 ' CD1' HD21 ' C' ' 43' ' ' LEU . 93.2 mt -64.64 -40.37 88.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.981 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.86 -42.5 93.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.488 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.15 -40.13 95.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.416 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.561 ' HG3' HD21 ' C' ' 15' ' ' LEU . 18.2 mttt -74.66 -60.73 2.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -106.73 155.33 19.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.83 55.23 4.21 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.592 HG23 HD22 ' C' ' 71' ' ' LEU . 30.4 mm -109.64 113.26 58.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.44 150.66 58.41 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.664 1.576 . . . . 0.0 111.621 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.46 -38.35 43.66 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.193 1.929 . . . . 0.0 112.474 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.24 -39.18 89.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.353 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -89.92 -2.32 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.245 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -86.19 100.7 12.42 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.208 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -104.32 100.46 10.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.745 HD21 ' CD1' ' C' ' 30' ' ' ILE . 59.5 mt -96.7 117.97 32.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.469 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 93.9 mt -126.36 128.26 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -128.41 130.46 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.674 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 24.52 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.73 3.04 90.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -106.96 128.51 54.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.68 133.04 47.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.678 HD23 HD12 ' C' ' 23' ' ' ILE . 7.6 mp -80.33 95.61 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.47 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.22 139.01 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.339 0.59 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -59.43 150.74 25.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.396 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 -13.38 64.66 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -94.9 151.61 19.07 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.255 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -92.26 164.22 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.193 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.601 HD12 ' O ' ' C' ' 18' ' ' GLU . 81.4 mt -62.02 -39.05 90.95 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.577 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -62.48 -23.93 67.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.625 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.71 -38.25 87.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.174 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -96.86 16.21 19.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.339 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 56.28 40.38 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 84.3 mt -91.78 113.52 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.0 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -102.22 -170.83 1.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -69.62 149.08 48.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 57.27 35.54 26.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.629 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -91.28 128.23 37.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.984 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.482 ' C ' HD12 ' C' ' 67' ' ' LEU . 89.6 m -78.97 128.19 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.986 0.422 . . . . 0.0 110.485 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.482 HD12 ' C ' ' C' ' 66' ' ' THR . 8.3 mp -117.0 139.88 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -87.44 111.36 21.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.469 HD23 HG22 ' C' ' 7' ' ' THR . 59.1 tp -102.55 120.6 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.9 t -119.4 137.68 52.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.592 HD22 HG23 ' C' ' 36' ' ' ILE . 24.9 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.01 161.19 24.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.829 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.525 HD13 HD21 ' D' ' 56' ' ' LEU . 16.1 pt -142.87 145.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.015 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -92.24 123.29 35.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.647 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.439 HG11 HD12 ' D' ' 69' ' ' LEU . 93.9 t -103.22 109.8 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.388 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -87.63 120.93 29.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.519 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -80.86 170.98 15.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.787 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.79 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.3 mt -64.35 -25.16 67.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.029 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -86.52 -0.99 57.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.43 -7.32 80.27 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.78 115.66 7.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 70.0 m -92.82 135.62 33.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.252 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.2 105.6 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.11 122.89 26.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' D' ' 29' ' ' LYS . 92.0 mt -122.22 131.86 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.42 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.88 114.4 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.696 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.5 m -133.98 167.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.473 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.34 154.95 44.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.98 -37.89 95.46 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.901 1.734 . . . . 0.0 111.815 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -77.92 -9.95 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.079 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.19 134.66 57.2 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.731 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -79.11 163.08 25.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.226 0.536 . . . . 0.0 110.525 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.835 HD12 HD23 ' D' ' 50' ' ' LEU . 47.2 mm -63.16 -38.27 81.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.91 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.07 -39.89 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -62.38 -41.1 98.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.273 0.559 . . . . 0.0 110.549 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.792 HG21 HD11 ' D' ' 56' ' ' LEU . 73.1 t -63.3 -42.91 98.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.461 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.89 -40.01 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.295 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.42 90.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.172 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.696 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -59.75 -38.71 82.54 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.802 ' CD1' HD21 ' D' ' 43' ' ' LEU . 86.6 mt -64.49 -41.34 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.068 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.51 -45.52 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.243 0.544 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -67.69 -32.01 72.37 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.855 -0.528 . . . . 0.0 111.276 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.438 ' HD2' HD21 ' D' ' 15' ' ' LEU . 7.7 mttm -92.25 -3.51 55.39 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -148.48 -49.91 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.06 10.46 15.79 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.208 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.469 HD13 HD21 ' D' ' 71' ' ' LEU . 33.5 mt -82.14 118.76 73.18 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.885 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.43 153.13 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.943 1.762 . . . . 0.0 111.47 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.36 -40.92 80.75 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.985 1.79 . . . . 0.0 112.184 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.9 -38.94 76.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -62.34 -39.7 93.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.811 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.464 ' HB3' HG21 ' D' ' 36' ' ' ILE . 0.0 OUTLIER -102.72 144.27 31.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.273 0.559 . . . . 0.0 111.384 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -124.89 117.29 23.75 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.802 HD21 ' CD1' ' D' ' 30' ' ' ILE . 73.3 mt -83.78 126.93 33.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.463 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.85 131.4 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.457 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 80.3 t80 -148.47 153.11 38.03 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.916 0.388 . . . . 0.0 111.074 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.02 16.28 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -9.23 72.68 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.407 ' HB3' HD22 ' A' ' 73' ' ' LEU . 12.8 ptm180 -119.74 145.89 46.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.936 0.398 . . . . 0.0 110.277 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.33 141.34 50.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.202 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.835 HD23 HD12 ' D' ' 23' ' ' ILE . 7.1 mp -83.37 111.85 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.951 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -75.32 135.88 40.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.787 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -57.75 149.95 20.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.453 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.44 -16.21 60.48 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -85.77 170.27 12.61 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.336 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -113.13 157.33 21.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.965 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.792 HD11 HG21 ' D' ' 26' ' ' VAL . 3.8 mp -57.91 -39.61 78.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.625 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 88.0 p -63.14 -23.46 67.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.299 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.98 -37.56 87.63 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.131 0.491 . . . . 0.0 109.932 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.74 10.73 39.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.295 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 62.1 t30 57.34 42.54 24.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.396 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ILE . . . . . 0.764 HD11 HD21 ' D' ' 50' ' ' LEU . 66.8 mt -86.51 108.14 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -93.84 175.65 6.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.384 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -58.85 150.76 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 59.25 46.58 12.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.1 t -96.74 123.34 40.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.185 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -80.34 85.84 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.908 0.385 . . . . 0.0 110.347 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.509 HD22 HD12 ' D' ' 3' ' ' ILE . 7.4 mp -73.2 150.06 42.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -99.83 124.87 45.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.36 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.448 HD11 HG21 ' D' ' 30' ' ' ILE . 2.9 tt -101.77 117.51 35.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.918 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.678 HG11 HD11 ' A' ' 56' ' ' LEU . 90.9 t -111.29 129.55 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.79 ' H ' HD11 ' D' ' 8' ' ' LEU . 66.8 mt . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.344 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -92.8 113.28 25.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.279 0.562 . . . . 0.0 109.524 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.55 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.1 mt -65.75 -38.31 88.77 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.609 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.6 162.47 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.796 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.29 122.49 0.37 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.831 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.61 157.68 37.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.877 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 46' ' ' LEU . 81.7 mtt85 -75.58 121.78 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.983 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.57 144.1 22.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.256 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.58 150.65 16.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -90.47 175.16 7.18 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.002 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.4 mtp -138.96 174.17 10.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -124.05 125.71 45.0 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 37' ' ' THR . 25.3 tp -106.58 118.58 37.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -121.37 108.88 14.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.772 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.61 0.51 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -137.5 20.19 2.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.781 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.2 m -122.55 131.73 53.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.1 t -111.48 123.52 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.028 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.5 p -113.5 132.01 22.71 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.147 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.25 146.2 50.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.919 1.746 . . . . 0.0 113.32 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -98.4 119.9 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.45 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -64.0 -14.92 57.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.752 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 -74.45 74.02 1.91 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 109.962 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -49.91 139.35 13.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.762 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.66 -159.09 8.88 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.651 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.1 tp -137.03 125.12 22.92 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.8 t -97.51 110.02 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -133.43 153.71 51.38 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.51 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.7 mt -119.64 139.3 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.093 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -136.8 132.42 34.66 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.651 0.594 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.525 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.2 tt0 -100.77 125.1 47.22 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.1 p -85.34 171.99 11.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -65.16 -9.54 23.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.13 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.55 0.74 56.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t 70.4 21.02 5.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 110.351 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.678 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 74.7 mt -99.23 122.6 42.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.55 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.8 mm -80.6 122.57 36.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.463 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.474 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.9 m-70 -98.65 114.44 26.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.763 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -97.77 107.9 20.5 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 143.96 50.89 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.687 -0.805 . . . . 0.0 113.125 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -118.9 117.12 27.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.569 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -106.34 144.76 32.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.373 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.11 131.31 35.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -72.86 -16.69 61.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.9 m -59.69 -45.16 92.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.367 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.1 m -116.63 -14.01 10.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.92 22.29 77.1 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -102.25 152.66 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.61 102.71 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.221 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -73.44 -37.38 65.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.913 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -127.24 145.18 50.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HD23 ' A' ' 73' ' ' LEU . 66.7 t0 -158.08 99.76 1.67 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 72' ' ' ASP . 35.1 mt -127.34 136.83 52.46 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.3 124.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.272 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 80' ' ' CYS . 29.0 mm -113.46 121.77 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.121 0.486 . . . . 0.0 110.861 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.678 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 67.5 m-85 -88.37 162.8 38.73 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.382 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.42 139.11 86.31 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.972 1.781 . . . . 0.0 111.585 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 59.75 12.82 3.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -86.44 -25.78 25.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.703 ' SG ' HG21 ' A' ' 75' ' ' ILE . 13.7 p -145.92 168.09 21.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.431 0.634 . . . . 0.0 110.38 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -135.24 126.56 28.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.91 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -102.14 116.77 33.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -145.18 167.26 23.19 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.012 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.53 160.02 19.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.131 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.56 89.78 13.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.148 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.74 59.76 7.55 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.925 1.75 . . . . 0.0 112.12 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -114.88 -39.07 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.627 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.4 t -124.0 86.99 53.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.479 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.15 130.0 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.593 1.528 . . . . 0.0 111.486 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p 167.37 -29.69 0.0 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.56 178.52 34.74 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.472 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.01 113.38 20.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 111.122 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.94 127.78 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.03 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -120.44 152.58 37.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.839 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.9 132.75 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.385 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.568 HD11 ' SG ' ' A' ' 80' ' ' CYS . 65.6 tp -102.24 121.35 42.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -119.76 130.81 55.14 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.47 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -79.99 115.23 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.0 -37.67 85.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.385 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.75 21.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.565 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.96 -175.65 22.88 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -116.47 12.96 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.601 0.239 . . . . 0.0 110.534 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HD3' HD21 ' A' ' 105' ' ' LEU . 11.9 ttmm -89.7 142.62 27.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.977 0.417 . . . . 0.0 111.101 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -134.29 133.01 40.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.503 HD21 ' HD3' ' A' ' 103' ' ' LYS . 48.4 mt -115.55 149.44 38.19 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.716 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.31 137.86 54.75 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.608 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -138.63 156.73 47.2 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.241 0.543 . . . . 0.0 111.307 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -131.75 135.58 46.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.272 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 137.7 57.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.66 -0.19 13.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.287 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.99 149.76 73.99 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.49 -31.14 28.0 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.13 1.887 . . . . 0.0 112.765 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -123.63 142.29 51.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.125 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -94.29 5.7 50.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.763 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.04 -21.05 58.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -118.72 -15.14 9.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.0 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.95 -39.58 94.46 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.116 0.484 . . . . 0.0 110.411 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.45 -35.14 79.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.017 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.89 -40.96 83.44 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.126 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 124' ' ' VAL . 65.1 m170 -61.36 -39.47 90.73 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.183 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -61.71 -44.83 96.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.454 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -67.96 -39.41 83.39 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.914 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -66.4 -42.2 88.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.746 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -58.07 -46.48 88.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.021 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -63.97 -38.57 91.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.561 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -75.55 -23.44 56.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.231 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.1 m-85 -87.51 -29.09 21.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 57' ' ' ILE . 73.8 mt -92.85 -18.3 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.614 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -116.33 -18.81 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -137.99 65.37 44.43 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.094 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.49 151.76 70.65 Favored 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.612 2.208 . . . . 0.0 112.243 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 C-N-CA 122.412 2.074 . . . . 0.0 112.147 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.85 154.71 81.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.92 147.19 49.1 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.584 2.189 . . . . 0.0 111.951 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.03 153.87 63.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.36 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.77 144.13 98.48 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.595 2.196 . . . . 0.0 112.209 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.14 -174.77 2.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.32 2.013 . . . . 0.0 111.849 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -111.58 160.27 30.09 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.581 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.75 147.23 89.23 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.687 2.258 . . . . 0.0 112.231 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.08 163.34 39.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.835 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.01 137.34 32.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.648 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -122.42 122.54 39.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.921 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 47.6 mt -132.26 125.13 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -79.23 84.25 5.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.045 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 32.7 t0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.59 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.1 ttp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -58.96 163.19 3.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.029 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.501 HD12 ' CD1' ' C' ' 67' ' ' LEU . 20.1 pt -143.02 139.59 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.006 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.692 ' HD2' HG21 ' C' ' 12' ' ' THR . 5.4 m-85 -83.86 121.91 27.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.27 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.793 HG11 HD11 ' C' ' 30' ' ' ILE . 90.6 t -107.02 106.12 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -87.88 133.84 33.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.301 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.899 HG22 HD23 ' C' ' 69' ' ' LEU . 77.2 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 111.742 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' THR . . . . . 0.692 HG21 ' HD2' ' C' ' 4' ' ' PHE . 97.9 m . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.897 0.379 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.41 HD13 HG21 ' C' ' 13' ' ' ILE . 0.4 OUTLIER -120.83 100.68 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.1 m -75.5 127.2 32.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.492 HD13 ' CB ' ' C' ' 29' ' ' LYS . 83.7 mt -120.49 124.64 45.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.602 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.01 112.68 3.96 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.383 0.611 . . . . 0.0 110.701 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.536 HG12 ' HE3' ' C' ' 29' ' ' LYS . 24.1 m -135.24 164.27 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -106.37 153.88 40.17 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.49 -36.48 94.33 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.99 1.793 . . . . 0.0 112.026 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -82.08 -6.56 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -60.44 135.25 57.69 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -76.65 161.39 28.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.903 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' C' ' 50' ' ' LEU . 45.1 mm -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.214 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.28 -39.55 87.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.93 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.54 -42.96 99.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.277 0.56 . . . . 0.0 110.381 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.402 HG22 HG11 ' C' ' 17' ' ' VAL . 54.3 t -62.07 -42.62 95.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.71 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.92 -38.02 84.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.33 89.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.536 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.3 mttm -60.38 -38.14 82.98 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.793 HD11 HG11 ' C' ' 5' ' ' VAL . 6.8 mm -63.55 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.927 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -61.68 -46.05 91.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.85 -13.75 60.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -104.96 -12.49 16.17 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -141.33 -37.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.77 14.42 27.17 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.488 HG21 HD22 ' C' ' 71' ' ' LEU . 34.9 mt -89.16 117.68 68.46 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.12 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.13 146.56 94.03 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.994 . . . . 0.0 111.397 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.99 -39.5 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.049 1.833 . . . . 0.0 112.294 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.99 -31.14 70.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -83.87 -10.5 57.97 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.636 ' HB2' HD11 ' C' ' 69' ' ' LEU . 28.6 pt20 -121.78 145.18 48.31 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.143 0.497 . . . . 0.0 111.105 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -127.66 131.03 49.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.648 ' CB ' HD12 ' C' ' 50' ' ' LEU . 72.7 mt -102.68 122.24 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.105 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -126.97 126.63 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' PHE . . . . . 0.406 ' CD1' HD23 ' C' ' 67' ' ' LEU . 49.7 t80 -116.06 119.94 37.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.946 0.403 . . . . 0.0 110.909 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.54 39.45 30.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.99 14.79 80.04 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.94 105.7 13.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.42 132.97 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.648 HD12 ' CB ' ' C' ' 43' ' ' LEU . 63.3 mt -84.82 100.13 11.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.65 146.95 39.88 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.37 0.605 . . . . 0.0 111.431 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -63.53 150.43 43.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.249 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.28 -12.63 64.03 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -91.09 167.83 12.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.036 0.446 . . . . 0.0 110.471 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 59.6 p -116.45 163.77 15.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.911 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.33 -39.85 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.2 p -63.31 -24.35 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.591 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.26 -37.96 87.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.117 0.484 . . . . 0.0 110.301 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -96.57 13.35 28.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.71 42.81 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.029 0.442 . . . . 0.0 110.274 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.467 HG23 ' CB ' ' C' ' 65' ' ' SER . 80.8 mt -91.9 116.97 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -101.02 -178.76 3.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.594 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -61.52 144.67 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.185 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 63.77 17.1 10.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' SER . . . . . 0.467 ' CB ' HG23 ' C' ' 61' ' ' ILE . 28.8 t -66.04 131.05 45.29 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -85.26 128.31 34.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 0.0 109.996 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' C' ' 3' ' ' ILE . 68.4 mt -117.25 146.16 43.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -91.32 116.95 29.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.849 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.899 HD23 HG22 ' C' ' 7' ' ' THR . 57.4 tp -97.01 119.58 35.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.1 t -116.65 129.78 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 0.0 110.626 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.488 HD22 HG21 ' C' ' 36' ' ' ILE . 29.8 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.839 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 2' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' D' ' 16' ' ' GLU . 9.8 pt20 -62.22 161.62 10.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.311 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.623 HD12 HD22 ' D' ' 67' ' ' LEU . 12.3 pt -143.46 142.53 25.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -90.4 116.52 28.4 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.822 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.3 102.92 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.452 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.15 124.09 31.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.184 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.47 HG22 HD23 ' D' ' 69' ' ' LEU . 60.7 p -77.46 -171.6 2.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.515 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.583 HD21 ' HA ' ' D' ' 70' ' ' VAL . 89.4 mt -60.16 -18.78 50.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -115.9 -172.88 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.139 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.53 -20.25 58.87 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.79 131.27 34.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.306 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -128.02 140.48 51.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.569 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.83 102.25 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.781 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.78 128.97 34.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.585 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.613 HD13 ' CB ' ' D' ' 29' ' ' LYS . 81.5 mt -127.64 124.17 37.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 16' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' D' ' 2' ' ' GLN . 19.2 pt-20 -68.24 112.49 5.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.249 0.547 . . . . 0.0 110.532 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.733 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.3 m -135.69 165.63 29.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.111 -0.368 . . . . 0.0 110.552 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' GLU . . . . . 0.533 ' O ' HD12 ' D' ' 56' ' ' LEU . 75.2 mm-40 -111.28 154.53 43.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -55.7 -41.3 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.055 1.837 . . . . 0.0 112.253 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -70.29 -15.82 62.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -57.93 136.75 57.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.32 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -81.44 163.83 22.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.159 0.505 . . . . 0.0 110.999 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.46 HD12 HD13 ' D' ' 50' ' ' LEU . 46.5 mm -63.13 -38.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.933 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.78 -40.31 83.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.03 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.6 -43.36 94.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 0.0 110.417 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.486 HG21 HD21 ' D' ' 56' ' ' LEU . 66.8 t -62.49 -47.36 93.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.28 -31.46 72.05 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.89 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.4 97.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.947 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.733 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -60.17 -38.99 84.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' D' ' 43' ' ' LEU . 86.5 mt -64.62 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.913 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.37 -39.21 82.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.98 -45.31 67.6 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.529 ' HD2' HD21 ' D' ' 15' ' ' LEU . 24.5 mttp -68.39 -40.67 81.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.845 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -130.23 148.41 52.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.425 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 59.4 3.04 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' D' ' 41' ' ' GLN . 19.9 mm -111.36 106.95 57.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.02 152.44 51.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.877 1.718 . . . . 0.0 111.306 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.98 -41.49 56.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.952 1.768 . . . . 0.0 112.51 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -68.09 -40.12 82.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.856 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -63.31 -40.31 96.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.724 ' HB2' HD11 ' D' ' 69' ' ' LEU . 1.4 pt20 -94.29 143.59 26.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.264 0.555 . . . . 0.0 111.461 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -131.9 120.52 22.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' D' ' 30' ' ' ILE . 86.9 mt -89.73 122.85 33.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.51 HG23 ' HA ' ' D' ' 49' ' ' GLN . 56.5 mt -131.42 131.14 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.788 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' D' ' 50' ' ' LEU . 70.4 t80 -144.96 152.99 41.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.981 0.419 . . . . 0.0 111.092 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.5 19.04 10.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.528 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.71 -7.68 72.64 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.743 ' HB3' HD22 ' A' ' 73' ' ' LEU . 32.5 ptt-85 -123.53 144.6 49.45 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 110.764 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.51 ' HA ' HG23 ' D' ' 44' ' ' ILE . 15.8 pt20 -62.28 150.03 40.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.194 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.588 HD21 ' HB3' ' D' ' 45' ' ' PHE . 74.9 mt -87.21 120.46 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.124 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -75.58 130.72 39.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.76 137.21 58.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.55 -17.0 54.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -88.85 166.17 14.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.439 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -101.14 168.21 9.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.533 HD12 ' O ' ' D' ' 18' ' ' GLU . 85.1 mt -65.67 -38.89 90.58 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.697 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -63.45 -25.01 68.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.996 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.82 -28.8 70.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.15 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.79 14.98 28.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.552 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 55.44 39.73 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.233 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -88.32 102.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -90.43 -177.66 5.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.915 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.27 145.89 55.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.606 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 66.16 10.38 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.356 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 52.8 m -64.28 135.85 56.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -90.05 112.43 23.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.623 HD22 HD12 ' D' ' 3' ' ' ILE . 9.0 mp -95.03 137.28 34.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.852 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 76' ' ' PHE . 93.8 m-70 -85.71 125.77 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.036 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' D' ' 41' ' ' GLN . 60.4 tp -111.55 124.41 52.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.925 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 56' ' ' LEU . 57.7 t -111.61 130.39 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.957 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.142 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.239 0.536 0 CA-C-O 121.013 0.435 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.1 114.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.683 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 57' ' ' ILE . 96.4 mt -66.37 -37.78 86.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.3 p -149.91 162.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.802 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.49 123.13 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -154.17 159.38 41.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.981 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HA ' HD12 ' A' ' 46' ' ' LEU . 78.8 mtp180 -74.96 121.61 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.631 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.29 141.65 17.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.697 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.4 157.66 15.76 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -93.16 153.52 18.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.603 0.24 . . . . 0.0 110.946 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.482 ' HE3' HG12 ' A' ' 38' ' ' VAL . 1.4 mtm -127.02 175.78 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.1 m -126.79 139.08 53.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.758 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.656 HD13 HG22 ' A' ' 38' ' ' VAL . 22.4 tp -117.71 119.0 33.62 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.421 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -120.03 111.01 17.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.26 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 -101.52 0.89 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -127.62 21.66 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.606 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.6 m -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.656 HG22 HD13 ' A' ' 33' ' ' LEU . 48.1 t -108.96 121.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.47 HG22 ' HB3' ' B' ' 947' ' ' PRO . 17.8 p -113.63 133.68 22.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.07 140.85 23.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.94 1.76 . . . . 0.0 112.424 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -97.97 145.25 26.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.82 -6.05 58.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.087 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -73.87 65.7 1.08 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -49.57 132.15 21.23 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.92 -157.98 8.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.139 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.6 tp -138.34 127.52 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.79 110.56 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.344 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -132.89 154.35 50.48 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.305 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.8 mt -117.39 137.57 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.232 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 131.98 37.34 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 123.799 0.687 . . . . 0.0 110.031 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.538 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.5 tt0 -100.52 124.79 46.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.889 0.376 . . . . 0.0 109.997 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.504 HG23 ' CD2' ' A' ' 58' ' ' HIS . 17.1 p -85.88 170.31 12.49 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.459 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -61.85 -13.16 21.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.0 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' OD2' HG11 ' D' ' 70' ' ' VAL . 33.4 t0 -84.66 0.26 50.93 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.402 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 t 68.93 20.42 7.89 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.105 0.478 . . . . 0.0 110.376 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.595 HD11 HG11 ' D' ' 70' ' ' VAL . 72.7 mt -100.06 125.47 46.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.7 mm -80.23 124.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.403 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.504 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -100.89 115.8 31.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.788 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -93.76 108.65 20.38 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.7 m -120.75 147.94 44.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.812 0.815 . . . . 0.0 112.778 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.0 t90 -126.98 114.35 17.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.289 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.49 133.03 52.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.955 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.79 133.05 43.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.447 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -74.35 -18.68 60.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 110.806 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.9 m -59.97 -46.07 90.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.723 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.4 m -116.45 -14.9 10.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.452 . . . . 0.0 110.035 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.9 22.47 78.03 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.59 144.48 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.945 0.402 . . . . 0.0 110.246 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.43 108.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -89.02 -26.34 21.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.715 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 61' ' ' TRP . 40.3 m-20 -127.91 143.7 51.1 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.211 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.636 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.4 p30 -158.34 98.58 1.57 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.378 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' D' ' 48' ' ' ARG . 25.2 mt -127.93 133.74 49.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.79 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.37 125.97 35.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.342 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.606 HG21 ' SG ' ' A' ' 80' ' ' CYS . 24.6 mm -113.06 124.79 70.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.357 0.599 . . . . 0.0 110.83 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HZ ' HD12 ' D' ' 44' ' ' ILE . 78.2 m-85 -91.3 162.54 31.83 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.332 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.4 136.78 77.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.015 1.81 . . . . 0.0 111.434 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 60.79 8.45 1.81 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.609 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -72.89 -36.4 67.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.821 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.782 ' SG ' HD11 ' A' ' 96' ' ' LEU . 18.3 p -143.98 165.49 27.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.437 0.637 . . . . 0.0 110.31 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -125.95 128.17 47.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.303 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -102.87 119.85 39.57 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -148.2 166.72 27.07 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.886 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -80.1 159.84 25.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.114 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.17 89.97 13.0 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.856 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.41 60.78 7.65 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.944 1.763 . . . . 0.0 112.43 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -39.72 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.2 t -129.89 77.33 76.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.68 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.1 130.43 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.391 2.06 . . . . 0.0 111.495 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.45 -43.71 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.34 -160.65 9.05 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.534 ' HG2' HG22 ' A' ' 114' ' ' THR . 1.0 OUTLIER -102.92 106.38 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.79 128.58 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.775 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.12 152.42 47.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.79 138.66 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.367 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.782 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.2 tp -100.87 116.3 32.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -104.17 107.68 18.69 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -75.73 106.05 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.86 -37.79 83.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.47 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.98 -22.61 13.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.744 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.29 -14.48 82.17 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.638 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.5 m 56.15 21.19 4.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' CD ' HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -119.42 153.09 35.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.351 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -131.09 136.3 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.678 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.486 HD21 ' CD ' ' A' ' 103' ' ' LYS . 57.6 mt -120.07 147.22 45.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 94.9 m-85 -114.98 132.47 56.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.98 155.37 49.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.875 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -134.14 135.62 43.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.9 mtp -83.7 136.73 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.5 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -100.74 12.79 36.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.78 129.44 91.15 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.944 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.64 -37.79 94.92 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.822 1.681 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.81 144.91 46.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.83 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 92' ' ' ARG . 69.1 p -90.84 0.7 57.4 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.04 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.9 -20.6 53.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.202 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -113.87 -16.05 12.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.786 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.62 -40.42 94.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.892 0.377 . . . . 0.0 110.703 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -41.32 99.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.004 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.04 -41.96 94.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.814 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.704 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.2 m170 -64.39 -40.44 95.8 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.786 0.803 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.42 -44.82 95.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.126 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -64.19 -43.91 93.62 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.3 -40.97 98.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.984 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 120' ' ' HIS . 61.5 t -59.1 -48.56 86.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.843 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.64 -38.77 90.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.228 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.93 -22.85 55.58 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.606 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.462 ' CE2' HD22 ' A' ' 23' ' ' LEU . 18.6 m-85 -89.88 -28.2 19.39 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.6 mt -92.66 -18.06 23.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -117.25 -17.14 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.265 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -139.76 65.21 31.08 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.207 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.0 156.22 63.25 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 C-N-CA 122.821 2.347 . . . . 0.0 112.359 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.311 -1.417 0 C-N-CA 122.525 2.15 . . . . 0.0 112.262 -179.794 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -127.27 130.78 23.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.439 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.85 146.29 37.59 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.935 1.757 . . . . 0.0 111.968 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.79 153.4 87.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.09 158.03 56.14 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.39 2.06 . . . . 0.0 112.12 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -58.2 -172.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.279 1.986 . . . . 0.0 111.806 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -128.92 158.2 73.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' A' ' 39' ' ' THR . 41.2 Cg_exo -57.65 141.75 95.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.105 1.87 . . . . 0.0 112.326 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.53 165.47 36.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.589 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.92 135.84 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.439 . . . . 0.0 110.542 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -115.32 128.5 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.151 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.22 122.58 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.54 85.5 5.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.087 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.617 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -63.29 158.85 19.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.438 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.04 144.47 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.528 ' HD2' HG21 ' C' ' 12' ' ' THR . 5.3 m-85 -88.02 125.27 34.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.199 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.747 HG11 HD11 ' C' ' 30' ' ' ILE . 92.0 t -111.74 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -99.84 128.48 45.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.784 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.902 HG22 HD23 ' C' ' 69' ' ' LEU . 75.1 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 111.483 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' THR . . . . . 0.528 HG21 ' HD2' ' C' ' 4' ' ' PHE . 99.0 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.16 105.06 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -75.04 131.09 40.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.042 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' C' ' 29' ' ' LYS . 91.9 mt -122.71 129.21 51.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.16 115.94 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.068 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.49 HG12 ' HE2' ' C' ' 29' ' ' LYS . 18.2 m -138.73 165.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.59 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -107.89 155.65 39.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.7 -37.64 95.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.041 1.827 . . . . 0.0 112.015 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -80.93 -7.42 59.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.191 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -58.69 137.96 57.3 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.058 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.06 161.02 26.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 110.952 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 0.445 HD12 HD13 ' C' ' 50' ' ' LEU . 48.5 mm -63.69 -39.21 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.08 -39.11 84.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.864 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.99 -42.75 99.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.396 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.417 HG22 HG11 ' C' ' 17' ' ' VAL . 53.9 t -61.76 -42.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.204 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -39.89 80.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.551 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.85 -41.29 95.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 110.063 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' C' ' 15' ' ' LEU . 11.1 mttp -59.6 -38.63 81.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.747 HD11 HG11 ' C' ' 5' ' ' VAL . 8.8 mm -65.18 -39.9 87.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.984 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.21 -41.96 89.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.823 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -69.48 -50.3 46.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.504 ' HG3' HD21 ' C' ' 15' ' ' LEU . 20.3 mttt -63.97 -41.2 97.63 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -131.67 148.92 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.58 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.42 63.61 2.19 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.632 HG22 ' HG3' ' C' ' 41' ' ' GLN . 45.0 mt -115.97 119.81 36.49 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.28 159.93 48.35 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.779 1.653 . . . . 0.0 111.457 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.05 -31.68 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.041 1.827 . . . . 0.0 112.613 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.75 -42.59 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.961 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.71 -10.8 57.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.412 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.632 ' HG3' HG22 ' C' ' 36' ' ' ILE . 75.3 mt-30 -80.62 86.55 5.86 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.799 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -96.86 103.76 15.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.683 ' HB3' HD12 ' C' ' 50' ' ' LEU . 76.6 mt -95.9 119.36 34.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.122 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.6 127.57 71.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.084 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -129.2 130.34 46.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.521 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.67 28.04 14.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.54 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.97 15.3 81.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -119.37 132.75 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 110.371 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -72.61 131.94 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.106 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.683 HD12 ' HB3' ' C' ' 43' ' ' LEU . 78.2 mt -81.34 97.74 7.84 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.968 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.17 139.83 52.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.781 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.23 143.68 52.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.43 -17.73 58.55 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -84.39 171.38 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.806 0.336 . . . . 0.0 110.105 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -119.0 165.69 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.246 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' C' ' 56' ' ' LEU . 82.5 mt -62.33 -39.83 94.36 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.381 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.97 -27.02 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.248 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.78 -35.98 79.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.206 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.509 ' CE2' HD23 ' C' ' 50' ' ' LEU . 66.3 m-85 -96.51 12.6 30.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.319 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.29 40.67 27.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.342 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -89.58 114.92 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -99.22 -175.2 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.354 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -65.3 150.12 48.79 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.946 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 54.89 42.54 31.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.947 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 45.3 m -96.25 124.46 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.032 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.454 ' C ' HD12 ' C' ' 67' ' ' LEU . 53.3 m -75.01 128.19 34.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.906 0.384 . . . . 0.0 110.074 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.454 HD12 ' C ' ' C' ' 66' ' ' THR . 7.4 mp -118.35 143.46 46.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -89.96 112.08 23.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.07 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.902 HD23 HG22 ' C' ' 7' ' ' THR . 59.2 tp -100.51 120.42 39.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.635 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -117.45 133.83 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.793 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.007 -178.883 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -68.93 158.32 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.448 HD13 HD21 ' D' ' 56' ' ' LEU . 11.4 pt -138.97 146.5 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.754 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -94.82 122.07 37.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.59 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.688 HG11 HD11 ' D' ' 30' ' ' ILE . 85.8 t -104.42 113.23 40.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.395 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -98.49 130.29 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.719 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.606 HG22 HD23 ' D' ' 69' ' ' LEU . 74.5 p -86.76 -177.56 6.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.203 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.515 HD11 ' H ' ' D' ' 71' ' ' LEU . 52.1 mt -72.83 -17.07 61.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.365 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 56.1 p -90.87 -2.35 57.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.041 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -9.09 75.9 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.47 130.73 44.36 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -111.47 134.1 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.996 0.427 . . . . 0.0 110.979 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.91 109.8 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.351 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.94 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.457 HD21 ' HD2' ' D' ' 33' ' ' LYS . 96.0 mt -122.34 124.86 44.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.204 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.31 114.51 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.563 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.685 HG12 ' HE3' ' D' ' 29' ' ' LYS . 23.7 m -135.33 168.5 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -109.86 154.86 42.37 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.294 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.57 -32.93 91.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.893 1.728 . . . . 0.0 111.893 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -83.19 -6.28 59.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.113 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -60.99 144.9 52.45 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -89.45 161.28 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.73 -38.69 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.088 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.16 -42.66 91.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.084 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -62.86 -40.63 98.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.341 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.558 HG12 HD21 ' D' ' 43' ' ' LEU . 62.4 t -61.91 -42.97 96.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.618 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.589 ' HG3' HD22 ' D' ' 43' ' ' LEU . 58.6 mtmt -61.17 -39.4 90.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.201 0.524 . . . . 0.0 109.951 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.35 90.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.685 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.9 -38.09 81.31 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.688 HD11 HG11 ' D' ' 5' ' ' VAL . 6.1 mm -63.01 -41.95 94.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.506 0.67 . . . . 0.0 109.949 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.8 -44.74 96.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.09 -20.33 62.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.457 ' HD2' HD21 ' D' ' 15' ' ' LEU . 8.2 mttm -101.61 -6.14 24.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -145.36 -43.63 0.22 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.28 0.562 . . . . 0.0 110.226 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.97 14.13 12.62 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' D' ' 41' ' ' GLN . 57.4 mt -87.93 119.17 70.4 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.438 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.52 160.14 44.91 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.823 1.682 . . . . 0.0 111.943 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.63 -22.26 59.64 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.418 2.079 . . . . 0.0 112.215 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -87.48 1.36 53.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.443 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -126.42 21.2 7.25 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.652 ' HB2' HD11 ' D' ' 69' ' ' LEU . 22.4 pt20 -162.42 154.97 19.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 111.214 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.23 132.38 35.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.666 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.703 ' HB3' HD12 ' D' ' 50' ' ' LEU . 5.8 mp -91.46 122.26 33.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.547 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.596 HG23 ' HA ' ' D' ' 49' ' ' GLN . 70.0 mt -128.99 132.23 67.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.784 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.532 ' HB3' HD21 ' D' ' 50' ' ' LEU . 87.4 t80 -151.9 155.14 37.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.365 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.68 16.69 7.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 47' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.56 -12.69 62.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.81 ' HB3' HD22 ' A' ' 73' ' ' LEU . 39.8 ptt180 -119.71 146.38 45.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.138 0.494 . . . . 0.0 110.397 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.596 ' HA ' HG23 ' D' ' 44' ' ' ILE . 27.0 pt20 -65.11 142.66 58.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.979 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' D' ' 43' ' ' LEU . 75.9 mt -84.43 114.79 22.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.411 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.51 149.59 38.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.228 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -71.21 165.05 24.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.73 26.82 74.0 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -128.01 157.3 41.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.868 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -100.91 160.79 14.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.277 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.492 HD11 HG21 ' D' ' 26' ' ' VAL . 7.4 mp -62.59 -40.47 97.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.4 p -62.62 -23.63 67.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -62.9 -38.08 89.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.112 0.482 . . . . 0.0 109.907 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.62 13.83 30.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.277 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.91 40.36 28.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.568 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.94 98.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 109.995 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -86.1 178.38 7.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.256 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -60.75 151.68 28.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.289 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 57.13 44.47 22.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 123.42 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.86 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -81.88 96.83 7.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.081 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.407 ' N ' HD12 ' D' ' 67' ' ' LEU . 9.2 mp -84.19 152.47 24.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.04 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -101.87 122.39 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.302 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' D' ' 41' ' ' GLN . 34.1 tp -103.35 114.0 27.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.884 HG11 HD11 ' A' ' 56' ' ' LEU . 64.0 t -106.43 120.07 56.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.515 ' H ' HD11 ' D' ' 8' ' ' LEU . 65.3 mt . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.804 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 C--O 1.238 0.454 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.27 115.1 26.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.682 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.1 mt -68.05 -36.86 80.58 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.682 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.09 161.9 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.818 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.0 122.23 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.295 0.569 . . . . 0.0 111.091 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.89 158.61 38.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.924 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HA ' HD12 ' A' ' 46' ' ' LEU . 83.1 mtt85 -77.22 123.23 26.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.602 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 146.28 23.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.221 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.55 151.58 17.04 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -89.73 172.46 8.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.04 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 24.6 mtp -138.22 174.34 10.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.739 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.2 m -124.54 127.27 47.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD22 ' CE1' ' A' ' 106' ' ' PHE . 34.6 tp -107.72 117.2 33.49 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.184 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.97 110.33 16.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.826 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.73 -83.22 0.58 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.15 18.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.473 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.8 m -119.17 130.14 55.36 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 33' ' ' LEU . 64.1 t -108.5 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.6 p -115.64 132.6 23.06 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.044 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.32 146.66 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.552 1.501 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -101.04 121.47 41.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.456 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -62.36 -14.62 41.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -71.29 80.55 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -64.27 130.58 44.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.641 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.03 -154.64 8.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.348 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.5 tp -138.11 127.24 24.3 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.6 110.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.9 p90 -134.17 154.66 51.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.189 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.0 mt -120.36 138.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.63 132.64 37.31 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 123.772 0.67 . . . . 0.0 110.045 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.549 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.2 tt0 -102.01 125.29 48.66 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 58' ' ' HIS . 13.4 p -84.9 171.78 11.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.873 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.85 -10.34 27.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.566 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.31 5.42 47.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.424 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m 64.02 25.16 13.77 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.578 0.704 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.884 HD11 HG11 ' D' ' 70' ' ' VAL . 78.7 mt -101.55 122.77 44.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.7 mm -80.92 123.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.234 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.487 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.1 m-70 -99.45 115.64 29.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.827 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -94.7 108.65 20.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 72.9 m -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.86 0.838 . . . . 0.0 113.108 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -125.67 114.85 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.113 -1.403 . . . . 0.0 107.646 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -106.51 132.74 52.17 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.582 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -74.5 134.22 42.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -75.59 -16.5 60.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.69 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 m -60.41 -44.84 95.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.754 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.9 p -116.47 -17.41 10.66 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.763 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.39 22.01 74.05 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -101.53 153.01 20.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.56 102.47 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -77.21 -32.8 56.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -125.87 144.84 50.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.589 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.61 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.4 t0 -157.34 99.23 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.81 HD22 ' HB3' ' D' ' 48' ' ' ARG . 36.6 mt -130.53 133.83 46.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.771 0.32 . . . . 0.0 110.877 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -78.73 125.45 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.307 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.653 HG21 ' SG ' ' A' ' 80' ' ' CYS . 17.9 mm -111.06 126.15 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.915 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.47 162.2 32.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.351 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.08 138.69 83.54 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.817 1.678 . . . . 0.0 111.235 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.8 t0 59.44 11.74 2.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.731 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.67 -27.05 37.2 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.616 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.653 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.5 p -151.65 166.97 29.61 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.759 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.01 132.33 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.277 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -104.5 118.51 36.78 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -142.39 166.81 23.66 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.719 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.49 159.99 19.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.967 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.03 89.46 19.96 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.8 60.44 7.56 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.829 1.686 . . . . 0.0 112.149 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -113.84 -42.8 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.329 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.1 t -120.22 96.97 49.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.042 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 131.04 18.46 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.122 1.215 . . . . 0.0 111.487 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 168.17 -31.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.985 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.58 -174.31 28.13 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.552 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.483 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.3 OUTLIER -88.72 112.6 23.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.486 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.2 128.83 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.21 152.97 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.4 p -130.62 136.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.149 0.5 . . . . 0.0 110.283 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.4 tp -103.78 120.84 41.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -116.7 120.11 37.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.147 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' HE2' HD12 ' A' ' 75' ' ' ILE . 47.6 m-85 -79.2 113.73 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.43 -37.78 84.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.054 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.89 -23.0 12.51 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.58 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.4 -17.37 79.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.274 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m 58.32 21.19 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.627 -0.337 . . . . 0.0 111.165 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.509 ' HD3' HD21 ' A' ' 105' ' ' LEU . 5.0 ttmt -119.1 151.4 38.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.099 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.436 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.7 mtt180 -131.42 138.4 49.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.0 110.852 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 95' ' ' VAL . 47.3 mt -123.42 153.05 40.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.146 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HD22 ' A' ' 33' ' ' LEU . 97.8 m-85 -124.76 135.76 53.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.819 0.342 . . . . 0.0 110.683 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -139.6 156.67 46.72 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.301 0.572 . . . . 0.0 111.224 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -130.43 138.91 50.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.439 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 77.6 mmm -75.07 139.15 42.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.843 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.56 2.09 33.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.894 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -73.83 146.36 85.27 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.746 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.82 -28.01 17.25 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.999 1.8 . . . . 0.0 112.601 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.77 144.13 48.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.891 0.377 . . . . 0.0 110.334 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 92' ' ' ARG . 82.7 p -91.47 1.15 57.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.922 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.01 -19.51 44.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -118.52 -20.2 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.88 -41.7 98.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.273 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.51 -40.87 96.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.48 -42.44 92.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.415 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.7 m170 -64.44 -39.94 94.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.674 0.749 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.0 t -61.02 -45.83 93.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.491 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -63.42 -43.1 98.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.153 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -65.62 -35.44 80.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.9 t -58.51 -48.35 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.987 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.32 -28.99 53.36 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.777 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.8 -34.99 74.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.97 -31.32 31.24 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -81.48 -26.94 34.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -106.39 -26.82 11.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.477 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.58 73.66 72.23 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.433 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.6 Cg_exo -59.78 151.2 72.47 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.945 2.43 . . . . 0.0 111.964 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.49 1.318 0 C-N-CA 122.394 2.063 . . . . 0.0 112.068 -179.84 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -134.27 154.77 80.15 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.978 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.28 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.268 1.979 . . . . 0.0 111.569 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -73.63 159.0 85.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -54.92 140.77 79.09 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.411 2.074 . . . . 0.0 112.193 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.42 174.12 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.387 2.058 . . . . 0.0 111.84 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -97.11 154.49 38.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.53 147.0 88.73 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.463 2.108 . . . . 0.0 112.105 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.43 161.4 42.64 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.84 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.04 136.21 33.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 0.0 110.572 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -118.69 124.72 48.03 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 951' ' ' ILE . 1.7 mp -130.46 122.69 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.477 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.26 83.97 7.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.932 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.4 p30 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.586 179.571 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.91 160.76 14.11 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -136.94 154.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.082 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' C' ' 14' ' ' THR . 11.7 m-30 -93.53 122.69 36.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.115 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.03 108.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.42 108.25 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.971 HG22 HD23 ' C' ' 69' ' ' LEU . 23.7 p . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.571 0.701 . . . . 0.0 111.08 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 94.8 m . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -132.42 118.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' THR . . . . . 0.467 HG23 ' CD1' ' C' ' 4' ' ' PHE . 9.7 m -86.7 122.98 31.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.54 128.11 52.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.508 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -70.62 116.37 10.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.858 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.545 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.5 m -135.92 166.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.515 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -111.98 153.76 44.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.091 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 -38.25 93.92 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.062 1.841 . . . . 0.0 112.156 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -81.45 -8.74 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.07 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.72 134.76 57.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -78.57 163.82 25.2 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.043 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.25 -35.74 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.943 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.8 tm-20 -58.44 -40.01 81.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.2 -41.51 94.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.537 HG21 HD21 ' C' ' 56' ' ' LEU . 62.7 t -63.09 -47.59 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.044 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -62.82 -33.35 75.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.053 0.454 . . . . 0.0 110.17 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.05 97.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.545 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.4 mttm -60.34 -39.3 86.62 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.083 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.669 HD13 HD22 ' C' ' 69' ' ' LEU . 92.1 mt -66.17 -39.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.001 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -46.53 88.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.29 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.77 -15.1 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.033 -0.417 . . . . 0.0 111.906 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -101.14 -6.34 24.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -148.61 -41.03 0.16 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.181 0.515 . . . . 0.0 110.501 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 11.17 21.02 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.765 HD13 HD21 ' C' ' 71' ' ' LEU . 73.8 mt -77.52 125.25 86.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.43 158.05 48.55 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.675 1.583 . . . . 0.0 112.05 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.18 -38.62 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.113 1.875 . . . . 0.0 112.274 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.07 -39.93 94.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.906 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.79 -3.63 58.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.404 ' OE1' HG21 ' C' ' 30' ' ' ILE . 10.4 mm100 -80.02 96.2 6.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -96.22 85.28 3.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.578 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.783 ' HB3' HD12 ' C' ' 50' ' ' LEU . 86.8 mt -89.17 113.08 24.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.63 129.03 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.616 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -132.72 132.49 42.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.859 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 24.34 14.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.65 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.94 3.43 90.6 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.344 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -110.69 127.14 55.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.645 -0.326 . . . . 0.0 110.238 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -70.18 134.25 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.783 HD12 ' HB3' ' C' ' 43' ' ' LEU . 59.4 mt -79.6 94.43 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.429 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.06 146.61 39.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.295 0.569 . . . . 0.0 111.038 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -61.44 150.6 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.07 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.85 -17.65 57.5 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -90.2 164.12 14.54 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.211 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.8 p -113.34 167.06 10.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.309 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.537 HD21 HG21 ' C' ' 26' ' ' VAL . 81.5 mt -62.39 -39.41 93.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.384 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -62.96 -26.75 68.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.094 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.08 -35.91 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.525 ' CE2' HD23 ' C' ' 50' ' ' LEU . 57.9 m-85 -95.52 14.29 23.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.213 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 55.77 40.41 30.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 0.0 110.497 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.71 121.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.977 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.18 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.598 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -58.96 145.12 42.77 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.972 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 59.18 26.17 14.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 123.37 25.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.479 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.439 ' C ' HD12 ' C' ' 67' ' ' LEU . 91.3 m -72.63 130.07 39.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.226 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.439 HD12 ' C ' ' C' ' 66' ' ' THR . 6.5 mp -120.57 143.11 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.288 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -93.24 109.22 20.74 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.971 HD23 HG22 ' C' ' 7' ' ' THR . 24.8 tp -106.66 123.62 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.434 ' N ' HD12 ' C' ' 69' ' ' LEU . 74.5 t -123.11 141.32 43.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.765 HD21 HD13 ' C' ' 36' ' ' ILE . 19.6 mt . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.332 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -64.13 157.23 26.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.599 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 pt -136.72 152.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.131 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.498 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.4 m-30 -93.46 122.02 35.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.714 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.24 107.47 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.678 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -91.88 125.56 36.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.599 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.665 HG22 HD23 ' D' ' 69' ' ' LEU . 82.4 p -83.32 174.53 10.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.189 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.705 HD11 ' H ' ' D' ' 71' ' ' LEU . 70.7 mt -62.46 -25.95 68.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.076 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p -78.48 -9.45 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 -11.7 66.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.41 134.61 52.87 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.88 0.34 . . . . 0.0 110.124 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -104.3 133.68 48.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.719 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -122.7 113.05 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.644 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' THR . . . . . 0.498 HG23 ' CD2' ' D' ' 4' ' ' PHE . 4.8 m -80.96 125.24 29.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.089 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' D' ' 29' ' ' LYS . 91.4 mt -119.58 116.56 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.716 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.98 108.89 2.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.465 0.65 . . . . 0.0 110.883 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.546 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.8 m -134.49 164.73 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -107.76 155.06 40.5 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.172 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.87 -37.29 96.03 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.864 1.71 . . . . 0.0 111.814 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -79.21 -9.4 59.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.78 136.28 58.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.904 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -79.74 162.94 24.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.39 -38.95 83.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.761 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.51 -41.58 90.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.947 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.89 -41.52 97.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.147 0.499 . . . . 0.0 110.578 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.457 HG22 HG11 ' D' ' 17' ' ' VAL . 68.5 t -63.43 -42.03 94.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.43 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.484 ' HG2' HD13 ' D' ' 43' ' ' LEU . 56.4 mtmt -60.61 -39.34 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 110.245 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.15 93.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.097 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.625 ' HB3' HD22 ' D' ' 15' ' ' LEU . 66.6 mttm -60.37 -39.22 86.45 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.49 ' CD1' HD11 ' D' ' 43' ' ' LEU . 92.4 mt -63.59 -42.12 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.199 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 27.0 tm0? -60.57 -40.08 90.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.636 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -83.52 12.0 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.498 ' HG3' HD21 ' D' ' 15' ' ' LEU . 11.3 mmtt -118.56 -47.89 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -112.08 2.28 16.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.246 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.15 24.8 75.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.509 HG21 ' HB3' ' D' ' 41' ' ' GLN . 13.6 mm -85.82 116.24 64.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.164 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.5 147.2 70.57 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 122.083 1.855 . . . . 0.0 112.32 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.69 -33.06 78.52 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.223 1.949 . . . . 0.0 112.643 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 9.85 31.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -121.14 28.61 7.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.672 ' HB2' HD11 ' D' ' 69' ' ' LEU . 5.3 pt20 -160.53 151.27 18.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.065 0.46 . . . . 0.0 111.142 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -132.0 126.27 33.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.792 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' D' ' 30' ' ' ILE . 6.8 mp -88.74 124.06 33.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.707 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.449 HG21 ' HE1' ' A' ' 76' ' ' PHE . 83.6 mt -127.38 129.11 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.736 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.445 ' HB3' HD21 ' D' ' 50' ' ' LEU . 70.9 t80 -148.59 151.54 35.22 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.997 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.8 17.74 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 47' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 85.49 -8.77 70.21 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.763 ' HB3' HD22 ' A' ' 73' ' ' LEU . 13.0 ptm180 -119.57 145.3 46.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.127 0.489 . . . . 0.0 110.735 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.29 132.41 47.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.967 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' D' ' 45' ' ' PHE . 55.0 mt -81.64 104.94 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.71 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.97 168.29 20.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.474 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -78.39 172.66 13.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.3 21.35 77.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -130.59 157.2 43.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.876 0.37 . . . . 0.0 110.693 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -105.83 162.97 13.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.134 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.88 -39.79 93.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.393 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -63.56 -23.02 67.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.378 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.48 -38.35 86.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.012 0.434 . . . . 0.0 110.233 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -99.23 15.7 25.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.368 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.24 40.82 24.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.264 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -90.65 104.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.23 -171.55 2.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.255 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -68.78 146.4 52.94 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.07 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 63.14 42.34 7.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -99.54 125.71 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.785 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -76.11 126.01 30.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.01 139.53 51.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.627 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 68' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 76' ' ' PHE . 91.3 m-70 -88.48 118.38 28.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.57 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' D' ' 41' ' ' GLN . 58.5 tp -100.48 120.0 39.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.53 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' D' ' 8' ' ' LEU . 78.0 t -109.41 127.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.705 ' H ' HD11 ' D' ' 8' ' ' LEU . 70.1 mt . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.683 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp . . . . . 0 CA--C 1.521 -0.17 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -89.11 112.87 23.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.517 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.1 mt -66.11 -38.38 88.07 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.6 162.94 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.644 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.72 122.92 0.34 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.281 0.562 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -154.47 158.95 40.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.845 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -74.33 122.57 23.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.415 . . . . 0.0 110.819 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.14 143.83 20.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.96 153.57 16.92 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -86.78 157.36 19.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.903 0.383 . . . . 0.0 110.871 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.8 mtp -125.53 172.95 9.28 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.44 124.64 41.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.374 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 37' ' ' THR . 37.7 tp -106.84 117.48 34.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.879 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -122.05 119.81 32.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.857 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -86.83 0.22 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -148.15 24.51 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.705 0.288 . . . . 0.0 110.722 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.625 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.9 m -126.26 131.18 51.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.548 HG22 HD13 ' A' ' 33' ' ' LEU . 59.5 t -105.99 122.18 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.646 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.783 HG22 ' HB3' ' B' ' 947' ' ' PRO . 42.8 p -121.35 122.94 27.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.53 146.41 55.35 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.269 1.313 . . . . 0.0 112.902 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -99.74 142.58 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.53 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -72.33 -6.26 42.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -73.1 74.11 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -55.42 135.68 50.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.89 -160.89 9.69 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.9 tp -137.26 126.97 25.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.3 t -99.69 109.58 24.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.3 p90 -133.19 154.49 50.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.609 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -117.89 137.89 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.236 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.91 131.3 35.02 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.549 0.531 . . . . 0.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.51 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.0 tt0 -100.45 124.73 46.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.231 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.0 p -84.35 172.32 11.88 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.604 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.11 -10.36 30.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.533 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.48 -0.06 56.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.626 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 71.03 19.68 5.52 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.51 HD11 HG11 ' D' ' 70' ' ' VAL . 73.7 mt -98.62 122.62 42.07 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.8 mm -78.97 125.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.491 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.8 m-70 -101.07 116.69 33.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.669 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -95.96 107.48 19.76 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 71.9 m -121.41 146.99 46.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 113.041 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.6 t90 -124.79 114.27 19.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.948 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -106.13 131.53 53.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.723 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -75.89 131.04 39.41 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -72.26 -18.86 61.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 110.662 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.5 m -59.91 -44.68 94.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.964 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p -115.94 -16.01 11.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.091 0.472 . . . . 0.0 109.991 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.17 19.6 79.78 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -102.54 146.52 28.02 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.82 102.05 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 110.06 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -74.44 -36.5 63.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -126.27 145.98 50.19 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.761 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.607 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.5 p-10 -158.08 100.61 1.72 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.83 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' D' ' 48' ' ' ARG . 31.7 mt -127.89 133.21 49.29 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.84 0.352 . . . . 0.0 110.756 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 125.55 35.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.144 0.497 . . . . 0.0 110.123 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.438 ' HB ' HD22 ' A' ' 128' ' ' LEU . 31.4 mm -112.09 118.18 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.897 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HE1' HG21 ' D' ' 44' ' ' ILE . 61.2 m-85 -82.95 161.58 57.57 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.858 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -54.59 131.98 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.676 1.584 . . . . 0.0 111.699 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 62.37 12.29 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.446 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -81.26 -26.89 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.111 0.481 . . . . 0.0 110.18 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -142.12 151.08 41.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.209 -178.566 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.533 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.0 tp10 -121.06 129.26 53.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.977 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.09 118.11 35.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -141.97 167.82 21.23 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.648 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -85.1 159.99 20.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.026 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.72 90.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.118 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.33 61.1 8.07 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.921 1.747 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -113.28 -38.04 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.6 t -131.44 77.26 74.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.697 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.13 130.33 40.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.151 1.901 . . . . 0.0 111.359 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 t 167.78 -47.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.723 0.64 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.8 -149.32 7.06 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.58 106.43 13.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.394 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -124.9 129.3 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.58 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.46 153.71 45.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.535 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.6 p -129.7 135.78 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 0.0 109.894 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 81' ' ' GLU . 60.8 tp -104.73 122.3 45.4 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -120.19 130.39 54.54 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.135 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 53.3 m-85 -86.24 116.41 24.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.78 -36.24 78.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.271 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.27 -20.88 12.14 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.398 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -73.23 -20.77 80.02 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.058 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 m 59.44 27.6 16.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -125.53 151.23 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.125 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -131.77 139.78 49.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.17 0.509 . . . . 0.0 110.934 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.483 ' O ' HG23 ' A' ' 95' ' ' VAL . 52.1 mt -122.91 149.1 44.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.7 m-85 -119.25 135.21 54.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.58 157.14 46.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.317 0.58 . . . . 0.0 111.318 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -135.05 137.07 42.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.523 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.4 ttm -73.7 135.22 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.238 0.542 . . . . 0.0 111.244 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.23 0.25 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.13 139.1 89.93 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.72 -25.74 33.55 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.979 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -117.51 141.68 48.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.41 . . . . 0.0 110.434 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.2 p -95.15 9.56 39.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.47 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.9 -21.0 60.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.362 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -121.05 3.16 10.47 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.476 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -62.02 -49.22 76.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.997 0.427 . . . . 0.0 110.986 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.14 -39.73 93.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.272 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.76 -42.98 99.94 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.737 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.662 ' O ' HG23 ' A' ' 124' ' ' VAL . 66.2 m170 -64.26 -41.06 97.11 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.036 0.922 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.88 -44.11 96.99 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.409 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -65.46 -43.51 90.1 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.53 -41.42 98.86 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.665 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.9 t -58.77 -49.38 83.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.014 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.501 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.87 -25.04 59.84 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.384 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.433 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.4 m-85 -87.84 -28.92 21.32 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.438 HD22 ' HB ' ' A' ' 75' ' ' ILE . 73.8 mt -91.23 -15.58 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.294 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -118.21 -17.95 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.165 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -142.1 66.74 21.07 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.255 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.4 155.0 64.76 Favored 'Trans proline' 0 C--N 1.297 -2.176 0 C-N-CA 122.604 2.203 . . . . 0.0 112.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 C-N-CA 122.559 2.173 . . . . 0.0 112.099 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -68.95 139.92 90.95 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.505 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.72 143.83 21.55 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.091 1.861 . . . . 0.0 112.079 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -79.81 155.25 75.65 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.1 150.48 72.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.933 1.755 . . . . 0.0 112.167 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.58 160.11 44.79 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.86 156.0 84.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.511 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.783 ' HB3' HG22 ' A' ' 39' ' ' THR . 30.9 Cg_endo -64.7 151.39 85.86 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.39 2.06 . . . . 0.0 111.883 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.91 165.77 33.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.835 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -85.47 136.91 33.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.039 0.447 . . . . 0.0 110.638 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -122.66 129.54 51.96 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.056 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 951' ' ' ILE . 2.7 mp -130.72 130.08 64.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -69.99 83.09 0.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.383 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.838 179.591 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -58.65 159.27 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.005 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 3' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 17' ' ' VAL . 13.8 pt -137.83 154.05 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.45 ' CD2' HG23 ' C' ' 14' ' ' THR . 17.3 m-30 -92.43 123.7 35.94 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.426 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -111.15 106.73 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 6' ' ' LYS . . . . . 0.535 ' HG3' HG23 ' C' ' 66' ' ' THR . 24.8 mtmt -91.25 133.18 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.383 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.28 -179.947 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.409 HG21 HD13 ' C' ' 13' ' ' ILE . 1.1 mt -123.82 113.62 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 14' ' ' THR . . . . . 0.45 HG23 ' CD2' ' C' ' 4' ' ' PHE . 7.2 m -80.98 126.68 31.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.584 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.07 126.45 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.17 116.36 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.944 0.402 . . . . 0.0 110.301 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.663 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 10.8 m -136.71 173.06 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.519 ' O ' HD12 ' C' ' 56' ' ' LEU . 76.5 mm-40 -125.8 155.32 72.92 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.135 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.72 -29.25 89.05 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 121.896 1.731 . . . . 0.0 111.761 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -85.19 -15.47 43.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.62 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.38 142.37 58.42 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.592 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -85.98 167.83 14.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 110.808 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.8 -35.57 71.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.95 -42.56 90.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.94 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -62.36 -42.2 99.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.522 HG12 HD21 ' C' ' 43' ' ' LEU . 79.1 t -62.9 -42.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.807 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.628 ' CG ' HD22 ' C' ' 43' ' ' LEU . 56.2 mtmt -61.11 -41.09 96.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.272 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.663 ' NZ ' HG12 ' C' ' 17' ' ' VAL . 27.2 mttt -59.61 -39.22 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.58 HD12 HD11 ' C' ' 43' ' ' LEU . 71.6 mt -66.0 -41.14 89.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.157 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.76 11.05 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.62 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -120.45 -33.86 3.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -125.17 -14.91 6.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.057 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 12.52 75.87 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.579 HG22 ' HG3' ' C' ' 41' ' ' GLN . 28.6 mt -77.1 129.02 79.56 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.035 0.417 . . . . 0.0 110.083 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.69 154.78 59.35 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.243 1.962 . . . . 0.0 111.536 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.15 -37.77 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.927 1.751 . . . . 0.0 112.768 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.86 -43.79 98.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.625 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -83.06 -12.34 57.24 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' GLN . . . . . 0.579 ' HG3' HG22 ' C' ' 36' ' ' ILE . 19.8 mt-30 -83.81 102.49 12.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.809 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -102.26 109.5 21.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.766 ' HB3' HD12 ' C' ' 50' ' ' LEU . 8.0 mp -98.41 109.62 22.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.69 128.38 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.821 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 90.0 t80 -132.93 132.45 42.01 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.842 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.35 26.67 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.37 14.19 81.02 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -119.5 133.79 55.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.782 0.325 . . . . 0.0 110.148 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -72.32 131.83 43.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.867 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' C' ' 43' ' ' LEU . 70.8 mt -84.57 100.15 11.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.43 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.11 143.11 41.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.269 0.557 . . . . 0.0 111.171 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.0 144.44 55.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.68 -18.05 57.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.83 145.46 24.75 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.26 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -88.64 162.35 16.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.518 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.519 HD21 HG21 ' C' ' 26' ' ' VAL . 74.6 mt -61.39 -38.88 88.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.803 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -62.41 -23.07 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.769 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.66 -37.42 83.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.682 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.5 ' CE2' HD23 ' C' ' 50' ' ' LEU . 69.9 m-85 -96.42 14.28 24.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.56 39.21 25.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.925 0.393 . . . . 0.0 110.336 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.94 120.06 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.926 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.45 -179.04 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 110.902 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -60.23 145.77 46.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.934 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 59.67 23.67 12.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.8 t -74.06 124.39 26.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.05 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.535 HG23 ' HG3' ' C' ' 6' ' ' LYS . 37.9 m -73.54 128.43 35.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -115.35 140.07 49.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' HIS . . . . . 0.41 ' ND1' HG23 ' C' ' 70' ' ' VAL . 44.6 t-80 -88.17 108.01 19.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.737 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.44 120.6 40.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.688 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.41 HG23 ' ND1' ' C' ' 68' ' ' HIS . 72.2 t -120.59 138.96 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.155 0.502 . . . . 0.0 110.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.534 ' CD2' HD13 ' C' ' 36' ' ' ILE . 22.0 mt . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.405 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -64.79 161.98 17.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.867 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -143.67 147.41 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.95 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -94.95 121.43 36.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.053 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -103.41 111.28 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.519 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -95.6 124.53 39.67 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.739 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 7' ' ' THR . . . . . 0.842 HG22 HD23 ' D' ' 69' ' ' LEU . 80.7 p -83.5 172.78 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.347 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.619 HD11 ' H ' ' D' ' 71' ' ' LEU . 58.8 mt -63.2 -24.07 67.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.153 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 48.8 p -81.41 -8.51 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.22 63.16 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -62.67 131.06 47.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.412 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -108.15 133.3 52.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.92 108.78 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.904 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.72 124.12 28.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.527 HD21 ' HD2' ' D' ' 33' ' ' LYS . 80.5 mt -122.52 129.72 52.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.405 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -74.38 114.95 13.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.52 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.62 HG12 ' HE3' ' D' ' 29' ' ' LYS . 15.8 m -135.28 170.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.187 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' GLU . . . . . 0.602 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.8 mt-10 -120.88 153.95 57.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.55 -38.38 94.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.866 1.71 . . . . 0.0 112.169 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -70.52 -21.77 62.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.818 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.65 144.11 56.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -87.89 168.59 12.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.85 -36.24 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.865 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tm-20 -59.36 -41.56 89.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -62.72 -41.34 99.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.732 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.517 HG21 HD21 ' D' ' 56' ' ' LEU . 78.4 t -64.26 -42.28 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.605 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -60.76 -39.25 88.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.983 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.82 91.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.971 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.62 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -59.88 -39.32 84.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.814 ' CD1' HD21 ' D' ' 43' ' ' LEU . 79.7 mt -64.57 -39.36 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.173 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.31 -39.7 83.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.863 0.363 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -68.14 -55.6 11.81 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.843 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.527 ' HD2' HD21 ' D' ' 15' ' ' LEU . 67.5 mttt -64.54 -40.67 96.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.096 0.474 . . . . 0.0 111.737 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.53 140.29 52.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.92 62.77 2.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.92 110.59 43.81 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.33 150.1 69.45 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.851 1.7 . . . . 0.0 110.739 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.77 -42.2 51.82 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.156 1.904 . . . . 0.0 112.87 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.63 -43.69 92.89 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.49 -41.76 99.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.046 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.651 ' HB2' HD11 ' D' ' 69' ' ' LEU . 26.3 pt20 -84.91 142.39 29.72 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.287 0.565 . . . . 0.0 111.378 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -137.34 109.29 7.16 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.306 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.814 HD21 ' CD1' ' D' ' 30' ' ' ILE . 83.3 mt -80.97 132.21 35.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.081 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 78.9 mt -131.38 128.88 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.672 ' HB3' HD21 ' D' ' 50' ' ' LEU . 62.1 t80 -147.78 153.93 39.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.858 0.361 . . . . 0.0 110.677 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.77 16.17 10.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.391 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.23 -7.93 76.19 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.577 ' HB3' HD22 ' A' ' 73' ' ' LEU . 17.4 ptm180 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 110.8 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -67.21 133.84 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.221 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' D' ' 45' ' ' PHE . 74.4 mt -73.85 104.49 4.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.291 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -75.84 153.05 37.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.75 154.43 41.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.72 20.96 64.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -130.43 140.02 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.355 . . . . 0.0 110.293 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -79.92 163.55 24.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.773 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.602 HD12 ' O ' ' D' ' 18' ' ' GLU . 74.4 mt -66.03 -38.18 87.76 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.866 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.58 -23.72 67.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.132 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.96 -30.1 71.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 110.447 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -101.86 12.88 36.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.342 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.92 34.08 23.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.255 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 71.9 mt -80.16 104.57 8.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -93.09 178.84 5.62 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.73 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -62.39 142.8 57.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.001 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.07 16.06 10.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.558 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -67.64 133.8 50.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.4 m -89.57 116.08 27.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.792 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.45 129.7 34.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.288 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.842 HD23 HG22 ' D' ' 7' ' ' THR . 64.2 tp -108.04 121.53 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.947 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 56' ' ' LEU . 93.0 t -109.71 129.09 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.619 ' H ' HD11 ' D' ' 8' ' ' LEU . 57.8 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.646 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.822 0.344 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.6 112.44 24.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.178 0.513 . . . . 0.0 109.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.2 mt -67.19 -37.34 83.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.793 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.432 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -149.55 162.07 4.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.813 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.46 122.47 0.36 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.179 0.514 . . . . 0.0 110.882 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.27 156.38 35.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.0 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HA ' HD12 ' A' ' 46' ' ' LEU . 90.9 mtm180 -75.91 123.7 26.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.472 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 145.62 22.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.401 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.93 149.67 16.74 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -92.49 174.93 7.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.016 0.436 . . . . 0.0 111.106 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.438 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 31.1 mtp -135.12 173.57 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.9 m -122.52 120.98 35.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 38' ' ' VAL . 28.2 tp -105.39 117.08 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.236 0.541 . . . . 0.0 110.244 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -122.05 116.9 25.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 -87.7 0.27 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.6 p -144.92 21.25 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.686 0.279 . . . . 0.0 110.799 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.502 ' O ' HD12 ' A' ' 33' ' ' LEU . 88.3 m -123.03 131.23 53.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 110.478 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 33' ' ' LEU . 64.7 t -109.75 123.31 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.045 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -116.76 137.07 23.41 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.249 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.77 146.57 54.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.776 1.651 . . . . 0.0 112.987 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -103.87 119.13 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.427 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.37 -16.2 53.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.46 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -70.25 82.72 0.54 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -62.32 136.41 57.91 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.398 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.1 -157.45 8.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.686 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -137.13 125.68 23.64 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.3 t -97.85 110.67 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -133.85 153.93 51.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.382 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.9 mt -119.27 137.75 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.232 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 130.35 34.61 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 123.624 0.578 . . . . 0.0 110.28 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.3 tt0 -101.09 123.76 45.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.895 0.379 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.49 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.7 p -83.2 172.17 12.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.704 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.89 -10.2 26.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.706 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.09 1.8 55.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.74 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 70.5 21.06 5.68 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 110.501 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.592 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 77.5 mt -97.74 120.72 38.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.521 HG21 HD23 ' A' ' 128' ' ' LEU . 50.8 mm -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.5 m-70 -97.66 113.8 25.62 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.662 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -97.01 106.74 19.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.53 147.34 49.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.856 0.836 . . . . 0.0 112.929 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -122.02 116.21 23.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.57 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -105.39 144.32 32.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.298 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.91 131.31 35.2 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -72.61 -16.3 61.73 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.837 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.65 -45.33 92.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.04 -14.15 10.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.172 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.62 74.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -102.23 152.49 20.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.9 102.27 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.152 0.501 . . . . 0.0 110.475 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.897 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -126.75 145.01 50.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.24 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.565 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.9 t0 -157.5 101.46 1.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.145 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' D' ' 48' ' ' ARG . 35.6 mt -127.4 136.14 51.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.966 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.19 122.59 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.401 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.714 HG21 ' SG ' ' A' ' 80' ' ' CYS . 28.2 mm -113.2 122.55 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.777 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.592 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 67.3 m-85 -87.23 162.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.518 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.95 140.61 92.67 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.006 1.804 . . . . 0.0 111.625 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t0 60.43 12.46 3.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.454 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.93 -21.85 23.38 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.039 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.714 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.7 p -148.77 169.07 21.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.396 0.617 . . . . 0.0 110.584 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -140.17 130.7 25.53 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.352 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -101.07 118.91 37.92 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -142.01 170.1 16.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.663 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.18 161.81 20.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -114.37 88.95 16.46 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.645 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.79 59.48 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.983 1.788 . . . . 0.0 112.105 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -115.41 -37.25 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.387 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 p -126.28 75.61 73.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.633 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.27 130.04 34.23 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.771 1.647 . . . . 0.0 111.196 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p 170.27 -41.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.13 -125.59 2.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.431 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -143.03 107.63 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.257 0.551 . . . . 0.0 110.384 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.62 132.49 70.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.595 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.99 155.5 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.45 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.25 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.027 0.441 . . . . 0.0 110.381 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.3 tp -101.15 121.92 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -119.19 133.05 55.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.091 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -83.43 115.48 22.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 0.0 109.678 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.77 -37.77 85.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.635 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.06 18.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.79 -179.91 26.55 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -115.25 18.03 16.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.704 0.288 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.738 ' HD3' HD21 ' A' ' 105' ' ' LEU . 19.9 ttmt -95.28 144.41 25.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.407 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.47 129.1 30.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.97 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.738 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.8 mt -114.68 148.34 38.36 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.771 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 33' ' ' LEU . 90.3 m-85 -122.58 136.81 54.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.213 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.84 154.46 50.51 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.397 0.617 . . . . 0.0 111.246 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -126.58 136.37 52.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.056 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 139.2 57.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.272 0.558 . . . . 0.0 111.301 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -2.01 11.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.066 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.55 139.0 54.8 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.933 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.89 -39.41 91.6 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.972 1.781 . . . . 0.0 112.372 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -112.02 143.79 42.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.3 p -94.29 1.86 55.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.857 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -57.54 -20.46 32.02 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.55 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -118.76 -16.18 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.49 -41.6 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.855 0.359 . . . . 0.0 110.569 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.75 -40.88 97.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.03 -40.38 90.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.486 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.752 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.7 m170 -62.52 -39.54 93.87 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.728 0.775 . . . . 0.0 109.15 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.76 -45.52 93.99 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.54 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -65.94 -41.88 90.73 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.525 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -63.27 -38.34 90.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.301 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -59.17 -47.94 88.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.153 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -80.02 -29.75 39.4 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.714 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.17 -37.85 81.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.517 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -81.36 -31.85 33.19 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.767 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.562 HD22 ' HB ' ' A' ' 75' ' ' ILE . 72.5 mt -81.36 -24.79 36.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -109.75 -23.63 11.31 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -137.37 68.32 54.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.931 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.86 160.82 48.17 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 C-N-CA 122.849 2.366 . . . . 0.0 112.283 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.311 -1.431 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 -179.583 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.31 127.84 93.51 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.319 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.31 141.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.836 1.691 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.43 151.16 55.76 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.61 158.49 53.49 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.429 2.086 . . . . 0.0 112.222 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.6 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.709 2.273 . . . . 0.0 112.027 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -120.82 158.59 51.71 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.498 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.15 140.7 87.61 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.564 2.176 . . . . 0.0 112.19 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.37 162.94 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -86.96 136.81 32.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.495 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -124.06 127.65 48.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.285 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 951' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.4 mp -130.3 126.74 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.249 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -77.11 83.76 3.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.726 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.636 179.537 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -79.51 162.08 25.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.4 pt -141.91 149.88 19.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -97.42 126.94 42.97 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.817 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -110.12 116.92 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.292 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -101.27 133.52 45.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.589 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.72 HG22 HD23 ' C' ' 69' ' ' LEU . 67.6 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 120.863 0.363 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 105.04 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.442 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 134.81 42.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.075 0.464 . . . . 0.0 110.366 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.727 HD21 ' HG3' ' C' ' 33' ' ' LYS . 62.4 mt -132.21 132.91 43.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.965 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.53 117.63 18.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.52 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.09 -178.7 2.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' GLU . . . . . 0.446 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.3 mt-10 -127.24 154.0 76.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.94 -27.83 85.78 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.016 1.811 . . . . 0.0 112.181 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.6 m -87.04 -10.04 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.692 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.69 142.94 58.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.023 0.44 . . . . 0.0 110.795 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -81.25 164.53 22.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.86 -38.83 83.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.988 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.71 -40.32 87.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.045 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.66 -42.97 99.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 0.0 110.393 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.556 HG21 HD21 ' C' ' 56' ' ' LEU . 62.1 t -61.64 -42.63 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.273 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.413 ' HG2' HD23 ' C' ' 43' ' ' LEU . 34.2 mtmt -59.89 -38.93 83.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.597 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -41.83 96.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.713 ' HB3' HD13 ' C' ' 15' ' ' LEU . 13.9 mttp -59.67 -38.47 81.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.617 HD11 HD11 ' C' ' 43' ' ' LEU . 96.5 mt -66.36 -39.54 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.816 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -58.66 -40.48 83.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.88 -41.62 71.1 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.417 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.727 ' HG3' HD21 ' C' ' 15' ' ' LEU . 4.3 mmtm -65.75 -41.18 92.43 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.93 156.93 47.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.969 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.21 59.02 2.77 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 35.1 mm -112.28 114.89 50.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.53 162.31 41.73 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.825 1.683 . . . . 0.0 112.001 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.97 -36.72 96.31 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.419 2.079 . . . . 0.0 112.804 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.28 -39.6 95.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.428 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -88.49 -13.95 39.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.74 86.32 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.66 107.55 19.4 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.757 ' HB3' HD12 ' C' ' 50' ' ' LEU . 4.6 mm? -99.48 118.47 36.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.421 . . . . 0.0 110.663 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 84.7 mt -129.06 129.7 67.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.583 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -117.55 121.83 42.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.577 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.4 14.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.14 80.52 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -90.58 121.42 32.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -69.01 132.27 46.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.757 HD12 ' HB3' ' C' ' 43' ' ' LEU . 56.2 mt -85.01 101.73 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.124 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.3 144.8 42.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.18 143.49 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.203 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.65 -19.23 55.2 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -83.12 169.39 15.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -119.82 164.69 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.819 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.556 HD21 HG21 ' C' ' 26' ' ' VAL . 81.1 mt -60.82 -40.56 93.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.6 -24.0 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.459 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.46 -37.67 84.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 110.476 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' TYR . . . . . 0.487 ' CE2' HD23 ' C' ' 50' ' ' LEU . 66.9 m-85 -97.99 15.41 24.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 57.51 40.45 27.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.346 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.53 107.61 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -96.52 179.09 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -58.16 149.12 24.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 57.82 40.58 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -94.67 123.13 37.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.007 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.487 ' O ' HD22 ' C' ' 67' ' ' LEU . 8.3 m -76.8 131.07 38.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.487 HD22 ' O ' ' C' ' 66' ' ' THR . 3.5 mm? -115.24 141.1 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.578 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -91.01 108.32 19.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.989 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.72 HD23 HG22 ' C' ' 7' ' ' THR . 64.9 tp -100.73 118.78 37.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.21 133.43 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.25 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.42 -178.506 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -58.13 159.84 5.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.169 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -139.69 141.4 34.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.349 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 4' ' ' PHE . . . . . 0.579 ' HD2' HG21 ' D' ' 12' ' ' THR . 3.9 m-85 -83.93 123.8 30.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.529 ' CG1' HD12 ' D' ' 69' ' ' LEU . 81.4 t -109.78 103.75 15.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.5 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -94.45 122.91 37.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.841 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -82.71 179.36 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.129 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.502 HD11 ' H ' ' D' ' 71' ' ' LEU . 79.6 mt -62.87 -35.48 80.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.085 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -67.01 -14.92 63.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.792 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.05 59.13 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.55 131.01 47.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.275 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' THR . . . . . 0.579 HG21 ' HD2' ' D' ' 4' ' ' PHE . 97.7 m -104.15 132.59 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.806 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.401 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.2 mt -127.16 107.14 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.872 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -81.85 127.67 33.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.606 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.4 mt -123.16 126.36 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.8 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -66.1 113.88 4.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.446 HG12 ' CD ' ' D' ' 29' ' ' LYS . 20.3 m -135.62 162.63 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.131 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.42 152.75 40.69 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.09 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.65 -37.24 91.22 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.988 1.792 . . . . 0.0 111.956 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -81.16 -8.64 59.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -57.92 138.1 56.11 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.014 0.435 . . . . 0.0 110.991 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -80.37 162.87 24.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.12 -39.34 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.071 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.5 -39.89 89.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -62.45 -42.67 99.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.112 0.482 . . . . 0.0 110.477 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.28 -42.71 96.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.655 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.461 ' HG2' HD11 ' D' ' 43' ' ' LEU . 56.9 mtmt -60.23 -39.76 87.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.323 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.65 92.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.488 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.446 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -60.16 -38.83 84.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' ILE . . . . . 0.646 HD13 HD11 ' D' ' 69' ' ' LEU . 97.2 mt -64.71 -39.69 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.701 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.68 -40.94 93.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.17 -40.29 97.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.606 ' HD2' HD21 ' D' ' 15' ' ' LEU . 59.4 mttt -78.59 -71.41 0.43 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.892 0.377 . . . . 0.0 111.007 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.32 166.64 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.086 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.5 21.77 23.92 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' ILE . . . . . 0.566 HG22 ' HG3' ' D' ' 41' ' ' GLN . 27.1 mm -78.08 119.3 76.85 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.367 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.45 161.95 42.81 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.173 1.915 . . . . 0.0 111.538 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.12 -37.51 87.15 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.236 1.957 . . . . 0.0 112.479 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.3 -42.75 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.348 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -82.8 -12.52 57.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.566 ' HG3' HG22 ' D' ' 36' ' ' ILE . 79.4 mt-30 -80.86 80.57 7.31 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -97.8 94.59 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.687 ' HB2' HD12 ' D' ' 50' ' ' LEU . 11.9 mt -85.15 129.67 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.596 HG23 ' HA ' ' D' ' 49' ' ' GLN . 49.1 mt -129.1 130.18 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.376 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.644 ' HB3' HD21 ' D' ' 50' ' ' LEU . 68.2 t80 -148.45 154.75 40.3 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.832 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 70.0 22.25 5.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.757 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 -2.24 77.62 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.529 ' HB3' HD22 ' A' ' 73' ' ' LEU . 5.3 ptm180 -132.26 150.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.08 0.467 . . . . 0.0 110.47 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 49' ' ' GLN . . . . . 0.596 ' HA ' HG23 ' D' ' 44' ' ' ILE . 21.1 pt20 -65.13 148.5 51.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.566 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' D' ' 43' ' ' LEU . 81.0 mt -84.88 109.44 18.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.82 151.8 37.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.201 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -74.9 167.93 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.221 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.51 24.58 76.1 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -129.3 169.29 15.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.821 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.4 p -115.53 164.63 14.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.452 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.82 -39.66 95.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.7 p -62.72 -28.49 69.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.07 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.49 -35.97 79.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.025 0.441 . . . . 0.0 110.158 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -94.92 12.04 29.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.224 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 56.21 39.6 30.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.143 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.48 112.83 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -97.11 177.18 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.531 0.681 . . . . 0.0 111.133 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -61.7 142.58 57.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.121 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 65.13 18.61 11.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 65' ' ' SER . . . . . 0.427 ' O ' HD12 ' D' ' 67' ' ' LEU . 32.0 m -70.55 130.79 42.78 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.94 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -82.32 126.3 31.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 67' ' ' LEU . . . . . 0.581 HD23 HD11 ' D' ' 50' ' ' LEU . 5.6 mp -117.09 142.85 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.06 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -89.19 117.67 28.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.232 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.646 HD11 HD13 ' D' ' 30' ' ' ILE . 0.4 OUTLIER -97.7 100.26 11.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.31 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.68 128.83 38.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.502 ' H ' HD11 ' D' ' 8' ' ' LEU . 75.6 mt . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -89.28 126.94 35.72 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.366 0.603 . . . . 0.0 110.208 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' ILE . 83.4 mt -67.35 -38.46 84.87 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.878 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG11 HG22 ' A' ' 124' ' ' VAL . 0.9 OUTLIER -147.48 161.99 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 179.494 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -173.06 122.14 0.39 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.048 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -153.51 153.16 31.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.68 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.608 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -70.51 123.38 21.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.572 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.59 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -153.46 145.69 23.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.266 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.15 151.74 17.69 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -89.25 172.61 8.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.419 . . . . 0.0 110.99 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 33.3 mtp -136.41 170.47 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.632 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.9 m -120.8 121.31 37.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 37' ' ' THR . 22.0 tp -104.57 118.26 36.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.639 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.55 107.23 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.743 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 -92.88 0.61 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.4 p -135.13 19.84 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.942 -0.152 . . . . 0.0 110.972 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.551 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.6 m -121.52 130.94 53.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.838 0.351 . . . . 0.0 110.369 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.476 ' CG2' HD13 ' A' ' 33' ' ' LEU . 76.8 t -112.31 124.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.194 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -116.51 136.15 23.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 147.18 45.46 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.956 1.771 . . . . 0.0 112.918 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -101.94 122.31 43.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.635 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -65.3 -11.34 40.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.762 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -73.8 78.79 1.58 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -55.47 137.36 48.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.86 -159.49 8.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.312 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.1 tp -139.09 124.43 19.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 28' ' ' ALA . 55.4 t -96.91 109.62 23.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.454 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 39.5 p90 -132.72 154.52 50.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.905 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 23' ' ' LEU . 84.5 mt -120.8 141.77 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.625 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -142.85 140.95 31.48 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 123.75 0.657 . . . . 0.0 110.048 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -104.43 127.43 52.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.975 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 58' ' ' HIS . 27.9 p -87.67 173.95 8.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.77 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.69 -11.08 22.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.822 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.21 -1.24 57.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.399 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.97 19.88 6.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 110.529 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.76 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 54.9 mt -101.96 128.79 48.22 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 131' ' ' PRO . 51.5 mm -82.21 127.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.527 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.4 m-70 -104.99 114.82 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.112 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.578 ' CB ' HD13 ' A' ' 75' ' ' ILE . 59.9 t80 -89.57 107.77 19.27 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 95.0 m -119.36 140.8 49.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -121.59 114.08 20.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.187 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -105.99 147.61 28.65 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.348 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -79.8 137.19 36.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.737 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -76.55 -21.1 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.3 m -60.14 -45.17 93.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -116.48 -12.17 11.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.492 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.4 77.12 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.01 146.29 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.17 105.93 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.174 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -84.0 -31.55 25.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.832 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -128.12 147.92 50.56 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.392 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.572 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.1 p-10 -158.7 99.14 1.55 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 72' ' ' ASP . 38.5 mt -126.7 134.53 50.66 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.645 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.586 ' C ' HD12 ' A' ' 75' ' ' ILE . 97.3 mt -79.12 129.22 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.136 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.586 HD12 ' C ' ' A' ' 74' ' ' ILE . 1.9 mp -117.28 117.14 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.841 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.76 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 52.4 m-85 -83.4 163.56 49.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.28 137.97 78.39 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.736 1.624 . . . . 0.0 111.003 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 58.25 14.29 2.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -90.02 -40.81 12.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.462 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -128.06 147.91 50.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.864 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.6 tp10 -121.34 129.68 53.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.254 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.03 117.63 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.1 167.97 20.83 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.629 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -82.38 160.83 22.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.865 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.93 90.44 13.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.145 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.35 59.83 7.6 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.069 1.846 . . . . 0.0 112.342 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.12 -39.8 3.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.371 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 36.9 t -127.89 81.09 70.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.11 130.55 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.804 1.669 . . . . 0.0 111.528 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p 170.27 -39.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.887 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.7 -146.07 5.01 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.418 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.38 106.96 13.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.43 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -126.62 129.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.22 154.14 43.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.325 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -130.19 135.99 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 110.349 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.4 tp -104.65 118.29 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -117.45 131.2 56.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.194 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 59.9 m-85 -86.84 114.81 23.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -31.6 70.93 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.449 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.93 -21.98 11.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -71.98 -23.25 78.26 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.827 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.79 12.24 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.563 0.22 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.81 155.81 30.52 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.797 0.332 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 143.78 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.747 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 95' ' ' VAL . 57.8 mt -120.21 151.98 38.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.522 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 31' ' ' MET . 98.1 m-85 -121.28 134.23 55.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.69 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.62 158.14 44.62 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.0 111.148 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -132.73 138.71 47.31 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.893 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.408 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 52.2 tpp -70.5 132.75 46.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.766 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.72 1.81 14.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.426 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 109' ' ' MET . 88.6 mt-10 -66.34 146.48 99.04 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.04 -40.47 84.74 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.923 1.748 . . . . 0.0 112.659 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -122.98 146.61 47.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.3 p -96.88 11.96 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -59.72 -21.46 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.368 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -116.63 6.32 13.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.95 -46.79 87.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.86 -40.88 97.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.042 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.06 -43.66 94.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.695 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.698 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.2 m170 -64.65 -40.97 96.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.755 0.788 . . . . 0.0 109.535 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.5 t -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.874 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 tpp85 -67.51 -42.33 83.0 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.44 -41.39 98.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.244 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.7 t -58.34 -47.77 86.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.15 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -63.93 -38.2 90.22 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.575 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.47 -29.46 63.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.219 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -83.01 -29.77 28.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.502 HD22 ' HB ' ' A' ' 75' ' ' ILE . 81.4 mt -89.23 -20.64 23.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.5 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -111.39 -23.99 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.154 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -134.51 72.45 69.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.434 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.4 Cg_exo -59.83 150.83 75.24 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.744 2.296 . . . . 0.0 112.081 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 122.402 2.068 . . . . 0.0 112.088 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -71.18 149.38 94.37 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.692 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.02 150.32 29.63 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.182 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -81.91 153.47 69.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.166 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 158.96 53.65 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.413 2.075 . . . . 0.0 112.144 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.31 -169.27 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.783 2.322 . . . . 0.0 112.027 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -120.06 159.83 45.52 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.349 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.53 143.98 86.19 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.92 164.73 38.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -86.22 134.95 33.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -120.29 132.62 55.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.349 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.11 130.61 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.45 85.22 3.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.158 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.406 179.696 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.92 164.89 9.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.6 pt -144.35 141.05 24.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.193 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 4' ' ' PHE . . . . . 0.477 ' HD2' HG21 ' C' ' 12' ' ' THR . 7.8 m-85 -86.12 123.85 31.88 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.847 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.07 116.83 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -95.08 121.74 37.01 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.757 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 7' ' ' THR . . . . . 0.556 HG22 HD23 ' C' ' 69' ' ' LEU . 81.9 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.22 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 12' ' ' THR . . . . . 0.477 HG21 ' HD2' ' C' ' 4' ' ' PHE . 97.5 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.43 HG21 ' HG2' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -125.66 110.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.841 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.0 m -81.31 130.15 34.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.092 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.626 HD21 ' CD ' ' C' ' 33' ' ' LYS . 70.0 mt -122.32 131.41 53.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.701 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -71.94 116.03 11.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 110.729 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.489 HG12 ' CD ' ' C' ' 29' ' ' LYS . 20.3 m -136.08 164.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.394 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -105.33 153.22 39.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.223 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.41 -34.91 95.67 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.081 1.854 . . . . 0.0 112.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.53 -2.19 58.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.42 136.66 58.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 110.737 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 59.8 p -78.59 163.07 25.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.931 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' ILE . . . . . 1.002 HD12 HD23 ' C' ' 50' ' ' LEU . 40.3 mm -64.84 -41.27 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.429 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -58.16 -36.81 73.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.996 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.08 -41.76 94.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.382 0.611 . . . . 0.0 110.826 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.559 HG12 HD21 ' C' ' 43' ' ' LEU . 70.5 t -64.24 -42.27 94.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.588 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 27' ' ' LYS . . . . . 0.497 ' HG2' HD13 ' C' ' 43' ' ' LEU . 56.4 mtmt -60.82 -39.72 90.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.315 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.16 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.043 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' LYS . . . . . 0.489 ' CD ' HG12 ' C' ' 17' ' ' VAL . 67.3 mttm -60.31 -39.17 86.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' ILE . . . . . 0.486 HD12 HD11 ' C' ' 43' ' ' LEU . 91.4 mt -65.15 -40.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.179 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -59.75 -41.11 90.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.326 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -40.47 96.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.153 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.626 ' CD ' HD21 ' C' ' 15' ' ' LEU . 0.0 OUTLIER -71.88 -63.7 1.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.47 -178.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -107.05 159.66 16.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.893 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.23 55.25 3.99 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' ILE . . . . . 0.462 HG23 HD22 ' C' ' 71' ' ' LEU . 33.8 mm -107.91 121.01 45.28 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.56 159.94 47.75 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.651 1.568 . . . . 0.0 111.868 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.93 -39.08 94.07 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.186 1.924 . . . . 0.0 112.47 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -61.48 -50.22 73.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -67.63 -39.69 84.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.692 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.2 96.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.279 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' ARG . . . . . 0.594 ' NE ' HD11 ' C' ' 44' ' ' ILE . 76.9 ttt180 -104.24 110.75 23.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.559 HD21 HG12 ' C' ' 26' ' ' VAL . 7.2 mp -92.68 117.91 30.49 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' ILE . . . . . 0.594 HD11 ' NE ' ' C' ' 42' ' ' ARG . 92.4 mt -130.06 128.36 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -127.9 128.87 45.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.662 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 25.62 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.527 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.28 1.63 90.12 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.17 123.14 46.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -66.95 134.08 51.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.222 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 1.002 HD23 HD12 ' C' ' 23' ' ' ILE . 9.7 mp -87.25 102.27 14.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.344 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -74.21 146.17 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.912 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.67 144.93 53.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.536 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.15 -15.38 63.3 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -83.22 168.09 17.08 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 56.9 p -116.45 161.76 18.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.447 HD21 HG21 ' C' ' 26' ' ' VAL . 83.0 mt -61.74 -40.36 94.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.959 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.19 -24.68 67.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -62.78 -37.78 88.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.145 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -95.59 14.15 23.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.165 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.93 41.77 27.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.419 . . . . 0.0 110.171 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ILE . . . . . 0.547 HD11 HD21 ' C' ' 50' ' ' LEU . 86.2 mt -91.87 106.16 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.667 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -92.51 -173.77 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.961 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.63 144.78 56.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.221 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 63.64 13.07 7.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.075 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -65.6 132.78 49.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' THR . . . . . 0.629 ' C ' HD12 ' C' ' 67' ' ' LEU . 56.6 m -85.02 127.67 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 67' ' ' LEU . . . . . 0.629 HD12 ' C ' ' C' ' 66' ' ' THR . 10.2 mp -119.39 140.38 50.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -86.15 123.72 31.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.171 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 69' ' ' LEU . . . . . 0.556 HD23 HG22 ' C' ' 7' ' ' THR . 66.5 tp -109.33 120.1 41.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.626 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.83 131.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' LEU . . . . . 0.462 HD22 HG23 ' C' ' 36' ' ' ILE . 18.9 mt . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.591 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.02 162.59 16.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 3' ' ' ILE . . . . . 0.472 HG22 ' HB3' ' D' ' 65' ' ' SER . 7.9 pt -141.17 146.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.942 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -90.58 101.14 13.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.686 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -87.75 101.03 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 132.65 41.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -64.45 -150.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.04 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.551 HD21 ' H ' ' D' ' 71' ' ' LEU . 83.8 mt -59.85 -40.01 87.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.589 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 9' ' ' THR . . . . . 0.452 HG22 ' C ' ' D' ' 8' ' ' LEU . 0.0 OUTLIER 179.96 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.123 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.46 -89.35 0.44 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.096 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.36 139.88 14.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.887 0.375 . . . . 0.0 110.762 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -126.43 137.78 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.833 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.537 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.5 mt -121.65 111.7 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -85.78 125.78 33.51 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.126 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -122.63 130.42 52.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.56 115.97 13.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.589 HG12 ' HE3' ' D' ' 29' ' ' LYS . 21.2 m -133.65 166.3 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.616 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.46 152.66 44.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.893 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.7 -27.28 82.82 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.76 1.64 . . . . 0.0 111.765 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -87.36 -11.42 49.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.37 142.19 58.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 57.4 p -82.32 165.41 20.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' ILE . . . . . 0.567 HD12 HD13 ' D' ' 50' ' ' LEU . 49.9 mm -62.42 -38.75 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.8 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.29 -41.41 88.86 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -60.86 -42.82 98.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.569 . . . . 0.0 110.375 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -41.39 90.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.933 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' LYS . . . . . 0.486 ' HG2' HD11 ' D' ' 43' ' ' LEU . 56.2 mtmt -60.5 -40.09 90.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.36 91.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.393 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' LYS . . . . . 0.589 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -59.78 -38.33 81.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.79 -39.73 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.371 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.66 -43.95 97.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.31 -20.15 62.23 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.985 -0.447 . . . . 0.0 111.871 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.537 ' HD2' HG22 ' D' ' 13' ' ' ILE . 6.8 mttm -102.9 -7.67 21.34 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -141.32 -43.8 0.37 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.252 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.16 14.92 10.3 Favored Glycine 0 C--N 1.321 -0.268 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.038 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -88.79 117.64 68.5 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.622 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.32 172.67 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.961 1.774 . . . . 0.0 111.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.67 -27.13 18.87 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.494 2.129 . . . . 0.0 111.763 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -100.24 -176.15 3.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.837 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 64.94 16.9 10.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.539 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 41' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' D' ' 69' ' ' LEU . 14.4 pt20 -157.2 159.15 37.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.777 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -147.27 131.32 17.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.486 HD11 ' HG2' ' D' ' 27' ' ' LYS . 22.4 mt -100.49 114.52 28.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 44' ' ' ILE . . . . . 0.417 HD12 ' HZ ' ' A' ' 76' ' ' PHE . 77.0 mt -118.71 130.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.61 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 90.1 t80 -142.38 149.23 39.1 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.984 0.421 . . . . 0.0 111.192 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.25 15.78 10.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.14 64.23 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' ARG . . . . . 0.655 ' HB3' HD22 ' A' ' 73' ' ' LEU . 38.2 ptt180 -114.62 142.34 46.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.102 0.477 . . . . 0.0 110.534 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -69.51 146.14 52.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.24 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.567 HD13 HD12 ' D' ' 23' ' ' ILE . 83.2 mt -84.32 115.66 22.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.477 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.23 138.81 42.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -60.13 147.93 37.83 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.77 68.13 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -84.08 167.77 16.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.776 0.288 . . . . 0.0 110.607 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -114.07 159.44 20.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.025 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.21 -39.89 94.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.714 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -63.61 -24.13 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -63.09 -38.1 89.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.079 0.466 . . . . 0.0 110.234 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' TYR . . . . . 0.407 ' CE2' HD23 ' D' ' 50' ' ' LEU . 63.5 m-85 -96.12 12.73 29.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.206 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.45 41.37 26.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.326 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.04 103.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -90.55 179.33 5.87 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.239 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -61.74 150.7 36.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.987 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 60.07 31.3 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 65' ' ' SER . . . . . 0.472 ' HB3' HG22 ' D' ' 3' ' ' ILE . 18.4 t -86.57 125.88 34.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.919 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 123.22 26.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.05 149.72 31.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.815 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -99.13 117.76 34.33 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.626 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 69' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' D' ' 41' ' ' GLN . 61.4 tp -100.69 112.73 25.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.904 HG11 HD11 ' A' ' 56' ' ' LEU . 66.7 t -112.6 123.52 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 71' ' ' LEU . . . . . 0.551 ' H ' HD21 ' D' ' 8' ' ' LEU . 61.4 mt . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.759 0.314 . . . . 0.0 110.534 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -94.82 125.17 39.31 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.452 0.644 . . . . 0.0 110.419 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 51' ' ' GLN . 92.4 mt -68.87 -36.54 78.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.304 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.95 160.78 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.729 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -172.84 122.73 0.42 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.0 158.98 38.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.1 mtm-85 -77.35 119.57 21.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.831 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.21 146.05 25.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.395 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.25 150.88 16.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -89.3 162.15 15.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.07 0.462 . . . . 0.0 111.031 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.496 ' HE3' HG12 ' A' ' 38' ' ' VAL . 1.2 mtm -133.23 168.54 18.36 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -121.75 134.24 54.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.653 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD13 HG22 ' A' ' 38' ' ' VAL . 25.3 tp -115.42 118.96 34.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -123.8 120.76 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.926 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.0 -85.79 0.22 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.32 22.56 0.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.752 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.569 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.7 m -123.77 128.73 49.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.946 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.706 HG22 HD13 ' A' ' 33' ' ' LEU . 40.4 t -107.89 119.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.822 HG22 ' HB3' ' B' ' 947' ' ' PRO . 22.0 p -114.3 135.31 22.19 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.656 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.74 149.25 37.71 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.064 1.843 . . . . 0.0 112.856 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -105.53 142.91 34.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -80.61 -7.97 59.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -72.3 75.87 1.0 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -57.38 135.23 56.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.295 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.68 -159.15 8.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.5 tp -137.3 125.71 23.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.53 109.14 23.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.55 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 38.8 p90 -132.44 153.97 50.32 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.4 139.85 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.458 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 128.81 29.91 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 123.922 0.764 . . . . 0.0 110.736 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.667 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.1 tt0 -99.29 124.23 44.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' CD2' ' A' ' 58' ' ' HIS . 13.7 p -85.11 170.74 12.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.414 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.03 -10.73 15.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.71 0.53 55.59 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.556 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.81 20.45 6.77 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.225 0.536 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HG11 ' D' ' 70' ' ' VAL . 75.9 mt -99.56 121.94 41.91 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.512 HG21 HD23 ' A' ' 128' ' ' LEU . 50.5 mm -79.32 124.83 38.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.495 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.497 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.0 m-70 -100.32 115.42 29.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.833 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.08 108.29 20.38 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -121.61 143.7 49.17 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.787 0.804 . . . . 0.0 112.836 -177.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -124.86 114.42 19.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.025 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -104.93 144.13 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.419 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -80.8 131.5 35.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -72.29 -18.43 61.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.899 0.381 . . . . 0.0 110.786 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.7 m -59.54 -45.43 91.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.649 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -117.09 -13.46 10.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.446 . . . . 0.0 110.32 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.36 23.73 74.89 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -102.15 152.16 21.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.82 102.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -76.16 -35.01 59.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.12 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -125.59 147.07 49.42 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.725 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.5 t0 -157.81 98.88 1.67 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' D' ' 48' ' ' ARG . 40.1 mt -128.9 133.04 47.76 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.901 0.382 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.09 124.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.913 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.525 ' HB ' HD22 ' A' ' 128' ' ' LEU . 25.5 mm -111.37 128.15 68.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.076 0.465 . . . . 0.0 110.62 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.417 ' HZ ' HD12 ' D' ' 44' ' ' ILE . 66.4 m-85 -93.04 162.17 29.3 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.364 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.56 140.2 89.3 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.931 1.754 . . . . 0.0 111.362 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 59.52 13.2 3.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.249 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -87.28 -37.79 16.87 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-O 120.872 0.368 . . . . 0.0 110.415 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.597 ' HB3' HD11 ' A' ' 96' ' ' LEU . 81.8 m -131.75 153.41 50.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.261 0.553 . . . . 0.0 111.653 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -125.5 129.49 49.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -103.57 117.45 34.44 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.04 166.39 24.83 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.602 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -83.73 160.11 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.987 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.93 90.26 12.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.51 60.65 7.65 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.049 1.832 . . . . 0.0 112.31 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -114.01 -37.97 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.328 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.0 t -132.3 76.25 72.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.72 130.57 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.278 1.985 . . . . 0.0 111.435 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.83 -42.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.055 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.27 -149.72 6.18 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.408 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.26 105.68 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.0 t -125.19 127.71 72.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.13 152.23 46.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.2 p -128.35 137.85 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.457 . . . . 0.0 110.228 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 80' ' ' CYS . 59.4 tp -102.33 120.22 40.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -118.47 134.86 54.73 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.49 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -84.36 117.03 23.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -61.24 -37.54 83.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.744 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -100.42 -10.28 21.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.728 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.83 152.92 17.15 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -93.18 22.02 5.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.331 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HD3' HD21 ' A' ' 105' ' ' LEU . 1.2 tmmm? -118.33 144.85 45.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.912 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.421 ' O ' HD23 ' A' ' 105' ' ' LEU . 33.7 ptt180 -139.72 152.79 46.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.958 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 95' ' ' VAL . 36.1 mt -121.58 159.39 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.252 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.502 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 87.9 m-85 -126.12 137.54 53.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.42 161.24 38.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.353 0.597 . . . . 0.0 111.088 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.76 140.56 40.7 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.637 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.9 mmm -72.77 139.1 46.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.143 0.497 . . . . 0.0 110.788 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.94 4.27 15.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.844 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.96 147.49 93.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.49 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.94 -38.93 65.25 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.812 1.674 . . . . 0.0 112.223 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -118.81 145.76 45.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.148 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.0 p -91.9 1.25 57.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.972 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.24 -19.79 48.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.364 0.415 . . . . 0.0 110.151 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.86 -17.42 10.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.29 -41.49 97.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.503 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.64 -41.06 98.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.388 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.92 -41.77 90.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.531 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.732 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.5 m170 -63.82 -39.91 95.36 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.698 0.761 . . . . 0.0 109.196 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m -62.41 -42.35 99.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.641 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -65.22 -43.96 89.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -61.88 -37.72 85.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.025 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.5 t -58.35 -48.76 84.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.24 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.54 -27.83 41.3 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.904 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.88 -37.99 79.39 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.482 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -80.91 -31.78 34.97 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.753 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.525 HD22 ' HB ' ' A' ' 75' ' ' ILE . 59.6 mt -82.16 -20.57 37.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -114.13 -17.36 11.93 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.116 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -146.56 72.88 12.82 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.753 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 160.95 45.42 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 123.03 2.487 . . . . 0.0 112.139 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.495 1.579 0 C-N-CA 122.651 2.234 . . . . 0.0 112.377 -179.556 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 50.12 71.89 1.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.83 144.09 99.51 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.913 2.408 . . . . 0.0 112.15 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.89 154.66 92.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.77 150.2 88.99 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.332 2.021 . . . . 0.0 111.824 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.5 -169.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.237 1.958 . . . . 0.0 112.319 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.04 154.86 76.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 947' ' ' PRO . . . . . 0.822 ' HB3' HG22 ' A' ' 39' ' ' THR . 33.1 Cg_endo -63.86 143.32 85.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.252 1.968 . . . . 0.0 112.124 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -156.79 164.81 37.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.701 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -88.05 133.33 34.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -121.49 125.88 47.9 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.311 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.4 mp -129.83 120.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.506 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -81.53 83.71 6.93 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.962 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.583 179.458 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -63.2 158.77 19.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.558 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.27 149.76 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.166 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' C' ' 14' ' ' THR . 13.3 m-30 -91.82 124.31 35.86 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.697 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -108.64 114.09 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -91.55 123.86 35.28 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.308 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.71 HG22 HD23 ' C' ' 69' ' ' LEU . 67.3 p -84.28 174.86 9.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 111.101 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.746 HD11 ' H ' ' C' ' 71' ' ' LEU . 86.8 mt -60.88 -38.56 86.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.35 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -72.84 -8.98 58.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.85 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.63 -10.65 64.74 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -63.58 126.5 27.74 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -98.87 133.61 42.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.99 0.424 . . . . 0.0 110.786 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.25 106.37 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.402 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' THR . . . . . 0.416 HG23 ' CD2' ' C' ' 4' ' ' PHE . 22.0 m -74.92 129.17 37.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.3 126.31 47.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.473 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.11 112.97 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.503 HG12 ' HE3' ' C' ' 29' ' ' LYS . 31.0 m -134.22 161.68 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.72 154.26 38.67 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.079 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.65 -36.74 98.39 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.151 1.901 . . . . 0.0 112.272 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.01 0.13 55.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -62.36 136.64 58.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 63.2 p -78.59 163.47 25.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.96 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.633 HD12 HD23 ' C' ' 50' ' ' LEU . 46.3 mm -64.66 -37.7 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tm-20 -59.03 -42.17 89.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.914 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.89 -41.33 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 110.736 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.68 -42.99 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -60.87 -39.4 89.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.11 93.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.099 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.503 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.6 mttm -60.42 -39.95 89.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.744 ' CD1' HD21 ' C' ' 43' ' ' LEU . 91.2 mt -64.69 -42.18 94.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.138 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.71 -39.73 89.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.85 7.34 15.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.412 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -115.83 -44.42 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.87 1.18 13.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.419 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.47 20.11 78.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.522 HG21 ' HB3' ' C' ' 41' ' ' GLN . 17.9 mm -79.83 120.87 81.35 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.05 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.1 150.7 54.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.72 1.614 . . . . 0.0 111.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -24.51 29.58 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -93.26 22.27 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.222 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -152.92 52.14 0.75 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 111.062 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.522 ' HB3' HG21 ' C' ' 36' ' ' ILE . 2.3 pt20 -172.71 140.65 1.01 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.084 0.469 . . . . 0.0 110.856 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.93 128.47 43.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.254 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.744 HD21 ' CD1' ' C' ' 30' ' ' ILE . 64.0 mt -104.38 119.68 39.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.98 128.45 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.416 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -129.78 130.25 45.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.004 0.431 . . . . 0.0 111.002 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.36 16.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.603 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 2.17 89.87 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.703 ' HE3' HD22 ' D' ' 73' ' ' LEU . 57.0 mtpt -104.64 125.78 51.09 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.88 0.34 . . . . 0.0 110.227 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -72.16 132.16 43.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.633 HD23 HD12 ' C' ' 23' ' ' ILE . 8.2 mp -83.07 95.43 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.106 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.62 148.13 41.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.858 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -62.83 138.62 58.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 -18.31 54.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -84.24 177.5 8.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.14 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 64.7 p -126.3 165.76 18.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.38 -40.03 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.275 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -63.52 -28.28 69.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.55 -29.99 70.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.044 0.45 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.08 15.21 29.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 55.54 43.22 28.78 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.906 0.384 . . . . 0.0 110.251 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.38 109.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.045 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -97.55 -175.5 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.403 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -64.54 149.77 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.052 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 56.71 42.22 27.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.88 0.372 . . . . 0.0 110.903 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 53.6 m -100.02 127.53 46.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.099 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 89.1 m -77.24 127.67 33.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.68 142.24 47.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -85.99 117.77 25.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.27 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.71 HD23 HG22 ' C' ' 7' ' ' THR . 55.1 tp -106.46 123.56 48.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.633 ' HA ' HD21 ' C' ' 8' ' ' LEU . 88.9 t -121.69 131.97 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.55 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.746 ' H ' HD11 ' C' ' 8' ' ' LEU . 31.2 mt -105.44 142.71 34.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.53 88.14 4.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.268 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 64.7 tp -64.62 -46.17 83.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.861 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -63.04 -38.86 92.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.901 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.69 13.76 80.93 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.34 -131.81 52.24 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.411 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -62.93 161.4 12.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.435 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.488 ' HB ' HD13 ' D' ' 67' ' ' LEU . 18.1 pt -143.93 139.13 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.061 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.529 ' HD2' HG21 ' D' ' 12' ' ' THR . 9.5 m-85 -85.66 120.16 26.79 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.948 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.78 108.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.65 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.51 120.43 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.691 HG22 HD23 ' D' ' 69' ' ' LEU . 82.0 p -80.78 170.76 15.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.774 HD11 ' H ' ' D' ' 71' ' ' LEU . 68.6 mt -65.78 -22.5 66.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.154 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -87.58 -0.54 56.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.72 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.86 79.12 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -68.7 115.85 8.54 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.529 HG21 ' HD2' ' D' ' 4' ' ' PHE . 94.9 m -92.69 137.79 32.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.022 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.75 105.72 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 12.9 m -80.92 125.62 30.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.446 HD21 ' HD2' ' D' ' 33' ' ' LYS . 66.9 mt -122.32 123.47 41.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.17 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -65.79 108.84 2.25 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.672 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 24.2 m -132.45 163.66 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.717 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' GLU . . . . . 0.461 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.4 mt-10 -108.98 149.79 40.08 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.01 -0.366 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -42.47 65.26 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.851 1.701 . . . . 0.0 112.368 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -68.72 -19.77 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.245 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -58.0 136.7 57.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.384 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -79.62 166.2 22.12 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.849 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.877 HD12 HD13 ' D' ' 50' ' ' LEU . 48.9 mm -66.25 -37.13 79.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.8 -44.27 86.22 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.65 -41.09 98.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 110.651 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.0 -41.87 94.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -60.3 -40.64 91.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.18 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.305 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.672 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 98.6 mttt -59.82 -38.77 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.777 ' CD1' HD21 ' D' ' 43' ' ' LEU . 81.3 mt -64.8 -39.4 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.859 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' D' ' 35' ' ' GLY . 64.8 tt0 -59.83 -44.81 93.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.261 0.553 . . . . 0.0 109.946 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -65.99 -35.05 79.53 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.815 -0.553 . . . . 0.0 111.159 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.446 ' HD2' HD21 ' D' ' 15' ' ' LEU . 18.4 mttt -88.94 -4.02 58.57 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -147.61 -53.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.277 0.561 . . . . 0.0 110.467 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 117.22 13.51 7.59 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.561 HD13 HD21 ' D' ' 71' ' ' LEU . 33.6 mt -83.69 119.88 74.36 Favored Pre-proline 0 N--CA 1.447 -0.606 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.346 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.88 164.03 34.32 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.865 1.71 . . . . 0.0 111.338 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.25 -34.15 94.1 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.466 2.111 . . . . 0.0 112.666 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -92.52 -17.29 24.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.955 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.642 ' OE1' HD12 ' D' ' 30' ' ' ILE . 5.1 tt0 -96.05 131.17 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.467 . . . . 0.0 111.522 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -133.9 103.18 5.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.83 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.777 HD21 ' CD1' ' D' ' 30' ' ' ILE . 81.3 mt -83.6 129.85 34.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.054 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' D' ' 49' ' ' GLN . 66.4 mt -129.33 130.94 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.68 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 78.5 t80 -150.59 155.62 39.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.741 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.45 20.62 7.17 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.545 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.91 -3.19 77.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.409 ' HB3' HD22 ' A' ' 73' ' ' LEU . 38.7 ptt180 -129.21 147.68 51.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.083 0.468 . . . . 0.0 110.73 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.491 ' HA ' HG23 ' D' ' 44' ' ' ILE . 18.7 pt20 -69.86 140.67 53.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.351 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.877 HD13 HD12 ' D' ' 23' ' ' ILE . 81.7 mt -73.48 144.91 46.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.33 -82.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.268 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 177.38 -72.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 110.572 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.14 -18.51 69.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -59.46 155.05 15.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.986 0.422 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -96.44 164.97 12.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.153 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.461 HD12 ' O ' ' D' ' 18' ' ' GLU . 81.7 mt -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -63.05 -23.91 67.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.405 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.47 -38.26 86.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.026 0.441 . . . . 0.0 110.354 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' TYR . . . . . 0.442 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.0 m-85 -97.49 15.25 23.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.192 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 56.34 39.11 30.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.247 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.68 103.7 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.786 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.32 178.76 5.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.0 110.824 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -61.8 150.04 38.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.906 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 59.67 17.94 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.172 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -67.59 129.08 38.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -85.49 105.42 16.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.488 HD13 ' HB ' ' D' ' 3' ' ' ILE . 8.5 mp -93.35 142.6 27.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 123.1 34.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.272 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.691 HD23 HG22 ' D' ' 7' ' ' THR . 28.3 tp -100.09 119.19 37.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.181 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 56' ' ' LEU . 69.1 t -109.84 129.71 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.774 ' H ' HD11 ' D' ' 8' ' ' LEU . 64.1 mt -110.01 137.39 47.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -78.83 -163.94 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.426 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.703 HD22 ' HE3' ' C' ' 48' ' ' LYS . 94.6 mt -65.22 143.41 57.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 51.1 mmm-85 -98.25 26.82 5.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.264 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.46 7.11 72.82 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.742 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.643 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -68.36 152.98 44.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.33 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.05 126.43 37.14 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.41 0.624 . . . . 0.0 109.998 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -66.96 -38.53 86.26 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.942 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -147.15 161.42 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.898 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.67 122.88 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -153.5 157.51 39.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.486 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -73.71 120.6 19.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.603 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -153.33 145.4 23.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.72 154.66 16.63 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -87.21 156.89 19.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.812 0.339 . . . . 0.0 110.811 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 28.3 mtp -125.23 174.1 8.33 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.8 m -127.7 122.05 31.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 37' ' ' THR . 30.9 tp -107.86 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.96 0.409 . . . . 0.0 110.247 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.63 120.25 31.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.809 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.41 -90.19 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -144.32 21.85 1.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.506 0.193 . . . . 0.0 110.765 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.596 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.9 m -123.45 130.71 53.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' CG2' HD13 ' A' ' 33' ' ' LEU . 71.4 t -107.14 120.28 58.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.694 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.781 HG22 ' HB3' ' B' ' 947' ' ' PRO . 44.6 p -118.82 124.01 28.65 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.202 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 141.76 42.08 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.817 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -91.88 132.31 36.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.533 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -67.74 -7.6 28.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -74.42 75.24 1.91 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -53.1 136.14 36.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.211 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -161.17 9.86 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.357 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 27' ' ' ARG . 8.7 tp -137.72 124.92 21.64 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 28' ' ' ALA . 44.3 t -98.45 108.67 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.1 p90 -132.29 154.57 49.56 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.922 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 24' ' ' VAL . 95.8 mt -121.52 141.11 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.786 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -142.9 141.9 31.62 Favored 'General case' 0 C--O 1.219 -0.505 0 O-C-N 123.716 0.635 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -104.99 129.17 53.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.188 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.511 HG23 ' CD2' ' A' ' 58' ' ' HIS . 21.1 p -89.01 173.57 8.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.73 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.16 -10.84 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.717 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.32 -1.07 57.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.445 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 t 70.12 20.9 6.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.284 0.564 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD11 HG11 ' D' ' 70' ' ' VAL . 66.2 mt -103.13 126.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.55 HD11 ' HD2' ' A' ' 132' ' ' PRO . 51.7 mm -80.54 127.83 39.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.511 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.8 m-70 -104.41 117.91 35.34 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.709 0.631 . . . . 0.0 110.933 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -94.35 107.82 19.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 90.4 m -119.35 142.81 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.82 0.819 . . . . 0.0 112.978 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.38 114.17 19.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.2 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -105.91 145.22 31.56 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.566 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -80.74 131.54 35.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.33 -19.35 62.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.969 0.414 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.5 m -59.58 -45.58 91.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.719 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.3 m -117.1 -11.82 10.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.2 23.39 78.03 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.36 148.21 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 110.662 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.88 102.7 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.039 0.447 . . . . 0.0 110.691 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -75.5 -36.32 60.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -125.89 148.18 49.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.624 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.565 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.8 p30 -158.81 96.38 1.36 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 72' ' ' ASP . 29.5 mt -125.48 132.53 52.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.474 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -73.98 129.03 36.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.662 HG21 ' SG ' ' A' ' 80' ' ' CYS . 22.9 mm -116.61 120.18 64.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.277 0.561 . . . . 0.0 110.62 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.4 m-85 -84.37 160.51 56.75 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.244 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 140.09 92.53 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.679 1.586 . . . . 0.0 111.041 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.37 11.15 3.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.032 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -85.07 -27.67 26.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.653 0.263 . . . . 0.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.693 ' SG ' HD11 ' A' ' 96' ' ' LEU . 13.9 p -145.1 164.75 30.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.235 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 2.7 tt0 -132.02 121.86 24.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.111 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' HG11 ' A' ' 124' ' ' VAL . 44.8 t80 -97.11 119.33 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -148.12 166.88 26.5 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.788 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -83.85 159.79 21.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.162 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 87' ' ' GLN . 48.8 t -109.39 95.82 20.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.77 60.25 7.61 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.99 1.793 . . . . 0.0 112.428 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.44 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -114.51 -41.68 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 178.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.24 81.14 71.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.56 130.76 27.45 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.874 1.716 . . . . 0.0 111.646 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 169.68 -41.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.94 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.31 -150.06 6.43 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.99 105.74 13.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.814 0.34 . . . . 0.0 110.517 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.26 127.49 72.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 110.71 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.57 152.63 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.367 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.8 p -129.62 139.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.615 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.693 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.1 tp -99.95 116.7 32.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -103.31 106.74 17.32 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 103' ' ' LYS . 53.1 m-85 -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 98.8 mttt -61.24 -37.37 82.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.72 -22.92 12.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.726 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.66 81.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.639 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.7 m 58.6 18.04 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 110.992 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' CD ' HD21 ' A' ' 105' ' ' LEU . 4.0 ttmt -117.15 152.0 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.504 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -128.56 135.5 49.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.858 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 95' ' ' VAL . 59.5 mt -118.53 148.19 42.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.4 m-85 -117.2 134.49 54.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.844 0.354 . . . . 0.0 111.097 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 156.44 46.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.219 0.533 . . . . 0.0 111.152 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -135.37 136.55 41.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.601 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.2 ttm -73.56 132.57 42.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.168 0.509 . . . . 0.0 111.372 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 3.14 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.969 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.12 142.31 92.77 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.84 -28.45 36.31 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.903 1.735 . . . . 0.0 112.674 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.41 141.92 51.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.267 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -98.28 10.64 40.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.45 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -54.27 -24.16 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.296 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.435 ' NE2' ' OE1' ' A' ' 119' ' ' GLU . 26.1 mm100 -119.41 6.39 11.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.241 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.71 -46.16 90.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.919 0.39 . . . . 0.0 110.748 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.66 -41.08 98.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' OE1' ' NE2' ' A' ' 116' ' ' GLN . 88.7 tt0 -63.76 -43.34 96.68 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.551 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.732 ' O ' HG23 ' A' ' 124' ' ' VAL . 61.4 m170 -64.06 -41.09 97.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.79 -41.14 97.99 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.122 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.05 -42.84 79.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.494 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.26 -40.48 96.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -57.68 -49.06 81.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.766 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -65.33 -39.2 92.09 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.126 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -72.34 -26.18 61.83 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.496 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -88.12 -26.27 22.57 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.796 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.4 mt -94.21 -17.56 22.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -115.06 -22.39 9.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.202 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -134.44 72.18 70.64 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.053 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.81 151.47 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.806 2.337 . . . . 0.0 112.123 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.55 ' HD2' HD11 ' A' ' 57' ' ' ILE . 51.1 Cg_exo . . . . . 0 N--CA 1.494 1.503 0 C-N-CA 122.451 2.101 . . . . 0.0 112.127 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.24 152.19 79.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.773 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.7 147.81 25.12 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.798 2.332 . . . . 0.0 112.024 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -82.42 154.02 68.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.228 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.17 150.95 82.02 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.141 1.894 . . . . 0.0 112.086 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.07 163.71 36.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -81.75 156.33 70.32 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.781 ' HB3' HG22 ' A' ' 39' ' ' THR . 21.4 Cg_endo -62.31 151.39 82.75 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.471 2.114 . . . . 0.0 112.124 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -151.76 164.04 37.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 111.087 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -85.65 134.68 33.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -117.94 132.48 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.536 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.1 mt -132.26 128.68 58.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.52 85.35 3.22 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.913 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.349 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -61.63 158.7 14.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.9 148.92 23.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.242 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -92.66 120.87 33.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.605 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -106.69 110.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.372 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -88.66 126.39 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.76 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.83 HG22 HD23 ' C' ' 69' ' ' LEU . 82.0 p -88.31 174.26 8.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 111.196 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.677 HD11 ' H ' ' C' ' 71' ' ' LEU . 80.6 mt -62.69 -37.09 85.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -69.01 -11.41 60.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.603 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.77 -12.21 62.67 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -65.66 127.77 33.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.142 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -100.77 131.05 46.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.296 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.439 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -122.89 116.61 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.46 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -84.05 130.32 34.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' C' ' 33' ' ' LYS . 94.0 mt -123.76 123.1 39.76 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.656 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.17 112.42 5.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.769 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.444 HG12 ' HE3' ' C' ' 29' ' ' LYS . 30.8 m -135.26 162.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.728 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -104.72 153.83 38.98 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.635 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.62 -35.64 93.22 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.056 1.837 . . . . 0.0 112.102 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -84.89 -5.74 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.105 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -59.56 136.96 58.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.012 0.434 . . . . 0.0 110.823 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -76.98 160.84 28.83 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' C' ' 50' ' ' LEU . 46.8 mm -64.41 -39.38 85.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.232 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.56 -40.78 88.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.89 -41.71 98.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.418 HG22 HG11 ' C' ' 17' ' ' VAL . 57.2 t -63.23 -42.78 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.544 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.632 ' HG3' HD11 ' C' ' 43' ' ' LEU . 4.1 mtpt -59.02 -40.93 86.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.69 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.31 91.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.265 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.4 mttm -60.05 -38.85 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.85 -39.54 83.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.266 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.71 -38.86 82.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -68.81 -50.85 46.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.108 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.439 ' HD2' HG22 ' C' ' 13' ' ' ILE . 21.7 mttt -63.77 -42.74 97.73 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.02 150.42 49.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.964 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.13 55.7 2.73 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.468 HG22 ' HG3' ' C' ' 41' ' ' GLN . 27.7 mm -109.86 114.97 55.93 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.17 153.99 66.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.639 1.559 . . . . 0.0 112.056 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.77 -38.01 66.25 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.143 1.895 . . . . 0.0 112.385 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.13 -39.92 94.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.378 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -87.27 -9.44 54.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.468 ' HG3' HG22 ' C' ' 36' ' ' ILE . 85.1 mt-30 -80.9 88.95 5.85 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -99.11 105.27 17.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.689 ' CB ' HD12 ' C' ' 50' ' ' LEU . 21.5 mt -97.51 122.28 40.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.6 mt -128.72 123.09 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -112.48 114.51 27.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.447 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.97 49.94 20.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.4 27.84 73.58 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -127.75 102.96 7.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.393 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.09 132.07 51.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.689 HD12 ' CB ' ' C' ' 43' ' ' LEU . 41.9 mt -85.3 87.65 7.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.395 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.16 144.85 42.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -59.63 165.68 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.95 8.09 87.85 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.03 173.56 9.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.572 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -123.52 170.5 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.838 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.5 -39.95 92.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.354 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.1 -30.59 71.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.87 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.05 -28.68 69.76 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.008 0.432 . . . . 0.0 110.422 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.415 ' CD2' HD23 ' C' ' 50' ' ' LEU . 57.7 m-85 -101.61 12.63 36.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.073 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.06 40.33 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -91.77 118.88 38.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.37 -179.25 3.9 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -63.58 149.67 45.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.733 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 59.86 18.73 7.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.216 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -74.44 129.15 37.23 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.29 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.545 ' C ' HD12 ' C' ' 67' ' ' LEU . 90.5 m -80.46 129.85 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.225 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.545 HD12 ' C ' ' C' ' 66' ' ' THR . 8.4 mp -119.26 144.48 46.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.367 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -90.39 114.18 26.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.284 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.83 HD23 HG22 ' C' ' 7' ' ' THR . 65.6 tp -101.88 120.5 40.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.896 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.537 ' HA ' HD21 ' C' ' 8' ' ' LEU . 89.5 t -118.6 132.9 67.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.955 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.677 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.2 mt -96.76 137.36 35.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -96.55 126.97 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.686 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -112.32 139.29 47.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.962 0.41 . . . . 0.0 110.458 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -63.18 -40.91 98.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.464 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.49 -41.41 99.78 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.57 -40.77 99.17 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.533 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -59.68 158.72 9.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -138.31 144.32 30.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.112 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.36 124.62 33.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.2 t -108.89 105.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.329 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 128.63 34.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.647 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -87.49 171.39 10.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.757 HD11 ' H ' ' D' ' 71' ' ' LEU . 83.9 mt -66.8 -29.15 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.303 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -78.09 -10.94 59.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 -12.66 56.08 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.48 125.55 26.05 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.232 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -98.11 135.27 40.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.291 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.47 109.93 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.565 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -84.9 129.3 34.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.45 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.643 HD21 ' HD2' ' D' ' 33' ' ' LYS . 89.0 mt -124.7 126.62 45.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.883 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -65.81 113.26 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.454 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.698 HG12 ' HE3' ' D' ' 29' ' ' LYS . 15.3 m -134.75 167.26 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 O-C-N 121.933 -0.479 . . . . 0.0 110.056 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' GLU . . . . . 0.425 ' O ' HD12 ' D' ' 56' ' ' LEU . 79.2 mm-40 -111.77 154.17 44.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.613 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.36 -26.58 83.03 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.116 1.877 . . . . 0.0 112.045 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.1 p -89.97 -12.04 39.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.03 142.83 57.3 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.144 0.497 . . . . 0.0 111.043 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -81.96 164.24 21.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.056 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.784 HD12 HD23 ' D' ' 50' ' ' LEU . 47.4 mm -62.02 -37.79 79.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.2 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -58.5 -40.32 82.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.37 -41.41 97.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 110.242 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.437 HG21 HD21 ' D' ' 56' ' ' LEU . 78.7 t -64.02 -42.51 95.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.574 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.83 -41.04 90.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.84 89.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.331 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.698 ' HE3' HG12 ' D' ' 17' ' ' VAL . 64.6 mttm -60.45 -40.11 89.96 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.785 ' CD1' HD21 ' D' ' 43' ' ' LEU . 79.6 mt -63.8 -41.48 92.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.699 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.82 -50.96 71.76 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.888 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -57.26 -24.05 52.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.643 ' HD2' HD21 ' D' ' 15' ' ' LEU . 11.6 mttm -96.9 -61.32 1.43 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.62 -25.39 22.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.907 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.27 11.54 64.48 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.385 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.09 121.49 80.67 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.908 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 149.36 55.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.519 1.48 . . . . 0.0 111.709 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.42 -41.75 65.25 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.889 1.726 . . . . 0.0 112.64 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.06 -40.59 74.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.98 -39.18 93.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.788 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.84 ' HB2' HD11 ' D' ' 69' ' ' LEU . 0.0 OUTLIER -97.24 147.25 24.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.781 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -131.79 125.85 32.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.785 HD21 ' CD1' ' D' ' 30' ' ' ILE . 72.9 mt -91.41 122.67 34.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.482 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.431 HG21 ' HE1' ' A' ' 76' ' ' PHE . 81.9 mt -128.3 126.8 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.255 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.86 149.72 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 110.805 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.58 20.12 11.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.37 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.38 86.22 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.807 ' HG2' HD22 ' A' ' 73' ' ' LEU . 99.0 mtt180 -114.23 140.7 48.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -75.48 119.39 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.716 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.813 HD21 HD11 ' D' ' 61' ' ' ILE . 9.6 mp -74.42 95.64 2.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.865 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.9 163.61 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 159.38 32.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.5 18.78 63.39 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -128.01 162.21 27.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.618 0.246 . . . . 0.0 110.576 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -113.43 160.81 18.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.399 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.437 HD21 HG21 ' D' ' 26' ' ' VAL . 78.2 mt -61.32 -40.11 92.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.688 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -63.34 -24.7 67.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 0.0 110.394 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -62.87 -37.46 86.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.091 0.472 . . . . 0.0 110.281 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -96.12 12.74 29.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.077 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.6 t30 57.15 40.37 28.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.005 0.431 . . . . 0.0 110.446 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ILE . . . . . 0.813 HD11 HD21 ' D' ' 50' ' ' LEU . 69.9 mt -86.98 108.91 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.055 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -94.58 -179.43 4.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -61.66 145.37 52.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 61.75 36.28 16.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' SER . . . . . 0.562 ' O ' HD12 ' D' ' 67' ' ' LEU . 28.9 t -87.28 123.78 32.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.226 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -78.44 124.22 27.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.562 HD12 ' O ' ' D' ' 65' ' ' SER . 4.9 mp -117.8 143.31 46.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.187 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -87.97 123.03 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.84 HD11 ' HB2' ' D' ' 41' ' ' GLN . 48.6 tp -103.42 109.6 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.706 HG11 HD11 ' A' ' 56' ' ' LEU . 52.5 t -98.31 134.28 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.757 ' H ' HD11 ' D' ' 8' ' ' LEU . 81.9 mt -107.86 147.36 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.642 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -129.74 154.18 47.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.41 129.2 54.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.447 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -55.5 137.9 47.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.744 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.87 -153.41 19.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.896 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.86 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.0 m120 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.19 148.37 27.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.254 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -90.58 110.83 21.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.126 0.489 . . . . 0.0 109.694 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.416 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.3 mt -65.58 -38.45 89.58 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.649 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -149.19 162.51 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.163 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.08 122.35 0.31 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.01 156.69 36.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.92 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.62 ' HA ' HD12 ' A' ' 46' ' ' LEU . 89.7 mtm180 -71.89 123.81 23.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.53 143.71 18.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.188 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.89 153.11 16.92 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -91.73 170.98 9.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.87 0.367 . . . . 0.0 111.416 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 20.4 mtp -136.83 175.27 9.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.14 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.08 124.44 41.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 37' ' ' THR . 28.6 tp -106.08 117.89 35.21 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.446 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -121.46 110.48 16.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.057 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 -87.89 0.58 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 p -143.32 22.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.54 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.2 m -125.59 131.49 52.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.428 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' CG2' HD13 ' A' ' 33' ' ' LEU . 80.3 t -109.66 122.34 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.008 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.0 p -113.35 132.33 22.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.315 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.05 144.25 46.73 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.147 1.898 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.27 121.93 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.507 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -64.52 -12.52 45.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.851 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -73.17 74.48 1.27 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -54.99 135.32 48.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.08 -154.3 7.45 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' ARG . 1.8 tp -142.52 125.54 16.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.3 t -95.87 108.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.64 154.36 47.98 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.068 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HB ' HG12 ' A' ' 24' ' ' VAL . 91.4 mt -121.67 140.55 45.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.582 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -142.74 142.65 31.99 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 123.48 0.488 . . . . 0.0 110.191 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -105.84 128.28 53.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.285 0.564 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 58' ' ' HIS . 23.3 p -87.84 172.06 9.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.606 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.89 -10.68 22.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.72 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.51 -1.1 56.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.452 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t 70.14 20.43 6.36 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.132 0.491 . . . . 0.0 110.962 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.706 HD11 HG11 ' D' ' 70' ' ' VAL . 63.8 mt -104.15 127.54 51.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 23' ' ' LEU . 43.4 mm -80.18 128.17 38.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.8 m-70 -105.08 116.62 32.26 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.551 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -98.02 107.27 19.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 147.2 47.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.822 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -119.94 111.64 18.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.899 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -102.03 134.45 45.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.279 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.7 137.57 40.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.864 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -78.49 -16.8 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -60.97 -45.62 94.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.501 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.3 m -117.07 -16.63 10.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.065 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.24 70.32 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -101.07 152.86 20.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.4 102.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -75.87 -37.53 58.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -126.65 145.58 50.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.3 t0 -159.17 100.71 1.55 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.328 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.807 HD22 ' HG2' ' D' ' 48' ' ' ARG . 23.7 mt -127.25 139.4 52.94 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.386 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.7 mt -77.72 127.23 38.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 80' ' ' CYS . 29.6 mm -113.86 125.81 71.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.924 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.567 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 72.6 m-85 -96.28 159.48 31.93 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.939 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.32 140.25 93.69 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.016 1.811 . . . . 0.0 111.348 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 62.34 13.18 5.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.031 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -95.44 -35.75 11.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 110.778 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -136.46 147.12 47.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -121.49 128.91 52.57 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.194 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -104.16 116.78 32.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -139.87 168.25 20.26 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -85.12 160.97 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.41 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.15 88.97 18.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.458 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.19 59.81 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.266 1.977 . . . . 0.0 112.005 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -114.5 -45.44 3.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.2 t -120.74 95.56 48.94 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.442 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.87 130.08 18.58 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.758 1.638 . . . . 0.0 111.658 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 167.93 -29.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.612 0.57 . . . . 0.0 110.315 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.7 -171.42 24.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.06 111.92 22.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 110.485 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.24 130.3 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.87 155.55 45.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.3 p -129.68 133.36 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.471 HD11 ' SG ' ' A' ' 80' ' ' CYS . 68.5 tp -100.74 119.83 39.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -119.01 129.6 55.22 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.474 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.468 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 54.3 m-85 -87.66 116.5 25.84 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.62 -33.43 72.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.474 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.93 -19.04 10.55 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.191 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -75.61 -18.75 79.64 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 m 58.75 27.69 16.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.62 ' HD3' HD21 ' A' ' 105' ' ' LEU . 15.7 ttmt -121.72 149.7 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.415 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.416 ' O ' HD23 ' A' ' 105' ' ' LEU . 94.5 mtt-85 -133.19 130.91 39.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.267 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.62 HD21 ' HD3' ' A' ' 103' ' ' LYS . 43.8 mt -120.99 148.87 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CE1' HD22 ' A' ' 33' ' ' LEU . 93.8 m-85 -119.8 135.32 54.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.4 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.47 153.26 48.82 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -128.46 134.7 48.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.561 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.0 mtp -77.62 139.01 39.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.967 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -100.82 7.76 43.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.043 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.38 134.21 86.93 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.522 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.2 -25.9 36.57 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.029 1.819 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.05 143.13 49.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 110.328 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.6 p -89.38 -1.05 57.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.97 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.22 -18.53 37.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -116.86 -17.38 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.42 -41.76 97.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.64 -40.61 95.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.082 0.467 . . . . 0.0 111.047 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -66.04 -41.67 90.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.5 m170 -62.41 -40.85 97.85 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.94 -43.26 99.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.04 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -67.73 -42.6 81.61 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.545 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.88 -43.02 97.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.656 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.7 t -57.38 -47.64 84.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.822 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.98 -39.46 93.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.048 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -72.69 -22.13 60.95 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.423 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.91 -26.87 19.1 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.809 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.8 mt -96.94 -16.22 20.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -118.04 -19.5 9.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -135.77 67.2 64.42 Favored Pre-proline 0 CA--C 1.519 -0.224 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.73 153.79 72.48 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 C-N-CA 122.459 2.106 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--N 1.312 -1.342 0 C-N-CA 122.545 2.163 . . . . 0.0 112.174 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -130.26 150.58 76.55 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.32 145.27 26.93 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.54 154.96 85.69 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.478 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 158.98 52.92 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.159 1.906 . . . . 0.0 112.451 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.54 -178.69 3.53 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.882 2.388 . . . . 0.0 111.935 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -115.33 158.89 40.2 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.67 141.79 83.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.069 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -153.68 164.11 38.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.2 139.48 31.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.972 0.415 . . . . 0.0 110.566 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.82 130.24 51.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 951' ' ' ILE . 3.0 mp -131.48 126.71 58.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -74.58 83.65 2.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.116 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.539 179.644 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' GLN . . . . . 0.416 ' OE1' HG21 ' C' ' 14' ' ' THR . 12.8 pt20 -62.48 160.96 12.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.59 153.9 31.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.277 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.461 ' CD1' HG23 ' C' ' 14' ' ' THR . 11.2 m-30 -96.61 124.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.681 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.12 113.56 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.532 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -86.93 131.46 34.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -91.13 177.39 6.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.719 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' C' ' 70' ' ' VAL . 92.6 mt -60.99 -37.59 83.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.788 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 30.8 p -76.42 -6.44 51.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.007 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.79 -8.48 73.79 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -62.08 129.26 40.02 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m -102.05 131.66 48.38 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.581 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -120.87 108.59 23.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.342 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 14' ' ' THR . . . . . 0.461 HG23 ' CD1' ' C' ' 4' ' ' PHE . 9.6 m -77.0 129.62 36.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.229 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.1 mt -124.28 123.9 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.619 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -69.57 115.48 8.87 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.416 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.2 m -137.67 164.79 27.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.619 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -106.77 154.28 40.23 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.97 -35.74 94.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.786 1.657 . . . . 0.0 111.968 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -82.78 -6.6 59.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.6 135.23 57.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.864 0.364 . . . . 0.0 110.803 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -78.61 163.34 25.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.966 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.498 HD12 HD23 ' C' ' 50' ' ' LEU . 48.1 mm -63.48 -38.65 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.267 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -59.17 -42.79 91.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.041 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -62.15 -41.15 98.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.561 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.435 HG21 HD21 ' C' ' 56' ' ' LEU . 58.4 t -63.44 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.789 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.418 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.6 mtmt -61.24 -39.39 90.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.271 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.15 -40.73 94.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.259 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.484 ' HB3' HD22 ' C' ' 15' ' ' LEU . 67.3 mttm -60.66 -39.68 89.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.19 -40.01 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.98 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.41 -39.57 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.305 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.21 -43.36 86.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.393 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.553 ' HG3' HD21 ' C' ' 15' ' ' LEU . 11.5 mttm -71.4 -40.25 70.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -132.76 155.76 48.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.002 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.58 64.75 1.78 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.746 HG22 ' HG2' ' C' ' 41' ' ' GLN . 33.0 mm -116.36 98.75 51.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 150.76 74.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.624 1.55 . . . . 0.0 112.016 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.23 -25.19 12.84 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.392 2.061 . . . . 0.0 112.39 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -90.08 31.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -167.23 31.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.814 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' C' ' 36' ' ' ILE . 0.9 OUTLIER -123.36 97.81 5.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.64 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -97.08 107.16 19.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.497 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.418 HD11 ' HG2' ' C' ' 27' ' ' LYS . 60.6 mt -102.9 120.87 41.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.222 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 95.1 mt -128.78 129.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.705 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -120.43 118.66 30.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.53 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.68 88.1 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.768 ' HE3' HD22 ' D' ' 73' ' ' LEU . 20.0 tptt -95.81 112.87 24.49 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -66.44 129.48 39.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.03 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.498 HD23 HD12 ' C' ' 23' ' ' ILE . 7.3 mp -76.9 88.0 3.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.333 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.25 138.34 51.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.13 145.52 46.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.328 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.72 60.49 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -93.1 170.31 9.74 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 65.2 p -113.39 167.12 10.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.389 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.435 HD21 HG21 ' C' ' 26' ' ' VAL . 84.7 mt -62.14 -39.86 94.0 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.3 p -63.09 -27.29 69.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.245 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.93 -35.96 79.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.009 0.433 . . . . 0.0 110.074 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.794 ' CZ ' HD11 ' D' ' 73' ' ' LEU . 59.1 m-85 -95.5 14.45 22.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.089 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.03 40.28 30.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.218 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.16 110.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.541 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -99.25 -170.26 1.89 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.029 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -65.03 145.78 55.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.513 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 57.24 41.02 27.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.035 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -91.7 122.19 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.103 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 63.8 m -72.61 127.13 31.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.204 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -118.79 147.25 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.23 113.18 25.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.271 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.7 tp -102.5 119.84 39.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.683 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.71 ' HA ' HD21 ' C' ' 8' ' ' LEU . 95.9 t -121.15 133.75 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.558 ' H ' HD11 ' C' ' 8' ' ' LEU . 25.1 mt -102.68 133.84 47.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.376 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -86.93 136.7 32.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.412 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.85 118.0 35.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.395 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 54.33 39.11 30.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.403 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.31 146.24 45.59 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.55 -172.61 38.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.349 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.04 159.31 14.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.095 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' D' ' 67' ' ' LEU . 10.5 pt -139.31 148.49 23.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.808 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.412 ' CD2' HG23 ' D' ' 14' ' ' THR . 13.7 m-30 -91.95 113.92 26.31 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.898 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 64.1 t -97.88 108.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.641 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -94.92 121.87 36.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.752 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.766 HG22 HD23 ' D' ' 69' ' ' LEU . 82.1 p -81.02 172.99 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.649 HD11 ' H ' ' D' ' 71' ' ' LEU . 87.9 mt -59.99 -36.14 76.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.819 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.77 -10.96 60.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 -9.84 66.47 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.61 126.83 29.12 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -100.68 132.2 46.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.556 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.65 109.16 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.904 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.412 HG23 ' CD2' ' D' ' 4' ' ' PHE . 22.3 m -78.95 128.37 33.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' D' ' 33' ' ' LYS . 94.8 mt -124.32 121.83 36.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.389 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -67.03 113.71 5.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.306 0.574 . . . . 0.0 111.146 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' D' ' 29' ' ' LYS . 25.7 m -136.63 162.01 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.8 153.39 38.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.57 -39.34 91.64 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.873 1.715 . . . . 0.0 111.955 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -79.59 -8.75 59.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.083 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -58.24 135.6 57.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -76.15 161.78 28.54 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.879 HD12 HD23 ' D' ' 50' ' ' LEU . 46.3 mm -64.3 -38.43 82.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.929 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.77 90.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.046 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.28 -42.04 99.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.131 0.491 . . . . 0.0 110.838 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.13 -43.5 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.23 -38.75 87.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.54 93.52 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.411 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.517 ' HB3' HD22 ' D' ' 15' ' ' LEU . 13.7 mttp -59.68 -39.12 83.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.856 ' CD1' HD21 ' D' ' 43' ' ' LEU . 93.1 mt -65.88 -39.98 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.336 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.26 -39.41 82.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.953 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -68.49 -51.04 47.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.759 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.551 ' HD2' HD21 ' D' ' 15' ' ' LEU . 65.9 mttt -65.17 -40.85 94.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -128.77 147.47 50.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.18 60.53 2.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -110.73 106.31 57.65 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.99 154.88 41.99 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.062 1.842 . . . . 0.0 111.766 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.29 -28.46 79.91 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.365 2.043 . . . . 0.0 112.781 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.84 -10.21 58.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.981 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.74 -52.93 3.44 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.558 ' CB ' HD11 ' D' ' 69' ' ' LEU . 0.6 OUTLIER -66.24 116.36 7.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.356 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -116.23 103.65 10.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.56 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.856 HD21 ' CD1' ' D' ' 30' ' ' ILE . 80.3 mt -78.79 129.06 34.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' D' ' 49' ' ' GLN . 55.0 mt -133.83 130.55 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.615 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 55.3 t80 -151.14 157.19 42.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.47 20.34 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.668 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.73 -6.09 75.61 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -129.16 150.06 50.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.128 0.49 . . . . 0.0 111.04 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.6 ' HA ' HG23 ' D' ' 44' ' ' ILE . 24.0 pt20 -69.89 142.47 53.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.455 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.879 HD23 HD12 ' D' ' 23' ' ' ILE . 8.1 mp -81.55 112.95 19.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.31 138.23 41.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.947 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -58.46 150.12 23.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.251 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.71 64.62 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -84.85 -178.59 6.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.936 0.398 . . . . 0.0 110.758 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -126.54 162.29 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.099 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.72 -39.56 94.45 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.68 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -63.75 -28.34 69.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.48 -34.59 75.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.029 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -97.84 12.37 34.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.432 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 m120 55.73 39.78 30.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.888 0.375 . . . . 0.0 110.23 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ILE . . . . . 0.715 HD11 HD21 ' D' ' 50' ' ' LEU . 75.9 mt -86.59 106.8 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.35 177.19 6.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.629 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -61.33 150.26 35.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.347 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 61.73 13.07 5.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.935 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m -70.75 136.3 48.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -86.31 119.94 27.12 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.83 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.52 HD21 HD13 ' D' ' 61' ' ' ILE . 7.6 mp -110.4 125.31 53.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.285 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -75.22 133.06 41.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.766 HD23 HG22 ' D' ' 7' ' ' THR . 69.2 tp -112.56 115.84 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -103.94 129.08 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.649 ' H ' HD11 ' D' ' 8' ' ' LEU . 47.8 mt -96.78 124.95 40.91 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.309 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 73.8 mtp85 -95.86 140.84 30.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.432 . . . . 0.0 110.848 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.794 HD11 ' CZ ' ' C' ' 59' ' ' TYR . 4.3 tt -76.92 131.65 38.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.176 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 74' ' ' ARG . . . . . 0.529 ' O ' HD23 ' D' ' 73' ' ' LEU . 56.0 mmm-85 -64.54 137.09 57.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.878 0.371 . . . . 0.0 110.505 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.61 2.23 90.45 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.582 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.727 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -84.1 150.4 25.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.097 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -91.67 112.36 24.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.155 0.502 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.4 mt -66.64 -37.43 84.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.7 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.3 p -150.29 162.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.58 122.92 0.36 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.816 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.7 159.81 42.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.253 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.472 ' HA ' HD12 ' A' ' 46' ' ' LEU . 77.3 mtp180 -75.89 118.82 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.675 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.37 22.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.23 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.48 158.51 14.7 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -92.97 156.4 16.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.6 mtp -122.65 171.05 9.43 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.1 m -122.95 120.33 33.1 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.263 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 38' ' ' VAL . 28.1 tp -106.57 117.72 34.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.202 0.525 . . . . 0.0 110.337 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -123.45 118.21 26.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.521 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.68 -98.27 0.6 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.7 p -135.0 22.58 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.52 0.2 . . . . 0.0 111.074 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 33' ' ' LEU . 87.1 m -124.37 130.76 53.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.802 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 33' ' ' LEU . 59.9 t -109.15 124.46 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.644 HG22 ' HB3' ' B' ' 947' ' ' PRO . 21.7 p -124.03 118.21 26.88 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.09 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.5 148.38 66.64 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.541 1.494 . . . . 0.0 113.122 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.55 140.94 34.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.975 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -71.26 -7.37 46.51 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.947 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -70.01 78.52 0.49 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.24 133.76 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -162.7 10.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.216 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.0 tp -136.08 124.27 23.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.18 110.59 24.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -132.55 154.13 50.29 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.388 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.9 mt -119.42 136.5 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.918 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.47 130.99 33.43 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.509 0.506 . . . . 0.0 110.288 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.462 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.9 tt0 -100.37 125.18 46.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.124 0.488 . . . . 0.0 109.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 58' ' ' HIS . 15.1 p -84.78 172.17 11.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.575 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.54 -10.63 27.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.21 0.11 56.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.452 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t 70.66 21.32 5.38 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.148 0.499 . . . . 0.0 110.41 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD22 ' HE2' ' A' ' 76' ' ' PHE . 70.1 mt -99.28 123.67 43.75 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.9 mm -81.17 122.2 35.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.501 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.9 m-70 -99.01 114.56 27.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.719 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -96.54 109.08 21.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 142.99 51.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.229 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.71 116.53 28.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.458 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -106.42 133.25 51.4 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.04 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.489 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -72.03 -19.86 61.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.029 0.442 . . . . 0.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.2 m -60.09 -44.82 94.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.044 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -115.37 -15.49 11.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.74 20.31 79.77 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.08 146.78 27.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.62 102.32 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.187 0.518 . . . . 0.0 109.824 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.17 -38.26 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -126.63 144.91 50.75 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.087 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.0 t0 -157.78 101.56 1.81 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.246 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 72' ' ' ASP . 37.2 mt -127.9 136.31 51.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.01 123.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.9 mm -110.77 131.6 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.234 0.54 . . . . 0.0 111.169 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.537 ' HE2' HD22 ' A' ' 56' ' ' LEU . 57.2 m-85 -95.7 159.62 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.928 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.72 139.95 91.96 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.686 1.591 . . . . 0.0 111.23 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 61.68 11.2 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.334 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 100' ' ' ALA . 17.1 t70 -88.25 -22.53 23.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.178 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.703 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.5 p -147.93 164.91 32.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 7.5 tt0 -137.7 127.27 25.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.58 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -97.05 121.39 38.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -144.93 163.47 34.06 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.544 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 -88.41 157.03 18.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.225 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.95 88.78 10.51 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.45 60.97 8.03 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.995 1.797 . . . . 0.0 112.028 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -112.99 -48.87 2.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.136 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.22 102.2 54.64 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.165 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.64 130.75 16.32 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.435 1.424 . . . . 0.0 111.691 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 168.22 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.74 -179.06 33.32 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.566 ' NE ' HG22 ' A' ' 114' ' ' THR . 0.5 OUTLIER -88.01 109.68 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.91 127.58 75.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.301 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.62 152.35 43.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.6 p -130.03 140.48 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.21 122.49 40.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -109.34 110.08 21.14 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -73.62 105.1 4.8 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 81' ' ' GLU . 57.8 mttm -60.99 -37.78 83.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.611 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.621 ' HB3' ' OD1' ' A' ' 79' ' ' ASP . . . -97.66 -20.49 17.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.633 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.82 140.8 15.14 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -83.78 52.84 2.37 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.169 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.629 ' HD3' HD21 ' A' ' 105' ' ' LEU . 8.7 ttmt -140.22 144.32 36.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -130.94 138.45 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.181 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD21 ' HD3' ' A' ' 103' ' ' LYS . 55.5 mt -116.24 149.4 39.23 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.2 m-85 -118.92 134.82 54.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.766 0.317 . . . . 0.0 111.133 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.93 155.97 47.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.326 0.584 . . . . 0.0 111.259 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -133.28 138.48 46.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.492 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.3 tpp -73.17 129.04 37.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.331 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -5.7 19.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.482 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.84 146.35 97.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.34 -25.82 15.12 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.091 1.861 . . . . 0.0 112.882 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -119.7 141.96 48.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.566 HG22 ' NE ' ' A' ' 92' ' ' ARG . 73.9 p -96.98 10.81 38.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.492 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.36 -20.43 59.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -125.92 6.75 7.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.423 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.63 -50.23 73.38 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.164 0.507 . . . . 0.0 110.769 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -65.22 -40.47 94.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.225 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.65 -44.64 96.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.89 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.79 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.5 m170 -64.59 -40.09 94.9 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.648 0.737 . . . . 0.0 109.498 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.0 m -64.2 -41.58 97.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.141 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -67.18 -41.79 85.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -64.97 -35.77 82.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.364 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 120' ' ' HIS . 61.3 t -59.54 -48.26 87.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.111 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.15 -30.23 38.92 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.859 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -67.68 -37.92 83.0 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -81.03 -33.8 33.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.57 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.539 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.4 mt -77.79 -27.0 50.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -106.98 -23.3 12.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.386 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -140.08 67.74 33.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.132 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.68 160.86 46.96 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.997 2.465 . . . . 0.0 112.391 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.31 -1.496 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 -179.494 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -71.37 149.15 93.85 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.65 146.03 53.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.598 2.199 . . . . 0.0 112.675 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.74 161.78 62.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.94 149.82 81.77 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.554 2.17 . . . . 0.0 112.238 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.33 163.08 39.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.443 2.095 . . . . 0.0 112.151 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -74.74 156.79 86.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.52 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.644 ' HB3' HG22 ' A' ' 39' ' ' THR . 44.8 Cg_exo -57.86 147.09 83.3 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.62 162.57 41.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -86.22 137.79 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -115.72 127.64 55.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.92 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.39 121.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -81.45 85.21 6.51 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.078 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.296 179.714 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -58.76 159.33 6.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.7 pt -140.22 141.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.274 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -85.28 124.06 31.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.75 112.26 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -96.82 119.73 35.85 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.876 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.656 HG22 ' CB ' ' C' ' 69' ' ' LEU . 29.9 p -112.56 178.61 4.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.172 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.481 ' C ' HG23 ' C' ' 9' ' ' THR . 2.4 mm? -45.04 159.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.239 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.481 HG23 ' C ' ' C' ' 8' ' ' LEU . 1.4 p 66.11 8.49 5.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.887 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.09 29.07 73.23 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -84.98 111.34 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.783 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m -96.4 131.57 42.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.955 0.407 . . . . 0.0 110.706 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.421 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -134.62 113.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.271 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -85.8 131.96 34.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' C' ' 33' ' ' LYS . 25.9 mt -124.19 125.64 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.343 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.41 112.79 4.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 110.907 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.697 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.5 m -136.18 162.89 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.323 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -104.19 154.5 38.19 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.55 -37.22 95.31 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.947 1.765 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -79.56 -7.88 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.13 135.35 53.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.981 0.419 . . . . 0.0 110.865 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -78.25 161.58 27.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.9 mm -64.76 -41.38 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.93 -36.17 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.083 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ASN . . . . . 0.419 ' HA ' HD21 ' C' ' 25' ' ' ASN . 9.1 m120 -65.02 -41.28 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.32 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 56' ' ' LEU . 58.9 t -63.81 -42.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.468 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.589 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.3 mtmt -60.81 -40.93 94.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.603 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -40.11 94.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.958 0.409 . . . . 0.0 110.478 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.697 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.0 mttm -60.21 -39.07 85.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.341 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.73 HD13 ' CD1' ' C' ' 69' ' ' LEU . 96.6 mt -66.92 -39.07 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.7 -40.96 85.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.22 -41.92 72.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.726 ' HG3' HD21 ' C' ' 15' ' ' LEU . 11.6 mmtt -66.09 -42.34 89.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.924 0.392 . . . . 0.0 112.039 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -136.83 154.98 50.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.992 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 57.07 3.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.631 HG22 ' HG3' ' C' ' 41' ' ' GLN . 28.8 mm -109.8 106.26 58.12 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.81 153.41 56.78 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.707 1.605 . . . . 0.0 111.672 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.74 -39.56 76.52 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.015 1.81 . . . . 0.0 112.366 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -39.09 91.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 0.0 110.322 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -86.58 -6.48 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.204 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.631 ' HG3' HG22 ' C' ' 36' ' ' ILE . 19.2 mt-30 -88.24 77.43 8.25 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.978 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -84.11 107.81 16.67 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.632 ' CB ' HD12 ' C' ' 50' ' ' LEU . 17.3 mt -99.16 119.26 37.57 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.009 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -126.51 127.75 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.354 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -130.41 129.65 43.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.86 25.59 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.66 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.14 2.69 90.59 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.517 ' HE3' HD22 ' D' ' 73' ' ' LEU . 26.6 mtpp -108.14 126.17 52.46 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 122.538 -0.39 . . . . 0.0 109.978 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -72.08 133.58 45.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.209 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' C' ' 43' ' ' LEU . 69.1 mt -77.23 102.91 6.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 110.287 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.22 139.96 42.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.946 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -61.56 137.08 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.241 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -17.37 55.64 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -83.4 -179.96 7.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.828 0.346 . . . . 0.0 110.359 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -127.32 165.41 19.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 26' ' ' VAL . 84.3 mt -62.0 -40.09 94.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -63.45 -27.6 69.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.007 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.53 -35.23 77.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 109.894 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.68 12.88 32.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.244 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.68 41.46 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.26 109.17 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.06 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.28 -176.08 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.504 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -66.05 148.14 52.27 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.34 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 58.21 41.11 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 42.8 m -93.68 125.07 38.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.258 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.47 ' C ' HD12 ' C' ' 67' ' ' LEU . 41.7 m -75.76 128.83 36.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.831 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.47 HD12 ' C ' ' C' ' 66' ' ' THR . 9.1 mp -115.64 152.05 33.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -101.83 112.62 25.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.73 ' CD1' HD13 ' C' ' 30' ' ' ILE . 0.7 OUTLIER -104.91 128.61 53.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.448 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -124.46 136.12 61.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.151 0.501 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mt -97.78 153.5 18.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.366 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -99.0 129.8 45.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.425 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 86.6 mt -122.02 147.03 46.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.616 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -60.44 -43.88 96.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.785 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.95 173.05 45.05 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.13 -177.06 47.23 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 33.7 t0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.547 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -62.26 160.0 13.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.442 HD12 HD22 ' D' ' 67' ' ' LEU . 15.2 pt -142.83 146.93 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -95.34 123.27 38.78 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.755 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.747 HG11 HD11 ' D' ' 30' ' ' ILE . 83.8 t -104.96 110.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.44 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -97.8 132.69 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.524 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -88.27 -178.32 5.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.081 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.617 HD11 ' H ' ' D' ' 71' ' ' LEU . 83.8 mt -61.92 -37.02 83.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.302 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.9 p -73.72 -9.6 58.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.71 -6.45 67.47 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.654 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -59.07 121.79 12.16 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -100.66 133.11 45.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.046 0.45 . . . . 0.0 110.902 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.76 108.44 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 129.47 34.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.092 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' D' ' 29' ' ' LYS . 66.9 mt -127.35 126.3 42.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.541 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.1 114.63 10.41 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.35 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.652 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.0 m -135.71 164.14 33.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.716 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -110.68 155.62 41.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.051 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.02 -36.59 96.26 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.087 1.858 . . . . 0.0 111.763 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -77.45 -10.06 59.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.046 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -57.76 137.2 56.78 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -78.84 160.97 27.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.753 HD12 HD23 ' D' ' 50' ' ' LEU . 43.6 mm -63.3 -43.02 98.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.185 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -59.93 -34.51 73.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.257 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -64.92 -42.71 94.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.138 0.494 . . . . 0.0 110.71 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.553 HG21 HD21 ' D' ' 56' ' ' LEU . 69.1 t -62.36 -43.22 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.549 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.24 -38.85 88.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.56 87.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.059 0.457 . . . . 0.0 109.796 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.652 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -60.03 -37.18 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.747 HD11 HG11 ' D' ' 5' ' ' VAL . 6.2 mm -62.85 -39.46 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.89 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.2 -45.27 93.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.512 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.82 -38.22 90.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.783 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.416 ' HG3' HD21 ' D' ' 15' ' ' LEU . 23.5 mttm -90.19 -4.4 57.26 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -148.1 -47.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 8.41 32.79 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -80.42 120.69 80.12 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.43 156.98 62.68 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.259 1.306 . . . . 0.0 111.419 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -51.85 -36.04 61.73 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.163 1.908 . . . . 0.0 112.429 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -67.37 -46.02 74.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -64.54 -40.32 95.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.4 ' HB2' HD11 ' D' ' 69' ' ' LEU . 2.0 pt20 -98.68 151.03 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.37 0.605 . . . . 0.0 111.424 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -133.34 118.05 18.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.499 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.652 HD23 HD12 ' D' ' 69' ' ' LEU . 66.2 mt -86.15 122.29 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.587 HD12 HG21 ' D' ' 70' ' ' VAL . 83.9 mt -125.19 130.24 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.745 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 71.4 t80 -153.45 156.22 37.77 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.32 19.03 9.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.719 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -6.74 74.22 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -126.79 149.76 49.49 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 110.598 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -73.71 137.07 43.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.474 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.766 HD21 HD11 ' D' ' 61' ' ' ILE . 8.2 mp -83.53 112.2 19.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.841 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -75.23 175.93 7.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.734 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.28 162.89 21.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.454 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.17 -151.08 41.61 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 51.69 179.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.334 0.588 . . . . 0.0 111.462 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 71.8 p -131.69 170.31 14.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.553 HD21 HG21 ' D' ' 26' ' ' VAL . 84.8 mt -61.68 -39.63 92.13 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.401 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -65.37 -27.36 68.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.01 -28.08 69.85 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.137 0.494 . . . . 0.0 110.067 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -103.49 14.73 30.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.326 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 57.02 39.46 29.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.597 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ILE . . . . . 0.766 HD11 HD21 ' D' ' 50' ' ' LEU . 81.2 mt -88.69 117.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.078 0.466 . . . . 0.0 110.136 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -101.18 176.51 5.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.387 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -60.43 150.74 30.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.902 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 60.11 14.87 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.185 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -63.47 136.39 57.56 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -95.38 107.13 19.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.93 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.442 HD22 HD12 ' D' ' 3' ' ' ILE . 8.9 mp -92.34 155.81 17.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.254 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -106.69 124.12 49.14 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.76 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.652 HD12 HD23 ' D' ' 43' ' ' LEU . 7.7 tp -99.89 92.88 5.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.815 HG11 HD11 ' A' ' 56' ' ' LEU . 58.3 t -87.36 129.81 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.617 ' H ' HD11 ' D' ' 8' ' ' LEU . 65.1 mt -95.13 134.91 37.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.011 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -63.56 -40.37 96.8 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.116 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.517 HD22 ' HE3' ' C' ' 48' ' ' LYS . 2.0 tt -138.93 128.14 24.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 110.414 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -67.85 135.36 52.41 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.876 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.99 -14.96 62.25 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.777 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.408 179.548 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -69.65 145.97 52.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.189 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -93.74 126.27 38.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.249 0.547 . . . . 0.0 109.913 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 51' ' ' GLN . 90.8 mt -68.99 -37.33 78.67 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.973 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.99 160.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.802 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -173.87 122.22 0.32 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -152.77 157.24 40.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HA ' HD12 ' A' ' 46' ' ' LEU . 72.9 mtp180 -76.31 121.82 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.09 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.88 143.95 22.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.648 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.42 151.47 17.45 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -95.12 157.14 16.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.916 0.389 . . . . 0.0 110.974 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 43.0 mtp -121.84 172.77 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.1 m -122.44 122.43 38.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.211 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 37' ' ' THR . 25.7 tp -106.45 118.99 38.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.729 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -121.25 111.54 17.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.437 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -102.11 1.0 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.5 p -127.62 20.38 6.64 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.359 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.61 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.7 m -122.32 129.88 52.6 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 33' ' ' LEU . 62.1 t -109.01 123.88 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.705 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 p -115.59 134.88 22.59 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.58 143.85 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.72 1.613 . . . . 0.0 112.305 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -106.57 131.49 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -72.35 -7.18 48.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.153 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -73.14 75.96 1.26 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -57.42 131.06 48.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.18 -160.25 10.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.523 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.9 tp -136.42 124.67 23.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.2 t -98.03 111.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.304 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -133.86 155.7 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.917 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.6 mt -123.94 140.24 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.389 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -141.38 141.64 33.79 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.096 0.474 . . . . 0.0 110.136 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.508 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.9 tt0 -106.1 127.58 53.29 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.535 HG23 ' CD2' ' A' ' 58' ' ' HIS . 27.0 p -88.48 172.46 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.477 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.53 -10.73 19.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.073 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.14 0.18 55.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.262 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t 68.46 21.76 8.07 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 110.482 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.815 HD11 HG11 ' D' ' 70' ' ' VAL . 70.2 mt -101.7 124.69 47.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 131' ' ' PRO . 50.9 mm -80.84 125.73 39.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.0 m-70 -102.79 116.42 32.53 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.571 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -92.5 109.35 20.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.4 m -120.69 144.84 48.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.877 0.846 . . . . 0.0 112.904 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.98 114.08 18.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.183 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -107.53 131.31 54.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.295 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -73.03 131.98 42.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -72.51 -19.12 61.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 110.415 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -60.24 -45.07 94.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.15 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.8 p -116.0 -15.18 11.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 20.59 79.48 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -101.62 145.49 28.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.4 t -73.98 103.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.261 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -78.44 -31.55 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -126.77 145.89 50.44 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.641 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.599 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.5 t0 -157.53 98.73 1.7 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.332 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 72' ' ' ASP . 35.9 mt -128.07 134.47 49.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.563 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.6 127.29 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.55 HG23 ' SG ' ' A' ' 80' ' ' CYS . 31.3 mm -113.77 123.55 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.905 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.462 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 64.6 m-85 -90.33 163.23 32.04 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.114 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.62 140.66 90.65 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.072 1.848 . . . . 0.0 111.309 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 59.89 13.61 3.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.246 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -90.15 -32.34 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.502 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.598 ' HB3' HD11 ' A' ' 96' ' ' LEU . 71.4 m -134.95 152.37 51.67 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.331 0.586 . . . . 0.0 111.93 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.29 129.11 48.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.58 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.94 118.73 37.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -144.35 166.58 24.7 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.9 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -88.69 159.69 17.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.956 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 t -114.83 89.76 20.29 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.47 59.98 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.015 1.81 . . . . 0.0 111.972 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -47.43 2.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.8 t -114.27 99.33 50.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.96 130.03 16.13 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.559 1.506 . . . . 0.0 111.488 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.6 -35.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.682 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.37 176.67 36.13 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.697 ' HE ' HG21 ' A' ' 114' ' ' THR . 94.6 mtt-85 -81.12 113.82 19.55 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.916 0.389 . . . . 0.0 110.783 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.97 125.16 67.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.969 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.79 152.34 35.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.307 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 105' ' ' LEU . 15.0 p -131.23 135.95 58.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.0 110.125 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 80' ' ' CYS . 63.6 tp -102.53 118.11 36.16 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -113.83 132.6 55.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.616 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -85.17 116.07 23.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.244 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.48 -37.1 82.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.03 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.19 -24.13 8.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.104 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.13 72.14 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 p 81.57 -6.11 1.52 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 124.128 0.546 . . . . 0.0 110.721 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.707 ' HD3' HD21 ' A' ' 105' ' ' LEU . 9.1 ttmm -79.7 148.19 31.66 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.259 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.4 mtt180 -133.76 133.43 41.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.795 0.331 . . . . 0.0 110.479 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.707 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.7 mt -121.74 152.8 39.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.033 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.05 137.69 54.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.912 0.386 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.98 159.93 41.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -136.99 139.83 41.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.013 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.13 131.04 49.85 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 111.282 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.42 0.89 10.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.73 147.82 81.68 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.27 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.77 -40.07 67.14 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.814 1.676 . . . . 0.0 112.299 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.92 144.54 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.697 HG21 ' HE ' ' A' ' 92' ' ' ARG . 74.7 p -100.28 12.01 38.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -55.76 -20.76 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.965 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -124.06 17.48 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.702 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.54 -45.48 93.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -71.63 -34.82 70.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.432 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -44.43 88.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.736 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.1 m170 -64.14 -39.78 94.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.8 -46.03 91.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.749 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -65.64 -43.15 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.262 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -62.72 -39.82 95.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.544 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 120' ' ' HIS . 59.3 t -59.51 -47.77 89.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.408 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -79.87 -24.93 40.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.936 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -69.59 -42.38 74.54 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.866 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -79.0 -35.45 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.674 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 124' ' ' VAL . 80.4 mt -71.34 -36.05 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -98.84 -27.79 13.76 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.497 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -132.89 76.25 70.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.353 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.491 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.2 Cg_exo -58.58 155.57 36.09 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.819 2.346 . . . . 0.0 112.037 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.492 1.429 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 -179.406 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.62 149.24 90.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.12 148.04 38.97 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.29 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -73.89 151.7 88.72 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.35 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 944' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' B' ' 945' ' ' PRO . 73.6 Cg_endo -73.97 156.44 47.7 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.021 . . . . 0.0 112.372 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 945' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 944' ' ' PRO . 22.5 Cg_exo -61.71 -169.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.439 2.093 . . . . 0.0 112.023 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.09 157.24 77.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 140.01 82.59 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.42 2.08 . . . . 0.0 112.338 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -157.59 164.73 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.621 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -86.32 136.73 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -118.05 129.7 55.72 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.723 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.19 132.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.15 84.64 0.74 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.326 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.472 179.578 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -64.23 161.48 16.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.489 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -142.1 145.22 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.045 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -87.87 122.77 31.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.826 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.86 108.73 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.169 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -89.63 124.23 34.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.651 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.49 HG22 HD23 ' C' ' 69' ' ' LEU . 72.8 p -75.37 -166.69 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.347 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' C' ' 70' ' ' VAL . 95.4 mt -59.45 -28.17 66.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.394 . . . . 0.0 109.993 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 14.3 p -103.71 -178.38 3.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.227 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.23 -19.12 56.86 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -53.21 129.66 32.11 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.975 0.417 . . . . 0.0 110.618 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.7 m -124.48 138.82 54.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.684 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 111.94 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.496 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 37.4 m -83.05 129.77 35.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.691 -0.404 . . . . 0.0 109.911 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.56 131.76 53.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.57 114.14 10.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.941 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.439 HG12 ' HD2' ' C' ' 29' ' ' LYS . 24.5 m -136.1 165.43 29.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -107.13 152.36 41.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.1 -37.43 94.04 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.054 1.836 . . . . 0.0 112.096 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -82.27 -8.34 59.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.237 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -58.39 137.35 57.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 50.0 p -79.08 163.52 25.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.786 HD12 HD23 ' C' ' 50' ' ' LEU . 41.3 mm -64.88 -37.39 80.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.804 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -43.4 90.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.46 -41.9 99.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.025 0.44 . . . . 0.0 110.81 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.18 -43.07 98.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.812 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.43 ' HG2' HD11 ' C' ' 43' ' ' LEU . 58.4 mtmt -60.89 -39.48 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.71 91.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.058 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.439 ' HD2' HG12 ' C' ' 17' ' ' VAL . 68.0 mttm -60.61 -40.08 90.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.18 -40.39 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.111 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.96 -44.31 94.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.201 0.524 . . . . 0.0 110.206 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -74.24 -17.86 60.82 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -101.02 -4.62 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -149.56 -46.01 0.14 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 110.456 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 3.26 26.62 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.072 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.48 HG22 ' HG3' ' C' ' 41' ' ' GLN . 32.7 mm -65.99 117.22 40.3 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.863 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.39 150.17 86.21 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.108 1.872 . . . . 0.0 112.089 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.88 -38.05 67.54 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.996 1.798 . . . . 0.0 112.482 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.26 -40.22 96.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.819 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.44 -4.61 59.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.48 ' HG3' HG22 ' C' ' 36' ' ' ILE . 45.3 mt-30 -84.68 103.1 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.166 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.53 103.2 12.46 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.43 HD11 ' HG2' ' C' ' 27' ' ' LYS . 58.0 mt -100.34 119.91 39.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -127.46 128.22 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.138 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -129.33 126.75 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 110.798 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.03 27.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.727 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.86 2.08 89.99 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -106.38 117.59 34.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -69.28 127.78 34.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.786 HD23 HD12 ' C' ' 23' ' ' ILE . 7.8 mp -74.82 98.17 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.121 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.07 146.58 47.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.136 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.03 137.7 58.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.482 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.96 -17.0 57.86 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -83.44 175.27 9.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.706 0.289 . . . . 0.0 110.263 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -121.58 164.61 16.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.68 -40.14 96.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.469 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.0 p -64.1 -26.26 68.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.989 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.864 0.364 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -104.02 14.03 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.346 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 57.06 40.2 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.401 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.506 ' CD1' HD21 ' C' ' 50' ' ' LEU . 83.3 mt -90.66 107.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.157 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.81 -173.48 3.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.285 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -67.0 150.2 49.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.059 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 55.44 39.86 31.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.024 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -93.46 126.64 38.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.097 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.528 ' C ' HD12 ' C' ' 67' ' ' LEU . 43.8 m -76.18 129.18 36.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.157 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.528 HD12 ' C ' ' C' ' 66' ' ' THR . 8.7 mp -119.11 146.55 45.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.395 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.33 112.58 24.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.551 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.49 HD23 HG22 ' C' ' 7' ' ' THR . 51.3 tp -104.46 121.57 43.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.666 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.425 ' HA ' HD21 ' C' ' 8' ' ' LEU . 97.2 t -121.51 138.06 53.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.893 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.455 HD22 ' CG2' ' C' ' 36' ' ' ILE . 22.7 mt -103.07 137.37 41.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.114 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -72.2 143.02 49.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.792 0.33 . . . . 0.0 110.86 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.19 -39.32 92.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.971 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 mmt-85 58.65 22.8 10.28 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.688 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.46 -41.36 99.53 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.05 -131.05 51.85 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 118.1 -0.953 . . . . 0.0 110.477 179.749 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -62.65 161.57 12.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.093 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.602 HD13 HD21 ' D' ' 56' ' ' LEU . 12.7 pt -139.55 139.32 38.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.013 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.653 ' HD2' HG21 ' D' ' 12' ' ' THR . 3.9 m-85 -83.4 121.38 27.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.465 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -110.26 98.76 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -84.59 123.81 30.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 110.917 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.428 HG22 HD13 ' D' ' 69' ' ' LEU . 80.9 p -86.66 173.45 9.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.981 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.519 HD11 ' H ' ' D' ' 71' ' ' LEU . 70.6 mt -63.14 -24.67 68.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -71.89 -14.78 62.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.68 -15.54 59.64 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -70.92 141.8 51.12 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.653 HG21 ' HD2' ' D' ' 4' ' ' PHE . 95.6 m -104.88 132.61 50.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.083 0.468 . . . . 0.0 110.96 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.67 101.52 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.174 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -83.53 122.7 28.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.634 HD21 ' HD2' ' D' ' 33' ' ' LYS . 79.2 mt -121.98 129.13 52.22 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.823 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.59 115.49 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.654 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.422 HG12 ' HE3' ' D' ' 29' ' ' LYS . 16.2 m -136.93 177.07 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.99 156.22 69.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.392 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.27 -43.55 54.95 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.935 1.757 . . . . 0.0 112.073 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 82.7 p -72.35 -14.66 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -57.8 138.82 55.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.963 0.411 . . . . 0.0 110.638 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -80.97 161.66 24.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.785 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.645 HD12 HD13 ' D' ' 50' ' ' LEU . 49.7 mm -64.24 -41.29 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.081 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -58.3 -35.78 72.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.322 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -65.14 -43.48 91.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.483 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.621 HG21 HD11 ' D' ' 56' ' ' LEU . 78.1 t -62.41 -41.81 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -60.55 -39.03 86.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.227 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.4 90.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 0.0 110.136 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.501 ' CB ' HD13 ' D' ' 15' ' ' LEU . 66.7 mttm -60.44 -39.08 86.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.928 HD11 HD21 ' D' ' 43' ' ' LEU . 91.1 mt -63.81 -40.75 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.096 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.06 -41.38 92.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.23 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.59 -41.4 97.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.634 ' HD2' HD21 ' D' ' 15' ' ' LEU . 76.6 mttt -78.38 -76.73 0.18 Allowed 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.779 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.58 152.9 24.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.86 53.02 4.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mm -107.92 113.9 60.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.967 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.61 155.78 62.46 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.94 1.76 . . . . 0.0 112.147 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.72 -27.05 49.96 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.337 2.025 . . . . 0.0 112.603 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -83.36 -1.66 53.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.447 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -114.47 -49.18 2.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.557 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.485 ' HA ' HD21 ' D' ' 69' ' ' LEU . 0.8 OUTLIER -70.12 128.1 35.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.037 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mmt-85 -126.99 102.51 7.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.928 HD21 HD11 ' D' ' 30' ' ' ILE . 91.3 mt -76.13 125.55 29.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' D' ' 49' ' ' GLN . 72.3 mt -130.59 130.76 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.0 t80 -151.77 155.29 37.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 70.23 21.6 5.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 0.04 85.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.511 ' HB3' HD22 ' A' ' 73' ' ' LEU . 3.0 ptm180 -136.08 149.74 48.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.505 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.415 ' HA ' HG23 ' D' ' 44' ' ' ILE . 20.3 pt20 -68.48 148.28 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.473 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.645 HD13 HD12 ' D' ' 23' ' ' ILE . 68.0 mt -83.01 117.11 22.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.691 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -76.12 137.99 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.1 142.81 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 0.0 110.345 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.98 -15.84 62.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -83.11 163.8 20.65 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.699 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -104.77 171.09 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.222 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.621 HD11 HG21 ' D' ' 26' ' ' VAL . 5.1 mp -71.27 -38.81 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.071 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -62.77 -25.82 68.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.54 -37.73 87.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.113 0.482 . . . . 0.0 110.374 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.19 11.3 34.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.274 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 56.14 40.19 30.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 110.435 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -85.56 109.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -94.22 178.1 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.673 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.25 146.09 49.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 63.61 14.71 8.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.331 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -63.37 135.11 56.76 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -91.1 121.97 33.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.93 0.395 . . . . 0.0 110.313 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.521 HD23 HD11 ' D' ' 50' ' ' LEU . 5.4 mp -118.07 144.85 45.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.333 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -90.48 129.75 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.515 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.615 HD11 HG21 ' D' ' 30' ' ' ILE . 3.2 tt -104.24 101.53 11.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.798 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 56' ' ' LEU . 60.0 t -87.74 132.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.519 ' H ' HD11 ' D' ' 8' ' ' LEU . 57.2 mt -98.51 134.59 41.26 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -135.68 168.28 19.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.762 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.91 146.0 55.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.156 0.503 . . . . 0.0 111.096 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -69.06 176.41 3.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.725 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.7 -39.76 95.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.56 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -80.88 142.77 33.27 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.166 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.17 115.26 27.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.87 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' HD12 ' A' ' 57' ' ' ILE . 98.0 mt -66.81 -36.7 82.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.361 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -151.22 163.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.419 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.77 122.84 0.34 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.224 0.535 . . . . 0.0 110.988 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -156.21 159.54 39.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.034 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -77.9 118.79 20.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.636 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.45 139.87 20.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.955 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.17 151.53 17.55 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -88.06 154.77 20.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.968 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.6 mtp -122.33 171.75 8.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -121.94 125.84 47.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.472 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 37' ' ' THR . 22.5 tp -107.29 119.2 38.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.443 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -119.11 107.83 13.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.805 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 -94.28 0.63 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.0 p -133.98 21.54 3.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.459 0.171 . . . . 0.0 110.79 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.634 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.8 m -124.46 131.23 53.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.533 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' CG2' HD13 ' A' ' 33' ' ' LEU . 76.6 t -110.41 125.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.107 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.442 HG22 ' HB3' ' B' ' 947' ' ' PRO . 21.7 p -119.8 138.07 26.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.623 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.55 142.84 29.9 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.84 1.693 . . . . 0.0 112.405 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.66 135.73 44.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.614 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.84 -6.78 47.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.934 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -77.72 62.2 2.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -56.02 133.8 52.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.62 -152.08 7.81 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -138.2 125.01 21.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.67 107.02 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.4 p90 -131.08 152.72 50.08 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.791 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.4 mt -120.57 140.52 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -140.66 143.49 35.16 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.624 0.577 . . . . 0.0 109.831 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -107.23 127.44 53.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.309 0.576 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' CD2' ' A' ' 58' ' ' HIS . 22.7 p -86.58 172.1 10.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.952 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -11.34 22.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.662 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.52 3.45 47.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.46 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.6 m 64.79 22.89 12.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.154 0.502 . . . . 0.0 111.065 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.75 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 65.9 mt -102.5 126.08 49.43 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.577 HD12 ' CD1' ' A' ' 23' ' ' LEU . 46.7 mm -80.56 126.87 39.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.3 m-70 -103.78 117.74 35.07 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.489 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -94.34 107.97 19.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -120.87 144.04 48.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.708 0.766 . . . . 0.0 112.681 -177.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -125.09 112.09 16.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.616 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -105.34 133.09 50.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.345 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.51 138.55 47.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.053 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.8 -18.55 50.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.607 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.4 m -60.53 -45.79 92.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.5 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.6 m -116.84 -13.93 10.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.5 23.66 76.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -102.56 144.15 31.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.383 . . . . 0.0 110.987 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.7 t -73.79 108.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -89.56 -25.97 21.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.751 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -127.76 143.4 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.566 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 73' ' ' LEU . 66.8 t0 -158.11 94.62 1.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.544 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 72' ' ' ASP . 30.6 mt -126.43 134.19 51.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.822 0.344 . . . . 0.0 110.872 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.3 mt -77.23 127.15 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.306 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.521 ' HB ' HD22 ' A' ' 128' ' ' LEU . 27.2 mm -111.53 121.79 64.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.746 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.75 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 59.7 m-85 -94.77 163.48 22.26 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.055 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.04 137.85 77.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.0 1.8 . . . . 0.0 111.755 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.34 12.44 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.584 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -89.85 -34.01 16.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 120.764 0.316 . . . . 0.0 110.428 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -141.52 145.44 35.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.103 0.478 . . . . 0.0 111.341 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.8 tt0 -123.95 131.97 53.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.344 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.8 118.43 36.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -142.61 167.31 22.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.084 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -89.74 160.63 16.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 t -113.75 89.25 15.49 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.381 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.67 60.35 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.946 1.764 . . . . 0.0 111.642 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -114.85 -39.88 3.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.118 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.1 t -121.21 87.95 44.88 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.237 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.14 130.72 24.87 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.656 1.571 . . . . 0.0 111.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 168.81 -40.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.67 -149.04 5.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.286 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.48 105.79 12.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.347 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.2 t -121.66 126.62 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.704 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.61 154.02 33.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.06 133.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.126 0.489 . . . . 0.0 110.283 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 81' ' ' GLU . 57.2 tp -102.92 122.88 45.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -119.73 133.52 55.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.032 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 51.7 m-85 -88.61 115.09 25.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.87 -32.65 72.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.507 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.24 -23.7 9.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.967 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.91 -25.84 68.35 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.997 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.81 7.3 5.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HD3' HD21 ' A' ' 105' ' ' LEU . 9.1 ttmm -96.54 148.75 22.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.857 0.36 . . . . 0.0 110.732 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -129.37 133.15 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.918 0.389 . . . . 0.0 110.601 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.453 HD21 ' HD3' ' A' ' 103' ' ' LYS . 45.9 mt -120.42 148.0 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.711 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.6 136.74 54.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.769 0.319 . . . . 0.0 111.394 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.02 154.07 48.19 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.378 0.609 . . . . 0.0 111.554 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -130.45 135.8 48.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.351 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 141.81 50.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.256 0.55 . . . . 0.0 110.925 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.62 2.94 4.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.463 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -77.08 155.22 82.58 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.104 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.52 -41.67 38.6 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.251 1.967 . . . . 0.0 113.162 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.89 146.87 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.91 -1.76 56.43 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.46 -18.37 28.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -117.02 -17.67 10.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.695 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.24 -41.21 96.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.819 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.03 -40.66 96.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.03 0.443 . . . . 0.0 111.167 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.32 -40.04 85.91 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.253 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.738 ' O ' HG23 ' A' ' 124' ' ' VAL . 65.0 m170 -61.33 -39.73 91.61 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.59 -45.78 92.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.367 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -64.98 -41.59 95.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.383 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -66.47 -37.05 84.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.45 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.9 t -58.19 -48.35 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.248 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -78.24 -27.28 47.59 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.008 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.7 -37.61 76.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.885 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -80.99 -31.55 34.67 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.804 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 75' ' ' ILE . 51.7 mt -81.58 -27.11 34.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -104.83 -27.66 11.61 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.243 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -133.83 73.2 71.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.76 152.52 62.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.935 2.423 . . . . 0.0 112.345 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 122.384 2.056 . . . . 0.0 112.025 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -128.46 153.42 79.24 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.597 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.64 150.0 68.36 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.374 2.049 . . . . 0.0 112.299 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.46 153.66 91.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.81 161.82 44.73 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.345 2.03 . . . . 0.0 112.301 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.2 -170.26 0.48 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.881 2.388 . . . . 0.0 111.816 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -116.67 158.71 42.87 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.553 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.442 ' HB3' HG22 ' A' ' 39' ' ' THR . 51.0 Cg_exo -56.14 142.66 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.564 2.176 . . . . 0.0 112.105 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.48 165.58 36.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.69 139.57 31.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.37 122.21 37.07 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.821 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 64.3 mt -131.88 122.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.597 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -67.61 83.92 0.18 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.584 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 31.2 t0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.59 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -151.29 170.54 19.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.127 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.614 HG22 ' HB3' ' C' ' 65' ' ' SER . 5.2 pt -143.41 147.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.861 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.75 111.96 24.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -93.47 110.86 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.357 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.83 122.1 31.06 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.086 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 58.1 p -74.59 -170.02 0.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' C' ' 70' ' ' VAL . 95.4 mt -60.26 -21.81 62.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.308 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 9.4 p -113.79 -171.63 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.379 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.83 -18.73 59.99 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.87 131.0 45.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.409 . . . . 0.0 110.402 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 83.3 m -127.75 139.33 52.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.304 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.427 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -122.62 111.08 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.759 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.33 128.8 34.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.705 0.288 . . . . 0.0 110.265 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.773 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.9 mt -125.66 133.86 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.15 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.99 120.63 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.972 0.415 . . . . 0.0 110.293 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.749 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 32.8 m -138.49 177.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.965 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.415 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.7 mt-10 -122.71 155.19 63.5 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.327 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.63 -27.61 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.945 . . . . 0.0 112.312 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -91.83 -9.84 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.516 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -60.69 141.18 57.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.815 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -79.09 160.21 27.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.49 -37.65 80.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.34 -41.99 85.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.017 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.14 -40.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 110.185 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.458 HG21 HD21 ' C' ' 56' ' ' LEU . 54.9 t -62.04 -42.87 96.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.798 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.492 ' HG2' HD11 ' C' ' 43' ' ' LEU . 54.6 mtmt -60.01 -39.73 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.97 93.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.497 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.749 ' NZ ' HG12 ' C' ' 17' ' ' VAL . 75.4 mttt -60.35 -39.09 85.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.227 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.69 -37.99 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.071 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.09 -38.85 80.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.071 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.31 -50.35 47.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.773 ' HG3' HD21 ' C' ' 15' ' ' LEU . 5.0 mttt -63.28 -40.85 98.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.682 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -133.21 148.9 52.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.174 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.02 59.57 2.67 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.591 ' CG2' HD22 ' C' ' 71' ' ' LEU . 28.9 mm -111.16 103.69 55.22 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.81 150.61 70.11 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.227 1.952 . . . . 0.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.61 -37.97 54.19 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.174 1.916 . . . . 0.0 112.278 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.76 -38.58 91.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.556 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.84 -2.88 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.189 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.576 ' HG3' HG22 ' C' ' 36' ' ' ILE . 91.1 mt-30 -89.44 94.14 9.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.29 109.47 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' C' ' 27' ' ' LYS . 33.9 mt -104.11 119.98 40.12 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.622 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.86 120.55 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.228 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -66.87 -46.68 74.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.55 79.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.936 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.88 88.86 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.528 ' CE ' HD22 ' D' ' 73' ' ' LEU . 7.5 mtpp -126.69 126.63 43.83 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.961 0.41 . . . . 0.0 110.733 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -76.75 146.09 38.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.36 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.558 HD11 HD23 ' C' ' 67' ' ' LEU . 59.8 mt -95.7 112.64 24.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.611 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.07 148.35 36.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.17 -40.15 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.105 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.67 -12.05 66.61 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 166.48 13.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.079 0.466 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 77.6 p -117.42 165.67 13.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.191 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.458 HD21 HG21 ' C' ' 26' ' ' VAL . 77.2 mt -60.92 -40.53 93.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.905 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -64.36 -23.92 67.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.891 0.377 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.41 -34.53 75.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.729 ' OH ' HD21 ' D' ' 73' ' ' LEU . 69.5 m-85 -99.88 16.95 22.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.036 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 57.28 37.59 28.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.632 HG23 ' OG ' ' C' ' 65' ' ' SER . 86.6 mt -84.79 117.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.19 -176.56 3.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.676 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.53 145.3 33.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.906 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 60.56 25.73 15.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.393 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' SER . . . . . 0.632 ' OG ' HG23 ' C' ' 61' ' ' ILE . 2.4 t -73.93 124.06 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.037 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -85.83 128.1 34.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.558 HD23 HD11 ' C' ' 50' ' ' LEU . 1.5 mp -118.5 149.89 40.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.49 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -94.19 119.47 33.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.83 124.15 49.1 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.281 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.477 ' HA ' HD21 ' C' ' 8' ' ' LEU . 99.6 t -121.41 133.06 69.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.591 HD22 ' CG2' ' C' ' 36' ' ' ILE . 17.5 mt -105.15 136.33 44.85 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -75.95 146.38 39.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' LEU . . . . . 0.535 HD21 ' HB2' ' C' ' 77' ' ' ASP . 62.8 tp -114.92 128.36 56.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.372 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -88.74 117.28 27.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.124 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.96 -171.58 54.49 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.55 179.87 50.4 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' ASP . . . . . 0.535 ' HB2' HD21 ' C' ' 73' ' ' LEU . 65.1 t0 . . . . . 0 C--O 1.222 -0.375 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.38 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.04 161.67 18.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -142.07 139.82 30.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.364 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -83.27 122.86 28.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -106.52 109.19 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.318 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -80.0 114.99 19.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.843 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.58 ' CG2' HD11 ' D' ' 13' ' ' ILE . 59.9 p -70.66 176.29 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -26.16 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -108.46 -175.96 2.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.906 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.58 -20.66 59.47 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -53.77 133.38 42.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 110.494 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -124.2 137.39 54.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.58 HD11 ' CG2' ' D' ' 7' ' ' THR . 0.1 OUTLIER -123.54 112.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.404 -179.022 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 28.8 m -84.11 127.2 33.76 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.296 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.626 HD21 ' HD2' ' D' ' 33' ' ' LYS . 87.4 mt -120.86 130.7 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.572 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.87 115.22 10.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.486 HG12 ' HE3' ' D' ' 29' ' ' LYS . 21.4 m -135.61 164.32 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.66 153.71 39.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.453 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -37.01 91.43 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.236 1.957 . . . . 0.0 112.026 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.1 p -82.26 -7.4 59.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.185 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.73 136.51 58.02 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.915 0.388 . . . . 0.0 110.904 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -80.04 162.88 24.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.761 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.06 -37.67 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.614 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.35 -43.22 92.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.274 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.24 -40.4 96.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.184 0.516 . . . . 0.0 110.59 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.503 HG12 HD21 ' D' ' 43' ' ' LEU . 69.6 t -62.94 -42.39 96.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.469 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.507 ' HG2' HD13 ' D' ' 43' ' ' LEU . 57.3 mtmt -60.25 -39.81 88.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.115 0.484 . . . . 0.0 110.362 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -39.71 91.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.332 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.486 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.9 mttm -60.48 -38.79 85.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.428 ' CD1' HD11 ' D' ' 43' ' ' LEU . 90.2 mt -63.37 -41.05 91.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.035 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.5 -40.36 96.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.626 ' HD2' HD21 ' D' ' 15' ' ' LEU . 52.3 mttt -78.03 -64.81 1.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.286 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -97.81 161.25 13.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.235 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.99 53.68 3.77 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.727 HG22 ' HG2' ' D' ' 41' ' ' GLN . 33.8 mm -109.28 107.56 59.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.63 150.94 69.66 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.081 1.854 . . . . 0.0 112.03 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.27 -20.63 8.35 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.297 1.998 . . . . 0.0 112.612 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -92.75 19.85 7.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.606 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -152.49 26.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.624 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.727 ' HG2' HG22 ' D' ' 36' ' ' ILE . 1.3 mt-30 -118.86 95.86 5.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' D' ' 70' ' ' VAL . 82.6 mtp180 -96.19 100.17 11.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.672 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.566 ' HB3' HD12 ' D' ' 50' ' ' LEU . 7.5 mp -85.66 122.33 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' D' ' 49' ' ' GLN . 67.1 mt -128.28 131.48 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.546 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.492 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 72.2 t80 -153.25 157.55 40.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.68 18.89 7.47 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.796 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.27 -5.9 78.43 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -130.94 149.11 52.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.562 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.522 ' HA ' HG23 ' D' ' 44' ' ' ILE . 18.5 pt20 -66.79 140.53 57.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.37 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.566 HD12 ' HB3' ' D' ' 43' ' ' LEU . 69.2 mt -81.68 123.51 28.78 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.621 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.67 139.39 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.177 0.513 . . . . 0.0 110.612 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -63.41 138.99 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.316 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.89 -12.52 64.12 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -80.22 172.07 14.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -115.29 157.53 23.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.226 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.99 -40.82 96.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.542 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -63.33 -24.14 67.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.456 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -62.54 -37.66 86.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.117 0.484 . . . . 0.0 110.424 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -98.68 14.64 27.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 m120 56.46 38.77 29.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.454 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.87 104.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.91 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.56 179.05 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.39 151.64 27.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 57.87 42.09 23.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.967 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' SER . . . . . 0.421 ' O ' HD12 ' D' ' 67' ' ' LEU . 30.2 t -90.22 122.73 33.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.268 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -79.69 85.68 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.045 0.45 . . . . 0.0 110.589 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.438 ' N ' HD12 ' D' ' 67' ' ' LEU . 7.1 mp -77.19 154.36 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.891 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -102.64 122.67 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.256 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -104.59 121.49 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.225 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 56' ' ' LEU . 61.3 t -115.62 132.34 65.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt -101.94 123.65 46.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.009 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -63.4 -39.43 94.48 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.797 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.729 HD21 ' OH ' ' C' ' 59' ' ' TYR . 1.0 OUTLIER -117.76 80.57 1.53 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.495 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -61.02 -44.99 96.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.91 -176.52 50.09 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.56 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.628 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -70.28 146.48 50.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -85.44 127.12 34.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.287 0.565 . . . . 0.0 110.293 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' CD1' HD12 ' A' ' 57' ' ' ILE . 86.3 mt -67.53 -36.17 80.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.88 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.74 161.71 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.01 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.99 122.47 0.31 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.165 0.507 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 120' ' ' HIS . 50.6 p90 -155.36 156.16 34.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.857 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.663 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -74.62 119.2 18.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.474 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.86 144.86 25.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.222 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.75 149.12 16.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -91.98 163.47 13.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.3 mtp -124.9 175.96 6.95 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -121.62 121.22 36.9 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.354 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 37' ' ' THR . 30.4 tp -107.68 117.93 35.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.58 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -121.14 114.41 21.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.986 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 -86.68 0.56 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -146.46 22.16 1.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.558 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.603 ' O ' HD12 ' A' ' 33' ' ' LEU . 93.3 m -124.36 129.5 50.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.431 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' HD13 ' A' ' 33' ' ' LEU . 64.2 t -106.33 121.63 59.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.74 HG23 ' HG3' ' B' ' 947' ' ' PRO . 98.4 m -116.05 122.52 32.24 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.515 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -55.41 142.31 80.35 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.178 1.919 . . . . 0.0 112.23 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -108.13 132.66 53.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.879 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -70.63 -6.69 38.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.153 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -72.37 73.17 0.98 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -59.67 135.17 57.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.713 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.15 -154.99 7.02 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.0 tp -140.64 124.93 17.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.34 108.27 21.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.84 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.8 p90 -131.24 153.23 49.73 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.661 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 94.9 mt -121.17 141.21 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.933 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -141.86 140.73 32.98 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.786 0.679 . . . . 0.0 110.269 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -104.35 128.82 52.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.08 0.467 . . . . 0.0 110.399 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.52 HG23 ' CD2' ' A' ' 58' ' ' HIS . 22.7 p -88.09 172.74 9.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.673 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.72 -10.37 19.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -86.15 -0.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.343 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t 69.4 19.65 7.56 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.05 0.452 . . . . 0.0 110.698 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 60.1 mt -103.34 126.95 50.77 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 23' ' ' LEU . 45.5 mm -79.26 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.485 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.7 m-70 -104.95 116.65 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.691 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -92.81 107.25 19.07 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.9 m -118.53 144.79 45.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.653 0.739 . . . . 0.0 112.805 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -125.76 111.18 14.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.745 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -103.3 136.29 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.989 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -76.12 139.58 41.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -79.17 -18.97 52.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.614 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -61.08 -46.29 91.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -117.04 -12.47 10.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.328 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.95 77.16 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.78 147.66 26.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.32 . . . . 0.0 111.028 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.5 103.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.103 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -83.15 -28.74 29.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.28 143.46 51.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.057 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.798 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.5 t0 -158.11 99.98 1.68 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.769 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 72' ' ' ASP . 6.2 mt -132.09 130.13 40.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.0 mt -74.32 129.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.687 HG21 ' SG ' ' A' ' 80' ' ' CYS . 21.4 mm -117.26 120.24 64.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.647 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.6 m-85 -86.02 163.55 42.67 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.191 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.8 136.27 75.39 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.023 1.815 . . . . 0.0 111.525 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t0 61.4 12.06 4.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.44 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.85 -25.32 30.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.889 -0.142 . . . . 0.0 110.778 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 75' ' ' ILE . 10.2 p -147.04 169.17 19.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.253 0.549 . . . . 0.0 110.672 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.93 132.42 30.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.448 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -102.29 117.77 35.47 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -141.74 164.8 29.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.072 0.463 . . . . 0.0 111.461 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -83.81 160.71 21.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.383 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.7 88.43 20.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.45 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.96 59.86 7.64 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.298 1.999 . . . . 0.0 112.038 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -48.83 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.42 102.77 54.79 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.828 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.73 129.6 14.72 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 121.516 1.478 . . . . 0.0 111.478 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 p 167.46 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.7 0.625 . . . . 0.0 110.416 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.35 -179.26 33.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -88.09 114.7 24.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.655 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.12 129.81 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.199 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -119.83 157.3 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.7 p -134.21 136.94 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.5 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.609 HD11 ' SG ' ' A' ' 80' ' ' CYS . 67.6 tp -102.55 121.79 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -118.53 134.37 55.14 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.242 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CE2' HD12 ' A' ' 75' ' ' ILE . 40.1 m-85 -85.75 114.16 22.49 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -37.13 84.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.8 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.06 -22.52 22.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.454 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.44 -169.78 20.39 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.6 p -121.42 13.2 10.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.626 0.251 . . . . 0.0 110.572 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.467 ' HD3' HD21 ' A' ' 105' ' ' LEU . 14.3 ttmm -85.87 142.6 28.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.847 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -135.33 129.22 33.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.314 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' VAL . 46.2 mt -112.48 150.7 30.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.889 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.466 ' CE1' HD22 ' A' ' 33' ' ' LEU . 93.2 m-85 -123.65 135.62 54.02 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.654 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -137.49 152.1 49.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.26 0.552 . . . . 0.0 111.425 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -128.87 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.475 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.25 134.62 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.83 -6.53 11.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.363 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -75.06 150.57 85.76 Favored Pre-proline 0 C--O 1.231 0.119 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.703 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.38 -40.41 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.022 1.814 . . . . 0.0 112.393 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.93 147.67 45.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.8 p -95.99 8.53 43.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.234 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.38 -20.43 43.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -121.45 -15.71 7.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.823 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.79 -40.04 93.81 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.663 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.02 -40.98 99.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.14 -40.02 86.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.174 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.74 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.3 m170 -60.57 -39.67 88.84 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.1 m -62.05 -41.98 98.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.718 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -66.83 -40.91 88.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.192 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -67.22 -36.72 82.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.8 t -58.32 -48.49 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.083 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -78.56 -25.49 45.4 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.026 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.22 -37.68 75.09 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.452 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -82.05 -31.7 30.77 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.727 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.4 mt -81.33 -20.67 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.038 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -114.97 -18.23 11.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.279 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -146.42 73.83 12.84 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.848 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 161.28 43.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.771 2.314 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.718 2.279 . . . . 0.0 112.145 -179.638 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -71.38 152.97 94.12 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.21 147.23 65.98 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.497 2.131 . . . . 0.0 111.944 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.02 154.74 77.65 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.11 150.2 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.228 1.952 . . . . 0.0 112.46 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.99 -153.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.503 2.135 . . . . 0.0 111.581 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -129.5 158.86 72.04 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.526 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.74 ' HG3' HG23 ' A' ' 39' ' ' THR . 50.8 Cg_exo -56.45 140.42 89.04 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.71 2.273 . . . . 0.0 111.974 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -155.69 165.6 36.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.07 138.08 32.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.864 0.364 . . . . 0.0 110.62 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -122.31 123.51 41.57 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.815 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 122.43 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -72.53 84.09 1.12 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.106 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 38.4 t0 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.797 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -62.23 157.69 18.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.794 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.73 142.04 35.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.302 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.48 125.22 32.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.561 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.885 HG11 HD11 ' C' ' 30' ' ' ILE . 62.5 t -113.44 118.32 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.848 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -90.19 121.17 31.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.205 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.418 HG23 ' O ' ' C' ' 11' ' ' LYS . 80.7 p -78.02 169.81 17.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.867 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.521 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -60.12 -41.16 92.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.218 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -72.07 -8.46 54.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.695 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.04 -12.84 60.61 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' LYS . . . . . 0.418 ' O ' HG23 ' C' ' 7' ' ' THR . 88.8 tttt -63.21 123.24 18.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -98.83 132.39 44.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.964 0.411 . . . . 0.0 111.286 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.416 HD12 HD13 ' C' ' 30' ' ' ILE . 0.0 OUTLIER -128.04 105.5 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.422 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -73.09 128.83 36.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.659 HD13 ' CB ' ' C' ' 29' ' ' LYS . 62.8 mt -120.5 124.53 45.61 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.889 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.81 108.91 2.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.062 0.458 . . . . 0.0 111.071 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.586 HG12 ' HE3' ' C' ' 29' ' ' LYS . 20.5 m -132.45 167.58 26.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.442 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.4 mt-10 -114.12 154.81 46.12 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.93 -29.12 80.93 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.701 . . . . 0.0 111.73 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.5 p -85.27 -12.82 51.54 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.856 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -64.89 142.95 58.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.021 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -83.86 164.14 19.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.491 0.662 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.9 -34.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.34 -43.44 88.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -63.01 -40.8 98.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 110.467 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.565 HG22 HG11 ' C' ' 17' ' ' VAL . 55.6 t -63.72 -42.94 97.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -62.05 -39.63 93.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.194 0.521 . . . . 0.0 110.329 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.06 89.5 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.824 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.659 ' CB ' HD13 ' C' ' 15' ' ' LEU . 66.9 mttm -60.11 -37.97 81.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.885 HD11 HG11 ' C' ' 5' ' ' VAL . 8.4 mm -63.41 -39.63 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.595 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -59.46 -46.75 87.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -62.09 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.772 -0.58 . . . . 0.0 111.136 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.27 -26.16 61.89 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -137.16 -53.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.238 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.0 10.35 8.28 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.55 HG22 ' HG3' ' C' ' 41' ' ' GLN . 62.7 mt -76.14 122.11 86.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.37 160.64 48.09 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.395 1.397 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.69 -39.89 88.46 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.538 2.159 . . . . 0.0 112.828 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.94 -37.06 83.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.246 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.24 21.53 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.725 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.55 ' HG3' HG22 ' C' ' 36' ' ' ILE . 14.0 mt-30 -109.73 -46.55 3.49 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 35.37 77.86 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.033 0.833 . . . . 0.0 110.862 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.684 ' CB ' HD12 ' C' ' 50' ' ' LEU . 84.3 mt -80.53 132.58 35.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -130.05 130.83 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.503 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.73 129.22 43.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.46 26.36 15.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.56 90.53 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.594 ' HE3' HD22 ' D' ' 73' ' ' LEU . 26.4 mtpp -104.49 126.65 51.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.933 0.366 . . . . 0.0 110.02 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.72 132.66 46.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' C' ' 43' ' ' LEU . 68.6 mt -81.71 97.74 8.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 110.31 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.03 139.13 42.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.8 135.87 57.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.263 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.55 -18.65 52.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -81.92 157.15 24.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.683 0.278 . . . . 0.0 110.304 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -99.69 162.21 13.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.065 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.463 HD21 HG21 ' C' ' 26' ' ' VAL . 75.8 mt -61.75 -39.07 90.31 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.28 -22.6 66.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.01 -38.69 89.6 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.2 14.53 25.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 57.05 39.86 28.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.023 0.439 . . . . 0.0 110.335 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.96 117.77 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.033 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -102.58 -170.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.351 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -69.72 152.47 44.62 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.545 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 51.59 39.1 24.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.452 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -90.63 125.03 35.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.515 ' C ' HD12 ' C' ' 67' ' ' LEU . 49.6 m -75.94 130.16 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.249 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.515 HD12 ' C ' ' C' ' 66' ' ' THR . 8.2 mp -119.05 156.17 30.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -105.21 121.49 43.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.448 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.425 HD11 HG21 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -98.54 118.34 35.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.108 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.07 127.12 65.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.243 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.521 ' HG ' HD23 ' C' ' 8' ' ' LEU . 18.9 mt -85.64 144.98 27.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.551 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -100.33 120.97 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.802 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 65.6 tp -122.83 130.06 52.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.281 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -67.46 146.58 53.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.476 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.8 143.79 15.74 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.02 169.6 54.8 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 54.9 p30 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.646 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.84 161.37 18.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.229 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.473 HD12 HD22 ' D' ' 67' ' ' LEU . 9.3 pt -139.75 143.32 30.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.131 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -88.65 119.56 29.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -102.34 108.12 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.11 120.93 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.378 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.464 HG22 HD23 ' D' ' 69' ' ' LEU . 80.2 p -80.91 172.52 13.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.774 HD11 ' H ' ' D' ' 71' ' ' LEU . 87.7 mt -61.15 -37.77 84.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.031 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.12 -8.51 55.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.809 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.42 8.12 60.05 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -81.03 113.67 19.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.849 0.356 . . . . 0.0 110.158 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -86.14 134.2 33.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.685 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.4 mt -129.59 106.7 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.398 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -79.65 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' D' ' 33' ' ' LYS . 75.5 mt -123.77 124.02 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.661 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.04 114.5 7.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.895 0.379 . . . . 0.0 110.25 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.53 HG12 ' CD ' ' D' ' 29' ' ' LYS . 25.9 m -136.24 163.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.492 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' GLU . . . . . 0.43 ' O ' HD12 ' D' ' 56' ' ' LEU . 73.8 mm-40 -109.43 154.72 42.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.097 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.68 -28.62 86.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.79 1.66 . . . . 0.0 111.728 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 62.7 m -86.27 -10.17 55.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.707 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.7 144.4 57.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.529 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -79.12 162.6 25.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.022 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.602 HD12 HD23 ' D' ' 50' ' ' LEU . 27.4 mm -63.33 -39.23 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.2 -41.46 88.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.091 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.79 -41.01 97.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.117 0.484 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.462 HG21 HD21 ' D' ' 56' ' ' LEU . 58.0 t -62.79 -43.98 99.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.789 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.429 ' HG2' HD11 ' D' ' 43' ' ' LEU . 58.6 mtmt -61.06 -39.73 90.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.09 92.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.45 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.53 ' CD ' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -60.01 -40.71 90.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.558 HD12 ' OE1' ' D' ' 41' ' ' GLN . 91.7 mt -65.05 -41.35 91.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.179 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.95 -40.36 88.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.515 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.94 6.98 7.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.714 ' HG3' HD21 ' D' ' 15' ' ' LEU . 5.3 mttt -114.39 -52.75 2.7 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.635 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -107.42 -0.79 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 18.58 78.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mm -80.25 119.23 75.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.09 154.25 52.31 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.921 1.747 . . . . 0.0 111.822 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.29 -40.01 79.2 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.314 2.009 . . . . 0.0 112.263 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.96 -39.25 91.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.546 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.69 32.2 2.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.558 ' OE1' HD12 ' D' ' 30' ' ' ILE . 8.2 tt0 -136.9 120.14 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -124.48 114.11 19.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.429 HD11 ' HG2' ' D' ' 27' ' ' LYS . 27.1 mt -96.05 128.63 43.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' D' ' 49' ' ' GLN . 66.2 mt -127.67 129.48 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.542 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.7 t80 -147.65 152.51 37.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.22 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.81 15.65 8.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.679 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 89.17 -15.33 58.47 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.649 ' HB3' HD22 ' A' ' 73' ' ' LEU . 41.2 ptt180 -113.78 146.52 39.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.354 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.448 ' HA ' HG23 ' D' ' 44' ' ' ILE . 22.9 pt20 -71.35 139.23 49.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.255 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.829 HD21 HD11 ' D' ' 61' ' ' ILE . 7.7 mp -88.91 114.39 25.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.808 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 51' ' ' GLU . . . . . 0.443 ' O ' HG21 ' D' ' 23' ' ' ILE . 24.1 pt-20 -74.89 -169.12 0.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.672 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.48 -146.2 44.13 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 50.56 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.593 . . . . 0.0 111.446 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -132.6 168.43 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.236 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.462 HD21 HG21 ' D' ' 26' ' ' VAL . 79.2 mt -61.83 -39.68 92.66 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.552 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -64.98 -26.82 68.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.72 -31.12 71.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.059 0.457 . . . . 0.0 109.897 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -101.31 13.15 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.51 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.46 40.04 29.75 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.374 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ILE . . . . . 0.829 HD11 HD21 ' D' ' 50' ' ' LEU . 88.6 mt -89.46 107.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.012 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.38 -177.16 4.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.423 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.93 150.56 49.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.993 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 60.44 45.97 10.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 57.5 m -94.87 123.7 38.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 31.5 m -77.77 80.23 4.23 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.179 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.473 HD22 HD12 ' D' ' 3' ' ' ILE . 10.7 mp -71.06 140.18 50.64 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.209 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -93.89 122.96 36.91 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.259 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.464 HD23 HG22 ' D' ' 7' ' ' THR . 40.3 tp -102.59 120.26 40.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.542 . . . . 0.0 110.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.54 HG11 HD11 ' A' ' 56' ' ' LEU . 91.6 t -111.9 130.87 64.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.596 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.774 ' H ' HD11 ' D' ' 8' ' ' LEU . 54.8 mt -105.69 142.06 36.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.86 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -62.82 -40.27 96.86 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.654 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.594 HD22 ' HE3' ' C' ' 48' ' ' LYS . 2.4 tt -122.9 121.16 35.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.565 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.54 140.81 58.59 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.178 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.66 -12.07 70.12 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.552 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -83.26 138.63 33.51 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.703 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -97.61 116.25 29.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.408 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.7 mt -67.13 -37.3 83.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.771 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.431 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.1 p -150.17 161.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.821 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -173.22 122.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.182 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.44 157.17 38.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.599 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -75.83 123.41 25.61 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.607 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -154.43 146.45 23.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.06 153.63 16.91 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -89.06 174.87 7.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.029 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 23.0 mtp -139.72 172.69 12.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.585 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.51 127.16 49.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 37' ' ' THR . 32.4 tp -107.58 117.19 33.45 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.49 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -120.6 111.84 18.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.813 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.17 -86.21 0.49 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -145.59 20.66 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 0.0 110.792 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.5 m -122.2 130.64 53.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.941 0.401 . . . . 0.0 110.467 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 33' ' ' LEU . 57.5 t -109.07 123.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.1 p -112.89 133.34 21.99 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 147.32 54.51 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.871 1.714 . . . . 0.0 113.055 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -101.5 117.21 34.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.85 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -59.42 -14.6 12.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.03 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -71.78 82.83 0.89 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -59.11 136.85 58.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.102 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.12 -159.64 9.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.971 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.4 tp -138.35 125.17 21.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' A' ' 28' ' ' ALA . 46.1 t -98.36 111.58 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -134.64 154.59 51.44 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.241 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 24' ' ' VAL . 98.0 mt -121.11 138.03 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.14 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.42 133.62 34.95 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 123.675 0.609 . . . . 0.0 110.168 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.424 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.1 tt0 -102.18 126.37 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.031 0.443 . . . . 0.0 110.536 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' CD2' ' A' ' 58' ' ' HIS . 16.4 p -85.72 171.48 11.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.692 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.67 -10.69 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.78 0.41 56.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.631 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t 70.78 21.04 5.34 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.171 0.51 . . . . 0.0 110.314 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD11 HG11 ' D' ' 70' ' ' VAL . 85.1 mt -98.54 121.7 40.81 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.547 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.0 mm -80.5 122.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.497 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.0 m-70 -98.92 115.64 29.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -98.59 107.83 20.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.91 143.12 51.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.551 -0.859 . . . . 0.0 112.941 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -116.95 117.19 29.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.298 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -106.72 146.05 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.355 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.9 128.49 34.58 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.41 -27.72 64.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -58.26 -36.75 73.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.853 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.9 m -116.75 -16.98 10.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.998 0.428 . . . . 0.0 110.241 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.4 21.87 79.18 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -102.4 151.1 22.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.24 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.51 102.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.5 -38.05 62.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.228 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -126.63 145.79 50.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.251 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.578 ' O ' HD23 ' A' ' 73' ' ' LEU . 17.8 t70 -157.47 101.58 1.86 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.184 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' D' ' 48' ' ' ARG . 37.5 mt -128.34 136.73 51.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.881 0.372 . . . . 0.0 110.72 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.3 123.61 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.417 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.522 ' HB ' HD22 ' A' ' 128' ' ' LEU . 26.2 mm -108.75 123.77 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.318 0.58 . . . . 0.0 111.466 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 56.5 m-85 -91.48 162.47 31.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.126 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.63 138.02 79.76 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.21 1.94 . . . . 0.0 111.778 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.1 11.81 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.452 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.37 -36.84 18.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.752 0.311 . . . . 0.0 110.492 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.468 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -140.41 145.12 36.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.506 -178.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.615 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.5 tt0 -121.73 135.24 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.616 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -106.29 120.24 41.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -143.06 166.82 23.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.831 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -84.34 160.13 20.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.087 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.23 89.74 12.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -79.84 60.12 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.799 1.666 . . . . 0.0 112.29 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -114.07 -37.45 4.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.343 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.5 t -130.51 82.77 64.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.05 130.89 26.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.791 1.661 . . . . 0.0 111.477 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p 170.25 -38.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.38 -150.09 5.48 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.47 105.85 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.777 0.323 . . . . 0.0 110.429 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.87 128.23 71.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 110.783 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.31 156.35 40.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.56 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 105' ' ' LEU . 12.4 p -133.15 136.07 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.514 . . . . 0.0 110.232 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 81' ' ' GLU . 57.3 tp -104.56 123.36 47.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -118.08 137.7 52.75 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.081 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -91.94 108.44 19.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.359 0.599 . . . . 0.0 110.056 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.8 -38.26 87.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.694 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.61 -22.38 24.78 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.33 -177.96 30.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -121.03 30.17 6.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.76 155.82 42.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.198 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.477 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.8 mtt180 -136.75 148.25 47.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.632 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 104' ' ' ARG . 36.7 mt -122.97 152.81 40.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.866 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.454 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 97.3 m-85 -125.22 136.86 53.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.87 156.31 47.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.185 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -130.26 137.78 50.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.587 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttm -72.72 133.4 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.17 0.509 . . . . 0.0 111.887 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 4.74 21.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.437 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -71.95 139.58 82.79 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.03 -26.83 42.97 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.845 1.697 . . . . 0.0 112.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.63 141.8 48.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.471 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -98.13 10.87 39.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.588 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -54.28 -21.61 9.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -130.02 16.52 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.1 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -62.17 -47.68 83.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.2 0.524 . . . . 0.0 110.253 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -74.49 -32.98 62.73 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.461 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.04 -46.54 83.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.531 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.791 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.8 m170 -63.87 -40.83 97.47 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.601 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.91 -45.37 94.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.804 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -64.72 -43.85 92.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.453 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.19 -36.28 83.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.881 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.5 t -58.83 -48.33 86.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -77.69 -29.56 51.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.741 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.61 -36.68 76.4 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.618 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -80.02 -31.42 39.61 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.754 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.522 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.0 mt -82.45 -27.67 31.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -103.23 -27.46 12.49 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.0 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -133.23 73.75 73.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.084 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.6 Cg_exo -59.38 156.66 34.62 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.119 2.546 . . . . 0.0 112.034 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.492 1.426 0 C-N-CA 122.486 2.124 . . . . 0.0 112.148 -179.456 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -129.56 152.02 78.97 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.83 146.94 26.83 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.68 2.253 . . . . 0.0 112.149 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.53 153.62 87.65 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.68 158.63 55.22 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.251 1.967 . . . . 0.0 112.021 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.24 -171.81 0.77 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.726 2.284 . . . . 0.0 112.056 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -119.06 159.15 46.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.04 141.91 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.503 2.136 . . . . 0.0 112.324 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.52 162.14 41.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.671 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -87.25 136.82 32.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.621 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -120.88 125.72 48.19 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.415 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.0 mp -130.67 123.14 54.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.588 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -82.06 83.73 7.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.899 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.2 t0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.298 179.494 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.96 157.47 18.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.203 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -139.66 144.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.451 ' HD2' HG21 ' C' ' 12' ' ' THR . 8.1 m-85 -88.93 123.34 33.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.127 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.585 HG11 HD11 ' C' ' 30' ' ' ILE . 80.5 t -109.02 105.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -85.77 127.65 34.59 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.72 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.458 HG22 HD23 ' C' ' 69' ' ' LEU . 73.1 p -77.95 -168.64 1.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' C' ' 70' ' ' VAL . 93.0 mt -59.85 -21.94 61.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.105 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 10.0 p -111.97 -174.39 2.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.147 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.22 -20.06 57.93 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -52.41 129.48 28.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.964 0.411 . . . . 0.0 110.783 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' THR . . . . . 0.451 HG21 ' HD2' ' C' ' 4' ' ' PHE . 88.1 m -125.96 136.72 53.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.602 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -123.12 109.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.653 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.9 m -84.16 132.97 34.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.271 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.766 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.0 mt -126.56 126.9 44.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.5 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.02 108.39 2.6 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 110.866 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.789 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.6 m -131.47 164.03 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.122 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.89 155.05 38.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.312 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.22 -33.92 92.04 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.056 1.837 . . . . 0.0 111.984 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -85.21 -3.91 58.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.152 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.12 136.87 58.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.857 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -79.07 160.53 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.564 HG21 ' O ' ' C' ' 50' ' ' LEU . 47.1 mm -64.29 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.769 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.85 -42.14 88.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -62.07 -42.41 99.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -61.96 -43.83 98.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.912 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.73 -39.62 89.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.285 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.02 89.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.256 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.789 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.7 mttm -59.89 -39.57 85.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.585 HD11 HG11 ' C' ' 5' ' ' VAL . 7.8 mm -64.52 -39.97 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.318 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.62 -39.32 83.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.05 9.61 19.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.766 ' HG3' HD21 ' C' ' 15' ' ' LEU . 2.8 mmtt -113.26 -42.51 3.5 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.7 2.41 8.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.362 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.12 79.43 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.588 HG22 ' HG3' ' C' ' 41' ' ' GLN . 51.5 mt -81.11 128.51 70.59 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.733 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.49 153.11 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.721 1.614 . . . . 0.0 111.62 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.96 -36.19 63.42 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.297 1.998 . . . . 0.0 112.594 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.96 -38.07 84.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -95.85 17.88 14.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.31 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.588 ' HG3' HG22 ' C' ' 36' ' ' ILE . 90.6 mt-30 -112.53 103.73 11.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.138 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.53 109.83 18.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' C' ' 50' ' ' LEU . 69.8 mt -101.19 123.49 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -128.9 127.99 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 128.66 48.61 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.69 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.74 27.03 16.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.41 89.72 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.421 ' HE3' HD23 ' D' ' 73' ' ' LEU . 49.4 mtpt -102.79 126.2 49.83 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.913 0.387 . . . . 0.0 110.179 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.89 130.22 42.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.425 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' C' ' 43' ' ' LEU . 55.7 mt -88.96 82.88 6.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -73.01 173.4 9.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -78.3 171.16 15.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.04 12.68 81.34 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.94 165.68 19.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.981 0.419 . . . . 0.0 110.58 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.42 167.78 11.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' C' ' 56' ' ' LEU . 82.7 mt -61.95 -39.77 93.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -62.82 -28.29 69.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -62.54 -29.27 70.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.419 . . . . 0.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' C' ' 50' ' ' LEU . 68.4 m-85 -102.95 13.46 34.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.29 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 56.35 40.48 29.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.239 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -89.56 108.88 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.073 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -93.09 -174.05 3.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.485 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -67.0 151.48 47.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 54.77 38.66 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -92.51 124.73 36.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.044 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.416 ' C ' HD12 ' C' ' 67' ' ' LEU . 28.0 m -75.94 129.46 36.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.97 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.416 HD12 ' C ' ' C' ' 66' ' ' THR . 6.3 mp -120.45 148.91 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.324 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -93.07 114.61 27.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.458 HD23 HG22 ' C' ' 7' ' ' THR . 54.3 tp -103.93 121.12 42.46 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.565 ' HA ' HD21 ' C' ' 8' ' ' LEU . 95.6 t -119.08 131.4 71.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.827 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.472 ' CD2' HD13 ' C' ' 36' ' ' ILE . 13.3 mt -101.41 80.77 2.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.157 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 55.34 179.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.707 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.22 148.44 43.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.425 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -106.96 145.28 32.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.477 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.17 -39.96 97.88 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.67 161.42 54.23 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.647 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.4 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.6 157.47 17.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.18 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 pt -138.18 147.56 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.059 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -88.68 123.27 32.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.301 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' D' ' 69' ' ' LEU . 64.8 t -108.21 102.7 14.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.636 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -92.94 120.73 33.56 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.664 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.5 p -81.37 173.48 12.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.623 HD11 ' H ' ' D' ' 71' ' ' LEU . 74.6 mt -61.73 -26.78 68.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.147 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -72.29 -12.98 61.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 -13.6 63.06 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 132.95 49.37 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.2 m -103.64 132.58 49.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.661 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.86 108.83 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -81.04 128.65 33.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.484 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.647 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.6 mt -125.17 127.76 47.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.599 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -69.33 114.77 7.88 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.716 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.579 HG12 ' HE2' ' D' ' 29' ' ' LYS . 23.3 m -134.88 165.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.543 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -108.64 153.83 42.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.11 -35.08 94.53 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.928 1.752 . . . . 0.0 112.243 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -86.49 -2.59 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.166 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' D' ' 26' ' ' VAL . 18.8 t70 -61.38 133.68 56.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.668 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.434 HD12 HD13 ' D' ' 50' ' ' LEU . 48.7 mm -64.16 -38.71 83.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.39 -42.05 90.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.1 -41.75 98.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 110.904 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.549 HG23 ' OD1' ' D' ' 21' ' ' ASP . 57.5 t -63.6 -42.24 95.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.484 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.92 -38.83 87.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.84 90.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.064 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.579 ' HE2' HG12 ' D' ' 17' ' ' VAL . 61.4 mttp -59.98 -39.74 86.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.805 ' CD1' HD21 ' D' ' 43' ' ' LEU . 88.9 mt -65.05 -40.48 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.449 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.58 -40.8 93.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -63.66 -43.48 96.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.647 ' HD2' HD21 ' D' ' 15' ' ' LEU . 62.4 mttt -75.24 -72.74 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.134 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -84.63 166.99 16.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.173 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.77 15.08 56.71 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.578 HG22 ' HG3' ' D' ' 41' ' ' GLN . 33.3 mm -70.39 124.8 91.5 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.174 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.93 155.79 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.026 1.817 . . . . 0.0 111.585 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.67 -40.89 82.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.993 1.795 . . . . 0.0 112.971 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.89 -45.28 94.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.898 0.38 . . . . 0.0 110.966 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -69.92 -38.73 76.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.741 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.578 ' HG3' HG22 ' D' ' 36' ' ' ILE . 59.9 mt-30 -54.46 106.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.35 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -118.9 88.12 2.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.805 HD21 ' CD1' ' D' ' 30' ' ' ILE . 77.3 mt -74.39 129.19 37.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.361 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.536 HD12 HG21 ' D' ' 70' ' ' VAL . 79.0 mt -131.0 129.75 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 73.2 t80 -150.69 154.61 37.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.65 19.58 9.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.68 80.13 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -127.38 147.55 50.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 110.45 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -71.61 141.01 49.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.068 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' D' ' 43' ' ' LEU . 82.7 mt -74.9 115.85 14.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.797 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.96 139.54 41.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.87 143.92 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.17 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.67 69.23 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -83.58 179.01 7.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.765 0.317 . . . . 0.0 110.773 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -126.1 163.65 22.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.285 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.79 -39.88 95.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.543 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.07 -29.2 70.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.16 -35.14 76.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 110.122 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' TYR . . . . . 0.474 ' CE2' HD23 ' D' ' 50' ' ' LEU . 59.2 m-85 -97.31 14.15 27.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.246 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.65 40.81 32.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.851 0.358 . . . . 0.0 110.329 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.83 107.24 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.308 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -93.95 177.32 6.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.66 150.49 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.248 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 58.92 40.34 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' SER . . . . . 0.434 ' O ' HD12 ' D' ' 67' ' ' LEU . 30.2 t -97.31 123.4 41.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.186 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 69.0 m -74.97 127.55 33.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.0 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.434 HD12 ' O ' ' D' ' 65' ' ' SER . 5.3 mp -118.22 146.76 44.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.887 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -95.89 117.48 30.68 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.093 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.607 HD11 HD13 ' D' ' 30' ' ' ILE . 0.6 OUTLIER -93.99 97.67 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.1 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.536 HG21 HD12 ' D' ' 44' ' ' ILE . 46.1 t -83.96 134.6 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.095 0.474 . . . . 0.0 110.478 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.623 ' H ' HD11 ' D' ' 8' ' ' LEU . 75.3 mt -105.96 -177.49 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.59 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -127.04 165.15 20.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.571 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.517 ' H ' HD12 ' D' ' 73' ' ' LEU . 1.8 mp -65.75 138.68 58.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -146.55 104.18 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.493 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.0 24.57 76.4 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -74.77 147.51 41.23 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.419 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -89.4 112.26 23.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.331 0.586 . . . . 0.0 109.898 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 51' ' ' GLN . 88.6 mt -65.2 -38.25 89.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.606 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -151.36 162.93 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.115 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -172.82 122.58 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.262 0.553 . . . . 0.0 110.969 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -157.51 159.89 37.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.076 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -75.62 120.64 21.3 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.45 140.81 18.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.074 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.16 150.79 17.11 Favored Glycine 0 C--O 1.226 -0.347 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -95.03 177.38 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.99 0.424 . . . . 0.0 111.068 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.3 mtp -140.35 168.44 19.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.0 m -119.03 120.94 38.7 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 37' ' ' THR . 52.6 tp -101.13 123.43 45.27 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.919 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -119.54 104.02 9.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.091 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -81.14 0.86 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 p -146.84 19.07 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.562 0.22 . . . . 0.0 110.973 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.745 ' O ' HD12 ' A' ' 33' ' ' LEU . 94.7 m -120.85 128.97 53.33 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.535 HG22 HD13 ' A' ' 33' ' ' LEU . 63.5 t -103.0 123.21 56.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.144 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.6 p -110.46 114.5 55.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.54 141.04 95.09 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.121 1.88 . . . . 0.0 112.621 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.98 113.03 24.76 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.58 -18.29 39.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.541 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -75.43 73.57 2.48 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -56.04 137.21 51.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.65 -152.98 8.45 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.508 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.12 124.24 21.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.49 107.28 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.2 p90 -130.96 153.34 49.3 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.927 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 23' ' ' LEU . 96.6 mt -119.54 140.88 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.658 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -136.6 132.93 35.77 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 123.787 0.679 . . . . 0.0 109.936 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.689 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.1 tt0 -100.53 123.46 44.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.09 0.471 . . . . 0.0 110.182 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.449 HG23 ' CD2' ' A' ' 58' ' ' HIS . 7.6 p -84.26 168.86 15.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.787 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.13 -10.38 10.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.929 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -91.03 6.66 43.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.629 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 m 63.88 23.66 13.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.234 0.54 . . . . 0.0 110.93 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 76.8 mt -100.02 122.85 43.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.658 HG21 HD23 ' A' ' 128' ' ' LEU . 50.6 mm -81.06 121.89 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.449 ' CD2' HG23 ' A' ' 52' ' ' THR . 75.6 m-70 -98.77 114.17 26.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.786 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -95.18 107.83 19.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 72.4 m -120.62 146.61 46.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 0.0 112.648 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -125.86 112.68 16.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.583 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -105.16 128.89 53.6 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.829 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.16 136.56 48.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.21 -17.19 58.68 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.714 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.7 m -60.49 -45.25 94.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.593 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.5 m -116.58 -16.28 10.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.77 20.84 79.33 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -102.07 145.82 28.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.656 0.265 . . . . 0.0 110.388 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.6 t -73.27 103.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.091 0.472 . . . . 0.0 110.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -79.91 -32.91 40.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.766 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -126.32 145.27 50.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.202 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.593 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.2 p-10 -160.83 98.32 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 72' ' ' ASP . 34.2 mt -128.26 137.1 51.84 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.12 123.11 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.672 ' HB ' HD22 ' A' ' 128' ' ' LEU . 29.4 mm -111.27 121.05 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.13 0.49 . . . . 0.0 110.599 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.539 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 50.7 m-85 -85.12 163.65 44.7 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.257 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.17 138.33 82.71 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.813 1.675 . . . . 0.0 111.785 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 59.58 12.68 2.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.449 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.2 -38.66 24.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.44 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB3' HD11 ' A' ' 96' ' ' LEU . 85.3 m -129.87 155.78 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.122 0.486 . . . . 0.0 110.99 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 2.1 tt0 -126.11 130.46 51.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.59 117.64 35.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -138.56 162.98 33.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -82.08 161.35 22.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.54 88.89 14.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.331 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.24 60.41 7.38 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.145 1.897 . . . . 0.0 112.084 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -114.45 -39.53 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.44 78.09 76.27 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.59 130.43 40.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.271 1.981 . . . . 0.0 111.178 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 169.12 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.111 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.45 -165.77 12.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.508 ' HD3' HG22 ' A' ' 114' ' ' THR . 4.2 mtt-85 -96.78 105.18 17.26 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.3 t -126.38 128.24 71.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -124.93 160.52 28.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.009 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 105' ' ' LEU . 9.7 p -135.16 135.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 110.044 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 80' ' ' CYS . 58.6 tp -101.61 123.51 45.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -120.39 140.39 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.147 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.413 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 21.6 m-85 -88.34 116.92 26.89 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 98.5 mttt -62.35 -37.38 85.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.832 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.87 -19.78 18.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.533 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -106.58 -178.39 23.11 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.0 m -114.89 13.46 17.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.661 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.611 ' HD3' HD21 ' A' ' 105' ' ' LEU . 25.5 ttmt -84.98 142.81 29.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.227 0.537 . . . . 0.0 110.983 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -136.07 121.47 19.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.556 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.611 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.0 mt -111.35 152.46 27.25 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.79 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CE1' HD22 ' A' ' 33' ' ' LEU . 91.8 m-85 -126.18 136.63 53.08 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.443 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.62 153.77 49.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.249 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -129.66 138.6 51.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.599 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.55 136.25 49.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.82 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -104.94 -1.04 26.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.451 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.0 131.86 65.47 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.296 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.9 -18.6 46.83 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.081 1.854 . . . . 0.0 112.727 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -113.74 140.34 48.35 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.508 HG22 ' HD3' ' A' ' 92' ' ' ARG . 79.1 p -96.06 8.19 44.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.61 -16.97 62.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.604 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -131.98 -5.37 3.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.625 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.38 -41.69 98.81 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.942 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -74.17 -34.53 63.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.956 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.55 -42.31 92.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.156 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.701 ' O ' HG23 ' A' ' 124' ' ' VAL . 67.9 m170 -63.6 -41.74 98.3 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.9 t -60.98 -44.23 97.68 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.299 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -66.79 -43.59 83.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.939 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -63.71 -40.09 95.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 120' ' ' HIS . 47.3 t -58.71 -48.1 86.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.203 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.24 -22.1 42.12 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.406 -0.917 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.85 -39.86 69.42 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' A' ' 23' ' ' LEU . 31.1 m-85 -79.88 -35.89 37.37 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.551 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 75' ' ' ILE . 70.9 mt -71.15 -36.7 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.079 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -98.4 -27.83 13.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.333 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -134.48 73.59 67.99 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.894 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' A' ' 57' ' ' ILE . 35.2 Cg_exo -59.67 155.88 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.958 2.439 . . . . 0.0 112.286 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.544 2.163 . . . . 0.0 112.042 -179.718 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.27 80.97 69.55 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.69 141.92 91.5 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.595 2.196 . . . . 0.0 112.147 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.21 153.6 94.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.063 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.98 149.22 77.22 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.018 1.812 . . . . 0.0 112.244 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -54.96 -172.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.352 2.035 . . . . 0.0 111.851 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.15 159.55 58.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.93 138.84 78.73 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.511 2.141 . . . . 0.0 112.431 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.71 163.87 39.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -86.58 137.63 32.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.359 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -125.18 129.23 49.71 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.188 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.41 129.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -72.32 84.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.83 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.619 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -63.84 159.02 20.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.158 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -138.95 150.84 23.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.983 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -94.11 124.08 37.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.552 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.58 115.61 49.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.192 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -93.35 129.92 39.29 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.506 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.469 HG22 HD23 ' C' ' 69' ' ' LEU . 76.8 p -92.9 175.42 6.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.751 HD11 ' H ' ' C' ' 71' ' ' LEU . 81.9 mt -62.43 -37.7 86.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.295 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -70.05 -10.0 57.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.852 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.36 -11.66 65.2 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.36 130.81 45.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.749 0.309 . . . . 0.0 110.367 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -106.48 131.15 54.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.946 0.403 . . . . 0.0 110.409 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.94 118.21 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.527 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.9 m -85.1 130.37 34.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.303 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.561 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.0 mt -123.41 127.1 47.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.241 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.39 113.72 8.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.825 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.471 HG12 ' CD ' ' C' ' 29' ' ' LYS . 21.3 m -136.43 167.36 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.79 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.601 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.8 mt-10 -116.94 152.24 48.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.56 -43.9 51.45 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.026 1.817 . . . . 0.0 112.485 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.21 -37.13 86.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.242 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -41.65 133.07 2.77 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.106 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -82.4 167.9 18.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.307 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.678 HD12 HD23 ' C' ' 50' ' ' LEU . 35.8 mm -62.03 -35.78 70.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.47 -42.53 87.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.084 0.469 . . . . 0.0 110.377 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.96 -41.38 91.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.231 0.538 . . . . 0.0 110.875 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.541 HG21 HD21 ' C' ' 56' ' ' LEU . 62.9 t -64.43 -46.41 93.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.796 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -62.81 -32.5 73.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.255 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.29 98.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 110.099 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.471 ' CD ' HG12 ' C' ' 17' ' ' VAL . 66.8 mttm -60.78 -39.4 88.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.163 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.745 ' CD1' HD21 ' C' ' 43' ' ' LEU . 93.2 mt -64.64 -40.37 88.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.981 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.86 -42.5 93.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.488 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.15 -40.13 95.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.416 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.561 ' HG3' HD21 ' C' ' 15' ' ' LEU . 18.2 mttt -74.66 -60.73 2.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -106.73 155.33 19.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.83 55.23 4.21 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.592 HG23 HD22 ' C' ' 71' ' ' LEU . 30.4 mm -109.64 113.26 58.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.44 150.66 58.41 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.664 1.576 . . . . 0.0 111.621 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.46 -38.35 43.66 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.193 1.929 . . . . 0.0 112.474 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.24 -39.18 89.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.353 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -89.92 -2.32 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.245 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -86.19 100.7 12.42 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.208 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -104.32 100.46 10.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.745 HD21 ' CD1' ' C' ' 30' ' ' ILE . 59.5 mt -96.7 117.97 32.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.469 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 93.9 mt -126.36 128.26 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -128.41 130.46 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.674 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 24.52 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.73 3.04 90.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.703 ' HE3' HD22 ' D' ' 73' ' ' LEU . 61.2 mtpt -106.96 128.51 54.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.68 133.04 47.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.678 HD23 HD12 ' C' ' 23' ' ' ILE . 7.6 mp -80.33 95.61 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.47 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.22 139.01 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.339 0.59 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -59.43 150.74 25.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.396 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 -13.38 64.66 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -94.9 151.61 19.07 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.255 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -92.26 164.22 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.193 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.601 HD12 ' O ' ' C' ' 18' ' ' GLU . 81.4 mt -62.02 -39.05 90.95 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.577 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -62.48 -23.93 67.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.625 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.71 -38.25 87.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.174 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -96.86 16.21 19.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.339 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 56.28 40.38 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 84.3 mt -91.78 113.52 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.0 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -102.22 -170.83 1.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -69.62 149.08 48.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 57.27 35.54 26.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.629 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -91.28 128.23 37.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.984 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.482 ' C ' HD12 ' C' ' 67' ' ' LEU . 89.6 m -78.97 128.19 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.986 0.422 . . . . 0.0 110.485 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.482 HD12 ' C ' ' C' ' 66' ' ' THR . 8.3 mp -117.0 139.88 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -87.44 111.36 21.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.469 HD23 HG22 ' C' ' 7' ' ' THR . 59.1 tp -102.55 120.6 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.555 ' HA ' HD21 ' C' ' 8' ' ' LEU . 97.9 t -119.4 137.68 52.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.751 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.9 mt -105.55 142.71 34.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.79 -39.71 95.09 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.593 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 67.1 tp -104.04 124.64 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 mmm-85 -73.33 146.7 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.386 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.15 179.29 53.4 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.81 -40.04 97.63 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 t0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.685 179.93 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.01 161.19 24.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.829 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.525 HD13 HD21 ' D' ' 56' ' ' LEU . 16.1 pt -142.87 145.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.015 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -92.24 123.29 35.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.647 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.439 HG11 HD12 ' D' ' 69' ' ' LEU . 93.9 t -103.22 109.8 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.388 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -87.63 120.93 29.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.519 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -80.86 170.98 15.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.787 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.79 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.3 mt -64.35 -25.16 67.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.029 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -86.52 -0.99 57.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.43 -7.32 80.27 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.78 115.66 7.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 70.0 m -92.82 135.62 33.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.252 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.2 105.6 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.11 122.89 26.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' D' ' 29' ' ' LYS . 92.0 mt -122.22 131.86 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.42 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.88 114.4 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.696 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.5 m -133.98 167.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.473 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.34 154.95 44.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.98 -37.89 95.46 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.901 1.734 . . . . 0.0 111.815 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -77.92 -9.95 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.079 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.19 134.66 57.2 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.731 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -79.11 163.08 25.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.226 0.536 . . . . 0.0 110.525 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.835 HD12 HD23 ' D' ' 50' ' ' LEU . 47.2 mm -63.16 -38.27 81.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.91 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.07 -39.89 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -62.38 -41.1 98.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.273 0.559 . . . . 0.0 110.549 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.792 HG21 HD11 ' D' ' 56' ' ' LEU . 73.1 t -63.3 -42.91 98.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.461 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.89 -40.01 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.295 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.42 90.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.172 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.696 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -59.75 -38.71 82.54 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.802 ' CD1' HD21 ' D' ' 43' ' ' LEU . 86.6 mt -64.49 -41.34 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.068 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.51 -45.52 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.243 0.544 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -67.69 -32.01 72.37 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.855 -0.528 . . . . 0.0 111.276 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.438 ' HD2' HD21 ' D' ' 15' ' ' LEU . 7.7 mttm -92.25 -3.51 55.39 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -148.48 -49.91 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.06 10.46 15.79 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.208 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.469 HD13 HD21 ' D' ' 71' ' ' LEU . 33.5 mt -82.14 118.76 73.18 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.885 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.43 153.13 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.943 1.762 . . . . 0.0 111.47 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.36 -40.92 80.75 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.985 1.79 . . . . 0.0 112.184 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.9 -38.94 76.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -62.34 -39.7 93.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.811 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.464 ' HB3' HG21 ' D' ' 36' ' ' ILE . 0.0 OUTLIER -102.72 144.27 31.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.273 0.559 . . . . 0.0 111.384 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -124.89 117.29 23.75 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.802 HD21 ' CD1' ' D' ' 30' ' ' ILE . 73.3 mt -83.78 126.93 33.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.463 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.85 131.4 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.457 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 80.3 t80 -148.47 153.11 38.03 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.916 0.388 . . . . 0.0 111.074 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.02 16.28 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -9.23 72.68 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.407 ' HB3' HD22 ' A' ' 73' ' ' LEU . 12.8 ptm180 -119.74 145.89 46.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.936 0.398 . . . . 0.0 110.277 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.33 141.34 50.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.202 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.835 HD23 HD12 ' D' ' 23' ' ' ILE . 7.1 mp -83.37 111.85 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.951 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -75.32 135.88 40.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.787 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -57.75 149.95 20.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.453 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.44 -16.21 60.48 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -85.77 170.27 12.61 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.336 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -113.13 157.33 21.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.965 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.792 HD11 HG21 ' D' ' 26' ' ' VAL . 3.8 mp -57.91 -39.61 78.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.625 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 88.0 p -63.14 -23.46 67.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.299 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.98 -37.56 87.63 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.131 0.491 . . . . 0.0 109.932 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.74 10.73 39.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.295 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 62.1 t30 57.34 42.54 24.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.396 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ILE . . . . . 0.764 HD11 HD21 ' D' ' 50' ' ' LEU . 66.8 mt -86.51 108.14 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -93.84 175.65 6.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.384 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -58.85 150.76 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 59.25 46.58 12.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.1 t -96.74 123.34 40.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.185 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -80.34 85.84 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.908 0.385 . . . . 0.0 110.347 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.509 HD22 HD12 ' D' ' 3' ' ' ILE . 7.4 mp -73.2 150.06 42.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -99.83 124.87 45.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.36 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.448 HD11 HG21 ' D' ' 30' ' ' ILE . 2.9 tt -101.77 117.51 35.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.918 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.678 HG11 HD11 ' A' ' 56' ' ' LEU . 90.9 t -111.29 129.55 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.79 ' H ' HD11 ' D' ' 8' ' ' LEU . 66.8 mt -104.93 140.4 38.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.344 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.57 -80.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.703 HD22 ' HE3' ' C' ' 48' ' ' LYS . 94.4 mt -139.43 149.06 43.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.736 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -92.65 35.93 1.02 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.379 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.72 23.77 77.3 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.8 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -82.76 138.3 34.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.783 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -92.8 113.28 25.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.279 0.562 . . . . 0.0 109.524 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.55 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.1 mt -65.75 -38.31 88.77 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.609 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.6 162.47 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.796 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.29 122.49 0.37 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.831 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.61 157.68 37.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.877 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 46' ' ' LEU . 81.7 mtt85 -75.58 121.78 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.983 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.57 144.1 22.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.256 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.58 150.65 16.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -90.47 175.16 7.18 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.002 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.4 mtp -138.96 174.17 10.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -124.05 125.71 45.0 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 37' ' ' THR . 25.3 tp -106.58 118.58 37.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -121.37 108.88 14.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.772 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.61 0.51 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -137.5 20.19 2.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.781 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.2 m -122.55 131.73 53.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.1 t -111.48 123.52 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.028 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.5 p -113.5 132.01 22.71 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.147 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.25 146.2 50.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.919 1.746 . . . . 0.0 113.32 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -98.4 119.9 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.45 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -64.0 -14.92 57.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.752 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 -74.45 74.02 1.91 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 109.962 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -49.91 139.35 13.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.762 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.66 -159.09 8.88 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.651 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.1 tp -137.03 125.12 22.92 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.8 t -97.51 110.02 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -133.43 153.71 51.38 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.51 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.7 mt -119.64 139.3 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.093 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -136.8 132.42 34.66 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.651 0.594 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.525 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.2 tt0 -100.77 125.1 47.22 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.1 p -85.34 171.99 11.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -65.16 -9.54 23.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.13 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.55 0.74 56.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t 70.4 21.02 5.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 110.351 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.678 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 74.7 mt -99.23 122.6 42.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.55 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.8 mm -80.6 122.57 36.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.463 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.474 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.9 m-70 -98.65 114.44 26.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.763 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -97.77 107.9 20.5 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 143.96 50.89 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.687 -0.805 . . . . 0.0 113.125 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -118.9 117.12 27.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.569 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -106.34 144.76 32.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.373 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.11 131.31 35.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -72.86 -16.69 61.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.9 m -59.69 -45.16 92.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.367 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.1 m -116.63 -14.01 10.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.92 22.29 77.1 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -102.25 152.66 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.61 102.71 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.221 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -73.44 -37.38 65.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.913 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -127.24 145.18 50.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HD23 ' A' ' 73' ' ' LEU . 66.7 t0 -158.08 99.76 1.67 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 72' ' ' ASP . 35.1 mt -127.34 136.83 52.46 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.3 124.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.272 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 80' ' ' CYS . 29.0 mm -113.46 121.77 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.121 0.486 . . . . 0.0 110.861 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.678 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 67.5 m-85 -88.37 162.8 38.73 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.382 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.42 139.11 86.31 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.972 1.781 . . . . 0.0 111.585 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 59.75 12.82 3.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -86.44 -25.78 25.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.703 ' SG ' HG21 ' A' ' 75' ' ' ILE . 13.7 p -145.92 168.09 21.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.431 0.634 . . . . 0.0 110.38 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -135.24 126.56 28.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.91 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -102.14 116.77 33.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -145.18 167.26 23.19 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.012 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.53 160.02 19.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.131 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.56 89.78 13.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.148 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.74 59.76 7.55 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.925 1.75 . . . . 0.0 112.12 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -114.88 -39.07 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.627 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.4 t -124.0 86.99 53.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.479 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.15 130.0 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.593 1.528 . . . . 0.0 111.486 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p 167.37 -29.69 0.0 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.56 178.52 34.74 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.472 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.01 113.38 20.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 111.122 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.94 127.78 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.03 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -120.44 152.58 37.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.839 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.9 132.75 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.385 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.568 HD11 ' SG ' ' A' ' 80' ' ' CYS . 65.6 tp -102.24 121.35 42.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -119.76 130.81 55.14 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.47 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -79.99 115.23 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.0 -37.67 85.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.385 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.75 21.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.565 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.96 -175.65 22.88 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -116.47 12.96 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.601 0.239 . . . . 0.0 110.534 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HD3' HD21 ' A' ' 105' ' ' LEU . 11.9 ttmm -89.7 142.62 27.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.977 0.417 . . . . 0.0 111.101 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -134.29 133.01 40.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.503 HD21 ' HD3' ' A' ' 103' ' ' LYS . 48.4 mt -115.55 149.44 38.19 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.716 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.31 137.86 54.75 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.608 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -138.63 156.73 47.2 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.241 0.543 . . . . 0.0 111.307 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -131.75 135.58 46.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.272 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 137.7 57.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.66 -0.19 13.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.287 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.99 149.76 73.99 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.49 -31.14 28.0 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.13 1.887 . . . . 0.0 112.765 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -123.63 142.29 51.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.125 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -94.29 5.7 50.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.763 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.04 -21.05 58.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -118.72 -15.14 9.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.0 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.95 -39.58 94.46 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.116 0.484 . . . . 0.0 110.411 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.45 -35.14 79.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.017 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.89 -40.96 83.44 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.126 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 124' ' ' VAL . 65.1 m170 -61.36 -39.47 90.73 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.183 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -61.71 -44.83 96.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.454 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -67.96 -39.41 83.39 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.914 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -66.4 -42.2 88.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.746 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -58.07 -46.48 88.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.021 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -63.97 -38.57 91.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.561 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -75.55 -23.44 56.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.231 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.1 m-85 -87.51 -29.09 21.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 57' ' ' ILE . 73.8 mt -92.85 -18.3 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.614 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -116.33 -18.81 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -137.99 65.37 44.43 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.094 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.49 151.76 70.65 Favored 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.612 2.208 . . . . 0.0 112.243 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 C-N-CA 122.412 2.074 . . . . 0.0 112.147 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.85 154.71 81.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.92 147.19 49.1 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.584 2.189 . . . . 0.0 111.951 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.03 153.87 63.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.36 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.77 144.13 98.48 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.595 2.196 . . . . 0.0 112.209 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.14 -174.77 2.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.32 2.013 . . . . 0.0 111.849 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -111.58 160.27 30.09 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.581 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.75 147.23 89.23 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.687 2.258 . . . . 0.0 112.231 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.08 163.34 39.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.835 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.01 137.34 32.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.648 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -122.42 122.54 39.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.921 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 47.6 mt -132.26 125.13 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -79.23 84.25 5.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.045 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 32.7 t0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.59 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.1 ttp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -58.96 163.19 3.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.029 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.501 HD12 ' CD1' ' C' ' 67' ' ' LEU . 20.1 pt -143.02 139.59 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.006 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.692 ' HD2' HG21 ' C' ' 12' ' ' THR . 5.4 m-85 -83.86 121.91 27.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.27 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.793 HG11 HD11 ' C' ' 30' ' ' ILE . 90.6 t -107.02 106.12 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -87.88 133.84 33.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.301 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.899 HG22 HD23 ' C' ' 69' ' ' LEU . 77.2 p -97.18 170.93 8.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 111.742 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.682 ' CD1' HG23 ' C' ' 9' ' ' THR . 0.3 OUTLIER -66.35 -13.41 60.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.884 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.682 HG23 ' CD1' ' C' ' 8' ' ' LEU . 58.4 p -93.1 -0.5 57.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.488 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.02 -9.41 77.88 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.0 131.46 39.56 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.674 0.273 . . . . 0.0 110.412 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' THR . . . . . 0.692 HG21 ' HD2' ' C' ' 4' ' ' PHE . 97.9 m -107.73 132.57 53.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.897 0.379 . . . . 0.0 110.698 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.41 HD13 HG21 ' C' ' 13' ' ' ILE . 0.4 OUTLIER -120.83 100.68 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.1 m -75.5 127.2 32.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.492 HD13 ' CB ' ' C' ' 29' ' ' LYS . 83.7 mt -120.49 124.64 45.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.602 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.01 112.68 3.96 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.383 0.611 . . . . 0.0 110.701 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.536 HG12 ' HE3' ' C' ' 29' ' ' LYS . 24.1 m -135.24 164.27 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -106.37 153.88 40.17 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.49 -36.48 94.33 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.99 1.793 . . . . 0.0 112.026 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -82.08 -6.56 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -60.44 135.25 57.69 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -76.65 161.39 28.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.903 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' C' ' 50' ' ' LEU . 45.1 mm -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.214 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.28 -39.55 87.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.93 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.54 -42.96 99.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.277 0.56 . . . . 0.0 110.381 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.402 HG22 HG11 ' C' ' 17' ' ' VAL . 54.3 t -62.07 -42.62 95.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.71 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.92 -38.02 84.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.33 89.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.536 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.3 mttm -60.38 -38.14 82.98 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.793 HD11 HG11 ' C' ' 5' ' ' VAL . 6.8 mm -63.55 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.927 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -61.68 -46.05 91.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.85 -13.75 60.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -104.96 -12.49 16.17 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -141.33 -37.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.77 14.42 27.17 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.488 HG21 HD22 ' C' ' 71' ' ' LEU . 34.9 mt -89.16 117.68 68.46 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.12 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.13 146.56 94.03 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.994 . . . . 0.0 111.397 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.99 -39.5 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.049 1.833 . . . . 0.0 112.294 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.99 -31.14 70.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -83.87 -10.5 57.97 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.636 ' HB2' HD11 ' C' ' 69' ' ' LEU . 28.6 pt20 -121.78 145.18 48.31 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.143 0.497 . . . . 0.0 111.105 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -127.66 131.03 49.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.648 ' CB ' HD12 ' C' ' 50' ' ' LEU . 72.7 mt -102.68 122.24 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.105 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -126.97 126.63 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' PHE . . . . . 0.406 ' CD1' HD23 ' C' ' 67' ' ' LEU . 49.7 t80 -116.06 119.94 37.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.946 0.403 . . . . 0.0 110.909 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.54 39.45 30.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.99 14.79 80.04 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.799 ' HE3' HD22 ' D' ' 73' ' ' LEU . 0.3 OUTLIER -112.94 105.7 13.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.42 132.97 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.648 HD12 ' CB ' ' C' ' 43' ' ' LEU . 63.3 mt -84.82 100.13 11.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.65 146.95 39.88 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.37 0.605 . . . . 0.0 111.431 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -63.53 150.43 43.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.249 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.28 -12.63 64.03 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -91.09 167.83 12.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.036 0.446 . . . . 0.0 110.471 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 59.6 p -116.45 163.77 15.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.911 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.33 -39.85 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.2 p -63.31 -24.35 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.591 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.26 -37.96 87.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.117 0.484 . . . . 0.0 110.301 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -96.57 13.35 28.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.71 42.81 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.029 0.442 . . . . 0.0 110.274 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.467 HG23 ' CB ' ' C' ' 65' ' ' SER . 80.8 mt -91.9 116.97 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -101.02 -178.76 3.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.594 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -61.52 144.67 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.185 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 63.77 17.1 10.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' SER . . . . . 0.467 ' CB ' HG23 ' C' ' 61' ' ' ILE . 28.8 t -66.04 131.05 45.29 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -85.26 128.31 34.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 0.0 109.996 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' C' ' 3' ' ' ILE . 68.4 mt -117.25 146.16 43.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -91.32 116.95 29.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.849 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.899 HD23 HG22 ' C' ' 7' ' ' THR . 57.4 tp -97.01 119.58 35.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.1 t -116.65 129.78 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 0.0 110.626 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.488 HD22 HG21 ' C' ' 36' ' ' ILE . 29.8 mt -109.38 135.92 49.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.839 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -70.81 159.03 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.68 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.7 173.68 11.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.33 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -117.55 141.42 48.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.624 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.72 -179.49 52.1 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -137.21 157.75 24.03 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.644 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' D' ' 16' ' ' GLU . 9.8 pt20 -62.22 161.62 10.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.311 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.623 HD12 HD22 ' D' ' 67' ' ' LEU . 12.3 pt -143.46 142.53 25.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -90.4 116.52 28.4 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.822 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.3 102.92 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.452 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.15 124.09 31.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.184 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.47 HG22 HD23 ' D' ' 69' ' ' LEU . 60.7 p -77.46 -171.6 2.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.515 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.583 HD21 ' HA ' ' D' ' 70' ' ' VAL . 89.4 mt -60.16 -18.78 50.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -115.9 -172.88 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.139 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.53 -20.25 58.87 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.79 131.27 34.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.306 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -128.02 140.48 51.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.569 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.83 102.25 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.781 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.78 128.97 34.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.585 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.613 HD13 ' CB ' ' D' ' 29' ' ' LYS . 81.5 mt -127.64 124.17 37.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 16' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' D' ' 2' ' ' GLN . 19.2 pt-20 -68.24 112.49 5.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.249 0.547 . . . . 0.0 110.532 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.733 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.3 m -135.69 165.63 29.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.111 -0.368 . . . . 0.0 110.552 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' GLU . . . . . 0.533 ' O ' HD12 ' D' ' 56' ' ' LEU . 75.2 mm-40 -111.28 154.53 43.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -55.7 -41.3 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.055 1.837 . . . . 0.0 112.253 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -70.29 -15.82 62.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -57.93 136.75 57.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.32 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -81.44 163.83 22.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.159 0.505 . . . . 0.0 110.999 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.46 HD12 HD13 ' D' ' 50' ' ' LEU . 46.5 mm -63.13 -38.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.933 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.78 -40.31 83.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.03 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.6 -43.36 94.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 0.0 110.417 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.486 HG21 HD21 ' D' ' 56' ' ' LEU . 66.8 t -62.49 -47.36 93.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.28 -31.46 72.05 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.89 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.4 97.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.947 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.733 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -60.17 -38.99 84.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' D' ' 43' ' ' LEU . 86.5 mt -64.62 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.913 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.37 -39.21 82.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.98 -45.31 67.6 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.529 ' HD2' HD21 ' D' ' 15' ' ' LEU . 24.5 mttp -68.39 -40.67 81.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.845 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -130.23 148.41 52.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.425 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 59.4 3.04 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' D' ' 41' ' ' GLN . 19.9 mm -111.36 106.95 57.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.02 152.44 51.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.877 1.718 . . . . 0.0 111.306 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.98 -41.49 56.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.952 1.768 . . . . 0.0 112.51 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -68.09 -40.12 82.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.856 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -63.31 -40.31 96.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.724 ' HB2' HD11 ' D' ' 69' ' ' LEU . 1.4 pt20 -94.29 143.59 26.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.264 0.555 . . . . 0.0 111.461 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -131.9 120.52 22.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' D' ' 30' ' ' ILE . 86.9 mt -89.73 122.85 33.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.51 HG23 ' HA ' ' D' ' 49' ' ' GLN . 56.5 mt -131.42 131.14 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.788 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' D' ' 50' ' ' LEU . 70.4 t80 -144.96 152.99 41.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.981 0.419 . . . . 0.0 111.092 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.5 19.04 10.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.528 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.71 -7.68 72.64 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.743 ' HB3' HD22 ' A' ' 73' ' ' LEU . 32.5 ptt-85 -123.53 144.6 49.45 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 110.764 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.51 ' HA ' HG23 ' D' ' 44' ' ' ILE . 15.8 pt20 -62.28 150.03 40.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.194 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.588 HD21 ' HB3' ' D' ' 45' ' ' PHE . 74.9 mt -87.21 120.46 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.124 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -75.58 130.72 39.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.76 137.21 58.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.55 -17.0 54.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -88.85 166.17 14.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.439 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -101.14 168.21 9.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.533 HD12 ' O ' ' D' ' 18' ' ' GLU . 85.1 mt -65.67 -38.89 90.58 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.697 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -63.45 -25.01 68.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.996 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.82 -28.8 70.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.15 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.79 14.98 28.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.552 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 55.44 39.73 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.233 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -88.32 102.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -90.43 -177.66 5.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.915 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.27 145.89 55.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.606 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 66.16 10.38 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.356 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 52.8 m -64.28 135.85 56.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -90.05 112.43 23.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.623 HD22 HD12 ' D' ' 3' ' ' ILE . 9.0 mp -95.03 137.28 34.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.852 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 76' ' ' PHE . 93.8 m-70 -85.71 125.77 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.036 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' D' ' 41' ' ' GLN . 60.4 tp -111.55 124.41 52.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.925 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 56' ' ' LEU . 57.7 t -111.61 130.39 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.957 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 mt -107.27 133.89 51.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.142 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -89.5 -71.01 0.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.771 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.799 HD22 ' HE3' ' C' ' 48' ' ' LYS . 3.9 tt -146.89 139.52 25.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.462 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 74' ' ' ARG . . . . . 0.666 ' O ' HD23 ' D' ' 73' ' ' LEU . 97.0 mtt180 -65.48 139.18 58.48 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.82 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.91 1.89 90.4 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.789 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -69.98 142.13 52.87 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.013 0.435 . . . . 0.0 110.153 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.1 114.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.683 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 57' ' ' ILE . 96.4 mt -66.37 -37.78 86.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.3 p -149.91 162.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.802 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.49 123.13 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -154.17 159.38 41.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.981 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HA ' HD12 ' A' ' 46' ' ' LEU . 78.8 mtp180 -74.96 121.61 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.631 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.29 141.65 17.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.697 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.4 157.66 15.76 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -93.16 153.52 18.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.603 0.24 . . . . 0.0 110.946 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.482 ' HE3' HG12 ' A' ' 38' ' ' VAL . 1.4 mtm -127.02 175.78 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.1 m -126.79 139.08 53.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.758 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.656 HD13 HG22 ' A' ' 38' ' ' VAL . 22.4 tp -117.71 119.0 33.62 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.421 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -120.03 111.01 17.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.26 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 -101.52 0.89 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -127.62 21.66 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.606 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.6 m -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.656 HG22 HD13 ' A' ' 33' ' ' LEU . 48.1 t -108.96 121.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.47 HG22 ' HB3' ' B' ' 947' ' ' PRO . 17.8 p -113.63 133.68 22.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.07 140.85 23.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.94 1.76 . . . . 0.0 112.424 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -97.97 145.25 26.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.82 -6.05 58.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.087 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -73.87 65.7 1.08 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -49.57 132.15 21.23 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.92 -157.98 8.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.139 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.6 tp -138.34 127.52 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.79 110.56 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.344 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -132.89 154.35 50.48 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.305 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.8 mt -117.39 137.57 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.232 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 131.98 37.34 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 123.799 0.687 . . . . 0.0 110.031 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.538 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.5 tt0 -100.52 124.79 46.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.889 0.376 . . . . 0.0 109.997 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.504 HG23 ' CD2' ' A' ' 58' ' ' HIS . 17.1 p -85.88 170.31 12.49 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.459 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -61.85 -13.16 21.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.0 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' OD2' HG11 ' D' ' 70' ' ' VAL . 33.4 t0 -84.66 0.26 50.93 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.402 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 t 68.93 20.42 7.89 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.105 0.478 . . . . 0.0 110.376 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.595 HD11 HG11 ' D' ' 70' ' ' VAL . 72.7 mt -100.06 125.47 46.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.7 mm -80.23 124.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.403 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.504 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -100.89 115.8 31.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.788 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -93.76 108.65 20.38 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.7 m -120.75 147.94 44.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.812 0.815 . . . . 0.0 112.778 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.0 t90 -126.98 114.35 17.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.289 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.49 133.03 52.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.955 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.79 133.05 43.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.447 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -74.35 -18.68 60.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 110.806 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.9 m -59.97 -46.07 90.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.723 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.4 m -116.45 -14.9 10.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.452 . . . . 0.0 110.035 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.9 22.47 78.03 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.59 144.48 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.945 0.402 . . . . 0.0 110.246 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.43 108.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -89.02 -26.34 21.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.715 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 61' ' ' TRP . 40.3 m-20 -127.91 143.7 51.1 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.211 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.636 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.4 p30 -158.34 98.58 1.57 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.378 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' D' ' 48' ' ' ARG . 25.2 mt -127.93 133.74 49.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.79 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.37 125.97 35.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.342 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.606 HG21 ' SG ' ' A' ' 80' ' ' CYS . 24.6 mm -113.06 124.79 70.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.357 0.599 . . . . 0.0 110.83 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HZ ' HD12 ' D' ' 44' ' ' ILE . 78.2 m-85 -91.3 162.54 31.83 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.332 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.4 136.78 77.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.015 1.81 . . . . 0.0 111.434 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 60.79 8.45 1.81 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.609 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -72.89 -36.4 67.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.821 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.782 ' SG ' HD11 ' A' ' 96' ' ' LEU . 18.3 p -143.98 165.49 27.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.437 0.637 . . . . 0.0 110.31 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -125.95 128.17 47.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.303 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -102.87 119.85 39.57 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -148.2 166.72 27.07 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.886 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -80.1 159.84 25.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.114 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.17 89.97 13.0 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.856 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.41 60.78 7.65 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.944 1.763 . . . . 0.0 112.43 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -39.72 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.2 t -129.89 77.33 76.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.68 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.1 130.43 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.391 2.06 . . . . 0.0 111.495 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.45 -43.71 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.34 -160.65 9.05 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.534 ' HG2' HG22 ' A' ' 114' ' ' THR . 1.0 OUTLIER -102.92 106.38 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.79 128.58 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.775 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.12 152.42 47.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.79 138.66 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.367 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.782 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.2 tp -100.87 116.3 32.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -104.17 107.68 18.69 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -75.73 106.05 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.86 -37.79 83.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.47 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.98 -22.61 13.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.744 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.29 -14.48 82.17 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.638 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.5 m 56.15 21.19 4.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' CD ' HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -119.42 153.09 35.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.351 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -131.09 136.3 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.678 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.486 HD21 ' CD ' ' A' ' 103' ' ' LYS . 57.6 mt -120.07 147.22 45.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 94.9 m-85 -114.98 132.47 56.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.98 155.37 49.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.875 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -134.14 135.62 43.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.9 mtp -83.7 136.73 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.5 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -100.74 12.79 36.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.78 129.44 91.15 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.944 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.64 -37.79 94.92 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.822 1.681 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.81 144.91 46.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.83 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 92' ' ' ARG . 69.1 p -90.84 0.7 57.4 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.04 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.9 -20.6 53.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.202 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -113.87 -16.05 12.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.786 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.62 -40.42 94.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.892 0.377 . . . . 0.0 110.703 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -41.32 99.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.004 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.04 -41.96 94.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.814 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.704 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.2 m170 -64.39 -40.44 95.8 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.786 0.803 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.42 -44.82 95.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.126 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -64.19 -43.91 93.62 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.3 -40.97 98.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.984 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 120' ' ' HIS . 61.5 t -59.1 -48.56 86.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.843 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.64 -38.77 90.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.228 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.93 -22.85 55.58 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.606 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.462 ' CE2' HD22 ' A' ' 23' ' ' LEU . 18.6 m-85 -89.88 -28.2 19.39 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.6 mt -92.66 -18.06 23.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -117.25 -17.14 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.265 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -139.76 65.21 31.08 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.207 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.0 156.22 63.25 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 C-N-CA 122.821 2.347 . . . . 0.0 112.359 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.311 -1.417 0 C-N-CA 122.525 2.15 . . . . 0.0 112.262 -179.794 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -127.27 130.78 23.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.439 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.85 146.29 37.59 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.935 1.757 . . . . 0.0 111.968 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.79 153.4 87.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.09 158.03 56.14 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.39 2.06 . . . . 0.0 112.12 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -58.2 -172.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.279 1.986 . . . . 0.0 111.806 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -128.92 158.2 73.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' A' ' 39' ' ' THR . 41.2 Cg_exo -57.65 141.75 95.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.105 1.87 . . . . 0.0 112.326 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.53 165.47 36.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.589 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.92 135.84 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.439 . . . . 0.0 110.542 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -115.32 128.5 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.151 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.22 122.58 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.54 85.5 5.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.087 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.617 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -63.29 158.85 19.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.438 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.04 144.47 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.528 ' HD2' HG21 ' C' ' 12' ' ' THR . 5.3 m-85 -88.02 125.27 34.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.199 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.747 HG11 HD11 ' C' ' 30' ' ' ILE . 92.0 t -111.74 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -99.84 128.48 45.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.784 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.902 HG22 HD23 ' C' ' 69' ' ' LEU . 75.1 p -88.02 179.33 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 111.483 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.495 HD11 ' H ' ' C' ' 71' ' ' LEU . 83.7 mt -62.59 -36.86 84.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.254 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -69.3 -12.17 61.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.804 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.68 63.4 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.5 131.36 48.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.382 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' THR . . . . . 0.528 HG21 ' HD2' ' C' ' 4' ' ' PHE . 99.0 m -107.85 131.92 53.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.16 105.06 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -75.04 131.09 40.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.042 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' C' ' 29' ' ' LYS . 91.9 mt -122.71 129.21 51.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.16 115.94 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.068 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.49 HG12 ' HE2' ' C' ' 29' ' ' LYS . 18.2 m -138.73 165.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.59 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -107.89 155.65 39.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.7 -37.64 95.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.041 1.827 . . . . 0.0 112.015 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -80.93 -7.42 59.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.191 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -58.69 137.96 57.3 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.058 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.06 161.02 26.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 110.952 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 0.445 HD12 HD13 ' C' ' 50' ' ' LEU . 48.5 mm -63.69 -39.21 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.08 -39.11 84.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.864 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.99 -42.75 99.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.396 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.417 HG22 HG11 ' C' ' 17' ' ' VAL . 53.9 t -61.76 -42.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.204 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -39.89 80.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.551 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.85 -41.29 95.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 110.063 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' C' ' 15' ' ' LEU . 11.1 mttp -59.6 -38.63 81.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.747 HD11 HG11 ' C' ' 5' ' ' VAL . 8.8 mm -65.18 -39.9 87.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.984 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.21 -41.96 89.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.823 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -69.48 -50.3 46.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.504 ' HG3' HD21 ' C' ' 15' ' ' LEU . 20.3 mttt -63.97 -41.2 97.63 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -131.67 148.92 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.58 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.42 63.61 2.19 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.632 HG22 ' HG3' ' C' ' 41' ' ' GLN . 45.0 mt -115.97 119.81 36.49 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.28 159.93 48.35 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.779 1.653 . . . . 0.0 111.457 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.05 -31.68 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.041 1.827 . . . . 0.0 112.613 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.75 -42.59 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.961 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.71 -10.8 57.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.412 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.632 ' HG3' HG22 ' C' ' 36' ' ' ILE . 75.3 mt-30 -80.62 86.55 5.86 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.799 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -96.86 103.76 15.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.683 ' HB3' HD12 ' C' ' 50' ' ' LEU . 76.6 mt -95.9 119.36 34.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.122 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.6 127.57 71.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.084 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -129.2 130.34 46.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.521 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.67 28.04 14.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.54 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.97 15.3 81.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.657 ' CE ' HD22 ' D' ' 73' ' ' LEU . 29.4 mtpp -119.37 132.75 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 110.371 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -72.61 131.94 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.106 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.683 HD12 ' HB3' ' C' ' 43' ' ' LEU . 78.2 mt -81.34 97.74 7.84 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.968 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.17 139.83 52.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.781 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.23 143.68 52.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.43 -17.73 58.55 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -84.39 171.38 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.806 0.336 . . . . 0.0 110.105 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -119.0 165.69 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.246 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' C' ' 56' ' ' LEU . 82.5 mt -62.33 -39.83 94.36 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.381 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.97 -27.02 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.248 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.78 -35.98 79.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.206 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.509 ' CE2' HD23 ' C' ' 50' ' ' LEU . 66.3 m-85 -96.51 12.6 30.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.319 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.29 40.67 27.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.342 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -89.58 114.92 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -99.22 -175.2 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.354 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -65.3 150.12 48.79 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.946 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 54.89 42.54 31.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.947 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 45.3 m -96.25 124.46 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.032 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.454 ' C ' HD12 ' C' ' 67' ' ' LEU . 53.3 m -75.01 128.19 34.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.906 0.384 . . . . 0.0 110.074 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.454 HD12 ' C ' ' C' ' 66' ' ' THR . 7.4 mp -118.35 143.46 46.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -89.96 112.08 23.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.07 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.902 HD23 HG22 ' C' ' 7' ' ' THR . 59.2 tp -100.51 120.42 39.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.635 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -117.45 133.83 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.793 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.495 ' H ' HD11 ' C' ' 8' ' ' LEU . 12.4 mt -92.46 122.5 34.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.007 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -71.25 132.81 45.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.501 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -116.65 141.05 48.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.289 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -75.19 144.56 42.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.616 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.24 178.95 52.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.22 -40.26 98.33 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 61.3 t0 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.501 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -68.93 158.32 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.448 HD13 HD21 ' D' ' 56' ' ' LEU . 11.4 pt -138.97 146.5 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.754 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -94.82 122.07 37.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.59 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.688 HG11 HD11 ' D' ' 30' ' ' ILE . 85.8 t -104.42 113.23 40.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.395 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -98.49 130.29 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.719 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.606 HG22 HD23 ' D' ' 69' ' ' LEU . 74.5 p -86.76 -177.56 6.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.203 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.515 HD11 ' H ' ' D' ' 71' ' ' LEU . 52.1 mt -72.83 -17.07 61.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.365 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 56.1 p -90.87 -2.35 57.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.041 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -9.09 75.9 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.47 130.73 44.36 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -111.47 134.1 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.996 0.427 . . . . 0.0 110.979 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.91 109.8 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.351 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.94 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.457 HD21 ' HD2' ' D' ' 33' ' ' LYS . 96.0 mt -122.34 124.86 44.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.204 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.31 114.51 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.563 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.685 HG12 ' HE3' ' D' ' 29' ' ' LYS . 23.7 m -135.33 168.5 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -109.86 154.86 42.37 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.294 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.57 -32.93 91.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.893 1.728 . . . . 0.0 111.893 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -83.19 -6.28 59.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.113 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -60.99 144.9 52.45 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -89.45 161.28 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.73 -38.69 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.088 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.16 -42.66 91.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.084 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -62.86 -40.63 98.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.341 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.558 HG12 HD21 ' D' ' 43' ' ' LEU . 62.4 t -61.91 -42.97 96.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.618 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.589 ' HG3' HD22 ' D' ' 43' ' ' LEU . 58.6 mtmt -61.17 -39.4 90.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.201 0.524 . . . . 0.0 109.951 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.35 90.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.685 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.9 -38.09 81.31 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.688 HD11 HG11 ' D' ' 5' ' ' VAL . 6.1 mm -63.01 -41.95 94.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.506 0.67 . . . . 0.0 109.949 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.8 -44.74 96.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.09 -20.33 62.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.457 ' HD2' HD21 ' D' ' 15' ' ' LEU . 8.2 mttm -101.61 -6.14 24.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -145.36 -43.63 0.22 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.28 0.562 . . . . 0.0 110.226 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.97 14.13 12.62 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' D' ' 41' ' ' GLN . 57.4 mt -87.93 119.17 70.4 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.438 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.52 160.14 44.91 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.823 1.682 . . . . 0.0 111.943 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.63 -22.26 59.64 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.418 2.079 . . . . 0.0 112.215 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -87.48 1.36 53.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.443 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -126.42 21.2 7.25 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.652 ' HB2' HD11 ' D' ' 69' ' ' LEU . 22.4 pt20 -162.42 154.97 19.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 111.214 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.23 132.38 35.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.666 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.703 ' HB3' HD12 ' D' ' 50' ' ' LEU . 5.8 mp -91.46 122.26 33.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.547 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.596 HG23 ' HA ' ' D' ' 49' ' ' GLN . 70.0 mt -128.99 132.23 67.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.784 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.532 ' HB3' HD21 ' D' ' 50' ' ' LEU . 87.4 t80 -151.9 155.14 37.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.365 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.68 16.69 7.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 47' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.56 -12.69 62.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.81 ' HB3' HD22 ' A' ' 73' ' ' LEU . 39.8 ptt180 -119.71 146.38 45.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.138 0.494 . . . . 0.0 110.397 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.596 ' HA ' HG23 ' D' ' 44' ' ' ILE . 27.0 pt20 -65.11 142.66 58.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.979 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' D' ' 43' ' ' LEU . 75.9 mt -84.43 114.79 22.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.411 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.51 149.59 38.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.228 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -71.21 165.05 24.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.73 26.82 74.0 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -128.01 157.3 41.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.868 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -100.91 160.79 14.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.277 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.492 HD11 HG21 ' D' ' 26' ' ' VAL . 7.4 mp -62.59 -40.47 97.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.4 p -62.62 -23.63 67.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -62.9 -38.08 89.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.112 0.482 . . . . 0.0 109.907 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.62 13.83 30.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.277 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.91 40.36 28.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.568 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.94 98.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 109.995 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -86.1 178.38 7.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.256 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -60.75 151.68 28.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.289 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 57.13 44.47 22.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 123.42 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.86 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -81.88 96.83 7.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.081 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.407 ' N ' HD12 ' D' ' 67' ' ' LEU . 9.2 mp -84.19 152.47 24.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.04 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -101.87 122.39 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.302 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' D' ' 41' ' ' GLN . 34.1 tp -103.35 114.0 27.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.884 HG11 HD11 ' A' ' 56' ' ' LEU . 64.0 t -106.43 120.07 56.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.515 ' H ' HD11 ' D' ' 8' ' ' LEU . 65.3 mt -82.29 146.6 29.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.804 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -120.9 131.45 54.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.657 HD22 ' CE ' ' C' ' 48' ' ' LYS . 1.4 tt -93.35 125.47 37.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.139 0.495 . . . . 0.0 110.385 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -65.85 134.13 52.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.057 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.29 -17.87 43.07 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.707 179.413 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.3 m120 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -66.85 151.46 47.49 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.032 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.27 115.1 26.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.682 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.1 mt -68.05 -36.86 80.58 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.682 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.09 161.9 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.818 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.0 122.23 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.295 0.569 . . . . 0.0 111.091 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.89 158.61 38.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.924 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HA ' HD12 ' A' ' 46' ' ' LEU . 83.1 mtt85 -77.22 123.23 26.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.602 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 146.28 23.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.221 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.55 151.58 17.04 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -89.73 172.46 8.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.04 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 24.6 mtp -138.22 174.34 10.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.739 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.2 m -124.54 127.27 47.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD22 ' CE1' ' A' ' 106' ' ' PHE . 34.6 tp -107.72 117.2 33.49 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.184 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.97 110.33 16.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.826 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.73 -83.22 0.58 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.15 18.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.473 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.8 m -119.17 130.14 55.36 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 33' ' ' LEU . 64.1 t -108.5 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.6 p -115.64 132.6 23.06 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.044 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.32 146.66 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.552 1.501 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -101.04 121.47 41.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.456 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -62.36 -14.62 41.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -71.29 80.55 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -64.27 130.58 44.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.641 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.03 -154.64 8.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.348 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.5 tp -138.11 127.24 24.3 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.6 110.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.9 p90 -134.17 154.66 51.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.189 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.0 mt -120.36 138.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.63 132.64 37.31 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 123.772 0.67 . . . . 0.0 110.045 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.549 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.2 tt0 -102.01 125.29 48.66 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 58' ' ' HIS . 13.4 p -84.9 171.78 11.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.873 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.85 -10.34 27.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.566 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.31 5.42 47.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.424 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m 64.02 25.16 13.77 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.578 0.704 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.884 HD11 HG11 ' D' ' 70' ' ' VAL . 78.7 mt -101.55 122.77 44.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.7 mm -80.92 123.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.234 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.487 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.1 m-70 -99.45 115.64 29.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.827 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -94.7 108.65 20.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 72.9 m -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.86 0.838 . . . . 0.0 113.108 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -125.67 114.85 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.113 -1.403 . . . . 0.0 107.646 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -106.51 132.74 52.17 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.582 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -74.5 134.22 42.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -75.59 -16.5 60.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.69 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 m -60.41 -44.84 95.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.754 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.9 p -116.47 -17.41 10.66 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.763 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.39 22.01 74.05 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -101.53 153.01 20.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.56 102.47 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -77.21 -32.8 56.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -125.87 144.84 50.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.589 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.61 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.4 t0 -157.34 99.23 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.81 HD22 ' HB3' ' D' ' 48' ' ' ARG . 36.6 mt -130.53 133.83 46.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.771 0.32 . . . . 0.0 110.877 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -78.73 125.45 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.307 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.653 HG21 ' SG ' ' A' ' 80' ' ' CYS . 17.9 mm -111.06 126.15 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.915 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.47 162.2 32.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.351 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.08 138.69 83.54 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.817 1.678 . . . . 0.0 111.235 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.8 t0 59.44 11.74 2.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.731 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.67 -27.05 37.2 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.616 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.653 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.5 p -151.65 166.97 29.61 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.759 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.01 132.33 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.277 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -104.5 118.51 36.78 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -142.39 166.81 23.66 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.719 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.49 159.99 19.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.967 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.03 89.46 19.96 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.8 60.44 7.56 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.829 1.686 . . . . 0.0 112.149 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -113.84 -42.8 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.329 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.1 t -120.22 96.97 49.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.042 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 131.04 18.46 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.122 1.215 . . . . 0.0 111.487 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 168.17 -31.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.985 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.58 -174.31 28.13 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.552 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.483 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.3 OUTLIER -88.72 112.6 23.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.486 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.2 128.83 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.21 152.97 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.4 p -130.62 136.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.149 0.5 . . . . 0.0 110.283 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.4 tp -103.78 120.84 41.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -116.7 120.11 37.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.147 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' HE2' HD12 ' A' ' 75' ' ' ILE . 47.6 m-85 -79.2 113.73 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.43 -37.78 84.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.054 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.89 -23.0 12.51 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.58 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.4 -17.37 79.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.274 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m 58.32 21.19 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.627 -0.337 . . . . 0.0 111.165 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.509 ' HD3' HD21 ' A' ' 105' ' ' LEU . 5.0 ttmt -119.1 151.4 38.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.099 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.436 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.7 mtt180 -131.42 138.4 49.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.0 110.852 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 95' ' ' VAL . 47.3 mt -123.42 153.05 40.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.146 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HD22 ' A' ' 33' ' ' LEU . 97.8 m-85 -124.76 135.76 53.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.819 0.342 . . . . 0.0 110.683 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -139.6 156.67 46.72 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.301 0.572 . . . . 0.0 111.224 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -130.43 138.91 50.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.439 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 77.6 mmm -75.07 139.15 42.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.843 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.56 2.09 33.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.894 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -73.83 146.36 85.27 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.746 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.82 -28.01 17.25 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.999 1.8 . . . . 0.0 112.601 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.77 144.13 48.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.891 0.377 . . . . 0.0 110.334 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 92' ' ' ARG . 82.7 p -91.47 1.15 57.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.922 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.01 -19.51 44.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -118.52 -20.2 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.88 -41.7 98.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.273 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.51 -40.87 96.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.48 -42.44 92.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.415 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.7 m170 -64.44 -39.94 94.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.674 0.749 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.0 t -61.02 -45.83 93.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.491 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -63.42 -43.1 98.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.153 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -65.62 -35.44 80.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.9 t -58.51 -48.35 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.987 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.32 -28.99 53.36 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.777 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.8 -34.99 74.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.97 -31.32 31.24 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -81.48 -26.94 34.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -106.39 -26.82 11.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.477 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.58 73.66 72.23 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.433 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.6 Cg_exo -59.78 151.2 72.47 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.945 2.43 . . . . 0.0 111.964 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.49 1.318 0 C-N-CA 122.394 2.063 . . . . 0.0 112.068 -179.84 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -134.27 154.77 80.15 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.978 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.28 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.268 1.979 . . . . 0.0 111.569 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -73.63 159.0 85.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -54.92 140.77 79.09 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.411 2.074 . . . . 0.0 112.193 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.42 174.12 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.387 2.058 . . . . 0.0 111.84 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -97.11 154.49 38.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.53 147.0 88.73 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.463 2.108 . . . . 0.0 112.105 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.43 161.4 42.64 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.84 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.04 136.21 33.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 0.0 110.572 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -118.69 124.72 48.03 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 951' ' ' ILE . 1.7 mp -130.46 122.69 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.477 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.26 83.97 7.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.932 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.4 p30 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.586 179.571 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.91 160.76 14.11 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -136.94 154.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.082 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' C' ' 14' ' ' THR . 11.7 m-30 -93.53 122.69 36.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.115 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.03 108.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.42 108.25 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.971 HG22 HD23 ' C' ' 69' ' ' LEU . 23.7 p -96.3 -173.32 2.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.571 0.701 . . . . 0.0 111.08 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.489 ' C ' HG23 ' C' ' 9' ' ' THR . 90.7 mt -55.42 159.92 2.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.311 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.489 HG23 ' C ' ' C' ' 8' ' ' LEU . 1.3 p 66.43 6.29 4.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.74 24.46 76.05 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.315 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -83.73 107.0 15.88 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.459 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 94.8 m -87.74 135.99 33.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.796 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -132.42 118.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' THR . . . . . 0.467 HG23 ' CD1' ' C' ' 4' ' ' PHE . 9.7 m -86.7 122.98 31.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.54 128.11 52.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.508 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -70.62 116.37 10.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.858 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.545 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.5 m -135.92 166.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.515 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -111.98 153.76 44.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.091 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 -38.25 93.92 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.062 1.841 . . . . 0.0 112.156 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -81.45 -8.74 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.07 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.72 134.76 57.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -78.57 163.82 25.2 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.043 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.25 -35.74 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.943 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.8 tm-20 -58.44 -40.01 81.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.2 -41.51 94.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.537 HG21 HD21 ' C' ' 56' ' ' LEU . 62.7 t -63.09 -47.59 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.044 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -62.82 -33.35 75.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.053 0.454 . . . . 0.0 110.17 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.05 97.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.545 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.4 mttm -60.34 -39.3 86.62 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.083 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.669 HD13 HD22 ' C' ' 69' ' ' LEU . 92.1 mt -66.17 -39.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.001 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -46.53 88.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.29 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.77 -15.1 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.033 -0.417 . . . . 0.0 111.906 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -101.14 -6.34 24.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -148.61 -41.03 0.16 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.181 0.515 . . . . 0.0 110.501 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 11.17 21.02 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.765 HD13 HD21 ' C' ' 71' ' ' LEU . 73.8 mt -77.52 125.25 86.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.43 158.05 48.55 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.675 1.583 . . . . 0.0 112.05 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.18 -38.62 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.113 1.875 . . . . 0.0 112.274 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.07 -39.93 94.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.906 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.79 -3.63 58.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.404 ' OE1' HG21 ' C' ' 30' ' ' ILE . 10.4 mm100 -80.02 96.2 6.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -96.22 85.28 3.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.578 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.783 ' HB3' HD12 ' C' ' 50' ' ' LEU . 86.8 mt -89.17 113.08 24.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.63 129.03 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.616 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -132.72 132.49 42.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.859 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 24.34 14.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.65 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.94 3.43 90.6 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.344 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.583 ' HE2' HD22 ' D' ' 73' ' ' LEU . 48.3 mtpt -110.69 127.14 55.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.645 -0.326 . . . . 0.0 110.238 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -70.18 134.25 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.783 HD12 ' HB3' ' C' ' 43' ' ' LEU . 59.4 mt -79.6 94.43 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.429 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.06 146.61 39.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.295 0.569 . . . . 0.0 111.038 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -61.44 150.6 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.07 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.85 -17.65 57.5 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -90.2 164.12 14.54 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.211 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.8 p -113.34 167.06 10.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.309 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.537 HD21 HG21 ' C' ' 26' ' ' VAL . 81.5 mt -62.39 -39.41 93.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.384 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -62.96 -26.75 68.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.094 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.08 -35.91 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.777 ' CZ ' HD11 ' D' ' 73' ' ' LEU . 57.9 m-85 -95.52 14.29 23.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.213 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 55.77 40.41 30.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 0.0 110.497 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.71 121.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.977 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.18 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.598 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -58.96 145.12 42.77 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.972 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 59.18 26.17 14.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 123.37 25.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.479 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.439 ' C ' HD12 ' C' ' 67' ' ' LEU . 91.3 m -72.63 130.07 39.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.226 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.439 HD12 ' C ' ' C' ' 66' ' ' THR . 6.5 mp -120.57 143.11 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.288 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -93.24 109.22 20.74 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.971 HD23 HG22 ' C' ' 7' ' ' THR . 24.8 tp -106.66 123.62 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.434 ' N ' HD12 ' C' ' 69' ' ' LEU . 74.5 t -123.11 141.32 43.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.765 HD21 HD13 ' C' ' 36' ' ' ILE . 19.6 mt -109.25 142.59 39.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.332 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.425 ' C ' HD12 ' C' ' 73' ' ' LEU . 84.3 mtp180 -71.94 143.37 49.31 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.708 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 73' ' ' LEU . . . . . 0.425 HD12 ' C ' ' C' ' 72' ' ' ARG . 8.7 mp -112.92 124.03 51.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.327 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.73 -38.78 91.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.655 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.38 95.98 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.08 -131.48 50.17 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.657 -179.898 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -64.13 157.23 26.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.599 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 pt -136.72 152.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.131 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.498 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.4 m-30 -93.46 122.02 35.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.714 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.24 107.47 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.678 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -91.88 125.56 36.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.599 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.665 HG22 HD23 ' D' ' 69' ' ' LEU . 82.4 p -83.32 174.53 10.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.189 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.705 HD11 ' H ' ' D' ' 71' ' ' LEU . 70.7 mt -62.46 -25.95 68.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.076 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p -78.48 -9.45 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 -11.7 66.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.41 134.61 52.87 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.88 0.34 . . . . 0.0 110.124 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -104.3 133.68 48.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.719 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -122.7 113.05 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.644 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' THR . . . . . 0.498 HG23 ' CD2' ' D' ' 4' ' ' PHE . 4.8 m -80.96 125.24 29.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.089 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' D' ' 29' ' ' LYS . 91.4 mt -119.58 116.56 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.716 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.98 108.89 2.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.465 0.65 . . . . 0.0 110.883 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.546 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.8 m -134.49 164.73 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -107.76 155.06 40.5 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.172 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.87 -37.29 96.03 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.864 1.71 . . . . 0.0 111.814 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -79.21 -9.4 59.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.78 136.28 58.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.904 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -79.74 162.94 24.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.39 -38.95 83.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.761 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.51 -41.58 90.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.947 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.89 -41.52 97.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.147 0.499 . . . . 0.0 110.578 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.457 HG22 HG11 ' D' ' 17' ' ' VAL . 68.5 t -63.43 -42.03 94.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.43 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.484 ' HG2' HD13 ' D' ' 43' ' ' LEU . 56.4 mtmt -60.61 -39.34 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 110.245 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.15 93.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.097 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.625 ' HB3' HD22 ' D' ' 15' ' ' LEU . 66.6 mttm -60.37 -39.22 86.45 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.49 ' CD1' HD11 ' D' ' 43' ' ' LEU . 92.4 mt -63.59 -42.12 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.199 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 27.0 tm0? -60.57 -40.08 90.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.636 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -83.52 12.0 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.498 ' HG3' HD21 ' D' ' 15' ' ' LEU . 11.3 mmtt -118.56 -47.89 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -112.08 2.28 16.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.246 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.15 24.8 75.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.509 HG21 ' HB3' ' D' ' 41' ' ' GLN . 13.6 mm -85.82 116.24 64.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.164 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.5 147.2 70.57 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 122.083 1.855 . . . . 0.0 112.32 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.69 -33.06 78.52 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.223 1.949 . . . . 0.0 112.643 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 9.85 31.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -121.14 28.61 7.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.672 ' HB2' HD11 ' D' ' 69' ' ' LEU . 5.3 pt20 -160.53 151.27 18.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.065 0.46 . . . . 0.0 111.142 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -132.0 126.27 33.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.792 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' D' ' 30' ' ' ILE . 6.8 mp -88.74 124.06 33.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.707 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.449 HG21 ' HE1' ' A' ' 76' ' ' PHE . 83.6 mt -127.38 129.11 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.736 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.445 ' HB3' HD21 ' D' ' 50' ' ' LEU . 70.9 t80 -148.59 151.54 35.22 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.997 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.8 17.74 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 47' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 85.49 -8.77 70.21 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.763 ' HB3' HD22 ' A' ' 73' ' ' LEU . 13.0 ptm180 -119.57 145.3 46.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.127 0.489 . . . . 0.0 110.735 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.29 132.41 47.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.967 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' D' ' 45' ' ' PHE . 55.0 mt -81.64 104.94 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.71 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.97 168.29 20.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.474 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -78.39 172.66 13.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.3 21.35 77.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -130.59 157.2 43.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.876 0.37 . . . . 0.0 110.693 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -105.83 162.97 13.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.134 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.88 -39.79 93.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.393 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -63.56 -23.02 67.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.378 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.48 -38.35 86.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.012 0.434 . . . . 0.0 110.233 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -99.23 15.7 25.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.368 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.24 40.82 24.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.264 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -90.65 104.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.23 -171.55 2.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.255 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -68.78 146.4 52.94 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.07 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 63.14 42.34 7.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -99.54 125.71 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.785 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -76.11 126.01 30.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.01 139.53 51.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.627 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 68' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 76' ' ' PHE . 91.3 m-70 -88.48 118.38 28.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.57 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' D' ' 41' ' ' GLN . 58.5 tp -100.48 120.0 39.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.53 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' D' ' 8' ' ' LEU . 78.0 t -109.41 127.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.705 ' H ' HD11 ' D' ' 8' ' ' LEU . 70.1 mt -107.75 126.82 53.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.683 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.99 -42.98 99.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.669 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.777 HD11 ' CZ ' ' C' ' 59' ' ' TYR . 26.4 mt -145.62 147.08 31.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.734 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -113.59 116.83 30.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.252 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.75 2.32 88.1 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 76' ' ' GLY . . . . . 0.755 ' O ' HD13 ' D' ' 73' ' ' LEU . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -76.96 152.3 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.176 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -89.11 112.87 23.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.517 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.1 mt -66.11 -38.38 88.07 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.6 162.94 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.644 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.72 122.92 0.34 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.281 0.562 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -154.47 158.95 40.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.845 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -74.33 122.57 23.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.415 . . . . 0.0 110.819 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.14 143.83 20.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.96 153.57 16.92 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -86.78 157.36 19.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.903 0.383 . . . . 0.0 110.871 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.8 mtp -125.53 172.95 9.28 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.44 124.64 41.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.374 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 37' ' ' THR . 37.7 tp -106.84 117.48 34.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.879 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -122.05 119.81 32.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.857 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -86.83 0.22 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -148.15 24.51 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.705 0.288 . . . . 0.0 110.722 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.625 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.9 m -126.26 131.18 51.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.548 HG22 HD13 ' A' ' 33' ' ' LEU . 59.5 t -105.99 122.18 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.646 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.783 HG22 ' HB3' ' B' ' 947' ' ' PRO . 42.8 p -121.35 122.94 27.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.53 146.41 55.35 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.269 1.313 . . . . 0.0 112.902 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -99.74 142.58 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.53 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -72.33 -6.26 42.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -73.1 74.11 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -55.42 135.68 50.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.89 -160.89 9.69 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.9 tp -137.26 126.97 25.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.3 t -99.69 109.58 24.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.3 p90 -133.19 154.49 50.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.609 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -117.89 137.89 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.236 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.91 131.3 35.02 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.549 0.531 . . . . 0.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.51 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.0 tt0 -100.45 124.73 46.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.231 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.0 p -84.35 172.32 11.88 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.604 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.11 -10.36 30.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.533 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.48 -0.06 56.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.626 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 71.03 19.68 5.52 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.51 HD11 HG11 ' D' ' 70' ' ' VAL . 73.7 mt -98.62 122.62 42.07 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.8 mm -78.97 125.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.491 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.8 m-70 -101.07 116.69 33.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.669 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -95.96 107.48 19.76 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 71.9 m -121.41 146.99 46.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 113.041 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.6 t90 -124.79 114.27 19.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.948 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -106.13 131.53 53.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.723 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -75.89 131.04 39.41 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -72.26 -18.86 61.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 110.662 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.5 m -59.91 -44.68 94.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.964 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p -115.94 -16.01 11.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.091 0.472 . . . . 0.0 109.991 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.17 19.6 79.78 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -102.54 146.52 28.02 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.82 102.05 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 110.06 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -74.44 -36.5 63.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -126.27 145.98 50.19 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.761 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.607 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.5 p-10 -158.08 100.61 1.72 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.83 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' D' ' 48' ' ' ARG . 31.7 mt -127.89 133.21 49.29 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.84 0.352 . . . . 0.0 110.756 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 125.55 35.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.144 0.497 . . . . 0.0 110.123 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.438 ' HB ' HD22 ' A' ' 128' ' ' LEU . 31.4 mm -112.09 118.18 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.897 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HE1' HG21 ' D' ' 44' ' ' ILE . 61.2 m-85 -82.95 161.58 57.57 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.858 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -54.59 131.98 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.676 1.584 . . . . 0.0 111.699 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 62.37 12.29 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.446 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -81.26 -26.89 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.111 0.481 . . . . 0.0 110.18 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -142.12 151.08 41.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.209 -178.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.533 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.0 tp10 -121.06 129.26 53.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.977 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.09 118.11 35.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -141.97 167.82 21.23 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.648 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -85.1 159.99 20.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.026 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.72 90.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.118 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.33 61.1 8.07 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.921 1.747 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -113.28 -38.04 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.6 t -131.44 77.26 74.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.697 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.13 130.33 40.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.151 1.901 . . . . 0.0 111.359 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 t 167.78 -47.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.723 0.64 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.8 -149.32 7.06 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.58 106.43 13.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.394 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -124.9 129.3 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.58 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.46 153.71 45.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.535 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.6 p -129.7 135.78 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 0.0 109.894 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 81' ' ' GLU . 60.8 tp -104.73 122.3 45.4 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -120.19 130.39 54.54 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.135 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 53.3 m-85 -86.24 116.41 24.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.78 -36.24 78.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.271 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.27 -20.88 12.14 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.398 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -73.23 -20.77 80.02 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.058 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 m 59.44 27.6 16.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -125.53 151.23 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.125 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -131.77 139.78 49.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.17 0.509 . . . . 0.0 110.934 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.483 ' O ' HG23 ' A' ' 95' ' ' VAL . 52.1 mt -122.91 149.1 44.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.7 m-85 -119.25 135.21 54.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.58 157.14 46.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.317 0.58 . . . . 0.0 111.318 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -135.05 137.07 42.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.523 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.4 ttm -73.7 135.22 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.238 0.542 . . . . 0.0 111.244 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.23 0.25 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.13 139.1 89.93 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.72 -25.74 33.55 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.979 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -117.51 141.68 48.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.41 . . . . 0.0 110.434 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.2 p -95.15 9.56 39.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.47 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.9 -21.0 60.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.362 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -121.05 3.16 10.47 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.476 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -62.02 -49.22 76.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.997 0.427 . . . . 0.0 110.986 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.14 -39.73 93.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.272 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.76 -42.98 99.94 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.737 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.662 ' O ' HG23 ' A' ' 124' ' ' VAL . 66.2 m170 -64.26 -41.06 97.11 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.036 0.922 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.88 -44.11 96.99 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.409 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -65.46 -43.51 90.1 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.53 -41.42 98.86 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.665 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.9 t -58.77 -49.38 83.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.014 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.501 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.87 -25.04 59.84 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.384 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.433 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.4 m-85 -87.84 -28.92 21.32 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.438 HD22 ' HB ' ' A' ' 75' ' ' ILE . 73.8 mt -91.23 -15.58 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.294 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -118.21 -17.95 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.165 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -142.1 66.74 21.07 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.255 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.4 155.0 64.76 Favored 'Trans proline' 0 C--N 1.297 -2.176 0 C-N-CA 122.604 2.203 . . . . 0.0 112.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 C-N-CA 122.559 2.173 . . . . 0.0 112.099 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -68.95 139.92 90.95 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.505 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.72 143.83 21.55 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.091 1.861 . . . . 0.0 112.079 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -79.81 155.25 75.65 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.1 150.48 72.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.933 1.755 . . . . 0.0 112.167 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.58 160.11 44.79 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.86 156.0 84.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.511 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.783 ' HB3' HG22 ' A' ' 39' ' ' THR . 30.9 Cg_endo -64.7 151.39 85.86 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.39 2.06 . . . . 0.0 111.883 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.91 165.77 33.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.835 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -85.47 136.91 33.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.039 0.447 . . . . 0.0 110.638 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -122.66 129.54 51.96 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.056 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 951' ' ' ILE . 2.7 mp -130.72 130.08 64.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -69.99 83.09 0.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.383 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.838 179.591 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -58.65 159.27 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.005 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 17' ' ' VAL . 13.8 pt -137.83 154.05 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.45 ' CD2' HG23 ' C' ' 14' ' ' THR . 17.3 m-30 -92.43 123.7 35.94 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.426 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -111.15 106.73 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' LYS . . . . . 0.535 ' HG3' HG23 ' C' ' 66' ' ' THR . 24.8 mtmt -91.25 133.18 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.383 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 49.2 p -81.16 -162.47 0.5 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.28 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.47 -20.86 58.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -113.8 -176.28 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.811 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.43 -14.58 54.79 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -50.53 128.05 19.24 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.16 137.28 54.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.761 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.409 HG21 HD13 ' C' ' 13' ' ' ILE . 1.1 mt -123.82 113.62 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 14' ' ' THR . . . . . 0.45 HG23 ' CD2' ' C' ' 4' ' ' PHE . 7.2 m -80.98 126.68 31.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.584 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.07 126.45 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.17 116.36 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.944 0.402 . . . . 0.0 110.301 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.663 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 10.8 m -136.71 173.06 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.519 ' O ' HD12 ' C' ' 56' ' ' LEU . 76.5 mm-40 -125.8 155.32 72.92 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.135 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.72 -29.25 89.05 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 121.896 1.731 . . . . 0.0 111.761 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -85.19 -15.47 43.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.62 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.38 142.37 58.42 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.592 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -85.98 167.83 14.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 110.808 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.8 -35.57 71.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.95 -42.56 90.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.94 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -62.36 -42.2 99.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.522 HG12 HD21 ' C' ' 43' ' ' LEU . 79.1 t -62.9 -42.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.807 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.628 ' CG ' HD22 ' C' ' 43' ' ' LEU . 56.2 mtmt -61.11 -41.09 96.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.272 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.663 ' NZ ' HG12 ' C' ' 17' ' ' VAL . 27.2 mttt -59.61 -39.22 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.58 HD12 HD11 ' C' ' 43' ' ' LEU . 71.6 mt -66.0 -41.14 89.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.157 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.76 11.05 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.62 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -120.45 -33.86 3.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -125.17 -14.91 6.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.057 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 12.52 75.87 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.579 HG22 ' HG3' ' C' ' 41' ' ' GLN . 28.6 mt -77.1 129.02 79.56 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.035 0.417 . . . . 0.0 110.083 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.69 154.78 59.35 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.243 1.962 . . . . 0.0 111.536 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.15 -37.77 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.927 1.751 . . . . 0.0 112.768 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.86 -43.79 98.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.625 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -83.06 -12.34 57.24 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' GLN . . . . . 0.579 ' HG3' HG22 ' C' ' 36' ' ' ILE . 19.8 mt-30 -83.81 102.49 12.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.809 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -102.26 109.5 21.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.766 ' HB3' HD12 ' C' ' 50' ' ' LEU . 8.0 mp -98.41 109.62 22.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.69 128.38 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.821 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 90.0 t80 -132.93 132.45 42.01 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.842 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.35 26.67 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.37 14.19 81.02 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.766 ' CE ' HD22 ' D' ' 73' ' ' LEU . 41.4 mtpt -119.5 133.79 55.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.782 0.325 . . . . 0.0 110.148 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -72.32 131.83 43.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.867 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' C' ' 43' ' ' LEU . 70.8 mt -84.57 100.15 11.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.43 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.11 143.11 41.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.269 0.557 . . . . 0.0 111.171 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.0 144.44 55.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.68 -18.05 57.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.83 145.46 24.75 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.26 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -88.64 162.35 16.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.518 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.519 HD21 HG21 ' C' ' 26' ' ' VAL . 74.6 mt -61.39 -38.88 88.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.803 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -62.41 -23.07 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.769 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.66 -37.42 83.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.682 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.5 ' CE2' HD23 ' C' ' 50' ' ' LEU . 69.9 m-85 -96.42 14.28 24.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.56 39.21 25.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.925 0.393 . . . . 0.0 110.336 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.94 120.06 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.926 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.45 -179.04 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 110.902 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -60.23 145.77 46.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.934 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 59.67 23.67 12.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.8 t -74.06 124.39 26.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.05 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.535 HG23 ' HG3' ' C' ' 6' ' ' LYS . 37.9 m -73.54 128.43 35.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -115.35 140.07 49.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' HIS . . . . . 0.41 ' ND1' HG23 ' C' ' 70' ' ' VAL . 44.6 t-80 -88.17 108.01 19.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.737 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.44 120.6 40.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.688 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.41 HG23 ' ND1' ' C' ' 68' ' ' HIS . 72.2 t -120.59 138.96 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.155 0.502 . . . . 0.0 110.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.534 ' CD2' HD13 ' C' ' 36' ' ' ILE . 22.0 mt -109.1 142.21 40.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.405 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -62.85 -39.5 94.58 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.371 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.94 136.59 39.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.493 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.13 26.08 5.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.655 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.76 18.39 77.34 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.13 175.07 43.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.606 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -64.79 161.98 17.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.867 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -143.67 147.41 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.95 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -94.95 121.43 36.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.053 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -103.41 111.28 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.519 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -95.6 124.53 39.67 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.739 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.842 HG22 HD23 ' D' ' 69' ' ' LEU . 80.7 p -83.5 172.78 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.347 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.619 HD11 ' H ' ' D' ' 71' ' ' LEU . 58.8 mt -63.2 -24.07 67.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.153 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 48.8 p -81.41 -8.51 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.22 63.16 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -62.67 131.06 47.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.412 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -108.15 133.3 52.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.92 108.78 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.904 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.72 124.12 28.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.527 HD21 ' HD2' ' D' ' 33' ' ' LYS . 80.5 mt -122.52 129.72 52.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.405 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -74.38 114.95 13.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.52 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.62 HG12 ' HE3' ' D' ' 29' ' ' LYS . 15.8 m -135.28 170.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.187 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' GLU . . . . . 0.602 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.8 mt-10 -120.88 153.95 57.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.55 -38.38 94.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.866 1.71 . . . . 0.0 112.169 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -70.52 -21.77 62.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.818 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.65 144.11 56.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -87.89 168.59 12.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.85 -36.24 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.865 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tm-20 -59.36 -41.56 89.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -62.72 -41.34 99.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.732 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.517 HG21 HD21 ' D' ' 56' ' ' LEU . 78.4 t -64.26 -42.28 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.605 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -60.76 -39.25 88.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.983 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.82 91.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.971 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.62 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -59.88 -39.32 84.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.814 ' CD1' HD21 ' D' ' 43' ' ' LEU . 79.7 mt -64.57 -39.36 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.173 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.31 -39.7 83.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.863 0.363 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -68.14 -55.6 11.81 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.843 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.527 ' HD2' HD21 ' D' ' 15' ' ' LEU . 67.5 mttt -64.54 -40.67 96.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.096 0.474 . . . . 0.0 111.737 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.53 140.29 52.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.92 62.77 2.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.92 110.59 43.81 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.33 150.1 69.45 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.851 1.7 . . . . 0.0 110.739 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.77 -42.2 51.82 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.156 1.904 . . . . 0.0 112.87 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.63 -43.69 92.89 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.49 -41.76 99.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.046 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.651 ' HB2' HD11 ' D' ' 69' ' ' LEU . 26.3 pt20 -84.91 142.39 29.72 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.287 0.565 . . . . 0.0 111.378 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -137.34 109.29 7.16 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.306 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.814 HD21 ' CD1' ' D' ' 30' ' ' ILE . 83.3 mt -80.97 132.21 35.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.081 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 78.9 mt -131.38 128.88 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.672 ' HB3' HD21 ' D' ' 50' ' ' LEU . 62.1 t80 -147.78 153.93 39.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.858 0.361 . . . . 0.0 110.677 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.77 16.17 10.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.391 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.23 -7.93 76.19 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.577 ' HB3' HD22 ' A' ' 73' ' ' LEU . 17.4 ptm180 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 110.8 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -67.21 133.84 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.221 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' D' ' 45' ' ' PHE . 74.4 mt -73.85 104.49 4.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.291 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -75.84 153.05 37.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.75 154.43 41.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.72 20.96 64.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -130.43 140.02 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.355 . . . . 0.0 110.293 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -79.92 163.55 24.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.773 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.602 HD12 ' O ' ' D' ' 18' ' ' GLU . 74.4 mt -66.03 -38.18 87.76 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.866 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.58 -23.72 67.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.132 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.96 -30.1 71.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 110.447 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -101.86 12.88 36.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.342 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.92 34.08 23.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.255 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 71.9 mt -80.16 104.57 8.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -93.09 178.84 5.62 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.73 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -62.39 142.8 57.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.001 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.07 16.06 10.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.558 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -67.64 133.8 50.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.4 m -89.57 116.08 27.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.792 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.45 129.7 34.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.288 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.842 HD23 HG22 ' D' ' 7' ' ' THR . 64.2 tp -108.04 121.53 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.947 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 56' ' ' LEU . 93.0 t -109.71 129.09 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.619 ' H ' HD11 ' D' ' 8' ' ' LEU . 57.8 mt -111.83 117.15 32.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.646 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -62.83 -44.56 95.83 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.612 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.766 HD22 ' CE ' ' C' ' 48' ' ' LYS . 0.3 OUTLIER -147.48 137.93 23.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -68.77 120.2 14.34 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.239 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.56 24.51 75.22 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.351 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.9 m120 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.01 147.02 47.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.175 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.6 112.44 24.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.178 0.513 . . . . 0.0 109.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.2 mt -67.19 -37.34 83.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.793 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.432 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -149.55 162.07 4.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.813 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.46 122.47 0.36 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.179 0.514 . . . . 0.0 110.882 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.27 156.38 35.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.0 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HA ' HD12 ' A' ' 46' ' ' LEU . 90.9 mtm180 -75.91 123.7 26.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.472 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 145.62 22.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.401 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.93 149.67 16.74 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -92.49 174.93 7.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.016 0.436 . . . . 0.0 111.106 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.438 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 31.1 mtp -135.12 173.57 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.9 m -122.52 120.98 35.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 38' ' ' VAL . 28.2 tp -105.39 117.08 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.236 0.541 . . . . 0.0 110.244 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -122.05 116.9 25.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 -87.7 0.27 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.6 p -144.92 21.25 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.686 0.279 . . . . 0.0 110.799 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.502 ' O ' HD12 ' A' ' 33' ' ' LEU . 88.3 m -123.03 131.23 53.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 110.478 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 33' ' ' LEU . 64.7 t -109.75 123.31 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.045 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -116.76 137.07 23.41 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.249 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.77 146.57 54.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.776 1.651 . . . . 0.0 112.987 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -103.87 119.13 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.427 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.37 -16.2 53.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.46 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -70.25 82.72 0.54 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -62.32 136.41 57.91 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.398 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.1 -157.45 8.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.686 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -137.13 125.68 23.64 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.3 t -97.85 110.67 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -133.85 153.93 51.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.382 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.9 mt -119.27 137.75 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.232 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 130.35 34.61 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 123.624 0.578 . . . . 0.0 110.28 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.3 tt0 -101.09 123.76 45.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.895 0.379 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.49 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.7 p -83.2 172.17 12.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.704 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.89 -10.2 26.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.706 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.09 1.8 55.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.74 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 70.5 21.06 5.68 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 110.501 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.592 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 77.5 mt -97.74 120.72 38.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.521 HG21 HD23 ' A' ' 128' ' ' LEU . 50.8 mm -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.5 m-70 -97.66 113.8 25.62 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.662 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -97.01 106.74 19.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.53 147.34 49.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.856 0.836 . . . . 0.0 112.929 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -122.02 116.21 23.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.57 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -105.39 144.32 32.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.298 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.91 131.31 35.2 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -72.61 -16.3 61.73 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.837 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.65 -45.33 92.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.04 -14.15 10.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.172 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.62 74.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -102.23 152.49 20.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.9 102.27 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.152 0.501 . . . . 0.0 110.475 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.897 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -126.75 145.01 50.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.24 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.565 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.9 t0 -157.5 101.46 1.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.145 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' D' ' 48' ' ' ARG . 35.6 mt -127.4 136.14 51.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.966 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.19 122.59 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.401 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.714 HG21 ' SG ' ' A' ' 80' ' ' CYS . 28.2 mm -113.2 122.55 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.777 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.592 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 67.3 m-85 -87.23 162.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.518 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.95 140.61 92.67 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.006 1.804 . . . . 0.0 111.625 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t0 60.43 12.46 3.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.454 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.93 -21.85 23.38 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.039 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.714 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.7 p -148.77 169.07 21.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.396 0.617 . . . . 0.0 110.584 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -140.17 130.7 25.53 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.352 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -101.07 118.91 37.92 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -142.01 170.1 16.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.663 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.18 161.81 20.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -114.37 88.95 16.46 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.645 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.79 59.48 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.983 1.788 . . . . 0.0 112.105 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -115.41 -37.25 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.387 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 p -126.28 75.61 73.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.633 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.27 130.04 34.23 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.771 1.647 . . . . 0.0 111.196 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p 170.27 -41.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.13 -125.59 2.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.431 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -143.03 107.63 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.257 0.551 . . . . 0.0 110.384 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.62 132.49 70.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.595 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.99 155.5 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.45 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.25 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.027 0.441 . . . . 0.0 110.381 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.3 tp -101.15 121.92 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -119.19 133.05 55.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.091 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -83.43 115.48 22.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 0.0 109.678 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.77 -37.77 85.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.635 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.06 18.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.79 -179.91 26.55 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -115.25 18.03 16.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.704 0.288 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.738 ' HD3' HD21 ' A' ' 105' ' ' LEU . 19.9 ttmt -95.28 144.41 25.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.407 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.47 129.1 30.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.97 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.738 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.8 mt -114.68 148.34 38.36 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.771 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 33' ' ' LEU . 90.3 m-85 -122.58 136.81 54.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.213 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.84 154.46 50.51 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.397 0.617 . . . . 0.0 111.246 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -126.58 136.37 52.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.056 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 139.2 57.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.272 0.558 . . . . 0.0 111.301 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -2.01 11.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.066 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.55 139.0 54.8 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.933 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.89 -39.41 91.6 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.972 1.781 . . . . 0.0 112.372 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -112.02 143.79 42.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.3 p -94.29 1.86 55.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.857 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -57.54 -20.46 32.02 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.55 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -118.76 -16.18 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.49 -41.6 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.855 0.359 . . . . 0.0 110.569 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.75 -40.88 97.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.03 -40.38 90.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.486 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.752 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.7 m170 -62.52 -39.54 93.87 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.728 0.775 . . . . 0.0 109.15 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.76 -45.52 93.99 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.54 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -65.94 -41.88 90.73 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.525 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -63.27 -38.34 90.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.301 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -59.17 -47.94 88.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.153 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -80.02 -29.75 39.4 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.714 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.17 -37.85 81.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.517 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -81.36 -31.85 33.19 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.767 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.562 HD22 ' HB ' ' A' ' 75' ' ' ILE . 72.5 mt -81.36 -24.79 36.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -109.75 -23.63 11.31 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -137.37 68.32 54.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.931 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.86 160.82 48.17 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 C-N-CA 122.849 2.366 . . . . 0.0 112.283 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.311 -1.431 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 -179.583 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.31 127.84 93.51 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.319 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.31 141.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.836 1.691 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.43 151.16 55.76 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.61 158.49 53.49 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.429 2.086 . . . . 0.0 112.222 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.6 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.709 2.273 . . . . 0.0 112.027 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -120.82 158.59 51.71 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.498 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.15 140.7 87.61 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.564 2.176 . . . . 0.0 112.19 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.37 162.94 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -86.96 136.81 32.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.495 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -124.06 127.65 48.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.285 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 951' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.4 mp -130.3 126.74 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.249 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -77.11 83.76 3.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.726 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.636 179.537 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -79.51 162.08 25.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.4 pt -141.91 149.88 19.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -97.42 126.94 42.97 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.817 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -110.12 116.92 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.292 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -101.27 133.52 45.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.589 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.72 HG22 HD23 ' C' ' 69' ' ' LEU . 67.6 p -90.33 -175.19 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.0 110.803 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.579 HD11 ' H ' ' C' ' 71' ' ' LEU . 83.9 mt -62.49 -38.9 91.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.238 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 38.3 p -72.58 -9.49 58.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.434 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.84 -7.07 70.27 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -57.36 125.73 24.12 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -104.9 131.93 51.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.863 0.363 . . . . 0.0 110.592 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 105.04 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.442 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 134.81 42.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.075 0.464 . . . . 0.0 110.366 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.727 HD21 ' HG3' ' C' ' 33' ' ' LYS . 62.4 mt -132.21 132.91 43.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.965 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.53 117.63 18.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.52 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.09 -178.7 2.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.446 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.3 mt-10 -127.24 154.0 76.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.94 -27.83 85.78 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.016 1.811 . . . . 0.0 112.181 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.6 m -87.04 -10.04 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.692 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.69 142.94 58.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.023 0.44 . . . . 0.0 110.795 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -81.25 164.53 22.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.86 -38.83 83.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.988 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.71 -40.32 87.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.045 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -61.66 -42.97 99.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 0.0 110.393 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.556 HG21 HD21 ' C' ' 56' ' ' LEU . 62.1 t -61.64 -42.63 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.273 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.413 ' HG2' HD23 ' C' ' 43' ' ' LEU . 34.2 mtmt -59.89 -38.93 83.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.597 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -41.83 96.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.713 ' HB3' HD13 ' C' ' 15' ' ' LEU . 13.9 mttp -59.67 -38.47 81.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.617 HD11 HD11 ' C' ' 43' ' ' LEU . 96.5 mt -66.36 -39.54 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.816 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -58.66 -40.48 83.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.88 -41.62 71.1 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.417 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.727 ' HG3' HD21 ' C' ' 15' ' ' LEU . 4.3 mmtm -65.75 -41.18 92.43 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.93 156.93 47.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.969 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.21 59.02 2.77 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 35.1 mm -112.28 114.89 50.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.53 162.31 41.73 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.825 1.683 . . . . 0.0 112.001 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.97 -36.72 96.31 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.419 2.079 . . . . 0.0 112.804 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.28 -39.6 95.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.428 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -88.49 -13.95 39.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.74 86.32 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.66 107.55 19.4 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.757 ' HB3' HD12 ' C' ' 50' ' ' LEU . 4.6 mm? -99.48 118.47 36.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.421 . . . . 0.0 110.663 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 84.7 mt -129.06 129.7 67.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.583 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -117.55 121.83 42.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.577 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.4 14.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.14 80.52 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -90.58 121.42 32.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -69.01 132.27 46.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.757 HD12 ' HB3' ' C' ' 43' ' ' LEU . 56.2 mt -85.01 101.73 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.124 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.3 144.8 42.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.18 143.49 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.203 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.65 -19.23 55.2 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -83.12 169.39 15.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -119.82 164.69 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.819 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.556 HD21 HG21 ' C' ' 26' ' ' VAL . 81.1 mt -60.82 -40.56 93.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.6 -24.0 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.459 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.46 -37.67 84.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 110.476 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.526 ' CZ ' HD13 ' D' ' 73' ' ' LEU . 66.9 m-85 -97.99 15.41 24.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 57.51 40.45 27.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.346 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.53 107.61 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -96.52 179.09 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -58.16 149.12 24.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 57.82 40.58 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -94.67 123.13 37.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.007 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.487 ' O ' HD22 ' C' ' 67' ' ' LEU . 8.3 m -76.8 131.07 38.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.487 HD22 ' O ' ' C' ' 66' ' ' THR . 3.5 mm? -115.24 141.1 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.578 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -91.01 108.32 19.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.989 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.72 HD23 HG22 ' C' ' 7' ' ' THR . 64.9 tp -100.73 118.78 37.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' C' ' 8' ' ' LEU . 92.6 t -112.21 133.43 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.25 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.579 ' H ' HD11 ' C' ' 8' ' ' LEU . 18.8 mt -109.58 149.09 30.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.42 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -93.62 155.66 17.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.555 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 67.0 tp -101.15 122.78 44.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.556 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -63.06 -39.69 95.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.763 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.19 -163.0 54.45 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.32 166.27 54.71 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.606 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -58.13 159.84 5.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.169 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -139.69 141.4 34.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.349 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' PHE . . . . . 0.579 ' HD2' HG21 ' D' ' 12' ' ' THR . 3.9 m-85 -83.93 123.8 30.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.529 ' CG1' HD12 ' D' ' 69' ' ' LEU . 81.4 t -109.78 103.75 15.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.5 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -94.45 122.91 37.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.841 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -82.71 179.36 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.129 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.502 HD11 ' H ' ' D' ' 71' ' ' LEU . 79.6 mt -62.87 -35.48 80.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.085 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -67.01 -14.92 63.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.792 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.05 59.13 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.55 131.01 47.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.275 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' THR . . . . . 0.579 HG21 ' HD2' ' D' ' 4' ' ' PHE . 97.7 m -104.15 132.59 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.806 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.401 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.2 mt -127.16 107.14 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.872 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -81.85 127.67 33.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.606 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.4 mt -123.16 126.36 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.8 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -66.1 113.88 4.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.446 HG12 ' CD ' ' D' ' 29' ' ' LYS . 20.3 m -135.62 162.63 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.131 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.42 152.75 40.69 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.09 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.65 -37.24 91.22 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.988 1.792 . . . . 0.0 111.956 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -81.16 -8.64 59.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -57.92 138.1 56.11 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.014 0.435 . . . . 0.0 110.991 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -80.37 162.87 24.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.12 -39.34 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.071 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.5 -39.89 89.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -62.45 -42.67 99.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.112 0.482 . . . . 0.0 110.477 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.28 -42.71 96.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.655 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.461 ' HG2' HD11 ' D' ' 43' ' ' LEU . 56.9 mtmt -60.23 -39.76 87.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.323 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.65 92.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.488 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.446 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -60.16 -38.83 84.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' ILE . . . . . 0.646 HD13 HD11 ' D' ' 69' ' ' LEU . 97.2 mt -64.71 -39.69 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.701 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.68 -40.94 93.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.17 -40.29 97.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.606 ' HD2' HD21 ' D' ' 15' ' ' LEU . 59.4 mttt -78.59 -71.41 0.43 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.892 0.377 . . . . 0.0 111.007 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.32 166.64 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.086 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.5 21.77 23.92 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' ILE . . . . . 0.566 HG22 ' HG3' ' D' ' 41' ' ' GLN . 27.1 mm -78.08 119.3 76.85 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.367 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.45 161.95 42.81 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.173 1.915 . . . . 0.0 111.538 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.12 -37.51 87.15 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.236 1.957 . . . . 0.0 112.479 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.3 -42.75 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.348 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -82.8 -12.52 57.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.566 ' HG3' HG22 ' D' ' 36' ' ' ILE . 79.4 mt-30 -80.86 80.57 7.31 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -97.8 94.59 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.687 ' HB2' HD12 ' D' ' 50' ' ' LEU . 11.9 mt -85.15 129.67 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.596 HG23 ' HA ' ' D' ' 49' ' ' GLN . 49.1 mt -129.1 130.18 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.376 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.644 ' HB3' HD21 ' D' ' 50' ' ' LEU . 68.2 t80 -148.45 154.75 40.3 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.832 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 70.0 22.25 5.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.757 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 -2.24 77.62 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.529 ' HB3' HD22 ' A' ' 73' ' ' LEU . 5.3 ptm180 -132.26 150.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.08 0.467 . . . . 0.0 110.47 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 49' ' ' GLN . . . . . 0.596 ' HA ' HG23 ' D' ' 44' ' ' ILE . 21.1 pt20 -65.13 148.5 51.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.566 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' D' ' 43' ' ' LEU . 81.0 mt -84.88 109.44 18.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.82 151.8 37.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.201 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -74.9 167.93 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.221 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.51 24.58 76.1 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -129.3 169.29 15.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.821 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.4 p -115.53 164.63 14.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.452 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.82 -39.66 95.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.7 p -62.72 -28.49 69.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.07 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.49 -35.97 79.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.025 0.441 . . . . 0.0 110.158 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -94.92 12.04 29.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.224 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 56.21 39.6 30.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.143 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.48 112.83 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -97.11 177.18 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.531 0.681 . . . . 0.0 111.133 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -61.7 142.58 57.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.121 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 65.13 18.61 11.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' SER . . . . . 0.427 ' O ' HD12 ' D' ' 67' ' ' LEU . 32.0 m -70.55 130.79 42.78 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.94 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -82.32 126.3 31.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 67' ' ' LEU . . . . . 0.581 HD23 HD11 ' D' ' 50' ' ' LEU . 5.6 mp -117.09 142.85 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.06 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -89.19 117.67 28.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.232 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.646 HD11 HD13 ' D' ' 30' ' ' ILE . 0.4 OUTLIER -97.7 100.26 11.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.31 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.68 128.83 38.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.502 ' H ' HD11 ' D' ' 8' ' ' LEU . 75.6 mt -104.62 148.87 26.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -128.27 129.85 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.4 . . . . 0.0 110.949 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.526 HD13 ' CZ ' ' C' ' 59' ' ' TYR . 81.4 mt -109.2 16.51 22.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -60.08 128.07 34.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.946 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.12 -9.6 76.85 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.658 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -69.94 149.27 47.96 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.068 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -89.28 126.94 35.72 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.366 0.603 . . . . 0.0 110.208 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' ILE . 83.4 mt -67.35 -38.46 84.87 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.878 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG11 HG22 ' A' ' 124' ' ' VAL . 0.9 OUTLIER -147.48 161.99 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 179.494 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -173.06 122.14 0.39 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.048 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -153.51 153.16 31.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.68 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.608 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -70.51 123.38 21.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.572 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.59 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -153.46 145.69 23.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.266 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.15 151.74 17.69 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -89.25 172.61 8.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.419 . . . . 0.0 110.99 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 33.3 mtp -136.41 170.47 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.632 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.9 m -120.8 121.31 37.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 37' ' ' THR . 22.0 tp -104.57 118.26 36.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.639 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.55 107.23 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.743 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 -92.88 0.61 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.4 p -135.13 19.84 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.942 -0.152 . . . . 0.0 110.972 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.551 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.6 m -121.52 130.94 53.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.838 0.351 . . . . 0.0 110.369 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.476 ' CG2' HD13 ' A' ' 33' ' ' LEU . 76.8 t -112.31 124.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.194 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -116.51 136.15 23.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 147.18 45.46 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.956 1.771 . . . . 0.0 112.918 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -101.94 122.31 43.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.635 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -65.3 -11.34 40.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.762 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -73.8 78.79 1.58 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -55.47 137.36 48.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.86 -159.49 8.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.312 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.1 tp -139.09 124.43 19.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 28' ' ' ALA . 55.4 t -96.91 109.62 23.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.454 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 39.5 p90 -132.72 154.52 50.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.905 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 23' ' ' LEU . 84.5 mt -120.8 141.77 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.625 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -142.85 140.95 31.48 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 123.75 0.657 . . . . 0.0 110.048 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -104.43 127.43 52.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.975 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 58' ' ' HIS . 27.9 p -87.67 173.95 8.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.77 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.69 -11.08 22.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.822 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.21 -1.24 57.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.399 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.97 19.88 6.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 110.529 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.76 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 54.9 mt -101.96 128.79 48.22 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 131' ' ' PRO . 51.5 mm -82.21 127.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.527 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.4 m-70 -104.99 114.82 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.112 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.578 ' CB ' HD13 ' A' ' 75' ' ' ILE . 59.9 t80 -89.57 107.77 19.27 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 95.0 m -119.36 140.8 49.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -121.59 114.08 20.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.187 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -105.99 147.61 28.65 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.348 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -79.8 137.19 36.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.737 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -76.55 -21.1 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.3 m -60.14 -45.17 93.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -116.48 -12.17 11.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.492 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.4 77.12 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.01 146.29 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.17 105.93 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.174 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -84.0 -31.55 25.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.832 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -128.12 147.92 50.56 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.392 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.572 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.1 p-10 -158.7 99.14 1.55 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 72' ' ' ASP . 38.5 mt -126.7 134.53 50.66 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.645 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.586 ' C ' HD12 ' A' ' 75' ' ' ILE . 97.3 mt -79.12 129.22 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.136 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.586 HD12 ' C ' ' A' ' 74' ' ' ILE . 1.9 mp -117.28 117.14 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.841 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.76 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 52.4 m-85 -83.4 163.56 49.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.28 137.97 78.39 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.736 1.624 . . . . 0.0 111.003 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 58.25 14.29 2.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -90.02 -40.81 12.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.462 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -128.06 147.91 50.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.864 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.6 tp10 -121.34 129.68 53.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.254 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.03 117.63 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.1 167.97 20.83 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.629 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -82.38 160.83 22.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.865 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.93 90.44 13.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.145 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.35 59.83 7.6 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.069 1.846 . . . . 0.0 112.342 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.12 -39.8 3.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.371 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 36.9 t -127.89 81.09 70.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.11 130.55 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.804 1.669 . . . . 0.0 111.528 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p 170.27 -39.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.887 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.7 -146.07 5.01 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.418 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.38 106.96 13.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.43 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -126.62 129.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.22 154.14 43.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.325 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -130.19 135.99 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 110.349 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.4 tp -104.65 118.29 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -117.45 131.2 56.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.194 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 59.9 m-85 -86.84 114.81 23.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -31.6 70.93 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.449 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.93 -21.98 11.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -71.98 -23.25 78.26 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.827 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.79 12.24 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.563 0.22 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.81 155.81 30.52 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.797 0.332 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 143.78 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.747 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 95' ' ' VAL . 57.8 mt -120.21 151.98 38.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.522 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 31' ' ' MET . 98.1 m-85 -121.28 134.23 55.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.69 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.62 158.14 44.62 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.0 111.148 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -132.73 138.71 47.31 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.893 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.408 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 52.2 tpp -70.5 132.75 46.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.766 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.72 1.81 14.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.426 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 109' ' ' MET . 88.6 mt-10 -66.34 146.48 99.04 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.04 -40.47 84.74 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.923 1.748 . . . . 0.0 112.659 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -122.98 146.61 47.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.3 p -96.88 11.96 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -59.72 -21.46 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.368 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -116.63 6.32 13.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.95 -46.79 87.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.86 -40.88 97.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.042 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.06 -43.66 94.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.695 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.698 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.2 m170 -64.65 -40.97 96.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.755 0.788 . . . . 0.0 109.535 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.5 t -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.874 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 tpp85 -67.51 -42.33 83.0 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.44 -41.39 98.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.244 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.7 t -58.34 -47.77 86.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.15 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -63.93 -38.2 90.22 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.575 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.47 -29.46 63.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.219 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -83.01 -29.77 28.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.502 HD22 ' HB ' ' A' ' 75' ' ' ILE . 81.4 mt -89.23 -20.64 23.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.5 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -111.39 -23.99 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.154 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -134.51 72.45 69.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.434 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.4 Cg_exo -59.83 150.83 75.24 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.744 2.296 . . . . 0.0 112.081 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 122.402 2.068 . . . . 0.0 112.088 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -71.18 149.38 94.37 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.692 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.02 150.32 29.63 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.182 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -81.91 153.47 69.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.166 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 158.96 53.65 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.413 2.075 . . . . 0.0 112.144 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.31 -169.27 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.783 2.322 . . . . 0.0 112.027 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -120.06 159.83 45.52 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.349 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.53 143.98 86.19 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.92 164.73 38.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -86.22 134.95 33.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -120.29 132.62 55.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.349 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.11 130.61 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.45 85.22 3.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.158 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.406 179.696 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.92 164.89 9.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.6 pt -144.35 141.05 24.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.193 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' PHE . . . . . 0.477 ' HD2' HG21 ' C' ' 12' ' ' THR . 7.8 m-85 -86.12 123.85 31.88 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.847 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.07 116.83 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -95.08 121.74 37.01 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.757 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.556 HG22 HD23 ' C' ' 69' ' ' LEU . 81.9 p -83.51 172.59 12.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.22 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.647 HD11 ' H ' ' C' ' 71' ' ' LEU . 81.9 mt -61.94 -36.6 81.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.203 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 48.7 p -68.22 -11.62 59.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.801 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.28 -12.75 63.46 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -66.61 130.28 42.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' THR . . . . . 0.477 HG21 ' HD2' ' C' ' 4' ' ' PHE . 97.5 m -104.62 131.27 52.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.43 HG21 ' HG2' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -125.66 110.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.841 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.0 m -81.31 130.15 34.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.092 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.626 HD21 ' CD ' ' C' ' 33' ' ' LYS . 70.0 mt -122.32 131.41 53.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.701 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -71.94 116.03 11.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 110.729 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.489 HG12 ' CD ' ' C' ' 29' ' ' LYS . 20.3 m -136.08 164.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.394 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -105.33 153.22 39.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.223 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.41 -34.91 95.67 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.081 1.854 . . . . 0.0 112.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.53 -2.19 58.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.42 136.66 58.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 110.737 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 59.8 p -78.59 163.07 25.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.931 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' ILE . . . . . 1.002 HD12 HD23 ' C' ' 50' ' ' LEU . 40.3 mm -64.84 -41.27 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.429 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -58.16 -36.81 73.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.996 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.08 -41.76 94.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.382 0.611 . . . . 0.0 110.826 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.559 HG12 HD21 ' C' ' 43' ' ' LEU . 70.5 t -64.24 -42.27 94.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.588 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.497 ' HG2' HD13 ' C' ' 43' ' ' LEU . 56.4 mtmt -60.82 -39.72 90.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.315 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.16 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.043 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' LYS . . . . . 0.489 ' CD ' HG12 ' C' ' 17' ' ' VAL . 67.3 mttm -60.31 -39.17 86.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' ILE . . . . . 0.486 HD12 HD11 ' C' ' 43' ' ' LEU . 91.4 mt -65.15 -40.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.179 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -59.75 -41.11 90.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.326 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -40.47 96.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.153 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.626 ' CD ' HD21 ' C' ' 15' ' ' LEU . 0.0 OUTLIER -71.88 -63.7 1.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.47 -178.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -107.05 159.66 16.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.893 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.23 55.25 3.99 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' ILE . . . . . 0.462 HG23 HD22 ' C' ' 71' ' ' LEU . 33.8 mm -107.91 121.01 45.28 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.56 159.94 47.75 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.651 1.568 . . . . 0.0 111.868 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.93 -39.08 94.07 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.186 1.924 . . . . 0.0 112.47 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -61.48 -50.22 73.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -67.63 -39.69 84.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.692 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.2 96.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.279 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' ARG . . . . . 0.594 ' NE ' HD11 ' C' ' 44' ' ' ILE . 76.9 ttt180 -104.24 110.75 23.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.559 HD21 HG12 ' C' ' 26' ' ' VAL . 7.2 mp -92.68 117.91 30.49 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' ILE . . . . . 0.594 HD11 ' NE ' ' C' ' 42' ' ' ARG . 92.4 mt -130.06 128.36 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -127.9 128.87 45.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.662 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 25.62 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.527 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.28 1.63 90.12 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' LYS . . . . . 0.633 ' HE2' HD23 ' D' ' 73' ' ' LEU . 57.1 mtpt -103.17 123.14 46.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -66.95 134.08 51.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.222 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 1.002 HD23 HD12 ' C' ' 23' ' ' ILE . 9.7 mp -87.25 102.27 14.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.344 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -74.21 146.17 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.912 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.67 144.93 53.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.536 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.15 -15.38 63.3 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -83.22 168.09 17.08 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 56.9 p -116.45 161.76 18.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.447 HD21 HG21 ' C' ' 26' ' ' VAL . 83.0 mt -61.74 -40.36 94.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.959 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.19 -24.68 67.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -62.78 -37.78 88.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.145 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' TYR . . . . . 0.708 ' CE2' HD22 ' D' ' 73' ' ' LEU . 60.7 m-85 -95.59 14.15 23.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.165 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.93 41.77 27.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.419 . . . . 0.0 110.171 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ILE . . . . . 0.547 HD11 HD21 ' C' ' 50' ' ' LEU . 86.2 mt -91.87 106.16 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.667 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -92.51 -173.77 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.961 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.63 144.78 56.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.221 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 63.64 13.07 7.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.075 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -65.6 132.78 49.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' THR . . . . . 0.629 ' C ' HD12 ' C' ' 67' ' ' LEU . 56.6 m -85.02 127.67 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 67' ' ' LEU . . . . . 0.629 HD12 ' C ' ' C' ' 66' ' ' THR . 10.2 mp -119.39 140.38 50.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -86.15 123.72 31.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.171 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 69' ' ' LEU . . . . . 0.556 HD23 HG22 ' C' ' 7' ' ' THR . 66.5 tp -109.33 120.1 41.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.626 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.633 HG12 ' H ' ' C' ' 72' ' ' ARG . 87.6 t -116.83 131.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 71' ' ' LEU . . . . . 0.647 ' H ' HD11 ' C' ' 8' ' ' LEU . 18.9 mt -92.84 32.47 1.25 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.591 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.633 ' H ' HG12 ' C' ' 70' ' ' VAL . 40.3 mmt180 59.49 43.82 15.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.384 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 66.4 tp -103.01 122.98 45.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.274 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -95.42 125.59 40.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.243 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.15 -40.01 97.95 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.12 90.7 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.599 -179.748 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.02 162.59 16.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' ILE . . . . . 0.472 HG22 ' HB3' ' D' ' 65' ' ' SER . 7.9 pt -141.17 146.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.942 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -90.58 101.14 13.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.686 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -87.75 101.03 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 132.65 41.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -64.45 -150.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.04 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.598 HD13 ' NH1' ' D' ' 74' ' ' ARG . 83.8 mt -59.85 -40.01 87.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.589 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 9' ' ' THR . . . . . 0.452 HG22 ' C ' ' D' ' 8' ' ' LEU . 0.0 OUTLIER 179.96 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.123 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.46 -89.35 0.44 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.096 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.36 139.88 14.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.887 0.375 . . . . 0.0 110.762 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -126.43 137.78 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.833 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.537 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.5 mt -121.65 111.7 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -85.78 125.78 33.51 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.126 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -122.63 130.42 52.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.56 115.97 13.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.589 HG12 ' HE3' ' D' ' 29' ' ' LYS . 21.2 m -133.65 166.3 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.616 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.46 152.66 44.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.893 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.7 -27.28 82.82 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.76 1.64 . . . . 0.0 111.765 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -87.36 -11.42 49.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.37 142.19 58.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 57.4 p -82.32 165.41 20.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' ILE . . . . . 0.567 HD12 HD13 ' D' ' 50' ' ' LEU . 49.9 mm -62.42 -38.75 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.8 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.29 -41.41 88.86 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -60.86 -42.82 98.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.569 . . . . 0.0 110.375 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -41.39 90.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.933 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' LYS . . . . . 0.486 ' HG2' HD11 ' D' ' 43' ' ' LEU . 56.2 mtmt -60.5 -40.09 90.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.36 91.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.393 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' LYS . . . . . 0.589 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -59.78 -38.33 81.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.79 -39.73 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.371 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.66 -43.95 97.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.31 -20.15 62.23 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.985 -0.447 . . . . 0.0 111.871 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.537 ' HD2' HG22 ' D' ' 13' ' ' ILE . 6.8 mttm -102.9 -7.67 21.34 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -141.32 -43.8 0.37 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.252 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.16 14.92 10.3 Favored Glycine 0 C--N 1.321 -0.268 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.038 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -88.79 117.64 68.5 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.622 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.32 172.67 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.961 1.774 . . . . 0.0 111.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.67 -27.13 18.87 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.494 2.129 . . . . 0.0 111.763 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -100.24 -176.15 3.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.837 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 64.94 16.9 10.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.539 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 41' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' D' ' 69' ' ' LEU . 14.4 pt20 -157.2 159.15 37.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.777 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -147.27 131.32 17.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.486 HD11 ' HG2' ' D' ' 27' ' ' LYS . 22.4 mt -100.49 114.52 28.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 44' ' ' ILE . . . . . 0.417 HD12 ' HZ ' ' A' ' 76' ' ' PHE . 77.0 mt -118.71 130.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.61 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 90.1 t80 -142.38 149.23 39.1 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.984 0.421 . . . . 0.0 111.192 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.25 15.78 10.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.14 64.23 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' ARG . . . . . 0.655 ' HB3' HD22 ' A' ' 73' ' ' LEU . 38.2 ptt180 -114.62 142.34 46.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.102 0.477 . . . . 0.0 110.534 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -69.51 146.14 52.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.24 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.567 HD13 HD12 ' D' ' 23' ' ' ILE . 83.2 mt -84.32 115.66 22.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.477 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.23 138.81 42.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -60.13 147.93 37.83 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.77 68.13 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -84.08 167.77 16.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.776 0.288 . . . . 0.0 110.607 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -114.07 159.44 20.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.025 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.21 -39.89 94.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.714 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -63.61 -24.13 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -63.09 -38.1 89.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.079 0.466 . . . . 0.0 110.234 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' TYR . . . . . 0.407 ' CE2' HD23 ' D' ' 50' ' ' LEU . 63.5 m-85 -96.12 12.73 29.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.206 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.45 41.37 26.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.326 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.04 103.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -90.55 179.33 5.87 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.239 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -61.74 150.7 36.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.987 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 60.07 31.3 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 65' ' ' SER . . . . . 0.472 ' HB3' HG22 ' D' ' 3' ' ' ILE . 18.4 t -86.57 125.88 34.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.919 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 123.22 26.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.05 149.72 31.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.815 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -99.13 117.76 34.33 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.626 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 69' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' D' ' 41' ' ' GLN . 61.4 tp -100.69 112.73 25.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.904 HG11 HD11 ' A' ' 56' ' ' LEU . 66.7 t -112.6 123.52 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 71' ' ' LEU . . . . . 0.551 ' H ' HD21 ' D' ' 8' ' ' LEU . 61.4 mt -96.76 140.67 31.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.759 0.314 . . . . 0.0 110.534 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -62.9 -40.59 98.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.738 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' LEU . . . . . 0.708 HD22 ' CE2' ' C' ' 59' ' ' TYR . 15.9 tp -141.3 54.53 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.337 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' ARG . . . . . 0.598 ' NH1' HD13 ' D' ' 8' ' ' LEU . 2.7 mpt_? 48.6 34.43 5.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.95 -177.54 25.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.782 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -71.06 148.17 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.127 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -94.82 125.17 39.31 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.452 0.644 . . . . 0.0 110.419 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 51' ' ' GLN . 92.4 mt -68.87 -36.54 78.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.304 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.95 160.78 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.729 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -172.84 122.73 0.42 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.0 158.98 38.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.1 mtm-85 -77.35 119.57 21.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.831 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.21 146.05 25.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.395 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.25 150.88 16.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -89.3 162.15 15.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.07 0.462 . . . . 0.0 111.031 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.496 ' HE3' HG12 ' A' ' 38' ' ' VAL . 1.2 mtm -133.23 168.54 18.36 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -121.75 134.24 54.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.653 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD13 HG22 ' A' ' 38' ' ' VAL . 25.3 tp -115.42 118.96 34.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -123.8 120.76 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.926 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.0 -85.79 0.22 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.32 22.56 0.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.752 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.569 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.7 m -123.77 128.73 49.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.946 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.706 HG22 HD13 ' A' ' 33' ' ' LEU . 40.4 t -107.89 119.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.822 HG22 ' HB3' ' B' ' 947' ' ' PRO . 22.0 p -114.3 135.31 22.19 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.656 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.74 149.25 37.71 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.064 1.843 . . . . 0.0 112.856 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -105.53 142.91 34.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -80.61 -7.97 59.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -72.3 75.87 1.0 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -57.38 135.23 56.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.295 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.68 -159.15 8.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.5 tp -137.3 125.71 23.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.53 109.14 23.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.55 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 38.8 p90 -132.44 153.97 50.32 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.4 139.85 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.458 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 128.81 29.91 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 123.922 0.764 . . . . 0.0 110.736 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.667 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.1 tt0 -99.29 124.23 44.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' CD2' ' A' ' 58' ' ' HIS . 13.7 p -85.11 170.74 12.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.414 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.03 -10.73 15.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.71 0.53 55.59 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.556 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.81 20.45 6.77 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.225 0.536 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HG11 ' D' ' 70' ' ' VAL . 75.9 mt -99.56 121.94 41.91 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.512 HG21 HD23 ' A' ' 128' ' ' LEU . 50.5 mm -79.32 124.83 38.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.495 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.497 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.0 m-70 -100.32 115.42 29.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.833 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.08 108.29 20.38 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -121.61 143.7 49.17 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.787 0.804 . . . . 0.0 112.836 -177.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -124.86 114.42 19.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.025 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -104.93 144.13 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.419 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -80.8 131.5 35.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -72.29 -18.43 61.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.899 0.381 . . . . 0.0 110.786 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.7 m -59.54 -45.43 91.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.649 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -117.09 -13.46 10.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.446 . . . . 0.0 110.32 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.36 23.73 74.89 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -102.15 152.16 21.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.82 102.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -76.16 -35.01 59.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.12 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -125.59 147.07 49.42 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.725 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.5 t0 -157.81 98.88 1.67 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' D' ' 48' ' ' ARG . 40.1 mt -128.9 133.04 47.76 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.901 0.382 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.09 124.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.913 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.525 ' HB ' HD22 ' A' ' 128' ' ' LEU . 25.5 mm -111.37 128.15 68.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.076 0.465 . . . . 0.0 110.62 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.417 ' HZ ' HD12 ' D' ' 44' ' ' ILE . 66.4 m-85 -93.04 162.17 29.3 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.364 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.56 140.2 89.3 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.931 1.754 . . . . 0.0 111.362 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 59.52 13.2 3.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.249 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -87.28 -37.79 16.87 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-O 120.872 0.368 . . . . 0.0 110.415 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.597 ' HB3' HD11 ' A' ' 96' ' ' LEU . 81.8 m -131.75 153.41 50.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.261 0.553 . . . . 0.0 111.653 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -125.5 129.49 49.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -103.57 117.45 34.44 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.04 166.39 24.83 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.602 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -83.73 160.11 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.987 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.93 90.26 12.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.51 60.65 7.65 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.049 1.832 . . . . 0.0 112.31 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -114.01 -37.97 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.328 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.0 t -132.3 76.25 72.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.72 130.57 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.278 1.985 . . . . 0.0 111.435 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.83 -42.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.055 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.27 -149.72 6.18 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.408 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.26 105.68 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.0 t -125.19 127.71 72.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.13 152.23 46.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.2 p -128.35 137.85 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.457 . . . . 0.0 110.228 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 80' ' ' CYS . 59.4 tp -102.33 120.22 40.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -118.47 134.86 54.73 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.49 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -84.36 117.03 23.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -61.24 -37.54 83.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.744 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -100.42 -10.28 21.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.728 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.83 152.92 17.15 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -93.18 22.02 5.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.331 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HD3' HD21 ' A' ' 105' ' ' LEU . 1.2 tmmm? -118.33 144.85 45.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.912 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.421 ' O ' HD23 ' A' ' 105' ' ' LEU . 33.7 ptt180 -139.72 152.79 46.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.958 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 95' ' ' VAL . 36.1 mt -121.58 159.39 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.252 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.502 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 87.9 m-85 -126.12 137.54 53.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.42 161.24 38.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.353 0.597 . . . . 0.0 111.088 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.76 140.56 40.7 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.637 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.9 mmm -72.77 139.1 46.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.143 0.497 . . . . 0.0 110.788 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.94 4.27 15.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.844 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.96 147.49 93.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.49 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.94 -38.93 65.25 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.812 1.674 . . . . 0.0 112.223 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -118.81 145.76 45.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.148 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.0 p -91.9 1.25 57.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.972 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.24 -19.79 48.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.364 0.415 . . . . 0.0 110.151 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.86 -17.42 10.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.29 -41.49 97.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.503 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.64 -41.06 98.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.388 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.92 -41.77 90.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.531 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.732 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.5 m170 -63.82 -39.91 95.36 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.698 0.761 . . . . 0.0 109.196 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m -62.41 -42.35 99.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.641 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -65.22 -43.96 89.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -61.88 -37.72 85.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.025 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.5 t -58.35 -48.76 84.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.24 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.54 -27.83 41.3 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.904 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.88 -37.99 79.39 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.482 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -80.91 -31.78 34.97 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.753 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.525 HD22 ' HB ' ' A' ' 75' ' ' ILE . 59.6 mt -82.16 -20.57 37.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -114.13 -17.36 11.93 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.116 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -146.56 72.88 12.82 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.753 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 160.95 45.42 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 123.03 2.487 . . . . 0.0 112.139 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.495 1.579 0 C-N-CA 122.651 2.234 . . . . 0.0 112.377 -179.556 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 50.12 71.89 1.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.83 144.09 99.51 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.913 2.408 . . . . 0.0 112.15 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.89 154.66 92.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.77 150.2 88.99 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.332 2.021 . . . . 0.0 111.824 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.5 -169.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.237 1.958 . . . . 0.0 112.319 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.04 154.86 76.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 947' ' ' PRO . . . . . 0.822 ' HB3' HG22 ' A' ' 39' ' ' THR . 33.1 Cg_endo -63.86 143.32 85.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.252 1.968 . . . . 0.0 112.124 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -156.79 164.81 37.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.701 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -88.05 133.33 34.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -121.49 125.88 47.9 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.311 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.4 mp -129.83 120.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.506 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -81.53 83.71 6.93 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.962 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.583 179.458 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -63.2 158.77 19.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.558 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.27 149.76 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.166 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' C' ' 14' ' ' THR . 13.3 m-30 -91.82 124.31 35.86 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.697 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -108.64 114.09 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -91.55 123.86 35.28 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.308 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.71 HG22 HD23 ' C' ' 69' ' ' LEU . 67.3 p . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 111.101 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.99 0.424 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.25 106.37 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.402 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . 0.416 HG23 ' CD2' ' C' ' 4' ' ' PHE . 22.0 m -74.92 129.17 37.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.3 126.31 47.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.473 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.11 112.97 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.503 HG12 ' HE3' ' C' ' 29' ' ' LYS . 31.0 m -134.22 161.68 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.72 154.26 38.67 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.079 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.65 -36.74 98.39 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.151 1.901 . . . . 0.0 112.272 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.01 0.13 55.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -62.36 136.64 58.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 63.2 p -78.59 163.47 25.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.96 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.633 HD12 HD23 ' C' ' 50' ' ' LEU . 46.3 mm -64.66 -37.7 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tm-20 -59.03 -42.17 89.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.914 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.89 -41.33 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 110.736 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.68 -42.99 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -60.87 -39.4 89.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.11 93.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.099 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.503 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.6 mttm -60.42 -39.95 89.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.744 ' CD1' HD21 ' C' ' 43' ' ' LEU . 91.2 mt -64.69 -42.18 94.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.138 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.71 -39.73 89.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.85 7.34 15.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.412 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -115.83 -44.42 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.87 1.18 13.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.419 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.47 20.11 78.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.522 HG21 ' HB3' ' C' ' 41' ' ' GLN . 17.9 mm -79.83 120.87 81.35 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.05 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.1 150.7 54.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.72 1.614 . . . . 0.0 111.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -24.51 29.58 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -93.26 22.27 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.222 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -152.92 52.14 0.75 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 111.062 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.522 ' HB3' HG21 ' C' ' 36' ' ' ILE . 5.8 pt20 -172.71 140.65 1.01 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.084 0.469 . . . . 0.0 110.856 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.93 128.47 43.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.254 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.744 HD21 ' CD1' ' C' ' 30' ' ' ILE . 64.0 mt -104.38 119.68 39.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.98 128.45 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.416 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -129.78 130.25 45.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.004 0.431 . . . . 0.0 111.002 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.36 16.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.603 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 2.17 89.87 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -104.64 125.78 51.09 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.88 0.34 . . . . 0.0 110.227 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -72.16 132.16 43.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.633 HD23 HD12 ' C' ' 23' ' ' ILE . 8.2 mp -83.07 95.43 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.106 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.62 148.13 41.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.858 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -62.83 138.62 58.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 -18.31 54.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -84.24 177.5 8.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.14 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 64.7 p -126.3 165.76 18.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.38 -40.03 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.275 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -63.52 -28.28 69.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.55 -29.99 70.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.044 0.45 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.08 15.21 29.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 55.54 43.22 28.78 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.906 0.384 . . . . 0.0 110.251 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.38 109.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.045 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -97.55 -175.5 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.403 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -64.54 149.77 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.052 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 56.71 42.22 27.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.88 0.372 . . . . 0.0 110.903 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 53.6 m -100.02 127.53 46.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.099 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 89.1 m -77.24 127.67 33.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.68 142.24 47.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -85.99 117.77 25.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.27 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.71 HD23 HG22 ' C' ' 7' ' ' THR . 55.1 tp -106.46 123.56 48.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.69 131.97 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.55 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 31.2 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 -179.169 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -62.93 161.4 12.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.435 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.488 ' HB ' HD13 ' D' ' 67' ' ' LEU . 18.1 pt -143.93 139.13 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.061 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.529 ' HD2' HG21 ' D' ' 12' ' ' THR . 9.5 m-85 -85.66 120.16 26.79 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.948 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.78 108.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.65 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.51 120.43 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.691 HG22 HD23 ' D' ' 69' ' ' LEU . 82.0 p -80.78 170.76 15.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.774 HD11 ' H ' ' D' ' 71' ' ' LEU . 68.6 mt -65.78 -22.5 66.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.154 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -87.58 -0.54 56.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.72 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.86 79.12 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -68.7 115.85 8.54 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.529 HG21 ' HD2' ' D' ' 4' ' ' PHE . 94.9 m -92.69 137.79 32.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.022 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.75 105.72 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 12.9 m -80.92 125.62 30.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.446 HD21 ' HD2' ' D' ' 33' ' ' LYS . 66.9 mt -122.32 123.47 41.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.17 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -65.79 108.84 2.25 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.672 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 24.2 m -132.45 163.66 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.717 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . 0.461 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.4 mt-10 -108.98 149.79 40.08 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.01 -0.366 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -42.47 65.26 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.851 1.701 . . . . 0.0 112.368 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -68.72 -19.77 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.245 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -58.0 136.7 57.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.384 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -79.62 166.2 22.12 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.849 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.877 HD12 HD13 ' D' ' 50' ' ' LEU . 48.9 mm -66.25 -37.13 79.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.8 -44.27 86.22 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.65 -41.09 98.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 110.651 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.0 -41.87 94.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -60.3 -40.64 91.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.18 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.305 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.672 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 98.6 mttt -59.82 -38.77 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.777 ' CD1' HD21 ' D' ' 43' ' ' LEU . 81.3 mt -64.8 -39.4 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.859 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' D' ' 35' ' ' GLY . 64.8 tt0 -59.83 -44.81 93.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.261 0.553 . . . . 0.0 109.946 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -65.99 -35.05 79.53 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.815 -0.553 . . . . 0.0 111.159 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.446 ' HD2' HD21 ' D' ' 15' ' ' LEU . 18.4 mttt -88.94 -4.02 58.57 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -147.61 -53.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.277 0.561 . . . . 0.0 110.467 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 117.22 13.51 7.59 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.561 HD13 HD21 ' D' ' 71' ' ' LEU . 33.6 mt -83.69 119.88 74.36 Favored Pre-proline 0 N--CA 1.447 -0.606 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.346 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.88 164.03 34.32 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.865 1.71 . . . . 0.0 111.338 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.25 -34.15 94.1 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.466 2.111 . . . . 0.0 112.666 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -92.52 -17.29 24.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.955 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.642 ' OE1' HD12 ' D' ' 30' ' ' ILE . 5.1 tt0 -96.05 131.17 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.467 . . . . 0.0 111.522 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -133.9 103.18 5.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.83 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.777 HD21 ' CD1' ' D' ' 30' ' ' ILE . 81.3 mt -83.6 129.85 34.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.054 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' D' ' 49' ' ' GLN . 66.4 mt -129.33 130.94 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.68 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 78.5 t80 -150.59 155.62 39.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.741 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.45 20.62 7.17 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.545 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.91 -3.19 77.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.409 ' HB3' HD22 ' A' ' 73' ' ' LEU . 38.7 ptt180 -129.21 147.68 51.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.083 0.468 . . . . 0.0 110.73 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.491 ' HA ' HG23 ' D' ' 44' ' ' ILE . 18.7 pt20 -69.86 140.67 53.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.351 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.877 HD13 HD12 ' D' ' 23' ' ' ILE . 81.7 mt -73.48 144.91 46.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.33 -82.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.268 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 177.38 -72.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 110.572 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.14 -18.51 69.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -59.46 155.05 15.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.986 0.422 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -96.44 164.97 12.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.153 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.461 HD12 ' O ' ' D' ' 18' ' ' GLU . 81.7 mt -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -63.05 -23.91 67.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.405 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.47 -38.26 86.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.026 0.441 . . . . 0.0 110.354 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . 0.442 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.0 m-85 -97.49 15.25 23.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.192 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 56.34 39.11 30.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.247 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.68 103.7 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.786 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.32 178.76 5.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.0 110.824 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -61.8 150.04 38.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.906 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 59.67 17.94 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.172 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -67.59 129.08 38.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -85.49 105.42 16.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.488 HD13 ' HB ' ' D' ' 3' ' ' ILE . 8.5 mp -93.35 142.6 27.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 123.1 34.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.272 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.691 HD23 HG22 ' D' ' 7' ' ' THR . 28.3 tp -100.09 119.19 37.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.181 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 56' ' ' LEU . 69.1 t -109.84 129.71 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.774 ' H ' HD11 ' D' ' 8' ' ' LEU . 64.1 mt . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 pttp . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.642 0.258 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.05 126.43 37.14 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.41 0.624 . . . . 0.0 109.998 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -66.96 -38.53 86.26 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.942 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -147.15 161.42 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.898 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.67 122.88 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -153.5 157.51 39.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.486 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -73.71 120.6 19.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.603 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -153.33 145.4 23.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.72 154.66 16.63 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -87.21 156.89 19.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.812 0.339 . . . . 0.0 110.811 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 28.3 mtp -125.23 174.1 8.33 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.8 m -127.7 122.05 31.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 37' ' ' THR . 30.9 tp -107.86 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.96 0.409 . . . . 0.0 110.247 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.63 120.25 31.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.809 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.41 -90.19 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -144.32 21.85 1.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.506 0.193 . . . . 0.0 110.765 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.596 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.9 m -123.45 130.71 53.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' CG2' HD13 ' A' ' 33' ' ' LEU . 71.4 t -107.14 120.28 58.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.694 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.781 HG22 ' HB3' ' B' ' 947' ' ' PRO . 44.6 p -118.82 124.01 28.65 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.202 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 141.76 42.08 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.817 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -91.88 132.31 36.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.533 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -67.74 -7.6 28.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -74.42 75.24 1.91 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -53.1 136.14 36.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.211 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -161.17 9.86 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.357 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 27' ' ' ARG . 8.7 tp -137.72 124.92 21.64 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 28' ' ' ALA . 44.3 t -98.45 108.67 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.1 p90 -132.29 154.57 49.56 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.922 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 24' ' ' VAL . 95.8 mt -121.52 141.11 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.786 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -142.9 141.9 31.62 Favored 'General case' 0 C--O 1.219 -0.505 0 O-C-N 123.716 0.635 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -104.99 129.17 53.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.188 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.511 HG23 ' CD2' ' A' ' 58' ' ' HIS . 21.1 p -89.01 173.57 8.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.73 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.16 -10.84 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.717 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.32 -1.07 57.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.445 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 t 70.12 20.9 6.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.284 0.564 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD11 HG11 ' D' ' 70' ' ' VAL . 66.2 mt -103.13 126.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.55 HD11 ' HD2' ' A' ' 132' ' ' PRO . 51.7 mm -80.54 127.83 39.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.511 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.8 m-70 -104.41 117.91 35.34 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.709 0.631 . . . . 0.0 110.933 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -94.35 107.82 19.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 90.4 m -119.35 142.81 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.82 0.819 . . . . 0.0 112.978 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.38 114.17 19.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.2 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -105.91 145.22 31.56 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.566 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -80.74 131.54 35.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.33 -19.35 62.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.969 0.414 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.5 m -59.58 -45.58 91.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.719 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.3 m -117.1 -11.82 10.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.2 23.39 78.03 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.36 148.21 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 110.662 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.88 102.7 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.039 0.447 . . . . 0.0 110.691 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -75.5 -36.32 60.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -125.89 148.18 49.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.624 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.565 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.8 p30 -158.81 96.38 1.36 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 72' ' ' ASP . 29.5 mt -125.48 132.53 52.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.474 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -73.98 129.03 36.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.662 HG21 ' SG ' ' A' ' 80' ' ' CYS . 22.9 mm -116.61 120.18 64.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.277 0.561 . . . . 0.0 110.62 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.4 m-85 -84.37 160.51 56.75 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.244 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 140.09 92.53 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.679 1.586 . . . . 0.0 111.041 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.37 11.15 3.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.032 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -85.07 -27.67 26.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.653 0.263 . . . . 0.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.693 ' SG ' HD11 ' A' ' 96' ' ' LEU . 13.9 p -145.1 164.75 30.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.235 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 2.7 tt0 -132.02 121.86 24.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.111 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' HG11 ' A' ' 124' ' ' VAL . 44.8 t80 -97.11 119.33 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -148.12 166.88 26.5 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.788 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -83.85 159.79 21.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.162 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 87' ' ' GLN . 48.8 t -109.39 95.82 20.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.77 60.25 7.61 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.99 1.793 . . . . 0.0 112.428 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.44 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -114.51 -41.68 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 178.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.24 81.14 71.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.56 130.76 27.45 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.874 1.716 . . . . 0.0 111.646 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 169.68 -41.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.94 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.31 -150.06 6.43 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.99 105.74 13.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.814 0.34 . . . . 0.0 110.517 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.26 127.49 72.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 110.71 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.57 152.63 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.367 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.8 p -129.62 139.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.615 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.693 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.1 tp -99.95 116.7 32.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -103.31 106.74 17.32 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 103' ' ' LYS . 53.1 m-85 -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 98.8 mttt -61.24 -37.37 82.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.72 -22.92 12.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.726 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.66 81.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.639 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.7 m 58.6 18.04 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 110.992 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.439 ' CD ' HD21 ' A' ' 105' ' ' LEU . 4.0 ttmt -117.15 152.0 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.504 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -128.56 135.5 49.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.858 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 95' ' ' VAL . 59.5 mt -118.53 148.19 42.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.4 m-85 -117.2 134.49 54.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.844 0.354 . . . . 0.0 111.097 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 156.44 46.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.219 0.533 . . . . 0.0 111.152 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -135.37 136.55 41.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.601 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.2 ttm -73.56 132.57 42.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.168 0.509 . . . . 0.0 111.372 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 3.14 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.969 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.12 142.31 92.77 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.84 -28.45 36.31 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.903 1.735 . . . . 0.0 112.674 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.41 141.92 51.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.267 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -98.28 10.64 40.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.45 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -54.27 -24.16 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.296 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -119.41 6.39 11.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.241 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.71 -46.16 90.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.919 0.39 . . . . 0.0 110.748 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.66 -41.08 98.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.76 -43.34 96.68 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.551 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.732 ' O ' HG23 ' A' ' 124' ' ' VAL . 61.4 m170 -64.06 -41.09 97.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.79 -41.14 97.99 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.122 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.05 -42.84 79.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.494 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.26 -40.48 96.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -57.68 -49.06 81.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.766 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -65.33 -39.2 92.09 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.126 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -72.34 -26.18 61.83 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.496 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -88.12 -26.27 22.57 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.796 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.4 mt -94.21 -17.56 22.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.06 -22.39 9.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.202 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -134.44 72.18 70.64 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.053 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.81 151.47 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.806 2.337 . . . . 0.0 112.123 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.55 ' HD2' HD11 ' A' ' 57' ' ' ILE . 51.1 Cg_exo . . . . . 0 N--CA 1.494 1.503 0 C-N-CA 122.451 2.101 . . . . 0.0 112.127 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.24 152.19 79.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.773 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.7 147.81 25.12 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.798 2.332 . . . . 0.0 112.024 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -82.42 154.02 68.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.228 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.17 150.95 82.02 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.141 1.894 . . . . 0.0 112.086 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.07 163.71 36.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -81.75 156.33 70.32 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.781 ' HB3' HG22 ' A' ' 39' ' ' THR . 21.4 Cg_endo -62.31 151.39 82.75 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.471 2.114 . . . . 0.0 112.124 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -151.76 164.04 37.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 111.087 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -85.65 134.68 33.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -117.94 132.48 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.536 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.1 mt -132.26 128.68 58.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.52 85.35 3.22 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.913 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.349 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.63 158.7 14.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.9 148.92 23.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.242 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -92.66 120.87 33.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.605 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -106.69 110.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.372 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -88.66 126.39 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.76 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.83 HG22 HD23 ' C' ' 69' ' ' LEU . 82.0 p . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 111.196 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.792 0.329 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.439 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -122.89 116.61 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.46 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -84.05 130.32 34.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' C' ' 33' ' ' LYS . 94.0 mt -123.76 123.1 39.76 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.656 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.17 112.42 5.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.769 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.444 HG12 ' HE3' ' C' ' 29' ' ' LYS . 30.8 m -135.26 162.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.728 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -104.72 153.83 38.98 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.635 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.62 -35.64 93.22 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.056 1.837 . . . . 0.0 112.102 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -84.89 -5.74 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.105 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -59.56 136.96 58.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.012 0.434 . . . . 0.0 110.823 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -76.98 160.84 28.83 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' C' ' 50' ' ' LEU . 46.8 mm -64.41 -39.38 85.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.232 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.56 -40.78 88.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.89 -41.71 98.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.418 HG22 HG11 ' C' ' 17' ' ' VAL . 57.2 t -63.23 -42.78 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.544 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.632 ' HG3' HD11 ' C' ' 43' ' ' LEU . 4.1 mtpt -59.02 -40.93 86.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.69 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.31 91.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.265 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.4 mttm -60.05 -38.85 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.85 -39.54 83.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.266 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.71 -38.86 82.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -68.81 -50.85 46.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.108 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.439 ' HD2' HG22 ' C' ' 13' ' ' ILE . 21.7 mttt -63.77 -42.74 97.73 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.02 150.42 49.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.964 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.13 55.7 2.73 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.468 HG22 ' HG3' ' C' ' 41' ' ' GLN . 27.7 mm -109.86 114.97 55.93 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.17 153.99 66.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.639 1.559 . . . . 0.0 112.056 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.77 -38.01 66.25 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.143 1.895 . . . . 0.0 112.385 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.13 -39.92 94.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.378 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -87.27 -9.44 54.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.468 ' HG3' HG22 ' C' ' 36' ' ' ILE . 85.1 mt-30 -80.9 88.95 5.85 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -99.11 105.27 17.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.689 ' CB ' HD12 ' C' ' 50' ' ' LEU . 21.5 mt -97.51 122.28 40.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.6 mt -128.72 123.09 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -112.48 114.51 27.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.447 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.97 49.94 20.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.4 27.84 73.58 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -127.75 102.96 7.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.393 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.09 132.07 51.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.689 HD12 ' CB ' ' C' ' 43' ' ' LEU . 41.9 mt -85.3 87.65 7.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.395 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.16 144.85 42.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -59.63 165.68 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.95 8.09 87.85 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.03 173.56 9.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.572 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -123.52 170.5 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.838 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.5 -39.95 92.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.354 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.1 -30.59 71.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.87 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.05 -28.68 69.76 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.008 0.432 . . . . 0.0 110.422 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.415 ' CD2' HD23 ' C' ' 50' ' ' LEU . 57.7 m-85 -101.61 12.63 36.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.073 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.06 40.33 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -91.77 118.88 38.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.37 -179.25 3.9 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -63.58 149.67 45.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.733 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 59.86 18.73 7.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.216 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -74.44 129.15 37.23 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.29 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.545 ' C ' HD12 ' C' ' 67' ' ' LEU . 90.5 m -80.46 129.85 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.225 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.545 HD12 ' C ' ' C' ' 66' ' ' THR . 8.4 mp -119.26 144.48 46.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.367 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -90.39 114.18 26.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.284 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.83 HD23 HG22 ' C' ' 7' ' ' THR . 65.6 tp -101.88 120.5 40.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.896 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 89.5 t -118.6 132.9 67.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.955 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.449 HD22 HG23 ' C' ' 36' ' ' ILE . 24.2 mt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -59.68 158.72 9.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -138.31 144.32 30.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.112 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.36 124.62 33.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.2 t -108.89 105.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.329 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 128.63 34.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.647 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -87.49 171.39 10.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.757 HD11 ' H ' ' D' ' 71' ' ' LEU . 83.9 mt -66.8 -29.15 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.303 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -78.09 -10.94 59.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 -12.66 56.08 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.48 125.55 26.05 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.232 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -98.11 135.27 40.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.291 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.47 109.93 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.565 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -84.9 129.3 34.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.45 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.643 HD21 ' HD2' ' D' ' 33' ' ' LYS . 89.0 mt -124.7 126.62 45.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.883 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -65.81 113.26 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.454 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.698 HG12 ' HE3' ' D' ' 29' ' ' LYS . 15.3 m -134.75 167.26 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 O-C-N 121.933 -0.479 . . . . 0.0 110.056 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . 0.425 ' O ' HD12 ' D' ' 56' ' ' LEU . 79.2 mm-40 -111.77 154.17 44.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.613 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.36 -26.58 83.03 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.116 1.877 . . . . 0.0 112.045 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.1 p -89.97 -12.04 39.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.03 142.83 57.3 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.144 0.497 . . . . 0.0 111.043 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -81.96 164.24 21.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.056 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.784 HD12 HD23 ' D' ' 50' ' ' LEU . 47.4 mm -62.02 -37.79 79.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.2 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -58.5 -40.32 82.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.37 -41.41 97.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 110.242 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.437 HG21 HD21 ' D' ' 56' ' ' LEU . 78.7 t -64.02 -42.51 95.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.574 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.83 -41.04 90.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.84 89.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.331 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.698 ' HE3' HG12 ' D' ' 17' ' ' VAL . 64.6 mttm -60.45 -40.11 89.96 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.785 ' CD1' HD21 ' D' ' 43' ' ' LEU . 79.6 mt -63.8 -41.48 92.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.699 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.82 -50.96 71.76 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.888 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -57.26 -24.05 52.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.643 ' HD2' HD21 ' D' ' 15' ' ' LEU . 11.6 mttm -96.9 -61.32 1.43 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.62 -25.39 22.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.907 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.27 11.54 64.48 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.385 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.09 121.49 80.67 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.908 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 149.36 55.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.519 1.48 . . . . 0.0 111.709 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.42 -41.75 65.25 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.889 1.726 . . . . 0.0 112.64 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.06 -40.59 74.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.98 -39.18 93.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.788 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.84 ' HB2' HD11 ' D' ' 69' ' ' LEU . 0.0 OUTLIER -97.24 147.25 24.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.781 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -131.79 125.85 32.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.785 HD21 ' CD1' ' D' ' 30' ' ' ILE . 72.9 mt -91.41 122.67 34.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.482 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.431 HG21 ' HE1' ' A' ' 76' ' ' PHE . 81.9 mt -128.3 126.8 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.255 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.86 149.72 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 110.805 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.58 20.12 11.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.37 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.38 86.22 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.807 ' HG2' HD22 ' A' ' 73' ' ' LEU . 99.0 mtt180 -114.23 140.7 48.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -75.48 119.39 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.716 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.813 HD21 HD11 ' D' ' 61' ' ' ILE . 9.6 mp -74.42 95.64 2.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.865 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.9 163.61 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 159.38 32.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.5 18.78 63.39 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -128.01 162.21 27.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.618 0.246 . . . . 0.0 110.576 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -113.43 160.81 18.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.399 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.437 HD21 HG21 ' D' ' 26' ' ' VAL . 78.2 mt -61.32 -40.11 92.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.688 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -63.34 -24.7 67.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 0.0 110.394 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -62.87 -37.46 86.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.091 0.472 . . . . 0.0 110.281 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -96.12 12.74 29.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.077 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.6 t30 57.15 40.37 28.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.005 0.431 . . . . 0.0 110.446 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . 0.813 HD11 HD21 ' D' ' 50' ' ' LEU . 69.9 mt -86.98 108.91 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.055 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -94.58 -179.43 4.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -61.66 145.37 52.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 61.75 36.28 16.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . 0.562 ' O ' HD12 ' D' ' 67' ' ' LEU . 28.9 t -87.28 123.78 32.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.226 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -78.44 124.22 27.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.562 HD12 ' O ' ' D' ' 65' ' ' SER . 4.9 mp -117.8 143.31 46.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.187 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -87.97 123.03 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.84 HD11 ' HB2' ' D' ' 41' ' ' GLN . 48.6 tp -103.42 109.6 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.706 HG11 HD11 ' A' ' 56' ' ' LEU . 52.5 t -98.31 134.28 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.757 ' H ' HD11 ' D' ' 8' ' ' LEU . 81.9 mt . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.642 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -90.58 110.83 21.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.126 0.489 . . . . 0.0 109.694 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.416 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.3 mt -65.58 -38.45 89.58 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.649 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -149.19 162.51 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.163 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.08 122.35 0.31 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.01 156.69 36.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.92 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.62 ' HA ' HD12 ' A' ' 46' ' ' LEU . 89.7 mtm180 -71.89 123.81 23.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.53 143.71 18.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.188 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.89 153.11 16.92 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -91.73 170.98 9.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.87 0.367 . . . . 0.0 111.416 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 20.4 mtp -136.83 175.27 9.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.14 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.08 124.44 41.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 37' ' ' THR . 28.6 tp -106.08 117.89 35.21 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.446 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -121.46 110.48 16.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.057 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 -87.89 0.58 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 p -143.32 22.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.54 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.2 m -125.59 131.49 52.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.428 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' CG2' HD13 ' A' ' 33' ' ' LEU . 80.3 t -109.66 122.34 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.008 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.0 p -113.35 132.33 22.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.315 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.05 144.25 46.73 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.147 1.898 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.27 121.93 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.507 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -64.52 -12.52 45.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.851 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -73.17 74.48 1.27 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -54.99 135.32 48.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.08 -154.3 7.45 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' ARG . 1.8 tp -142.52 125.54 16.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.3 t -95.87 108.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.64 154.36 47.98 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.068 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HB ' HG12 ' A' ' 24' ' ' VAL . 91.4 mt -121.67 140.55 45.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.582 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -142.74 142.65 31.99 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 123.48 0.488 . . . . 0.0 110.191 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -105.84 128.28 53.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.285 0.564 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 58' ' ' HIS . 23.3 p -87.84 172.06 9.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.606 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.89 -10.68 22.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.72 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.51 -1.1 56.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.452 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t 70.14 20.43 6.36 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.132 0.491 . . . . 0.0 110.962 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.706 HD11 HG11 ' D' ' 70' ' ' VAL . 63.8 mt -104.15 127.54 51.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 23' ' ' LEU . 43.4 mm -80.18 128.17 38.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.8 m-70 -105.08 116.62 32.26 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.551 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -98.02 107.27 19.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 147.2 47.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.822 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -119.94 111.64 18.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.899 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -102.03 134.45 45.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.279 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.7 137.57 40.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.864 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -78.49 -16.8 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -60.97 -45.62 94.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.501 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.3 m -117.07 -16.63 10.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.065 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.24 70.32 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -101.07 152.86 20.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.4 102.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -75.87 -37.53 58.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -126.65 145.58 50.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.3 t0 -159.17 100.71 1.55 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.328 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.807 HD22 ' HG2' ' D' ' 48' ' ' ARG . 23.7 mt -127.25 139.4 52.94 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.386 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.7 mt -77.72 127.23 38.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 80' ' ' CYS . 29.6 mm -113.86 125.81 71.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.924 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.567 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 72.6 m-85 -96.28 159.48 31.93 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.939 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.32 140.25 93.69 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.016 1.811 . . . . 0.0 111.348 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 62.34 13.18 5.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.031 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -95.44 -35.75 11.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 110.778 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -136.46 147.12 47.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -121.49 128.91 52.57 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.194 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -104.16 116.78 32.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -139.87 168.25 20.26 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -85.12 160.97 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.41 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.15 88.97 18.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.458 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.19 59.81 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.266 1.977 . . . . 0.0 112.005 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -114.5 -45.44 3.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.2 t -120.74 95.56 48.94 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.442 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.87 130.08 18.58 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.758 1.638 . . . . 0.0 111.658 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 167.93 -29.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.612 0.57 . . . . 0.0 110.315 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.7 -171.42 24.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.06 111.92 22.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 110.485 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.24 130.3 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.87 155.55 45.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.3 p -129.68 133.36 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.471 HD11 ' SG ' ' A' ' 80' ' ' CYS . 68.5 tp -100.74 119.83 39.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -119.01 129.6 55.22 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.474 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.468 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 54.3 m-85 -87.66 116.5 25.84 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.62 -33.43 72.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.474 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.93 -19.04 10.55 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.191 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -75.61 -18.75 79.64 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 m 58.75 27.69 16.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.62 ' HD3' HD21 ' A' ' 105' ' ' LEU . 15.7 ttmt -121.72 149.7 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.415 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.416 ' O ' HD23 ' A' ' 105' ' ' LEU . 94.5 mtt-85 -133.19 130.91 39.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.267 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.62 HD21 ' HD3' ' A' ' 103' ' ' LYS . 43.8 mt -120.99 148.87 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CE1' HD22 ' A' ' 33' ' ' LEU . 93.8 m-85 -119.8 135.32 54.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.4 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.47 153.26 48.82 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -128.46 134.7 48.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.561 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.0 mtp -77.62 139.01 39.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.967 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -100.82 7.76 43.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.043 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.38 134.21 86.93 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.522 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.2 -25.9 36.57 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.029 1.819 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.05 143.13 49.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 110.328 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.6 p -89.38 -1.05 57.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.97 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.22 -18.53 37.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -116.86 -17.38 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.42 -41.76 97.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.64 -40.61 95.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.082 0.467 . . . . 0.0 111.047 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -66.04 -41.67 90.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.5 m170 -62.41 -40.85 97.85 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.94 -43.26 99.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.04 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -67.73 -42.6 81.61 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.545 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.88 -43.02 97.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.656 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.7 t -57.38 -47.64 84.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.822 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.98 -39.46 93.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.048 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -72.69 -22.13 60.95 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.423 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.91 -26.87 19.1 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.809 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.8 mt -96.94 -16.22 20.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -118.04 -19.5 9.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -135.77 67.2 64.42 Favored Pre-proline 0 CA--C 1.519 -0.224 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.73 153.79 72.48 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 C-N-CA 122.459 2.106 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--N 1.312 -1.342 0 C-N-CA 122.545 2.163 . . . . 0.0 112.174 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -130.26 150.58 76.55 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.32 145.27 26.93 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.54 154.96 85.69 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.478 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 158.98 52.92 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.159 1.906 . . . . 0.0 112.451 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.54 -178.69 3.53 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.882 2.388 . . . . 0.0 111.935 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -115.33 158.89 40.2 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.67 141.79 83.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.069 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -153.68 164.11 38.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.2 139.48 31.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.972 0.415 . . . . 0.0 110.566 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.82 130.24 51.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 951' ' ' ILE . 3.0 mp -131.48 126.71 58.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -74.58 83.65 2.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.116 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.539 179.644 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . 0.416 ' OE1' HG21 ' C' ' 14' ' ' THR . 12.8 pt20 -62.48 160.96 12.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.59 153.9 31.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.277 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.461 ' CD1' HG23 ' C' ' 14' ' ' THR . 11.2 m-30 -96.61 124.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.681 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.12 113.56 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.532 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -86.93 131.46 34.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.719 179.533 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.193 0.52 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -120.87 108.59 23.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.342 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . 0.461 HG23 ' CD1' ' C' ' 4' ' ' PHE . 9.6 m -77.0 129.62 36.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.229 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.1 mt -124.28 123.9 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.619 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -69.57 115.48 8.87 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.416 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.2 m -137.67 164.79 27.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.619 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -106.77 154.28 40.23 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.97 -35.74 94.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.786 1.657 . . . . 0.0 111.968 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -82.78 -6.6 59.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.6 135.23 57.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.864 0.364 . . . . 0.0 110.803 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -78.61 163.34 25.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.966 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.498 HD12 HD23 ' C' ' 50' ' ' LEU . 48.1 mm -63.48 -38.65 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.267 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -59.17 -42.79 91.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.041 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -62.15 -41.15 98.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.561 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.435 HG21 HD21 ' C' ' 56' ' ' LEU . 58.4 t -63.44 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.789 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.418 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.6 mtmt -61.24 -39.39 90.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.271 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.15 -40.73 94.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.259 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.484 ' HB3' HD22 ' C' ' 15' ' ' LEU . 67.3 mttm -60.66 -39.68 89.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.19 -40.01 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.98 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.41 -39.57 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.305 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.21 -43.36 86.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.393 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.553 ' HG3' HD21 ' C' ' 15' ' ' LEU . 11.5 mttm -71.4 -40.25 70.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -132.76 155.76 48.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.002 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.58 64.75 1.78 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.746 HG22 ' HG2' ' C' ' 41' ' ' GLN . 33.0 mm -116.36 98.75 51.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 150.76 74.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.624 1.55 . . . . 0.0 112.016 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.23 -25.19 12.84 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.392 2.061 . . . . 0.0 112.39 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -90.08 31.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -167.23 31.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.814 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' C' ' 36' ' ' ILE . 0.9 OUTLIER -123.36 97.81 5.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.64 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -97.08 107.16 19.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.497 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.418 HD11 ' HG2' ' C' ' 27' ' ' LYS . 60.6 mt -102.9 120.87 41.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.222 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 95.1 mt -128.78 129.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.705 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -120.43 118.66 30.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.53 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.68 88.1 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 tptt -95.81 112.87 24.49 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -66.44 129.48 39.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.03 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.498 HD23 HD12 ' C' ' 23' ' ' ILE . 7.3 mp -76.9 88.0 3.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.333 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.25 138.34 51.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.13 145.52 46.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.328 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.72 60.49 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -93.1 170.31 9.74 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 65.2 p -113.39 167.12 10.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.389 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.435 HD21 HG21 ' C' ' 26' ' ' VAL . 84.7 mt -62.14 -39.86 94.0 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.3 p -63.09 -27.29 69.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.245 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.93 -35.96 79.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.009 0.433 . . . . 0.0 110.074 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -95.5 14.45 22.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.089 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.03 40.28 30.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.218 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.16 110.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.541 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -99.25 -170.26 1.89 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.029 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -65.03 145.78 55.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.513 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 57.24 41.02 27.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.035 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -91.7 122.19 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.103 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 63.8 m -72.61 127.13 31.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.204 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -118.79 147.25 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.23 113.18 25.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.271 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.7 tp -102.5 119.84 39.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.683 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.9 t -121.15 133.75 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.376 -178.707 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.04 159.31 14.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.095 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' D' ' 67' ' ' LEU . 10.5 pt -139.31 148.49 23.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.808 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.412 ' CD2' HG23 ' D' ' 14' ' ' THR . 13.7 m-30 -91.95 113.92 26.31 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.898 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 64.1 t -97.88 108.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.641 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -94.92 121.87 36.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.752 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.766 HG22 HD23 ' D' ' 69' ' ' LEU . 82.1 p -81.02 172.99 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.649 HD11 ' H ' ' D' ' 71' ' ' LEU . 87.9 mt -59.99 -36.14 76.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.819 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.77 -10.96 60.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 -9.84 66.47 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.61 126.83 29.12 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -100.68 132.2 46.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.556 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.65 109.16 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.904 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.412 HG23 ' CD2' ' D' ' 4' ' ' PHE . 22.3 m -78.95 128.37 33.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' D' ' 33' ' ' LYS . 94.8 mt -124.32 121.83 36.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.389 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -67.03 113.71 5.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.306 0.574 . . . . 0.0 111.146 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' D' ' 29' ' ' LYS . 25.7 m -136.63 162.01 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.8 153.39 38.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.57 -39.34 91.64 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.873 1.715 . . . . 0.0 111.955 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -79.59 -8.75 59.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.083 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -58.24 135.6 57.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -76.15 161.78 28.54 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.879 HD12 HD23 ' D' ' 50' ' ' LEU . 46.3 mm -64.3 -38.43 82.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.929 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.77 90.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.046 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.28 -42.04 99.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.131 0.491 . . . . 0.0 110.838 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.13 -43.5 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.23 -38.75 87.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.54 93.52 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.411 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.517 ' HB3' HD22 ' D' ' 15' ' ' LEU . 13.7 mttp -59.68 -39.12 83.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.856 ' CD1' HD21 ' D' ' 43' ' ' LEU . 93.1 mt -65.88 -39.98 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.336 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.26 -39.41 82.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.953 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -68.49 -51.04 47.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.759 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.551 ' HD2' HD21 ' D' ' 15' ' ' LEU . 65.9 mttt -65.17 -40.85 94.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -128.77 147.47 50.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.18 60.53 2.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -110.73 106.31 57.65 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.99 154.88 41.99 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.062 1.842 . . . . 0.0 111.766 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.29 -28.46 79.91 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.365 2.043 . . . . 0.0 112.781 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.84 -10.21 58.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.981 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.74 -52.93 3.44 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.558 ' CB ' HD11 ' D' ' 69' ' ' LEU . 0.6 OUTLIER -66.24 116.36 7.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.356 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -116.23 103.65 10.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.56 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.856 HD21 ' CD1' ' D' ' 30' ' ' ILE . 80.3 mt -78.79 129.06 34.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' D' ' 49' ' ' GLN . 55.0 mt -133.83 130.55 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.615 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 55.3 t80 -151.14 157.19 42.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.47 20.34 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.668 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.73 -6.09 75.61 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -129.16 150.06 50.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.128 0.49 . . . . 0.0 111.04 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.6 ' HA ' HG23 ' D' ' 44' ' ' ILE . 24.0 pt20 -69.89 142.47 53.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.455 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.879 HD23 HD12 ' D' ' 23' ' ' ILE . 8.1 mp -81.55 112.95 19.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.31 138.23 41.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.947 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -58.46 150.12 23.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.251 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.71 64.62 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -84.85 -178.59 6.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.936 0.398 . . . . 0.0 110.758 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -126.54 162.29 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.099 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.72 -39.56 94.45 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.68 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -63.75 -28.34 69.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.48 -34.59 75.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.029 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -97.84 12.37 34.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.432 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 m120 55.73 39.78 30.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.888 0.375 . . . . 0.0 110.23 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . 0.715 HD11 HD21 ' D' ' 50' ' ' LEU . 75.9 mt -86.59 106.8 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.35 177.19 6.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.629 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -61.33 150.26 35.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.347 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 61.73 13.07 5.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.935 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m -70.75 136.3 48.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -86.31 119.94 27.12 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.83 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.52 HD21 HD13 ' D' ' 61' ' ' ILE . 7.6 mp -110.4 125.31 53.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.285 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -75.22 133.06 41.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.766 HD23 HG22 ' D' ' 7' ' ' THR . 69.2 tp -112.56 115.84 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -103.94 129.08 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.649 ' H ' HD11 ' D' ' 8' ' ' LEU . 47.8 mt . . . . . 0 C--N 1.324 -0.52 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.309 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -91.67 112.36 24.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.155 0.502 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.4 mt -66.64 -37.43 84.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.7 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.438 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.3 p -150.29 162.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.58 122.92 0.36 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.816 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.7 159.81 42.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.253 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.472 ' HA ' HD12 ' A' ' 46' ' ' LEU . 77.3 mtp180 -75.89 118.82 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.675 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.37 22.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.23 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.48 158.51 14.7 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -92.97 156.4 16.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.6 mtp -122.65 171.05 9.43 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.1 m -122.95 120.33 33.1 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.263 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 38' ' ' VAL . 28.1 tp -106.57 117.72 34.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.202 0.525 . . . . 0.0 110.337 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -123.45 118.21 26.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.521 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.68 -98.27 0.6 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.7 p -135.0 22.58 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.52 0.2 . . . . 0.0 111.074 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 33' ' ' LEU . 87.1 m -124.37 130.76 53.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.802 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 33' ' ' LEU . 59.9 t -109.15 124.46 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.644 HG22 ' HB3' ' B' ' 947' ' ' PRO . 21.7 p -124.03 118.21 26.88 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.09 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.5 148.38 66.64 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.541 1.494 . . . . 0.0 113.122 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.55 140.94 34.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.975 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -71.26 -7.37 46.51 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.947 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -70.01 78.52 0.49 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.24 133.76 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -162.7 10.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.216 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.0 tp -136.08 124.27 23.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.18 110.59 24.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -132.55 154.13 50.29 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.388 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.9 mt -119.42 136.5 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.918 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.47 130.99 33.43 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.509 0.506 . . . . 0.0 110.288 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.462 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.9 tt0 -100.37 125.18 46.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.124 0.488 . . . . 0.0 109.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 58' ' ' HIS . 15.1 p -84.78 172.17 11.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.575 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.54 -10.63 27.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.21 0.11 56.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.452 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t 70.66 21.32 5.38 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.148 0.499 . . . . 0.0 110.41 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD22 ' HE2' ' A' ' 76' ' ' PHE . 70.1 mt -99.28 123.67 43.75 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.9 mm -81.17 122.2 35.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.501 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.9 m-70 -99.01 114.56 27.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.719 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -96.54 109.08 21.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 142.99 51.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.229 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.71 116.53 28.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.458 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -106.42 133.25 51.4 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.04 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.489 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -72.03 -19.86 61.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.029 0.442 . . . . 0.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.2 m -60.09 -44.82 94.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.044 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -115.37 -15.49 11.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.74 20.31 79.77 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.08 146.78 27.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.62 102.32 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.187 0.518 . . . . 0.0 109.824 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.17 -38.26 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -126.63 144.91 50.75 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.087 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.0 t0 -157.78 101.56 1.81 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.246 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 72' ' ' ASP . 37.2 mt -127.9 136.31 51.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.01 123.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.9 mm -110.77 131.6 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.234 0.54 . . . . 0.0 111.169 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.537 ' HE2' HD22 ' A' ' 56' ' ' LEU . 57.2 m-85 -95.7 159.62 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.928 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.72 139.95 91.96 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.686 1.591 . . . . 0.0 111.23 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 61.68 11.2 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.334 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 100' ' ' ALA . 17.1 t70 -88.25 -22.53 23.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.178 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.703 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.5 p -147.93 164.91 32.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 7.5 tt0 -137.7 127.27 25.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.58 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -97.05 121.39 38.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -144.93 163.47 34.06 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.544 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 -88.41 157.03 18.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.225 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.95 88.78 10.51 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.45 60.97 8.03 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.995 1.797 . . . . 0.0 112.028 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -112.99 -48.87 2.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.136 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.22 102.2 54.64 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.165 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.64 130.75 16.32 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.435 1.424 . . . . 0.0 111.691 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 168.22 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.74 -179.06 33.32 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.566 ' NE ' HG22 ' A' ' 114' ' ' THR . 0.5 OUTLIER -88.01 109.68 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.91 127.58 75.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.301 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.62 152.35 43.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.6 p -130.03 140.48 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.21 122.49 40.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -109.34 110.08 21.14 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -73.62 105.1 4.8 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 81' ' ' GLU . 57.8 mttm -60.99 -37.78 83.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.611 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.621 ' HB3' ' OD1' ' A' ' 79' ' ' ASP . . . -97.66 -20.49 17.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.633 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.82 140.8 15.14 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -83.78 52.84 2.37 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.169 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.629 ' HD3' HD21 ' A' ' 105' ' ' LEU . 8.7 ttmt -140.22 144.32 36.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -130.94 138.45 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.181 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD21 ' HD3' ' A' ' 103' ' ' LYS . 55.5 mt -116.24 149.4 39.23 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.2 m-85 -118.92 134.82 54.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.766 0.317 . . . . 0.0 111.133 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.93 155.97 47.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.326 0.584 . . . . 0.0 111.259 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -133.28 138.48 46.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.492 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.3 tpp -73.17 129.04 37.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.331 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -5.7 19.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.482 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.84 146.35 97.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.34 -25.82 15.12 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.091 1.861 . . . . 0.0 112.882 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -119.7 141.96 48.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.566 HG22 ' NE ' ' A' ' 92' ' ' ARG . 73.9 p -96.98 10.81 38.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.492 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.36 -20.43 59.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -125.92 6.75 7.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.423 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.63 -50.23 73.38 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.164 0.507 . . . . 0.0 110.769 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -65.22 -40.47 94.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.225 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.65 -44.64 96.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.89 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.79 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.5 m170 -64.59 -40.09 94.9 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.648 0.737 . . . . 0.0 109.498 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.0 m -64.2 -41.58 97.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.141 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -67.18 -41.79 85.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -64.97 -35.77 82.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.364 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 120' ' ' HIS . 61.3 t -59.54 -48.26 87.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.111 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.15 -30.23 38.92 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.859 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -67.68 -37.92 83.0 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -81.03 -33.8 33.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.57 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.539 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.4 mt -77.79 -27.0 50.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -106.98 -23.3 12.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.386 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -140.08 67.74 33.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.132 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.68 160.86 46.96 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.997 2.465 . . . . 0.0 112.391 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.31 -1.496 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 -179.494 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -71.37 149.15 93.85 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.65 146.03 53.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.598 2.199 . . . . 0.0 112.675 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.74 161.78 62.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.94 149.82 81.77 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.554 2.17 . . . . 0.0 112.238 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.33 163.08 39.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.443 2.095 . . . . 0.0 112.151 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -74.74 156.79 86.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.52 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.644 ' HB3' HG22 ' A' ' 39' ' ' THR . 44.8 Cg_exo -57.86 147.09 83.3 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.62 162.57 41.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -86.22 137.79 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -115.72 127.64 55.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.92 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.39 121.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -81.45 85.21 6.51 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.078 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.296 179.714 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -58.76 159.33 6.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.7 pt -140.22 141.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.274 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -85.28 124.06 31.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.75 112.26 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -96.82 119.73 35.85 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.876 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.656 HG22 ' CB ' ' C' ' 69' ' ' LEU . 29.9 p . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.172 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.955 0.407 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.421 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -134.62 113.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.271 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -85.8 131.96 34.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' C' ' 33' ' ' LYS . 25.9 mt -124.19 125.64 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.343 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.41 112.79 4.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 110.907 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.697 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.5 m -136.18 162.89 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.323 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -104.19 154.5 38.19 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.55 -37.22 95.31 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.947 1.765 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -79.56 -7.88 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.13 135.35 53.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.981 0.419 . . . . 0.0 110.865 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -78.25 161.58 27.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.9 mm -64.76 -41.38 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.93 -36.17 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.083 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.02 -41.28 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.32 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 56' ' ' LEU . 58.9 t -63.81 -42.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.468 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.589 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.3 mtmt -60.81 -40.93 94.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.603 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -40.11 94.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.958 0.409 . . . . 0.0 110.478 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.697 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.0 mttm -60.21 -39.07 85.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.341 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.73 HD13 ' CD1' ' C' ' 69' ' ' LEU . 96.6 mt -66.92 -39.07 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.7 -40.96 85.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.22 -41.92 72.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.726 ' HG3' HD21 ' C' ' 15' ' ' LEU . 11.6 mmtt -66.09 -42.34 89.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.924 0.392 . . . . 0.0 112.039 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -136.83 154.98 50.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.992 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 57.07 3.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.631 HG22 ' HG3' ' C' ' 41' ' ' GLN . 28.8 mm -109.8 106.26 58.12 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.81 153.41 56.78 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.707 1.605 . . . . 0.0 111.672 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.74 -39.56 76.52 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.015 1.81 . . . . 0.0 112.366 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -39.09 91.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 0.0 110.322 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -86.58 -6.48 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.204 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.631 ' HG3' HG22 ' C' ' 36' ' ' ILE . 19.2 mt-30 -88.24 77.43 8.25 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.978 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -84.11 107.81 16.67 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.632 ' CB ' HD12 ' C' ' 50' ' ' LEU . 17.3 mt -99.16 119.26 37.57 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.009 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -126.51 127.75 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.354 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -130.41 129.65 43.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.86 25.59 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.66 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.14 2.69 90.59 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -108.14 126.17 52.46 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 122.538 -0.39 . . . . 0.0 109.978 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -72.08 133.58 45.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.209 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' C' ' 43' ' ' LEU . 69.1 mt -77.23 102.91 6.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 110.287 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.22 139.96 42.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.946 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -61.56 137.08 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.241 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -17.37 55.64 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -83.4 -179.96 7.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.828 0.346 . . . . 0.0 110.359 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -127.32 165.41 19.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 26' ' ' VAL . 84.3 mt -62.0 -40.09 94.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -63.45 -27.6 69.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.007 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.53 -35.23 77.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 109.894 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.68 12.88 32.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.244 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.68 41.46 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.26 109.17 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.06 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.28 -176.08 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.504 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -66.05 148.14 52.27 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.34 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 58.21 41.11 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 42.8 m -93.68 125.07 38.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.258 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.47 ' C ' HD12 ' C' ' 67' ' ' LEU . 41.7 m -75.76 128.83 36.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.831 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.47 HD12 ' C ' ' C' ' 66' ' ' THR . 9.1 mp -115.64 152.05 33.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -101.83 112.62 25.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.73 ' CD1' HD13 ' C' ' 30' ' ' ILE . 0.7 OUTLIER -104.91 128.61 53.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.448 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -124.46 136.12 61.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.151 0.501 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 C--N 1.332 -0.156 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.366 -179.309 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -62.26 160.0 13.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.442 HD12 HD22 ' D' ' 67' ' ' LEU . 15.2 pt -142.83 146.93 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -95.34 123.27 38.78 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.755 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.747 HG11 HD11 ' D' ' 30' ' ' ILE . 83.8 t -104.96 110.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.44 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -97.8 132.69 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.524 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -88.27 -178.32 5.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.081 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.617 HD11 ' H ' ' D' ' 71' ' ' LEU . 83.8 mt -61.92 -37.02 83.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.302 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.9 p -73.72 -9.6 58.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.71 -6.45 67.47 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.654 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -59.07 121.79 12.16 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -100.66 133.11 45.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.046 0.45 . . . . 0.0 110.902 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.76 108.44 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 129.47 34.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.092 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' D' ' 29' ' ' LYS . 66.9 mt -127.35 126.3 42.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.541 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.1 114.63 10.41 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.35 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.652 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.0 m -135.71 164.14 33.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.716 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -110.68 155.62 41.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.051 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.02 -36.59 96.26 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.087 1.858 . . . . 0.0 111.763 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -77.45 -10.06 59.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.046 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -57.76 137.2 56.78 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -78.84 160.97 27.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.753 HD12 HD23 ' D' ' 50' ' ' LEU . 43.6 mm -63.3 -43.02 98.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.185 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -59.93 -34.51 73.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.257 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -64.92 -42.71 94.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.138 0.494 . . . . 0.0 110.71 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.553 HG21 HD21 ' D' ' 56' ' ' LEU . 69.1 t -62.36 -43.22 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.549 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.24 -38.85 88.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.56 87.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.059 0.457 . . . . 0.0 109.796 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.652 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -60.03 -37.18 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.747 HD11 HG11 ' D' ' 5' ' ' VAL . 6.2 mm -62.85 -39.46 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.89 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.2 -45.27 93.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.512 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.82 -38.22 90.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.783 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.416 ' HG3' HD21 ' D' ' 15' ' ' LEU . 23.5 mttm -90.19 -4.4 57.26 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -148.1 -47.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 8.41 32.79 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -80.42 120.69 80.12 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.43 156.98 62.68 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.259 1.306 . . . . 0.0 111.419 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -51.85 -36.04 61.73 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.163 1.908 . . . . 0.0 112.429 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -67.37 -46.02 74.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.54 -40.32 95.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.4 ' HB2' HD11 ' D' ' 69' ' ' LEU . 2.0 pt20 -98.68 151.03 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.37 0.605 . . . . 0.0 111.424 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -133.34 118.05 18.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.499 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.652 HD23 HD12 ' D' ' 69' ' ' LEU . 66.2 mt -86.15 122.29 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.587 HD12 HG21 ' D' ' 70' ' ' VAL . 83.9 mt -125.19 130.24 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.745 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 71.4 t80 -153.45 156.22 37.77 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.32 19.03 9.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.719 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -6.74 74.22 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -126.79 149.76 49.49 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 110.598 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -73.71 137.07 43.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.474 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.766 HD21 HD11 ' D' ' 61' ' ' ILE . 8.2 mp -83.53 112.2 19.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.841 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -75.23 175.93 7.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.734 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.28 162.89 21.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.454 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.17 -151.08 41.61 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 51.69 179.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.334 0.588 . . . . 0.0 111.462 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 71.8 p -131.69 170.31 14.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.553 HD21 HG21 ' D' ' 26' ' ' VAL . 84.8 mt -61.68 -39.63 92.13 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.401 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -65.37 -27.36 68.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.01 -28.08 69.85 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.137 0.494 . . . . 0.0 110.067 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -103.49 14.73 30.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.326 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 57.02 39.46 29.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.597 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . 0.766 HD11 HD21 ' D' ' 50' ' ' LEU . 81.2 mt -88.69 117.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.078 0.466 . . . . 0.0 110.136 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -101.18 176.51 5.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.387 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -60.43 150.74 30.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.902 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 60.11 14.87 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.185 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -63.47 136.39 57.56 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -95.38 107.13 19.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.93 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.442 HD22 HD12 ' D' ' 3' ' ' ILE . 8.9 mp -92.34 155.81 17.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.254 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -106.69 124.12 49.14 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.76 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.652 HD12 HD23 ' D' ' 43' ' ' LEU . 7.7 tp -99.89 92.88 5.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.815 HG11 HD11 ' A' ' 56' ' ' LEU . 58.3 t -87.36 129.81 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.617 ' H ' HD11 ' D' ' 8' ' ' LEU . 65.1 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.011 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.808 0.337 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -93.74 126.27 38.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.249 0.547 . . . . 0.0 109.913 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 51' ' ' GLN . 90.8 mt -68.99 -37.33 78.67 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.973 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.99 160.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.802 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -173.87 122.22 0.32 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -152.77 157.24 40.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HA ' HD12 ' A' ' 46' ' ' LEU . 72.9 mtp180 -76.31 121.82 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.09 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.88 143.95 22.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.648 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.42 151.47 17.45 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -95.12 157.14 16.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.916 0.389 . . . . 0.0 110.974 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 43.0 mtp -121.84 172.77 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.1 m -122.44 122.43 38.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.211 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 37' ' ' THR . 25.7 tp -106.45 118.99 38.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.729 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -121.25 111.54 17.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.437 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -102.11 1.0 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.5 p -127.62 20.38 6.64 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.359 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.61 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.7 m -122.32 129.88 52.6 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 33' ' ' LEU . 62.1 t -109.01 123.88 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.705 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 p -115.59 134.88 22.59 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.58 143.85 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.72 1.613 . . . . 0.0 112.305 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -106.57 131.49 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -72.35 -7.18 48.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.153 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -73.14 75.96 1.26 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -57.42 131.06 48.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.18 -160.25 10.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.523 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.9 tp -136.42 124.67 23.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.2 t -98.03 111.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.304 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -133.86 155.7 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.917 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.6 mt -123.94 140.24 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.389 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -141.38 141.64 33.79 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.096 0.474 . . . . 0.0 110.136 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.508 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.9 tt0 -106.1 127.58 53.29 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.535 HG23 ' CD2' ' A' ' 58' ' ' HIS . 27.0 p -88.48 172.46 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.477 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.53 -10.73 19.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.073 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.14 0.18 55.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.262 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t 68.46 21.76 8.07 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 110.482 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.815 HD11 HG11 ' D' ' 70' ' ' VAL . 70.2 mt -101.7 124.69 47.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 131' ' ' PRO . 50.9 mm -80.84 125.73 39.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.0 m-70 -102.79 116.42 32.53 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.571 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -92.5 109.35 20.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.4 m -120.69 144.84 48.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.877 0.846 . . . . 0.0 112.904 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.98 114.08 18.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.183 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -107.53 131.31 54.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.295 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -73.03 131.98 42.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -72.51 -19.12 61.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 110.415 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -60.24 -45.07 94.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.15 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.8 p -116.0 -15.18 11.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 20.59 79.48 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -101.62 145.49 28.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.4 t -73.98 103.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.261 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -78.44 -31.55 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -126.77 145.89 50.44 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.641 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.599 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.5 t0 -157.53 98.73 1.7 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.332 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 72' ' ' ASP . 35.9 mt -128.07 134.47 49.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.563 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.6 127.29 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.55 HG23 ' SG ' ' A' ' 80' ' ' CYS . 31.3 mm -113.77 123.55 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.905 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.462 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 64.6 m-85 -90.33 163.23 32.04 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.114 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.62 140.66 90.65 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.072 1.848 . . . . 0.0 111.309 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 59.89 13.61 3.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.246 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -90.15 -32.34 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.502 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.598 ' HB3' HD11 ' A' ' 96' ' ' LEU . 71.4 m -134.95 152.37 51.67 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.331 0.586 . . . . 0.0 111.93 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.29 129.11 48.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.58 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.94 118.73 37.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -144.35 166.58 24.7 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.9 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -88.69 159.69 17.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.956 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 t -114.83 89.76 20.29 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.47 59.98 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.015 1.81 . . . . 0.0 111.972 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -47.43 2.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.8 t -114.27 99.33 50.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.96 130.03 16.13 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.559 1.506 . . . . 0.0 111.488 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.6 -35.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.682 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.37 176.67 36.13 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.697 ' HE ' HG21 ' A' ' 114' ' ' THR . 94.6 mtt-85 -81.12 113.82 19.55 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.916 0.389 . . . . 0.0 110.783 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.97 125.16 67.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.969 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.79 152.34 35.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.307 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 105' ' ' LEU . 15.0 p -131.23 135.95 58.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.0 110.125 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 80' ' ' CYS . 63.6 tp -102.53 118.11 36.16 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -113.83 132.6 55.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.616 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -85.17 116.07 23.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.244 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.48 -37.1 82.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.03 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.19 -24.13 8.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.104 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.13 72.14 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 p 81.57 -6.11 1.52 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 124.128 0.546 . . . . 0.0 110.721 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.707 ' HD3' HD21 ' A' ' 105' ' ' LEU . 9.1 ttmm -79.7 148.19 31.66 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.259 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.4 mtt180 -133.76 133.43 41.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.795 0.331 . . . . 0.0 110.479 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.707 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.7 mt -121.74 152.8 39.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.033 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.05 137.69 54.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.912 0.386 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.98 159.93 41.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -136.99 139.83 41.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.013 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.13 131.04 49.85 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 111.282 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.42 0.89 10.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.73 147.82 81.68 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.27 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.77 -40.07 67.14 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.814 1.676 . . . . 0.0 112.299 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.92 144.54 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.697 HG21 ' HE ' ' A' ' 92' ' ' ARG . 74.7 p -100.28 12.01 38.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -55.76 -20.76 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.965 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -124.06 17.48 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.702 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.54 -45.48 93.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -71.63 -34.82 70.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.432 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -44.43 88.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.736 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.1 m170 -64.14 -39.78 94.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.8 -46.03 91.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.749 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -65.64 -43.15 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.262 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -62.72 -39.82 95.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.544 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 120' ' ' HIS . 59.3 t -59.51 -47.77 89.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.408 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -79.87 -24.93 40.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.936 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -69.59 -42.38 74.54 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.866 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -79.0 -35.45 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.674 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 124' ' ' VAL . 80.4 mt -71.34 -36.05 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -98.84 -27.79 13.76 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.497 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -132.89 76.25 70.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.353 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.491 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.2 Cg_exo -58.58 155.57 36.09 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.819 2.346 . . . . 0.0 112.037 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.492 1.429 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 -179.406 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.62 149.24 90.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.12 148.04 38.97 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.29 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -73.89 151.7 88.72 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.35 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' B' ' 945' ' ' PRO . 73.6 Cg_endo -73.97 156.44 47.7 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.021 . . . . 0.0 112.372 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 944' ' ' PRO . 22.5 Cg_exo -61.71 -169.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.439 2.093 . . . . 0.0 112.023 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.09 157.24 77.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 140.01 82.59 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.42 2.08 . . . . 0.0 112.338 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -157.59 164.73 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.621 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -86.32 136.73 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -118.05 129.7 55.72 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.723 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.19 132.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.15 84.64 0.74 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.326 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.472 179.578 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -64.23 161.48 16.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.489 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -142.1 145.22 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.045 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -87.87 122.77 31.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.826 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.86 108.73 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.169 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -89.63 124.23 34.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.651 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.49 HG22 HD23 ' C' ' 69' ' ' LEU . 72.8 p . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.347 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.834 0.35 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 111.94 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.496 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 37.4 m -83.05 129.77 35.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.691 -0.404 . . . . 0.0 109.911 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.56 131.76 53.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.57 114.14 10.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.941 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.439 HG12 ' HD2' ' C' ' 29' ' ' LYS . 24.5 m -136.1 165.43 29.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -107.13 152.36 41.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.1 -37.43 94.04 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.054 1.836 . . . . 0.0 112.096 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -82.27 -8.34 59.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.237 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -58.39 137.35 57.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 50.0 p -79.08 163.52 25.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.786 HD12 HD23 ' C' ' 50' ' ' LEU . 41.3 mm -64.88 -37.39 80.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.804 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -43.4 90.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.46 -41.9 99.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.025 0.44 . . . . 0.0 110.81 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.18 -43.07 98.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.812 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.43 ' HG2' HD11 ' C' ' 43' ' ' LEU . 58.4 mtmt -60.89 -39.48 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.71 91.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.058 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.439 ' HD2' HG12 ' C' ' 17' ' ' VAL . 68.0 mttm -60.61 -40.08 90.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.18 -40.39 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.111 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.96 -44.31 94.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.201 0.524 . . . . 0.0 110.206 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -74.24 -17.86 60.82 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -101.02 -4.62 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -149.56 -46.01 0.14 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 110.456 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 3.26 26.62 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.072 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.48 HG22 ' HG3' ' C' ' 41' ' ' GLN . 32.7 mm -65.99 117.22 40.3 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.863 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.39 150.17 86.21 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.108 1.872 . . . . 0.0 112.089 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.88 -38.05 67.54 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.996 1.798 . . . . 0.0 112.482 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.26 -40.22 96.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.819 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.44 -4.61 59.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.48 ' HG3' HG22 ' C' ' 36' ' ' ILE . 45.3 mt-30 -84.68 103.1 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.166 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.53 103.2 12.46 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.43 HD11 ' HG2' ' C' ' 27' ' ' LYS . 58.0 mt -100.34 119.91 39.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -127.46 128.22 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.138 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -129.33 126.75 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 110.798 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.03 27.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.727 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.86 2.08 89.99 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -106.38 117.59 34.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -69.28 127.78 34.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.786 HD23 HD12 ' C' ' 23' ' ' ILE . 7.8 mp -74.82 98.17 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.121 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.07 146.58 47.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.136 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.03 137.7 58.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.482 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.96 -17.0 57.86 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -83.44 175.27 9.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.706 0.289 . . . . 0.0 110.263 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -121.58 164.61 16.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.68 -40.14 96.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.469 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.0 p -64.1 -26.26 68.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.989 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.864 0.364 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -104.02 14.03 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.346 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 57.06 40.2 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.401 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.506 ' CD1' HD21 ' C' ' 50' ' ' LEU . 83.3 mt -90.66 107.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.157 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.81 -173.48 3.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.285 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -67.0 150.2 49.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.059 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 55.44 39.86 31.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.024 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -93.46 126.64 38.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.097 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.528 ' C ' HD12 ' C' ' 67' ' ' LEU . 43.8 m -76.18 129.18 36.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.157 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.528 HD12 ' C ' ' C' ' 66' ' ' THR . 8.7 mp -119.11 146.55 45.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.395 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.33 112.58 24.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.551 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.49 HD23 HG22 ' C' ' 7' ' ' THR . 51.3 tp -104.46 121.57 43.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.666 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.2 t -121.51 138.06 53.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.893 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.455 HD22 ' CG2' ' C' ' 36' ' ' ILE . 22.7 mt . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.114 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -62.65 161.57 12.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.093 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.602 HD13 HD21 ' D' ' 56' ' ' LEU . 12.7 pt -139.55 139.32 38.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.013 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.653 ' HD2' HG21 ' D' ' 12' ' ' THR . 3.9 m-85 -83.4 121.38 27.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.465 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -110.26 98.76 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -84.59 123.81 30.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 110.917 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.428 HG22 HD13 ' D' ' 69' ' ' LEU . 80.9 p -86.66 173.45 9.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.981 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.519 HD11 ' H ' ' D' ' 71' ' ' LEU . 70.6 mt -63.14 -24.67 68.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -71.89 -14.78 62.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.68 -15.54 59.64 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -70.92 141.8 51.12 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.653 HG21 ' HD2' ' D' ' 4' ' ' PHE . 95.6 m -104.88 132.61 50.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.083 0.468 . . . . 0.0 110.96 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.67 101.52 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.174 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -83.53 122.7 28.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.634 HD21 ' HD2' ' D' ' 33' ' ' LYS . 79.2 mt -121.98 129.13 52.22 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.823 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.59 115.49 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.654 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.422 HG12 ' HE3' ' D' ' 29' ' ' LYS . 16.2 m -136.93 177.07 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.99 156.22 69.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.392 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.27 -43.55 54.95 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.935 1.757 . . . . 0.0 112.073 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 82.7 p -72.35 -14.66 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -57.8 138.82 55.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.963 0.411 . . . . 0.0 110.638 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -80.97 161.66 24.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.785 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.645 HD12 HD13 ' D' ' 50' ' ' LEU . 49.7 mm -64.24 -41.29 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.081 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -58.3 -35.78 72.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.322 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -65.14 -43.48 91.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.483 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.621 HG21 HD11 ' D' ' 56' ' ' LEU . 78.1 t -62.41 -41.81 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -60.55 -39.03 86.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.227 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.4 90.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 0.0 110.136 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.501 ' CB ' HD13 ' D' ' 15' ' ' LEU . 66.7 mttm -60.44 -39.08 86.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.928 HD11 HD21 ' D' ' 43' ' ' LEU . 91.1 mt -63.81 -40.75 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.096 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.06 -41.38 92.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.23 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.59 -41.4 97.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.634 ' HD2' HD21 ' D' ' 15' ' ' LEU . 76.6 mttt -78.38 -76.73 0.18 Allowed 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.779 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.58 152.9 24.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.86 53.02 4.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mm -107.92 113.9 60.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.967 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.61 155.78 62.46 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.94 1.76 . . . . 0.0 112.147 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.72 -27.05 49.96 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.337 2.025 . . . . 0.0 112.603 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -83.36 -1.66 53.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.447 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -114.47 -49.18 2.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.557 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.485 ' HA ' HD21 ' D' ' 69' ' ' LEU . 0.8 OUTLIER -70.12 128.1 35.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.037 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mmt-85 -126.99 102.51 7.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.928 HD21 HD11 ' D' ' 30' ' ' ILE . 91.3 mt -76.13 125.55 29.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' D' ' 49' ' ' GLN . 72.3 mt -130.59 130.76 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.0 t80 -151.77 155.29 37.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 70.23 21.6 5.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 0.04 85.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.511 ' HB3' HD22 ' A' ' 73' ' ' LEU . 3.0 ptm180 -136.08 149.74 48.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.505 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.415 ' HA ' HG23 ' D' ' 44' ' ' ILE . 20.3 pt20 -68.48 148.28 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.473 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.645 HD13 HD12 ' D' ' 23' ' ' ILE . 68.0 mt -83.01 117.11 22.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.691 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -76.12 137.99 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.1 142.81 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 0.0 110.345 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.98 -15.84 62.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -83.11 163.8 20.65 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.699 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -104.77 171.09 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.222 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.621 HD11 HG21 ' D' ' 26' ' ' VAL . 5.1 mp -71.27 -38.81 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.071 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -62.77 -25.82 68.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.54 -37.73 87.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.113 0.482 . . . . 0.0 110.374 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.19 11.3 34.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.274 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 56.14 40.19 30.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 110.435 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -85.56 109.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -94.22 178.1 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.673 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.25 146.09 49.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 63.61 14.71 8.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.331 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -63.37 135.11 56.76 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -91.1 121.97 33.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.93 0.395 . . . . 0.0 110.313 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.521 HD23 HD11 ' D' ' 50' ' ' LEU . 5.4 mp -118.07 144.85 45.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.333 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -90.48 129.75 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.515 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.615 HD11 HG21 ' D' ' 30' ' ' ILE . 3.2 tt -104.24 101.53 11.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.798 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 56' ' ' LEU . 60.0 t -87.74 132.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.519 ' H ' HD11 ' D' ' 8' ' ' LEU . 57.2 mt . . . . . 0 C--N 1.326 -0.442 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm . . . . . 0 C--O 1.237 0.421 0 CA-C-O 120.998 0.427 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.17 115.26 27.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.87 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' HD12 ' A' ' 57' ' ' ILE . 98.0 mt -66.81 -36.7 82.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.361 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -151.22 163.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.419 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.77 122.84 0.34 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.224 0.535 . . . . 0.0 110.988 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -156.21 159.54 39.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.034 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -77.9 118.79 20.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.636 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.45 139.87 20.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.955 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.17 151.53 17.55 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -88.06 154.77 20.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.968 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.6 mtp -122.33 171.75 8.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -121.94 125.84 47.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.472 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 37' ' ' THR . 22.5 tp -107.29 119.2 38.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.443 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -119.11 107.83 13.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.805 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 -94.28 0.63 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.0 p -133.98 21.54 3.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.459 0.171 . . . . 0.0 110.79 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.634 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.8 m -124.46 131.23 53.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.533 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.474 ' CG2' HD13 ' A' ' 33' ' ' LEU . 76.6 t -110.41 125.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.107 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.442 HG22 ' HB3' ' B' ' 947' ' ' PRO . 21.7 p -119.8 138.07 26.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.623 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.55 142.84 29.9 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.84 1.693 . . . . 0.0 112.405 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.66 135.73 44.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.614 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.84 -6.78 47.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.934 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -77.72 62.2 2.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -56.02 133.8 52.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.62 -152.08 7.81 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -138.2 125.01 21.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.67 107.02 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.4 p90 -131.08 152.72 50.08 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.791 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.4 mt -120.57 140.52 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -140.66 143.49 35.16 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.624 0.577 . . . . 0.0 109.831 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -107.23 127.44 53.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.309 0.576 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' CD2' ' A' ' 58' ' ' HIS . 22.7 p -86.58 172.1 10.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.952 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -11.34 22.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.662 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.52 3.45 47.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.46 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.6 m 64.79 22.89 12.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.154 0.502 . . . . 0.0 111.065 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.75 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 65.9 mt -102.5 126.08 49.43 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.577 HD12 ' CD1' ' A' ' 23' ' ' LEU . 46.7 mm -80.56 126.87 39.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.3 m-70 -103.78 117.74 35.07 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.489 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -94.34 107.97 19.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -120.87 144.04 48.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.708 0.766 . . . . 0.0 112.681 -177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -125.09 112.09 16.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.616 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -105.34 133.09 50.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.345 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.51 138.55 47.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.053 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.8 -18.55 50.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.607 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.4 m -60.53 -45.79 92.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.5 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.6 m -116.84 -13.93 10.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.5 23.66 76.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -102.56 144.15 31.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.383 . . . . 0.0 110.987 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.7 t -73.79 108.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -89.56 -25.97 21.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.751 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -127.76 143.4 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.566 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 73' ' ' LEU . 66.8 t0 -158.11 94.62 1.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.544 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 72' ' ' ASP . 30.6 mt -126.43 134.19 51.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.822 0.344 . . . . 0.0 110.872 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.3 mt -77.23 127.15 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.306 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.521 ' HB ' HD22 ' A' ' 128' ' ' LEU . 27.2 mm -111.53 121.79 64.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.746 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.75 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 59.7 m-85 -94.77 163.48 22.26 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.055 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.04 137.85 77.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.0 1.8 . . . . 0.0 111.755 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.34 12.44 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.584 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -89.85 -34.01 16.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 120.764 0.316 . . . . 0.0 110.428 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -141.52 145.44 35.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.103 0.478 . . . . 0.0 111.341 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.8 tt0 -123.95 131.97 53.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.344 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.8 118.43 36.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -142.61 167.31 22.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.084 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -89.74 160.63 16.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 t -113.75 89.25 15.49 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.381 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.67 60.35 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.946 1.764 . . . . 0.0 111.642 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -114.85 -39.88 3.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.118 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.1 t -121.21 87.95 44.88 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.237 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.14 130.72 24.87 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.656 1.571 . . . . 0.0 111.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 168.81 -40.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.67 -149.04 5.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.286 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.48 105.79 12.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.347 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.2 t -121.66 126.62 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.704 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.61 154.02 33.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.06 133.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.126 0.489 . . . . 0.0 110.283 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 81' ' ' GLU . 57.2 tp -102.92 122.88 45.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -119.73 133.52 55.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.032 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 51.7 m-85 -88.61 115.09 25.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.87 -32.65 72.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.507 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.24 -23.7 9.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.967 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.91 -25.84 68.35 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.997 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.81 7.3 5.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HD3' HD21 ' A' ' 105' ' ' LEU . 9.1 ttmm -96.54 148.75 22.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.857 0.36 . . . . 0.0 110.732 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -129.37 133.15 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.918 0.389 . . . . 0.0 110.601 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.453 HD21 ' HD3' ' A' ' 103' ' ' LYS . 45.9 mt -120.42 148.0 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.711 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.6 136.74 54.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.769 0.319 . . . . 0.0 111.394 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.02 154.07 48.19 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.378 0.609 . . . . 0.0 111.554 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -130.45 135.8 48.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.351 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 141.81 50.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.256 0.55 . . . . 0.0 110.925 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.62 2.94 4.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.463 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -77.08 155.22 82.58 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.104 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.52 -41.67 38.6 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.251 1.967 . . . . 0.0 113.162 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.89 146.87 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.91 -1.76 56.43 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.46 -18.37 28.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -117.02 -17.67 10.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.695 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.24 -41.21 96.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.819 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.03 -40.66 96.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.03 0.443 . . . . 0.0 111.167 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.32 -40.04 85.91 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.253 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.738 ' O ' HG23 ' A' ' 124' ' ' VAL . 65.0 m170 -61.33 -39.73 91.61 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.59 -45.78 92.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.367 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -64.98 -41.59 95.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.383 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -66.47 -37.05 84.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.45 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.9 t -58.19 -48.35 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.248 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -78.24 -27.28 47.59 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.008 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.7 -37.61 76.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.885 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -80.99 -31.55 34.67 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.804 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 75' ' ' ILE . 51.7 mt -81.58 -27.11 34.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -104.83 -27.66 11.61 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.243 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -133.83 73.2 71.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.76 152.52 62.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.935 2.423 . . . . 0.0 112.345 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 122.384 2.056 . . . . 0.0 112.025 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -128.46 153.42 79.24 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.597 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.64 150.0 68.36 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.374 2.049 . . . . 0.0 112.299 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.46 153.66 91.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.81 161.82 44.73 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.345 2.03 . . . . 0.0 112.301 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.2 -170.26 0.48 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.881 2.388 . . . . 0.0 111.816 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -116.67 158.71 42.87 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.553 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.442 ' HB3' HG22 ' A' ' 39' ' ' THR . 51.0 Cg_exo -56.14 142.66 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.564 2.176 . . . . 0.0 112.105 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.48 165.58 36.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.69 139.57 31.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.37 122.21 37.07 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.821 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 64.3 mt -131.88 122.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.597 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -67.61 83.92 0.18 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.584 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 31.2 t0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.59 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -151.29 170.54 19.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.127 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.614 HG22 ' HB3' ' C' ' 65' ' ' SER . 5.2 pt -143.41 147.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.861 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.75 111.96 24.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -93.47 110.86 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.357 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.83 122.1 31.06 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.086 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 58.1 p . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 83.3 m . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.712 0.291 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.427 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -122.62 111.08 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.759 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.33 128.8 34.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.705 0.288 . . . . 0.0 110.265 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.773 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.9 mt -125.66 133.86 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.15 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.99 120.63 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.972 0.415 . . . . 0.0 110.293 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.749 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 32.8 m -138.49 177.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.965 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.415 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.7 mt-10 -122.71 155.19 63.5 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.327 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.63 -27.61 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.945 . . . . 0.0 112.312 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -91.83 -9.84 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.516 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -60.69 141.18 57.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.815 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -79.09 160.21 27.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.49 -37.65 80.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.34 -41.99 85.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.017 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.14 -40.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 110.185 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.458 HG21 HD21 ' C' ' 56' ' ' LEU . 54.9 t -62.04 -42.87 96.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.798 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.492 ' HG2' HD11 ' C' ' 43' ' ' LEU . 54.6 mtmt -60.01 -39.73 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.97 93.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.497 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.749 ' NZ ' HG12 ' C' ' 17' ' ' VAL . 75.4 mttt -60.35 -39.09 85.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.227 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.69 -37.99 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.071 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.09 -38.85 80.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.071 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.31 -50.35 47.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.773 ' HG3' HD21 ' C' ' 15' ' ' LEU . 5.0 mttt -63.28 -40.85 98.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.682 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -133.21 148.9 52.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.174 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.02 59.57 2.67 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.591 ' CG2' HD22 ' C' ' 71' ' ' LEU . 28.9 mm -111.16 103.69 55.22 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.81 150.61 70.11 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.227 1.952 . . . . 0.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.61 -37.97 54.19 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.174 1.916 . . . . 0.0 112.278 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.76 -38.58 91.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.556 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.84 -2.88 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.189 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.576 ' HG3' HG22 ' C' ' 36' ' ' ILE . 91.1 mt-30 -89.44 94.14 9.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.29 109.47 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' C' ' 27' ' ' LYS . 33.9 mt -104.11 119.98 40.12 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.622 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.86 120.55 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.228 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -66.87 -46.68 74.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.55 79.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.936 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.88 88.86 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -126.69 126.63 43.83 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.961 0.41 . . . . 0.0 110.733 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -76.75 146.09 38.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.36 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.558 HD11 HD23 ' C' ' 67' ' ' LEU . 59.8 mt -95.7 112.64 24.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.611 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.07 148.35 36.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.17 -40.15 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.105 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.67 -12.05 66.61 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 166.48 13.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.079 0.466 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 77.6 p -117.42 165.67 13.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.191 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.458 HD21 HG21 ' C' ' 26' ' ' VAL . 77.2 mt -60.92 -40.53 93.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.905 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -64.36 -23.92 67.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.891 0.377 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.41 -34.53 75.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.517 ' CE2' HD23 ' C' ' 50' ' ' LEU . 69.5 m-85 -99.88 16.95 22.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.036 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 57.28 37.59 28.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.632 HG23 ' OG ' ' C' ' 65' ' ' SER . 86.6 mt -84.79 117.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.19 -176.56 3.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.676 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.53 145.3 33.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.906 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 60.56 25.73 15.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.393 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . 0.632 ' OG ' HG23 ' C' ' 61' ' ' ILE . 2.4 t -73.93 124.06 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.037 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -85.83 128.1 34.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.558 HD23 HD11 ' C' ' 50' ' ' LEU . 1.5 mp -118.5 149.89 40.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.49 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -94.19 119.47 33.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.83 124.15 49.1 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.281 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.41 133.06 69.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.591 HD22 ' CG2' ' C' ' 36' ' ' ILE . 17.5 mt . . . . . 0 C--N 1.334 -0.099 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.04 161.67 18.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -142.07 139.82 30.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.364 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -83.27 122.86 28.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -106.52 109.19 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.318 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -80.0 114.99 19.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.843 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.58 ' CG2' HD11 ' D' ' 13' ' ' ILE . 59.9 p -70.66 176.29 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -26.16 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -108.46 -175.96 2.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.906 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.58 -20.66 59.47 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -53.77 133.38 42.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 110.494 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -124.2 137.39 54.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.58 HD11 ' CG2' ' D' ' 7' ' ' THR . 0.1 OUTLIER -123.54 112.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.404 -179.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 28.8 m -84.11 127.2 33.76 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.296 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.626 HD21 ' HD2' ' D' ' 33' ' ' LYS . 87.4 mt -120.86 130.7 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.572 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.87 115.22 10.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.486 HG12 ' HE3' ' D' ' 29' ' ' LYS . 21.4 m -135.61 164.32 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.66 153.71 39.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.453 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -37.01 91.43 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.236 1.957 . . . . 0.0 112.026 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.1 p -82.26 -7.4 59.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.185 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.73 136.51 58.02 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.915 0.388 . . . . 0.0 110.904 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -80.04 162.88 24.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.761 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.06 -37.67 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.614 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.35 -43.22 92.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.274 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.24 -40.4 96.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.184 0.516 . . . . 0.0 110.59 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.503 HG12 HD21 ' D' ' 43' ' ' LEU . 69.6 t -62.94 -42.39 96.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.469 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.507 ' HG2' HD13 ' D' ' 43' ' ' LEU . 57.3 mtmt -60.25 -39.81 88.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.115 0.484 . . . . 0.0 110.362 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -39.71 91.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.332 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.486 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.9 mttm -60.48 -38.79 85.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.428 ' CD1' HD11 ' D' ' 43' ' ' LEU . 90.2 mt -63.37 -41.05 91.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.035 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.5 -40.36 96.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.626 ' HD2' HD21 ' D' ' 15' ' ' LEU . 52.3 mttt -78.03 -64.81 1.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.286 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -97.81 161.25 13.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.235 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.99 53.68 3.77 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.727 HG22 ' HG2' ' D' ' 41' ' ' GLN . 33.8 mm -109.28 107.56 59.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.63 150.94 69.66 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.081 1.854 . . . . 0.0 112.03 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.27 -20.63 8.35 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.297 1.998 . . . . 0.0 112.612 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -92.75 19.85 7.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.606 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -152.49 26.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.624 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.727 ' HG2' HG22 ' D' ' 36' ' ' ILE . 1.3 mt-30 -118.86 95.86 5.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' D' ' 70' ' ' VAL . 82.6 mtp180 -96.19 100.17 11.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.672 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.566 ' HB3' HD12 ' D' ' 50' ' ' LEU . 7.5 mp -85.66 122.33 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' D' ' 49' ' ' GLN . 67.1 mt -128.28 131.48 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.546 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.492 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 72.2 t80 -153.25 157.55 40.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.68 18.89 7.47 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.796 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.27 -5.9 78.43 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -130.94 149.11 52.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.562 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.522 ' HA ' HG23 ' D' ' 44' ' ' ILE . 18.5 pt20 -66.79 140.53 57.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.37 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.566 HD12 ' HB3' ' D' ' 43' ' ' LEU . 69.2 mt -81.68 123.51 28.78 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.621 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.67 139.39 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.177 0.513 . . . . 0.0 110.612 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -63.41 138.99 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.316 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.89 -12.52 64.12 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -80.22 172.07 14.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -115.29 157.53 23.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.226 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.99 -40.82 96.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.542 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -63.33 -24.14 67.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.456 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -62.54 -37.66 86.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.117 0.484 . . . . 0.0 110.424 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -98.68 14.64 27.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 m120 56.46 38.77 29.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.454 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.87 104.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.91 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.56 179.05 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.39 151.64 27.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 57.87 42.09 23.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.967 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . 0.421 ' O ' HD12 ' D' ' 67' ' ' LEU . 30.2 t -90.22 122.73 33.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.268 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -79.69 85.68 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.045 0.45 . . . . 0.0 110.589 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.438 ' N ' HD12 ' D' ' 67' ' ' LEU . 7.1 mp -77.19 154.36 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.891 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -102.64 122.67 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.256 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -104.59 121.49 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.225 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 56' ' ' LEU . 61.3 t -115.62 132.34 65.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.009 -178.837 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.847 0.356 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -85.44 127.12 34.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.287 0.565 . . . . 0.0 110.293 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' CD1' HD12 ' A' ' 57' ' ' ILE . 86.3 mt -67.53 -36.17 80.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.88 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.74 161.71 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.01 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.99 122.47 0.31 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.165 0.507 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 120' ' ' HIS . 50.6 p90 -155.36 156.16 34.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.857 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.663 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -74.62 119.2 18.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.474 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.86 144.86 25.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.222 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.75 149.12 16.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -91.98 163.47 13.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.3 mtp -124.9 175.96 6.95 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -121.62 121.22 36.9 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.354 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 37' ' ' THR . 30.4 tp -107.68 117.93 35.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.58 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -121.14 114.41 21.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.986 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 -86.68 0.56 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -146.46 22.16 1.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.558 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.603 ' O ' HD12 ' A' ' 33' ' ' LEU . 93.3 m -124.36 129.5 50.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.431 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' HD13 ' A' ' 33' ' ' LEU . 64.2 t -106.33 121.63 59.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.74 HG23 ' HG3' ' B' ' 947' ' ' PRO . 98.4 m -116.05 122.52 32.24 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.515 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -55.41 142.31 80.35 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.178 1.919 . . . . 0.0 112.23 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -108.13 132.66 53.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.879 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -70.63 -6.69 38.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.153 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -72.37 73.17 0.98 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -59.67 135.17 57.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.713 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.15 -154.99 7.02 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.0 tp -140.64 124.93 17.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.34 108.27 21.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.84 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.8 p90 -131.24 153.23 49.73 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.661 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 94.9 mt -121.17 141.21 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.933 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -141.86 140.73 32.98 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.786 0.679 . . . . 0.0 110.269 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -104.35 128.82 52.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.08 0.467 . . . . 0.0 110.399 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.52 HG23 ' CD2' ' A' ' 58' ' ' HIS . 22.7 p -88.09 172.74 9.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.673 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.72 -10.37 19.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -86.15 -0.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.343 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t 69.4 19.65 7.56 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.05 0.452 . . . . 0.0 110.698 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 60.1 mt -103.34 126.95 50.77 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 23' ' ' LEU . 45.5 mm -79.26 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.485 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.7 m-70 -104.95 116.65 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.691 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -92.81 107.25 19.07 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.9 m -118.53 144.79 45.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.653 0.739 . . . . 0.0 112.805 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -125.76 111.18 14.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.745 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -103.3 136.29 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.989 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -76.12 139.58 41.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -79.17 -18.97 52.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.614 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -61.08 -46.29 91.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -117.04 -12.47 10.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.328 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.95 77.16 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.78 147.66 26.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.32 . . . . 0.0 111.028 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.5 103.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.103 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -83.15 -28.74 29.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.28 143.46 51.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.057 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.798 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.5 t0 -158.11 99.98 1.68 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.769 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 72' ' ' ASP . 6.2 mt -132.09 130.13 40.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.0 mt -74.32 129.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.687 HG21 ' SG ' ' A' ' 80' ' ' CYS . 21.4 mm -117.26 120.24 64.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.647 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.6 m-85 -86.02 163.55 42.67 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.191 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.8 136.27 75.39 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.023 1.815 . . . . 0.0 111.525 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t0 61.4 12.06 4.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.44 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.85 -25.32 30.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.889 -0.142 . . . . 0.0 110.778 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 75' ' ' ILE . 10.2 p -147.04 169.17 19.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.253 0.549 . . . . 0.0 110.672 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.93 132.42 30.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.448 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -102.29 117.77 35.47 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -141.74 164.8 29.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.072 0.463 . . . . 0.0 111.461 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -83.81 160.71 21.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.383 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.7 88.43 20.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.45 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.96 59.86 7.64 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.298 1.999 . . . . 0.0 112.038 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -48.83 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.42 102.77 54.79 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.828 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.73 129.6 14.72 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 121.516 1.478 . . . . 0.0 111.478 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 p 167.46 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.7 0.625 . . . . 0.0 110.416 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.35 -179.26 33.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -88.09 114.7 24.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.655 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.12 129.81 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.199 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -119.83 157.3 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.7 p -134.21 136.94 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.5 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.609 HD11 ' SG ' ' A' ' 80' ' ' CYS . 67.6 tp -102.55 121.79 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -118.53 134.37 55.14 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.242 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CE2' HD12 ' A' ' 75' ' ' ILE . 40.1 m-85 -85.75 114.16 22.49 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -37.13 84.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.8 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.06 -22.52 22.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.454 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.44 -169.78 20.39 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.6 p -121.42 13.2 10.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.626 0.251 . . . . 0.0 110.572 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.467 ' HD3' HD21 ' A' ' 105' ' ' LEU . 14.3 ttmm -85.87 142.6 28.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.847 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -135.33 129.22 33.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.314 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' VAL . 46.2 mt -112.48 150.7 30.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.889 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.466 ' CE1' HD22 ' A' ' 33' ' ' LEU . 93.2 m-85 -123.65 135.62 54.02 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.654 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -137.49 152.1 49.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.26 0.552 . . . . 0.0 111.425 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -128.87 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.475 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.25 134.62 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.83 -6.53 11.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.363 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -75.06 150.57 85.76 Favored Pre-proline 0 C--O 1.231 0.119 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.703 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.38 -40.41 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.022 1.814 . . . . 0.0 112.393 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.93 147.67 45.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.8 p -95.99 8.53 43.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.234 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.38 -20.43 43.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -121.45 -15.71 7.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.823 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.79 -40.04 93.81 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.663 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.02 -40.98 99.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.14 -40.02 86.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.174 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.74 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.3 m170 -60.57 -39.67 88.84 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.1 m -62.05 -41.98 98.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.718 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -66.83 -40.91 88.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.192 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -67.22 -36.72 82.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.8 t -58.32 -48.49 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.083 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -78.56 -25.49 45.4 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.026 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.22 -37.68 75.09 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.452 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -82.05 -31.7 30.77 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.727 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.4 mt -81.33 -20.67 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.038 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -114.97 -18.23 11.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.279 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -146.42 73.83 12.84 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.848 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 161.28 43.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.771 2.314 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.718 2.279 . . . . 0.0 112.145 -179.638 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -71.38 152.97 94.12 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.21 147.23 65.98 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.497 2.131 . . . . 0.0 111.944 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.02 154.74 77.65 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.11 150.2 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.228 1.952 . . . . 0.0 112.46 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.99 -153.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.503 2.135 . . . . 0.0 111.581 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -129.5 158.86 72.04 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.526 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.74 ' HG3' HG23 ' A' ' 39' ' ' THR . 50.8 Cg_exo -56.45 140.42 89.04 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.71 2.273 . . . . 0.0 111.974 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -155.69 165.6 36.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.07 138.08 32.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.864 0.364 . . . . 0.0 110.62 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -122.31 123.51 41.57 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.815 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 122.43 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -72.53 84.09 1.12 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.106 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 38.4 t0 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.797 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -62.23 157.69 18.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.794 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.73 142.04 35.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.302 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.48 125.22 32.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.561 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.885 HG11 HD11 ' C' ' 30' ' ' ILE . 62.5 t -113.44 118.32 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.848 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -90.19 121.17 31.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.205 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.7 p . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.867 179.85 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.964 0.411 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.416 HD12 HD13 ' C' ' 30' ' ' ILE . 0.0 OUTLIER -128.04 105.5 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.422 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -73.09 128.83 36.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.659 HD13 ' CB ' ' C' ' 29' ' ' LYS . 62.8 mt -120.5 124.53 45.61 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.889 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.81 108.91 2.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.062 0.458 . . . . 0.0 111.071 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.586 HG12 ' HE3' ' C' ' 29' ' ' LYS . 20.5 m -132.45 167.58 26.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.442 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.4 mt-10 -114.12 154.81 46.12 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.93 -29.12 80.93 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.701 . . . . 0.0 111.73 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.5 p -85.27 -12.82 51.54 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.856 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -64.89 142.95 58.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.021 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -83.86 164.14 19.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.491 0.662 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.9 -34.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.34 -43.44 88.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -63.01 -40.8 98.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 110.467 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.565 HG22 HG11 ' C' ' 17' ' ' VAL . 55.6 t -63.72 -42.94 97.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -62.05 -39.63 93.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.194 0.521 . . . . 0.0 110.329 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.06 89.5 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.824 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.659 ' CB ' HD13 ' C' ' 15' ' ' LEU . 66.9 mttm -60.11 -37.97 81.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.885 HD11 HG11 ' C' ' 5' ' ' VAL . 8.4 mm -63.41 -39.63 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.595 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -59.46 -46.75 87.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -62.09 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.772 -0.58 . . . . 0.0 111.136 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.27 -26.16 61.89 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -137.16 -53.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.238 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.0 10.35 8.28 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.55 HG22 ' HG3' ' C' ' 41' ' ' GLN . 62.7 mt -76.14 122.11 86.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.37 160.64 48.09 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.395 1.397 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.69 -39.89 88.46 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.538 2.159 . . . . 0.0 112.828 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.94 -37.06 83.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.246 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.24 21.53 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.725 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.55 ' HG3' HG22 ' C' ' 36' ' ' ILE . 14.0 mt-30 -109.73 -46.55 3.49 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 35.37 77.86 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.033 0.833 . . . . 0.0 110.862 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.684 ' CB ' HD12 ' C' ' 50' ' ' LEU . 84.3 mt -80.53 132.58 35.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -130.05 130.83 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.503 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.73 129.22 43.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.46 26.36 15.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.56 90.53 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -104.49 126.65 51.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.933 0.366 . . . . 0.0 110.02 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.72 132.66 46.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' C' ' 43' ' ' LEU . 68.6 mt -81.71 97.74 8.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 110.31 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.03 139.13 42.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.8 135.87 57.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.263 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.55 -18.65 52.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -81.92 157.15 24.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.683 0.278 . . . . 0.0 110.304 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -99.69 162.21 13.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.065 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.463 HD21 HG21 ' C' ' 26' ' ' VAL . 75.8 mt -61.75 -39.07 90.31 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.28 -22.6 66.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.01 -38.69 89.6 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.2 14.53 25.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 57.05 39.86 28.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.023 0.439 . . . . 0.0 110.335 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.96 117.77 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.033 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -102.58 -170.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.351 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -69.72 152.47 44.62 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.545 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 51.59 39.1 24.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.452 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -90.63 125.03 35.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.515 ' C ' HD12 ' C' ' 67' ' ' LEU . 49.6 m -75.94 130.16 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.249 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.515 HD12 ' C ' ' C' ' 66' ' ' THR . 8.2 mp -119.05 156.17 30.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -105.21 121.49 43.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.448 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.425 HD11 HG21 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -98.54 118.34 35.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.108 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.07 127.12 65.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.243 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.551 -179.002 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.84 161.37 18.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.229 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.473 HD12 HD22 ' D' ' 67' ' ' LEU . 9.3 pt -139.75 143.32 30.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.131 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -88.65 119.56 29.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -102.34 108.12 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.11 120.93 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.378 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.464 HG22 HD23 ' D' ' 69' ' ' LEU . 80.2 p -80.91 172.52 13.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.774 HD11 ' H ' ' D' ' 71' ' ' LEU . 87.7 mt -61.15 -37.77 84.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.031 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.12 -8.51 55.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.809 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.42 8.12 60.05 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -81.03 113.67 19.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.849 0.356 . . . . 0.0 110.158 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -86.14 134.2 33.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.685 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.4 mt -129.59 106.7 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.398 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -79.65 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' D' ' 33' ' ' LYS . 75.5 mt -123.77 124.02 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.661 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.04 114.5 7.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.895 0.379 . . . . 0.0 110.25 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.53 HG12 ' CD ' ' D' ' 29' ' ' LYS . 25.9 m -136.24 163.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.492 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . 0.43 ' O ' HD12 ' D' ' 56' ' ' LEU . 73.8 mm-40 -109.43 154.72 42.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.097 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.68 -28.62 86.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.79 1.66 . . . . 0.0 111.728 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 62.7 m -86.27 -10.17 55.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.707 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.7 144.4 57.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.529 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -79.12 162.6 25.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.022 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.602 HD12 HD23 ' D' ' 50' ' ' LEU . 27.4 mm -63.33 -39.23 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.2 -41.46 88.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.091 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.79 -41.01 97.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.117 0.484 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.462 HG21 HD21 ' D' ' 56' ' ' LEU . 58.0 t -62.79 -43.98 99.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.789 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.429 ' HG2' HD11 ' D' ' 43' ' ' LEU . 58.6 mtmt -61.06 -39.73 90.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.09 92.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.45 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.53 ' CD ' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -60.01 -40.71 90.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.558 HD12 ' OE1' ' D' ' 41' ' ' GLN . 91.7 mt -65.05 -41.35 91.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.179 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.95 -40.36 88.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.515 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.94 6.98 7.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.714 ' HG3' HD21 ' D' ' 15' ' ' LEU . 5.3 mttt -114.39 -52.75 2.7 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.635 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -107.42 -0.79 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 18.58 78.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mm -80.25 119.23 75.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.09 154.25 52.31 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.921 1.747 . . . . 0.0 111.822 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.29 -40.01 79.2 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.314 2.009 . . . . 0.0 112.263 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.96 -39.25 91.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.546 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.69 32.2 2.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.558 ' OE1' HD12 ' D' ' 30' ' ' ILE . 8.2 tt0 -136.9 120.14 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -124.48 114.11 19.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.429 HD11 ' HG2' ' D' ' 27' ' ' LYS . 27.1 mt -96.05 128.63 43.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' D' ' 49' ' ' GLN . 66.2 mt -127.67 129.48 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.542 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.7 t80 -147.65 152.51 37.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.22 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.81 15.65 8.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.679 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 89.17 -15.33 58.47 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.649 ' HB3' HD22 ' A' ' 73' ' ' LEU . 41.2 ptt180 -113.78 146.52 39.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.354 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.448 ' HA ' HG23 ' D' ' 44' ' ' ILE . 22.9 pt20 -71.35 139.23 49.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.255 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.829 HD21 HD11 ' D' ' 61' ' ' ILE . 7.7 mp -88.91 114.39 25.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.808 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . 0.443 ' O ' HG21 ' D' ' 23' ' ' ILE . 24.1 pt-20 -74.89 -169.12 0.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.672 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.48 -146.2 44.13 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 50.56 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.593 . . . . 0.0 111.446 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -132.6 168.43 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.236 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.462 HD21 HG21 ' D' ' 26' ' ' VAL . 79.2 mt -61.83 -39.68 92.66 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.552 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -64.98 -26.82 68.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.72 -31.12 71.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.059 0.457 . . . . 0.0 109.897 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -101.31 13.15 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.51 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.46 40.04 29.75 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.374 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . 0.829 HD11 HD21 ' D' ' 50' ' ' LEU . 88.6 mt -89.46 107.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.012 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.38 -177.16 4.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.423 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.93 150.56 49.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.993 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 60.44 45.97 10.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 57.5 m -94.87 123.7 38.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 31.5 m -77.77 80.23 4.23 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.179 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.473 HD22 HD12 ' D' ' 3' ' ' ILE . 10.7 mp -71.06 140.18 50.64 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.209 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -93.89 122.96 36.91 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.259 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.464 HD23 HG22 ' D' ' 7' ' ' THR . 40.3 tp -102.59 120.26 40.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.542 . . . . 0.0 110.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.54 HG11 HD11 ' A' ' 56' ' ' LEU . 91.6 t -111.9 130.87 64.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.596 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.774 ' H ' HD11 ' D' ' 8' ' ' LEU . 54.8 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.86 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 pttt . . . . . 0 C--O 1.238 0.484 0 CA-C-O 121.038 0.447 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -97.61 116.25 29.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.408 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.7 mt -67.13 -37.3 83.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.771 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.431 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.1 p -150.17 161.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.821 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -173.22 122.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.182 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.44 157.17 38.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.599 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -75.83 123.41 25.61 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.607 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -154.43 146.45 23.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.06 153.63 16.91 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -89.06 174.87 7.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.029 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 23.0 mtp -139.72 172.69 12.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.585 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.51 127.16 49.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 37' ' ' THR . 32.4 tp -107.58 117.19 33.45 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.49 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -120.6 111.84 18.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.813 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.17 -86.21 0.49 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -145.59 20.66 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 0.0 110.792 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.5 m -122.2 130.64 53.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.941 0.401 . . . . 0.0 110.467 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 33' ' ' LEU . 57.5 t -109.07 123.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.1 p -112.89 133.34 21.99 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 147.32 54.51 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.871 1.714 . . . . 0.0 113.055 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -101.5 117.21 34.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.85 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -59.42 -14.6 12.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.03 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -71.78 82.83 0.89 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -59.11 136.85 58.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.102 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.12 -159.64 9.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.971 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.4 tp -138.35 125.17 21.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' A' ' 28' ' ' ALA . 46.1 t -98.36 111.58 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -134.64 154.59 51.44 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.241 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 24' ' ' VAL . 98.0 mt -121.11 138.03 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.14 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.42 133.62 34.95 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 123.675 0.609 . . . . 0.0 110.168 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.424 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.1 tt0 -102.18 126.37 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.031 0.443 . . . . 0.0 110.536 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' CD2' ' A' ' 58' ' ' HIS . 16.4 p -85.72 171.48 11.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.692 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.67 -10.69 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.78 0.41 56.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.631 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t 70.78 21.04 5.34 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.171 0.51 . . . . 0.0 110.314 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD11 HG11 ' D' ' 70' ' ' VAL . 85.1 mt -98.54 121.7 40.81 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.547 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.0 mm -80.5 122.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.497 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.0 m-70 -98.92 115.64 29.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -98.59 107.83 20.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.91 143.12 51.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.551 -0.859 . . . . 0.0 112.941 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -116.95 117.19 29.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.298 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -106.72 146.05 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.355 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.9 128.49 34.58 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.41 -27.72 64.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -58.26 -36.75 73.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.853 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.9 m -116.75 -16.98 10.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.998 0.428 . . . . 0.0 110.241 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.4 21.87 79.18 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -102.4 151.1 22.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.24 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.51 102.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.5 -38.05 62.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.228 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -126.63 145.79 50.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.251 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.578 ' O ' HD23 ' A' ' 73' ' ' LEU . 17.8 t70 -157.47 101.58 1.86 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.184 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' D' ' 48' ' ' ARG . 37.5 mt -128.34 136.73 51.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.881 0.372 . . . . 0.0 110.72 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.3 123.61 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.417 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.522 ' HB ' HD22 ' A' ' 128' ' ' LEU . 26.2 mm -108.75 123.77 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.318 0.58 . . . . 0.0 111.466 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 56.5 m-85 -91.48 162.47 31.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.126 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.63 138.02 79.76 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.21 1.94 . . . . 0.0 111.778 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.1 11.81 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.452 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.37 -36.84 18.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.752 0.311 . . . . 0.0 110.492 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.468 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -140.41 145.12 36.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.506 -178.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.615 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.5 tt0 -121.73 135.24 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.616 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -106.29 120.24 41.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -143.06 166.82 23.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.831 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -84.34 160.13 20.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.087 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.23 89.74 12.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -79.84 60.12 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.799 1.666 . . . . 0.0 112.29 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -114.07 -37.45 4.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.343 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.5 t -130.51 82.77 64.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.05 130.89 26.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.791 1.661 . . . . 0.0 111.477 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p 170.25 -38.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.38 -150.09 5.48 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.47 105.85 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.777 0.323 . . . . 0.0 110.429 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.87 128.23 71.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 110.783 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.31 156.35 40.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.56 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 105' ' ' LEU . 12.4 p -133.15 136.07 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.514 . . . . 0.0 110.232 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 81' ' ' GLU . 57.3 tp -104.56 123.36 47.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -118.08 137.7 52.75 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.081 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -91.94 108.44 19.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.359 0.599 . . . . 0.0 110.056 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.8 -38.26 87.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.694 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.61 -22.38 24.78 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.33 -177.96 30.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -121.03 30.17 6.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.76 155.82 42.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.198 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.477 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.8 mtt180 -136.75 148.25 47.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.632 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 104' ' ' ARG . 36.7 mt -122.97 152.81 40.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.866 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.454 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 97.3 m-85 -125.22 136.86 53.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.87 156.31 47.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.185 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -130.26 137.78 50.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.587 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttm -72.72 133.4 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.17 0.509 . . . . 0.0 111.887 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 4.74 21.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.437 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -71.95 139.58 82.79 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.03 -26.83 42.97 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.845 1.697 . . . . 0.0 112.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.63 141.8 48.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.471 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -98.13 10.87 39.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.588 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -54.28 -21.61 9.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -130.02 16.52 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.1 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -62.17 -47.68 83.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.2 0.524 . . . . 0.0 110.253 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -74.49 -32.98 62.73 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.461 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.04 -46.54 83.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.531 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.791 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.8 m170 -63.87 -40.83 97.47 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.601 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.91 -45.37 94.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.804 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -64.72 -43.85 92.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.453 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.19 -36.28 83.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.881 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.5 t -58.83 -48.33 86.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -77.69 -29.56 51.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.741 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.61 -36.68 76.4 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.618 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -80.02 -31.42 39.61 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.754 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.522 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.0 mt -82.45 -27.67 31.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -103.23 -27.46 12.49 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.0 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -133.23 73.75 73.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.084 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.6 Cg_exo -59.38 156.66 34.62 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.119 2.546 . . . . 0.0 112.034 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.492 1.426 0 C-N-CA 122.486 2.124 . . . . 0.0 112.148 -179.456 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -129.56 152.02 78.97 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.83 146.94 26.83 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.68 2.253 . . . . 0.0 112.149 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.53 153.62 87.65 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.68 158.63 55.22 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.251 1.967 . . . . 0.0 112.021 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.24 -171.81 0.77 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.726 2.284 . . . . 0.0 112.056 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -119.06 159.15 46.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.04 141.91 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.503 2.136 . . . . 0.0 112.324 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.52 162.14 41.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.671 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -87.25 136.82 32.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.621 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -120.88 125.72 48.19 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.415 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.0 mp -130.67 123.14 54.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.588 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -82.06 83.73 7.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.899 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.2 t0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.298 179.494 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.96 157.47 18.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.203 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -139.66 144.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.451 ' HD2' HG21 ' C' ' 12' ' ' THR . 8.1 m-85 -88.93 123.34 33.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.127 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.585 HG11 HD11 ' C' ' 30' ' ' ILE . 80.5 t -109.02 105.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -85.77 127.65 34.59 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.72 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.458 HG22 HD23 ' C' ' 69' ' ' LEU . 73.1 p . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . 0.451 HG21 ' HD2' ' C' ' 4' ' ' PHE . 88.1 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.793 0.33 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -123.12 109.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.653 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.9 m -84.16 132.97 34.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.271 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.766 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.0 mt -126.56 126.9 44.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.5 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.02 108.39 2.6 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 110.866 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.789 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.6 m -131.47 164.03 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.122 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.89 155.05 38.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.312 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.22 -33.92 92.04 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.056 1.837 . . . . 0.0 111.984 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -85.21 -3.91 58.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.152 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.12 136.87 58.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.857 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -79.07 160.53 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.564 HG21 ' O ' ' C' ' 50' ' ' LEU . 47.1 mm -64.29 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.769 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.85 -42.14 88.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -62.07 -42.41 99.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -61.96 -43.83 98.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.912 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.73 -39.62 89.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.285 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.02 89.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.256 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.789 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.7 mttm -59.89 -39.57 85.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.585 HD11 HG11 ' C' ' 5' ' ' VAL . 7.8 mm -64.52 -39.97 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.318 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.62 -39.32 83.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.05 9.61 19.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.766 ' HG3' HD21 ' C' ' 15' ' ' LEU . 2.8 mmtt -113.26 -42.51 3.5 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.7 2.41 8.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.362 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.12 79.43 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.588 HG22 ' HG3' ' C' ' 41' ' ' GLN . 51.5 mt -81.11 128.51 70.59 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.733 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.49 153.11 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.721 1.614 . . . . 0.0 111.62 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.96 -36.19 63.42 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.297 1.998 . . . . 0.0 112.594 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.96 -38.07 84.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -95.85 17.88 14.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.31 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.588 ' HG3' HG22 ' C' ' 36' ' ' ILE . 90.6 mt-30 -112.53 103.73 11.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.138 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.53 109.83 18.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' C' ' 50' ' ' LEU . 69.8 mt -101.19 123.49 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -128.9 127.99 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 128.66 48.61 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.69 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.74 27.03 16.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.41 89.72 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -102.79 126.2 49.83 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.913 0.387 . . . . 0.0 110.179 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.89 130.22 42.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.425 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' C' ' 43' ' ' LEU . 55.7 mt -88.96 82.88 6.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -73.01 173.4 9.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -78.3 171.16 15.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.04 12.68 81.34 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.94 165.68 19.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.981 0.419 . . . . 0.0 110.58 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.42 167.78 11.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' C' ' 56' ' ' LEU . 82.7 mt -61.95 -39.77 93.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -62.82 -28.29 69.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -62.54 -29.27 70.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.419 . . . . 0.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' C' ' 50' ' ' LEU . 68.4 m-85 -102.95 13.46 34.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.29 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 56.35 40.48 29.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.239 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -89.56 108.88 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.073 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -93.09 -174.05 3.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.485 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -67.0 151.48 47.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 54.77 38.66 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -92.51 124.73 36.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.044 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.416 ' C ' HD12 ' C' ' 67' ' ' LEU . 28.0 m -75.94 129.46 36.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.97 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.416 HD12 ' C ' ' C' ' 66' ' ' THR . 6.3 mp -120.45 148.91 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.324 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -93.07 114.61 27.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.458 HD23 HG22 ' C' ' 7' ' ' THR . 54.3 tp -103.93 121.12 42.46 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.08 131.4 71.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.827 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.472 ' CD2' HD13 ' C' ' 36' ' ' ILE . 13.3 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.157 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.4 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.6 157.47 17.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.18 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 pt -138.18 147.56 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.059 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -88.68 123.27 32.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.301 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' D' ' 69' ' ' LEU . 64.8 t -108.21 102.7 14.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.636 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -92.94 120.73 33.56 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.664 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.5 p -81.37 173.48 12.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.623 HD11 ' H ' ' D' ' 71' ' ' LEU . 74.6 mt -61.73 -26.78 68.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.147 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -72.29 -12.98 61.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 -13.6 63.06 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 132.95 49.37 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.2 m -103.64 132.58 49.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.661 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.86 108.83 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -81.04 128.65 33.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.484 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.647 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.6 mt -125.17 127.76 47.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.599 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -69.33 114.77 7.88 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.716 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.579 HG12 ' HE2' ' D' ' 29' ' ' LYS . 23.3 m -134.88 165.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.543 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -108.64 153.83 42.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.11 -35.08 94.53 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.928 1.752 . . . . 0.0 112.243 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -86.49 -2.59 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.166 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' D' ' 26' ' ' VAL . 18.8 t70 -61.38 133.68 56.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.668 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.434 HD12 HD13 ' D' ' 50' ' ' LEU . 48.7 mm -64.16 -38.71 83.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.39 -42.05 90.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.1 -41.75 98.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 110.904 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.549 HG23 ' OD1' ' D' ' 21' ' ' ASP . 57.5 t -63.6 -42.24 95.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.484 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.92 -38.83 87.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.84 90.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.064 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.579 ' HE2' HG12 ' D' ' 17' ' ' VAL . 61.4 mttp -59.98 -39.74 86.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.805 ' CD1' HD21 ' D' ' 43' ' ' LEU . 88.9 mt -65.05 -40.48 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.449 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.58 -40.8 93.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -63.66 -43.48 96.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.647 ' HD2' HD21 ' D' ' 15' ' ' LEU . 62.4 mttt -75.24 -72.74 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.134 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -84.63 166.99 16.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.173 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.77 15.08 56.71 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.578 HG22 ' HG3' ' D' ' 41' ' ' GLN . 33.3 mm -70.39 124.8 91.5 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.174 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.93 155.79 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.026 1.817 . . . . 0.0 111.585 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.67 -40.89 82.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.993 1.795 . . . . 0.0 112.971 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.89 -45.28 94.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.898 0.38 . . . . 0.0 110.966 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -69.92 -38.73 76.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.741 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.578 ' HG3' HG22 ' D' ' 36' ' ' ILE . 59.9 mt-30 -54.46 106.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.35 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -118.9 88.12 2.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.805 HD21 ' CD1' ' D' ' 30' ' ' ILE . 77.3 mt -74.39 129.19 37.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.361 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.536 HD12 HG21 ' D' ' 70' ' ' VAL . 79.0 mt -131.0 129.75 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 73.2 t80 -150.69 154.61 37.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.65 19.58 9.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.68 80.13 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -127.38 147.55 50.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 110.45 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -71.61 141.01 49.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.068 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' D' ' 43' ' ' LEU . 82.7 mt -74.9 115.85 14.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.797 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.96 139.54 41.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.87 143.92 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.17 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.67 69.23 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -83.58 179.01 7.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.765 0.317 . . . . 0.0 110.773 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -126.1 163.65 22.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.285 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.79 -39.88 95.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.543 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.07 -29.2 70.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.16 -35.14 76.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 110.122 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . 0.474 ' CE2' HD23 ' D' ' 50' ' ' LEU . 59.2 m-85 -97.31 14.15 27.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.246 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.65 40.81 32.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.851 0.358 . . . . 0.0 110.329 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.83 107.24 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.308 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -93.95 177.32 6.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.66 150.49 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.248 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 58.92 40.34 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . 0.434 ' O ' HD12 ' D' ' 67' ' ' LEU . 30.2 t -97.31 123.4 41.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.186 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 69.0 m -74.97 127.55 33.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.0 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.434 HD12 ' O ' ' D' ' 65' ' ' SER . 5.3 mp -118.22 146.76 44.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.887 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -95.89 117.48 30.68 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.093 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.607 HD11 HD13 ' D' ' 30' ' ' ILE . 0.6 OUTLIER -93.99 97.67 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.1 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.536 HG21 HD12 ' D' ' 44' ' ' ILE . 46.1 t -83.96 134.6 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.095 0.474 . . . . 0.0 110.478 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.623 ' H ' HD11 ' D' ' 8' ' ' LEU . 75.3 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.59 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.713 0.292 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -89.4 112.26 23.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.331 0.586 . . . . 0.0 109.898 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 51' ' ' GLN . 88.6 mt -65.2 -38.25 89.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.606 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -151.36 162.93 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.115 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -172.82 122.58 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.262 0.553 . . . . 0.0 110.969 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -157.51 159.89 37.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.076 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -75.62 120.64 21.3 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.45 140.81 18.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.074 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.16 150.79 17.11 Favored Glycine 0 C--O 1.226 -0.347 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -95.03 177.38 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.99 0.424 . . . . 0.0 111.068 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.3 mtp -140.35 168.44 19.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.0 m -119.03 120.94 38.7 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 37' ' ' THR . 52.6 tp -101.13 123.43 45.27 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.919 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -119.54 104.02 9.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.091 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -81.14 0.86 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 p -146.84 19.07 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.562 0.22 . . . . 0.0 110.973 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.745 ' O ' HD12 ' A' ' 33' ' ' LEU . 94.7 m -120.85 128.97 53.33 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.535 HG22 HD13 ' A' ' 33' ' ' LEU . 63.5 t -103.0 123.21 56.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.144 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.6 p -110.46 114.5 55.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.54 141.04 95.09 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.121 1.88 . . . . 0.0 112.621 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.98 113.03 24.76 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.58 -18.29 39.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.541 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -75.43 73.57 2.48 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -56.04 137.21 51.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.65 -152.98 8.45 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.508 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.12 124.24 21.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.49 107.28 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.2 p90 -130.96 153.34 49.3 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.927 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 23' ' ' LEU . 96.6 mt -119.54 140.88 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.658 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -136.6 132.93 35.77 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 123.787 0.679 . . . . 0.0 109.936 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.689 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.1 tt0 -100.53 123.46 44.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.09 0.471 . . . . 0.0 110.182 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.449 HG23 ' CD2' ' A' ' 58' ' ' HIS . 7.6 p -84.26 168.86 15.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.787 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.13 -10.38 10.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.929 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -91.03 6.66 43.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.629 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 m 63.88 23.66 13.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.234 0.54 . . . . 0.0 110.93 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 76.8 mt -100.02 122.85 43.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.658 HG21 HD23 ' A' ' 128' ' ' LEU . 50.6 mm -81.06 121.89 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.449 ' CD2' HG23 ' A' ' 52' ' ' THR . 75.6 m-70 -98.77 114.17 26.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.786 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -95.18 107.83 19.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 72.4 m -120.62 146.61 46.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 0.0 112.648 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -125.86 112.68 16.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.583 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -105.16 128.89 53.6 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.829 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.16 136.56 48.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.21 -17.19 58.68 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.714 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.7 m -60.49 -45.25 94.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.593 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.5 m -116.58 -16.28 10.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.77 20.84 79.33 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -102.07 145.82 28.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.656 0.265 . . . . 0.0 110.388 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.6 t -73.27 103.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.091 0.472 . . . . 0.0 110.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -79.91 -32.91 40.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.766 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -126.32 145.27 50.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.202 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.593 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.2 p-10 -160.83 98.32 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 72' ' ' ASP . 34.2 mt -128.26 137.1 51.84 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.12 123.11 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.672 ' HB ' HD22 ' A' ' 128' ' ' LEU . 29.4 mm -111.27 121.05 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.13 0.49 . . . . 0.0 110.599 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.539 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 50.7 m-85 -85.12 163.65 44.7 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.257 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.17 138.33 82.71 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.813 1.675 . . . . 0.0 111.785 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 59.58 12.68 2.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.449 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.2 -38.66 24.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.44 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB3' HD11 ' A' ' 96' ' ' LEU . 85.3 m -129.87 155.78 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.122 0.486 . . . . 0.0 110.99 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 2.1 tt0 -126.11 130.46 51.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.59 117.64 35.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -138.56 162.98 33.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -82.08 161.35 22.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.54 88.89 14.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.331 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.24 60.41 7.38 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.145 1.897 . . . . 0.0 112.084 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -114.45 -39.53 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.44 78.09 76.27 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.59 130.43 40.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.271 1.981 . . . . 0.0 111.178 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 169.12 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.111 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.45 -165.77 12.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.508 ' HD3' HG22 ' A' ' 114' ' ' THR . 4.2 mtt-85 -96.78 105.18 17.26 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.3 t -126.38 128.24 71.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -124.93 160.52 28.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.009 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 105' ' ' LEU . 9.7 p -135.16 135.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 110.044 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 80' ' ' CYS . 58.6 tp -101.61 123.51 45.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -120.39 140.39 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.147 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.413 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 21.6 m-85 -88.34 116.92 26.89 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 98.5 mttt -62.35 -37.38 85.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.832 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.87 -19.78 18.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.533 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -106.58 -178.39 23.11 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.0 m -114.89 13.46 17.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.661 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.611 ' HD3' HD21 ' A' ' 105' ' ' LEU . 25.5 ttmt -84.98 142.81 29.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.227 0.537 . . . . 0.0 110.983 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -136.07 121.47 19.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.556 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.611 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.0 mt -111.35 152.46 27.25 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.79 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CE1' HD22 ' A' ' 33' ' ' LEU . 91.8 m-85 -126.18 136.63 53.08 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.443 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.62 153.77 49.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.249 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -129.66 138.6 51.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.599 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.55 136.25 49.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.82 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.94 -1.04 26.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.451 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.0 131.86 65.47 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.296 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.9 -18.6 46.83 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.081 1.854 . . . . 0.0 112.727 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -113.74 140.34 48.35 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.508 HG22 ' HD3' ' A' ' 92' ' ' ARG . 79.1 p -96.06 8.19 44.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.61 -16.97 62.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.604 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -131.98 -5.37 3.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.625 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.38 -41.69 98.81 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.942 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -74.17 -34.53 63.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.956 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.55 -42.31 92.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.156 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.701 ' O ' HG23 ' A' ' 124' ' ' VAL . 67.9 m170 -63.6 -41.74 98.3 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.9 t -60.98 -44.23 97.68 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.299 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -66.79 -43.59 83.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.939 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -63.71 -40.09 95.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 120' ' ' HIS . 47.3 t -58.71 -48.1 86.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.203 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.24 -22.1 42.12 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.406 -0.917 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.85 -39.86 69.42 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' A' ' 23' ' ' LEU . 31.1 m-85 -79.88 -35.89 37.37 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.551 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 75' ' ' ILE . 70.9 mt -71.15 -36.7 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.079 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -98.4 -27.83 13.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.333 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -134.48 73.59 67.99 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.894 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' A' ' 57' ' ' ILE . 35.2 Cg_exo -59.67 155.88 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.958 2.439 . . . . 0.0 112.286 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.544 2.163 . . . . 0.0 112.042 -179.718 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.27 80.97 69.55 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.69 141.92 91.5 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.595 2.196 . . . . 0.0 112.147 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.21 153.6 94.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.063 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.98 149.22 77.22 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.018 1.812 . . . . 0.0 112.244 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -54.96 -172.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.352 2.035 . . . . 0.0 111.851 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.15 159.55 58.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.93 138.84 78.73 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.511 2.141 . . . . 0.0 112.431 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.71 163.87 39.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -86.58 137.63 32.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.359 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -125.18 129.23 49.71 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.188 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.41 129.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -72.32 84.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.83 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.619 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -63.84 159.02 20.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.158 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -138.95 150.84 23.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.983 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -94.11 124.08 37.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.552 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.58 115.61 49.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.192 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -93.35 129.92 39.29 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.506 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.469 HG22 HD23 ' C' ' 69' ' ' LEU . 76.8 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 111.125 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.946 0.403 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.94 118.21 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.527 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.9 m -85.1 130.37 34.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.303 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.561 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.0 mt -123.41 127.1 47.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.241 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.39 113.72 8.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.825 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.471 HG12 ' CD ' ' C' ' 29' ' ' LYS . 21.3 m -136.43 167.36 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.79 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.601 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.8 mt-10 -116.94 152.24 48.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.56 -43.9 51.45 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.026 1.817 . . . . 0.0 112.485 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.21 -37.13 86.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.242 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -41.65 133.07 2.77 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.106 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -82.4 167.9 18.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.307 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.678 HD12 HD23 ' C' ' 50' ' ' LEU . 35.8 mm -62.03 -35.78 70.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.47 -42.53 87.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.084 0.469 . . . . 0.0 110.377 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.96 -41.38 91.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.231 0.538 . . . . 0.0 110.875 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.541 HG21 HD21 ' C' ' 56' ' ' LEU . 62.9 t -64.43 -46.41 93.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.796 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -62.81 -32.5 73.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.255 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.29 98.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 110.099 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.471 ' CD ' HG12 ' C' ' 17' ' ' VAL . 66.8 mttm -60.78 -39.4 88.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.163 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.745 ' CD1' HD21 ' C' ' 43' ' ' LEU . 93.2 mt -64.64 -40.37 88.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.981 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.86 -42.5 93.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.488 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.15 -40.13 95.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.416 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.561 ' HG3' HD21 ' C' ' 15' ' ' LEU . 18.2 mttt -74.66 -60.73 2.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -106.73 155.33 19.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.83 55.23 4.21 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.592 HG23 HD22 ' C' ' 71' ' ' LEU . 30.4 mm -109.64 113.26 58.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.44 150.66 58.41 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.664 1.576 . . . . 0.0 111.621 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.46 -38.35 43.66 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.193 1.929 . . . . 0.0 112.474 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.24 -39.18 89.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.353 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -89.92 -2.32 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.245 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -86.19 100.7 12.42 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.208 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -104.32 100.46 10.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.745 HD21 ' CD1' ' C' ' 30' ' ' ILE . 59.5 mt -96.7 117.97 32.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.469 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 93.9 mt -126.36 128.26 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -128.41 130.46 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.674 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 24.52 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.73 3.04 90.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -106.96 128.51 54.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.68 133.04 47.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.678 HD23 HD12 ' C' ' 23' ' ' ILE . 7.6 mp -80.33 95.61 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.47 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.22 139.01 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.339 0.59 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -59.43 150.74 25.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.396 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 -13.38 64.66 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -94.9 151.61 19.07 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.255 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -92.26 164.22 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.193 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.601 HD12 ' O ' ' C' ' 18' ' ' GLU . 81.4 mt -62.02 -39.05 90.95 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.577 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -62.48 -23.93 67.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.625 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.71 -38.25 87.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.174 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -96.86 16.21 19.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.339 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 56.28 40.38 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 84.3 mt -91.78 113.52 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.0 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -102.22 -170.83 1.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -69.62 149.08 48.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 57.27 35.54 26.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.629 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -91.28 128.23 37.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.984 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.482 ' C ' HD12 ' C' ' 67' ' ' LEU . 89.6 m -78.97 128.19 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.986 0.422 . . . . 0.0 110.485 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.482 HD12 ' C ' ' C' ' 66' ' ' THR . 8.3 mp -117.0 139.88 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -87.44 111.36 21.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.469 HD23 HG22 ' C' ' 7' ' ' THR . 59.1 tp -102.55 120.6 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 97.9 t -119.4 137.68 52.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.592 HD22 HG23 ' C' ' 36' ' ' ILE . 24.9 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.01 161.19 24.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.829 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.525 HD13 HD21 ' D' ' 56' ' ' LEU . 16.1 pt -142.87 145.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.015 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -92.24 123.29 35.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.647 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.439 HG11 HD12 ' D' ' 69' ' ' LEU . 93.9 t -103.22 109.8 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.388 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -87.63 120.93 29.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.519 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -80.86 170.98 15.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.787 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.79 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.3 mt -64.35 -25.16 67.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.029 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -86.52 -0.99 57.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.43 -7.32 80.27 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.78 115.66 7.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 70.0 m -92.82 135.62 33.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.252 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.2 105.6 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.11 122.89 26.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' D' ' 29' ' ' LYS . 92.0 mt -122.22 131.86 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.42 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.88 114.4 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.696 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.5 m -133.98 167.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.473 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.34 154.95 44.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.98 -37.89 95.46 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.901 1.734 . . . . 0.0 111.815 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -77.92 -9.95 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.079 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.19 134.66 57.2 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.731 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -79.11 163.08 25.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.226 0.536 . . . . 0.0 110.525 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.835 HD12 HD23 ' D' ' 50' ' ' LEU . 47.2 mm -63.16 -38.27 81.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.91 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.07 -39.89 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -62.38 -41.1 98.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.273 0.559 . . . . 0.0 110.549 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.792 HG21 HD11 ' D' ' 56' ' ' LEU . 73.1 t -63.3 -42.91 98.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.461 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.89 -40.01 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.295 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.42 90.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.172 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.696 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -59.75 -38.71 82.54 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.802 ' CD1' HD21 ' D' ' 43' ' ' LEU . 86.6 mt -64.49 -41.34 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.068 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.51 -45.52 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.243 0.544 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -67.69 -32.01 72.37 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.855 -0.528 . . . . 0.0 111.276 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.438 ' HD2' HD21 ' D' ' 15' ' ' LEU . 7.7 mttm -92.25 -3.51 55.39 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -148.48 -49.91 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.06 10.46 15.79 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.208 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.469 HD13 HD21 ' D' ' 71' ' ' LEU . 33.5 mt -82.14 118.76 73.18 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.885 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.43 153.13 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.943 1.762 . . . . 0.0 111.47 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.36 -40.92 80.75 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.985 1.79 . . . . 0.0 112.184 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.9 -38.94 76.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -62.34 -39.7 93.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.811 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.464 ' HB3' HG21 ' D' ' 36' ' ' ILE . 0.0 OUTLIER -102.72 144.27 31.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.273 0.559 . . . . 0.0 111.384 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -124.89 117.29 23.75 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.802 HD21 ' CD1' ' D' ' 30' ' ' ILE . 73.3 mt -83.78 126.93 33.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.463 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.85 131.4 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.457 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 80.3 t80 -148.47 153.11 38.03 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.916 0.388 . . . . 0.0 111.074 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.02 16.28 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -9.23 72.68 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.407 ' HB3' HD22 ' A' ' 73' ' ' LEU . 12.8 ptm180 -119.74 145.89 46.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.936 0.398 . . . . 0.0 110.277 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.33 141.34 50.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.202 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.835 HD23 HD12 ' D' ' 23' ' ' ILE . 7.1 mp -83.37 111.85 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.951 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -75.32 135.88 40.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.787 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -57.75 149.95 20.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.453 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.44 -16.21 60.48 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -85.77 170.27 12.61 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.336 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -113.13 157.33 21.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.965 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.792 HD11 HG21 ' D' ' 26' ' ' VAL . 3.8 mp -57.91 -39.61 78.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.625 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 88.0 p -63.14 -23.46 67.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.299 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.98 -37.56 87.63 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.131 0.491 . . . . 0.0 109.932 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.74 10.73 39.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.295 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 62.1 t30 57.34 42.54 24.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.396 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . 0.764 HD11 HD21 ' D' ' 50' ' ' LEU . 66.8 mt -86.51 108.14 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -93.84 175.65 6.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.384 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -58.85 150.76 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 59.25 46.58 12.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.1 t -96.74 123.34 40.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.185 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -80.34 85.84 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.908 0.385 . . . . 0.0 110.347 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.509 HD22 HD12 ' D' ' 3' ' ' ILE . 7.4 mp -73.2 150.06 42.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -99.83 124.87 45.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.36 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.448 HD11 HG21 ' D' ' 30' ' ' ILE . 2.9 tt -101.77 117.51 35.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.918 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.678 HG11 HD11 ' A' ' 56' ' ' LEU . 90.9 t -111.29 129.55 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.79 ' H ' HD11 ' D' ' 8' ' ' LEU . 66.8 mt . . . . . 0 C--N 1.324 -0.525 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.344 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm . . . . . 0 C--O 1.235 0.305 0 CA-C-O 120.8 0.333 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -92.8 113.28 25.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.279 0.562 . . . . 0.0 109.524 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.55 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.1 mt -65.75 -38.31 88.77 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.609 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.6 162.47 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.796 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.29 122.49 0.37 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.831 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.61 157.68 37.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.877 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 46' ' ' LEU . 81.7 mtt85 -75.58 121.78 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.983 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.57 144.1 22.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.256 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.58 150.65 16.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -90.47 175.16 7.18 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.002 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.4 mtp -138.96 174.17 10.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -124.05 125.71 45.0 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 37' ' ' THR . 25.3 tp -106.58 118.58 37.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -121.37 108.88 14.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.772 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.61 0.51 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -137.5 20.19 2.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.781 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.2 m -122.55 131.73 53.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.1 t -111.48 123.52 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.028 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.5 p -113.5 132.01 22.71 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.147 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.25 146.2 50.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.919 1.746 . . . . 0.0 113.32 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -98.4 119.9 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.45 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -64.0 -14.92 57.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.752 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 -74.45 74.02 1.91 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 109.962 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -49.91 139.35 13.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.762 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.66 -159.09 8.88 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.651 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.1 tp -137.03 125.12 22.92 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.8 t -97.51 110.02 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -133.43 153.71 51.38 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.51 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.7 mt -119.64 139.3 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.093 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -136.8 132.42 34.66 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.651 0.594 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.525 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.2 tt0 -100.77 125.1 47.22 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.1 p -85.34 171.99 11.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -65.16 -9.54 23.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.13 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.55 0.74 56.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t 70.4 21.02 5.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 110.351 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.678 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 74.7 mt -99.23 122.6 42.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.55 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.8 mm -80.6 122.57 36.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.463 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.474 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.9 m-70 -98.65 114.44 26.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.763 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -97.77 107.9 20.5 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 143.96 50.89 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.687 -0.805 . . . . 0.0 113.125 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -118.9 117.12 27.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.569 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -106.34 144.76 32.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.373 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.11 131.31 35.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -72.86 -16.69 61.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.9 m -59.69 -45.16 92.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.367 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.1 m -116.63 -14.01 10.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.92 22.29 77.1 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -102.25 152.66 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.61 102.71 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.221 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -73.44 -37.38 65.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.913 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -127.24 145.18 50.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HD23 ' A' ' 73' ' ' LEU . 66.7 t0 -158.08 99.76 1.67 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 72' ' ' ASP . 35.1 mt -127.34 136.83 52.46 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.3 124.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.272 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 80' ' ' CYS . 29.0 mm -113.46 121.77 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.121 0.486 . . . . 0.0 110.861 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.678 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 67.5 m-85 -88.37 162.8 38.73 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.382 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.42 139.11 86.31 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.972 1.781 . . . . 0.0 111.585 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 59.75 12.82 3.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -86.44 -25.78 25.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.703 ' SG ' HG21 ' A' ' 75' ' ' ILE . 13.7 p -145.92 168.09 21.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.431 0.634 . . . . 0.0 110.38 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -135.24 126.56 28.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.91 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -102.14 116.77 33.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -145.18 167.26 23.19 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.012 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.53 160.02 19.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.131 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.56 89.78 13.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.148 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.74 59.76 7.55 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.925 1.75 . . . . 0.0 112.12 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -114.88 -39.07 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.627 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.4 t -124.0 86.99 53.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.479 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.15 130.0 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.593 1.528 . . . . 0.0 111.486 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p 167.37 -29.69 0.0 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.56 178.52 34.74 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.472 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.01 113.38 20.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 111.122 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.94 127.78 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.03 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -120.44 152.58 37.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.839 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.9 132.75 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.385 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.568 HD11 ' SG ' ' A' ' 80' ' ' CYS . 65.6 tp -102.24 121.35 42.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -119.76 130.81 55.14 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.47 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -79.99 115.23 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.0 -37.67 85.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.385 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.75 21.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.565 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.96 -175.65 22.88 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -116.47 12.96 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.601 0.239 . . . . 0.0 110.534 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HD3' HD21 ' A' ' 105' ' ' LEU . 11.9 ttmm -89.7 142.62 27.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.977 0.417 . . . . 0.0 111.101 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -134.29 133.01 40.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.503 HD21 ' HD3' ' A' ' 103' ' ' LYS . 48.4 mt -115.55 149.44 38.19 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.716 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.31 137.86 54.75 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.608 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -138.63 156.73 47.2 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.241 0.543 . . . . 0.0 111.307 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -131.75 135.58 46.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.272 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 137.7 57.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.66 -0.19 13.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.287 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.99 149.76 73.99 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.49 -31.14 28.0 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.13 1.887 . . . . 0.0 112.765 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -123.63 142.29 51.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.125 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -94.29 5.7 50.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.763 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.04 -21.05 58.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -118.72 -15.14 9.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.0 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.95 -39.58 94.46 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.116 0.484 . . . . 0.0 110.411 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.45 -35.14 79.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.017 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.89 -40.96 83.44 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.126 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 124' ' ' VAL . 65.1 m170 -61.36 -39.47 90.73 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.183 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -61.71 -44.83 96.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.454 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -67.96 -39.41 83.39 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.914 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -66.4 -42.2 88.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.746 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -58.07 -46.48 88.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.021 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -63.97 -38.57 91.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.561 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -75.55 -23.44 56.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.231 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.1 m-85 -87.51 -29.09 21.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 57' ' ' ILE . 73.8 mt -92.85 -18.3 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.614 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -116.33 -18.81 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -137.99 65.37 44.43 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.094 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.49 151.76 70.65 Favored 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.612 2.208 . . . . 0.0 112.243 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 C-N-CA 122.412 2.074 . . . . 0.0 112.147 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.85 154.71 81.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.92 147.19 49.1 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.584 2.189 . . . . 0.0 111.951 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.03 153.87 63.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.36 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.77 144.13 98.48 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.595 2.196 . . . . 0.0 112.209 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.14 -174.77 2.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.32 2.013 . . . . 0.0 111.849 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -111.58 160.27 30.09 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.581 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.75 147.23 89.23 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.687 2.258 . . . . 0.0 112.231 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.08 163.34 39.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.835 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.01 137.34 32.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.648 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -122.42 122.54 39.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.921 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 47.6 mt -132.26 125.13 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -79.23 84.25 5.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.045 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 32.7 t0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.59 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.1 ttp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -58.96 163.19 3.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.029 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.501 HD12 ' CD1' ' C' ' 67' ' ' LEU . 20.1 pt -143.02 139.59 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.006 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.692 ' HD2' HG21 ' C' ' 12' ' ' THR . 5.4 m-85 -83.86 121.91 27.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.27 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.793 HG11 HD11 ' C' ' 30' ' ' ILE . 90.6 t -107.02 106.12 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -87.88 133.84 33.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.301 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.899 HG22 HD23 ' C' ' 69' ' ' LEU . 77.2 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 111.742 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . 0.692 HG21 ' HD2' ' C' ' 4' ' ' PHE . 97.9 m . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.897 0.379 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.41 HD13 HG21 ' C' ' 13' ' ' ILE . 0.4 OUTLIER -120.83 100.68 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.1 m -75.5 127.2 32.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.492 HD13 ' CB ' ' C' ' 29' ' ' LYS . 83.7 mt -120.49 124.64 45.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.602 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.01 112.68 3.96 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.383 0.611 . . . . 0.0 110.701 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.536 HG12 ' HE3' ' C' ' 29' ' ' LYS . 24.1 m -135.24 164.27 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -106.37 153.88 40.17 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.49 -36.48 94.33 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.99 1.793 . . . . 0.0 112.026 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -82.08 -6.56 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -60.44 135.25 57.69 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -76.65 161.39 28.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.903 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' C' ' 50' ' ' LEU . 45.1 mm -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.214 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.28 -39.55 87.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.93 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.54 -42.96 99.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.277 0.56 . . . . 0.0 110.381 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.402 HG22 HG11 ' C' ' 17' ' ' VAL . 54.3 t -62.07 -42.62 95.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.71 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.92 -38.02 84.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.33 89.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.536 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.3 mttm -60.38 -38.14 82.98 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.793 HD11 HG11 ' C' ' 5' ' ' VAL . 6.8 mm -63.55 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.927 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -61.68 -46.05 91.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.85 -13.75 60.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -104.96 -12.49 16.17 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -141.33 -37.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.77 14.42 27.17 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.488 HG21 HD22 ' C' ' 71' ' ' LEU . 34.9 mt -89.16 117.68 68.46 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.12 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.13 146.56 94.03 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.994 . . . . 0.0 111.397 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.99 -39.5 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.049 1.833 . . . . 0.0 112.294 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.99 -31.14 70.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -83.87 -10.5 57.97 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.636 ' HB2' HD11 ' C' ' 69' ' ' LEU . 28.6 pt20 -121.78 145.18 48.31 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.143 0.497 . . . . 0.0 111.105 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -127.66 131.03 49.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.648 ' CB ' HD12 ' C' ' 50' ' ' LEU . 72.7 mt -102.68 122.24 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.105 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -126.97 126.63 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . 0.406 ' CD1' HD23 ' C' ' 67' ' ' LEU . 49.7 t80 -116.06 119.94 37.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.946 0.403 . . . . 0.0 110.909 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.54 39.45 30.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.99 14.79 80.04 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.94 105.7 13.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.42 132.97 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.648 HD12 ' CB ' ' C' ' 43' ' ' LEU . 63.3 mt -84.82 100.13 11.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.65 146.95 39.88 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.37 0.605 . . . . 0.0 111.431 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -63.53 150.43 43.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.249 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.28 -12.63 64.03 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -91.09 167.83 12.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.036 0.446 . . . . 0.0 110.471 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 59.6 p -116.45 163.77 15.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.911 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.33 -39.85 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.2 p -63.31 -24.35 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.591 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.26 -37.96 87.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.117 0.484 . . . . 0.0 110.301 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -96.57 13.35 28.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.71 42.81 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.029 0.442 . . . . 0.0 110.274 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.467 HG23 ' CB ' ' C' ' 65' ' ' SER . 80.8 mt -91.9 116.97 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -101.02 -178.76 3.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.594 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -61.52 144.67 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.185 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 63.77 17.1 10.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . 0.467 ' CB ' HG23 ' C' ' 61' ' ' ILE . 28.8 t -66.04 131.05 45.29 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -85.26 128.31 34.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 0.0 109.996 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' C' ' 3' ' ' ILE . 68.4 mt -117.25 146.16 43.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -91.32 116.95 29.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.849 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.899 HD23 HG22 ' C' ' 7' ' ' THR . 57.4 tp -97.01 119.58 35.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.1 t -116.65 129.78 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 0.0 110.626 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.488 HD22 HG21 ' C' ' 36' ' ' ILE . 29.8 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.839 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' D' ' 16' ' ' GLU . 9.8 pt20 -62.22 161.62 10.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.311 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.623 HD12 HD22 ' D' ' 67' ' ' LEU . 12.3 pt -143.46 142.53 25.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -90.4 116.52 28.4 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.822 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.3 102.92 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.452 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.15 124.09 31.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.184 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.47 HG22 HD23 ' D' ' 69' ' ' LEU . 60.7 p -77.46 -171.6 2.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.515 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.583 HD21 ' HA ' ' D' ' 70' ' ' VAL . 89.4 mt -60.16 -18.78 50.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -115.9 -172.88 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.139 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.53 -20.25 58.87 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.79 131.27 34.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.306 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -128.02 140.48 51.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.569 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.83 102.25 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.781 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.78 128.97 34.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.585 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.613 HD13 ' CB ' ' D' ' 29' ' ' LYS . 81.5 mt -127.64 124.17 37.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' D' ' 2' ' ' GLN . 19.2 pt-20 -68.24 112.49 5.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.249 0.547 . . . . 0.0 110.532 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.733 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.3 m -135.69 165.63 29.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.111 -0.368 . . . . 0.0 110.552 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . 0.533 ' O ' HD12 ' D' ' 56' ' ' LEU . 75.2 mm-40 -111.28 154.53 43.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -55.7 -41.3 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.055 1.837 . . . . 0.0 112.253 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -70.29 -15.82 62.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -57.93 136.75 57.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.32 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -81.44 163.83 22.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.159 0.505 . . . . 0.0 110.999 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.46 HD12 HD13 ' D' ' 50' ' ' LEU . 46.5 mm -63.13 -38.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.933 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.78 -40.31 83.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.03 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.6 -43.36 94.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 0.0 110.417 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.486 HG21 HD21 ' D' ' 56' ' ' LEU . 66.8 t -62.49 -47.36 93.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.28 -31.46 72.05 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.89 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.4 97.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.947 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.733 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -60.17 -38.99 84.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' D' ' 43' ' ' LEU . 86.5 mt -64.62 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.913 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.37 -39.21 82.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.98 -45.31 67.6 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.529 ' HD2' HD21 ' D' ' 15' ' ' LEU . 24.5 mttp -68.39 -40.67 81.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.845 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -130.23 148.41 52.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.425 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 59.4 3.04 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' D' ' 41' ' ' GLN . 19.9 mm -111.36 106.95 57.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.02 152.44 51.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.877 1.718 . . . . 0.0 111.306 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.98 -41.49 56.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.952 1.768 . . . . 0.0 112.51 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -68.09 -40.12 82.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.856 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -63.31 -40.31 96.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.724 ' HB2' HD11 ' D' ' 69' ' ' LEU . 0.0 OUTLIER -94.29 143.59 26.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.264 0.555 . . . . 0.0 111.461 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -131.9 120.52 22.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' D' ' 30' ' ' ILE . 86.9 mt -89.73 122.85 33.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.51 HG23 ' HA ' ' D' ' 49' ' ' GLN . 56.5 mt -131.42 131.14 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.788 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' D' ' 50' ' ' LEU . 70.4 t80 -144.96 152.99 41.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.981 0.419 . . . . 0.0 111.092 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.5 19.04 10.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.528 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.71 -7.68 72.64 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.743 ' HB3' HD22 ' A' ' 73' ' ' LEU . 32.5 ptt-85 -123.53 144.6 49.45 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 110.764 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.51 ' HA ' HG23 ' D' ' 44' ' ' ILE . 15.8 pt20 -62.28 150.03 40.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.194 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.588 HD21 ' HB3' ' D' ' 45' ' ' PHE . 74.9 mt -87.21 120.46 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.124 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -75.58 130.72 39.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.76 137.21 58.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.55 -17.0 54.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -88.85 166.17 14.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.439 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -101.14 168.21 9.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.533 HD12 ' O ' ' D' ' 18' ' ' GLU . 85.1 mt -65.67 -38.89 90.58 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.697 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -63.45 -25.01 68.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.996 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.82 -28.8 70.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.15 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.79 14.98 28.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.552 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 55.44 39.73 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.233 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -88.32 102.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -90.43 -177.66 5.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.915 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.27 145.89 55.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.606 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 66.16 10.38 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.356 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 52.8 m -64.28 135.85 56.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -90.05 112.43 23.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.623 HD22 HD12 ' D' ' 3' ' ' ILE . 9.0 mp -95.03 137.28 34.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.852 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -85.71 125.77 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.036 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' D' ' 41' ' ' GLN . 60.4 tp -111.55 124.41 52.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.925 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 56' ' ' LEU . 57.7 t -111.61 130.39 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.957 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.142 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.239 0.536 0 CA-C-O 121.013 0.435 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.1 114.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.683 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 57' ' ' ILE . 96.4 mt -66.37 -37.78 86.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.3 p -149.91 162.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.802 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.49 123.13 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -154.17 159.38 41.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.981 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HA ' HD12 ' A' ' 46' ' ' LEU . 78.8 mtp180 -74.96 121.61 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.631 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.29 141.65 17.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.697 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.4 157.66 15.76 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -93.16 153.52 18.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.603 0.24 . . . . 0.0 110.946 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.482 ' HE3' HG12 ' A' ' 38' ' ' VAL . 1.4 mtm -127.02 175.78 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.1 m -126.79 139.08 53.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.758 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.656 HD13 HG22 ' A' ' 38' ' ' VAL . 22.4 tp -117.71 119.0 33.62 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.421 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -120.03 111.01 17.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.26 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 -101.52 0.89 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -127.62 21.66 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.606 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.6 m -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.656 HG22 HD13 ' A' ' 33' ' ' LEU . 48.1 t -108.96 121.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.47 HG22 ' HB3' ' B' ' 947' ' ' PRO . 17.8 p -113.63 133.68 22.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.07 140.85 23.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.94 1.76 . . . . 0.0 112.424 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -97.97 145.25 26.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.82 -6.05 58.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.087 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -73.87 65.7 1.08 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -49.57 132.15 21.23 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.92 -157.98 8.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.139 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.6 tp -138.34 127.52 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.79 110.56 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.344 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -132.89 154.35 50.48 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.305 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.8 mt -117.39 137.57 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.232 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 131.98 37.34 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 123.799 0.687 . . . . 0.0 110.031 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.538 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.5 tt0 -100.52 124.79 46.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.889 0.376 . . . . 0.0 109.997 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.504 HG23 ' CD2' ' A' ' 58' ' ' HIS . 17.1 p -85.88 170.31 12.49 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.459 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -61.85 -13.16 21.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.0 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.481 ' OD2' HG11 ' D' ' 70' ' ' VAL . 33.4 t0 -84.66 0.26 50.93 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.402 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 t 68.93 20.42 7.89 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.105 0.478 . . . . 0.0 110.376 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.595 HD11 HG11 ' D' ' 70' ' ' VAL . 72.7 mt -100.06 125.47 46.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.7 mm -80.23 124.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.403 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.504 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -100.89 115.8 31.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.788 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -93.76 108.65 20.38 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.7 m -120.75 147.94 44.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.812 0.815 . . . . 0.0 112.778 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.0 t90 -126.98 114.35 17.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.289 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.49 133.03 52.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.955 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.79 133.05 43.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.447 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -74.35 -18.68 60.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 110.806 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.9 m -59.97 -46.07 90.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.723 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.4 m -116.45 -14.9 10.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.452 . . . . 0.0 110.035 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.9 22.47 78.03 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.59 144.48 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.945 0.402 . . . . 0.0 110.246 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.43 108.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -89.02 -26.34 21.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.715 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 61' ' ' TRP . 40.3 m-20 -127.91 143.7 51.1 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.211 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.636 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.4 p30 -158.34 98.58 1.57 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.378 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' D' ' 48' ' ' ARG . 25.2 mt -127.93 133.74 49.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.79 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.37 125.97 35.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.342 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.606 HG21 ' SG ' ' A' ' 80' ' ' CYS . 24.6 mm -113.06 124.79 70.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.357 0.599 . . . . 0.0 110.83 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HZ ' HD12 ' D' ' 44' ' ' ILE . 78.2 m-85 -91.3 162.54 31.83 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.332 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.4 136.78 77.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.015 1.81 . . . . 0.0 111.434 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 60.79 8.45 1.81 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.609 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -72.89 -36.4 67.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.821 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.782 ' SG ' HD11 ' A' ' 96' ' ' LEU . 18.3 p -143.98 165.49 27.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.437 0.637 . . . . 0.0 110.31 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -125.95 128.17 47.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.303 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -102.87 119.85 39.57 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -148.2 166.72 27.07 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.886 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -80.1 159.84 25.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.114 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.17 89.97 13.0 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.856 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.41 60.78 7.65 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.944 1.763 . . . . 0.0 112.43 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -39.72 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.2 t -129.89 77.33 76.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.68 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.1 130.43 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.391 2.06 . . . . 0.0 111.495 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.45 -43.71 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.34 -160.65 9.05 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.534 ' HG2' HG22 ' A' ' 114' ' ' THR . 1.0 OUTLIER -102.92 106.38 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.79 128.58 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.775 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.12 152.42 47.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.79 138.66 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.367 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.782 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.2 tp -100.87 116.3 32.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -104.17 107.68 18.69 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -75.73 106.05 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.86 -37.79 83.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.47 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.98 -22.61 13.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.744 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.29 -14.48 82.17 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.638 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.5 m 56.15 21.19 4.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' CD ' HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -119.42 153.09 35.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.351 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -131.09 136.3 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.678 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.486 HD21 ' CD ' ' A' ' 103' ' ' LYS . 57.6 mt -120.07 147.22 45.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 94.9 m-85 -114.98 132.47 56.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.98 155.37 49.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.875 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -134.14 135.62 43.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.9 mtp -83.7 136.73 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.5 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -100.74 12.79 36.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.78 129.44 91.15 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.944 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.64 -37.79 94.92 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.822 1.681 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.81 144.91 46.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.83 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 92' ' ' ARG . 69.1 p -90.84 0.7 57.4 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.04 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.9 -20.6 53.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.202 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -113.87 -16.05 12.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.786 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.62 -40.42 94.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.892 0.377 . . . . 0.0 110.703 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -41.32 99.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.004 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.04 -41.96 94.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.814 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.704 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.2 m170 -64.39 -40.44 95.8 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.786 0.803 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.42 -44.82 95.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.126 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -64.19 -43.91 93.62 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.3 -40.97 98.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.984 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 120' ' ' HIS . 61.5 t -59.1 -48.56 86.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.843 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.64 -38.77 90.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.228 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.93 -22.85 55.58 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.606 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.462 ' CE2' HD22 ' A' ' 23' ' ' LEU . 18.6 m-85 -89.88 -28.2 19.39 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.6 mt -92.66 -18.06 23.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -117.25 -17.14 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.265 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -139.76 65.21 31.08 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.207 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.0 156.22 63.25 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 C-N-CA 122.821 2.347 . . . . 0.0 112.359 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.311 -1.417 0 C-N-CA 122.525 2.15 . . . . 0.0 112.262 -179.794 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -127.27 130.78 23.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.439 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.85 146.29 37.59 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.935 1.757 . . . . 0.0 111.968 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.79 153.4 87.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.09 158.03 56.14 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.39 2.06 . . . . 0.0 112.12 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -58.2 -172.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.279 1.986 . . . . 0.0 111.806 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -128.92 158.2 73.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' A' ' 39' ' ' THR . 41.2 Cg_exo -57.65 141.75 95.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.105 1.87 . . . . 0.0 112.326 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.53 165.47 36.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.589 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.92 135.84 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.439 . . . . 0.0 110.542 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -115.32 128.5 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.151 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.22 122.58 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.54 85.5 5.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.087 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.617 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -63.29 158.85 19.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.438 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.04 144.47 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.528 ' HD2' HG21 ' C' ' 12' ' ' THR . 5.3 m-85 -88.02 125.27 34.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.199 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.747 HG11 HD11 ' C' ' 30' ' ' ILE . 92.0 t -111.74 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -99.84 128.48 45.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.784 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.902 HG22 HD23 ' C' ' 69' ' ' LEU . 75.1 p . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 111.483 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . 0.528 HG21 ' HD2' ' C' ' 4' ' ' PHE . 99.0 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.16 105.06 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -75.04 131.09 40.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.042 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' C' ' 29' ' ' LYS . 91.9 mt -122.71 129.21 51.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.16 115.94 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.068 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.49 HG12 ' HE2' ' C' ' 29' ' ' LYS . 18.2 m -138.73 165.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.59 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -107.89 155.65 39.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.7 -37.64 95.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.041 1.827 . . . . 0.0 112.015 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -80.93 -7.42 59.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.191 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -58.69 137.96 57.3 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.058 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.06 161.02 26.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 110.952 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 0.445 HD12 HD13 ' C' ' 50' ' ' LEU . 48.5 mm -63.69 -39.21 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.08 -39.11 84.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.864 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.99 -42.75 99.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.396 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.417 HG22 HG11 ' C' ' 17' ' ' VAL . 53.9 t -61.76 -42.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.204 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -39.89 80.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.551 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.85 -41.29 95.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 110.063 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' C' ' 15' ' ' LEU . 11.1 mttp -59.6 -38.63 81.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.747 HD11 HG11 ' C' ' 5' ' ' VAL . 8.8 mm -65.18 -39.9 87.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.984 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.21 -41.96 89.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.823 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -69.48 -50.3 46.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.504 ' HG3' HD21 ' C' ' 15' ' ' LEU . 20.3 mttt -63.97 -41.2 97.63 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -131.67 148.92 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.58 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.42 63.61 2.19 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.632 HG22 ' HG3' ' C' ' 41' ' ' GLN . 45.0 mt -115.97 119.81 36.49 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.28 159.93 48.35 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.779 1.653 . . . . 0.0 111.457 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.05 -31.68 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.041 1.827 . . . . 0.0 112.613 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.75 -42.59 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.961 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.71 -10.8 57.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.412 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.632 ' HG3' HG22 ' C' ' 36' ' ' ILE . 75.3 mt-30 -80.62 86.55 5.86 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.799 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -96.86 103.76 15.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.683 ' HB3' HD12 ' C' ' 50' ' ' LEU . 76.6 mt -95.9 119.36 34.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.122 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.6 127.57 71.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.084 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -129.2 130.34 46.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.521 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.67 28.04 14.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.54 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.97 15.3 81.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -119.37 132.75 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 110.371 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -72.61 131.94 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.106 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.683 HD12 ' HB3' ' C' ' 43' ' ' LEU . 78.2 mt -81.34 97.74 7.84 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.968 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.17 139.83 52.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.781 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.23 143.68 52.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.43 -17.73 58.55 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -84.39 171.38 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.806 0.336 . . . . 0.0 110.105 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -119.0 165.69 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.246 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' C' ' 56' ' ' LEU . 82.5 mt -62.33 -39.83 94.36 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.381 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.97 -27.02 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.248 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.78 -35.98 79.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.206 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.509 ' CE2' HD23 ' C' ' 50' ' ' LEU . 66.3 m-85 -96.51 12.6 30.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.319 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.29 40.67 27.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.342 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -89.58 114.92 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -99.22 -175.2 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.354 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -65.3 150.12 48.79 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.946 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 54.89 42.54 31.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.947 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 45.3 m -96.25 124.46 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.032 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.454 ' C ' HD12 ' C' ' 67' ' ' LEU . 53.3 m -75.01 128.19 34.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.906 0.384 . . . . 0.0 110.074 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.454 HD12 ' C ' ' C' ' 66' ' ' THR . 7.4 mp -118.35 143.46 46.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -89.96 112.08 23.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.07 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.902 HD23 HG22 ' C' ' 7' ' ' THR . 59.2 tp -100.51 120.42 39.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.635 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -117.45 133.83 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.793 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.007 -178.883 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -68.93 158.32 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.448 HD13 HD21 ' D' ' 56' ' ' LEU . 11.4 pt -138.97 146.5 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.754 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -94.82 122.07 37.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.59 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.688 HG11 HD11 ' D' ' 30' ' ' ILE . 85.8 t -104.42 113.23 40.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.395 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -98.49 130.29 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.719 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.606 HG22 HD23 ' D' ' 69' ' ' LEU . 74.5 p -86.76 -177.56 6.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.203 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.515 HD11 ' H ' ' D' ' 71' ' ' LEU . 52.1 mt -72.83 -17.07 61.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.365 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 56.1 p -90.87 -2.35 57.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.041 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -9.09 75.9 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.47 130.73 44.36 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -111.47 134.1 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.996 0.427 . . . . 0.0 110.979 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.91 109.8 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.351 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.94 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.457 HD21 ' HD2' ' D' ' 33' ' ' LYS . 96.0 mt -122.34 124.86 44.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.204 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.31 114.51 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.563 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.685 HG12 ' HE3' ' D' ' 29' ' ' LYS . 23.7 m -135.33 168.5 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -109.86 154.86 42.37 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.294 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.57 -32.93 91.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.893 1.728 . . . . 0.0 111.893 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -83.19 -6.28 59.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.113 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -60.99 144.9 52.45 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -89.45 161.28 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.73 -38.69 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.088 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.16 -42.66 91.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.084 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -62.86 -40.63 98.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.341 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.558 HG12 HD21 ' D' ' 43' ' ' LEU . 62.4 t -61.91 -42.97 96.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.618 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.589 ' HG3' HD22 ' D' ' 43' ' ' LEU . 58.6 mtmt -61.17 -39.4 90.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.201 0.524 . . . . 0.0 109.951 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.35 90.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.685 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.9 -38.09 81.31 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.688 HD11 HG11 ' D' ' 5' ' ' VAL . 6.1 mm -63.01 -41.95 94.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.506 0.67 . . . . 0.0 109.949 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.8 -44.74 96.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.09 -20.33 62.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.457 ' HD2' HD21 ' D' ' 15' ' ' LEU . 8.2 mttm -101.61 -6.14 24.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -145.36 -43.63 0.22 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.28 0.562 . . . . 0.0 110.226 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.97 14.13 12.62 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' D' ' 41' ' ' GLN . 57.4 mt -87.93 119.17 70.4 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.438 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.52 160.14 44.91 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.823 1.682 . . . . 0.0 111.943 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.63 -22.26 59.64 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.418 2.079 . . . . 0.0 112.215 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -87.48 1.36 53.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.443 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -126.42 21.2 7.25 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.652 ' HB2' HD11 ' D' ' 69' ' ' LEU . 22.4 pt20 -162.42 154.97 19.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 111.214 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.23 132.38 35.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.666 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.703 ' HB3' HD12 ' D' ' 50' ' ' LEU . 5.8 mp -91.46 122.26 33.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.547 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.596 HG23 ' HA ' ' D' ' 49' ' ' GLN . 70.0 mt -128.99 132.23 67.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.784 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.532 ' HB3' HD21 ' D' ' 50' ' ' LEU . 87.4 t80 -151.9 155.14 37.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.365 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.68 16.69 7.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.56 -12.69 62.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.81 ' HB3' HD22 ' A' ' 73' ' ' LEU . 39.8 ptt180 -119.71 146.38 45.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.138 0.494 . . . . 0.0 110.397 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.596 ' HA ' HG23 ' D' ' 44' ' ' ILE . 27.0 pt20 -65.11 142.66 58.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.979 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' D' ' 43' ' ' LEU . 75.9 mt -84.43 114.79 22.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.411 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.51 149.59 38.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.228 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -71.21 165.05 24.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.73 26.82 74.0 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -128.01 157.3 41.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.868 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -100.91 160.79 14.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.277 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.492 HD11 HG21 ' D' ' 26' ' ' VAL . 7.4 mp -62.59 -40.47 97.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.4 p -62.62 -23.63 67.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -62.9 -38.08 89.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.112 0.482 . . . . 0.0 109.907 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.62 13.83 30.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.277 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.91 40.36 28.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.568 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.94 98.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 109.995 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -86.1 178.38 7.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.256 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -60.75 151.68 28.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.289 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 57.13 44.47 22.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 123.42 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.86 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -81.88 96.83 7.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.081 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.407 ' N ' HD12 ' D' ' 67' ' ' LEU . 9.2 mp -84.19 152.47 24.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.04 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -101.87 122.39 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.302 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' D' ' 41' ' ' GLN . 34.1 tp -103.35 114.0 27.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.884 HG11 HD11 ' A' ' 56' ' ' LEU . 64.0 t -106.43 120.07 56.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.515 ' H ' HD11 ' D' ' 8' ' ' LEU . 65.3 mt . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.804 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 C--O 1.238 0.454 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.27 115.1 26.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.682 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.1 mt -68.05 -36.86 80.58 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.682 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.09 161.9 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.818 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.0 122.23 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.295 0.569 . . . . 0.0 111.091 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.89 158.61 38.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.924 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HA ' HD12 ' A' ' 46' ' ' LEU . 83.1 mtt85 -77.22 123.23 26.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.602 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 146.28 23.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.221 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.55 151.58 17.04 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -89.73 172.46 8.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.04 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 24.6 mtp -138.22 174.34 10.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.739 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.2 m -124.54 127.27 47.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD22 ' CE1' ' A' ' 106' ' ' PHE . 34.6 tp -107.72 117.2 33.49 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.184 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.97 110.33 16.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.826 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.73 -83.22 0.58 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.15 18.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.473 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.8 m -119.17 130.14 55.36 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 33' ' ' LEU . 64.1 t -108.5 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.6 p -115.64 132.6 23.06 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.044 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.32 146.66 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.552 1.501 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -101.04 121.47 41.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.456 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -62.36 -14.62 41.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -71.29 80.55 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -64.27 130.58 44.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.641 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.03 -154.64 8.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.348 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.5 tp -138.11 127.24 24.3 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.6 110.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.9 p90 -134.17 154.66 51.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.189 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.0 mt -120.36 138.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.63 132.64 37.31 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 123.772 0.67 . . . . 0.0 110.045 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.549 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.2 tt0 -102.01 125.29 48.66 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 58' ' ' HIS . 13.4 p -84.9 171.78 11.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.873 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.85 -10.34 27.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.566 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.31 5.42 47.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.424 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m 64.02 25.16 13.77 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.578 0.704 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.884 HD11 HG11 ' D' ' 70' ' ' VAL . 78.7 mt -101.55 122.77 44.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.7 mm -80.92 123.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.234 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.487 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.1 m-70 -99.45 115.64 29.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.827 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -94.7 108.65 20.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 72.9 m -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.86 0.838 . . . . 0.0 113.108 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -125.67 114.85 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.113 -1.403 . . . . 0.0 107.646 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -106.51 132.74 52.17 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.582 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -74.5 134.22 42.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -75.59 -16.5 60.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.69 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 m -60.41 -44.84 95.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.754 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.9 p -116.47 -17.41 10.66 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.763 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.39 22.01 74.05 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -101.53 153.01 20.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.56 102.47 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -77.21 -32.8 56.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -125.87 144.84 50.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.589 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.61 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.4 t0 -157.34 99.23 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.81 HD22 ' HB3' ' D' ' 48' ' ' ARG . 36.6 mt -130.53 133.83 46.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.771 0.32 . . . . 0.0 110.877 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -78.73 125.45 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.307 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.653 HG21 ' SG ' ' A' ' 80' ' ' CYS . 17.9 mm -111.06 126.15 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.915 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.47 162.2 32.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.351 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.08 138.69 83.54 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.817 1.678 . . . . 0.0 111.235 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.8 t0 59.44 11.74 2.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.731 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.67 -27.05 37.2 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.616 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.653 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.5 p -151.65 166.97 29.61 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.759 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.01 132.33 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.277 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -104.5 118.51 36.78 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -142.39 166.81 23.66 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.719 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.49 159.99 19.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.967 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.03 89.46 19.96 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.8 60.44 7.56 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.829 1.686 . . . . 0.0 112.149 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -113.84 -42.8 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.329 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.1 t -120.22 96.97 49.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.042 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 131.04 18.46 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.122 1.215 . . . . 0.0 111.487 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 168.17 -31.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.985 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.58 -174.31 28.13 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.552 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.483 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.3 OUTLIER -88.72 112.6 23.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.486 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.2 128.83 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.21 152.97 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.4 p -130.62 136.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.149 0.5 . . . . 0.0 110.283 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.4 tp -103.78 120.84 41.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -116.7 120.11 37.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.147 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.46 ' HE2' HD12 ' A' ' 75' ' ' ILE . 47.6 m-85 -79.2 113.73 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.43 -37.78 84.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.054 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.89 -23.0 12.51 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.58 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.4 -17.37 79.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.274 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m 58.32 21.19 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.627 -0.337 . . . . 0.0 111.165 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.509 ' HD3' HD21 ' A' ' 105' ' ' LEU . 5.0 ttmt -119.1 151.4 38.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.099 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.436 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.7 mtt180 -131.42 138.4 49.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.0 110.852 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 95' ' ' VAL . 47.3 mt -123.42 153.05 40.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.146 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HD22 ' A' ' 33' ' ' LEU . 97.8 m-85 -124.76 135.76 53.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.819 0.342 . . . . 0.0 110.683 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -139.6 156.67 46.72 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.301 0.572 . . . . 0.0 111.224 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -130.43 138.91 50.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.439 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 77.6 mmm -75.07 139.15 42.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.843 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.56 2.09 33.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.894 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -73.83 146.36 85.27 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.746 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.82 -28.01 17.25 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.999 1.8 . . . . 0.0 112.601 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.77 144.13 48.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.891 0.377 . . . . 0.0 110.334 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 92' ' ' ARG . 82.7 p -91.47 1.15 57.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.922 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.01 -19.51 44.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -118.52 -20.2 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.88 -41.7 98.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.273 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.51 -40.87 96.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.48 -42.44 92.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.415 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.7 m170 -64.44 -39.94 94.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.674 0.749 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.0 t -61.02 -45.83 93.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.491 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -63.42 -43.1 98.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.153 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -65.62 -35.44 80.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.9 t -58.51 -48.35 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.987 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.32 -28.99 53.36 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.777 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.8 -34.99 74.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.97 -31.32 31.24 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -81.48 -26.94 34.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -106.39 -26.82 11.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.477 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.58 73.66 72.23 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.433 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.6 Cg_exo -59.78 151.2 72.47 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.945 2.43 . . . . 0.0 111.964 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.49 1.318 0 C-N-CA 122.394 2.063 . . . . 0.0 112.068 -179.84 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -134.27 154.77 80.15 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.978 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.28 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.268 1.979 . . . . 0.0 111.569 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -73.63 159.0 85.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -54.92 140.77 79.09 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.411 2.074 . . . . 0.0 112.193 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.42 174.12 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.387 2.058 . . . . 0.0 111.84 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -97.11 154.49 38.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.53 147.0 88.73 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.463 2.108 . . . . 0.0 112.105 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.43 161.4 42.64 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.84 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.04 136.21 33.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 0.0 110.572 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -118.69 124.72 48.03 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 951' ' ' ILE . 1.7 mp -130.46 122.69 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.477 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.26 83.97 7.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.932 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.4 p30 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.586 179.571 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.91 160.76 14.11 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -136.94 154.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.082 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' C' ' 14' ' ' THR . 11.7 m-30 -93.53 122.69 36.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.115 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.03 108.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.42 108.25 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.971 HG22 HD23 ' C' ' 69' ' ' LEU . 23.7 p . . . . . 0 C--N 1.324 -0.527 0 CA-C-O 121.571 0.701 . . . . 0.0 111.08 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 94.8 m . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -132.42 118.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . 0.467 HG23 ' CD1' ' C' ' 4' ' ' PHE . 9.7 m -86.7 122.98 31.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.54 128.11 52.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.508 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -70.62 116.37 10.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.858 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.545 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.5 m -135.92 166.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.515 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -111.98 153.76 44.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.091 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 -38.25 93.92 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.062 1.841 . . . . 0.0 112.156 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -81.45 -8.74 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.07 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.72 134.76 57.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -78.57 163.82 25.2 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.043 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.25 -35.74 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.943 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.8 tm-20 -58.44 -40.01 81.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.2 -41.51 94.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.537 HG21 HD21 ' C' ' 56' ' ' LEU . 62.7 t -63.09 -47.59 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.044 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -62.82 -33.35 75.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.053 0.454 . . . . 0.0 110.17 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.05 97.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.545 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.4 mttm -60.34 -39.3 86.62 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.083 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.669 HD13 HD22 ' C' ' 69' ' ' LEU . 92.1 mt -66.17 -39.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.001 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -46.53 88.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.29 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.77 -15.1 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.033 -0.417 . . . . 0.0 111.906 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -101.14 -6.34 24.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -148.61 -41.03 0.16 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.181 0.515 . . . . 0.0 110.501 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 11.17 21.02 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.765 HD13 HD21 ' C' ' 71' ' ' LEU . 73.8 mt -77.52 125.25 86.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.43 158.05 48.55 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.675 1.583 . . . . 0.0 112.05 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.18 -38.62 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.113 1.875 . . . . 0.0 112.274 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.07 -39.93 94.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.906 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.79 -3.63 58.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.404 ' OE1' HG21 ' C' ' 30' ' ' ILE . 10.4 mm100 -80.02 96.2 6.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -96.22 85.28 3.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.578 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.783 ' HB3' HD12 ' C' ' 50' ' ' LEU . 86.8 mt -89.17 113.08 24.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.63 129.03 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.616 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -132.72 132.49 42.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.859 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 24.34 14.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.65 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.94 3.43 90.6 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.344 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -110.69 127.14 55.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.645 -0.326 . . . . 0.0 110.238 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -70.18 134.25 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.783 HD12 ' HB3' ' C' ' 43' ' ' LEU . 59.4 mt -79.6 94.43 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.429 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.06 146.61 39.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.295 0.569 . . . . 0.0 111.038 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -61.44 150.6 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.07 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.85 -17.65 57.5 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -90.2 164.12 14.54 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.211 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.8 p -113.34 167.06 10.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.309 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.537 HD21 HG21 ' C' ' 26' ' ' VAL . 81.5 mt -62.39 -39.41 93.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.384 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -62.96 -26.75 68.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.094 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.08 -35.91 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.525 ' CE2' HD23 ' C' ' 50' ' ' LEU . 57.9 m-85 -95.52 14.29 23.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.213 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 55.77 40.41 30.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 0.0 110.497 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.71 121.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.977 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.18 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.598 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -58.96 145.12 42.77 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.972 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 59.18 26.17 14.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 123.37 25.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.479 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.439 ' C ' HD12 ' C' ' 67' ' ' LEU . 91.3 m -72.63 130.07 39.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.226 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.439 HD12 ' C ' ' C' ' 66' ' ' THR . 6.5 mp -120.57 143.11 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.288 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -93.24 109.22 20.74 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.971 HD23 HG22 ' C' ' 7' ' ' THR . 24.8 tp -106.66 123.62 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.434 ' N ' HD12 ' C' ' 69' ' ' LEU . 74.5 t -123.11 141.32 43.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.765 HD21 HD13 ' C' ' 36' ' ' ILE . 19.6 mt . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.332 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -64.13 157.23 26.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.599 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 pt -136.72 152.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.131 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.498 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.4 m-30 -93.46 122.02 35.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.714 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.24 107.47 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.678 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -91.88 125.56 36.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.599 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.665 HG22 HD23 ' D' ' 69' ' ' LEU . 82.4 p -83.32 174.53 10.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.189 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.705 HD11 ' H ' ' D' ' 71' ' ' LEU . 70.7 mt -62.46 -25.95 68.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.076 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p -78.48 -9.45 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 -11.7 66.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.41 134.61 52.87 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.88 0.34 . . . . 0.0 110.124 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -104.3 133.68 48.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.719 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -122.7 113.05 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.644 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . 0.498 HG23 ' CD2' ' D' ' 4' ' ' PHE . 4.8 m -80.96 125.24 29.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.089 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' D' ' 29' ' ' LYS . 91.4 mt -119.58 116.56 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.716 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.98 108.89 2.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.465 0.65 . . . . 0.0 110.883 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.546 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.8 m -134.49 164.73 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -107.76 155.06 40.5 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.172 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.87 -37.29 96.03 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.864 1.71 . . . . 0.0 111.814 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -79.21 -9.4 59.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.78 136.28 58.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.904 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -79.74 162.94 24.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.39 -38.95 83.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.761 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.51 -41.58 90.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.947 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.89 -41.52 97.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.147 0.499 . . . . 0.0 110.578 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.457 HG22 HG11 ' D' ' 17' ' ' VAL . 68.5 t -63.43 -42.03 94.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.43 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.484 ' HG2' HD13 ' D' ' 43' ' ' LEU . 56.4 mtmt -60.61 -39.34 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 110.245 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.15 93.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.097 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.625 ' HB3' HD22 ' D' ' 15' ' ' LEU . 66.6 mttm -60.37 -39.22 86.45 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.49 ' CD1' HD11 ' D' ' 43' ' ' LEU . 92.4 mt -63.59 -42.12 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.199 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 27.0 tm0? -60.57 -40.08 90.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.636 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -83.52 12.0 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.498 ' HG3' HD21 ' D' ' 15' ' ' LEU . 11.3 mmtt -118.56 -47.89 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -112.08 2.28 16.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.246 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.15 24.8 75.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.509 HG21 ' HB3' ' D' ' 41' ' ' GLN . 13.6 mm -85.82 116.24 64.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.164 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.5 147.2 70.57 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 122.083 1.855 . . . . 0.0 112.32 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.69 -33.06 78.52 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.223 1.949 . . . . 0.0 112.643 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 9.85 31.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -121.14 28.61 7.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.672 ' HB2' HD11 ' D' ' 69' ' ' LEU . 5.3 pt20 -160.53 151.27 18.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.065 0.46 . . . . 0.0 111.142 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -132.0 126.27 33.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.792 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' D' ' 30' ' ' ILE . 6.8 mp -88.74 124.06 33.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.707 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.449 HG21 ' HE1' ' A' ' 76' ' ' PHE . 83.6 mt -127.38 129.11 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.736 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.445 ' HB3' HD21 ' D' ' 50' ' ' LEU . 70.9 t80 -148.59 151.54 35.22 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.997 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.8 17.74 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 85.49 -8.77 70.21 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.763 ' HB3' HD22 ' A' ' 73' ' ' LEU . 13.0 ptm180 -119.57 145.3 46.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.127 0.489 . . . . 0.0 110.735 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.29 132.41 47.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.967 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' D' ' 45' ' ' PHE . 55.0 mt -81.64 104.94 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.71 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.97 168.29 20.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.474 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -78.39 172.66 13.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.3 21.35 77.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -130.59 157.2 43.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.876 0.37 . . . . 0.0 110.693 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -105.83 162.97 13.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.134 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.88 -39.79 93.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.393 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -63.56 -23.02 67.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.378 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.48 -38.35 86.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.012 0.434 . . . . 0.0 110.233 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -99.23 15.7 25.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.368 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.24 40.82 24.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.264 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -90.65 104.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.23 -171.55 2.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.255 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -68.78 146.4 52.94 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.07 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 63.14 42.34 7.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -99.54 125.71 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.785 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -76.11 126.01 30.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.01 139.53 51.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.627 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -88.48 118.38 28.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.57 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' D' ' 41' ' ' GLN . 58.5 tp -100.48 120.0 39.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.53 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' D' ' 8' ' ' LEU . 78.0 t -109.41 127.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.705 ' H ' HD11 ' D' ' 8' ' ' LEU . 70.1 mt . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.683 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp . . . . . 0 CA--C 1.521 -0.17 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -89.11 112.87 23.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.517 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.1 mt -66.11 -38.38 88.07 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.6 162.94 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.644 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.72 122.92 0.34 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.281 0.562 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -154.47 158.95 40.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.845 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -74.33 122.57 23.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.415 . . . . 0.0 110.819 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.14 143.83 20.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.96 153.57 16.92 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -86.78 157.36 19.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.903 0.383 . . . . 0.0 110.871 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.8 mtp -125.53 172.95 9.28 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.44 124.64 41.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.374 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 37' ' ' THR . 37.7 tp -106.84 117.48 34.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.879 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -122.05 119.81 32.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.857 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -86.83 0.22 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -148.15 24.51 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.705 0.288 . . . . 0.0 110.722 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.625 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.9 m -126.26 131.18 51.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.548 HG22 HD13 ' A' ' 33' ' ' LEU . 59.5 t -105.99 122.18 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.646 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.783 HG22 ' HB3' ' B' ' 947' ' ' PRO . 42.8 p -121.35 122.94 27.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.53 146.41 55.35 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.269 1.313 . . . . 0.0 112.902 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -99.74 142.58 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.53 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -72.33 -6.26 42.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -73.1 74.11 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -55.42 135.68 50.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.89 -160.89 9.69 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.9 tp -137.26 126.97 25.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.3 t -99.69 109.58 24.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.3 p90 -133.19 154.49 50.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.609 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -117.89 137.89 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.236 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.91 131.3 35.02 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.549 0.531 . . . . 0.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.51 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.0 tt0 -100.45 124.73 46.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.231 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.0 p -84.35 172.32 11.88 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.604 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.11 -10.36 30.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.533 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.48 -0.06 56.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.626 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 71.03 19.68 5.52 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.51 HD11 HG11 ' D' ' 70' ' ' VAL . 73.7 mt -98.62 122.62 42.07 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.8 mm -78.97 125.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.491 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.8 m-70 -101.07 116.69 33.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.669 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -95.96 107.48 19.76 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 71.9 m -121.41 146.99 46.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 113.041 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.6 t90 -124.79 114.27 19.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.948 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -106.13 131.53 53.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.723 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -75.89 131.04 39.41 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -72.26 -18.86 61.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 110.662 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.5 m -59.91 -44.68 94.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.964 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p -115.94 -16.01 11.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.091 0.472 . . . . 0.0 109.991 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.17 19.6 79.78 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -102.54 146.52 28.02 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.82 102.05 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 110.06 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -74.44 -36.5 63.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -126.27 145.98 50.19 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.761 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.607 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.5 p-10 -158.08 100.61 1.72 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.83 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' D' ' 48' ' ' ARG . 31.7 mt -127.89 133.21 49.29 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.84 0.352 . . . . 0.0 110.756 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 125.55 35.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.144 0.497 . . . . 0.0 110.123 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.438 ' HB ' HD22 ' A' ' 128' ' ' LEU . 31.4 mm -112.09 118.18 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.897 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HE1' HG21 ' D' ' 44' ' ' ILE . 61.2 m-85 -82.95 161.58 57.57 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.858 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -54.59 131.98 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.676 1.584 . . . . 0.0 111.699 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 62.37 12.29 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.446 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -81.26 -26.89 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.111 0.481 . . . . 0.0 110.18 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -142.12 151.08 41.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.209 -178.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.533 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.0 tp10 -121.06 129.26 53.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.977 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.09 118.11 35.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -141.97 167.82 21.23 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.648 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -85.1 159.99 20.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.026 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.72 90.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.118 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.33 61.1 8.07 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.921 1.747 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -113.28 -38.04 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.6 t -131.44 77.26 74.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.697 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.13 130.33 40.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.151 1.901 . . . . 0.0 111.359 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 t 167.78 -47.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.723 0.64 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.8 -149.32 7.06 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.58 106.43 13.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.394 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -124.9 129.3 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.58 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.46 153.71 45.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.535 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.6 p -129.7 135.78 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 0.0 109.894 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 81' ' ' GLU . 60.8 tp -104.73 122.3 45.4 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -120.19 130.39 54.54 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.135 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 53.3 m-85 -86.24 116.41 24.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.78 -36.24 78.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.271 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.27 -20.88 12.14 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.398 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -73.23 -20.77 80.02 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.058 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 m 59.44 27.6 16.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -125.53 151.23 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.125 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -131.77 139.78 49.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.17 0.509 . . . . 0.0 110.934 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.483 ' O ' HG23 ' A' ' 95' ' ' VAL . 52.1 mt -122.91 149.1 44.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.7 m-85 -119.25 135.21 54.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.58 157.14 46.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.317 0.58 . . . . 0.0 111.318 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -135.05 137.07 42.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.523 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.4 ttm -73.7 135.22 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.238 0.542 . . . . 0.0 111.244 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.23 0.25 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.13 139.1 89.93 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.72 -25.74 33.55 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.979 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -117.51 141.68 48.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.41 . . . . 0.0 110.434 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.2 p -95.15 9.56 39.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.47 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.9 -21.0 60.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.362 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -121.05 3.16 10.47 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.476 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -62.02 -49.22 76.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.997 0.427 . . . . 0.0 110.986 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.14 -39.73 93.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.272 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.76 -42.98 99.94 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.737 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.662 ' O ' HG23 ' A' ' 124' ' ' VAL . 66.2 m170 -64.26 -41.06 97.11 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.036 0.922 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.88 -44.11 96.99 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.409 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -65.46 -43.51 90.1 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.53 -41.42 98.86 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.665 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.9 t -58.77 -49.38 83.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.014 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.501 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.87 -25.04 59.84 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.384 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.433 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.4 m-85 -87.84 -28.92 21.32 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.438 HD22 ' HB ' ' A' ' 75' ' ' ILE . 73.8 mt -91.23 -15.58 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.294 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -118.21 -17.95 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.165 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -142.1 66.74 21.07 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.255 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.4 155.0 64.76 Favored 'Trans proline' 0 C--N 1.297 -2.176 0 C-N-CA 122.604 2.203 . . . . 0.0 112.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 C-N-CA 122.559 2.173 . . . . 0.0 112.099 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -68.95 139.92 90.95 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.505 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.72 143.83 21.55 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.091 1.861 . . . . 0.0 112.079 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -79.81 155.25 75.65 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.1 150.48 72.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.933 1.755 . . . . 0.0 112.167 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.58 160.11 44.79 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.86 156.0 84.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.511 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.783 ' HB3' HG22 ' A' ' 39' ' ' THR . 30.9 Cg_endo -64.7 151.39 85.86 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.39 2.06 . . . . 0.0 111.883 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.91 165.77 33.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.835 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -85.47 136.91 33.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.039 0.447 . . . . 0.0 110.638 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -122.66 129.54 51.96 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.056 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 951' ' ' ILE . 2.7 mp -130.72 130.08 64.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -69.99 83.09 0.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.383 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.838 179.591 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -58.65 159.27 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.005 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 17' ' ' VAL . 13.8 pt -137.83 154.05 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.45 ' CD2' HG23 ' C' ' 14' ' ' THR . 17.3 m-30 -92.43 123.7 35.94 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.426 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -111.15 106.73 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . 0.535 ' HG3' HG23 ' C' ' 66' ' ' THR . 24.8 mtmt -91.25 133.18 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.383 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 49.2 p . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.28 -179.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.409 HG21 HD13 ' C' ' 13' ' ' ILE . 1.1 mt -123.82 113.62 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . 0.45 HG23 ' CD2' ' C' ' 4' ' ' PHE . 7.2 m -80.98 126.68 31.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.584 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.07 126.45 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.17 116.36 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.944 0.402 . . . . 0.0 110.301 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.663 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 10.8 m -136.71 173.06 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.519 ' O ' HD12 ' C' ' 56' ' ' LEU . 76.5 mm-40 -125.8 155.32 72.92 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.135 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.72 -29.25 89.05 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 121.896 1.731 . . . . 0.0 111.761 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -85.19 -15.47 43.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.62 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.38 142.37 58.42 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.592 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -85.98 167.83 14.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 110.808 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.8 -35.57 71.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.95 -42.56 90.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.94 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -62.36 -42.2 99.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.522 HG12 HD21 ' C' ' 43' ' ' LEU . 79.1 t -62.9 -42.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.807 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.628 ' CG ' HD22 ' C' ' 43' ' ' LEU . 56.2 mtmt -61.11 -41.09 96.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.272 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.663 ' NZ ' HG12 ' C' ' 17' ' ' VAL . 27.2 mttt -59.61 -39.22 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.58 HD12 HD11 ' C' ' 43' ' ' LEU . 71.6 mt -66.0 -41.14 89.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.157 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.76 11.05 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.62 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -120.45 -33.86 3.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -125.17 -14.91 6.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.057 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 12.52 75.87 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.579 HG22 ' HG3' ' C' ' 41' ' ' GLN . 28.6 mt -77.1 129.02 79.56 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.035 0.417 . . . . 0.0 110.083 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.69 154.78 59.35 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.243 1.962 . . . . 0.0 111.536 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.15 -37.77 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.927 1.751 . . . . 0.0 112.768 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.86 -43.79 98.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.625 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -83.06 -12.34 57.24 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . 0.579 ' HG3' HG22 ' C' ' 36' ' ' ILE . 19.8 mt-30 -83.81 102.49 12.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.809 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -102.26 109.5 21.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.766 ' HB3' HD12 ' C' ' 50' ' ' LEU . 8.0 mp -98.41 109.62 22.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.69 128.38 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.821 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 90.0 t80 -132.93 132.45 42.01 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.842 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.35 26.67 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.37 14.19 81.02 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -119.5 133.79 55.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.782 0.325 . . . . 0.0 110.148 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -72.32 131.83 43.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.867 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' C' ' 43' ' ' LEU . 70.8 mt -84.57 100.15 11.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.43 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.11 143.11 41.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.269 0.557 . . . . 0.0 111.171 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.0 144.44 55.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.68 -18.05 57.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.83 145.46 24.75 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.26 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -88.64 162.35 16.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.518 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.519 HD21 HG21 ' C' ' 26' ' ' VAL . 74.6 mt -61.39 -38.88 88.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.803 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -62.41 -23.07 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.769 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.66 -37.42 83.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.682 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.5 ' CE2' HD23 ' C' ' 50' ' ' LEU . 69.9 m-85 -96.42 14.28 24.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.56 39.21 25.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.925 0.393 . . . . 0.0 110.336 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.94 120.06 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.926 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.45 -179.04 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 110.902 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -60.23 145.77 46.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.934 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 59.67 23.67 12.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.8 t -74.06 124.39 26.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.05 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.535 HG23 ' HG3' ' C' ' 6' ' ' LYS . 37.9 m -73.54 128.43 35.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -115.35 140.07 49.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . 0.41 ' ND1' HG23 ' C' ' 70' ' ' VAL . 44.6 t-80 -88.17 108.01 19.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.737 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.44 120.6 40.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.688 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.41 HG23 ' ND1' ' C' ' 68' ' ' HIS . 72.2 t -120.59 138.96 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.155 0.502 . . . . 0.0 110.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.534 ' CD2' HD13 ' C' ' 36' ' ' ILE . 22.0 mt . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.405 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -64.79 161.98 17.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.867 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -143.67 147.41 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.95 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -94.95 121.43 36.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.053 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -103.41 111.28 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.519 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -95.6 124.53 39.67 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.739 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . 0.842 HG22 HD23 ' D' ' 69' ' ' LEU . 80.7 p -83.5 172.78 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.347 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.619 HD11 ' H ' ' D' ' 71' ' ' LEU . 58.8 mt -63.2 -24.07 67.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.153 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 48.8 p -81.41 -8.51 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.22 63.16 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -62.67 131.06 47.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.412 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -108.15 133.3 52.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.92 108.78 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.904 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.72 124.12 28.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.527 HD21 ' HD2' ' D' ' 33' ' ' LYS . 80.5 mt -122.52 129.72 52.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.405 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -74.38 114.95 13.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.52 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.62 HG12 ' HE3' ' D' ' 29' ' ' LYS . 15.8 m -135.28 170.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.187 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . 0.602 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.8 mt-10 -120.88 153.95 57.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.55 -38.38 94.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.866 1.71 . . . . 0.0 112.169 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -70.52 -21.77 62.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.818 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.65 144.11 56.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -87.89 168.59 12.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.85 -36.24 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.865 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tm-20 -59.36 -41.56 89.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -62.72 -41.34 99.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.732 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.517 HG21 HD21 ' D' ' 56' ' ' LEU . 78.4 t -64.26 -42.28 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.605 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -60.76 -39.25 88.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.983 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.82 91.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.971 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.62 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -59.88 -39.32 84.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.814 ' CD1' HD21 ' D' ' 43' ' ' LEU . 79.7 mt -64.57 -39.36 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.173 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.31 -39.7 83.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.863 0.363 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -68.14 -55.6 11.81 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.843 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.527 ' HD2' HD21 ' D' ' 15' ' ' LEU . 67.5 mttt -64.54 -40.67 96.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.096 0.474 . . . . 0.0 111.737 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.53 140.29 52.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.92 62.77 2.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.92 110.59 43.81 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.33 150.1 69.45 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.851 1.7 . . . . 0.0 110.739 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.77 -42.2 51.82 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.156 1.904 . . . . 0.0 112.87 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.63 -43.69 92.89 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.49 -41.76 99.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.046 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.651 ' HB2' HD11 ' D' ' 69' ' ' LEU . 26.3 pt20 -84.91 142.39 29.72 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.287 0.565 . . . . 0.0 111.378 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -137.34 109.29 7.16 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.306 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.814 HD21 ' CD1' ' D' ' 30' ' ' ILE . 83.3 mt -80.97 132.21 35.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.081 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 78.9 mt -131.38 128.88 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.672 ' HB3' HD21 ' D' ' 50' ' ' LEU . 62.1 t80 -147.78 153.93 39.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.858 0.361 . . . . 0.0 110.677 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.77 16.17 10.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.391 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.23 -7.93 76.19 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.577 ' HB3' HD22 ' A' ' 73' ' ' LEU . 17.4 ptm180 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 110.8 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -67.21 133.84 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.221 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' D' ' 45' ' ' PHE . 74.4 mt -73.85 104.49 4.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.291 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -75.84 153.05 37.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.75 154.43 41.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.72 20.96 64.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -130.43 140.02 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.355 . . . . 0.0 110.293 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -79.92 163.55 24.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.773 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.602 HD12 ' O ' ' D' ' 18' ' ' GLU . 74.4 mt -66.03 -38.18 87.76 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.866 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.58 -23.72 67.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.132 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.96 -30.1 71.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 110.447 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -101.86 12.88 36.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.342 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.92 34.08 23.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.255 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 71.9 mt -80.16 104.57 8.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -93.09 178.84 5.62 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.73 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -62.39 142.8 57.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.001 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.07 16.06 10.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.558 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -67.64 133.8 50.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.4 m -89.57 116.08 27.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.792 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.45 129.7 34.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.288 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.842 HD23 HG22 ' D' ' 7' ' ' THR . 64.2 tp -108.04 121.53 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.947 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 56' ' ' LEU . 93.0 t -109.71 129.09 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.619 ' H ' HD11 ' D' ' 8' ' ' LEU . 57.8 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.646 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.822 0.344 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.6 112.44 24.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.178 0.513 . . . . 0.0 109.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.2 mt -67.19 -37.34 83.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.793 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.432 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -149.55 162.07 4.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.813 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.46 122.47 0.36 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.179 0.514 . . . . 0.0 110.882 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.27 156.38 35.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.0 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HA ' HD12 ' A' ' 46' ' ' LEU . 90.9 mtm180 -75.91 123.7 26.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.472 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 145.62 22.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.401 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.93 149.67 16.74 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -92.49 174.93 7.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.016 0.436 . . . . 0.0 111.106 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.438 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 31.1 mtp -135.12 173.57 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.9 m -122.52 120.98 35.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 38' ' ' VAL . 28.2 tp -105.39 117.08 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.236 0.541 . . . . 0.0 110.244 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -122.05 116.9 25.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 -87.7 0.27 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.6 p -144.92 21.25 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.686 0.279 . . . . 0.0 110.799 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.502 ' O ' HD12 ' A' ' 33' ' ' LEU . 88.3 m -123.03 131.23 53.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 110.478 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 33' ' ' LEU . 64.7 t -109.75 123.31 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.045 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -116.76 137.07 23.41 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.249 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.77 146.57 54.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.776 1.651 . . . . 0.0 112.987 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -103.87 119.13 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.427 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.37 -16.2 53.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.46 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -70.25 82.72 0.54 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -62.32 136.41 57.91 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.398 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.1 -157.45 8.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.686 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -137.13 125.68 23.64 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.3 t -97.85 110.67 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -133.85 153.93 51.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.382 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.9 mt -119.27 137.75 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.232 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 130.35 34.61 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 123.624 0.578 . . . . 0.0 110.28 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.3 tt0 -101.09 123.76 45.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.895 0.379 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.49 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.7 p -83.2 172.17 12.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.704 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.89 -10.2 26.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.706 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.09 1.8 55.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.74 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 70.5 21.06 5.68 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 110.501 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.592 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 77.5 mt -97.74 120.72 38.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.521 HG21 HD23 ' A' ' 128' ' ' LEU . 50.8 mm -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.5 m-70 -97.66 113.8 25.62 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.662 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -97.01 106.74 19.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.53 147.34 49.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.856 0.836 . . . . 0.0 112.929 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -122.02 116.21 23.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.57 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -105.39 144.32 32.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.298 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.91 131.31 35.2 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -72.61 -16.3 61.73 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.837 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.65 -45.33 92.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.04 -14.15 10.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.172 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.62 74.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -102.23 152.49 20.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.9 102.27 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.152 0.501 . . . . 0.0 110.475 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.897 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -126.75 145.01 50.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.24 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.565 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.9 t0 -157.5 101.46 1.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.145 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' D' ' 48' ' ' ARG . 35.6 mt -127.4 136.14 51.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.966 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.19 122.59 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.401 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.714 HG21 ' SG ' ' A' ' 80' ' ' CYS . 28.2 mm -113.2 122.55 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.777 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.592 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 67.3 m-85 -87.23 162.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.518 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.95 140.61 92.67 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.006 1.804 . . . . 0.0 111.625 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t0 60.43 12.46 3.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.454 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.93 -21.85 23.38 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.039 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.714 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.7 p -148.77 169.07 21.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.396 0.617 . . . . 0.0 110.584 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -140.17 130.7 25.53 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.352 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -101.07 118.91 37.92 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -142.01 170.1 16.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.663 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.18 161.81 20.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -114.37 88.95 16.46 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.645 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.79 59.48 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.983 1.788 . . . . 0.0 112.105 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -115.41 -37.25 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.387 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 p -126.28 75.61 73.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.633 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.27 130.04 34.23 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.771 1.647 . . . . 0.0 111.196 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p 170.27 -41.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.13 -125.59 2.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.431 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -143.03 107.63 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.257 0.551 . . . . 0.0 110.384 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.62 132.49 70.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.595 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.99 155.5 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.45 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.25 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.027 0.441 . . . . 0.0 110.381 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.3 tp -101.15 121.92 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -119.19 133.05 55.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.091 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -83.43 115.48 22.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 0.0 109.678 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.77 -37.77 85.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.635 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.06 18.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.79 -179.91 26.55 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -115.25 18.03 16.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.704 0.288 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.738 ' HD3' HD21 ' A' ' 105' ' ' LEU . 19.9 ttmt -95.28 144.41 25.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.407 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.47 129.1 30.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.97 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.738 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.8 mt -114.68 148.34 38.36 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.771 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 33' ' ' LEU . 90.3 m-85 -122.58 136.81 54.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.213 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.84 154.46 50.51 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.397 0.617 . . . . 0.0 111.246 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -126.58 136.37 52.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.056 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 139.2 57.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.272 0.558 . . . . 0.0 111.301 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -2.01 11.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.066 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.55 139.0 54.8 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.933 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.89 -39.41 91.6 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.972 1.781 . . . . 0.0 112.372 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -112.02 143.79 42.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.3 p -94.29 1.86 55.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.857 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -57.54 -20.46 32.02 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.55 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -118.76 -16.18 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.49 -41.6 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.855 0.359 . . . . 0.0 110.569 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.75 -40.88 97.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.03 -40.38 90.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.486 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.752 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.7 m170 -62.52 -39.54 93.87 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.728 0.775 . . . . 0.0 109.15 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.76 -45.52 93.99 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.54 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -65.94 -41.88 90.73 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.525 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -63.27 -38.34 90.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.301 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -59.17 -47.94 88.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.153 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -80.02 -29.75 39.4 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.714 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.17 -37.85 81.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.517 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -81.36 -31.85 33.19 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.767 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.562 HD22 ' HB ' ' A' ' 75' ' ' ILE . 72.5 mt -81.36 -24.79 36.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.75 -23.63 11.31 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -137.37 68.32 54.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.931 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.86 160.82 48.17 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 C-N-CA 122.849 2.366 . . . . 0.0 112.283 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.311 -1.431 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 -179.583 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.31 127.84 93.51 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.319 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.31 141.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.836 1.691 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.43 151.16 55.76 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.61 158.49 53.49 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.429 2.086 . . . . 0.0 112.222 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.6 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.709 2.273 . . . . 0.0 112.027 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -120.82 158.59 51.71 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.498 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.15 140.7 87.61 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.564 2.176 . . . . 0.0 112.19 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.37 162.94 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -86.96 136.81 32.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.495 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -124.06 127.65 48.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.285 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.4 mp -130.3 126.74 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.249 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -77.11 83.76 3.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.726 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.636 179.537 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -79.51 162.08 25.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.4 pt -141.91 149.88 19.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -97.42 126.94 42.97 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.817 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -110.12 116.92 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.292 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -101.27 133.52 45.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.589 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.72 HG22 HD23 ' C' ' 69' ' ' LEU . 67.6 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m . . . . . 0 N--CA 1.46 0.074 0 CA-C-O 120.863 0.363 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 105.04 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.442 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 134.81 42.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.075 0.464 . . . . 0.0 110.366 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.727 HD21 ' HG3' ' C' ' 33' ' ' LYS . 62.4 mt -132.21 132.91 43.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.965 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.53 117.63 18.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.52 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.09 -178.7 2.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . 0.446 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.3 mt-10 -127.24 154.0 76.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.94 -27.83 85.78 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.016 1.811 . . . . 0.0 112.181 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.6 m -87.04 -10.04 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.692 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.69 142.94 58.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.023 0.44 . . . . 0.0 110.795 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -81.25 164.53 22.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.86 -38.83 83.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.988 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.71 -40.32 87.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.045 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.66 -42.97 99.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 0.0 110.393 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.556 HG21 HD21 ' C' ' 56' ' ' LEU . 62.1 t -61.64 -42.63 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.273 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.413 ' HG2' HD23 ' C' ' 43' ' ' LEU . 34.2 mtmt -59.89 -38.93 83.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.597 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -41.83 96.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.713 ' HB3' HD13 ' C' ' 15' ' ' LEU . 13.9 mttp -59.67 -38.47 81.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.617 HD11 HD11 ' C' ' 43' ' ' LEU . 96.5 mt -66.36 -39.54 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.816 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -58.66 -40.48 83.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.88 -41.62 71.1 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.417 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.727 ' HG3' HD21 ' C' ' 15' ' ' LEU . 4.3 mmtm -65.75 -41.18 92.43 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.93 156.93 47.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.969 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.21 59.02 2.77 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 35.1 mm -112.28 114.89 50.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.53 162.31 41.73 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.825 1.683 . . . . 0.0 112.001 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.97 -36.72 96.31 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.419 2.079 . . . . 0.0 112.804 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.28 -39.6 95.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.428 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -88.49 -13.95 39.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.74 86.32 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.66 107.55 19.4 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.757 ' HB3' HD12 ' C' ' 50' ' ' LEU . 4.6 mm? -99.48 118.47 36.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.421 . . . . 0.0 110.663 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 84.7 mt -129.06 129.7 67.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.583 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -117.55 121.83 42.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.577 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.4 14.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.14 80.52 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -90.58 121.42 32.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -69.01 132.27 46.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.757 HD12 ' HB3' ' C' ' 43' ' ' LEU . 56.2 mt -85.01 101.73 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.124 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.3 144.8 42.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.18 143.49 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.203 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.65 -19.23 55.2 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -83.12 169.39 15.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -119.82 164.69 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.819 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.556 HD21 HG21 ' C' ' 26' ' ' VAL . 81.1 mt -60.82 -40.56 93.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.6 -24.0 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.459 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.46 -37.67 84.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 110.476 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . 0.487 ' CE2' HD23 ' C' ' 50' ' ' LEU . 66.9 m-85 -97.99 15.41 24.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 57.51 40.45 27.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.346 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.53 107.61 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -96.52 179.09 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -58.16 149.12 24.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 57.82 40.58 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -94.67 123.13 37.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.007 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.487 ' O ' HD22 ' C' ' 67' ' ' LEU . 8.3 m -76.8 131.07 38.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.487 HD22 ' O ' ' C' ' 66' ' ' THR . 3.5 mm? -115.24 141.1 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.578 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -91.01 108.32 19.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.989 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.72 HD23 HG22 ' C' ' 7' ' ' THR . 64.9 tp -100.73 118.78 37.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.21 133.43 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.25 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.42 -178.506 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -58.13 159.84 5.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.169 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -139.69 141.4 34.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.349 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . 0.579 ' HD2' HG21 ' D' ' 12' ' ' THR . 3.9 m-85 -83.93 123.8 30.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.529 ' CG1' HD12 ' D' ' 69' ' ' LEU . 81.4 t -109.78 103.75 15.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.5 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -94.45 122.91 37.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.841 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -82.71 179.36 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.129 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.502 HD11 ' H ' ' D' ' 71' ' ' LEU . 79.6 mt -62.87 -35.48 80.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.085 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -67.01 -14.92 63.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.792 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.05 59.13 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.55 131.01 47.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.275 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . 0.579 HG21 ' HD2' ' D' ' 4' ' ' PHE . 97.7 m -104.15 132.59 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.806 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.401 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.2 mt -127.16 107.14 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.872 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -81.85 127.67 33.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.606 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.4 mt -123.16 126.36 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.8 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -66.1 113.88 4.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.446 HG12 ' CD ' ' D' ' 29' ' ' LYS . 20.3 m -135.62 162.63 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.131 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.42 152.75 40.69 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.09 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.65 -37.24 91.22 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.988 1.792 . . . . 0.0 111.956 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -81.16 -8.64 59.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -57.92 138.1 56.11 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.014 0.435 . . . . 0.0 110.991 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -80.37 162.87 24.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.12 -39.34 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.071 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.5 -39.89 89.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -62.45 -42.67 99.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.112 0.482 . . . . 0.0 110.477 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.28 -42.71 96.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.655 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.461 ' HG2' HD11 ' D' ' 43' ' ' LEU . 56.9 mtmt -60.23 -39.76 87.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.323 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.65 92.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.488 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.446 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -60.16 -38.83 84.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . 0.646 HD13 HD11 ' D' ' 69' ' ' LEU . 97.2 mt -64.71 -39.69 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.701 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.68 -40.94 93.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.17 -40.29 97.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.606 ' HD2' HD21 ' D' ' 15' ' ' LEU . 59.4 mttt -78.59 -71.41 0.43 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.892 0.377 . . . . 0.0 111.007 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.32 166.64 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.086 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.5 21.77 23.92 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . 0.566 HG22 ' HG3' ' D' ' 41' ' ' GLN . 27.1 mm -78.08 119.3 76.85 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.367 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.45 161.95 42.81 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.173 1.915 . . . . 0.0 111.538 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.12 -37.51 87.15 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.236 1.957 . . . . 0.0 112.479 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.3 -42.75 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.348 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -82.8 -12.52 57.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.566 ' HG3' HG22 ' D' ' 36' ' ' ILE . 79.4 mt-30 -80.86 80.57 7.31 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -97.8 94.59 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.687 ' HB2' HD12 ' D' ' 50' ' ' LEU . 11.9 mt -85.15 129.67 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.596 HG23 ' HA ' ' D' ' 49' ' ' GLN . 49.1 mt -129.1 130.18 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.376 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.644 ' HB3' HD21 ' D' ' 50' ' ' LEU . 68.2 t80 -148.45 154.75 40.3 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.832 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 70.0 22.25 5.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.757 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 -2.24 77.62 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.529 ' HB3' HD22 ' A' ' 73' ' ' LEU . 5.3 ptm180 -132.26 150.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.08 0.467 . . . . 0.0 110.47 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . 0.596 ' HA ' HG23 ' D' ' 44' ' ' ILE . 21.1 pt20 -65.13 148.5 51.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.566 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' D' ' 43' ' ' LEU . 81.0 mt -84.88 109.44 18.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.82 151.8 37.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.201 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -74.9 167.93 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.221 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.51 24.58 76.1 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -129.3 169.29 15.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.821 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.4 p -115.53 164.63 14.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.452 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.82 -39.66 95.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.7 p -62.72 -28.49 69.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.07 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.49 -35.97 79.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.025 0.441 . . . . 0.0 110.158 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -94.92 12.04 29.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.224 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 56.21 39.6 30.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.143 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.48 112.83 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -97.11 177.18 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.531 0.681 . . . . 0.0 111.133 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -61.7 142.58 57.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.121 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 65.13 18.61 11.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . 0.427 ' O ' HD12 ' D' ' 67' ' ' LEU . 32.0 m -70.55 130.79 42.78 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.94 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -82.32 126.3 31.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . 0.581 HD23 HD11 ' D' ' 50' ' ' LEU . 5.6 mp -117.09 142.85 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.06 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -89.19 117.67 28.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.232 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.646 HD11 HD13 ' D' ' 30' ' ' ILE . 0.4 OUTLIER -97.7 100.26 11.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.31 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.68 128.83 38.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.502 ' H ' HD11 ' D' ' 8' ' ' LEU . 75.6 mt . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -89.28 126.94 35.72 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.366 0.603 . . . . 0.0 110.208 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' ILE . 83.4 mt -67.35 -38.46 84.87 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.878 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG11 HG22 ' A' ' 124' ' ' VAL . 0.9 OUTLIER -147.48 161.99 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 179.494 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -173.06 122.14 0.39 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.048 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -153.51 153.16 31.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.68 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.608 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -70.51 123.38 21.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.572 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.59 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -153.46 145.69 23.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.266 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.15 151.74 17.69 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -89.25 172.61 8.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.419 . . . . 0.0 110.99 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 33.3 mtp -136.41 170.47 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.632 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.9 m -120.8 121.31 37.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 37' ' ' THR . 22.0 tp -104.57 118.26 36.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.639 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.55 107.23 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.743 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 -92.88 0.61 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.4 p -135.13 19.84 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.942 -0.152 . . . . 0.0 110.972 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.551 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.6 m -121.52 130.94 53.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.838 0.351 . . . . 0.0 110.369 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.476 ' CG2' HD13 ' A' ' 33' ' ' LEU . 76.8 t -112.31 124.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.194 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -116.51 136.15 23.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 147.18 45.46 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.956 1.771 . . . . 0.0 112.918 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -101.94 122.31 43.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.635 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -65.3 -11.34 40.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.762 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -73.8 78.79 1.58 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -55.47 137.36 48.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.86 -159.49 8.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.312 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.1 tp -139.09 124.43 19.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 28' ' ' ALA . 55.4 t -96.91 109.62 23.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.454 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 39.5 p90 -132.72 154.52 50.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.905 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 23' ' ' LEU . 84.5 mt -120.8 141.77 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.625 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -142.85 140.95 31.48 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 123.75 0.657 . . . . 0.0 110.048 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -104.43 127.43 52.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.975 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 58' ' ' HIS . 27.9 p -87.67 173.95 8.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.77 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.69 -11.08 22.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.822 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.21 -1.24 57.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.399 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.97 19.88 6.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 110.529 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.76 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 54.9 mt -101.96 128.79 48.22 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 131' ' ' PRO . 51.5 mm -82.21 127.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.527 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.4 m-70 -104.99 114.82 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.112 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.578 ' CB ' HD13 ' A' ' 75' ' ' ILE . 59.9 t80 -89.57 107.77 19.27 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 95.0 m -119.36 140.8 49.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -121.59 114.08 20.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.187 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -105.99 147.61 28.65 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.348 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -79.8 137.19 36.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.737 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -76.55 -21.1 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.3 m -60.14 -45.17 93.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -116.48 -12.17 11.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.492 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.4 77.12 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.01 146.29 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.17 105.93 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.174 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -84.0 -31.55 25.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.832 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -128.12 147.92 50.56 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.392 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.572 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.1 p-10 -158.7 99.14 1.55 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 72' ' ' ASP . 38.5 mt -126.7 134.53 50.66 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.645 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.586 ' C ' HD12 ' A' ' 75' ' ' ILE . 97.3 mt -79.12 129.22 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.136 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.586 HD12 ' C ' ' A' ' 74' ' ' ILE . 1.9 mp -117.28 117.14 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.841 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.76 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 52.4 m-85 -83.4 163.56 49.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.28 137.97 78.39 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.736 1.624 . . . . 0.0 111.003 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 58.25 14.29 2.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -90.02 -40.81 12.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.462 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -128.06 147.91 50.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.864 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.6 tp10 -121.34 129.68 53.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.254 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.03 117.63 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.1 167.97 20.83 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.629 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -82.38 160.83 22.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.865 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.93 90.44 13.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.145 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.35 59.83 7.6 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.069 1.846 . . . . 0.0 112.342 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.12 -39.8 3.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.371 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 36.9 t -127.89 81.09 70.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.11 130.55 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.804 1.669 . . . . 0.0 111.528 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p 170.27 -39.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.887 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.7 -146.07 5.01 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.418 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.38 106.96 13.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.43 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -126.62 129.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.22 154.14 43.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.325 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -130.19 135.99 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 110.349 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.4 tp -104.65 118.29 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -117.45 131.2 56.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.194 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 59.9 m-85 -86.84 114.81 23.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -31.6 70.93 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.449 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.93 -21.98 11.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -71.98 -23.25 78.26 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.827 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.79 12.24 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.563 0.22 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.81 155.81 30.52 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.797 0.332 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 143.78 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.747 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 95' ' ' VAL . 57.8 mt -120.21 151.98 38.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.522 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 31' ' ' MET . 98.1 m-85 -121.28 134.23 55.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.69 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.62 158.14 44.62 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.0 111.148 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -132.73 138.71 47.31 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.893 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.408 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 52.2 tpp -70.5 132.75 46.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.766 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.72 1.81 14.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.426 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 109' ' ' MET . 88.6 mt-10 -66.34 146.48 99.04 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.04 -40.47 84.74 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.923 1.748 . . . . 0.0 112.659 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -122.98 146.61 47.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.3 p -96.88 11.96 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -59.72 -21.46 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.368 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -116.63 6.32 13.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.95 -46.79 87.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.86 -40.88 97.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.042 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.06 -43.66 94.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.695 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.698 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.2 m170 -64.65 -40.97 96.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.755 0.788 . . . . 0.0 109.535 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.5 t -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.874 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 tpp85 -67.51 -42.33 83.0 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.44 -41.39 98.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.244 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.7 t -58.34 -47.77 86.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.15 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -63.93 -38.2 90.22 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.575 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.47 -29.46 63.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.219 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -83.01 -29.77 28.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.502 HD22 ' HB ' ' A' ' 75' ' ' ILE . 81.4 mt -89.23 -20.64 23.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.5 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -111.39 -23.99 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.154 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -134.51 72.45 69.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.434 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.4 Cg_exo -59.83 150.83 75.24 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.744 2.296 . . . . 0.0 112.081 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 122.402 2.068 . . . . 0.0 112.088 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -71.18 149.38 94.37 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.692 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.02 150.32 29.63 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.182 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -81.91 153.47 69.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.166 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 158.96 53.65 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.413 2.075 . . . . 0.0 112.144 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.31 -169.27 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.783 2.322 . . . . 0.0 112.027 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -120.06 159.83 45.52 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.349 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.53 143.98 86.19 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.92 164.73 38.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -86.22 134.95 33.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -120.29 132.62 55.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.349 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.11 130.61 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.45 85.22 3.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.158 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.406 179.696 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.92 164.89 9.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.6 pt -144.35 141.05 24.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.193 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' PHE . . . . . 0.477 ' HD2' HG21 ' C' ' 12' ' ' THR . 7.8 m-85 -86.12 123.85 31.88 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.847 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.07 116.83 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -95.08 121.74 37.01 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.757 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' THR . . . . . 0.556 HG22 HD23 ' C' ' 69' ' ' LEU . 81.9 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.22 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' THR . . . . . 0.477 HG21 ' HD2' ' C' ' 4' ' ' PHE . 97.5 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.43 HG21 ' HG2' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -125.66 110.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.841 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.0 m -81.31 130.15 34.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.092 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.626 HD21 ' CD ' ' C' ' 33' ' ' LYS . 70.0 mt -122.32 131.41 53.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.701 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -71.94 116.03 11.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 110.729 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.489 HG12 ' CD ' ' C' ' 29' ' ' LYS . 20.3 m -136.08 164.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.394 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -105.33 153.22 39.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.223 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.41 -34.91 95.67 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.081 1.854 . . . . 0.0 112.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.53 -2.19 58.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.42 136.66 58.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 110.737 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 59.8 p -78.59 163.07 25.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.931 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' ILE . . . . . 1.002 HD12 HD23 ' C' ' 50' ' ' LEU . 40.3 mm -64.84 -41.27 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.429 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -58.16 -36.81 73.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.996 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.08 -41.76 94.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.382 0.611 . . . . 0.0 110.826 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.559 HG12 HD21 ' C' ' 43' ' ' LEU . 70.5 t -64.24 -42.27 94.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.588 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' LYS . . . . . 0.497 ' HG2' HD13 ' C' ' 43' ' ' LEU . 56.4 mtmt -60.82 -39.72 90.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.315 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.16 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.043 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' LYS . . . . . 0.489 ' CD ' HG12 ' C' ' 17' ' ' VAL . 67.3 mttm -60.31 -39.17 86.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' ILE . . . . . 0.486 HD12 HD11 ' C' ' 43' ' ' LEU . 91.4 mt -65.15 -40.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.179 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -59.75 -41.11 90.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.326 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -40.47 96.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.153 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.626 ' CD ' HD21 ' C' ' 15' ' ' LEU . 0.0 OUTLIER -71.88 -63.7 1.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.47 -178.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -107.05 159.66 16.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.893 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.23 55.25 3.99 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' ILE . . . . . 0.462 HG23 HD22 ' C' ' 71' ' ' LEU . 33.8 mm -107.91 121.01 45.28 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.56 159.94 47.75 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.651 1.568 . . . . 0.0 111.868 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.93 -39.08 94.07 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.186 1.924 . . . . 0.0 112.47 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -61.48 -50.22 73.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -67.63 -39.69 84.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.692 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.2 96.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.279 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' ARG . . . . . 0.594 ' NE ' HD11 ' C' ' 44' ' ' ILE . 76.9 ttt180 -104.24 110.75 23.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.559 HD21 HG12 ' C' ' 26' ' ' VAL . 7.2 mp -92.68 117.91 30.49 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' ILE . . . . . 0.594 HD11 ' NE ' ' C' ' 42' ' ' ARG . 92.4 mt -130.06 128.36 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -127.9 128.87 45.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.662 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 25.62 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.527 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.28 1.63 90.12 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -103.17 123.14 46.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -66.95 134.08 51.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.222 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 1.002 HD23 HD12 ' C' ' 23' ' ' ILE . 9.7 mp -87.25 102.27 14.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.344 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -74.21 146.17 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.912 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.67 144.93 53.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.536 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.15 -15.38 63.3 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -83.22 168.09 17.08 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 56.9 p -116.45 161.76 18.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.447 HD21 HG21 ' C' ' 26' ' ' VAL . 83.0 mt -61.74 -40.36 94.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.959 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.19 -24.68 67.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -62.78 -37.78 88.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.145 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -95.59 14.15 23.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.165 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.93 41.77 27.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.419 . . . . 0.0 110.171 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ILE . . . . . 0.547 HD11 HD21 ' C' ' 50' ' ' LEU . 86.2 mt -91.87 106.16 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.667 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -92.51 -173.77 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.961 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.63 144.78 56.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.221 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 63.64 13.07 7.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.075 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -65.6 132.78 49.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' THR . . . . . 0.629 ' C ' HD12 ' C' ' 67' ' ' LEU . 56.6 m -85.02 127.67 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' LEU . . . . . 0.629 HD12 ' C ' ' C' ' 66' ' ' THR . 10.2 mp -119.39 140.38 50.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -86.15 123.72 31.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.171 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' LEU . . . . . 0.556 HD23 HG22 ' C' ' 7' ' ' THR . 66.5 tp -109.33 120.1 41.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.626 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.83 131.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' LEU . . . . . 0.462 HD22 HG23 ' C' ' 36' ' ' ILE . 18.9 mt . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.591 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.02 162.59 16.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 3' ' ' ILE . . . . . 0.472 HG22 ' HB3' ' D' ' 65' ' ' SER . 7.9 pt -141.17 146.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.942 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -90.58 101.14 13.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.686 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -87.75 101.03 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 132.65 41.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -64.45 -150.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.04 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.551 HD21 ' H ' ' D' ' 71' ' ' LEU . 83.8 mt -59.85 -40.01 87.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.589 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 0.452 HG22 ' C ' ' D' ' 8' ' ' LEU . 0.0 OUTLIER 179.96 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.123 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.46 -89.35 0.44 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.096 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.36 139.88 14.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.887 0.375 . . . . 0.0 110.762 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -126.43 137.78 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.833 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.537 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.5 mt -121.65 111.7 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -85.78 125.78 33.51 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.126 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -122.63 130.42 52.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.56 115.97 13.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.589 HG12 ' HE3' ' D' ' 29' ' ' LYS . 21.2 m -133.65 166.3 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.616 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.46 152.66 44.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.893 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.7 -27.28 82.82 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.76 1.64 . . . . 0.0 111.765 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -87.36 -11.42 49.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.37 142.19 58.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 57.4 p -82.32 165.41 20.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' ILE . . . . . 0.567 HD12 HD13 ' D' ' 50' ' ' LEU . 49.9 mm -62.42 -38.75 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.8 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.29 -41.41 88.86 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -60.86 -42.82 98.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.569 . . . . 0.0 110.375 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -41.39 90.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.933 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' LYS . . . . . 0.486 ' HG2' HD11 ' D' ' 43' ' ' LEU . 56.2 mtmt -60.5 -40.09 90.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.36 91.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.393 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' LYS . . . . . 0.589 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -59.78 -38.33 81.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.79 -39.73 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.371 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.66 -43.95 97.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.31 -20.15 62.23 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.985 -0.447 . . . . 0.0 111.871 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.537 ' HD2' HG22 ' D' ' 13' ' ' ILE . 6.8 mttm -102.9 -7.67 21.34 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -141.32 -43.8 0.37 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.252 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.16 14.92 10.3 Favored Glycine 0 C--N 1.321 -0.268 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.038 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -88.79 117.64 68.5 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.622 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.32 172.67 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.961 1.774 . . . . 0.0 111.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.67 -27.13 18.87 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.494 2.129 . . . . 0.0 111.763 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -100.24 -176.15 3.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.837 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 64.94 16.9 10.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.539 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' D' ' 69' ' ' LEU . 14.4 pt20 -157.2 159.15 37.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.777 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -147.27 131.32 17.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.486 HD11 ' HG2' ' D' ' 27' ' ' LYS . 22.4 mt -100.49 114.52 28.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' ILE . . . . . 0.417 HD12 ' HZ ' ' A' ' 76' ' ' PHE . 77.0 mt -118.71 130.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.61 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 90.1 t80 -142.38 149.23 39.1 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.984 0.421 . . . . 0.0 111.192 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.25 15.78 10.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.14 64.23 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' ARG . . . . . 0.655 ' HB3' HD22 ' A' ' 73' ' ' LEU . 38.2 ptt180 -114.62 142.34 46.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.102 0.477 . . . . 0.0 110.534 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -69.51 146.14 52.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.24 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.567 HD13 HD12 ' D' ' 23' ' ' ILE . 83.2 mt -84.32 115.66 22.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.477 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.23 138.81 42.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -60.13 147.93 37.83 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.77 68.13 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -84.08 167.77 16.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.776 0.288 . . . . 0.0 110.607 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -114.07 159.44 20.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.025 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.21 -39.89 94.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.714 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -63.61 -24.13 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -63.09 -38.1 89.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.079 0.466 . . . . 0.0 110.234 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' TYR . . . . . 0.407 ' CE2' HD23 ' D' ' 50' ' ' LEU . 63.5 m-85 -96.12 12.73 29.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.206 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.45 41.37 26.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.326 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.04 103.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -90.55 179.33 5.87 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.239 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -61.74 150.7 36.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.987 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 60.07 31.3 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' SER . . . . . 0.472 ' HB3' HG22 ' D' ' 3' ' ' ILE . 18.4 t -86.57 125.88 34.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.919 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 123.22 26.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.05 149.72 31.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.815 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -99.13 117.76 34.33 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.626 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' D' ' 41' ' ' GLN . 61.4 tp -100.69 112.73 25.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.904 HG11 HD11 ' A' ' 56' ' ' LEU . 66.7 t -112.6 123.52 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' LEU . . . . . 0.551 ' H ' HD21 ' D' ' 8' ' ' LEU . 61.4 mt . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.759 0.314 . . . . 0.0 110.534 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -94.82 125.17 39.31 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.452 0.644 . . . . 0.0 110.419 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 51' ' ' GLN . 92.4 mt -68.87 -36.54 78.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.304 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.95 160.78 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.729 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -172.84 122.73 0.42 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.0 158.98 38.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.1 mtm-85 -77.35 119.57 21.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.831 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.21 146.05 25.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.395 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.25 150.88 16.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -89.3 162.15 15.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.07 0.462 . . . . 0.0 111.031 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.496 ' HE3' HG12 ' A' ' 38' ' ' VAL . 1.2 mtm -133.23 168.54 18.36 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -121.75 134.24 54.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.653 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.706 HD13 HG22 ' A' ' 38' ' ' VAL . 25.3 tp -115.42 118.96 34.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -123.8 120.76 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.926 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.0 -85.79 0.22 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.32 22.56 0.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.752 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.569 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.7 m -123.77 128.73 49.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.946 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.706 HG22 HD13 ' A' ' 33' ' ' LEU . 40.4 t -107.89 119.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.822 HG22 ' HB3' ' B' ' 947' ' ' PRO . 22.0 p -114.3 135.31 22.19 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.656 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.74 149.25 37.71 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.064 1.843 . . . . 0.0 112.856 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -105.53 142.91 34.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -80.61 -7.97 59.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -72.3 75.87 1.0 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -57.38 135.23 56.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.295 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.68 -159.15 8.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.5 tp -137.3 125.71 23.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.53 109.14 23.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.55 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 38.8 p90 -132.44 153.97 50.32 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.4 139.85 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.458 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 128.81 29.91 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 123.922 0.764 . . . . 0.0 110.736 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.667 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.1 tt0 -99.29 124.23 44.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' CD2' ' A' ' 58' ' ' HIS . 13.7 p -85.11 170.74 12.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.414 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.03 -10.73 15.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.71 0.53 55.59 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.556 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.81 20.45 6.77 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.225 0.536 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HG11 ' D' ' 70' ' ' VAL . 75.9 mt -99.56 121.94 41.91 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.512 HG21 HD23 ' A' ' 128' ' ' LEU . 50.5 mm -79.32 124.83 38.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.495 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.497 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.0 m-70 -100.32 115.42 29.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.833 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.08 108.29 20.38 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -121.61 143.7 49.17 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.787 0.804 . . . . 0.0 112.836 -177.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -124.86 114.42 19.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.025 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -104.93 144.13 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.419 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -80.8 131.5 35.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -72.29 -18.43 61.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.899 0.381 . . . . 0.0 110.786 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.7 m -59.54 -45.43 91.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.649 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -117.09 -13.46 10.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.446 . . . . 0.0 110.32 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.36 23.73 74.89 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -102.15 152.16 21.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.82 102.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -76.16 -35.01 59.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.12 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -125.59 147.07 49.42 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.725 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.5 t0 -157.81 98.88 1.67 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' D' ' 48' ' ' ARG . 40.1 mt -128.9 133.04 47.76 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.901 0.382 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.09 124.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.913 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.525 ' HB ' HD22 ' A' ' 128' ' ' LEU . 25.5 mm -111.37 128.15 68.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.076 0.465 . . . . 0.0 110.62 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.417 ' HZ ' HD12 ' D' ' 44' ' ' ILE . 66.4 m-85 -93.04 162.17 29.3 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.364 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.56 140.2 89.3 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.931 1.754 . . . . 0.0 111.362 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 59.52 13.2 3.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.249 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -87.28 -37.79 16.87 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-O 120.872 0.368 . . . . 0.0 110.415 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.597 ' HB3' HD11 ' A' ' 96' ' ' LEU . 81.8 m -131.75 153.41 50.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.261 0.553 . . . . 0.0 111.653 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -125.5 129.49 49.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -103.57 117.45 34.44 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.04 166.39 24.83 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.602 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -83.73 160.11 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.987 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.93 90.26 12.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.51 60.65 7.65 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.049 1.832 . . . . 0.0 112.31 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -114.01 -37.97 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.328 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.0 t -132.3 76.25 72.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.72 130.57 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.278 1.985 . . . . 0.0 111.435 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.83 -42.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.055 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.27 -149.72 6.18 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.408 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.26 105.68 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.0 t -125.19 127.71 72.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.13 152.23 46.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.2 p -128.35 137.85 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.457 . . . . 0.0 110.228 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 80' ' ' CYS . 59.4 tp -102.33 120.22 40.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -118.47 134.86 54.73 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.49 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -84.36 117.03 23.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -61.24 -37.54 83.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.744 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -100.42 -10.28 21.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.728 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.83 152.92 17.15 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -93.18 22.02 5.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.331 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HD3' HD21 ' A' ' 105' ' ' LEU . 1.2 tmmm? -118.33 144.85 45.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.912 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.421 ' O ' HD23 ' A' ' 105' ' ' LEU . 33.7 ptt180 -139.72 152.79 46.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.958 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 95' ' ' VAL . 36.1 mt -121.58 159.39 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.252 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.502 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 87.9 m-85 -126.12 137.54 53.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.42 161.24 38.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.353 0.597 . . . . 0.0 111.088 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.76 140.56 40.7 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.637 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.9 mmm -72.77 139.1 46.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.143 0.497 . . . . 0.0 110.788 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.94 4.27 15.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.844 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.96 147.49 93.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.49 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.94 -38.93 65.25 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.812 1.674 . . . . 0.0 112.223 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -118.81 145.76 45.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.148 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.0 p -91.9 1.25 57.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.972 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.24 -19.79 48.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.364 0.415 . . . . 0.0 110.151 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.86 -17.42 10.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.29 -41.49 97.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.503 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.64 -41.06 98.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.388 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.92 -41.77 90.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.531 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.732 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.5 m170 -63.82 -39.91 95.36 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.698 0.761 . . . . 0.0 109.196 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m -62.41 -42.35 99.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.641 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -65.22 -43.96 89.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -61.88 -37.72 85.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.025 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.5 t -58.35 -48.76 84.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.24 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.54 -27.83 41.3 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.904 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.88 -37.99 79.39 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.482 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -80.91 -31.78 34.97 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.753 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.525 HD22 ' HB ' ' A' ' 75' ' ' ILE . 59.6 mt -82.16 -20.57 37.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -114.13 -17.36 11.93 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.116 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -146.56 72.88 12.82 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.753 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 160.95 45.42 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 123.03 2.487 . . . . 0.0 112.139 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.495 1.579 0 C-N-CA 122.651 2.234 . . . . 0.0 112.377 -179.556 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 50.12 71.89 1.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.83 144.09 99.51 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.913 2.408 . . . . 0.0 112.15 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.89 154.66 92.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.77 150.2 88.99 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.332 2.021 . . . . 0.0 111.824 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.5 -169.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.237 1.958 . . . . 0.0 112.319 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.04 154.86 76.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 947' ' ' PRO . . . . . 0.822 ' HB3' HG22 ' A' ' 39' ' ' THR . 33.1 Cg_endo -63.86 143.32 85.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.252 1.968 . . . . 0.0 112.124 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -156.79 164.81 37.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.701 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -88.05 133.33 34.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -121.49 125.88 47.9 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.311 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.4 mp -129.83 120.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.506 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -81.53 83.71 6.93 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.962 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.583 179.458 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -63.2 158.77 19.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.558 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -138.27 149.76 24.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.166 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.416 ' CD2' HG23 ' C' ' 14' ' ' THR . 13.3 m-30 -91.82 124.31 35.86 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.864 -0.335 . . . . 0.0 110.697 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.3 t -108.64 114.09 45.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.153 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -91.55 123.86 35.28 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.308 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.71 HG22 HD23 ' C' ' 69' ' ' LEU . 67.3 p -84.28 174.86 9.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.357 0.599 . . . . 0.0 111.101 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.746 HD11 ' H ' ' C' ' 71' ' ' LEU . 86.8 mt -60.88 -38.56 86.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.35 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -72.84 -8.98 58.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.85 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.63 -10.65 64.74 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -63.58 126.5 27.74 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 97.9 m -98.87 133.61 42.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.99 0.424 . . . . 0.0 110.786 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.25 106.37 15.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.402 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . 0.416 HG23 ' CD2' ' C' ' 4' ' ' PHE . 22.0 m -74.92 129.17 37.19 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.094 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.2 mt -122.3 126.31 47.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.473 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.11 112.97 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.976 0.417 . . . . 0.0 110.648 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.503 HG12 ' HE3' ' C' ' 29' ' ' LYS . 31.0 m -134.22 161.68 40.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.72 154.26 38.67 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.079 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -56.65 -36.74 98.39 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.151 1.901 . . . . 0.0 112.272 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.7 m -87.01 0.13 55.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.887 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -62.36 136.64 58.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 110.894 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 63.2 p -78.59 163.47 25.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.96 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.633 HD12 HD23 ' C' ' 50' ' ' LEU . 46.3 mm -64.66 -37.7 80.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.917 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tm-20 -59.03 -42.17 89.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.914 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.89 -41.33 99.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.998 0.428 . . . . 0.0 110.736 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.68 -42.99 97.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -60.87 -39.4 89.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.57 -40.11 93.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.099 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.503 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.6 mttm -60.42 -39.95 89.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.744 ' CD1' HD21 ' C' ' 43' ' ' LEU . 91.2 mt -64.69 -42.18 94.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.138 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.71 -39.73 89.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.203 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.85 7.34 15.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.412 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -115.83 -44.42 2.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 0.0 110.862 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -115.87 1.18 13.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.419 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.47 20.11 78.13 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.522 HG21 ' HB3' ' C' ' 41' ' ' GLN . 17.9 mm -79.83 120.87 81.35 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.05 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.1 150.7 54.47 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.72 1.614 . . . . 0.0 111.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.6 -24.51 29.58 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.496 2.131 . . . . 0.0 112.704 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -93.26 22.27 5.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.222 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -152.92 52.14 0.75 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.877 0.37 . . . . 0.0 111.062 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.522 ' HB3' HG21 ' C' ' 36' ' ' ILE . 5.8 pt20 -172.71 140.65 1.01 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.084 0.469 . . . . 0.0 110.856 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.93 128.47 43.82 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.254 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.744 HD21 ' CD1' ' C' ' 30' ' ' ILE . 64.0 mt -104.38 119.68 39.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.944 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.98 128.45 69.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.416 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -129.78 130.25 45.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.004 0.431 . . . . 0.0 111.002 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.1 26.36 16.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.603 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 2.17 89.87 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.703 ' HE3' HD22 ' D' ' 73' ' ' LEU . 57.0 mtpt -104.64 125.78 51.09 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.88 0.34 . . . . 0.0 110.227 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -72.16 132.16 43.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.432 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.633 HD23 HD12 ' C' ' 23' ' ' ILE . 8.2 mp -83.07 95.43 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.106 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.62 148.13 41.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.858 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -62.83 138.62 58.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.08 -18.31 54.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.7 mmp_? -84.24 177.5 8.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.14 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 64.7 p -126.3 165.76 18.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.341 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.38 -40.03 95.12 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.275 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.1 p -63.52 -28.28 69.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.55 -29.99 70.98 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.044 0.45 . . . . 0.0 110.21 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.08 15.21 29.97 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.169 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 64.0 t30 55.54 43.22 28.78 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.906 0.384 . . . . 0.0 110.251 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.38 109.23 21.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.045 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -97.55 -175.5 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.403 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -64.54 149.77 48.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.052 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 56.71 42.22 27.15 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.88 0.372 . . . . 0.0 110.903 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 53.6 m -100.02 127.53 46.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.099 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 89.1 m -77.24 127.67 33.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.68 142.24 47.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.317 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -85.99 117.77 25.05 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.27 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.71 HD23 HG22 ' C' ' 7' ' ' THR . 55.1 tp -106.46 123.56 48.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.01 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.633 ' HA ' HD21 ' C' ' 8' ' ' LEU . 88.9 t -121.69 131.97 71.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.55 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.746 ' H ' HD11 ' C' ' 8' ' ' LEU . 31.2 mt -105.44 142.71 34.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.361 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -78.53 88.14 4.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.268 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 64.7 tp -64.62 -46.17 83.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.861 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 92.5 mtm-85 -63.04 -38.86 92.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.901 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.69 13.76 80.93 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 58.34 -131.81 52.24 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.411 179.896 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -62.93 161.4 12.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.435 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.488 ' HB ' HD13 ' D' ' 67' ' ' LEU . 18.1 pt -143.93 139.13 25.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.061 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.529 ' HD2' HG21 ' D' ' 12' ' ' THR . 9.5 m-85 -85.66 120.16 26.79 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.948 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.78 108.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.65 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.51 120.43 28.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.691 HG22 HD23 ' D' ' 69' ' ' LEU . 82.0 p -80.78 170.76 15.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.635 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.774 HD11 ' H ' ' D' ' 71' ' ' LEU . 68.6 mt -65.78 -22.5 66.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.154 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -87.58 -0.54 56.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.72 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.69 -7.86 79.12 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -68.7 115.85 8.54 Favored 'General case' 0 C--O 1.227 -0.124 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.529 HG21 ' HD2' ' D' ' 4' ' ' PHE . 94.9 m -92.69 137.79 32.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.022 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.2 mt -131.75 105.72 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 12.9 m -80.92 125.62 30.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.446 HD21 ' HD2' ' D' ' 33' ' ' LYS . 66.9 mt -122.32 123.47 41.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.17 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -65.79 108.84 2.25 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.672 HG12 ' NZ ' ' D' ' 29' ' ' LYS . 24.2 m -132.45 163.66 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.717 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . 0.461 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.4 mt-10 -108.98 149.79 40.08 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.01 -0.366 . . . . 0.0 110.01 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.43 -42.47 65.26 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.851 1.701 . . . . 0.0 112.368 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -68.72 -19.77 64.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.245 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -58.0 136.7 57.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.384 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -79.62 166.2 22.12 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.849 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.877 HD12 HD13 ' D' ' 50' ' ' LEU . 48.9 mm -66.25 -37.13 79.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.8 -44.27 86.22 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.261 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.65 -41.09 98.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.971 0.415 . . . . 0.0 110.651 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.0 -41.87 94.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.977 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -60.3 -40.64 91.22 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.1 -39.18 91.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.305 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.672 ' NZ ' HG12 ' D' ' 17' ' ' VAL . 98.6 mttt -59.82 -38.77 82.94 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.777 ' CD1' HD21 ' D' ' 43' ' ' LEU . 81.3 mt -64.8 -39.4 85.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.859 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' D' ' 35' ' ' GLY . 64.8 tt0 -59.83 -44.81 93.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.261 0.553 . . . . 0.0 109.946 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -65.99 -35.05 79.53 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.815 -0.553 . . . . 0.0 111.159 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.446 ' HD2' HD21 ' D' ' 15' ' ' LEU . 18.4 mttt -88.94 -4.02 58.57 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -147.61 -53.19 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.277 0.561 . . . . 0.0 110.467 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' D' ' 31' ' ' GLN . . . 117.22 13.51 7.59 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.561 HD13 HD21 ' D' ' 71' ' ' LEU . 33.6 mt -83.69 119.88 74.36 Favored Pre-proline 0 N--CA 1.447 -0.606 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.346 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.88 164.03 34.32 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.865 1.71 . . . . 0.0 111.338 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.25 -34.15 94.1 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.466 2.111 . . . . 0.0 112.666 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm100 -92.52 -17.29 24.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.955 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.642 ' OE1' HD12 ' D' ' 30' ' ' ILE . 5.1 tt0 -96.05 131.17 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.082 0.467 . . . . 0.0 111.522 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -133.9 103.18 5.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.83 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.777 HD21 ' CD1' ' D' ' 30' ' ' ILE . 81.3 mt -83.6 129.85 34.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.054 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' D' ' 49' ' ' GLN . 66.4 mt -129.33 130.94 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.68 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 78.5 t80 -150.59 155.62 39.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.741 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.45 20.62 7.17 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.545 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.91 -3.19 77.16 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.409 ' HB3' HD22 ' A' ' 73' ' ' LEU . 38.7 ptt180 -129.21 147.68 51.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.083 0.468 . . . . 0.0 110.73 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.491 ' HA ' HG23 ' D' ' 44' ' ' ILE . 18.7 pt20 -69.86 140.67 53.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.351 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.877 HD13 HD12 ' D' ' 23' ' ' ILE . 81.7 mt -73.48 144.91 46.04 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.392 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.33 -82.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.268 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 177.38 -72.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 110.572 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.14 -18.51 69.2 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -59.46 155.05 15.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.986 0.422 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -96.44 164.97 12.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.153 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.461 HD12 ' O ' ' D' ' 18' ' ' GLU . 81.7 mt -63.96 -38.93 92.88 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.517 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -63.05 -23.91 67.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.405 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.47 -38.26 86.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.026 0.441 . . . . 0.0 110.354 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . 0.442 ' CE2' HD23 ' D' ' 50' ' ' LEU . 60.0 m-85 -97.49 15.25 23.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.192 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 56.34 39.11 30.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 110.247 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.68 103.7 12.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.786 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -91.32 178.76 5.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.0 110.824 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -61.8 150.04 38.26 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.906 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 59.67 17.94 6.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.172 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -67.59 129.08 38.78 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -85.49 105.42 16.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.488 HD13 ' HB ' ' D' ' 3' ' ' ILE . 8.5 mp -93.35 142.6 27.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 123.1 34.11 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.272 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.691 HD23 HG22 ' D' ' 7' ' ' THR . 28.3 tp -100.09 119.19 37.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.181 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 56' ' ' LEU . 69.1 t -109.84 129.71 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.774 ' H ' HD11 ' D' ' 8' ' ' LEU . 64.1 mt -110.01 137.39 47.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -78.83 -163.94 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.426 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.703 HD22 ' HE3' ' C' ' 48' ' ' LYS . 94.6 mt -65.22 143.41 57.84 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 51.1 mmm-85 -98.25 26.82 5.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.264 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.46 7.11 72.82 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.742 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.643 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -68.36 152.98 44.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.33 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -92.05 126.43 37.14 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.41 0.624 . . . . 0.0 109.998 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -66.96 -38.53 86.26 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.942 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -147.15 161.42 8.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.898 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -173.67 122.88 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.741 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -153.5 157.51 39.93 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.486 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.595 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -73.71 120.6 19.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.603 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -153.33 145.4 23.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.72 154.66 16.63 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -87.21 156.89 19.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.812 0.339 . . . . 0.0 110.811 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 28.3 mtp -125.23 174.1 8.33 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.8 m -127.7 122.05 31.94 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.274 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 37' ' ' THR . 30.9 tp -107.86 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.96 0.409 . . . . 0.0 110.247 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.63 120.25 31.35 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.809 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.41 -90.19 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -144.32 21.85 1.7 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.506 0.193 . . . . 0.0 110.765 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.596 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.9 m -123.45 130.71 53.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.504 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' CG2' HD13 ' A' ' 33' ' ' LEU . 71.4 t -107.14 120.28 58.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.694 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.781 HG22 ' HB3' ' B' ' 947' ' ' PRO . 44.6 p -118.82 124.01 28.65 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.202 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.72 141.76 42.08 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.817 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -91.88 132.31 36.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.533 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -67.74 -7.6 28.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -74.42 75.24 1.91 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -53.1 136.14 36.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.211 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -161.17 9.86 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.357 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 27' ' ' ARG . 8.7 tp -137.72 124.92 21.64 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 28' ' ' ALA . 44.3 t -98.45 108.67 22.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.683 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 40.1 p90 -132.29 154.57 49.56 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.922 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 24' ' ' VAL . 95.8 mt -121.52 141.11 43.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.786 -178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -142.9 141.9 31.62 Favored 'General case' 0 C--O 1.219 -0.505 0 O-C-N 123.716 0.635 . . . . 0.0 110.263 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -104.99 129.17 53.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.188 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.511 HG23 ' CD2' ' A' ' 58' ' ' HIS . 21.1 p -89.01 173.57 8.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.73 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -64.16 -10.84 25.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.717 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -86.32 -1.07 57.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.445 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 t 70.12 20.9 6.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.284 0.564 . . . . 0.0 110.47 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD11 HG11 ' D' ' 70' ' ' VAL . 66.2 mt -103.13 126.8 50.47 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.55 HD11 ' HD2' ' A' ' 132' ' ' PRO . 51.7 mm -80.54 127.83 39.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.511 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.8 m-70 -104.41 117.91 35.34 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.709 0.631 . . . . 0.0 110.933 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -94.35 107.82 19.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 90.4 m -119.35 142.81 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.82 0.819 . . . . 0.0 112.978 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.38 114.17 19.16 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.2 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -105.91 145.22 31.56 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.566 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -80.74 131.54 35.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.33 -19.35 62.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.969 0.414 . . . . 0.0 110.815 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.5 m -59.58 -45.58 91.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.719 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.3 m -117.1 -11.82 10.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.2 23.39 78.03 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -102.36 148.21 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.684 0.278 . . . . 0.0 110.662 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.0 t -75.88 102.7 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.039 0.447 . . . . 0.0 110.691 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -75.5 -36.32 60.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.868 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -125.89 148.18 49.27 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.624 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.565 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.8 p30 -158.81 96.38 1.36 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 72' ' ' ASP . 29.5 mt -125.48 132.53 52.65 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.986 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.474 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.7 mt -73.98 129.03 36.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.177 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.662 HG21 ' SG ' ' A' ' 80' ' ' CYS . 22.9 mm -116.61 120.18 64.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.277 0.561 . . . . 0.0 110.62 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.497 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.4 m-85 -84.37 160.51 56.75 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.244 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 140.09 92.53 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.679 1.586 . . . . 0.0 111.041 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 61.37 11.15 3.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.032 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -85.07 -27.67 26.16 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.653 0.263 . . . . 0.0 110.72 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.693 ' SG ' HD11 ' A' ' 96' ' ' LEU . 13.9 p -145.1 164.75 30.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.255 0.55 . . . . 0.0 110.235 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 2.7 tt0 -132.02 121.86 24.56 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.111 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' HG11 ' A' ' 124' ' ' VAL . 44.8 t80 -97.11 119.33 35.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -148.12 166.88 26.5 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.788 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.7 ptp180 -83.85 159.79 21.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.162 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 87' ' ' GLN . 48.8 t -109.39 95.82 20.18 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.093 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.77 60.25 7.61 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.99 1.793 . . . . 0.0 112.428 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.44 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -114.51 -41.68 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.393 178.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.0 t -129.24 81.14 71.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.56 130.76 27.45 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.874 1.716 . . . . 0.0 111.646 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 169.68 -41.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.94 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -132.31 -150.06 6.43 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.99 105.74 13.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.814 0.34 . . . . 0.0 110.517 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.26 127.49 72.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 110.71 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -127.57 152.63 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.367 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.8 p -129.62 139.96 50.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.615 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.693 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.1 tp -99.95 116.7 32.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -103.31 106.74 17.32 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 103' ' ' LYS . 53.1 m-85 -74.27 106.33 5.86 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 98.8 mttt -61.24 -37.37 82.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.233 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.72 -22.92 12.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.726 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.66 81.32 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.639 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.7 m 58.6 18.04 5.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 110.992 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.439 ' CD ' HD21 ' A' ' 105' ' ' LEU . 4.0 ttmt -117.15 152.0 35.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.504 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -128.56 135.5 49.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.858 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 95' ' ' VAL . 59.5 mt -118.53 148.19 42.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.479 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.4 m-85 -117.2 134.49 54.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.844 0.354 . . . . 0.0 111.097 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 156.44 46.88 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.219 0.533 . . . . 0.0 111.152 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -135.37 136.55 41.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.601 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.2 ttm -73.56 132.57 42.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.168 0.509 . . . . 0.0 111.372 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.94 3.14 25.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.969 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.12 142.31 92.77 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.84 -28.45 36.31 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.903 1.735 . . . . 0.0 112.674 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.41 141.92 51.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.987 0.422 . . . . 0.0 110.267 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -98.28 10.64 40.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.45 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -54.27 -24.16 17.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.296 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -119.41 6.39 11.13 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.241 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -61.71 -46.16 90.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.919 0.39 . . . . 0.0 110.748 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.66 -41.08 98.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.187 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.76 -43.34 96.68 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.551 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.732 ' O ' HG23 ' A' ' 124' ' ' VAL . 61.4 m170 -64.06 -41.09 97.48 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.79 -41.14 97.99 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.122 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.05 -42.84 79.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.494 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -64.26 -40.48 96.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.306 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -57.68 -49.06 81.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.766 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -65.33 -39.2 92.09 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.126 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -72.34 -26.18 61.83 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.496 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -88.12 -26.27 22.57 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.796 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.4 mt -94.21 -17.56 22.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.178 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -115.06 -22.39 9.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.202 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -134.44 72.18 70.64 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.053 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.81 151.47 64.19 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.806 2.337 . . . . 0.0 112.123 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.55 ' HD2' HD11 ' A' ' 57' ' ' ILE . 51.1 Cg_exo . . . . . 0 N--CA 1.494 1.503 0 C-N-CA 122.451 2.101 . . . . 0.0 112.127 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.24 152.19 79.03 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.773 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.7 147.81 25.12 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.798 2.332 . . . . 0.0 112.024 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -82.42 154.02 68.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.228 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.17 150.95 82.02 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.141 1.894 . . . . 0.0 112.086 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.07 163.71 36.09 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.73 2.287 . . . . 0.0 112.38 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -81.75 156.33 70.32 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.781 ' HB3' HG22 ' A' ' 39' ' ' THR . 21.4 Cg_endo -62.31 151.39 82.75 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.471 2.114 . . . . 0.0 112.124 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -151.76 164.04 37.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 111.087 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -85.65 134.68 33.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.453 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -117.94 132.48 56.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.536 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.1 mt -132.26 128.68 58.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.52 85.35 3.22 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.913 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.349 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -61.63 158.7 14.73 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -138.9 148.92 23.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.242 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -92.66 120.87 33.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.605 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -106.69 110.17 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.372 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -88.66 126.39 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.76 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.83 HG22 HD23 ' C' ' 69' ' ' LEU . 82.0 p -88.31 174.26 8.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 111.196 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.677 HD11 ' H ' ' C' ' 71' ' ' LEU . 80.6 mt -62.69 -37.09 85.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -69.01 -11.41 60.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.603 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.77 -12.21 62.67 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -65.66 127.77 33.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.142 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.8 m -100.77 131.05 46.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.296 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.439 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -122.89 116.61 49.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.46 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 27.2 m -84.05 130.32 34.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.621 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' C' ' 33' ' ' LYS . 94.0 mt -123.76 123.1 39.76 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.656 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.17 112.42 5.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.769 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.444 HG12 ' HE3' ' C' ' 29' ' ' LYS . 30.8 m -135.26 162.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.728 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -104.72 153.83 38.98 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.635 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.62 -35.64 93.22 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.056 1.837 . . . . 0.0 112.102 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 86.9 p -84.89 -5.74 59.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.105 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -59.56 136.96 58.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.012 0.434 . . . . 0.0 110.823 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -76.98 160.84 28.83 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.612 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' C' ' 50' ' ' LEU . 46.8 mm -64.41 -39.38 85.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.232 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.56 -40.78 88.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.89 -41.71 98.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.103 0.478 . . . . 0.0 110.612 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.418 HG22 HG11 ' C' ' 17' ' ' VAL . 57.2 t -63.23 -42.78 97.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.544 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.632 ' HG3' HD11 ' C' ' 43' ' ' LEU . 4.1 mtpt -59.02 -40.93 86.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.69 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.31 91.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.265 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.444 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.4 mttm -60.05 -38.85 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.85 -39.54 83.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.266 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.71 -38.86 82.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.502 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -68.81 -50.85 46.79 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.108 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.439 ' HD2' HG22 ' C' ' 13' ' ' ILE . 21.7 mttt -63.77 -42.74 97.73 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.02 150.42 49.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.964 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.13 55.7 2.73 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.468 HG22 ' HG3' ' C' ' 41' ' ' GLN . 27.7 mm -109.86 114.97 55.93 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.17 153.99 66.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.639 1.559 . . . . 0.0 112.056 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.77 -38.01 66.25 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.143 1.895 . . . . 0.0 112.385 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.13 -39.92 94.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.893 0.378 . . . . 0.0 110.561 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -87.27 -9.44 54.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.468 ' HG3' HG22 ' C' ' 36' ' ' ILE . 85.1 mt-30 -80.9 88.95 5.85 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -99.11 105.27 17.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.689 ' CB ' HD12 ' C' ' 50' ' ' LEU . 21.5 mt -97.51 122.28 40.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.324 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.6 mt -128.72 123.09 58.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -112.48 114.51 27.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.447 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.97 49.94 20.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.079 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.4 27.84 73.58 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -127.75 102.96 7.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.924 0.393 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.09 132.07 51.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.689 HD12 ' CB ' ' C' ' 43' ' ' LEU . 41.9 mt -85.3 87.65 7.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.395 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.16 144.85 42.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 p-10 -59.63 165.68 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.621 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.95 8.09 87.85 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -127.03 173.56 9.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.572 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -123.52 170.5 10.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.838 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.5 -39.95 92.82 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.354 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.1 -30.59 71.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.87 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.05 -28.68 69.76 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.008 0.432 . . . . 0.0 110.422 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.415 ' CD2' HD23 ' C' ' 50' ' ' LEU . 57.7 m-85 -101.61 12.63 36.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.073 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.06 40.33 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.015 0.436 . . . . 0.0 110.355 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.5 mt -91.77 118.88 38.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.37 -179.25 3.9 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 111.046 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -63.58 149.67 45.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.733 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 59.86 18.73 7.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.216 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -74.44 129.15 37.23 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.29 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.545 ' C ' HD12 ' C' ' 67' ' ' LEU . 90.5 m -80.46 129.85 34.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.225 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.545 HD12 ' C ' ' C' ' 66' ' ' THR . 8.4 mp -119.26 144.48 46.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.367 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -90.39 114.18 26.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.284 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.83 HD23 HG22 ' C' ' 7' ' ' THR . 65.6 tp -101.88 120.5 40.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.896 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.537 ' HA ' HD21 ' C' ' 8' ' ' LEU . 89.5 t -118.6 132.9 67.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.955 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.677 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.2 mt -96.76 137.36 35.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.324 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -96.55 126.97 42.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.686 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 84.2 mt -112.32 139.29 47.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.962 0.41 . . . . 0.0 110.458 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 52.3 mmm-85 -63.18 -40.91 98.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.464 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.49 -41.41 99.78 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.57 -40.77 99.17 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.533 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -59.68 158.72 9.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -138.31 144.32 30.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.112 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.36 124.62 33.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.963 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.2 t -108.89 105.79 19.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.329 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.05 128.63 34.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.647 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -87.49 171.39 10.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.971 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.757 HD11 ' H ' ' D' ' 71' ' ' LEU . 83.9 mt -66.8 -29.15 69.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.303 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -78.09 -10.94 59.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.758 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 -12.66 56.08 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -66.48 125.55 26.05 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.232 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -98.11 135.27 40.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.291 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.47 109.93 21.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.565 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.0 m -84.9 129.3 34.83 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.45 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.643 HD21 ' HD2' ' D' ' 33' ' ' LYS . 89.0 mt -124.7 126.62 45.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.883 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -65.81 113.26 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.106 0.479 . . . . 0.0 110.454 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.698 HG12 ' HE3' ' D' ' 29' ' ' LYS . 15.3 m -134.75 167.26 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 O-C-N 121.933 -0.479 . . . . 0.0 110.056 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . 0.425 ' O ' HD12 ' D' ' 56' ' ' LEU . 79.2 mm-40 -111.77 154.17 44.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.613 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.36 -26.58 83.03 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.116 1.877 . . . . 0.0 112.045 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 92.1 p -89.97 -12.04 39.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.449 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.03 142.83 57.3 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.144 0.497 . . . . 0.0 111.043 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 72.3 p -81.96 164.24 21.62 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.056 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.784 HD12 HD23 ' D' ' 50' ' ' LEU . 47.4 mm -62.02 -37.79 79.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.2 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -58.5 -40.32 82.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -61.37 -41.41 97.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.108 0.48 . . . . 0.0 110.242 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.437 HG21 HD21 ' D' ' 56' ' ' LEU . 78.7 t -64.02 -42.51 95.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.574 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.83 -41.04 90.49 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.85 -38.84 89.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.331 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.698 ' HE3' HG12 ' D' ' 17' ' ' VAL . 64.6 mttm -60.45 -40.11 89.96 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.785 ' CD1' HD21 ' D' ' 43' ' ' LEU . 79.6 mt -63.8 -41.48 92.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.699 178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -59.82 -50.96 71.76 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.888 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -57.26 -24.05 52.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.643 ' HD2' HD21 ' D' ' 15' ' ' LEU . 11.6 mttm -96.9 -61.32 1.43 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -88.62 -25.39 22.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.907 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.27 11.54 64.48 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 119.716 -1.23 . . . . 0.0 110.385 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.09 121.49 80.67 Favored Pre-proline 0 N--CA 1.449 -0.497 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.908 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.29 149.36 55.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.519 1.48 . . . . 0.0 111.709 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.42 -41.75 65.25 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.889 1.726 . . . . 0.0 112.64 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -70.06 -40.59 74.98 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.791 -0.363 . . . . 0.0 110.911 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -62.98 -39.18 93.94 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.788 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.84 ' HB2' HD11 ' D' ' 69' ' ' LEU . 0.0 OUTLIER -97.24 147.25 24.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.781 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -131.79 125.85 32.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.7 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.785 HD21 ' CD1' ' D' ' 30' ' ' ILE . 72.9 mt -91.41 122.67 34.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.482 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.431 HG21 ' HE1' ' A' ' 76' ' ' PHE . 81.9 mt -128.3 126.8 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.255 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -141.86 149.72 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.378 . . . . 0.0 110.805 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.58 20.12 11.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.37 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.38 86.22 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.807 ' HG2' HD22 ' A' ' 73' ' ' LEU . 99.0 mtt180 -114.23 140.7 48.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.846 0.355 . . . . 0.0 110.863 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -75.48 119.39 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.716 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.813 HD21 HD11 ' D' ' 61' ' ' ILE . 9.6 mp -74.42 95.64 2.75 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.865 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -75.9 163.61 27.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.48 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.03 159.38 32.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.5 18.78 63.39 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -128.01 162.21 27.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.618 0.246 . . . . 0.0 110.576 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -113.43 160.81 18.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.399 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.437 HD21 HG21 ' D' ' 26' ' ' VAL . 78.2 mt -61.32 -40.11 92.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.688 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -63.34 -24.7 67.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 0.0 110.394 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -62.87 -37.46 86.99 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.091 0.472 . . . . 0.0 110.281 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -96.12 12.74 29.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.077 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 61.6 t30 57.15 40.37 28.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.005 0.431 . . . . 0.0 110.446 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . 0.813 HD11 HD21 ' D' ' 50' ' ' LEU . 69.9 mt -86.98 108.91 18.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.055 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -94.58 -179.43 4.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.275 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -61.66 145.37 52.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.481 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 61.75 36.28 16.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.746 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . 0.562 ' O ' HD12 ' D' ' 67' ' ' LEU . 28.9 t -87.28 123.78 32.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.226 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 50.8 m -78.44 124.22 27.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.562 HD12 ' O ' ' D' ' 65' ' ' SER . 4.9 mp -117.8 143.31 46.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.187 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -87.97 123.03 32.28 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.84 HD11 ' HB2' ' D' ' 41' ' ' GLN . 48.6 tp -103.42 109.6 21.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.706 HG11 HD11 ' A' ' 56' ' ' LEU . 52.5 t -98.31 134.28 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.757 ' H ' HD11 ' D' ' 8' ' ' LEU . 81.9 mt -107.86 147.36 31.04 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.642 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -129.74 154.18 47.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.41 129.2 54.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.447 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -55.5 137.9 47.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.744 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.87 -153.41 19.16 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.896 0 N-CA-C 111.449 -0.66 . . . . 0.0 111.449 -179.86 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.0 m120 . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.19 148.37 27.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.254 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -90.58 110.83 21.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.126 0.489 . . . . 0.0 109.694 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.416 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.3 mt -65.58 -38.45 89.58 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.649 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG12 ' HB ' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -149.19 162.51 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.163 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.08 122.35 0.31 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.133 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -155.01 156.69 36.41 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.92 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.62 ' HA ' HD12 ' A' ' 46' ' ' LEU . 89.7 mtm180 -71.89 123.81 23.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.53 143.71 18.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.188 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.89 153.11 16.92 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -91.73 170.98 9.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.87 0.367 . . . . 0.0 111.416 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.419 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 20.4 mtp -136.83 175.27 9.77 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.14 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.08 124.44 41.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 37' ' ' THR . 28.6 tp -106.08 117.89 35.21 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.446 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -121.46 110.48 16.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.057 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.2 -87.89 0.58 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.7 p -143.32 22.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.54 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.2 m -125.59 131.49 52.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.428 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' CG2' HD13 ' A' ' 33' ' ' LEU . 80.3 t -109.66 122.34 64.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.008 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.0 p -113.35 132.33 22.52 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.315 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.05 144.25 46.73 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.147 1.898 . . . . 0.0 113.046 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.27 121.93 41.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.507 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -64.52 -12.52 45.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.851 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -73.17 74.48 1.27 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 mtpp -54.99 135.32 48.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.898 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.08 -154.3 7.45 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 27' ' ' ARG . 1.8 tp -142.52 125.54 16.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.3 t -95.87 108.14 20.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -130.64 154.36 47.98 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.068 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.42 ' HB ' HG12 ' A' ' 24' ' ' VAL . 91.4 mt -121.67 140.55 45.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.582 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -142.74 142.65 31.99 Favored 'General case' 0 C--O 1.223 -0.327 0 O-C-N 123.48 0.488 . . . . 0.0 110.191 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -105.84 128.28 53.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.285 0.564 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 58' ' ' HIS . 23.3 p -87.84 172.06 9.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.606 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.89 -10.68 22.15 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.72 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -85.51 -1.1 56.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.452 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 t 70.14 20.43 6.36 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.132 0.491 . . . . 0.0 110.962 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.706 HD11 HG11 ' D' ' 70' ' ' VAL . 63.8 mt -104.15 127.54 51.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 23' ' ' LEU . 43.4 mm -80.18 128.17 38.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.8 m-70 -105.08 116.62 32.26 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.551 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -98.02 107.27 19.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 147.2 47.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.822 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -119.94 111.64 18.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.899 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -102.03 134.45 45.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.279 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -75.7 137.57 40.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.864 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -78.49 -16.8 57.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.9 m -60.97 -45.62 94.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.501 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.3 m -117.07 -16.63 10.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.065 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.24 70.32 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.5 p-10 -101.07 152.86 20.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.3 t -79.4 102.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.986 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -75.87 -37.53 58.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -126.65 145.58 50.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.985 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.3 t0 -159.17 100.71 1.55 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.328 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.807 HD22 ' HG2' ' D' ' 48' ' ' ARG . 23.7 mt -127.25 139.4 52.94 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 120.789 0.328 . . . . 0.0 110.386 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.7 mt -77.72 127.23 38.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 80' ' ' CYS . 29.6 mm -113.86 125.81 71.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.924 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.567 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 72.6 m-85 -96.28 159.48 31.93 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.939 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.32 140.25 93.69 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.016 1.811 . . . . 0.0 111.348 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 62.34 13.18 5.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.031 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -95.44 -35.75 11.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.058 0.456 . . . . 0.0 110.778 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -136.46 147.12 47.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -121.49 128.91 52.57 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.194 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -104.16 116.78 32.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -139.87 168.25 20.26 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.878 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -85.12 160.97 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.41 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.1 t -115.15 88.97 18.96 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.458 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.19 59.81 7.59 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.266 1.977 . . . . 0.0 112.005 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -114.5 -45.44 3.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.736 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.2 t -120.74 95.56 48.94 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.442 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.87 130.08 18.58 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.758 1.638 . . . . 0.0 111.658 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 167.93 -29.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.612 0.57 . . . . 0.0 110.315 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.7 -171.42 24.52 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.06 111.92 22.76 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.056 0.455 . . . . 0.0 110.485 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.24 130.3 72.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -128.87 155.55 45.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.565 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.3 p -129.68 133.36 65.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.031 0.443 . . . . 0.0 110.464 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.471 HD11 ' SG ' ' A' ' 80' ' ' CYS . 68.5 tp -100.74 119.83 39.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -119.01 129.6 55.22 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.474 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.468 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 54.3 m-85 -87.66 116.5 25.84 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.62 -33.43 72.77 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.474 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.93 -19.04 10.55 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.359 -0.536 . . . . 0.0 111.191 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -75.61 -18.75 79.64 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.7 m 58.75 27.69 16.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.62 ' HD3' HD21 ' A' ' 105' ' ' LEU . 15.7 ttmt -121.72 149.7 42.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.415 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.416 ' O ' HD23 ' A' ' 105' ' ' LEU . 94.5 mtt-85 -133.19 130.91 39.74 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.267 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.62 HD21 ' HD3' ' A' ' 103' ' ' LYS . 43.8 mt -120.99 148.87 43.51 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.474 ' CE1' HD22 ' A' ' 33' ' ' LEU . 93.8 m-85 -119.8 135.32 54.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.4 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -138.47 153.26 48.82 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -128.46 134.7 48.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.561 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 40.0 mtp -77.62 139.01 39.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.967 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -100.82 7.76 43.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.043 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.38 134.21 86.93 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.522 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.2 -25.9 36.57 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.029 1.819 . . . . 0.0 112.744 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.05 143.13 49.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.943 0.401 . . . . 0.0 110.328 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.6 p -89.38 -1.05 57.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.97 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -59.22 -18.53 37.63 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.252 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -116.86 -17.38 10.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.654 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -61.42 -41.76 97.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.64 -40.61 95.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.082 0.467 . . . . 0.0 111.047 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -66.04 -41.67 90.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.503 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 124' ' ' VAL . 62.5 m170 -62.41 -40.85 97.85 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.9 t -62.94 -43.26 99.28 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.04 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -67.73 -42.6 81.61 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.545 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.88 -43.02 97.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.656 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.7 t -57.38 -47.64 84.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.822 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -64.98 -39.46 93.51 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.048 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -72.69 -22.13 60.95 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.423 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -90.91 -26.87 19.1 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.809 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.8 mt -96.94 -16.22 20.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.113 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -118.04 -19.5 9.08 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.533 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -135.77 67.2 64.42 Favored Pre-proline 0 CA--C 1.519 -0.224 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.851 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.73 153.79 72.48 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 C-N-CA 122.459 2.106 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--N 1.312 -1.342 0 C-N-CA 122.545 2.163 . . . . 0.0 112.174 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -130.26 150.58 76.55 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.906 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.32 145.27 26.93 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.698 2.265 . . . . 0.0 112.129 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.54 154.96 85.69 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.478 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.4 158.98 52.92 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.159 1.906 . . . . 0.0 112.451 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.54 -178.69 3.53 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.882 2.388 . . . . 0.0 111.935 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -115.33 158.89 40.2 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.661 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.67 141.79 83.44 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.069 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -153.68 164.11 38.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.765 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -86.2 139.48 31.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.972 0.415 . . . . 0.0 110.566 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -124.82 130.24 51.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 951' ' ' ILE . 3.0 mp -131.48 126.71 58.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.646 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -74.58 83.65 2.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.729 -0.788 . . . . 0.0 110.116 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.539 179.644 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . 0.416 ' OE1' HG21 ' C' ' 14' ' ' THR . 12.8 pt20 -62.48 160.96 12.63 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.058 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.59 153.9 31.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.277 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.461 ' CD1' HG23 ' C' ' 14' ' ' THR . 11.2 m-30 -96.61 124.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.681 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.2 t -111.12 113.56 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.532 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -86.93 131.46 34.09 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -91.13 177.39 6.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.024 0.44 . . . . 0.0 110.719 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' C' ' 70' ' ' VAL . 92.6 mt -60.99 -37.59 83.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.788 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 30.8 p -76.42 -6.44 51.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.007 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.79 -8.48 73.79 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -62.08 129.26 40.02 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.3 m -102.05 131.66 48.38 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.581 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -120.87 108.59 23.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.342 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . 0.461 HG23 ' CD1' ' C' ' 4' ' ' PHE . 9.6 m -77.0 129.62 36.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.229 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.1 mt -124.28 123.9 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.619 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -69.57 115.48 8.87 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.834 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.416 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.2 m -137.67 164.79 27.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.619 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -106.77 154.28 40.23 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.97 -35.74 94.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.786 1.657 . . . . 0.0 111.968 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.8 p -82.78 -6.6 59.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.291 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -59.6 135.23 57.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.864 0.364 . . . . 0.0 110.803 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 44.4 p -78.61 163.34 25.56 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.213 0.53 . . . . 0.0 110.966 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.498 HD12 HD23 ' C' ' 50' ' ' LEU . 48.1 mm -63.48 -38.65 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.267 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -59.17 -42.79 91.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.041 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -62.15 -41.15 98.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.199 0.523 . . . . 0.0 110.561 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.435 HG21 HD21 ' C' ' 56' ' ' LEU . 58.4 t -63.44 -42.85 97.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.789 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.418 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.6 mtmt -61.24 -39.39 90.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.271 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.15 -40.73 94.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.259 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.484 ' HB3' HD22 ' C' ' 15' ' ' LEU . 67.3 mttm -60.66 -39.68 89.27 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -65.19 -40.01 87.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.98 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.41 -39.57 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.305 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -66.21 -43.36 86.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.393 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.553 ' HG3' HD21 ' C' ' 15' ' ' LEU . 11.5 mttm -71.4 -40.25 70.63 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -132.76 155.76 48.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.002 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.58 64.75 1.78 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.746 HG22 ' HG2' ' C' ' 41' ' ' GLN . 33.0 mm -116.36 98.75 51.99 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.71 150.76 74.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.624 1.55 . . . . 0.0 112.016 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.23 -25.19 12.84 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.392 2.061 . . . . 0.0 112.39 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -90.08 31.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.554 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -167.23 31.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.814 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' C' ' 36' ' ' ILE . 0.9 OUTLIER -123.36 97.81 5.57 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.64 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -97.08 107.16 19.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.497 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.418 HD11 ' HG2' ' C' ' 27' ' ' LYS . 60.6 mt -102.9 120.87 41.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.222 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 95.1 mt -128.78 129.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.705 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -120.43 118.66 30.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.04 32.53 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.88 -0.68 88.1 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.768 ' HE3' HD22 ' D' ' 73' ' ' LEU . 20.0 tptt -95.81 112.87 24.49 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -66.44 129.48 39.97 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.03 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.498 HD23 HD12 ' C' ' 23' ' ' ILE . 7.3 mp -76.9 88.0 3.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.333 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.25 138.34 51.55 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.13 145.52 46.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.328 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.72 60.49 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -93.1 170.31 9.74 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 65.2 p -113.39 167.12 10.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.389 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.435 HD21 HG21 ' C' ' 26' ' ' VAL . 84.7 mt -62.14 -39.86 94.0 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.3 p -63.09 -27.29 69.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.245 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.93 -35.96 79.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.009 0.433 . . . . 0.0 110.074 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.794 ' CZ ' HD11 ' D' ' 73' ' ' LEU . 59.1 m-85 -95.5 14.45 22.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.089 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.03 40.28 30.34 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.941 0.401 . . . . 0.0 110.218 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.4 mt -92.16 110.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.541 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -99.25 -170.26 1.89 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.029 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -65.03 145.78 55.88 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.513 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 57.24 41.02 27.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.035 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -91.7 122.19 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.103 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 63.8 m -72.61 127.13 31.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.204 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 80.7 mt -118.79 147.25 44.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.195 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.23 113.18 25.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.271 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.7 tp -102.5 119.84 39.51 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.683 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.71 ' HA ' HD21 ' C' ' 8' ' ' LEU . 95.9 t -121.15 133.75 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.194 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.558 ' H ' HD11 ' C' ' 8' ' ' LEU . 25.1 mt -102.68 133.84 47.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.376 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -86.93 136.7 32.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.412 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.85 118.0 35.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.395 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 54.33 39.11 30.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.403 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.31 146.24 45.59 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.55 -172.61 38.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 66.6 t0 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.349 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -62.04 159.31 14.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.095 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.47 ' HB ' HD13 ' D' ' 67' ' ' LEU . 10.5 pt -139.31 148.49 23.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.808 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.412 ' CD2' HG23 ' D' ' 14' ' ' THR . 13.7 m-30 -91.95 113.92 26.31 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.898 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 64.1 t -97.88 108.94 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.641 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -94.92 121.87 36.98 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.752 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.766 HG22 HD23 ' D' ' 69' ' ' LEU . 82.1 p -81.02 172.99 13.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.649 HD11 ' H ' ' D' ' 71' ' ' LEU . 87.9 mt -59.99 -36.14 76.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.819 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.5 p -69.77 -10.96 60.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.941 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 -9.84 66.47 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -64.61 126.83 29.12 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -100.68 132.2 46.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.556 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -125.65 109.16 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.904 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.412 HG23 ' CD2' ' D' ' 4' ' ' PHE . 22.3 m -78.95 128.37 33.2 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.486 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' D' ' 33' ' ' LYS . 94.8 mt -124.32 121.83 36.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.389 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -67.03 113.71 5.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.306 0.574 . . . . 0.0 111.146 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.402 HG12 ' HE2' ' D' ' 29' ' ' LYS . 25.7 m -136.63 162.01 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.463 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -103.8 153.39 38.77 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.57 -39.34 91.64 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.873 1.715 . . . . 0.0 111.955 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -79.59 -8.75 59.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.083 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -58.24 135.6 57.15 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.953 0.406 . . . . 0.0 110.852 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -76.15 161.78 28.54 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.879 HD12 HD23 ' D' ' 50' ' ' LEU . 46.3 mm -64.3 -38.43 82.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.929 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -58.85 -42.77 90.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.046 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.28 -42.04 99.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.131 0.491 . . . . 0.0 110.838 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 63.4 t -62.13 -43.5 97.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.261 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.23 -38.75 87.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.54 93.52 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.854 -0.339 . . . . 0.0 110.411 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.517 ' HB3' HD22 ' D' ' 15' ' ' LEU . 13.7 mttp -59.68 -39.12 83.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.856 ' CD1' HD21 ' D' ' 43' ' ' LEU . 93.1 mt -65.88 -39.98 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.336 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.26 -39.41 82.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.953 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -68.49 -51.04 47.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.759 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.551 ' HD2' HD21 ' D' ' 15' ' ' LEU . 65.9 mttt -65.17 -40.85 94.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -128.77 147.47 50.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.18 60.53 2.7 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -110.73 106.31 57.65 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -58.99 154.88 41.99 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.062 1.842 . . . . 0.0 111.766 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.29 -28.46 79.91 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.365 2.043 . . . . 0.0 112.781 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.84 -10.21 58.96 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.981 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.74 -52.93 3.44 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.062 0.458 . . . . 0.0 110.68 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.558 ' CB ' HD11 ' D' ' 69' ' ' LEU . 0.6 OUTLIER -66.24 116.36 7.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.356 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -116.23 103.65 10.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.56 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.856 HD21 ' CD1' ' D' ' 30' ' ' ILE . 80.3 mt -78.79 129.06 34.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.309 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' D' ' 49' ' ' GLN . 55.0 mt -133.83 130.55 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.615 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 55.3 t80 -151.14 157.19 42.4 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.945 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.47 20.34 8.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.668 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.73 -6.09 75.61 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -129.16 150.06 50.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.128 0.49 . . . . 0.0 111.04 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.6 ' HA ' HG23 ' D' ' 44' ' ' ILE . 24.0 pt20 -69.89 142.47 53.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.455 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.879 HD23 HD12 ' D' ' 23' ' ' ILE . 8.1 mp -81.55 112.95 19.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 -179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.31 138.23 41.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.947 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -58.46 150.12 23.37 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.251 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.45 -13.71 64.62 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -84.85 -178.59 6.89 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 120.936 0.398 . . . . 0.0 110.758 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 60.4 p -126.54 162.29 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.099 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.72 -39.56 94.45 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.281 -0.567 . . . . 0.0 110.68 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -63.75 -28.34 69.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.48 -34.59 75.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.149 0.499 . . . . 0.0 110.029 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -97.84 12.37 34.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.432 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 32.4 m120 55.73 39.78 30.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.888 0.375 . . . . 0.0 110.23 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . 0.715 HD11 HD21 ' D' ' 50' ' ' LEU . 75.9 mt -86.59 106.8 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.836 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -92.35 177.19 6.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.629 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -61.33 150.26 35.59 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.347 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 61.73 13.07 5.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.935 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 43.6 m -70.75 136.3 48.8 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 91.4 m -86.31 119.94 27.12 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.83 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.52 HD21 HD13 ' D' ' 61' ' ' ILE . 7.6 mp -110.4 125.31 53.1 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.285 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -75.22 133.06 41.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.308 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.766 HD23 HG22 ' D' ' 7' ' ' THR . 69.2 tp -112.56 115.84 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.1 t -103.94 129.08 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.649 ' H ' HD11 ' D' ' 8' ' ' LEU . 47.8 mt -96.78 124.95 40.91 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.309 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 73.8 mtp85 -95.86 140.84 30.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.008 0.432 . . . . 0.0 110.848 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.794 HD11 ' CZ ' ' C' ' 59' ' ' TYR . 4.3 tt -76.92 131.65 38.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.176 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . 0.529 ' O ' HD23 ' D' ' 73' ' ' LEU . 56.0 mmm-85 -64.54 137.09 57.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.878 0.371 . . . . 0.0 110.505 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.61 2.23 90.45 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.582 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.727 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -84.1 150.4 25.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.097 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -91.67 112.36 24.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.155 0.502 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.4 mt -66.64 -37.43 84.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.7 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.438 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.3 p -150.29 162.16 3.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.743 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.58 122.92 0.36 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.816 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -153.7 159.81 42.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.253 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.472 ' HA ' HD12 ' A' ' 46' ' ' LEU . 77.3 mtp180 -75.89 118.82 19.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.675 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.37 22.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.23 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.48 158.51 14.7 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -92.97 156.4 16.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 35.6 mtp -122.65 171.05 9.43 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.1 m -122.95 120.33 33.1 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.263 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 38' ' ' VAL . 28.1 tp -106.57 117.72 34.8 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.202 0.525 . . . . 0.0 110.337 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -123.45 118.21 26.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.521 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.68 -98.27 0.6 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.7 p -135.0 22.58 3.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.52 0.2 . . . . 0.0 111.074 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 33' ' ' LEU . 87.1 m -124.37 130.76 53.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.77 0.319 . . . . 0.0 110.802 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 33' ' ' LEU . 59.9 t -109.15 124.46 65.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.644 HG22 ' HB3' ' B' ' 947' ' ' PRO . 21.7 p -124.03 118.21 26.88 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.09 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.5 148.38 66.64 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.541 1.494 . . . . 0.0 113.122 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.55 140.94 34.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.975 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -71.26 -7.37 46.51 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.947 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -70.01 78.52 0.49 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -57.24 133.76 55.35 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.55 -162.7 10.39 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.224 -0.989 . . . . 0.0 111.216 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.0 tp -136.08 124.27 23.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.18 110.59 24.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -132.55 154.13 50.29 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.388 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.438 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.9 mt -119.42 136.5 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.918 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.47 130.99 33.43 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.509 0.506 . . . . 0.0 110.288 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.462 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.9 tt0 -100.37 125.18 46.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.124 0.488 . . . . 0.0 109.986 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.501 HG23 ' CD2' ' A' ' 58' ' ' HIS . 15.1 p -84.78 172.17 11.69 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.575 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.54 -10.63 27.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.767 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.21 0.11 56.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.452 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t 70.66 21.32 5.38 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.148 0.499 . . . . 0.0 110.41 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD22 ' HE2' ' A' ' 76' ' ' PHE . 70.1 mt -99.28 123.67 43.75 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.525 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.9 mm -81.17 122.2 35.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.501 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.9 m-70 -99.01 114.56 27.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.719 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -96.54 109.08 21.74 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.9 142.99 51.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.407 -0.917 . . . . 0.0 113.229 -177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -114.71 116.53 28.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.458 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -106.42 133.25 51.4 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.04 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.489 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -72.03 -19.86 61.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.029 0.442 . . . . 0.0 110.583 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 47.2 m -60.09 -44.82 94.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.044 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.6 p -115.37 -15.49 11.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.059 0.457 . . . . 0.0 110.122 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.74 20.31 79.77 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -103.08 146.78 27.85 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.62 102.32 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.187 0.518 . . . . 0.0 109.824 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -73.17 -38.26 66.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -126.63 144.91 50.75 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.087 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.57 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.0 t0 -157.78 101.56 1.81 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.246 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 72' ' ' ASP . 37.2 mt -127.9 136.31 51.19 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.01 123.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 80' ' ' CYS . 27.9 mm -110.77 131.6 61.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.234 0.54 . . . . 0.0 111.169 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.537 ' HE2' HD22 ' A' ' 56' ' ' LEU . 57.2 m-85 -95.7 159.62 32.09 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.928 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.72 139.95 91.96 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.686 1.591 . . . . 0.0 111.23 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 61.68 11.2 3.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.334 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 100' ' ' ALA . 17.1 t70 -88.25 -22.53 23.9 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.178 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.703 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.5 p -147.93 164.91 32.28 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.519 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 99' ' ' LYS . 7.5 tt0 -137.7 127.27 25.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.58 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -97.05 121.39 38.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -144.93 163.47 34.06 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.544 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 -88.41 157.03 18.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.225 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -111.95 88.78 10.51 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.061 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.45 60.97 8.03 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.995 1.797 . . . . 0.0 112.028 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -112.99 -48.87 2.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.136 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.22 102.2 54.64 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.165 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.64 130.75 16.32 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 121.435 1.424 . . . . 0.0 111.691 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 168.22 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.937 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.74 -179.06 33.32 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.39 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.566 ' NE ' HG22 ' A' ' 114' ' ' THR . 0.5 OUTLIER -88.01 109.68 20.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 110.449 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.91 127.58 75.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.301 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.62 152.35 43.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.4 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 105' ' ' LEU . 11.6 p -130.03 140.48 48.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.0 110.557 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.21 122.49 40.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -109.34 110.08 21.14 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.942 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -73.62 105.1 4.8 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 81' ' ' GLU . 57.8 mttm -60.99 -37.78 83.66 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.036 -0.665 . . . . 0.0 110.611 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.621 ' HB3' ' OD1' ' A' ' 79' ' ' ASP . . . -97.66 -20.49 17.6 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.633 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.82 140.8 15.14 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -83.78 52.84 2.37 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.169 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.629 ' HD3' HD21 ' A' ' 105' ' ' LEU . 8.7 ttmt -140.22 144.32 36.47 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.961 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -130.94 138.45 49.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.181 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD21 ' HD3' ' A' ' 103' ' ' LYS . 55.5 mt -116.24 149.4 39.23 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.2 m-85 -118.92 134.82 54.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.766 0.317 . . . . 0.0 111.133 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -138.93 155.97 47.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.326 0.584 . . . . 0.0 111.259 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -133.28 138.48 46.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.492 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.3 tpp -73.17 129.04 37.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.331 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -5.7 19.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.482 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.84 146.35 97.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.448 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.34 -25.82 15.12 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.091 1.861 . . . . 0.0 112.882 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -119.7 141.96 48.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.948 0.404 . . . . 0.0 110.276 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.566 HG22 ' NE ' ' A' ' 92' ' ' ARG . 73.9 p -96.98 10.81 38.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.492 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -60.36 -20.43 59.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.499 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -125.92 6.75 7.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.423 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.63 -50.23 73.38 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.164 0.507 . . . . 0.0 110.769 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -65.22 -40.47 94.17 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.225 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.65 -44.64 96.59 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.89 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.79 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.5 m170 -64.59 -40.09 94.9 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.648 0.737 . . . . 0.0 109.498 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.0 m -64.2 -41.58 97.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.141 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -67.18 -41.79 85.33 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.513 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -64.97 -35.77 82.26 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.364 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 120' ' ' HIS . 61.3 t -59.54 -48.26 87.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.111 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -80.15 -30.23 38.92 Favored 'General case' 0 CA--C 1.509 -0.611 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.859 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -67.68 -37.92 83.0 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.551 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -81.03 -33.8 33.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.57 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.539 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.4 mt -77.79 -27.0 50.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.18 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -106.98 -23.3 12.38 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.386 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -140.08 67.74 33.83 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.132 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.68 160.86 46.96 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 122.997 2.465 . . . . 0.0 112.391 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 C--N 1.31 -1.496 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 -179.494 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 50.8 mp0 -71.37 149.15 93.85 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.713 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.65 146.03 53.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.598 2.199 . . . . 0.0 112.675 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.74 161.78 62.63 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.096 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.94 149.82 81.77 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.554 2.17 . . . . 0.0 112.238 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.33 163.08 39.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.443 2.095 . . . . 0.0 112.151 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -74.74 156.79 86.43 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.52 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.644 ' HB3' HG22 ' A' ' 39' ' ' THR . 44.8 Cg_exo -57.86 147.09 83.3 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.62 162.57 41.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.933 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -86.22 137.79 32.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.011 0.434 . . . . 0.0 110.722 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -115.72 127.64 55.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.92 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.8 mt -132.39 121.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -81.45 85.21 6.51 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.078 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 65.5 t0 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.296 179.714 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.9 ttp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -58.76 159.33 6.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.7 pt -140.22 141.52 33.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.274 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -85.28 124.06 31.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.75 112.26 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 tttm -96.82 119.73 35.85 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.876 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.656 HG22 ' CB ' ' C' ' 69' ' ' LEU . 29.9 p -112.56 178.61 4.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.172 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.481 ' C ' HG23 ' C' ' 9' ' ' THR . 2.4 mm? -45.04 159.7 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.239 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.481 HG23 ' C ' ' C' ' 8' ' ' LEU . 1.4 p 66.11 8.49 5.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.887 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.09 29.07 73.23 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -84.98 111.34 19.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.783 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m -96.4 131.57 42.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.955 0.407 . . . . 0.0 110.706 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.421 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -134.62 113.18 16.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.271 -179.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.4 m -85.8 131.96 34.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.175 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.726 HD21 ' HG3' ' C' ' 33' ' ' LYS . 25.9 mt -124.19 125.64 44.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.343 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.41 112.79 4.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 0.0 110.907 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.697 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.5 m -136.18 162.89 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.323 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -104.19 154.5 38.19 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.55 -37.22 95.31 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.947 1.765 . . . . 0.0 111.979 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -79.56 -7.88 58.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.024 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.13 135.35 53.06 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.981 0.419 . . . . 0.0 110.865 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 66.7 p -78.25 161.58 27.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.941 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' C' ' 50' ' ' LEU . 47.9 mm -64.76 -41.38 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.066 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -58.93 -36.17 74.32 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.083 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.02 -41.28 95.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.32 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.459 HG21 HD21 ' C' ' 56' ' ' LEU . 58.9 t -63.81 -42.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.468 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.589 ' HG2' HD11 ' C' ' 43' ' ' LEU . 56.3 mtmt -60.81 -40.93 94.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.603 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.88 -40.11 94.26 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.958 0.409 . . . . 0.0 110.478 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.697 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.0 mttm -60.21 -39.07 85.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.341 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.73 HD13 ' CD1' ' C' ' 69' ' ' LEU . 96.6 mt -66.92 -39.07 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.165 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -58.7 -40.96 85.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.244 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.22 -41.92 72.99 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.726 ' HG3' HD21 ' C' ' 15' ' ' LEU . 11.6 mmtt -66.09 -42.34 89.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.924 0.392 . . . . 0.0 112.039 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -136.83 154.98 50.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.992 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 57.07 3.09 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.631 HG22 ' HG3' ' C' ' 41' ' ' GLN . 28.8 mm -109.8 106.26 58.12 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.81 153.41 56.78 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.707 1.605 . . . . 0.0 111.672 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.74 -39.56 76.52 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.015 1.81 . . . . 0.0 112.366 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.35 -39.09 91.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 0.0 110.322 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -86.58 -6.48 58.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.204 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.631 ' HG3' HG22 ' C' ' 36' ' ' ILE . 19.2 mt-30 -88.24 77.43 8.25 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.978 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -84.11 107.81 16.67 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.632 ' CB ' HD12 ' C' ' 50' ' ' LEU . 17.3 mt -99.16 119.26 37.57 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.009 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.1 mt -126.51 127.75 70.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.354 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -130.41 129.65 43.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.86 25.59 15.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.66 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.14 2.69 90.59 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.517 ' HE3' HD22 ' D' ' 73' ' ' LEU . 26.6 mtpp -108.14 126.17 52.46 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 122.538 -0.39 . . . . 0.0 109.978 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -72.08 133.58 45.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.209 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.632 HD12 ' CB ' ' C' ' 43' ' ' LEU . 69.1 mt -77.23 102.91 6.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 110.287 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.22 139.96 42.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.946 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -61.56 137.08 58.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.241 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.36 -17.37 55.64 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -83.4 -179.96 7.51 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.828 0.346 . . . . 0.0 110.359 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.2 p -127.32 165.41 19.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.148 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.459 HD21 HG21 ' C' ' 26' ' ' VAL . 84.3 mt -62.0 -40.09 94.46 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -63.45 -27.6 69.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.007 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.53 -35.23 77.13 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 109.894 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -97.68 12.88 32.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.244 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 56.68 41.46 28.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 88.3 mt -90.26 109.17 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.06 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -93.28 -176.08 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.504 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -66.05 148.14 52.27 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.34 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 58.21 41.11 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 42.8 m -93.68 125.07 38.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.258 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.47 ' C ' HD12 ' C' ' 67' ' ' LEU . 41.7 m -75.76 128.83 36.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.831 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.47 HD12 ' C ' ' C' ' 66' ' ' THR . 9.1 mp -115.64 152.05 33.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.318 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -101.83 112.62 25.3 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.73 ' CD1' HD13 ' C' ' 30' ' ' ILE . 0.7 OUTLIER -104.91 128.61 53.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.448 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -124.46 136.12 61.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.151 0.501 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mt -97.78 153.5 18.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.366 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -99.0 129.8 45.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.902 0.382 . . . . 0.0 110.425 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 86.6 mt -122.02 147.03 46.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.616 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 -60.44 -43.88 96.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.785 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -171.95 173.05 45.05 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.13 -177.06 47.23 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 33.7 t0 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.547 179.917 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -62.26 160.0 13.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.697 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.442 HD12 HD22 ' D' ' 67' ' ' LEU . 15.2 pt -142.83 146.93 21.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -95.34 123.27 38.78 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.755 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.747 HG11 HD11 ' D' ' 30' ' ' ILE . 83.8 t -104.96 110.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.44 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mtmt -97.8 132.69 43.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.524 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.0 p -88.27 -178.32 5.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.062 0.458 . . . . 0.0 111.081 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.617 HD11 ' H ' ' D' ' 71' ' ' LEU . 83.8 mt -61.92 -37.02 83.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.302 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 37.9 p -73.72 -9.6 58.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.884 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.71 -6.45 67.47 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.654 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -59.07 121.79 12.16 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -100.66 133.11 45.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.046 0.45 . . . . 0.0 110.902 -178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.76 108.44 17.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.87 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 129.47 34.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.092 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' D' ' 29' ' ' LYS . 66.9 mt -127.35 126.3 42.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.541 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.1 114.63 10.41 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.35 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.652 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.0 m -135.71 164.14 33.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.716 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -110.68 155.62 41.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.051 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.02 -36.59 96.26 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.087 1.858 . . . . 0.0 111.763 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -77.45 -10.06 59.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.046 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -57.76 137.2 56.78 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.715 0.293 . . . . 0.0 110.852 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -78.84 160.97 27.08 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.753 HD12 HD23 ' D' ' 50' ' ' LEU . 43.6 mm -63.3 -43.02 98.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.185 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -59.93 -34.51 73.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.257 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -64.92 -42.71 94.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.138 0.494 . . . . 0.0 110.71 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.553 HG21 HD21 ' D' ' 56' ' ' LEU . 69.1 t -62.36 -43.22 97.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.549 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -61.24 -38.85 88.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.332 0.587 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.56 87.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.059 0.457 . . . . 0.0 109.796 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.652 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -60.03 -37.18 79.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.747 HD11 HG11 ' D' ' 5' ' ' VAL . 6.2 mm -62.85 -39.46 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.89 178.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.2 -45.27 93.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.512 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.82 -38.22 90.27 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.783 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.416 ' HG3' HD21 ' D' ' 15' ' ' LEU . 23.5 mttm -90.19 -4.4 57.26 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -148.1 -47.49 0.16 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.811 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 8.41 32.79 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 52.2 mt -80.42 120.69 80.12 Favored Pre-proline 0 N--CA 1.448 -0.541 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.43 156.98 62.68 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.259 1.306 . . . . 0.0 111.419 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -51.85 -36.04 61.73 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.163 1.908 . . . . 0.0 112.429 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -67.37 -46.02 74.56 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.628 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -64.54 -40.32 95.39 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.031 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.4 ' HB2' HD11 ' D' ' 69' ' ' LEU . 2.0 pt20 -98.68 151.03 21.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.37 0.605 . . . . 0.0 111.424 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -133.34 118.05 18.03 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.499 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.652 HD23 HD12 ' D' ' 69' ' ' LEU . 66.2 mt -86.15 122.29 29.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.587 HD12 HG21 ' D' ' 70' ' ' VAL . 83.9 mt -125.19 130.24 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.745 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 71.4 t80 -153.45 156.22 37.77 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.859 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.32 19.03 9.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.719 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -6.74 74.22 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -126.79 149.76 49.49 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 110.598 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -73.71 137.07 43.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.474 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.766 HD21 HD11 ' D' ' 61' ' ' ILE . 8.2 mp -83.53 112.2 19.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.841 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -75.23 175.93 7.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.734 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -67.28 162.89 21.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.454 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.17 -151.08 41.61 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 51.69 179.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.334 0.588 . . . . 0.0 111.462 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 71.8 p -131.69 170.31 14.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.553 HD21 HG21 ' D' ' 26' ' ' VAL . 84.8 mt -61.68 -39.63 92.13 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.401 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -65.37 -27.36 68.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.075 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.01 -28.08 69.85 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.137 0.494 . . . . 0.0 110.067 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -103.49 14.73 30.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.326 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 57.02 39.46 29.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.597 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . 0.766 HD11 HD21 ' D' ' 50' ' ' LEU . 81.2 mt -88.69 117.04 31.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.078 0.466 . . . . 0.0 110.136 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -101.18 176.51 5.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.387 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -60.43 150.74 30.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.902 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 60.11 14.87 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.185 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -63.47 136.39 57.56 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -95.38 107.13 19.24 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.93 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.442 HD22 HD12 ' D' ' 3' ' ' ILE . 8.9 mp -92.34 155.81 17.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.254 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -106.69 124.12 49.14 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.76 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.652 HD12 HD23 ' D' ' 43' ' ' LEU . 7.7 tp -99.89 92.88 5.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.815 HG11 HD11 ' A' ' 56' ' ' LEU . 58.3 t -87.36 129.81 38.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.617 ' H ' HD11 ' D' ' 8' ' ' LEU . 65.1 mt -95.13 134.91 37.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.011 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -63.56 -40.37 96.8 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.116 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.517 HD22 ' HE3' ' C' ' 48' ' ' LYS . 2.0 tt -138.93 128.14 24.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 0.0 110.414 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -67.85 135.36 52.41 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.876 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.99 -14.96 62.25 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.777 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.408 179.548 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -69.65 145.97 52.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.189 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.8 m-30 -93.74 126.27 38.83 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.249 0.547 . . . . 0.0 109.913 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' A' ' 51' ' ' GLN . 90.8 mt -68.99 -37.33 78.67 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.973 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.99 160.9 8.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.802 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -173.87 122.22 0.32 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.978 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -152.77 157.24 40.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.659 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HA ' HD12 ' A' ' 46' ' ' LEU . 72.9 mtp180 -76.31 121.82 23.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.09 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.88 143.95 22.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.648 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.42 151.47 17.45 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -95.12 157.14 16.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.916 0.389 . . . . 0.0 110.974 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 43.0 mtp -121.84 172.77 7.93 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.1 m -122.44 122.43 38.96 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.211 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 37' ' ' THR . 25.7 tp -106.45 118.99 38.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.729 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -121.25 111.54 17.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.437 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.68 -102.11 1.0 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.5 p -127.62 20.38 6.64 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.359 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.61 ' O ' HD12 ' A' ' 33' ' ' LEU . 91.7 m -122.32 129.88 52.6 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.74 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 33' ' ' LEU . 62.1 t -109.01 123.88 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.705 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.2 p -115.59 134.88 22.59 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.202 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.58 143.85 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.72 1.613 . . . . 0.0 112.305 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -106.57 131.49 53.67 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -72.35 -7.18 48.22 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.153 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -73.14 75.96 1.26 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -57.42 131.06 48.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -126.18 -160.25 10.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.523 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.9 tp -136.42 124.67 23.18 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.2 t -98.03 111.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.304 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -133.86 155.7 49.39 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.917 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.6 mt -123.94 140.24 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.389 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -141.38 141.64 33.79 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 121.096 0.474 . . . . 0.0 110.136 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.508 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.9 tt0 -106.1 127.58 53.29 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.535 HG23 ' CD2' ' A' ' 58' ' ' HIS . 27.0 p -88.48 172.46 9.34 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.477 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.53 -10.73 19.43 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.073 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.14 0.18 55.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.262 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t 68.46 21.76 8.07 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.157 0.503 . . . . 0.0 110.482 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.815 HD11 HG11 ' D' ' 70' ' ' VAL . 70.2 mt -101.7 124.69 47.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.491 HD11 ' HB3' ' A' ' 131' ' ' PRO . 50.9 mm -80.84 125.73 39.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.535 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.0 m-70 -102.79 116.42 32.53 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.571 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -92.5 109.35 20.74 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.4 m -120.69 144.84 48.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.877 0.846 . . . . 0.0 112.904 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -124.98 114.08 18.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.183 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -107.53 131.31 54.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.295 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -73.03 131.98 42.8 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -72.51 -19.12 61.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.035 0.445 . . . . 0.0 110.415 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -60.24 -45.07 94.5 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.15 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.8 p -116.0 -15.18 11.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.058 0.456 . . . . 0.0 110.112 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.46 20.59 79.48 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -101.62 145.49 28.99 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.4 t -73.98 103.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.261 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -78.44 -31.55 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.291 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -126.77 145.89 50.44 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.641 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.599 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.5 t0 -157.53 98.73 1.7 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.332 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 72' ' ' ASP . 35.9 mt -128.07 134.47 49.17 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.563 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.2 mt -77.6 127.29 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.966 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.55 HG23 ' SG ' ' A' ' 80' ' ' CYS . 31.3 mm -113.77 123.55 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.145 0.498 . . . . 0.0 110.905 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.462 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 64.6 m-85 -90.33 163.23 32.04 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.114 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.62 140.66 90.65 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.072 1.848 . . . . 0.0 111.309 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 59.89 13.61 3.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.246 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -90.15 -32.34 16.68 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.502 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.598 ' HB3' HD11 ' A' ' 96' ' ' LEU . 71.4 m -134.95 152.37 51.67 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.331 0.586 . . . . 0.0 111.93 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.29 129.11 48.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.58 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -101.94 118.73 37.52 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -144.35 166.58 24.7 Favored 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.9 -178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -88.69 159.69 17.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.956 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 t -114.83 89.76 20.29 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.47 59.98 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.015 1.81 . . . . 0.0 111.972 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -47.43 2.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 52.8 t -114.27 99.33 50.76 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.965 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.96 130.03 16.13 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.559 1.506 . . . . 0.0 111.488 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 169.6 -35.1 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.682 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.37 176.67 36.13 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.697 ' HE ' HG21 ' A' ' 114' ' ' THR . 94.6 mtt-85 -81.12 113.82 19.55 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.916 0.389 . . . . 0.0 110.783 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.8 t -125.97 125.16 67.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.969 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.79 152.34 35.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.307 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 105' ' ' LEU . 15.0 p -131.23 135.95 58.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.039 0.447 . . . . 0.0 110.125 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.598 HD11 ' HB3' ' A' ' 80' ' ' CYS . 63.6 tp -102.53 118.11 36.16 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -113.83 132.6 55.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.616 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -85.17 116.07 23.32 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.244 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.48 -37.1 82.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.03 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.19 -24.13 8.64 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.104 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.16 -37.13 72.14 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 p 81.57 -6.11 1.52 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 124.128 0.546 . . . . 0.0 110.721 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.707 ' HD3' HD21 ' A' ' 105' ' ' LEU . 9.1 ttmm -79.7 148.19 31.66 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.259 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.4 mtt180 -133.76 133.43 41.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.795 0.331 . . . . 0.0 110.479 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.707 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.7 mt -121.74 152.8 39.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.033 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.05 137.69 54.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.912 0.386 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -139.98 159.93 41.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.282 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -136.99 139.83 41.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.013 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.13 131.04 49.85 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.521 0.677 . . . . 0.0 111.282 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.42 0.89 10.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.73 147.82 81.68 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.27 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.77 -40.07 67.14 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.814 1.676 . . . . 0.0 112.299 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -116.92 144.54 44.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.028 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.697 HG21 ' HE ' ' A' ' 92' ' ' ARG . 74.7 p -100.28 12.01 38.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.633 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -55.76 -20.76 15.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.965 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -124.06 17.48 9.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.702 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.54 -45.48 93.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.284 0.564 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -71.63 -34.82 70.13 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.432 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -44.43 88.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.736 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.1 m170 -64.14 -39.78 94.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.8 -46.03 91.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.749 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -65.64 -43.15 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.262 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -62.72 -39.82 95.24 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.544 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 120' ' ' HIS . 59.3 t -59.51 -47.77 89.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.408 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -79.87 -24.93 40.89 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.936 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -69.59 -42.38 74.54 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.866 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -79.0 -35.45 42.82 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.674 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 124' ' ' VAL . 80.4 mt -71.34 -36.05 71.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -98.84 -27.79 13.76 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.497 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -132.89 76.25 70.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.353 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.491 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.2 Cg_exo -58.58 155.57 36.09 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.819 2.346 . . . . 0.0 112.037 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.492 1.429 0 C-N-CA 122.376 2.051 . . . . 0.0 112.085 -179.406 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -72.62 149.24 90.68 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.668 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.12 148.04 38.97 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.437 2.091 . . . . 0.0 112.29 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -73.89 151.7 88.72 Favored Pre-proline 0 C--N 1.331 -0.232 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.35 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' B' ' 945' ' ' PRO . 73.6 Cg_endo -73.97 156.44 47.7 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.021 . . . . 0.0 112.372 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 944' ' ' PRO . 22.5 Cg_exo -61.71 -169.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.439 2.093 . . . . 0.0 112.023 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -130.09 157.24 77.64 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.191 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 140.01 82.59 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.42 2.08 . . . . 0.0 112.338 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -157.59 164.73 36.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.621 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 59.6 mp0 -86.32 136.73 33.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.963 0.411 . . . . 0.0 110.802 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -118.05 129.7 55.72 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.723 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.19 132.53 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.15 84.64 0.74 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.326 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.472 179.578 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -64.23 161.48 16.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.489 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -142.1 145.22 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.045 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -87.87 122.77 31.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.826 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.86 108.73 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.169 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -89.63 124.23 34.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.651 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.49 HG22 HD23 ' C' ' 69' ' ' LEU . 72.8 p -75.37 -166.69 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.347 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' C' ' 70' ' ' VAL . 95.4 mt -59.45 -28.17 66.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.926 0.394 . . . . 0.0 109.993 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 14.3 p -103.71 -178.38 3.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.227 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.23 -19.12 56.86 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -53.21 129.66 32.11 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.975 0.417 . . . . 0.0 110.618 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.7 m -124.48 138.82 54.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.684 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.87 111.94 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.496 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 37.4 m -83.05 129.77 35.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 120.691 -0.404 . . . . 0.0 109.911 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.56 131.76 53.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -72.57 114.14 10.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.941 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.439 HG12 ' HD2' ' C' ' 29' ' ' LYS . 24.5 m -136.1 165.43 29.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.642 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -107.13 152.36 41.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.1 -37.43 94.04 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.054 1.836 . . . . 0.0 112.096 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 96.8 p -82.27 -8.34 59.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.237 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -58.39 137.35 57.32 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.034 0.445 . . . . 0.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 50.0 p -79.08 163.52 25.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.664 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.786 HD12 HD23 ' C' ' 50' ' ' LEU . 41.3 mm -64.88 -37.39 80.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.804 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.69 -43.4 90.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.234 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.46 -41.9 99.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.025 0.44 . . . . 0.0 110.81 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.18 -43.07 98.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.812 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.43 ' HG2' HD11 ' C' ' 43' ' ' LEU . 58.4 mtmt -60.89 -39.48 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.71 91.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.058 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.439 ' HD2' HG12 ' C' ' 17' ' ' VAL . 68.0 mttm -60.61 -40.08 90.54 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.18 -40.39 88.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.111 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.96 -44.31 94.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.201 0.524 . . . . 0.0 110.206 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -74.24 -17.86 60.82 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.084 -0.385 . . . . 0.0 111.7 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -101.02 -4.62 27.11 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -149.56 -46.01 0.14 Allowed 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.364 0.602 . . . . 0.0 110.456 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.92 3.26 26.62 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.072 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.48 HG22 ' HG3' ' C' ' 41' ' ' GLN . 32.7 mm -65.99 117.22 40.3 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 119.689 -0.805 . . . . 0.0 109.863 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -61.39 150.17 86.21 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.108 1.872 . . . . 0.0 112.089 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.88 -38.05 67.54 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.996 1.798 . . . . 0.0 112.482 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.26 -40.22 96.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.819 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -87.44 -4.61 59.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.205 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.48 ' HG3' HG22 ' C' ' 36' ' ' ILE . 45.3 mt-30 -84.68 103.1 13.48 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.166 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -107.53 103.2 12.46 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.43 HD11 ' HG2' ' C' ' 27' ' ' LYS . 58.0 mt -100.34 119.91 39.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.609 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -127.46 128.22 69.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.138 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -129.33 126.75 39.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.932 0.396 . . . . 0.0 110.798 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.03 27.9 17.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.727 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.86 2.08 89.99 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -106.38 117.59 34.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.065 0.46 . . . . 0.0 110.304 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -69.28 127.78 34.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.008 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.786 HD23 HD12 ' C' ' 23' ' ' ILE . 7.8 mp -74.82 98.17 3.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.121 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.07 146.58 47.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.136 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -64.03 137.7 58.11 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.482 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.96 -17.0 57.86 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -83.44 175.27 9.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.706 0.289 . . . . 0.0 110.263 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -121.58 164.61 16.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.68 -40.14 96.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.469 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.0 p -64.1 -26.26 68.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.989 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -63.71 -28.96 70.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.864 0.364 . . . . 0.0 110.245 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -104.02 14.03 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.346 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 57.06 40.2 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 110.401 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.506 ' CD1' HD21 ' C' ' 50' ' ' LEU . 83.3 mt -90.66 107.27 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.157 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -91.81 -173.48 3.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.285 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -67.0 150.2 49.58 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.059 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 55.44 39.86 31.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.024 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.8 m -93.46 126.64 38.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.097 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.528 ' C ' HD12 ' C' ' 67' ' ' LEU . 43.8 m -76.18 129.18 36.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 110.157 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.528 HD12 ' C ' ' C' ' 66' ' ' THR . 8.7 mp -119.11 146.55 45.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.395 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -92.33 112.58 24.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.551 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.49 HD23 HG22 ' C' ' 7' ' ' THR . 51.3 tp -104.46 121.57 43.72 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.666 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.425 ' HA ' HD21 ' C' ' 8' ' ' LEU . 97.2 t -121.51 138.06 53.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.893 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.455 HD22 ' CG2' ' C' ' 36' ' ' ILE . 22.7 mt -103.07 137.37 41.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.114 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -72.2 143.02 49.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.792 0.33 . . . . 0.0 110.86 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.19 -39.32 92.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.971 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 mmt-85 58.65 22.8 10.28 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.688 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.46 -41.36 99.53 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 57.05 -131.05 51.85 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 C--O 1.221 -0.447 0 CA-C-O 118.1 -0.953 . . . . 0.0 110.477 179.749 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -62.65 161.57 12.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.093 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.602 HD13 HD21 ' D' ' 56' ' ' LEU . 12.7 pt -139.55 139.32 38.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.013 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.653 ' HD2' HG21 ' D' ' 12' ' ' THR . 3.9 m-85 -83.4 121.38 27.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.465 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.1 t -110.26 98.76 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -84.59 123.81 30.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 110.917 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.428 HG22 HD13 ' D' ' 69' ' ' LEU . 80.9 p -86.66 173.45 9.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.981 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.519 HD11 ' H ' ' D' ' 71' ' ' LEU . 70.6 mt -63.14 -24.67 68.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.127 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -71.89 -14.78 62.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.68 -15.54 59.64 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -70.92 141.8 51.12 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.653 HG21 ' HD2' ' D' ' 4' ' ' PHE . 95.6 m -104.88 132.61 50.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.083 0.468 . . . . 0.0 110.96 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mm -117.67 101.52 12.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.174 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -83.53 122.7 28.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.634 HD21 ' HD2' ' D' ' 33' ' ' LYS . 79.2 mt -121.98 129.13 52.22 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.823 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.59 115.49 7.25 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.654 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.422 HG12 ' HE3' ' D' ' 29' ' ' LYS . 16.2 m -136.93 177.07 6.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.614 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -124.99 156.22 69.51 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.392 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -56.27 -43.55 54.95 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.935 1.757 . . . . 0.0 112.073 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 82.7 p -72.35 -14.66 61.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -57.8 138.82 55.23 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.963 0.411 . . . . 0.0 110.638 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -80.97 161.66 24.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.785 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.645 HD12 HD13 ' D' ' 50' ' ' LEU . 49.7 mm -64.24 -41.29 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.081 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -58.3 -35.78 72.35 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.322 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -65.14 -43.48 91.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.22 0.533 . . . . 0.0 110.483 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.621 HG21 HD11 ' D' ' 56' ' ' LEU . 78.1 t -62.41 -41.81 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.168 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -60.55 -39.03 86.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.227 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.4 90.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.833 0.349 . . . . 0.0 110.136 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.501 ' CB ' HD13 ' D' ' 15' ' ' LEU . 66.7 mttm -60.44 -39.08 86.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.928 HD11 HD21 ' D' ' 43' ' ' LEU . 91.1 mt -63.81 -40.75 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.096 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.06 -41.38 92.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.23 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.59 -41.4 97.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.634 ' HD2' HD21 ' D' ' 15' ' ' LEU . 76.6 mttt -78.38 -76.73 0.18 Allowed 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.779 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -83.58 152.9 24.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.003 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.86 53.02 4.54 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.109 -1.197 . . . . 0.0 110.109 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 mm -107.92 113.9 60.56 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.967 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.61 155.78 62.46 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.94 1.76 . . . . 0.0 112.147 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.72 -27.05 49.96 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.337 2.025 . . . . 0.0 112.603 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -83.36 -1.66 53.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.447 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -114.47 -49.18 2.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.557 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.485 ' HA ' HD21 ' D' ' 69' ' ' LEU . 0.8 OUTLIER -70.12 128.1 35.11 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.037 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 mmt-85 -126.99 102.51 7.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.928 HD21 HD11 ' D' ' 30' ' ' ILE . 91.3 mt -76.13 125.55 29.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.466 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.415 HG23 ' HA ' ' D' ' 49' ' ' GLN . 72.3 mt -130.59 130.76 65.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.0 t80 -151.77 155.29 37.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.837 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 70.23 21.6 5.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.818 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.33 0.04 85.64 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.511 ' HB3' HD22 ' A' ' 73' ' ' LEU . 3.0 ptm180 -136.08 149.74 48.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.505 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.415 ' HA ' HG23 ' D' ' 44' ' ' ILE . 20.3 pt20 -68.48 148.28 50.82 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.473 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.645 HD13 HD12 ' D' ' 23' ' ' ILE . 68.0 mt -83.01 117.11 22.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.691 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -76.12 137.99 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.941 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.1 142.81 58.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.964 0.411 . . . . 0.0 110.345 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.98 -15.84 62.24 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -83.11 163.8 20.65 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 120.824 0.345 . . . . 0.0 110.699 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 24.9 p -104.77 171.09 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.222 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.621 HD11 HG21 ' D' ' 26' ' ' VAL . 5.1 mp -71.27 -38.81 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.071 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -62.77 -25.82 68.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.54 -37.73 87.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.113 0.482 . . . . 0.0 110.374 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.19 11.3 34.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.274 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 56.14 40.19 30.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.72 0.295 . . . . 0.0 110.435 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -85.56 109.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -94.22 178.1 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.673 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.25 146.09 49.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.185 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 63.61 14.71 8.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.331 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -63.37 135.11 56.76 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -91.1 121.97 33.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.93 0.395 . . . . 0.0 110.313 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.521 HD23 HD11 ' D' ' 50' ' ' LEU . 5.4 mp -118.07 144.85 45.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.333 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -90.48 129.75 36.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.515 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.615 HD11 HG21 ' D' ' 30' ' ' ILE . 3.2 tt -104.24 101.53 11.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.798 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 56' ' ' LEU . 60.0 t -87.74 132.48 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.519 ' H ' HD11 ' D' ' 8' ' ' LEU . 57.2 mt -98.51 134.59 41.26 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -135.68 168.28 19.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.762 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 mt -64.91 146.0 55.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.156 0.503 . . . . 0.0 111.096 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -69.06 176.41 3.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.725 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.7 -39.76 95.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.56 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.5 mmtm -80.88 142.77 33.27 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.166 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.17 115.26 27.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.87 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' CD1' HD12 ' A' ' 57' ' ' ILE . 98.0 mt -66.81 -36.7 82.97 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.361 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -151.22 163.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.419 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -173.77 122.84 0.34 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.224 0.535 . . . . 0.0 110.988 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -156.21 159.54 39.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.034 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.8 mtt180 -77.9 118.79 20.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.636 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.45 139.87 20.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.955 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.17 151.53 17.55 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -88.06 154.77 20.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.968 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 45.6 mtp -122.33 171.75 8.82 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -121.94 125.84 47.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.472 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.634 HD12 ' O ' ' A' ' 37' ' ' THR . 22.5 tp -107.29 119.2 38.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.073 0.463 . . . . 0.0 110.443 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -119.11 107.83 13.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.805 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 -94.28 0.63 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.0 p -133.98 21.54 3.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.459 0.171 . . . . 0.0 110.79 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.634 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.8 m -124.46 131.23 53.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 110.533 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.474 ' CG2' HD13 ' A' ' 33' ' ' LEU . 76.6 t -110.41 125.76 67.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.107 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.442 HG22 ' HB3' ' B' ' 947' ' ' PRO . 21.7 p -119.8 138.07 26.4 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.623 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.55 142.84 29.9 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.84 1.693 . . . . 0.0 112.405 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -103.66 135.73 44.69 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.614 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.84 -6.78 47.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.934 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -77.72 62.2 2.56 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -56.02 133.8 52.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.428 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.62 -152.08 7.81 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -138.2 125.01 21.06 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.67 107.02 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.4 p90 -131.08 152.72 50.08 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.791 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.4 mt -120.57 140.52 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.43 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -140.66 143.49 35.16 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.624 0.577 . . . . 0.0 109.831 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -107.23 127.44 53.53 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.309 0.576 . . . . 0.0 110.516 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' CD2' ' A' ' 58' ' ' HIS . 22.7 p -86.58 172.1 10.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.952 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.44 -11.34 22.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.662 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.52 3.45 47.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.46 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.6 m 64.79 22.89 12.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.154 0.502 . . . . 0.0 111.065 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.75 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 65.9 mt -102.5 126.08 49.43 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.577 HD12 ' CD1' ' A' ' 23' ' ' LEU . 46.7 mm -80.56 126.87 39.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.3 m-70 -103.78 117.74 35.07 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.489 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -94.34 107.97 19.9 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -120.87 144.04 48.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.708 0.766 . . . . 0.0 112.681 -177.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.9 t90 -125.09 112.09 16.1 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.436 -1.256 . . . . 0.0 108.616 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -105.34 133.09 50.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.345 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -72.51 138.55 47.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.053 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -79.8 -18.55 50.66 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.607 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 54.4 m -60.53 -45.79 92.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.5 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.6 m -116.84 -13.93 10.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.198 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.5 23.66 76.57 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -102.56 144.15 31.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.903 0.383 . . . . 0.0 110.987 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.7 t -73.79 108.27 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -89.56 -25.97 21.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.751 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -127.76 143.4 51.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.566 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 73' ' ' LEU . 66.8 t0 -158.11 94.62 1.32 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.544 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 72' ' ' ASP . 30.6 mt -126.43 134.19 51.05 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.822 0.344 . . . . 0.0 110.872 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.3 mt -77.23 127.15 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.306 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.521 ' HB ' HD22 ' A' ' 128' ' ' LEU . 27.2 mm -111.53 121.79 64.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.746 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.75 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 59.7 m-85 -94.77 163.48 22.26 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.055 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.04 137.85 77.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.0 1.8 . . . . 0.0 111.755 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 60.34 12.44 3.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.584 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -89.85 -34.01 16.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-O 120.764 0.316 . . . . 0.0 110.428 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -141.52 145.44 35.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.103 0.478 . . . . 0.0 111.341 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.8 tt0 -123.95 131.97 53.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.344 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -102.8 118.43 36.82 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -142.61 167.31 22.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.084 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -89.74 160.63 16.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.333 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 t -113.75 89.25 15.49 Favored Pre-proline 0 C--N 1.327 -0.379 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.381 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.67 60.35 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.946 1.764 . . . . 0.0 111.642 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -114.85 -39.88 3.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.118 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 46.1 t -121.21 87.95 44.88 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.237 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.14 130.72 24.87 Favored 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.656 1.571 . . . . 0.0 111.59 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 168.81 -40.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -141.67 -149.04 5.14 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.286 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.48 105.79 12.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.094 0.473 . . . . 0.0 110.347 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.2 t -121.66 126.62 74.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.704 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.61 154.02 33.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.191 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -133.06 133.51 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.126 0.489 . . . . 0.0 110.283 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' ' 81' ' ' GLU . 57.2 tp -102.92 122.88 45.47 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -119.73 133.52 55.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.032 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 51.7 m-85 -88.61 115.09 25.89 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -60.87 -32.65 72.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.507 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.24 -23.7 9.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.967 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.91 -25.84 68.35 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.997 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.81 7.3 5.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HD3' HD21 ' A' ' 105' ' ' LEU . 9.1 ttmm -96.54 148.75 22.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.857 0.36 . . . . 0.0 110.732 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -129.37 133.15 47.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.918 0.389 . . . . 0.0 110.601 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.453 HD21 ' HD3' ' A' ' 103' ' ' LYS . 45.9 mt -120.42 148.0 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.711 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.6 136.74 54.24 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.769 0.319 . . . . 0.0 111.394 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -139.02 154.07 48.19 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.378 0.609 . . . . 0.0 111.554 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -130.45 135.8 48.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.351 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 141.81 50.77 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.256 0.55 . . . . 0.0 110.925 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.62 2.94 4.53 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.463 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -77.08 155.22 82.58 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.104 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -61.52 -41.67 38.6 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.251 1.967 . . . . 0.0 113.162 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -121.89 146.87 46.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.562 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.91 -1.76 56.43 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.895 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -58.46 -18.37 28.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.541 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -117.02 -17.67 10.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.695 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.24 -41.21 96.51 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.819 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -64.03 -40.66 96.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.03 0.443 . . . . 0.0 111.167 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.32 -40.04 85.91 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.253 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.738 ' O ' HG23 ' A' ' 124' ' ' VAL . 65.0 m170 -61.33 -39.73 91.61 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.6 t -60.59 -45.78 92.67 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.367 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 ttt85 -64.98 -41.59 95.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.383 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -66.47 -37.05 84.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.45 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.9 t -58.19 -48.35 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.248 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -78.24 -27.28 47.59 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.008 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.7 -37.61 76.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.885 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -80.99 -31.55 34.67 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.804 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.521 HD22 ' HB ' ' A' ' 75' ' ' ILE . 51.7 mt -81.58 -27.11 34.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.898 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -104.83 -27.66 11.61 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.243 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -133.83 73.2 71.89 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.045 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.76 152.52 62.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.935 2.423 . . . . 0.0 112.345 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 122.384 2.056 . . . . 0.0 112.025 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -128.46 153.42 79.24 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.597 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.64 150.0 68.36 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.374 2.049 . . . . 0.0 112.299 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -72.46 153.66 91.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.81 161.82 44.73 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.345 2.03 . . . . 0.0 112.301 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.2 -170.26 0.48 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.881 2.388 . . . . 0.0 111.816 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -116.67 158.71 42.87 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.553 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.442 ' HB3' HG22 ' A' ' 39' ' ' THR . 51.0 Cg_exo -56.14 142.66 86.29 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.564 2.176 . . . . 0.0 112.105 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.48 165.58 36.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -85.69 139.57 31.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.985 0.421 . . . . 0.0 110.633 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.37 122.21 37.07 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.821 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 64.3 mt -131.88 122.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.597 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -67.61 83.92 0.18 Allowed 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.099 -0.641 . . . . 0.0 110.584 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 31.2 t0 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.59 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -151.29 170.54 19.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.127 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.614 HG22 ' HB3' ' C' ' 65' ' ' SER . 5.2 pt -143.41 147.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.861 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -97.75 111.96 24.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.954 0.407 . . . . 0.0 110.44 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -93.47 110.86 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.357 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.83 122.1 31.06 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.086 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 58.1 p -74.59 -170.02 0.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.634 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' C' ' 70' ' ' VAL . 95.4 mt -60.26 -21.81 62.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.308 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 9.4 p -113.79 -171.63 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.379 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.83 -18.73 59.99 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.87 131.0 45.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.409 . . . . 0.0 110.402 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 83.3 m -127.75 139.33 52.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.304 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.427 HG22 ' HD2' ' C' ' 33' ' ' LYS . 0.2 OUTLIER -122.62 111.08 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.759 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.33 128.8 34.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.705 0.288 . . . . 0.0 110.265 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.773 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.9 mt -125.66 133.86 52.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.15 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.99 120.63 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.972 0.415 . . . . 0.0 110.293 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.749 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 32.8 m -138.49 177.2 5.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.965 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.415 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.7 mt-10 -122.71 155.19 63.5 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.327 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -59.63 -27.61 85.36 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.945 . . . . 0.0 112.312 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -91.83 -9.84 41.95 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.746 -0.381 . . . . 0.0 111.516 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -60.69 141.18 57.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.815 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.7 p -79.09 160.21 27.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 46.3 mm -64.49 -37.65 80.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.011 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -58.34 -41.99 85.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.017 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.14 -40.45 95.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.076 0.465 . . . . 0.0 110.185 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.458 HG21 HD21 ' C' ' 56' ' ' LEU . 54.9 t -62.04 -42.87 96.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.798 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.492 ' HG2' HD11 ' C' ' 43' ' ' LEU . 54.6 mtmt -60.01 -39.73 86.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.97 93.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.009 0.433 . . . . 0.0 110.497 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.749 ' NZ ' HG12 ' C' ' 17' ' ' VAL . 75.4 mttt -60.35 -39.09 85.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.227 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.69 -37.99 79.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.071 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -59.09 -38.85 80.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.071 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -69.31 -50.35 47.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.773 ' HG3' HD21 ' C' ' 15' ' ' LEU . 5.0 mttt -63.28 -40.85 98.54 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.682 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -133.21 148.9 52.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.174 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.02 59.57 2.67 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.591 ' CG2' HD22 ' C' ' 71' ' ' LEU . 28.9 mm -111.16 103.69 55.22 Favored Pre-proline 0 N--CA 1.449 -0.491 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -58.81 150.61 70.11 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.227 1.952 . . . . 0.0 112.44 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -50.61 -37.97 54.19 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.174 1.916 . . . . 0.0 112.278 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.76 -38.58 91.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.556 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -89.84 -2.88 58.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.189 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.576 ' HG3' HG22 ' C' ' 36' ' ' ILE . 91.1 mt-30 -89.44 94.14 9.77 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.07 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -100.29 109.47 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.492 HD11 ' HG2' ' C' ' 27' ' ' LYS . 33.9 mt -104.11 119.98 40.12 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.622 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 94.9 mt -129.86 120.55 50.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.228 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -66.87 -46.68 74.22 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.921 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . -177.55 79.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.936 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.77 0.88 88.86 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.528 ' CE ' HD22 ' D' ' 73' ' ' LEU . 7.5 mtpp -126.69 126.63 43.83 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.961 0.41 . . . . 0.0 110.733 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -76.75 146.09 38.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.36 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.558 HD11 HD23 ' C' ' 67' ' ' LEU . 59.8 mt -95.7 112.64 24.32 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.611 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -77.07 148.35 36.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.17 -40.15 96.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.105 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.67 -12.05 66.61 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.3 166.48 13.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.079 0.466 . . . . 0.0 110.842 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 77.6 p -117.42 165.67 13.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.191 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.458 HD21 HG21 ' C' ' 26' ' ' VAL . 77.2 mt -60.92 -40.53 93.53 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.905 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.7 p -64.36 -23.92 67.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.891 0.377 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -61.41 -34.53 75.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.039 0.447 . . . . 0.0 110.615 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.729 ' OH ' HD21 ' D' ' 73' ' ' LEU . 69.5 m-85 -99.88 16.95 22.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.036 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 57.28 37.59 28.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 120.719 0.295 . . . . 0.0 110.616 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.632 HG23 ' OG ' ' C' ' 65' ' ' SER . 86.6 mt -84.79 117.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -109.19 -176.56 3.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.676 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -57.53 145.3 33.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.906 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 60.56 25.73 15.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.393 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . 0.632 ' OG ' HG23 ' C' ' 61' ' ' ILE . 2.4 t -73.93 124.06 25.46 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.037 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 41.2 m -85.83 128.1 34.73 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.08 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.558 HD23 HD11 ' C' ' 50' ' ' LEU . 1.5 mp -118.5 149.89 40.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.49 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -94.19 119.47 33.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.578 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.83 124.15 49.1 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.281 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.477 ' HA ' HD21 ' C' ' 8' ' ' LEU . 99.6 t -121.41 133.06 69.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.037 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.591 HD22 ' CG2' ' C' ' 36' ' ' ILE . 17.5 mt -105.15 136.33 44.85 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.107 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -75.95 146.38 39.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . 0.535 HD21 ' HB2' ' C' ' 77' ' ' ASP . 62.8 tp -114.92 128.36 56.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.372 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -88.74 117.28 27.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.124 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.96 -171.58 54.49 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.55 179.87 50.4 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . 0.535 ' HB2' HD21 ' C' ' 73' ' ' LEU . 65.1 t0 . . . . . 0 C--O 1.222 -0.375 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.38 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.04 161.67 18.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.615 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -142.07 139.82 30.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.364 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -83.27 122.86 28.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -106.52 109.19 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.318 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -80.0 114.99 19.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.843 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.58 ' CG2' HD11 ' D' ' 13' ' ' ILE . 59.9 p -70.66 176.29 4.28 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.22 -26.16 1.11 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -108.46 -175.96 2.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.906 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.58 -20.66 59.47 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -53.77 133.38 42.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.819 0.342 . . . . 0.0 110.494 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -124.2 137.39 54.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.58 HD11 ' CG2' ' D' ' 7' ' ' THR . 0.1 OUTLIER -123.54 112.64 34.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.404 -179.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 28.8 m -84.11 127.2 33.76 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.296 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.626 HD21 ' HD2' ' D' ' 33' ' ' LYS . 87.4 mt -120.86 130.7 54.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.572 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -71.87 115.22 10.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.788 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.486 HG12 ' HE3' ' D' ' 29' ' ' LYS . 21.4 m -135.61 164.32 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.578 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -105.66 153.71 39.73 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.453 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.68 -37.01 91.43 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.236 1.957 . . . . 0.0 112.026 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.1 p -82.26 -7.4 59.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.185 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -59.73 136.51 58.02 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.915 0.388 . . . . 0.0 110.904 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -80.04 162.88 24.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.761 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.06 -37.67 80.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.614 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.35 -43.22 92.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.274 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.24 -40.4 96.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.184 0.516 . . . . 0.0 110.59 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.503 HG12 HD21 ' D' ' 43' ' ' LEU . 69.6 t -62.94 -42.39 96.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.469 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.507 ' HG2' HD13 ' D' ' 43' ' ' LEU . 57.3 mtmt -60.25 -39.81 88.06 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.115 0.484 . . . . 0.0 110.362 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.52 -39.71 91.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.332 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.486 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.9 mttm -60.48 -38.79 85.4 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.428 ' CD1' HD11 ' D' ' 43' ' ' LEU . 90.2 mt -63.37 -41.05 91.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.035 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -61.01 -39.36 89.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.5 -40.36 96.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.626 ' HD2' HD21 ' D' ' 15' ' ' LEU . 52.3 mttt -78.03 -64.81 1.07 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.286 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -97.81 161.25 13.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.235 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.99 53.68 3.77 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.727 HG22 ' HG2' ' D' ' 41' ' ' GLN . 33.8 mm -109.28 107.56 59.74 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.63 150.94 69.66 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.081 1.854 . . . . 0.0 112.03 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.27 -20.63 8.35 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.297 1.998 . . . . 0.0 112.612 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -92.75 19.85 7.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.606 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -152.49 26.31 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.624 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.727 ' HG2' HG22 ' D' ' 36' ' ' ILE . 1.3 mt-30 -118.86 95.86 5.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' D' ' 70' ' ' VAL . 82.6 mtp180 -96.19 100.17 11.83 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.672 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.566 ' HB3' HD12 ' D' ' 50' ' ' LEU . 7.5 mp -85.66 122.33 29.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.976 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' D' ' 49' ' ' GLN . 67.1 mt -128.28 131.48 69.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.546 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.492 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 72.2 t80 -153.25 157.55 40.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.772 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.68 18.89 7.47 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.796 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.27 -5.9 78.43 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -130.94 149.11 52.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.095 0.474 . . . . 0.0 110.562 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.522 ' HA ' HG23 ' D' ' 44' ' ' ILE . 18.5 pt20 -66.79 140.53 57.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.37 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.566 HD12 ' HB3' ' D' ' 43' ' ' LEU . 69.2 mt -81.68 123.51 28.78 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.621 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.67 139.39 40.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.177 0.513 . . . . 0.0 110.612 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -63.41 138.99 58.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.316 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.89 -12.52 64.12 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -80.22 172.07 14.25 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.832 0.349 . . . . 0.0 110.643 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 64.5 p -115.29 157.53 23.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.226 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.99 -40.82 96.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.542 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -63.33 -24.14 67.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.456 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -62.54 -37.66 86.97 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.117 0.484 . . . . 0.0 110.424 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -98.68 14.64 27.87 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.099 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 m120 56.46 38.77 29.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.454 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.87 104.55 12.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.91 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -89.56 179.05 6.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.522 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.39 151.64 27.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.252 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 57.87 42.09 23.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.967 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . 0.421 ' O ' HD12 ' D' ' 67' ' ' LEU . 30.2 t -90.22 122.73 33.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.268 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -79.69 85.68 5.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.045 0.45 . . . . 0.0 110.589 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.438 ' N ' HD12 ' D' ' 67' ' ' LEU . 7.1 mp -77.19 154.36 33.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.891 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -102.64 122.67 44.87 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.256 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -104.59 121.49 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.225 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.527 HG11 HD11 ' A' ' 56' ' ' LEU . 61.3 t -115.62 132.34 65.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt -101.94 123.65 46.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.009 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -63.4 -39.43 94.48 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.797 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.729 HD21 ' OH ' ' C' ' 59' ' ' TYR . 1.0 OUTLIER -117.76 80.57 1.53 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.495 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -61.02 -44.99 96.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.91 -176.52 50.09 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.56 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.628 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -70.28 146.48 50.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -85.44 127.12 34.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.287 0.565 . . . . 0.0 110.293 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' CD1' HD12 ' A' ' 57' ' ' ILE . 86.3 mt -67.53 -36.17 80.5 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.88 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.74 161.71 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.01 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -173.99 122.47 0.31 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.165 0.507 . . . . 0.0 110.847 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 120' ' ' HIS . 50.6 p90 -155.36 156.16 34.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.857 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.663 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.7 mtt180 -74.62 119.2 18.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.474 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.86 144.86 25.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.222 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.75 149.12 16.54 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.316 -1.113 . . . . 0.0 110.316 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -91.98 163.47 13.99 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 26.3 mtp -124.9 175.96 6.95 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -121.62 121.22 36.9 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 121.046 -0.261 . . . . 0.0 110.354 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 37' ' ' THR . 30.4 tp -107.68 117.93 35.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.58 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -121.14 114.41 21.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.986 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.92 -86.68 0.56 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.5 p -146.46 22.16 1.32 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.558 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.603 ' O ' HD12 ' A' ' 33' ' ' LEU . 93.3 m -124.36 129.5 50.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.34 . . . . 0.0 110.431 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.531 ' CG2' HD13 ' A' ' 33' ' ' LEU . 64.2 t -106.33 121.63 59.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.957 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.74 HG23 ' HG3' ' B' ' 947' ' ' PRO . 98.4 m -116.05 122.52 32.24 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.515 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -55.41 142.31 80.35 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.178 1.919 . . . . 0.0 112.23 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -108.13 132.66 53.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.879 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -70.63 -6.69 38.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.153 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -72.37 73.17 0.98 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -59.67 135.17 57.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.713 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -136.15 -154.99 7.02 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.663 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.0 tp -140.64 124.93 17.59 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.34 108.27 21.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.84 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.8 p90 -131.24 153.23 49.73 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.661 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 23' ' ' LEU . 94.9 mt -121.17 141.21 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.933 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -141.86 140.73 32.98 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 123.786 0.679 . . . . 0.0 110.269 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -104.35 128.82 52.24 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.08 0.467 . . . . 0.0 110.399 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.52 HG23 ' CD2' ' A' ' 58' ' ' HIS . 22.7 p -88.09 172.74 9.29 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.673 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.72 -10.37 19.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -86.15 -0.09 54.86 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.343 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 t 69.4 19.65 7.56 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.05 0.452 . . . . 0.0 110.698 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.647 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 60.1 mt -103.34 126.95 50.77 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 23' ' ' LEU . 45.5 mm -79.26 129.12 38.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.485 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.7 m-70 -104.95 116.65 32.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.691 -178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -92.81 107.25 19.07 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 94.9 m -118.53 144.79 45.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.653 0.739 . . . . 0.0 112.805 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -125.76 111.18 14.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.517 -1.22 . . . . 0.0 108.745 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -103.3 136.29 43.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.989 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 p-10 -76.12 139.58 41.39 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.194 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -79.17 -18.97 52.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.614 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -61.08 -46.29 91.23 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -117.04 -12.47 10.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.328 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.95 77.16 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -102.78 147.66 26.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.32 . . . . 0.0 111.028 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 68.0 t -75.5 103.48 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.113 0.482 . . . . 0.0 110.103 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -83.15 -28.74 29.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.064 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -127.28 143.46 51.23 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.057 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.798 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.5 t0 -158.11 99.98 1.68 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.769 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 72' ' ' ASP . 6.2 mt -132.09 130.13 40.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.805 0.336 . . . . 0.0 110.548 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' HD13 ' A' ' 75' ' ' ILE . 96.0 mt -74.32 129.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.434 179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.687 HG21 ' SG ' ' A' ' 80' ' ' CYS . 21.4 mm -117.26 120.24 64.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.212 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.647 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 48.6 m-85 -86.02 163.55 42.67 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.191 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.8 136.27 75.39 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.023 1.815 . . . . 0.0 111.525 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.8 t0 61.4 12.06 4.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.44 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -83.85 -25.32 30.41 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.889 -0.142 . . . . 0.0 110.778 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 75' ' ' ILE . 10.2 p -147.04 169.17 19.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.253 0.549 . . . . 0.0 110.672 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.93 132.42 30.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.448 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -102.29 117.77 35.47 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -141.74 164.8 29.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.072 0.463 . . . . 0.0 111.461 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -83.81 160.71 21.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.383 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 t -115.7 88.43 20.35 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.45 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.96 59.86 7.64 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.298 1.999 . . . . 0.0 112.038 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -48.83 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.1 t -112.42 102.77 54.79 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.828 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.73 129.6 14.72 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 C-N-CA 121.516 1.478 . . . . 0.0 111.478 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 p 167.46 -34.99 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 123.7 0.625 . . . . 0.0 110.416 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.35 -179.26 33.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -88.09 114.7 24.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.081 0.467 . . . . 0.0 110.655 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.12 129.81 69.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.199 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -119.83 157.3 28.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.7 p -134.21 136.94 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.5 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.609 HD11 ' SG ' ' A' ' 80' ' ' CYS . 67.6 tp -102.55 121.79 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -118.53 134.37 55.14 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.242 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CE2' HD12 ' A' ' 75' ' ' ILE . 40.1 m-85 -85.75 114.16 22.49 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -37.13 84.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.8 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.06 -22.52 22.9 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.454 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.44 -169.78 20.39 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 94.6 p -121.42 13.2 10.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.626 0.251 . . . . 0.0 110.572 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.467 ' HD3' HD21 ' A' ' 105' ' ' LEU . 14.3 ttmm -85.87 142.6 28.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.968 0.413 . . . . 0.0 110.847 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -135.33 129.22 33.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.314 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.488 ' O ' HG23 ' A' ' 95' ' ' VAL . 46.2 mt -112.48 150.7 30.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.889 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.466 ' CE1' HD22 ' A' ' 33' ' ' LEU . 93.2 m-85 -123.65 135.62 54.02 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.654 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -137.49 152.1 49.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.26 0.552 . . . . 0.0 111.425 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -128.87 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.475 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.25 134.62 39.25 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.236 0.541 . . . . 0.0 110.956 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.83 -6.53 11.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.363 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -75.06 150.57 85.76 Favored Pre-proline 0 C--O 1.231 0.119 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.703 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.38 -40.41 58.27 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.022 1.814 . . . . 0.0 112.393 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -121.93 147.67 45.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.534 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.8 p -95.99 8.53 43.42 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.234 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -58.38 -20.43 43.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.475 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -121.45 -15.71 7.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.823 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.79 -40.04 93.81 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.663 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.02 -40.98 99.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.176 0.512 . . . . 0.0 111.056 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.14 -40.02 86.67 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.174 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.74 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.3 m170 -60.57 -39.67 88.84 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.1 m -62.05 -41.98 98.7 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.718 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -66.83 -40.91 88.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.192 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -67.22 -36.72 82.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.149 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.8 t -58.32 -48.49 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.083 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -78.56 -25.49 45.4 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.026 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -70.22 -37.68 75.09 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.452 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -82.05 -31.7 30.77 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.727 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.4 mt -81.33 -20.67 40.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.038 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -114.97 -18.23 11.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.279 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -146.42 73.83 12.84 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.848 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.1 161.28 43.68 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 C-N-CA 122.771 2.314 . . . . 0.0 112.328 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 C--N 1.309 -1.501 0 C-N-CA 122.718 2.279 . . . . 0.0 112.145 -179.638 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -71.38 152.97 94.12 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.21 147.23 65.98 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.497 2.131 . . . . 0.0 111.944 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.02 154.74 77.65 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -61.11 150.2 85.49 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.228 1.952 . . . . 0.0 112.46 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -60.99 -153.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 122.503 2.135 . . . . 0.0 111.581 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -129.5 158.86 72.04 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.526 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.74 ' HG3' HG23 ' A' ' 39' ' ' THR . 50.8 Cg_exo -56.45 140.42 89.04 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.71 2.273 . . . . 0.0 111.974 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -155.69 165.6 36.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.771 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.07 138.08 32.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.864 0.364 . . . . 0.0 110.62 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -122.31 123.51 41.57 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.815 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 122.43 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -72.53 84.09 1.12 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.106 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 38.4 t0 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.797 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttp . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -62.23 157.69 18.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.794 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.7 pt -138.73 142.04 35.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.302 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -84.48 125.22 32.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.561 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.885 HG11 HD11 ' C' ' 30' ' ' ILE . 62.5 t -113.44 118.32 57.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.848 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -90.19 121.17 31.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.205 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.418 HG23 ' O ' ' C' ' 11' ' ' LYS . 80.7 p -78.02 169.81 17.65 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.867 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.521 HD23 ' HG ' ' C' ' 71' ' ' LEU . 0.1 OUTLIER -60.12 -41.16 92.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.218 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -72.07 -8.46 54.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.695 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.04 -12.84 60.61 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . 0.418 ' O ' HG23 ' C' ' 7' ' ' THR . 88.8 tttt -63.21 123.24 18.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 93.6 m -98.83 132.39 44.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.964 0.411 . . . . 0.0 111.286 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.416 HD12 HD13 ' C' ' 30' ' ' ILE . 0.0 OUTLIER -128.04 105.5 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.422 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -73.09 128.83 36.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.659 HD13 ' CB ' ' C' ' 29' ' ' LYS . 62.8 mt -120.5 124.53 45.61 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.889 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -65.81 108.91 2.28 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.062 0.458 . . . . 0.0 111.071 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.586 HG12 ' HE3' ' C' ' 29' ' ' LYS . 20.5 m -132.45 167.58 26.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.442 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.4 mt-10 -114.12 154.81 46.12 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.93 -29.12 80.93 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.701 . . . . 0.0 111.73 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 85.5 p -85.27 -12.82 51.54 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.856 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -64.89 142.95 58.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.461 -0.495 . . . . 0.0 111.021 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 46.7 p -83.86 164.14 19.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.491 0.662 . . . . 0.0 111.107 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 49.9 mm -61.9 -34.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.465 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.34 -43.44 88.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -63.01 -40.8 98.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 110.467 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.565 HG22 HG11 ' C' ' 17' ' ' VAL . 55.6 t -63.72 -42.94 97.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -62.05 -39.63 93.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.194 0.521 . . . . 0.0 110.329 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.46 -39.06 89.5 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.824 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.659 ' CB ' HD13 ' C' ' 15' ' ' LEU . 66.9 mttm -60.11 -37.97 81.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.885 HD11 HG11 ' C' ' 5' ' ' VAL . 8.4 mm -63.41 -39.63 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.595 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -59.46 -46.75 87.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.212 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -62.09 -43.46 98.78 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.772 -0.58 . . . . 0.0 111.136 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -72.27 -26.16 61.89 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -137.16 -53.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.238 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.0 10.35 8.28 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.55 HG22 ' HG3' ' C' ' 41' ' ' GLN . 62.7 mt -76.14 122.11 86.24 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.37 160.64 48.09 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.395 1.397 . . . . 0.0 110.914 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.69 -39.89 88.46 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 122.538 2.159 . . . . 0.0 112.828 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.94 -37.06 83.27 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.246 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -99.24 21.53 11.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.725 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.55 ' HG3' HG22 ' C' ' 36' ' ' ILE . 14.0 mt-30 -109.73 -46.55 3.49 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.208 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 35.37 77.86 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.033 0.833 . . . . 0.0 110.862 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.684 ' CB ' HD12 ' C' ' 50' ' ' LEU . 84.3 mt -80.53 132.58 35.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -130.05 130.83 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.503 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -129.73 129.22 43.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.959 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.46 26.36 15.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.56 90.53 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.594 ' HE3' HD22 ' D' ' 73' ' ' LEU . 26.4 mtpp -104.49 126.65 51.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.933 0.366 . . . . 0.0 110.02 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -69.72 132.66 46.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.684 HD12 ' CB ' ' C' ' 43' ' ' LEU . 68.6 mt -81.71 97.74 8.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.961 0.41 . . . . 0.0 110.31 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -75.03 139.13 42.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.8 135.87 57.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.263 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.55 -18.65 52.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -81.92 157.15 24.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.683 0.278 . . . . 0.0 110.304 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 43.6 p -99.69 162.21 13.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.065 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.463 HD21 HG21 ' C' ' 26' ' ' VAL . 75.8 mt -61.75 -39.07 90.31 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.282 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -63.28 -22.6 66.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.364 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.01 -38.69 89.6 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -97.2 14.53 25.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.379 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 57.05 39.86 28.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.023 0.439 . . . . 0.0 110.335 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.96 117.77 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.033 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -102.58 -170.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.351 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -69.72 152.47 44.62 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.545 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 51.59 39.1 24.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.452 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -90.63 125.03 35.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.303 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.515 ' C ' HD12 ' C' ' 67' ' ' LEU . 49.6 m -75.94 130.16 38.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.249 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.515 HD12 ' C ' ' C' ' 66' ' ' THR . 8.2 mp -119.05 156.17 30.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.566 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -105.21 121.49 43.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.448 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.425 HD11 HG21 ' C' ' 30' ' ' ILE . 0.5 OUTLIER -98.54 118.34 35.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.108 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 94.9 t -109.07 127.12 65.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.046 0.45 . . . . 0.0 110.243 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.521 ' HG ' HD23 ' C' ' 8' ' ' LEU . 18.9 mt -85.64 144.98 27.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.551 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -100.33 120.97 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.802 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 65.6 tp -122.83 130.06 52.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.281 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -67.46 146.58 53.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.476 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.8 143.79 15.74 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.02 169.6 54.8 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 54.9 p30 . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.646 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -64.84 161.37 18.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.229 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.473 HD12 HD22 ' D' ' 67' ' ' LEU . 9.3 pt -139.75 143.32 30.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.131 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -88.65 119.56 29.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 96.1 t -102.34 108.12 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.11 120.93 30.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.378 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.464 HG22 HD23 ' D' ' 69' ' ' LEU . 80.2 p -80.91 172.52 13.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.774 HD11 ' H ' ' D' ' 71' ' ' LEU . 87.7 mt -61.15 -37.77 84.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.031 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 43.1 p -72.12 -8.51 55.08 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.809 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.42 8.12 60.05 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -81.03 113.67 19.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 120.849 0.356 . . . . 0.0 110.158 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -86.14 134.2 33.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.685 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.5 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.4 mt -129.59 106.7 14.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.398 -178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -79.65 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.662 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.714 HD21 ' HG3' ' D' ' 33' ' ' LYS . 75.5 mt -123.77 124.02 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.661 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.04 114.5 7.38 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.895 0.379 . . . . 0.0 110.25 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.53 HG12 ' CD ' ' D' ' 29' ' ' LYS . 25.9 m -136.24 163.83 33.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.492 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . 0.43 ' O ' HD12 ' D' ' 56' ' ' LEU . 73.8 mm-40 -109.43 154.72 42.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.097 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -60.68 -28.62 86.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.79 1.66 . . . . 0.0 111.728 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 62.7 m -86.27 -10.17 55.08 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.707 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.7 144.4 57.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.529 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -79.12 162.6 25.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.022 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.602 HD12 HD23 ' D' ' 50' ' ' LEU . 27.4 mm -63.33 -39.23 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.927 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -59.2 -41.46 88.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.091 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.79 -41.01 97.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.117 0.484 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.462 HG21 HD21 ' D' ' 56' ' ' LEU . 58.0 t -62.79 -43.98 99.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.789 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.429 ' HG2' HD11 ' D' ' 43' ' ' LEU . 58.6 mtmt -61.06 -39.73 90.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.09 92.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.45 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.53 ' CD ' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -60.01 -40.71 90.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.558 HD12 ' OE1' ' D' ' 41' ' ' GLN . 91.7 mt -65.05 -41.35 91.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.179 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -59.95 -40.36 88.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.515 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -78.94 6.98 7.98 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.269 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.714 ' HG3' HD21 ' D' ' 15' ' ' LEU . 5.3 mttt -114.39 -52.75 2.7 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.635 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -107.42 -0.79 22.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.82 18.58 78.97 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 mm -80.25 119.23 75.82 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.09 154.25 52.31 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.921 1.747 . . . . 0.0 111.822 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.29 -40.01 79.2 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.314 2.009 . . . . 0.0 112.263 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.96 -39.25 91.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.546 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.69 32.2 2.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.902 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.558 ' OE1' HD12 ' D' ' 30' ' ' ILE . 8.2 tt0 -136.9 120.14 16.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -124.48 114.11 19.02 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.429 HD11 ' HG2' ' D' ' 27' ' ' LYS . 27.1 mt -96.05 128.63 43.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' D' ' 49' ' ' GLN . 66.2 mt -127.67 129.48 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.542 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 75.7 t80 -147.65 152.51 37.98 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.22 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.81 15.65 8.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.679 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 89.17 -15.33 58.47 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.649 ' HB3' HD22 ' A' ' 73' ' ' LEU . 41.2 ptt180 -113.78 146.52 39.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.135 0.493 . . . . 0.0 110.354 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.448 ' HA ' HG23 ' D' ' 44' ' ' ILE . 22.9 pt20 -71.35 139.23 49.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.255 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.829 HD21 HD11 ' D' ' 61' ' ' ILE . 7.7 mp -88.91 114.39 25.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.808 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . 0.443 ' O ' HG21 ' D' ' 23' ' ' ILE . 24.1 pt-20 -74.89 -169.12 0.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.672 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -81.54 -179.89 7.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.48 -146.2 44.13 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 50.56 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.344 0.593 . . . . 0.0 111.446 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 65.8 p -132.6 168.43 18.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.236 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.462 HD21 HG21 ' D' ' 26' ' ' VAL . 79.2 mt -61.83 -39.68 92.66 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.552 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 94.3 p -64.98 -26.82 68.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -62.72 -31.12 71.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.059 0.457 . . . . 0.0 109.897 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -101.31 13.15 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.51 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.2 m120 56.46 40.04 29.75 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.374 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . 0.829 HD11 HD21 ' D' ' 50' ' ' LEU . 88.6 mt -89.46 107.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.012 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -92.38 -177.16 4.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.423 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.93 150.56 49.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.993 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 60.44 45.97 10.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.347 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 57.5 m -94.87 123.7 38.48 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 31.5 m -77.77 80.23 4.23 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.179 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.473 HD22 HD12 ' D' ' 3' ' ' ILE . 10.7 mp -71.06 140.18 50.64 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.209 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -93.89 122.96 36.91 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.259 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.464 HD23 HG22 ' D' ' 7' ' ' THR . 40.3 tp -102.59 120.26 40.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.542 . . . . 0.0 110.26 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.54 HG11 HD11 ' A' ' 56' ' ' LEU . 91.6 t -111.9 130.87 64.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.596 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.774 ' H ' HD11 ' D' ' 8' ' ' LEU . 54.8 mt -105.69 142.06 36.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.86 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -62.82 -40.27 96.86 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.654 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.594 HD22 ' HE3' ' C' ' 48' ' ' LYS . 2.4 tt -122.9 121.16 35.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.565 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.54 140.81 58.59 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.178 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.66 -12.07 70.12 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 111.401 -0.679 . . . . 0.0 111.401 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.552 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -83.26 138.63 33.51 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.703 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -97.61 116.25 29.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.408 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.547 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.7 mt -67.13 -37.3 83.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.771 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.431 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.1 p -150.17 161.74 4.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.821 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -173.22 122.01 0.37 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.182 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.44 157.17 38.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.599 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -75.83 123.41 25.61 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.607 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -154.43 146.45 23.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.351 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.06 153.63 16.91 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -89.06 174.87 7.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.029 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 23.0 mtp -139.72 172.69 12.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.585 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -122.51 127.16 49.18 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 37' ' ' THR . 32.4 tp -107.58 117.19 33.45 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.49 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -120.6 111.84 18.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.813 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.17 -86.21 0.49 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.2 p -145.59 20.66 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 0.0 110.792 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.5 m -122.2 130.64 53.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.941 0.401 . . . . 0.0 110.467 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 33' ' ' LEU . 57.5 t -109.07 123.1 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.144 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.1 p -112.89 133.34 21.99 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.02 147.32 54.51 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.871 1.714 . . . . 0.0 113.055 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -101.5 117.21 34.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.85 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -59.42 -14.6 12.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.03 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -71.78 82.83 0.89 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -59.11 136.85 58.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.102 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.12 -159.64 9.2 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.971 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.603 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.4 tp -138.35 125.17 21.07 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' A' ' 28' ' ' ALA . 46.1 t -98.36 111.58 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -134.64 154.59 51.44 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.241 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.431 ' CG1' HG12 ' A' ' 24' ' ' VAL . 98.0 mt -121.11 138.03 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.14 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.42 133.62 34.95 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 123.675 0.609 . . . . 0.0 110.168 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.424 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.1 tt0 -102.18 126.37 49.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.031 0.443 . . . . 0.0 110.536 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' CD2' ' A' ' 58' ' ' HIS . 16.4 p -85.72 171.48 11.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.692 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.67 -10.69 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.705 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -88.78 0.41 56.53 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.631 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.2 t 70.78 21.04 5.34 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 121.171 0.51 . . . . 0.0 110.314 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD11 HG11 ' D' ' 70' ' ' VAL . 85.1 mt -98.54 121.7 40.81 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.547 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.0 mm -80.5 122.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.497 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.0 m-70 -98.92 115.64 29.34 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.719 -178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -98.59 107.83 20.38 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.91 143.12 51.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.551 -0.859 . . . . 0.0 112.941 -178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -116.95 117.19 29.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.827 -1.533 . . . . 0.0 108.298 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -106.72 146.05 31.29 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.355 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.9 128.49 34.58 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -70.41 -27.72 64.51 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -58.26 -36.75 73.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.853 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.9 m -116.75 -16.98 10.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.998 0.428 . . . . 0.0 110.241 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.4 21.87 79.18 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -102.4 151.1 22.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.603 0.24 . . . . 0.0 110.849 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.51 102.05 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.034 0.445 . . . . 0.0 110.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.5 -38.05 62.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.228 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -126.63 145.79 50.42 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.251 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.578 ' O ' HD23 ' A' ' 73' ' ' LEU . 17.8 t70 -157.47 101.58 1.86 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.184 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' D' ' 48' ' ' ARG . 37.5 mt -128.34 136.73 51.35 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.881 0.372 . . . . 0.0 110.72 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.3 123.61 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.417 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.522 ' HB ' HD22 ' A' ' 128' ' ' LEU . 26.2 mm -108.75 123.77 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.318 0.58 . . . . 0.0 111.466 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.531 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 56.5 m-85 -91.48 162.47 31.66 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.126 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.63 138.02 79.76 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.21 1.94 . . . . 0.0 111.778 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 59.1 11.81 2.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.452 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.37 -36.84 18.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.752 0.311 . . . . 0.0 110.492 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.468 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -140.41 145.12 36.64 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.506 -178.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.615 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.5 tt0 -121.73 135.24 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.616 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -106.29 120.24 41.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -143.06 166.82 23.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.831 -178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -84.34 160.13 20.74 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.087 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.23 89.74 12.72 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -79.84 60.12 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.799 1.666 . . . . 0.0 112.29 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 -114.07 -37.45 4.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.343 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.5 t -130.51 82.77 64.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.724 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.05 130.89 26.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.791 1.661 . . . . 0.0 111.477 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p 170.25 -38.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.692 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.38 -150.09 5.48 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.304 -0.719 . . . . 0.0 111.304 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.47 105.85 13.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.777 0.323 . . . . 0.0 110.429 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 91.4 t -125.87 128.23 71.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.129 0.49 . . . . 0.0 110.783 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -126.31 156.35 40.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.56 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 105' ' ' LEU . 12.4 p -133.15 136.07 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.514 . . . . 0.0 110.232 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 81' ' ' GLU . 57.3 tp -104.56 123.36 47.4 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -118.08 137.7 52.75 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.081 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -91.94 108.44 19.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.359 0.599 . . . . 0.0 110.056 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.8 -38.26 87.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.694 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.61 -22.38 24.78 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -100.33 -177.96 30.09 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.1 p -121.03 30.17 6.99 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.76 155.82 42.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.198 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.477 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.8 mtt180 -136.75 148.25 47.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.632 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 104' ' ' ARG . 36.7 mt -122.97 152.81 40.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.866 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.454 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 97.3 m-85 -125.22 136.86 53.98 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.553 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -138.87 156.31 47.4 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.295 0.569 . . . . 0.0 111.185 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -130.26 137.78 50.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.587 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttm -72.72 133.4 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.17 0.509 . . . . 0.0 111.887 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.89 4.74 21.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.437 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -71.95 139.58 82.79 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.03 -26.83 42.97 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.845 1.697 . . . . 0.0 112.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.63 141.8 48.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.928 0.394 . . . . 0.0 110.471 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.6 p -98.13 10.87 39.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.588 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -54.28 -21.61 9.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -130.02 16.52 5.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.1 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -62.17 -47.68 83.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.2 0.524 . . . . 0.0 110.253 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -74.49 -32.98 62.73 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.461 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.04 -46.54 83.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.531 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.791 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.8 m170 -63.87 -40.83 97.47 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.601 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 50.9 t -61.91 -45.37 94.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.804 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -64.72 -43.85 92.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.453 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.19 -36.28 83.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.881 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.5 t -58.83 -48.33 86.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.077 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -77.69 -29.56 51.47 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.741 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.61 -36.68 76.4 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.618 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -80.02 -31.42 39.61 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.754 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.522 HD22 ' HB ' ' A' ' 75' ' ' ILE . 56.0 mt -82.45 -27.67 31.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.191 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -103.23 -27.46 12.49 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.0 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -133.23 73.75 73.81 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.084 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' A' ' 57' ' ' ILE . 32.6 Cg_exo -59.38 156.66 34.62 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 123.119 2.546 . . . . 0.0 112.034 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.492 1.426 0 C-N-CA 122.486 2.124 . . . . 0.0 112.148 -179.456 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -129.56 152.02 78.97 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.666 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.83 146.94 26.83 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 122.68 2.253 . . . . 0.0 112.149 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.53 153.62 87.65 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.68 158.63 55.22 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.251 1.967 . . . . 0.0 112.021 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.24 -171.81 0.77 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.726 2.284 . . . . 0.0 112.056 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -119.06 159.15 46.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.545 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.04 141.91 86.22 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.503 2.136 . . . . 0.0 112.324 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.52 162.14 41.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.671 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -87.25 136.82 32.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.621 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -120.88 125.72 48.19 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.092 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.415 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.0 mp -130.67 123.14 54.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.588 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -82.06 83.73 7.22 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.899 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 66.2 t0 . . . . . 0 C--O 1.219 -0.541 0 CA-C-O 117.873 -1.06 . . . . 0.0 110.298 179.494 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.5 ttp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.96 157.47 18.51 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.203 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -139.66 144.86 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.993 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.451 ' HD2' HG21 ' C' ' 12' ' ' THR . 8.1 m-85 -88.93 123.34 33.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.127 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.585 HG11 HD11 ' C' ' 30' ' ' ILE . 80.5 t -109.02 105.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -85.77 127.65 34.59 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.72 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.458 HG22 HD23 ' C' ' 69' ' ' LEU . 73.1 p -77.95 -168.64 1.31 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.628 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' C' ' 70' ' ' VAL . 93.0 mt -59.85 -21.94 61.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.105 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 10.0 p -111.97 -174.39 2.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.147 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.22 -20.06 57.93 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -52.41 129.48 28.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.964 0.411 . . . . 0.0 110.783 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . 0.451 HG21 ' HD2' ' C' ' 4' ' ' PHE . 88.1 m -125.96 136.72 53.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.602 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.406 HG21 HD13 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -123.12 109.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.653 -179.262 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 41.9 m -84.16 132.97 34.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.271 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.766 HD21 ' HG3' ' C' ' 33' ' ' LYS . 77.0 mt -126.56 126.9 44.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.5 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -67.02 108.39 2.6 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.987 0.422 . . . . 0.0 110.866 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.789 HG12 ' HE3' ' C' ' 29' ' ' LYS . 21.6 m -131.47 164.03 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.122 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -105.89 155.05 38.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.312 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.22 -33.92 92.04 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.056 1.837 . . . . 0.0 111.984 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 70.9 m -85.21 -3.91 58.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.152 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -60.12 136.87 58.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.933 0.397 . . . . 0.0 110.857 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 58.9 p -79.07 160.53 27.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.564 HG21 ' O ' ' C' ' 50' ' ' LEU . 47.1 mm -64.29 -38.6 82.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.769 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.85 -42.14 88.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.138 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -62.07 -42.41 99.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.057 0.456 . . . . 0.0 110.558 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 56.5 t -61.96 -43.83 98.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.912 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.73 -39.62 89.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.285 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.02 89.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.256 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.789 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.7 mttm -59.89 -39.57 85.77 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.585 HD11 HG11 ' C' ' 5' ' ' VAL . 7.8 mm -64.52 -39.97 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.318 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -59.62 -39.32 83.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -87.05 9.61 19.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.806 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.766 ' HG3' HD21 ' C' ' 15' ' ' LEU . 2.8 mmtt -113.26 -42.51 3.5 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.796 0.331 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -123.7 2.41 8.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.362 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.12 79.43 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.588 HG22 ' HG3' ' C' ' 41' ' ' GLN . 51.5 mt -81.11 128.51 70.59 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.733 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.49 153.11 39.25 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.721 1.614 . . . . 0.0 111.62 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.96 -36.19 63.42 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 122.297 1.998 . . . . 0.0 112.594 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.96 -38.07 84.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.984 0.421 . . . . 0.0 110.428 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -95.85 17.88 14.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.31 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.588 ' HG3' HG22 ' C' ' 36' ' ' ILE . 90.6 mt-30 -112.53 103.73 11.81 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.138 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -114.53 109.83 18.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.57 ' HB3' HD12 ' C' ' 50' ' ' LEU . 69.8 mt -101.19 123.49 45.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.458 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 88.9 mt -128.9 127.99 66.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -125.28 128.66 48.61 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.69 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.74 27.03 16.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.41 89.72 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.421 ' HE3' HD23 ' D' ' 73' ' ' LEU . 49.4 mtpt -102.79 126.2 49.83 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.913 0.387 . . . . 0.0 110.179 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.89 130.22 42.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.425 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' C' ' 43' ' ' LEU . 55.7 mt -88.96 82.88 6.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.098 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -73.01 173.4 9.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -78.3 171.16 15.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.334 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.04 12.68 81.34 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -127.94 165.68 19.77 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 120.981 0.419 . . . . 0.0 110.58 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.42 167.78 11.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.523 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' C' ' 56' ' ' LEU . 82.7 mt -61.95 -39.77 93.24 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.369 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -62.82 -28.29 69.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.033 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -62.54 -29.27 70.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.979 0.419 . . . . 0.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.408 ' CE2' HD23 ' C' ' 50' ' ' LEU . 68.4 m-85 -102.95 13.46 34.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.29 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 56.35 40.48 29.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 110.239 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -89.56 108.88 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.073 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -93.09 -174.05 3.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.485 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -67.0 151.48 47.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.2 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 54.77 38.66 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.58 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 39.1 m -92.51 124.73 36.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.044 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.416 ' C ' HD12 ' C' ' 67' ' ' LEU . 28.0 m -75.94 129.46 36.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.97 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.416 HD12 ' C ' ' C' ' 66' ' ' THR . 6.3 mp -120.45 148.91 43.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.324 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -93.07 114.61 27.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.365 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.458 HD23 HG22 ' C' ' 7' ' ' THR . 54.3 tp -103.93 121.12 42.46 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.565 ' HA ' HD21 ' C' ' 8' ' ' LEU . 95.6 t -119.08 131.4 71.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.827 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.472 ' CD2' HD13 ' C' ' 36' ' ' ILE . 13.3 mt -101.41 80.77 2.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.157 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 55.34 179.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.707 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 79.6 mt -119.22 148.44 43.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.425 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -106.96 145.28 32.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.477 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.17 -39.96 97.88 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.67 161.42 54.23 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t0 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.647 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.4 ttp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -61.6 157.47 17.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.18 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 14.9 pt -138.18 147.56 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.059 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -88.68 123.27 32.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.301 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' D' ' 69' ' ' LEU . 64.8 t -108.21 102.7 14.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.636 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -92.94 120.73 33.56 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.664 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 81.5 p -81.37 173.48 12.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.623 HD11 ' H ' ' D' ' 71' ' ' LEU . 74.6 mt -61.73 -26.78 68.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.147 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -72.29 -12.98 61.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.928 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.22 -13.6 63.06 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.49 132.95 49.37 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 96.2 m -103.64 132.58 49.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.661 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 mt -126.86 108.83 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -81.04 128.65 33.95 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.484 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.647 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.6 mt -125.17 127.76 47.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.599 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -69.33 114.77 7.88 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.716 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.579 HG12 ' HE2' ' D' ' 29' ' ' LYS . 23.3 m -134.88 165.41 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.543 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -108.64 153.83 42.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.217 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.11 -35.08 94.53 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.928 1.752 . . . . 0.0 112.243 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 68.5 m -86.49 -2.59 58.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.166 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . 0.549 ' OD1' HG23 ' D' ' 26' ' ' VAL . 18.8 t70 -61.38 133.68 56.08 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.959 0.409 . . . . 0.0 110.957 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.668 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.434 HD12 HD13 ' D' ' 50' ' ' LEU . 48.7 mm -64.16 -38.71 83.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -59.39 -42.05 90.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.096 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.1 -41.75 98.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 110.904 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.549 HG23 ' OD1' ' D' ' 21' ' ' ASP . 57.5 t -63.6 -42.24 95.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.484 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -60.92 -38.83 87.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.407 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.91 -39.84 90.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.064 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.579 ' HE2' HG12 ' D' ' 17' ' ' VAL . 61.4 mttp -59.98 -39.74 86.75 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.805 ' CD1' HD21 ' D' ' 43' ' ' LEU . 88.9 mt -65.05 -40.48 89.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.449 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.58 -40.8 93.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -63.66 -43.48 96.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.647 ' HD2' HD21 ' D' ' 15' ' ' LEU . 62.4 mttt -75.24 -72.74 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.951 0.405 . . . . 0.0 111.134 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -84.63 166.99 16.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.173 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.77 15.08 56.71 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.578 HG22 ' HG3' ' D' ' 41' ' ' GLN . 33.3 mm -70.39 124.8 91.5 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.174 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.93 155.79 43.28 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.026 1.817 . . . . 0.0 111.585 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.67 -40.89 82.25 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.993 1.795 . . . . 0.0 112.971 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.89 -45.28 94.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.898 0.38 . . . . 0.0 110.966 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -69.92 -38.73 76.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.741 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.578 ' HG3' HG22 ' D' ' 36' ' ' ILE . 59.9 mt-30 -54.46 106.12 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.35 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -118.9 88.12 2.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.805 HD21 ' CD1' ' D' ' 30' ' ' ILE . 77.3 mt -74.39 129.19 37.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.361 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.536 HD12 HG21 ' D' ' 70' ' ' VAL . 79.0 mt -131.0 129.75 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.527 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.456 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 73.2 t80 -150.69 154.61 37.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.777 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.65 19.58 9.75 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.774 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.68 80.13 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -127.38 147.55 50.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.097 0.475 . . . . 0.0 110.45 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -71.61 141.01 49.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.068 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' D' ' 43' ' ' LEU . 82.7 mt -74.9 115.85 14.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.797 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.96 139.54 41.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.87 143.92 57.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.17 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.67 69.23 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -83.58 179.01 7.74 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.765 0.317 . . . . 0.0 110.773 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -126.1 163.65 22.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.285 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 85.8 mt -62.79 -39.88 95.62 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.543 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.07 -29.2 70.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.958 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.16 -35.14 76.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.044 0.45 . . . . 0.0 110.122 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . 0.474 ' CE2' HD23 ' D' ' 50' ' ' LEU . 59.2 m-85 -97.31 14.15 27.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.246 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 54.65 40.81 32.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.851 0.358 . . . . 0.0 110.329 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.83 107.24 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.308 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -93.95 177.32 6.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.343 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -59.66 150.49 27.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.248 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 58.92 40.34 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . 0.434 ' O ' HD12 ' D' ' 67' ' ' LEU . 30.2 t -97.31 123.4 41.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.186 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 69.0 m -74.97 127.55 33.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.0 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.434 HD12 ' O ' ' D' ' 65' ' ' SER . 5.3 mp -118.22 146.76 44.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.887 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -95.89 117.48 30.68 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.093 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.607 HD11 HD13 ' D' ' 30' ' ' ILE . 0.6 OUTLIER -93.99 97.67 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.1 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.536 HG21 HD12 ' D' ' 44' ' ' ILE . 46.1 t -83.96 134.6 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.095 0.474 . . . . 0.0 110.478 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.623 ' H ' HD11 ' D' ' 8' ' ' LEU . 75.3 mt -105.96 -177.49 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.59 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -127.04 165.15 20.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.571 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.517 ' H ' HD12 ' D' ' 73' ' ' LEU . 1.8 mp -65.75 138.68 58.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -146.55 104.18 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.493 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.0 24.57 76.4 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -74.77 147.51 41.23 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.419 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -89.4 112.26 23.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.331 0.586 . . . . 0.0 109.898 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 51' ' ' GLN . 88.6 mt -65.2 -38.25 89.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.606 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -151.36 162.93 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.115 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -172.82 122.58 0.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.262 0.553 . . . . 0.0 110.969 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -157.51 159.89 37.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.076 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -75.62 120.64 21.3 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.724 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.45 140.81 18.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.074 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.16 150.79 17.11 Favored Glycine 0 C--O 1.226 -0.347 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -95.03 177.38 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.99 0.424 . . . . 0.0 111.068 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.3 mtp -140.35 168.44 19.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.0 m -119.03 120.94 38.7 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.745 HD12 ' O ' ' A' ' 37' ' ' THR . 52.6 tp -101.13 123.43 45.27 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.919 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -119.54 104.02 9.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.091 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.57 -81.14 0.86 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.6 p -146.84 19.07 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.562 0.22 . . . . 0.0 110.973 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.745 ' O ' HD12 ' A' ' 33' ' ' LEU . 94.7 m -120.85 128.97 53.33 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.535 HG22 HD13 ' A' ' 33' ' ' LEU . 63.5 t -103.0 123.21 56.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.144 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.6 p -110.46 114.5 55.09 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -57.54 141.04 95.09 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.121 1.88 . . . . 0.0 112.621 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -97.98 113.03 24.76 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -59.58 -18.29 39.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.541 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -75.43 73.57 2.48 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -56.04 137.21 51.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.313 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.65 -152.98 8.45 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.508 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -137.12 124.24 21.66 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 t -96.49 107.28 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 42.2 p90 -130.96 153.34 49.3 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.927 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 23' ' ' LEU . 96.6 mt -119.54 140.88 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.658 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -136.6 132.93 35.77 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 123.787 0.679 . . . . 0.0 109.936 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.689 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.1 tt0 -100.53 123.46 44.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.09 0.471 . . . . 0.0 110.182 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.449 HG23 ' CD2' ' A' ' 58' ' ' HIS . 7.6 p -84.26 168.86 15.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.787 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -62.13 -10.38 10.16 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.929 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -91.03 6.66 43.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.629 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 36.7 m 63.88 23.66 13.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.234 0.54 . . . . 0.0 110.93 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 76.8 mt -100.02 122.85 43.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.658 HG21 HD23 ' A' ' 128' ' ' LEU . 50.6 mm -81.06 121.89 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.449 ' CD2' HG23 ' A' ' 52' ' ' THR . 75.6 m-70 -98.77 114.17 26.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.786 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -95.18 107.83 19.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 72.4 m -120.62 146.61 46.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.665 0.745 . . . . 0.0 112.648 -177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -125.86 112.68 16.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.578 -1.192 . . . . 0.0 108.583 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -105.16 128.89 53.6 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.829 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -71.16 136.56 48.19 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.21 -17.19 58.68 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.714 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.7 m -60.49 -45.25 94.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.593 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.5 m -116.58 -16.28 10.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.085 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.77 20.84 79.33 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -102.07 145.82 28.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.656 0.265 . . . . 0.0 110.388 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.6 t -73.27 103.62 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.091 0.472 . . . . 0.0 110.215 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -79.91 -32.91 40.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.766 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -126.32 145.27 50.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.202 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.593 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.2 p-10 -160.83 98.32 1.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 72' ' ' ASP . 34.2 mt -128.26 137.1 51.84 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.01 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.12 123.11 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.672 ' HB ' HD22 ' A' ' 128' ' ' LEU . 29.4 mm -111.27 121.05 63.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.13 0.49 . . . . 0.0 110.599 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.539 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 50.7 m-85 -85.12 163.65 44.7 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.257 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.17 138.33 82.71 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.813 1.675 . . . . 0.0 111.785 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 59.58 12.68 2.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.449 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.2 -38.66 24.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.44 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB3' HD11 ' A' ' 96' ' ' LEU . 85.3 m -129.87 155.78 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.122 0.486 . . . . 0.0 110.99 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB2' ' HE3' ' A' ' 99' ' ' LYS . 2.1 tt0 -126.11 130.46 51.12 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.543 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.59 117.64 35.14 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -138.56 162.98 33.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.527 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -82.08 161.35 22.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.388 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.54 88.89 14.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.331 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -82.24 60.41 7.38 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.145 1.897 . . . . 0.0 112.084 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -114.45 -39.53 3.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.44 78.09 76.27 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.519 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.59 130.43 40.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.271 1.981 . . . . 0.0 111.178 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 169.12 -34.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.111 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.45 -165.77 12.36 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.508 ' HD3' HG22 ' A' ' 114' ' ' THR . 4.2 mtt-85 -96.78 105.18 17.26 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.875 0.369 . . . . 0.0 110.18 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.3 t -126.38 128.24 71.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.78 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -124.93 160.52 28.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.009 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 105' ' ' LEU . 9.7 p -135.16 135.96 51.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.952 0.406 . . . . 0.0 110.044 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 80' ' ' CYS . 58.6 tp -101.61 123.51 45.75 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -120.39 140.39 51.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.147 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.413 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 21.6 m-85 -88.34 116.92 26.89 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 98.5 mttt -62.35 -37.38 85.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.832 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.87 -19.78 18.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.533 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -106.58 -178.39 23.11 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.0 m -114.89 13.46 17.1 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.661 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.611 ' HD3' HD21 ' A' ' 105' ' ' LEU . 25.5 ttmt -84.98 142.81 29.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 121.227 0.537 . . . . 0.0 110.983 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -136.07 121.47 19.3 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.556 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.611 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.0 mt -111.35 152.46 27.25 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.79 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CE1' HD22 ' A' ' 33' ' ' LEU . 91.8 m-85 -126.18 136.63 53.08 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.443 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.62 153.77 49.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.249 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -129.66 138.6 51.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.599 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.55 136.25 49.16 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.82 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.94 -1.04 26.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.451 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -79.0 131.86 65.47 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.296 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.9 -18.6 46.83 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.081 1.854 . . . . 0.0 112.727 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -113.74 140.34 48.35 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.285 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.508 HG22 ' HD3' ' A' ' 92' ' ' ARG . 79.1 p -96.06 8.19 44.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.644 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.61 -16.97 62.35 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.604 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -131.98 -5.37 3.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.625 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.38 -41.69 98.81 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.942 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -74.17 -34.53 63.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.956 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.55 -42.31 92.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.156 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.701 ' O ' HG23 ' A' ' 124' ' ' VAL . 67.9 m170 -63.6 -41.74 98.3 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 51.9 t -60.98 -44.23 97.68 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.299 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -66.79 -43.59 83.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.939 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -63.71 -40.09 95.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.145 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 120' ' ' HIS . 47.3 t -58.71 -48.1 86.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.203 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -80.24 -22.1 42.12 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.406 -0.917 . . . . 0.0 111.105 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.85 -39.86 69.42 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.475 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.571 ' HB3' HD13 ' A' ' 23' ' ' LEU . 31.1 m-85 -79.88 -35.89 37.37 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.551 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 75' ' ' ILE . 70.9 mt -71.15 -36.7 72.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.079 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -98.4 -27.83 13.91 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.333 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -134.48 73.59 67.99 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.894 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.479 ' HB3' HD11 ' A' ' 57' ' ' ILE . 35.2 Cg_exo -59.67 155.88 40.35 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.958 2.439 . . . . 0.0 112.286 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 N--CA 1.492 1.387 0 C-N-CA 122.544 2.163 . . . . 0.0 112.042 -179.718 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.27 80.97 69.55 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.097 -0.241 . . . . 0.0 110.601 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.69 141.92 91.5 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.595 2.196 . . . . 0.0 112.147 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.21 153.6 94.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.063 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.98 149.22 77.22 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.018 1.812 . . . . 0.0 112.244 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -54.96 -172.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.352 2.035 . . . . 0.0 111.851 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -125.15 159.55 58.89 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.93 138.84 78.73 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.511 2.141 . . . . 0.0 112.431 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -155.71 163.87 39.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.645 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 52.9 mp0 -86.58 137.63 32.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.359 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -125.18 129.23 49.71 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.188 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 38.3 mt -132.41 129.92 59.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -72.32 84.66 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.83 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.619 179.747 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -63.84 159.02 20.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.158 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.5 pt -138.95 150.84 23.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.983 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -94.11 124.08 37.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.552 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 92.7 t -108.58 115.61 49.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.192 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -93.35 129.92 39.29 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.506 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.469 HG22 HD23 ' C' ' 69' ' ' LEU . 76.8 p -92.9 175.42 6.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.278 0.561 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.751 HD11 ' H ' ' C' ' 71' ' ' LEU . 81.9 mt -62.43 -37.7 86.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.295 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -70.05 -10.0 57.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.852 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.36 -11.66 65.2 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -64.36 130.81 45.24 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.749 0.309 . . . . 0.0 110.367 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -106.48 131.15 54.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.946 0.403 . . . . 0.0 110.409 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.94 118.21 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.527 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.9 m -85.1 130.37 34.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.328 -0.549 . . . . 0.0 110.303 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.561 HD21 ' HG3' ' C' ' 33' ' ' LYS . 93.0 mt -123.41 127.1 47.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.241 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.39 113.72 8.72 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.825 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.471 HG12 ' CD ' ' C' ' 29' ' ' LYS . 21.3 m -136.43 167.36 24.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.79 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.601 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.8 mt-10 -116.94 152.24 48.42 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.56 -43.9 51.45 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.026 1.817 . . . . 0.0 112.485 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 45.9 t -64.21 -37.13 86.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.242 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -41.65 133.07 2.77 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.106 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -82.4 167.9 18.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.307 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.678 HD12 HD23 ' C' ' 50' ' ' LEU . 35.8 mm -62.03 -35.78 70.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.041 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.47 -42.53 87.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.084 0.469 . . . . 0.0 110.377 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.96 -41.38 91.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.231 0.538 . . . . 0.0 110.875 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.541 HG21 HD21 ' C' ' 56' ' ' LEU . 62.9 t -64.43 -46.41 93.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.796 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -62.81 -32.5 73.7 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.255 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.29 98.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.059 0.457 . . . . 0.0 110.099 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.471 ' CD ' HG12 ' C' ' 17' ' ' VAL . 66.8 mttm -60.78 -39.4 88.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.163 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.745 ' CD1' HD21 ' C' ' 43' ' ' LEU . 93.2 mt -64.64 -40.37 88.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.981 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.86 -42.5 93.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.488 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.15 -40.13 95.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.416 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.561 ' HG3' HD21 ' C' ' 15' ' ' LEU . 18.2 mttt -74.66 -60.73 2.15 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.94 0.4 . . . . 0.0 111.525 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -106.73 155.33 19.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.83 55.23 4.21 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.592 HG23 HD22 ' C' ' 71' ' ' LEU . 30.4 mm -109.64 113.26 58.04 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.44 150.66 58.41 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.664 1.576 . . . . 0.0 111.621 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.46 -38.35 43.66 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.193 1.929 . . . . 0.0 112.474 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.24 -39.18 89.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.353 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -89.92 -2.32 58.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.245 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -86.19 100.7 12.42 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.208 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -104.32 100.46 10.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.745 HD21 ' CD1' ' C' ' 30' ' ' ILE . 59.5 mt -96.7 117.97 32.15 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.469 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 93.9 mt -126.36 128.26 71.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.857 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -128.41 130.46 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.674 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.93 24.52 14.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.503 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.73 3.04 90.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.703 ' HE3' HD22 ' D' ' 73' ' ' LEU . 61.2 mtpt -106.96 128.51 54.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -69.68 133.04 47.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.306 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.678 HD23 HD12 ' C' ' 23' ' ' ILE . 7.6 mp -80.33 95.61 6.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.47 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -75.22 139.01 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.339 0.59 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -59.43 150.74 25.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.396 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.88 -13.38 64.66 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -94.9 151.61 19.07 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.255 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 52.9 p -92.26 164.22 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.193 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.601 HD12 ' O ' ' C' ' 18' ' ' GLU . 81.4 mt -62.02 -39.05 90.95 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.577 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.4 p -62.48 -23.93 67.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.625 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -61.71 -38.25 87.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.12 0.486 . . . . 0.0 110.174 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -96.86 16.21 19.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.339 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 56.28 40.38 29.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.925 0.393 . . . . 0.0 110.521 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 84.3 mt -91.78 113.52 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.0 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -102.22 -170.83 1.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -69.62 149.08 48.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 57.27 35.54 26.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.629 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 58.0 m -91.28 128.23 37.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.984 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.482 ' C ' HD12 ' C' ' 67' ' ' LEU . 89.6 m -78.97 128.19 32.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.986 0.422 . . . . 0.0 110.485 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.482 HD12 ' C ' ' C' ' 66' ' ' THR . 8.3 mp -117.0 139.88 50.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -87.44 111.36 21.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.469 HD23 HG22 ' C' ' 7' ' ' THR . 59.1 tp -102.55 120.6 40.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.555 ' HA ' HD21 ' C' ' 8' ' ' LEU . 97.9 t -119.4 137.68 52.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.19 0.519 . . . . 0.0 110.254 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.751 ' H ' HD11 ' C' ' 8' ' ' LEU . 24.9 mt -105.55 142.71 34.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -62.79 -39.71 95.09 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.593 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 67.1 tp -104.04 124.64 49.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 mmm-85 -73.33 146.7 45.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.386 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.15 179.29 53.4 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.81 -40.04 97.63 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 17.5 t0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.685 179.93 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.01 161.19 24.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.829 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.525 HD13 HD21 ' D' ' 56' ' ' LEU . 16.1 pt -142.87 145.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.015 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -92.24 123.29 35.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.647 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.439 HG11 HD12 ' D' ' 69' ' ' LEU . 93.9 t -103.22 109.8 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.388 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -87.63 120.93 29.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.519 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 82.5 p -80.86 170.98 15.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.787 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.79 HD11 ' H ' ' D' ' 71' ' ' LEU . 82.3 mt -64.35 -25.16 67.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.029 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -86.52 -0.99 57.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.848 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.43 -7.32 80.27 Favored Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.78 115.66 7.59 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 70.0 m -92.82 135.62 33.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.252 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.2 105.6 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.896 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.11 122.89 26.8 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' D' ' 29' ' ' LYS . 92.0 mt -122.22 131.86 54.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.42 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -75.88 114.4 14.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.01 0.433 . . . . 0.0 110.507 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.696 HG12 ' HE3' ' D' ' 29' ' ' LYS . 24.5 m -133.98 167.01 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.473 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -112.34 154.95 44.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.98 -37.89 95.46 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.901 1.734 . . . . 0.0 111.815 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.2 p -77.92 -9.95 59.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.079 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.19 134.66 57.2 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.731 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -79.11 163.08 25.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.226 0.536 . . . . 0.0 110.525 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.835 HD12 HD23 ' D' ' 50' ' ' LEU . 47.2 mm -63.16 -38.27 81.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.91 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -60.07 -39.89 87.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.143 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -62.38 -41.1 98.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.273 0.559 . . . . 0.0 110.549 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.792 HG21 HD11 ' D' ' 56' ' ' LEU . 73.1 t -63.3 -42.91 98.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.461 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -60.89 -40.01 91.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.295 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.42 90.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.172 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.696 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -59.75 -38.71 82.54 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.802 ' CD1' HD21 ' D' ' 43' ' ' LEU . 86.6 mt -64.49 -41.34 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.068 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.51 -45.52 93.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.243 0.544 . . . . 0.0 110.649 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -67.69 -32.01 72.37 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.855 -0.528 . . . . 0.0 111.276 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.438 ' HD2' HD21 ' D' ' 15' ' ' LEU . 7.7 mttm -92.25 -3.51 55.39 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 82.1 mm-40 -148.48 -49.91 0.16 Allowed 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.06 10.46 15.79 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.208 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.469 HD13 HD21 ' D' ' 71' ' ' LEU . 33.5 mt -82.14 118.76 73.18 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.885 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -58.43 153.13 49.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.943 1.762 . . . . 0.0 111.47 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -54.36 -40.92 80.75 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.985 1.79 . . . . 0.0 112.184 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -69.9 -38.94 76.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -62.34 -39.7 93.96 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.811 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.464 ' HB3' HG21 ' D' ' 36' ' ' ILE . 0.0 OUTLIER -102.72 144.27 31.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.273 0.559 . . . . 0.0 111.384 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -124.89 117.29 23.75 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.802 HD21 ' CD1' ' D' ' 30' ' ' ILE . 73.3 mt -83.78 126.93 33.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.463 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.85 131.4 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.457 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 80.3 t80 -148.47 153.11 38.03 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.916 0.388 . . . . 0.0 111.074 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 68.02 16.28 9.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.84 -9.23 72.68 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.407 ' HB3' HD22 ' A' ' 73' ' ' LEU . 12.8 ptm180 -119.74 145.89 46.14 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.936 0.398 . . . . 0.0 110.277 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.33 141.34 50.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.202 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.835 HD23 HD12 ' D' ' 23' ' ' ILE . 7.1 mp -83.37 111.85 19.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.951 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -75.32 135.88 40.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.787 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -57.75 149.95 20.93 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.453 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.44 -16.21 60.48 Favored Glycine 0 CA--C 1.529 0.961 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -85.77 170.27 12.61 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.336 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 66.5 p -113.13 157.33 21.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.965 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.792 HD11 HG21 ' D' ' 26' ' ' VAL . 3.8 mp -57.91 -39.61 78.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.625 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 88.0 p -63.14 -23.46 67.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.299 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.98 -37.56 87.63 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.131 0.491 . . . . 0.0 109.932 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -97.74 10.73 39.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.295 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 62.1 t30 57.34 42.54 24.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.396 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . 0.764 HD11 HD21 ' D' ' 50' ' ' LEU . 66.8 mt -86.51 108.14 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.963 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -93.84 175.65 6.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.384 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -58.85 150.76 23.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.164 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 59.25 46.58 12.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.973 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 27.1 t -96.74 123.34 40.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.185 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -80.34 85.84 5.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.908 0.385 . . . . 0.0 110.347 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.509 HD22 HD12 ' D' ' 3' ' ' ILE . 7.4 mp -73.2 150.06 42.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.118 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -99.83 124.87 45.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.36 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.448 HD11 HG21 ' D' ' 30' ' ' ILE . 2.9 tt -101.77 117.51 35.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.918 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.678 HG11 HD11 ' A' ' 56' ' ' LEU . 90.9 t -111.29 129.55 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.134 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.79 ' H ' HD11 ' D' ' 8' ' ' LEU . 66.8 mt -104.93 140.4 38.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.344 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.57 -80.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.703 HD22 ' HE3' ' C' ' 48' ' ' LYS . 94.4 mt -139.43 149.06 43.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.736 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -92.65 35.93 1.02 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.379 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.72 23.77 77.3 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 179.8 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -82.76 138.3 34.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.783 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -92.8 113.28 25.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.279 0.562 . . . . 0.0 109.524 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.55 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.1 mt -65.75 -38.31 88.77 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.609 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.6 162.47 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.796 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.29 122.49 0.37 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.831 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -155.61 157.68 37.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.877 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 46' ' ' LEU . 81.7 mtt85 -75.58 121.78 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.983 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -153.57 144.1 22.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.256 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.58 150.65 16.85 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -90.47 175.16 7.18 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.002 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 17.4 mtp -138.96 174.17 10.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.7 m -124.05 125.71 45.0 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 37' ' ' THR . 25.3 tp -106.58 118.58 37.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -121.37 108.88 14.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.772 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.61 0.51 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.5 p -137.5 20.19 2.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.273 -0.171 . . . . 0.0 110.781 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 33' ' ' LEU . 85.2 m -122.55 131.73 53.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 33' ' ' LEU . 62.1 t -111.48 123.52 67.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.028 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.5 p -113.5 132.01 22.71 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.147 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.25 146.2 50.59 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.919 1.746 . . . . 0.0 113.32 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -98.4 119.9 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.45 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -64.0 -14.92 57.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.752 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.8 mtm-85 -74.45 74.02 1.91 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 109.962 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -49.91 139.35 13.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.762 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.66 -159.09 8.88 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.651 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.1 tp -137.03 125.12 22.92 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.8 t -97.51 110.02 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -133.43 153.71 51.38 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.51 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.7 mt -119.64 139.3 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.093 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -136.8 132.42 34.66 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 123.651 0.594 . . . . 0.0 109.464 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.525 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.2 tt0 -100.77 125.1 47.22 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.1 p -85.34 171.99 11.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -65.16 -9.54 23.92 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.13 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -89.55 0.74 56.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.462 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 t 70.4 21.02 5.83 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 121.173 0.511 . . . . 0.0 110.351 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.678 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 74.7 mt -99.23 122.6 42.62 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.55 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.8 mm -80.6 122.57 36.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.463 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.474 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.9 m-70 -98.65 114.44 26.92 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.763 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -97.77 107.9 20.5 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 143.96 50.89 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 119.687 -0.805 . . . . 0.0 113.125 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -118.9 117.12 27.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.129 -1.396 . . . . 0.0 108.569 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -106.34 144.76 32.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.373 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -83.11 131.31 35.15 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -72.86 -16.69 61.58 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.733 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.9 m -59.69 -45.16 92.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.367 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.1 m -116.63 -14.01 10.84 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.093 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.92 22.29 77.1 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -102.25 152.66 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.7 t -80.61 102.71 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.221 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -73.44 -37.38 65.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.913 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -127.24 145.18 50.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.121 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.575 ' O ' HD23 ' A' ' 73' ' ' LEU . 66.7 t0 -158.08 99.76 1.67 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 72' ' ' ASP . 35.1 mt -127.34 136.83 52.46 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.944 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.3 124.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.272 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.703 HG21 ' SG ' ' A' ' 80' ' ' CYS . 29.0 mm -113.46 121.77 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.121 0.486 . . . . 0.0 110.861 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.678 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 67.5 m-85 -88.37 162.8 38.73 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.382 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.42 139.11 86.31 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.972 1.781 . . . . 0.0 111.585 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 59.75 12.82 3.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.313 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -86.44 -25.78 25.04 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.703 ' SG ' HG21 ' A' ' 75' ' ' ILE . 13.7 p -145.92 168.09 21.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.431 0.634 . . . . 0.0 110.38 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -135.24 126.56 28.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.91 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -102.14 116.77 33.38 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -145.18 167.26 23.19 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.012 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.53 160.02 19.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.131 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.56 89.78 13.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.148 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.74 59.76 7.55 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.925 1.75 . . . . 0.0 112.12 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -114.88 -39.07 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.627 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 40.4 t -124.0 86.99 53.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.479 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.15 130.0 23.11 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.593 1.528 . . . . 0.0 111.486 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 p 167.37 -29.69 0.0 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.56 178.52 34.74 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.472 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.01 113.38 20.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.023 0.439 . . . . 0.0 111.122 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.94 127.78 66.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.03 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -120.44 152.58 37.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.839 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.9 132.75 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.385 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.568 HD11 ' SG ' ' A' ' 80' ' ' CYS . 65.6 tp -102.24 121.35 42.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -119.76 130.81 55.14 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.47 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -79.99 115.23 19.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.267 0.556 . . . . 0.0 109.648 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.0 -37.67 85.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.385 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.09 -21.75 21.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.565 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.96 -175.65 22.88 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.3 p -116.47 12.96 15.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.601 0.239 . . . . 0.0 110.534 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.503 ' HD3' HD21 ' A' ' 105' ' ' LEU . 11.9 ttmm -89.7 142.62 27.52 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.977 0.417 . . . . 0.0 111.101 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 91.5 mtm180 -134.29 133.01 40.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.174 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.503 HD21 ' HD3' ' A' ' 103' ' ' LYS . 48.4 mt -115.55 149.44 38.19 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.716 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -123.31 137.86 54.75 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.608 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -138.63 156.73 47.2 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.241 0.543 . . . . 0.0 111.307 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -131.75 135.58 46.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.272 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 137.7 57.85 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.66 -0.19 13.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.287 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.99 149.76 73.99 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.487 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.49 -31.14 28.0 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.13 1.887 . . . . 0.0 112.765 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -123.63 142.29 51.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.125 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -94.29 5.7 50.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.763 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -59.04 -21.05 58.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -118.72 -15.14 9.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.0 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -63.95 -39.58 94.46 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.116 0.484 . . . . 0.0 110.411 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -64.45 -35.14 79.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.017 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.89 -40.96 83.44 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.126 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 124' ' ' VAL . 65.1 m170 -61.36 -39.47 90.73 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.183 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 52.0 t -61.71 -44.83 96.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.454 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -67.96 -39.41 83.39 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.914 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -66.4 -42.2 88.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.746 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -58.07 -46.48 88.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.021 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -63.97 -38.57 91.56 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.561 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -75.55 -23.44 56.6 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.231 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 18.1 m-85 -87.51 -29.09 21.61 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 57' ' ' ILE . 73.8 mt -92.85 -18.3 23.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.614 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -116.33 -18.81 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -137.99 65.37 44.43 Favored Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.094 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.49 151.76 70.65 Favored 'Trans proline' 0 C--N 1.296 -2.198 0 C-N-CA 122.612 2.208 . . . . 0.0 112.243 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 C-N-CA 122.412 2.074 . . . . 0.0 112.147 -179.844 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.85 154.71 81.99 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.539 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.92 147.19 49.1 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.584 2.189 . . . . 0.0 111.951 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -84.03 153.87 63.62 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.36 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -58.77 144.13 98.48 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.595 2.196 . . . . 0.0 112.209 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.14 -174.77 2.38 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.32 2.013 . . . . 0.0 111.849 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -111.58 160.27 30.09 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.581 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.75 147.23 89.23 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.687 2.258 . . . . 0.0 112.231 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -151.08 163.34 39.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.835 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.01 137.34 32.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 110.648 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -122.42 122.54 39.23 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.921 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 47.6 mt -132.26 125.13 53.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -79.23 84.25 5.2 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.045 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 32.7 t0 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.59 179.715 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.1 ttp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -58.96 163.19 3.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.029 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.501 HD12 ' CD1' ' C' ' 67' ' ' LEU . 20.1 pt -143.02 139.59 27.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.006 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.692 ' HD2' HG21 ' C' ' 12' ' ' THR . 5.4 m-85 -83.86 121.91 27.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.27 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.793 HG11 HD11 ' C' ' 30' ' ' ILE . 90.6 t -107.02 106.12 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -87.88 133.84 33.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.301 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.899 HG22 HD23 ' C' ' 69' ' ' LEU . 77.2 p -97.18 170.93 8.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.609 0.719 . . . . 0.0 111.742 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.682 ' CD1' HG23 ' C' ' 9' ' ' THR . 0.3 OUTLIER -66.35 -13.41 60.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.884 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.682 HG23 ' CD1' ' C' ' 8' ' ' LEU . 58.4 p -93.1 -0.5 57.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.488 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.02 -9.41 77.88 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.0 131.46 39.56 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 120.674 0.273 . . . . 0.0 110.412 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . 0.692 HG21 ' HD2' ' C' ' 4' ' ' PHE . 97.9 m -107.73 132.57 53.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.897 0.379 . . . . 0.0 110.698 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.41 HD13 HG21 ' C' ' 13' ' ' ILE . 0.4 OUTLIER -120.83 100.68 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.257 -179.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 33.1 m -75.5 127.2 32.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.492 HD13 ' CB ' ' C' ' 29' ' ' LYS . 83.7 mt -120.49 124.64 45.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.602 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.01 112.68 3.96 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.383 0.611 . . . . 0.0 110.701 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.536 HG12 ' HE3' ' C' ' 29' ' ' LYS . 24.1 m -135.24 164.27 33.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -106.37 153.88 40.17 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.49 -36.48 94.33 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.99 1.793 . . . . 0.0 112.026 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 71.2 m -82.08 -6.56 59.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -60.44 135.25 57.69 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -76.65 161.39 28.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.299 0.571 . . . . 0.0 110.903 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' C' ' 50' ' ' LEU . 45.1 mm -64.59 -39.62 86.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.214 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.28 -39.55 87.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.93 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.54 -42.96 99.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.277 0.56 . . . . 0.0 110.381 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.402 HG22 HG11 ' C' ' 17' ' ' VAL . 54.3 t -62.07 -42.62 95.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.71 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -60.92 -38.02 84.31 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.33 89.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.536 ' HE3' HG12 ' C' ' 17' ' ' VAL . 67.3 mttm -60.38 -38.14 82.98 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.793 HD11 HG11 ' C' ' 5' ' ' VAL . 6.8 mm -63.55 -41.0 91.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.927 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -61.68 -46.05 91.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -73.85 -13.75 60.97 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -104.96 -12.49 16.17 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -141.33 -37.09 0.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.068 0.461 . . . . 0.0 110.461 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.77 14.42 27.17 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.488 HG21 HD22 ' C' ' 71' ' ' LEU . 34.9 mt -89.16 117.68 68.46 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.12 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.13 146.56 94.03 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.994 . . . . 0.0 111.397 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.99 -39.5 69.33 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.049 1.833 . . . . 0.0 112.294 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.99 -31.14 70.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.726 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -83.87 -10.5 57.97 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.636 ' HB2' HD11 ' C' ' 69' ' ' LEU . 28.6 pt20 -121.78 145.18 48.31 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.143 0.497 . . . . 0.0 111.105 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -127.66 131.03 49.88 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.648 ' CB ' HD12 ' C' ' 50' ' ' LEU . 72.7 mt -102.68 122.24 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.105 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -126.97 126.63 68.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.378 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . 0.406 ' CD1' HD23 ' C' ' 67' ' ' LEU . 49.7 t80 -116.06 119.94 37.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.946 0.403 . . . . 0.0 110.909 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.54 39.45 30.07 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.064 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.99 14.79 80.04 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.799 ' HE3' HD22 ' D' ' 73' ' ' LEU . 0.3 OUTLIER -112.94 105.7 13.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.42 132.97 55.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.337 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.648 HD12 ' CB ' ' C' ' 43' ' ' LEU . 63.3 mt -84.82 100.13 11.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.118 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.65 146.95 39.88 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.37 0.605 . . . . 0.0 111.431 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p-10 -63.53 150.43 43.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.249 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.28 -12.63 64.03 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -91.09 167.83 12.08 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.036 0.446 . . . . 0.0 110.471 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 59.6 p -116.45 163.77 15.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.911 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.33 -39.85 92.06 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.745 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 98.2 p -63.31 -24.35 67.82 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.591 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.26 -37.96 87.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.117 0.484 . . . . 0.0 110.301 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -96.57 13.35 28.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.337 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 t30 57.71 42.81 23.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.029 0.442 . . . . 0.0 110.274 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.467 HG23 ' CB ' ' C' ' 65' ' ' SER . 80.8 mt -91.9 116.97 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -101.02 -178.76 3.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.594 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -61.52 144.67 53.89 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.185 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 63.77 17.1 10.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . 0.467 ' CB ' HG23 ' C' ' 61' ' ' ILE . 28.8 t -66.04 131.05 45.29 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . . . . . . . . . 85.0 m -85.26 128.31 34.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 0.0 109.996 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' C' ' 3' ' ' ILE . 68.4 mt -117.25 146.16 43.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.118 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -91.32 116.95 29.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.849 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.899 HD23 HG22 ' C' ' 7' ' ' THR . 57.4 tp -97.01 119.58 35.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 69.1 t -116.65 129.78 72.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.898 0.38 . . . . 0.0 110.626 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.488 HD22 HG21 ' C' ' 36' ' ' ILE . 29.8 mt -109.38 135.92 49.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.839 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -70.81 159.03 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.68 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.7 173.68 11.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.33 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -117.55 141.42 48.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.624 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.72 -179.49 52.1 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -137.21 157.75 24.03 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.644 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 58.4 ttp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' D' ' 16' ' ' GLU . 9.8 pt20 -62.22 161.62 10.96 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.311 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.623 HD12 HD22 ' D' ' 67' ' ' LEU . 12.3 pt -143.46 142.53 25.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.804 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -90.4 116.52 28.4 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.822 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.3 102.92 14.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.452 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.15 124.09 31.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.184 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.47 HG22 HD23 ' D' ' 69' ' ' LEU . 60.7 p -77.46 -171.6 2.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.515 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.583 HD21 ' HA ' ' D' ' 70' ' ' VAL . 89.4 mt -60.16 -18.78 50.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.858 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -115.9 -172.88 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.139 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.53 -20.25 58.87 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -52.79 131.27 34.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.306 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 62.5 m -128.02 140.48 51.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.569 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -124.83 102.25 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.781 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.78 128.97 34.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.585 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.613 HD13 ' CB ' ' D' ' 29' ' ' LYS . 81.5 mt -127.64 124.17 37.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.079 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' D' ' 2' ' ' GLN . 19.2 pt-20 -68.24 112.49 5.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.249 0.547 . . . . 0.0 110.532 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.733 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.3 m -135.69 165.63 29.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 O-C-N 122.111 -0.368 . . . . 0.0 110.552 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . 0.533 ' O ' HD12 ' D' ' 56' ' ' LEU . 75.2 mm-40 -111.28 154.53 43.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -55.7 -41.3 78.92 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.055 1.837 . . . . 0.0 112.253 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 85.4 p -70.29 -15.82 62.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.834 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -57.93 136.75 57.1 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 110.32 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -81.44 163.83 22.48 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.159 0.505 . . . . 0.0 110.999 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.46 HD12 HD13 ' D' ' 50' ' ' LEU . 46.5 mm -63.13 -38.08 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.933 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -58.78 -40.31 83.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.03 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -64.6 -43.36 94.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 0.0 110.417 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.486 HG21 HD21 ' D' ' 56' ' ' LEU . 66.8 t -62.49 -47.36 93.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.901 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -62.28 -31.46 72.05 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.89 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.4 97.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.947 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.733 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -60.17 -38.99 84.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' D' ' 43' ' ' LEU . 86.5 mt -64.62 -40.28 88.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.913 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.37 -39.21 82.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -69.98 -45.31 67.6 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.529 ' HD2' HD21 ' D' ' 15' ' ' LEU . 24.5 mttp -68.39 -40.67 81.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.991 0.424 . . . . 0.0 111.845 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -130.23 148.41 52.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.425 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.88 59.4 3.04 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' D' ' 41' ' ' GLN . 19.9 mm -111.36 106.95 57.22 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -58.02 152.44 51.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.877 1.718 . . . . 0.0 111.306 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.98 -41.49 56.18 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.952 1.768 . . . . 0.0 112.51 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -68.09 -40.12 82.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.856 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -63.31 -40.31 96.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.7 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.724 ' HB2' HD11 ' D' ' 69' ' ' LEU . 0.0 OUTLIER -94.29 143.59 26.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.264 0.555 . . . . 0.0 111.461 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -131.9 120.52 22.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' D' ' 30' ' ' ILE . 86.9 mt -89.73 122.85 33.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.289 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.51 HG23 ' HA ' ' D' ' 49' ' ' GLN . 56.5 mt -131.42 131.14 63.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.788 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.588 ' HB3' HD21 ' D' ' 50' ' ' LEU . 70.4 t80 -144.96 152.99 41.04 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.981 0.419 . . . . 0.0 111.092 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.5 19.04 10.03 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.528 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.71 -7.68 72.64 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.743 ' HB3' HD22 ' A' ' 73' ' ' LEU . 32.5 ptt-85 -123.53 144.6 49.45 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.189 0.518 . . . . 0.0 110.764 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.51 ' HA ' HG23 ' D' ' 44' ' ' ILE . 15.8 pt20 -62.28 150.03 40.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.194 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.588 HD21 ' HB3' ' D' ' 45' ' ' PHE . 74.9 mt -87.21 120.46 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.124 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -75.58 130.72 39.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.034 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -62.76 137.21 58.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.237 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.55 -17.0 54.36 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 -88.85 166.17 14.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.439 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -101.14 168.21 9.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.437 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.533 HD12 ' O ' ' D' ' 18' ' ' GLU . 85.1 mt -65.67 -38.89 90.58 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.697 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.4 p -63.45 -25.01 68.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.996 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.82 -28.8 70.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.018 0.437 . . . . 0.0 110.15 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -104.79 14.98 28.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.552 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 55.44 39.73 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.806 0.336 . . . . 0.0 110.233 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -88.32 102.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -90.43 -177.66 5.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.915 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.27 145.89 55.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.606 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 66.16 10.38 7.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.356 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 52.8 m -64.28 135.85 56.61 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -90.05 112.43 23.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.623 HD22 HD12 ' D' ' 3' ' ' ILE . 9.0 mp -95.03 137.28 34.29 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.852 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -85.71 125.77 33.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.036 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' D' ' 41' ' ' GLN . 60.4 tp -111.55 124.41 52.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.925 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 56' ' ' LEU . 57.7 t -111.61 130.39 65.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.957 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . . . . . . . . . 56.7 mt -107.27 133.89 51.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.142 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -89.5 -71.01 0.63 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.771 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.799 HD22 ' HE3' ' C' ' 48' ' ' LYS . 3.9 tt -146.89 139.52 25.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.462 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . 0.666 ' O ' HD23 ' D' ' 73' ' ' LEU . 97.0 mtt180 -65.48 139.18 58.48 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.82 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.91 1.89 90.4 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.789 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -69.98 142.13 52.87 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.013 0.435 . . . . 0.0 110.153 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.1 114.07 25.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.683 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.554 ' CD1' HD12 ' A' ' 57' ' ' ILE . 96.4 mt -66.37 -37.78 86.07 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.809 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.403 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.3 p -149.91 162.99 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.802 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.49 123.13 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.777 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -154.17 159.38 41.37 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.981 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.623 ' HA ' HD12 ' A' ' 46' ' ' LEU . 78.8 mtp180 -74.96 121.61 22.21 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.631 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -156.29 141.65 17.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.697 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.4 157.66 15.76 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -93.16 153.52 18.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.603 0.24 . . . . 0.0 110.946 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.482 ' HE3' HG12 ' A' ' 38' ' ' VAL . 1.4 mtm -127.02 175.78 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.1 m -126.79 139.08 53.38 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 120.511 -0.475 . . . . 0.0 110.758 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.656 HD13 HG22 ' A' ' 38' ' ' VAL . 22.4 tp -117.71 119.0 33.62 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.421 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -120.03 111.01 17.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.26 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.1 -101.52 0.89 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 p -127.62 21.66 6.49 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.097 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.606 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.6 m -124.33 128.72 49.53 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.573 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.656 HG22 HD13 ' A' ' 33' ' ' LEU . 48.1 t -108.96 121.44 62.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.47 HG22 ' HB3' ' B' ' 947' ' ' PRO . 17.8 p -113.63 133.68 22.16 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.683 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.07 140.85 23.03 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.94 1.76 . . . . 0.0 112.424 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -97.97 145.25 26.67 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.82 -6.05 58.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.087 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 mtp85 -73.87 65.7 1.08 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -49.57 132.15 21.23 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.67 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.92 -157.98 8.87 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.139 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.623 HD12 ' HA ' ' A' ' 27' ' ' ARG . 3.6 tp -138.34 127.52 24.31 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -99.79 110.56 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.344 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -132.89 154.35 50.48 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.305 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.8 mt -117.39 137.57 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.232 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 131.98 37.34 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 123.799 0.687 . . . . 0.0 110.031 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.538 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.5 tt0 -100.52 124.79 46.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.889 0.376 . . . . 0.0 109.997 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.504 HG23 ' CD2' ' A' ' 58' ' ' HIS . 17.1 p -85.88 170.31 12.49 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.459 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -61.85 -13.16 21.78 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.0 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.481 ' OD2' HG11 ' D' ' 70' ' ' VAL . 33.4 t0 -84.66 0.26 50.93 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.402 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 t 68.93 20.42 7.89 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.105 0.478 . . . . 0.0 110.376 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.595 HD11 HG11 ' D' ' 70' ' ' VAL . 72.7 mt -100.06 125.47 46.14 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.7 mm -80.23 124.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.403 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.504 ' CD2' HG23 ' A' ' 52' ' ' THR . 69.5 m-70 -100.89 115.8 31.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.788 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -93.76 108.65 20.38 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.7 m -120.75 147.94 44.64 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.812 0.815 . . . . 0.0 112.778 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 71' ' ' ASP . 91.0 t90 -126.98 114.35 17.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.217 -1.356 . . . . 0.0 108.289 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -107.49 133.03 52.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.955 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.79 133.05 43.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.447 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -74.35 -18.68 60.65 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.869 0.366 . . . . 0.0 110.806 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 48.9 m -59.97 -46.07 90.62 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.723 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 73.4 m -116.45 -14.9 10.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.452 . . . . 0.0 110.035 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.9 22.47 78.03 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -101.59 144.48 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.945 0.402 . . . . 0.0 110.246 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.3 t -74.43 108.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 -89.02 -26.34 21.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.715 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' HB2' ' HB3' ' A' ' 61' ' ' TRP . 40.3 m-20 -127.91 143.7 51.1 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.211 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.636 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.4 p30 -158.34 98.58 1.57 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.378 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' D' ' 48' ' ' ARG . 25.2 mt -127.93 133.74 49.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.996 0.427 . . . . 0.0 110.79 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.37 125.97 35.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.342 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.606 HG21 ' SG ' ' A' ' 80' ' ' CYS . 24.6 mm -113.06 124.79 70.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.357 0.599 . . . . 0.0 110.83 -179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HZ ' HD12 ' D' ' 44' ' ' ILE . 78.2 m-85 -91.3 162.54 31.83 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.332 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.4 136.78 77.47 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.015 1.81 . . . . 0.0 111.434 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 60.79 8.45 1.81 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.609 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -72.89 -36.4 67.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.766 0.317 . . . . 0.0 110.821 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.782 ' SG ' HD11 ' A' ' 96' ' ' LEU . 18.3 p -143.98 165.49 27.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.437 0.637 . . . . 0.0 110.31 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -125.95 128.17 47.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.303 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -102.87 119.85 39.57 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -148.2 166.72 27.07 Favored 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.886 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -80.1 159.84 25.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.114 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.17 89.97 13.0 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.44 . . . . 0.0 109.856 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.41 60.78 7.65 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.944 1.763 . . . . 0.0 112.43 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.71 -39.72 3.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.298 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 35.2 t -129.89 77.33 76.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.68 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.1 130.43 40.67 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.391 2.06 . . . . 0.0 111.495 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 168.45 -43.71 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.34 -160.65 9.05 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.534 ' HG2' HG22 ' A' ' 114' ' ' THR . 1.0 OUTLIER -102.92 106.38 16.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.862 0.363 . . . . 0.0 110.498 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.79 128.58 73.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.775 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.12 152.42 47.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.6 p -127.79 138.66 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.367 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.782 HD11 ' SG ' ' A' ' 80' ' ' CYS . 63.2 tp -100.87 116.3 32.42 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -104.17 107.68 18.69 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -75.73 106.05 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.86 -37.79 83.32 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.47 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -103.98 -22.61 13.44 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.744 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.29 -14.48 82.17 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.638 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.5 m 56.15 21.19 4.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.486 ' CD ' HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -119.42 153.09 35.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.351 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -131.09 136.3 48.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.678 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.486 HD21 ' CD ' ' A' ' 103' ' ' LYS . 57.6 mt -120.07 147.22 45.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.168 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.485 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 94.9 m-85 -114.98 132.47 56.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -136.98 155.37 49.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.269 0.557 . . . . 0.0 110.875 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -134.14 135.62 43.25 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.9 mtp -83.7 136.73 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.5 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -100.74 12.79 36.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -69.78 129.44 91.15 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.944 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.64 -37.79 94.92 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 121.822 1.681 . . . . 0.0 112.135 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -118.81 144.91 46.03 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.83 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 92' ' ' ARG . 69.1 p -90.84 0.7 57.4 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.04 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.9 -20.6 53.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.202 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -113.87 -16.05 12.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.786 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -61.62 -40.42 94.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.892 0.377 . . . . 0.0 110.703 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -41.32 99.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.004 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.04 -41.96 94.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.814 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.704 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.2 m170 -64.39 -40.44 95.8 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.786 0.803 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.42 -44.82 95.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.126 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -64.19 -43.91 93.62 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.3 -40.97 98.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.984 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 120' ' ' HIS . 61.5 t -59.1 -48.56 86.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.843 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.64 -38.77 90.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.228 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.93 -22.85 55.58 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.606 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.462 ' CE2' HD22 ' A' ' 23' ' ' LEU . 18.6 m-85 -89.88 -28.2 19.39 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.064 -0.655 . . . . 0.0 110.53 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 75' ' ' ILE . 76.6 mt -92.66 -18.06 23.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -117.25 -17.14 10.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.265 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -139.76 65.21 31.08 Favored Pre-proline 0 N--CA 1.463 0.225 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.207 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.0 156.22 63.25 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 C-N-CA 122.821 2.347 . . . . 0.0 112.359 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 C--N 1.311 -1.417 0 C-N-CA 122.525 2.15 . . . . 0.0 112.262 -179.794 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -127.27 130.78 23.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.439 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.85 146.29 37.59 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 121.935 1.757 . . . . 0.0 111.968 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -74.79 153.4 87.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.09 158.03 56.14 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.39 2.06 . . . . 0.0 112.12 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -58.2 -172.35 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.279 1.986 . . . . 0.0 111.806 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -128.92 158.2 73.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' A' ' 39' ' ' THR . 41.2 Cg_exo -57.65 141.75 95.54 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.105 1.87 . . . . 0.0 112.326 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -156.53 165.47 36.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.589 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -85.92 135.84 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.023 0.439 . . . . 0.0 110.542 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -115.32 128.5 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.151 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.22 122.58 41.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.54 85.5 5.95 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.087 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.617 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -63.29 158.85 19.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.438 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.04 144.47 29.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.528 ' HD2' HG21 ' C' ' 12' ' ' THR . 5.3 m-85 -88.02 125.27 34.46 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.199 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.747 HG11 HD11 ' C' ' 30' ' ' ILE . 92.0 t -111.74 115.56 50.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -99.84 128.48 45.93 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.784 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.902 HG22 HD23 ' C' ' 69' ' ' LEU . 75.1 p -88.02 179.33 6.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 111.483 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.495 HD11 ' H ' ' C' ' 71' ' ' LEU . 83.7 mt -62.59 -36.86 84.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.254 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -69.3 -12.17 61.44 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.804 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.32 -12.68 63.4 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -62.5 131.36 48.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.797 0.332 . . . . 0.0 110.382 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . 0.528 HG21 ' HD2' ' C' ' 4' ' ' PHE . 99.0 m -107.85 131.92 53.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.16 105.06 13.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -75.04 131.09 40.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.042 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' C' ' 29' ' ' LYS . 91.9 mt -122.71 129.21 51.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -71.16 115.94 10.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.068 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.49 HG12 ' HE2' ' C' ' 29' ' ' LYS . 18.2 m -138.73 165.53 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.59 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -107.89 155.65 39.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.7 -37.64 95.21 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.041 1.827 . . . . 0.0 112.015 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -80.93 -7.42 59.5 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.191 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -58.69 137.96 57.3 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.039 0.447 . . . . 0.0 111.058 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 54.3 p -79.06 161.02 26.85 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 110.952 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 0.445 HD12 HD13 ' C' ' 50' ' ' LEU . 48.5 mm -63.69 -39.21 84.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.986 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.08 -39.11 84.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.864 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.99 -42.75 99.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.031 0.443 . . . . 0.0 110.396 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.417 HG22 HG11 ' C' ' 17' ' ' VAL . 53.9 t -61.76 -42.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.204 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.4 -39.89 80.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.551 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.85 -41.29 95.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 110.063 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' C' ' 15' ' ' LEU . 11.1 mttp -59.6 -38.63 81.75 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.747 HD11 HG11 ' C' ' 5' ' ' VAL . 8.8 mm -65.18 -39.9 87.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.984 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -59.21 -41.96 89.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.823 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -69.48 -50.3 46.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.504 ' HG3' HD21 ' C' ' 15' ' ' LEU . 20.3 mttt -63.97 -41.2 97.63 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -131.67 148.92 52.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.58 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.42 63.61 2.19 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.632 HG22 ' HG3' ' C' ' 41' ' ' GLN . 45.0 mt -115.97 119.81 36.49 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.28 159.93 48.35 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.779 1.653 . . . . 0.0 111.457 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.05 -31.68 96.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.041 1.827 . . . . 0.0 112.613 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.75 -42.59 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.718 -0.393 . . . . 0.0 109.961 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -83.71 -10.8 57.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.412 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.632 ' HG3' HG22 ' C' ' 36' ' ' ILE . 75.3 mt-30 -80.62 86.55 5.86 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.799 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 76.2 mtp85 -96.86 103.76 15.71 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.683 ' HB3' HD12 ' C' ' 50' ' ' LEU . 76.6 mt -95.9 119.36 34.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.122 -179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.9 mt -125.6 127.57 71.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.084 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -129.2 130.34 46.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.521 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.67 28.04 14.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.54 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.97 15.3 81.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.657 ' CE ' HD22 ' D' ' 73' ' ' LEU . 29.4 mtpp -119.37 132.75 55.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 110.371 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -72.61 131.94 43.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.106 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.683 HD12 ' HB3' ' C' ' 43' ' ' LEU . 78.2 mt -81.34 97.74 7.84 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.72 -0.392 . . . . 0.0 109.968 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.17 139.83 52.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.781 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -60.23 143.68 52.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.43 -17.73 58.55 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -84.39 171.38 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.806 0.336 . . . . 0.0 110.105 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -119.0 165.69 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.246 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' C' ' 56' ' ' LEU . 82.5 mt -62.33 -39.83 94.36 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.381 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.9 p -62.97 -27.02 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.248 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.78 -35.98 79.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.03 0.443 . . . . 0.0 110.206 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.509 ' CE2' HD23 ' C' ' 50' ' ' LEU . 66.3 m-85 -96.51 12.6 30.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.319 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.29 40.67 27.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.342 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -89.58 114.92 28.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.814 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -99.22 -175.2 2.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.354 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -65.3 150.12 48.79 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.946 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 54.89 42.54 31.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.947 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 45.3 m -96.25 124.46 40.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.032 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.454 ' C ' HD12 ' C' ' 67' ' ' LEU . 53.3 m -75.01 128.19 34.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.906 0.384 . . . . 0.0 110.074 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.454 HD12 ' C ' ' C' ' 66' ' ' THR . 7.4 mp -118.35 143.46 46.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.258 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -89.96 112.08 23.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.07 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.902 HD23 HG22 ' C' ' 7' ' ' THR . 59.2 tp -100.51 120.42 39.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.635 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -117.45 133.83 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.793 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.495 ' H ' HD11 ' C' ' 8' ' ' LEU . 12.4 mt -92.46 122.5 34.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.007 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -71.25 132.81 45.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.501 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 83.9 mt -116.65 141.05 48.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.289 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -75.19 144.56 42.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.616 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.24 178.95 52.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.22 -40.26 98.33 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 61.3 t0 . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.501 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttp . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -68.93 158.32 34.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.448 HD13 HD21 ' D' ' 56' ' ' LEU . 11.4 pt -138.97 146.5 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.754 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -94.82 122.07 37.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.59 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.688 HG11 HD11 ' D' ' 30' ' ' ILE . 85.8 t -104.42 113.23 40.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.395 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -98.49 130.29 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.719 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.606 HG22 HD23 ' D' ' 69' ' ' LEU . 74.5 p -86.76 -177.56 6.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.203 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.515 HD11 ' H ' ' D' ' 71' ' ' LEU . 52.1 mt -72.83 -17.07 61.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.365 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 56.1 p -90.87 -2.35 57.76 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.041 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.93 -9.09 75.9 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.47 130.73 44.36 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.2 m -111.47 134.1 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.996 0.427 . . . . 0.0 110.979 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.91 109.8 22.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.351 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.67 124.94 29.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.457 HD21 ' HD2' ' D' ' 33' ' ' LYS . 96.0 mt -122.34 124.86 44.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.204 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -72.31 114.51 10.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.868 0.366 . . . . 0.0 110.563 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.685 HG12 ' HE3' ' D' ' 29' ' ' LYS . 23.7 m -135.33 168.5 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -109.86 154.86 42.37 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.294 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.57 -32.93 91.69 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.893 1.728 . . . . 0.0 111.893 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 69.6 m -83.19 -6.28 59.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.113 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -60.99 144.9 52.45 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.833 0.349 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 35.2 p -89.45 161.28 16.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.175 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 44.5 mm -64.73 -38.69 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.088 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.16 -42.66 91.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.084 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -62.86 -40.63 98.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.104 0.478 . . . . 0.0 110.341 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.558 HG12 HD21 ' D' ' 43' ' ' LEU . 62.4 t -61.91 -42.97 96.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.618 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.589 ' HG3' HD22 ' D' ' 43' ' ' LEU . 58.6 mtmt -61.17 -39.4 90.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.201 0.524 . . . . 0.0 109.951 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.35 90.62 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.685 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.1 mttm -59.9 -38.09 81.31 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.688 HD11 HG11 ' D' ' 5' ' ' VAL . 6.1 mm -63.01 -41.95 94.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.506 0.67 . . . . 0.0 109.949 178.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -61.8 -44.74 96.27 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.958 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.09 -20.33 62.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.457 ' HD2' HD21 ' D' ' 15' ' ' LEU . 8.2 mttm -101.61 -6.14 24.19 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -145.36 -43.63 0.22 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.28 0.562 . . . . 0.0 110.226 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.97 14.13 12.62 Favored Glycine 0 CA--C 1.52 0.391 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' D' ' 41' ' ' GLN . 57.4 mt -87.93 119.17 70.4 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.438 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.52 160.14 44.91 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.823 1.682 . . . . 0.0 111.943 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.63 -22.26 59.64 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.418 2.079 . . . . 0.0 112.215 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -87.48 1.36 53.68 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.443 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -126.42 21.2 7.25 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.721 0.296 . . . . 0.0 110.577 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.652 ' HB2' HD11 ' D' ' 69' ' ' LEU . 22.4 pt20 -162.42 154.97 19.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 111.214 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -136.23 132.38 35.77 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.666 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.703 ' HB3' HD12 ' D' ' 50' ' ' LEU . 5.8 mp -91.46 122.26 33.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.547 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.596 HG23 ' HA ' ' D' ' 49' ' ' GLN . 70.0 mt -128.99 132.23 67.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.784 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.532 ' HB3' HD21 ' D' ' 50' ' ' LEU . 87.4 t80 -151.9 155.14 37.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.684 -0.406 . . . . 0.0 111.365 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 69.68 16.69 7.93 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 87.56 -12.69 62.45 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.81 ' HB3' HD22 ' A' ' 73' ' ' LEU . 39.8 ptt180 -119.71 146.38 45.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.138 0.494 . . . . 0.0 110.397 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.596 ' HA ' HG23 ' D' ' 44' ' ' ILE . 27.0 pt20 -65.11 142.66 58.3 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.979 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' D' ' 43' ' ' LEU . 75.9 mt -84.43 114.79 22.16 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.411 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -75.51 149.59 38.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.228 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -71.21 165.05 24.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.73 26.82 74.0 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -128.01 157.3 41.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 110.868 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -100.91 160.79 14.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.277 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.492 HD11 HG21 ' D' ' 26' ' ' VAL . 7.4 mp -62.59 -40.47 97.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.86 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.4 p -62.62 -23.63 67.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.192 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -62.9 -38.08 89.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.112 0.482 . . . . 0.0 109.907 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.62 13.83 30.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.277 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 56.91 40.36 28.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.568 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.4 mt -85.94 98.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 109.995 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -86.1 178.38 7.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.256 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -60.75 151.68 28.89 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.289 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 57.13 44.47 22.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.07 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 123.42 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.86 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -81.88 96.83 7.77 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.081 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.407 ' N ' HD12 ' D' ' 67' ' ' LEU . 9.2 mp -84.19 152.47 24.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.04 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -101.87 122.39 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.302 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' D' ' 41' ' ' GLN . 34.1 tp -103.35 114.0 27.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.884 HG11 HD11 ' A' ' 56' ' ' LEU . 64.0 t -106.43 120.07 56.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.515 ' H ' HD11 ' D' ' 8' ' ' LEU . 65.3 mt -82.29 146.6 29.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.804 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -120.9 131.45 54.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.779 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.657 HD22 ' CE ' ' C' ' 48' ' ' LYS . 1.4 tt -93.35 125.47 37.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.139 0.495 . . . . 0.0 110.385 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -65.85 134.13 52.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.057 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.29 -17.87 43.07 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.707 179.413 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.3 m120 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -66.85 151.46 47.49 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.032 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -95.27 115.1 26.98 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.682 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 51' ' ' GLN . 96.1 mt -68.05 -36.86 80.58 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.682 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.09 161.9 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.818 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.0 122.23 0.4 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.295 0.569 . . . . 0.0 111.091 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -155.89 158.61 38.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.924 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.57 ' HA ' HD12 ' A' ' 46' ' ' LEU . 83.1 mtt85 -77.22 123.23 26.15 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.602 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 146.28 23.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.221 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.55 151.58 17.04 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -89.73 172.46 8.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.04 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 24.6 mtp -138.22 174.34 10.66 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.739 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.2 m -124.54 127.27 47.17 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD22 ' CE1' ' A' ' 106' ' ' PHE . 34.6 tp -107.72 117.2 33.49 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.184 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -119.97 110.33 16.57 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.826 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.73 -83.22 0.58 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.6 p -148.15 18.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.559 0.219 . . . . 0.0 110.609 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.473 ' O ' HD12 ' A' ' 33' ' ' LEU . 89.8 m -119.17 130.14 55.36 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 HD13 ' A' ' 33' ' ' LEU . 64.1 t -108.5 123.12 63.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.856 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.6 p -115.64 132.6 23.06 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.044 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.32 146.66 51.3 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.552 1.501 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -101.04 121.47 41.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.456 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -62.36 -14.62 41.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -71.29 80.55 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -64.27 130.58 44.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.641 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.03 -154.64 8.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.348 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.5 tp -138.11 127.24 24.3 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.6 110.84 26.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 43.9 p90 -134.17 154.66 51.09 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.189 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 97.0 mt -120.36 138.54 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.63 132.64 37.31 Favored 'General case' 0 C--O 1.222 -0.349 0 O-C-N 123.772 0.67 . . . . 0.0 110.045 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.549 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.2 tt0 -102.01 125.29 48.66 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 58' ' ' HIS . 13.4 p -84.9 171.78 11.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.873 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -64.85 -10.34 27.65 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.566 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.31 5.42 47.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.424 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m 64.02 25.16 13.77 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.578 0.704 . . . . 0.0 110.603 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.884 HD11 HG11 ' D' ' 70' ' ' VAL . 78.7 mt -101.55 122.77 44.43 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.509 HD12 ' CD1' ' A' ' 23' ' ' LEU . 50.7 mm -80.92 123.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.234 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.487 ' CD2' HG23 ' A' ' 52' ' ' THR . 72.1 m-70 -99.45 115.64 29.75 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.827 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -94.7 108.65 20.64 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 72.9 m -122.91 146.16 47.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.86 0.838 . . . . 0.0 113.108 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -125.67 114.85 19.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.113 -1.403 . . . . 0.0 107.646 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -106.51 132.74 52.17 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.582 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -74.5 134.22 42.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -75.59 -16.5 60.23 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.69 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.8 m -60.41 -44.84 95.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.754 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.9 p -116.47 -17.41 10.66 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.763 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.39 22.01 74.05 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.1 p-10 -101.53 153.01 20.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.71 0.29 . . . . 0.0 110.328 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 74.8 t -79.56 102.47 5.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -77.21 -32.8 56.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.985 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -125.87 144.84 50.5 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.589 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.61 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.4 t0 -157.34 99.23 1.76 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.488 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.81 HD22 ' HB3' ' D' ' 48' ' ' ARG . 36.6 mt -130.53 133.83 46.55 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.771 0.32 . . . . 0.0 110.877 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.0 mt -78.73 125.45 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.307 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.653 HG21 ' SG ' ' A' ' 80' ' ' CYS . 17.9 mm -111.06 126.15 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.915 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.47 162.2 32.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.351 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.08 138.69 83.54 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.817 1.678 . . . . 0.0 111.235 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.8 t0 59.44 11.74 2.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.731 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.67 -27.05 37.2 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.616 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.653 ' SG ' HG21 ' A' ' 75' ' ' ILE . 17.5 p -151.65 166.97 29.61 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.759 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -133.01 132.33 41.74 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.277 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -104.5 118.51 36.78 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -142.39 166.81 23.66 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.719 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -86.49 159.99 19.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.967 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.03 89.46 19.96 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.8 60.44 7.56 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.829 1.686 . . . . 0.0 112.149 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -113.84 -42.8 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.329 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.1 t -120.22 96.97 49.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.042 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.23 131.04 18.46 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 121.122 1.215 . . . . 0.0 111.487 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 p 168.17 -31.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.985 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -158.58 -174.31 28.13 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.552 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.483 ' HG2' HG22 ' A' ' 114' ' ' THR . 0.3 OUTLIER -88.72 112.6 23.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.486 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.2 t -126.2 128.83 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -126.21 152.97 45.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.363 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.4 p -130.62 136.68 57.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.149 0.5 . . . . 0.0 110.283 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.648 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.4 tp -103.78 120.84 41.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -116.7 120.11 37.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.147 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.46 ' HE2' HD12 ' A' ' 75' ' ' ILE . 47.6 m-85 -79.2 113.73 17.57 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -61.43 -37.78 84.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.054 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.89 -23.0 12.51 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.58 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -74.4 -17.37 79.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.274 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 43.7 m 58.32 21.19 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.627 -0.337 . . . . 0.0 111.165 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.509 ' HD3' HD21 ' A' ' 105' ' ' LEU . 5.0 ttmt -119.1 151.4 38.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.099 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.436 ' O ' HD23 ' A' ' 105' ' ' LEU . 99.7 mtt180 -131.42 138.4 49.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.0 110.852 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 95' ' ' VAL . 47.3 mt -123.42 153.05 40.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.146 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE1' HD22 ' A' ' 33' ' ' LEU . 97.8 m-85 -124.76 135.76 53.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.819 0.342 . . . . 0.0 110.683 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -139.6 156.67 46.72 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.301 0.572 . . . . 0.0 111.224 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -130.43 138.91 50.55 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.439 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 77.6 mmm -75.07 139.15 42.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.056 0.455 . . . . 0.0 110.843 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.56 2.09 33.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.894 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -73.83 146.36 85.27 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.746 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.82 -28.01 17.25 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.999 1.8 . . . . 0.0 112.601 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -120.77 144.13 48.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.891 0.377 . . . . 0.0 110.334 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 92' ' ' ARG . 82.7 p -91.47 1.15 57.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.922 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -59.01 -19.51 44.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -118.52 -20.2 8.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.88 -41.7 98.18 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.273 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.51 -40.87 96.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.201 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.48 -42.44 92.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.415 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.782 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.7 m170 -64.44 -39.94 94.79 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-O 121.674 0.749 . . . . 0.0 109.314 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.0 t -61.02 -45.83 93.19 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.491 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -63.42 -43.1 98.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.153 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -65.62 -35.44 80.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 120' ' ' HIS . 54.9 t -58.51 -48.35 85.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.987 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -77.32 -28.99 53.36 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.777 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.8 -34.99 74.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.564 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -81.97 -31.32 31.24 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 mt -81.48 -26.94 34.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.013 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -106.39 -26.82 11.31 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.477 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.58 73.66 72.23 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.433 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.6 Cg_exo -59.78 151.2 72.47 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.945 2.43 . . . . 0.0 111.964 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.49 1.318 0 C-N-CA 122.394 2.063 . . . . 0.0 112.068 -179.84 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -134.27 154.77 80.15 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.978 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.28 144.87 99.5 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.268 1.979 . . . . 0.0 111.569 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -73.63 159.0 85.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -54.92 140.77 79.09 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.411 2.074 . . . . 0.0 112.193 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.42 174.12 13.36 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.387 2.058 . . . . 0.0 111.84 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -97.11 154.49 38.13 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.415 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -58.53 147.0 88.73 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 122.463 2.108 . . . . 0.0 112.105 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.43 161.4 42.64 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.84 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -91.04 136.21 33.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 0.0 110.572 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -118.69 124.72 48.03 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 951' ' ' ILE . 1.7 mp -130.46 122.69 53.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.477 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -82.26 83.97 7.25 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.932 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.4 p30 . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.586 179.571 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -62.91 160.76 14.11 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.687 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -136.94 154.07 30.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.082 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.467 ' CD1' HG23 ' C' ' 14' ' ' THR . 11.7 m-30 -93.53 122.69 36.23 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.115 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 72.0 t -109.03 108.76 26.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.925 0.393 . . . . 0.0 110.638 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 tttt -92.42 108.25 19.82 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.971 HG22 HD23 ' C' ' 69' ' ' LEU . 23.7 p -96.3 -173.32 2.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.571 0.701 . . . . 0.0 111.08 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.489 ' C ' HG23 ' C' ' 9' ' ' THR . 90.7 mt -55.42 159.92 2.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.311 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.489 HG23 ' C ' ' C' ' 8' ' ' LEU . 1.3 p 66.43 6.29 4.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.121 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.74 24.46 76.05 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.315 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -83.73 107.0 15.88 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.459 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 94.8 m -87.74 135.99 33.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.796 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -132.42 118.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . 0.467 HG23 ' CD1' ' C' ' 4' ' ' PHE . 9.7 m -86.7 122.98 31.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.35 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 73.0 mt -120.54 128.11 52.79 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.508 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -70.62 116.37 10.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.055 0.455 . . . . 0.0 110.858 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.545 HG12 ' HE3' ' C' ' 29' ' ' LYS . 25.5 m -135.92 166.87 26.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.515 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -111.98 153.76 44.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.091 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.31 -38.25 93.92 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.062 1.841 . . . . 0.0 112.156 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 82.4 p -81.45 -8.74 59.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.07 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.72 134.76 57.32 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.012 0.434 . . . . 0.0 111.017 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -78.57 163.82 25.2 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.043 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.25 -35.74 74.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.943 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 16.8 tm-20 -58.44 -40.01 81.38 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.2 -41.51 94.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.537 HG21 HD21 ' C' ' 56' ' ' LEU . 62.7 t -63.09 -47.59 91.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.044 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -62.82 -33.35 75.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.053 0.454 . . . . 0.0 110.17 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.05 97.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.161 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.545 ' HE3' HG12 ' C' ' 17' ' ' VAL . 66.4 mttm -60.34 -39.3 86.62 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.083 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.669 HD13 HD22 ' C' ' 69' ' ' LEU . 92.1 mt -66.17 -39.67 84.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.001 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -59.31 -46.53 88.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.29 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -75.77 -15.1 60.31 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.033 -0.417 . . . . 0.0 111.906 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -101.14 -6.34 24.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -148.61 -41.03 0.16 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.181 0.515 . . . . 0.0 110.501 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.09 11.17 21.02 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.402 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.765 HD13 HD21 ' C' ' 71' ' ' LEU . 73.8 mt -77.52 125.25 86.35 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.43 158.05 48.55 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.675 1.583 . . . . 0.0 112.05 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.18 -38.62 93.49 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.113 1.875 . . . . 0.0 112.274 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.07 -39.93 94.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.906 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -88.79 -3.63 58.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.404 ' OE1' HG21 ' C' ' 30' ' ' ILE . 10.4 mm100 -80.02 96.2 6.38 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 121.038 -0.265 . . . . 0.0 111.411 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -96.22 85.28 3.94 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.578 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.783 ' HB3' HD12 ' C' ' 50' ' ' LEU . 86.8 mt -89.17 113.08 24.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.834 0.349 . . . . 0.0 110.22 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 87.3 mt -126.63 129.03 71.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.616 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -132.72 132.49 42.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.859 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.06 24.34 14.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.65 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.94 3.43 90.6 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.344 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.583 ' HE2' HD22 ' D' ' 73' ' ' LEU . 48.3 mtpt -110.69 127.14 55.18 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.645 -0.326 . . . . 0.0 110.238 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -70.18 134.25 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.028 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.783 HD12 ' HB3' ' C' ' 43' ' ' LEU . 59.4 mt -79.6 94.43 5.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.429 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.06 146.61 39.27 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.295 0.569 . . . . 0.0 111.038 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -61.44 150.6 34.99 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.07 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.85 -17.65 57.5 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -90.2 164.12 14.54 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.211 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 61.8 p -113.34 167.06 10.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.309 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.537 HD21 HG21 ' C' ' 26' ' ' VAL . 81.5 mt -62.39 -39.41 93.12 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.384 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 97.2 p -62.96 -26.75 68.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.094 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.08 -35.91 80.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.211 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.777 ' CZ ' HD11 ' D' ' 73' ' ' LEU . 57.9 m-85 -95.52 14.29 23.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.213 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 55.77 40.41 30.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.023 0.439 . . . . 0.0 110.497 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 92.1 mt -88.71 121.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.977 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.18 -179.95 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.598 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -58.96 145.12 42.77 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.972 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 59.18 26.17 14.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 123.37 25.32 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.479 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.439 ' C ' HD12 ' C' ' 67' ' ' LEU . 91.3 m -72.63 130.07 39.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.226 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.439 HD12 ' C ' ' C' ' 66' ' ' THR . 6.5 mp -120.57 143.11 48.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.288 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -93.24 109.22 20.74 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.118 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.971 HD23 HG22 ' C' ' 7' ' ' THR . 24.8 tp -106.66 123.62 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.434 ' N ' HD12 ' C' ' 69' ' ' LEU . 74.5 t -123.11 141.32 43.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.929 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.765 HD21 HD13 ' C' ' 36' ' ' ILE . 19.6 mt -109.25 142.59 39.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.332 -178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.425 ' C ' HD12 ' C' ' 73' ' ' LEU . 84.3 mtp180 -71.94 143.37 49.31 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.708 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . 0.425 HD12 ' C ' ' C' ' 72' ' ' ARG . 8.7 mp -112.92 124.03 51.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.327 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -62.73 -38.78 91.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.655 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.38 95.98 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.08 -131.48 50.17 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.657 -179.898 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -64.13 157.23 26.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.599 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 pt -136.72 152.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.131 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.498 ' CD2' HG23 ' D' ' 14' ' ' THR . 16.4 m-30 -93.46 122.02 35.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.714 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 70.2 t -109.24 107.47 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.678 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -91.88 125.56 36.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.599 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.665 HG22 HD23 ' D' ' 69' ' ' LEU . 82.4 p -83.32 174.53 10.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.189 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.705 HD11 ' H ' ' D' ' 71' ' ' LEU . 70.7 mt -62.46 -25.95 68.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.076 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p -78.48 -9.45 59.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 -11.7 66.85 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.41 134.61 52.87 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 116.88 0.34 . . . . 0.0 110.124 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 97.4 m -104.3 133.68 48.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.15 0.5 . . . . 0.0 110.719 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -122.7 113.05 36.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.644 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . 0.498 HG23 ' CD2' ' D' ' 4' ' ' PHE . 4.8 m -80.96 125.24 29.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.089 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' D' ' 29' ' ' LYS . 91.4 mt -119.58 116.56 26.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.716 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.98 108.89 2.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.465 0.65 . . . . 0.0 110.883 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.546 HG12 ' HE3' ' D' ' 29' ' ' LYS . 22.8 m -134.49 164.73 33.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -107.76 155.06 40.5 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.172 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -55.87 -37.29 96.03 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.864 1.71 . . . . 0.0 111.814 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.5 p -79.21 -9.4 59.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -60.78 136.28 58.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.904 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -79.74 162.94 24.87 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 49.8 mm -64.39 -38.95 83.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.761 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.51 -41.58 90.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.947 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -61.89 -41.52 97.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.147 0.499 . . . . 0.0 110.578 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.457 HG22 HG11 ' D' ' 17' ' ' VAL . 68.5 t -63.43 -42.03 94.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.43 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.484 ' HG2' HD13 ' D' ' 43' ' ' LEU . 56.4 mtmt -60.61 -39.34 87.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.961 0.41 . . . . 0.0 110.245 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.64 -40.15 93.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.097 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.625 ' HB3' HD22 ' D' ' 15' ' ' LEU . 66.6 mttm -60.37 -39.22 86.45 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.49 ' CD1' HD11 ' D' ' 43' ' ' LEU . 92.4 mt -63.59 -42.12 95.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.199 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 27.0 tm0? -60.57 -40.08 90.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.636 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -83.52 12.0 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.498 ' HG3' HD21 ' D' ' 15' ' ' LEU . 11.3 mmtt -118.56 -47.89 2.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 110.544 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -112.08 2.28 16.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.246 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.15 24.8 75.83 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.509 HG21 ' HB3' ' D' ' 41' ' ' GLN . 13.6 mm -85.82 116.24 64.88 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.164 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.5 147.2 70.57 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 122.083 1.855 . . . . 0.0 112.32 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.69 -33.06 78.52 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.223 1.949 . . . . 0.0 112.643 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -91.89 9.85 31.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.462 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -121.14 28.61 7.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.854 0.359 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.672 ' HB2' HD11 ' D' ' 69' ' ' LEU . 5.3 pt20 -160.53 151.27 18.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.065 0.46 . . . . 0.0 111.142 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -132.0 126.27 33.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.792 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' D' ' 30' ' ' ILE . 6.8 mp -88.74 124.06 33.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.707 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.449 HG21 ' HE1' ' A' ' 76' ' ' PHE . 83.6 mt -127.38 129.11 70.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.736 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.445 ' HB3' HD21 ' D' ' 50' ' ' LEU . 70.9 t80 -148.59 151.54 35.22 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.997 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 66.8 17.74 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 73' ' ' LEU . . . 85.49 -8.77 70.21 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.763 ' HB3' HD22 ' A' ' 73' ' ' LEU . 13.0 ptm180 -119.57 145.3 46.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.127 0.489 . . . . 0.0 110.735 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -68.29 132.41 47.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.967 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' D' ' 45' ' ' PHE . 55.0 mt -81.64 104.94 12.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.71 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -74.97 168.29 20.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.474 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -78.39 172.66 13.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.236 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.3 21.35 77.28 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -130.59 157.2 43.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.876 0.37 . . . . 0.0 110.693 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 47.6 p -105.83 162.97 13.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.134 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 83.2 mt -61.88 -39.79 93.14 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.393 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -63.56 -23.02 67.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.378 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.48 -38.35 86.97 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 121.012 0.434 . . . . 0.0 110.233 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -99.23 15.7 25.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.368 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 58.9 t30 58.24 40.82 24.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.264 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -90.65 104.15 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.899 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.23 -171.55 2.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.255 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttmt -68.78 146.4 52.94 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.07 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 63.14 42.34 7.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.109 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -99.54 125.71 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.785 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 87.2 m -76.11 126.01 30.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.016 0.436 . . . . 0.0 109.999 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.01 139.53 51.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.627 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -88.48 118.38 28.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.57 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' D' ' 41' ' ' GLN . 58.5 tp -100.48 120.0 39.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.53 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' D' ' 8' ' ' LEU . 78.0 t -109.41 127.94 65.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.038 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.705 ' H ' HD11 ' D' ' 8' ' ' LEU . 70.1 mt -107.75 126.82 53.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.683 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -62.99 -42.98 99.99 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.669 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.777 HD11 ' CZ ' ' C' ' 59' ' ' TYR . 26.4 mt -145.62 147.08 31.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.734 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 75.6 ttt-85 -113.59 116.83 30.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.252 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.75 2.32 88.1 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . 0.755 ' O ' HD13 ' D' ' 73' ' ' LEU . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -76.96 152.3 35.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.176 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -89.11 112.87 23.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.517 ' CD1' HD12 ' A' ' 57' ' ' ILE . 97.1 mt -66.11 -38.38 88.07 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.6 162.94 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.644 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.72 122.92 0.34 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.281 0.562 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -154.47 158.95 40.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.845 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -74.33 122.57 23.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.415 . . . . 0.0 110.819 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -155.14 143.83 20.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.135 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.96 153.57 16.92 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -86.78 157.36 19.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.903 0.383 . . . . 0.0 110.871 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 27.8 mtp -125.53 172.95 9.28 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.3 m -125.44 124.64 41.86 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.374 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 37' ' ' THR . 37.7 tp -106.84 117.48 34.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.879 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -122.05 119.81 32.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.857 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.07 -86.83 0.22 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -148.15 24.51 1.03 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.705 0.288 . . . . 0.0 110.722 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.625 ' O ' HD12 ' A' ' 33' ' ' LEU . 86.9 m -126.26 131.18 51.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.548 HG22 HD13 ' A' ' 33' ' ' LEU . 59.5 t -105.99 122.18 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.646 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.783 HG22 ' HB3' ' B' ' 947' ' ' PRO . 42.8 p -121.35 122.94 27.87 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.53 146.41 55.35 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.269 1.313 . . . . 0.0 112.902 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -99.74 142.58 31.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.53 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -72.33 -6.26 42.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -73.1 74.11 1.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -55.42 135.68 50.17 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.89 -160.89 9.69 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 27' ' ' ARG . 4.9 tp -137.26 126.97 25.41 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.3 t -99.69 109.58 24.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 44.3 p90 -133.19 154.49 50.58 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 119.345 -0.942 . . . . 0.0 111.609 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 23' ' ' LEU . 96.9 mt -117.89 137.89 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.236 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.91 131.3 35.02 Favored 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.549 0.531 . . . . 0.0 110.413 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.51 ' HB2' HD11 ' A' ' 23' ' ' LEU . 52.0 tt0 -100.45 124.73 46.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.219 0.533 . . . . 0.0 110.231 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 58' ' ' HIS . 12.0 p -84.35 172.32 11.88 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.604 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -65.11 -10.36 30.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.533 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -88.48 -0.06 56.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.626 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 71.03 19.68 5.52 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 121.305 0.574 . . . . 0.0 110.61 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.51 HD11 HG11 ' D' ' 70' ' ' VAL . 73.7 mt -98.62 122.62 42.07 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.517 HD12 ' CD1' ' A' ' 23' ' ' LEU . 51.8 mm -78.97 125.26 38.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.491 ' CD2' HG23 ' A' ' 52' ' ' THR . 71.8 m-70 -101.07 116.69 33.44 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.669 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -95.96 107.48 19.76 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 71.9 m -121.41 146.99 46.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 113.041 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 92.6 t90 -124.79 114.27 19.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.948 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.5 ttpt -106.13 131.53 53.28 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.723 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -75.89 131.04 39.41 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -72.26 -18.86 61.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 0.0 110.662 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.5 m -59.91 -44.68 94.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.964 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.6 p -115.94 -16.01 11.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.091 0.472 . . . . 0.0 109.991 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.17 19.6 79.78 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -102.54 146.52 28.02 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.82 102.05 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.15 0.5 . . . . 0.0 110.06 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -74.44 -36.5 63.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -126.27 145.98 50.19 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.761 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.607 ' O ' HD23 ' A' ' 73' ' ' LEU . 1.5 p-10 -158.08 100.61 1.72 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.83 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.763 HD22 ' HB3' ' D' ' 48' ' ' ARG . 31.7 mt -127.89 133.21 49.29 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.84 0.352 . . . . 0.0 110.756 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 125.55 35.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.144 0.497 . . . . 0.0 110.123 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.438 ' HB ' HD22 ' A' ' 128' ' ' LEU . 31.4 mm -112.09 118.18 57.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.897 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HE1' HG21 ' D' ' 44' ' ' ILE . 61.2 m-85 -82.95 161.58 57.57 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.858 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -54.59 131.98 48.75 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.676 1.584 . . . . 0.0 111.699 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 62.37 12.29 5.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.446 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -81.26 -26.89 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.111 0.481 . . . . 0.0 110.18 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.471 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -142.12 151.08 41.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.209 -178.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.533 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.0 tp10 -121.06 129.26 53.27 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.977 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.09 118.11 35.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -141.97 167.82 21.23 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.648 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -85.1 159.99 20.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.026 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.72 90.2 12.41 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.118 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.33 61.1 8.07 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.921 1.747 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -113.28 -38.04 4.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.419 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.6 t -131.44 77.26 74.01 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.697 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.13 130.33 40.15 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.151 1.901 . . . . 0.0 111.359 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 t 167.78 -47.58 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.723 0.64 . . . . 0.0 110.053 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.8 -149.32 7.06 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.58 106.43 13.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.394 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -124.9 129.3 73.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.58 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -127.46 153.71 45.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.535 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.6 p -129.7 135.78 60.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.159 0.504 . . . . 0.0 109.894 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 81' ' ' GLU . 60.8 tp -104.73 122.3 45.4 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -120.19 130.39 54.54 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.256 -0.578 . . . . 0.0 111.135 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.471 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 53.3 m-85 -86.24 116.41 24.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.78 -36.24 78.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.271 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.27 -20.88 12.14 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.398 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -73.23 -20.77 80.02 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.058 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.2 m 59.44 27.6 16.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -125.53 151.23 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.125 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -131.77 139.78 49.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.17 0.509 . . . . 0.0 110.934 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.483 ' O ' HG23 ' A' ' 95' ' ' VAL . 52.1 mt -122.91 149.1 44.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.473 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 96.7 m-85 -119.25 135.21 54.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -139.58 157.14 46.3 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.317 0.58 . . . . 0.0 111.318 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -135.05 137.07 42.57 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.523 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.4 ttm -73.7 135.22 43.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.238 0.542 . . . . 0.0 111.244 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.23 0.25 25.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.13 139.1 89.93 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.72 -25.74 33.55 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.979 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -117.51 141.68 48.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.962 0.41 . . . . 0.0 110.434 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 67.2 p -95.15 9.56 39.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.47 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.9 -21.0 60.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.362 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -121.05 3.16 10.47 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.476 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -62.02 -49.22 76.9 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.997 0.427 . . . . 0.0 110.986 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.14 -39.73 93.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.272 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.76 -42.98 99.94 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.737 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.662 ' O ' HG23 ' A' ' 124' ' ' VAL . 66.2 m170 -64.26 -41.06 97.11 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.036 0.922 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.88 -44.11 96.99 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.409 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -65.46 -43.51 90.1 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.602 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -62.53 -41.42 98.86 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.665 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 120' ' ' HIS . 55.9 t -58.77 -49.38 83.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.014 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.501 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.87 -25.04 59.84 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.384 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.433 ' CG ' ' HB3' ' A' ' 23' ' ' LEU . 21.4 m-85 -87.84 -28.92 21.32 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.563 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.438 HD22 ' HB ' ' A' ' 75' ' ' ILE . 73.8 mt -91.23 -15.58 29.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.294 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -118.21 -17.95 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.165 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -142.1 66.74 21.07 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.255 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.4 155.0 64.76 Favored 'Trans proline' 0 C--N 1.297 -2.176 0 C-N-CA 122.604 2.203 . . . . 0.0 112.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 C--N 1.311 -1.399 0 C-N-CA 122.559 2.173 . . . . 0.0 112.099 -179.848 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.6 mp0 -68.95 139.92 90.95 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.505 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.72 143.83 21.55 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.091 1.861 . . . . 0.0 112.079 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -79.81 155.25 75.65 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.1 150.48 72.31 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.933 1.755 . . . . 0.0 112.167 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.58 160.11 44.79 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -75.86 156.0 84.65 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.511 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.783 ' HB3' HG22 ' A' ' 39' ' ' THR . 30.9 Cg_endo -64.7 151.39 85.86 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.39 2.06 . . . . 0.0 111.883 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.91 165.77 33.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.835 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -85.47 136.91 33.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.039 0.447 . . . . 0.0 110.638 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -122.66 129.54 51.96 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.056 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.405 HD12 ' N ' ' B' ' 951' ' ' ILE . 2.7 mp -130.72 130.08 64.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -69.99 83.09 0.49 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.383 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.838 179.591 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -58.65 159.27 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.005 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 17' ' ' VAL . 13.8 pt -137.83 154.05 28.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.087 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.45 ' CD2' HG23 ' C' ' 14' ' ' THR . 17.3 m-30 -92.43 123.7 35.94 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.426 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 54.8 t -111.15 106.73 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.408 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . 0.535 ' HG3' HG23 ' C' ' 66' ' ' THR . 24.8 mtmt -91.25 133.18 35.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.383 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 49.2 p -81.16 -162.47 0.5 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.28 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.47 -20.86 58.41 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -113.8 -176.28 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.811 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.43 -14.58 54.79 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -50.53 128.05 19.24 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.16 137.28 54.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.761 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.409 HG21 HD13 ' C' ' 13' ' ' ILE . 1.1 mt -123.82 113.62 37.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.261 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . 0.45 HG23 ' CD2' ' C' ' 4' ' ' PHE . 7.2 m -80.98 126.68 31.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.584 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.07 126.45 48.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.267 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.17 116.36 9.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.944 0.402 . . . . 0.0 110.301 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.663 HG12 ' NZ ' ' C' ' 29' ' ' LYS . 10.8 m -136.71 173.06 14.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.519 ' O ' HD12 ' C' ' 56' ' ' LEU . 76.5 mm-40 -125.8 155.32 72.92 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.135 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -58.72 -29.25 89.05 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 121.896 1.731 . . . . 0.0 111.761 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 84.9 p -85.19 -15.47 43.58 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.62 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.38 142.37 58.42 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.592 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 30.2 p -85.98 167.83 14.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 110.808 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 mm -62.8 -35.57 71.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.973 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.95 -42.56 90.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.94 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -62.36 -42.2 99.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.111 0.481 . . . . 0.0 110.195 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.522 HG12 HD21 ' C' ' 43' ' ' LEU . 79.1 t -62.9 -42.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.807 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.628 ' CG ' HD22 ' C' ' 43' ' ' LEU . 56.2 mtmt -61.11 -41.09 96.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.06 86.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.272 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.663 ' NZ ' HG12 ' C' ' 17' ' ' VAL . 27.2 mttt -59.61 -39.22 83.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.58 HD12 HD11 ' C' ' 43' ' ' LEU . 71.6 mt -66.0 -41.14 89.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.157 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.19 -39.45 86.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.881 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.76 11.05 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.62 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -120.45 -33.86 3.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 110.995 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -125.17 -14.91 6.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.057 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.29 12.52 75.87 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.579 HG22 ' HG3' ' C' ' 41' ' ' GLN . 28.6 mt -77.1 129.02 79.56 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 117.035 0.417 . . . . 0.0 110.083 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.69 154.78 59.35 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.243 1.962 . . . . 0.0 111.536 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.15 -37.77 87.48 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.927 1.751 . . . . 0.0 112.768 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -61.86 -43.79 98.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.625 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -83.06 -12.34 57.24 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.968 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . 0.579 ' HG3' HG22 ' C' ' 36' ' ' ILE . 19.8 mt-30 -83.81 102.49 12.37 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.809 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -102.26 109.5 21.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.766 ' HB3' HD12 ' C' ' 50' ' ' LEU . 8.0 mp -98.41 109.62 22.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.844 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 90.1 mt -127.69 128.38 69.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.821 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . 0.429 ' O ' ' HB3' ' C' ' 46' ' ' ALA . 90.0 t80 -132.93 132.45 42.01 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.842 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' C' ' 45' ' ' PHE . . . 65.35 26.67 12.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.708 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.37 14.19 81.02 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.766 ' CE ' HD22 ' D' ' 73' ' ' LEU . 41.4 mtpt -119.5 133.79 55.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.782 0.325 . . . . 0.0 110.148 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -72.32 131.83 43.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.867 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' C' ' 43' ' ' LEU . 70.8 mt -84.57 100.15 11.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.43 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -76.11 143.11 41.46 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.269 0.557 . . . . 0.0 111.171 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.0 144.44 55.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.68 -18.05 57.46 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.83 145.46 24.75 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.26 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 51.2 p -88.64 162.35 16.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.518 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.519 HD21 HG21 ' C' ' 26' ' ' VAL . 74.6 mt -61.39 -38.88 88.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.803 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 96.2 p -62.41 -23.07 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.769 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.66 -37.42 83.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.682 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.5 ' CE2' HD23 ' C' ' 50' ' ' LEU . 69.9 m-85 -96.42 14.28 24.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.56 39.21 25.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.925 0.393 . . . . 0.0 110.336 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -85.94 120.06 35.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.926 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -109.45 -179.04 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.378 0.609 . . . . 0.0 110.902 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -60.23 145.77 46.08 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.934 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 59.67 23.67 12.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.083 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 25.8 t -74.06 124.39 26.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.05 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.535 HG23 ' HG3' ' C' ' 6' ' ' LYS . 37.9 m -73.54 128.43 35.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -115.35 140.07 49.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.74 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . 0.41 ' ND1' HG23 ' C' ' 70' ' ' VAL . 44.6 t-80 -88.17 108.01 19.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.737 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.44 120.6 40.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.688 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.41 HG23 ' ND1' ' C' ' 68' ' ' HIS . 72.2 t -120.59 138.96 49.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.155 0.502 . . . . 0.0 110.742 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.534 ' CD2' HD13 ' C' ' 36' ' ' ILE . 22.0 mt -109.1 142.21 40.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.405 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -62.85 -39.5 94.58 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.371 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.94 136.59 39.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.493 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.13 26.08 5.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.655 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.76 18.39 77.34 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.13 175.07 43.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.606 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.1 ttp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -64.79 161.98 17.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.867 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -143.67 147.41 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.95 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -94.95 121.43 36.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.053 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -103.41 111.28 32.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.519 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -95.6 124.53 39.67 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.739 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.842 HG22 HD23 ' D' ' 69' ' ' LEU . 80.7 p -83.5 172.78 12.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.347 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.619 HD11 ' H ' ' D' ' 71' ' ' LEU . 58.8 mt -63.2 -24.07 67.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.153 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 48.8 p -81.41 -8.51 59.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.137 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.22 63.16 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -62.67 131.06 47.69 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.412 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.3 m -108.15 133.3 52.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.92 108.78 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.904 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.72 124.12 28.77 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.527 HD21 ' HD2' ' D' ' 33' ' ' LYS . 80.5 mt -122.52 129.72 52.27 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.405 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -74.38 114.95 13.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.996 0.427 . . . . 0.0 110.52 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.62 HG12 ' HE3' ' D' ' 29' ' ' LYS . 15.8 m -135.28 170.13 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.187 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . 0.602 ' O ' HD12 ' D' ' 56' ' ' LEU . 97.8 mt-10 -120.88 153.95 57.43 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.55 -38.38 94.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.866 1.71 . . . . 0.0 112.169 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -70.52 -21.77 62.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.818 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.65 144.11 56.63 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.133 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -87.89 168.59 12.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.85 -36.24 72.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.865 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tm-20 -59.36 -41.56 89.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.873 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -62.72 -41.34 99.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.154 0.502 . . . . 0.0 110.732 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.517 HG21 HD21 ' D' ' 56' ' ' LEU . 78.4 t -64.26 -42.28 94.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.605 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -60.76 -39.25 88.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.983 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.82 91.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.971 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.62 ' HE3' HG12 ' D' ' 17' ' ' VAL . 66.5 mttm -59.88 -39.32 84.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.814 ' CD1' HD21 ' D' ' 43' ' ' LEU . 79.7 mt -64.57 -39.36 85.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.173 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.31 -39.7 83.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.863 0.363 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -68.14 -55.6 11.81 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.843 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.527 ' HD2' HD21 ' D' ' 15' ' ' LEU . 67.5 mttt -64.54 -40.67 96.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.096 0.474 . . . . 0.0 111.737 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -126.53 140.29 52.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.92 62.77 2.46 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.92 110.59 43.81 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -58.33 150.1 69.45 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.851 1.7 . . . . 0.0 110.739 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.77 -42.2 51.82 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.156 1.904 . . . . 0.0 112.87 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -64.63 -43.69 92.89 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.403 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.49 -41.76 99.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.046 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.651 ' HB2' HD11 ' D' ' 69' ' ' LEU . 26.3 pt20 -84.91 142.39 29.72 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.287 0.565 . . . . 0.0 111.378 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -137.34 109.29 7.16 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.306 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.814 HD21 ' CD1' ' D' ' 30' ' ' ILE . 83.3 mt -80.97 132.21 35.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.081 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . . . . . . . . . 78.9 mt -131.38 128.88 61.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.672 ' HB3' HD21 ' D' ' 50' ' ' LEU . 62.1 t80 -147.78 153.93 39.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.858 0.361 . . . . 0.0 110.677 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 65.77 16.17 10.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.391 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.23 -7.93 76.19 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.104 -0.799 . . . . 0.0 111.104 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.577 ' HB3' HD22 ' A' ' 73' ' ' LEU . 17.4 ptm180 -120.64 145.9 46.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 110.8 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -67.21 133.84 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.221 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' D' ' 45' ' ' PHE . 74.4 mt -73.85 104.49 4.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.291 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -75.84 153.05 37.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.71 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.75 154.43 41.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.694 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.72 20.96 64.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -130.43 140.02 50.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.355 . . . . 0.0 110.293 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -79.92 163.55 24.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.773 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.602 HD12 ' O ' ' D' ' 18' ' ' GLU . 74.4 mt -66.03 -38.18 87.76 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.866 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -62.58 -23.72 67.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.132 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.96 -30.1 71.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 110.447 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -101.86 12.88 36.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.342 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.92 34.08 23.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.919 0.39 . . . . 0.0 110.255 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 71.9 mt -80.16 104.57 8.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -93.09 178.84 5.62 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.73 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -62.39 142.8 57.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.001 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.07 16.06 10.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.558 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -67.64 133.8 50.02 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 35.4 m -89.57 116.08 27.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.792 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.45 129.7 34.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.288 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.842 HD23 HG22 ' D' ' 7' ' ' THR . 64.2 tp -108.04 121.53 45.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.947 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.436 HG11 HD11 ' A' ' 56' ' ' LEU . 93.0 t -109.71 129.09 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.619 ' H ' HD11 ' D' ' 8' ' ' LEU . 57.8 mt -111.83 117.15 32.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.646 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -62.83 -44.56 95.83 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.612 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.766 HD22 ' CE ' ' C' ' 48' ' ' LYS . 0.3 OUTLIER -147.48 137.93 23.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -68.77 120.2 14.34 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.239 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.56 24.51 75.22 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.351 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 12.9 m120 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.01 147.02 47.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.175 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -93.6 112.44 24.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.178 0.513 . . . . 0.0 109.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 51' ' ' GLN . 97.2 mt -67.19 -37.34 83.51 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.793 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.432 HG12 ' CG1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -149.55 162.07 4.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.813 179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.46 122.47 0.36 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.179 0.514 . . . . 0.0 110.882 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -155.27 156.38 35.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.0 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HA ' HD12 ' A' ' 46' ' ' LEU . 90.9 mtm180 -75.91 123.7 26.13 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.472 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -154.61 145.62 22.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.401 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.93 149.67 16.74 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -92.49 174.93 7.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.016 0.436 . . . . 0.0 111.106 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.438 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 31.1 mtp -135.12 173.57 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.6 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.9 m -122.52 120.98 35.44 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD13 ' CG2' ' A' ' 38' ' ' VAL . 28.2 tp -105.39 117.08 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.236 0.541 . . . . 0.0 110.244 179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -122.05 116.9 25.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.52 -87.7 0.27 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.6 p -144.92 21.25 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.686 0.279 . . . . 0.0 110.799 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.502 ' O ' HD12 ' A' ' 33' ' ' LEU . 88.3 m -123.03 131.23 53.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 110.478 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.507 ' CG2' HD13 ' A' ' 33' ' ' LEU . 64.7 t -109.75 123.31 65.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.045 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -116.76 137.07 23.41 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.249 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.77 146.57 54.29 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.776 1.651 . . . . 0.0 112.987 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -103.87 119.13 38.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.427 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -62.37 -16.2 53.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.46 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -70.25 82.72 0.54 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -62.32 136.41 57.91 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.398 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.1 -157.45 8.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.686 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' A' ' 27' ' ' ARG . 5.3 tp -137.13 125.68 23.64 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.3 t -97.85 110.67 25.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -133.85 153.93 51.39 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.382 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG1' HG12 ' A' ' 24' ' ' VAL . 97.9 mt -119.27 137.75 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.232 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 130.35 34.61 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 123.624 0.578 . . . . 0.0 110.28 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.513 ' HB2' HD11 ' A' ' 23' ' ' LEU . 50.3 tt0 -101.09 123.76 45.74 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.895 0.379 . . . . 0.0 110.013 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.49 HG23 ' CD2' ' A' ' 58' ' ' HIS . 11.7 p -83.2 172.17 12.9 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.704 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.89 -10.2 26.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.706 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -90.09 1.8 55.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.74 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.8 t 70.5 21.06 5.68 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 110.501 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.592 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 77.5 mt -97.74 120.72 38.63 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.521 HG21 HD23 ' A' ' 128' ' ' LEU . 50.8 mm -80.04 121.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 52' ' ' THR . 74.5 m-70 -97.66 113.8 25.62 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.662 -178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -97.01 106.74 19.14 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.53 147.34 49.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.856 0.836 . . . . 0.0 112.929 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -122.02 116.21 23.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.57 179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -105.39 144.32 32.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.298 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -82.91 131.31 35.2 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -72.61 -16.3 61.73 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.837 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -59.65 -45.33 92.33 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.0 m -117.04 -14.15 10.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.172 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.62 74.95 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -102.23 152.49 20.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.4 t -79.9 102.27 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.152 0.501 . . . . 0.0 110.475 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -72.64 -38.83 67.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.897 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -126.75 145.01 50.77 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.24 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.565 ' O ' HD23 ' A' ' 73' ' ' LEU . 67.9 t0 -157.5 101.46 1.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.145 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.577 HD22 ' HB3' ' D' ' 48' ' ' ARG . 35.6 mt -127.4 136.14 51.44 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.966 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.19 122.59 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.401 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.714 HG21 ' SG ' ' A' ' 80' ' ' CYS . 28.2 mm -113.2 122.55 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.777 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.592 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 67.3 m-85 -87.23 162.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.518 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.95 140.61 92.67 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.006 1.804 . . . . 0.0 111.625 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.6 t0 60.43 12.46 3.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.454 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -88.93 -21.85 23.38 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.039 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.714 ' SG ' HG21 ' A' ' 75' ' ' ILE . 16.7 p -148.77 169.07 21.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.396 0.617 . . . . 0.0 110.584 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -140.17 130.7 25.53 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.352 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -101.07 118.91 37.92 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -142.01 170.1 16.35 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.663 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.18 161.81 20.44 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -114.37 88.95 16.46 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.645 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.79 59.48 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.983 1.788 . . . . 0.0 112.105 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -115.41 -37.25 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.387 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 14.2 p -126.28 75.61 73.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.633 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.27 130.04 34.23 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.771 1.647 . . . . 0.0 111.196 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.8 p 170.27 -41.77 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -135.13 -125.59 2.54 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.431 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -143.03 107.63 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.257 0.551 . . . . 0.0 110.384 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 86.9 t -126.62 132.49 70.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.595 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.99 155.5 32.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.45 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.25 135.86 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.027 0.441 . . . . 0.0 110.381 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.3 tp -101.15 121.92 42.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -119.19 133.05 55.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.091 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -83.43 115.48 22.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 0.0 109.678 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.77 -37.77 85.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.635 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.06 18.54 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.54 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -102.79 -179.91 26.55 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.2 m -115.25 18.03 16.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.704 0.288 . . . . 0.0 110.726 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.738 ' HD3' HD21 ' A' ' 105' ' ' LEU . 19.9 ttmt -95.28 144.41 25.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.956 0.407 . . . . 0.0 110.949 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -136.47 129.1 30.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.97 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.738 HD21 ' HD3' ' A' ' 103' ' ' LYS . 41.8 mt -114.68 148.34 38.36 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.771 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.451 ' CE1' HD22 ' A' ' 33' ' ' LEU . 90.3 m-85 -122.58 136.81 54.98 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.213 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -136.84 154.46 50.51 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.397 0.617 . . . . 0.0 111.246 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 59.8 p-90 -126.58 136.37 52.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.056 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 139.2 57.12 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.272 0.558 . . . . 0.0 111.301 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.52 -2.01 11.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.066 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.55 139.0 54.8 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.933 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -56.89 -39.41 91.6 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.972 1.781 . . . . 0.0 112.372 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -112.02 143.79 42.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.3 p -94.29 1.86 55.91 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.857 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -57.54 -20.46 32.02 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.55 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -118.76 -16.18 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.49 -41.6 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.855 0.359 . . . . 0.0 110.569 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.75 -40.88 97.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.074 0.464 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.03 -40.38 90.99 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.486 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.752 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.7 m170 -62.52 -39.54 93.87 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.728 0.775 . . . . 0.0 109.15 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.76 -45.52 93.99 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.54 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -65.94 -41.88 90.73 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.525 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -63.27 -38.34 90.79 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.301 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.6 t -59.17 -47.94 88.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.153 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -80.02 -29.75 39.4 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 119.915 -0.714 . . . . 0.0 110.714 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -68.17 -37.85 81.45 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.517 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -81.36 -31.85 33.19 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.767 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.562 HD22 ' HB ' ' A' ' 75' ' ' ILE . 72.5 mt -81.36 -24.79 36.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.243 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.75 -23.63 11.31 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.428 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -137.37 68.32 54.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.931 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.86 160.82 48.17 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 C-N-CA 122.849 2.366 . . . . 0.0 112.283 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 C--N 1.311 -1.431 0 C-N-CA 122.704 2.27 . . . . 0.0 112.336 -179.583 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.31 127.84 93.51 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.319 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -56.31 141.76 88.53 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 121.836 1.691 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -85.43 151.16 55.76 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.61 158.49 53.49 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.429 2.086 . . . . 0.0 112.222 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.6 -168.62 0.46 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.709 2.273 . . . . 0.0 112.027 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -120.82 158.59 51.71 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.498 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.15 140.7 87.61 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.564 2.176 . . . . 0.0 112.19 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.37 162.94 40.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -86.96 136.81 32.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.495 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -124.06 127.65 48.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.285 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . 0.412 ' N ' HD12 ' B' ' 951' ' ' ILE . 2.4 mp -130.3 126.74 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.249 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -77.11 83.76 3.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.726 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.636 179.537 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.8 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -79.51 162.08 25.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 12.4 pt -141.91 149.88 19.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.173 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -97.42 126.94 42.97 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.817 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -110.12 116.92 53.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.292 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -101.27 133.52 45.72 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.589 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.72 HG22 HD23 ' C' ' 69' ' ' LEU . 67.6 p -90.33 -175.19 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.02 0.438 . . . . 0.0 110.803 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.579 HD11 ' H ' ' C' ' 71' ' ' LEU . 83.9 mt -62.49 -38.9 91.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.238 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 38.3 p -72.58 -9.49 58.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.434 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.84 -7.07 70.27 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -57.36 125.73 24.12 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . . . . . . . . . 89.6 m -104.9 131.93 51.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.863 0.363 . . . . 0.0 110.592 -179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.3 105.04 12.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.442 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 134.81 42.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.075 0.464 . . . . 0.0 110.366 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.727 HD21 ' HG3' ' C' ' 33' ' ' LYS . 62.4 mt -132.21 132.91 43.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.965 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -76.53 117.63 18.38 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.52 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.09 -178.7 2.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.678 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.446 ' O ' HD12 ' C' ' 56' ' ' LEU . 97.3 mt-10 -127.24 154.0 76.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -59.94 -27.83 85.78 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.016 1.811 . . . . 0.0 112.181 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 65.6 m -87.04 -10.04 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.692 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.69 142.94 58.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.023 0.44 . . . . 0.0 110.795 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -81.25 164.53 22.19 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . . . . . . . . . 45.3 mm -63.86 -38.83 83.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.988 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.71 -40.32 87.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.045 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.66 -42.97 99.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 0.0 110.393 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.556 HG21 HD21 ' C' ' 56' ' ' LEU . 62.1 t -61.64 -42.63 94.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.273 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.413 ' HG2' HD23 ' C' ' 43' ' ' LEU . 34.2 mtmt -59.89 -38.93 83.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.597 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -41.83 96.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.713 ' HB3' HD13 ' C' ' 15' ' ' LEU . 13.9 mttp -59.67 -38.47 81.56 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.617 HD11 HD11 ' C' ' 43' ' ' LEU . 96.5 mt -66.36 -39.54 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.816 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -58.66 -40.48 83.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -70.88 -41.62 71.1 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.417 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.727 ' HG3' HD21 ' C' ' 15' ' ' LEU . 4.3 mmtm -65.75 -41.18 92.43 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.93 156.93 47.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.969 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.21 59.02 2.77 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . . . . . . . . . 35.1 mm -112.28 114.89 50.42 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.53 162.31 41.73 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.825 1.683 . . . . 0.0 112.001 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -58.97 -36.72 96.31 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.419 2.079 . . . . 0.0 112.804 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.28 -39.6 95.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.428 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -88.49 -13.95 39.04 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.74 86.32 4.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.98 0.419 . . . . 0.0 110.509 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -93.66 107.55 19.4 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.757 ' HB3' HD12 ' C' ' 50' ' ' LEU . 4.6 mm? -99.48 118.47 36.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.421 . . . . 0.0 110.663 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . . . . . . . . . 84.7 mt -129.06 129.7 67.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.583 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -117.55 121.83 42.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.577 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.52 25.4 14.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.657 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.13 -8.14 80.52 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -90.58 121.42 32.49 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -69.01 132.27 46.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.198 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.757 HD12 ' HB3' ' C' ' 43' ' ' LEU . 56.2 mt -85.01 101.73 12.63 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.124 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -75.3 144.8 42.27 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.062 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.18 143.49 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.203 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.65 -19.23 55.2 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -83.12 169.39 15.91 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -119.82 164.69 15.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.819 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.556 HD21 HG21 ' C' ' 26' ' ' VAL . 81.1 mt -60.82 -40.56 93.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.501 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -63.6 -24.0 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.459 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.46 -37.67 84.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 110.476 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.526 ' CZ ' HD13 ' D' ' 73' ' ' LEU . 66.9 m-85 -97.99 15.41 24.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.072 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 59.7 t30 57.51 40.45 27.05 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.924 0.392 . . . . 0.0 110.346 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . . . . . . . . . 83.8 mt -87.53 107.61 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -96.52 179.09 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -58.16 149.12 24.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.084 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 57.82 40.58 25.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 18.3 t -94.67 123.13 37.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.007 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.487 ' O ' HD22 ' C' ' 67' ' ' LEU . 8.3 m -76.8 131.07 38.48 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.487 HD22 ' O ' ' C' ' 66' ' ' THR . 3.5 mm? -115.24 141.1 48.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.578 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -91.01 108.32 19.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.989 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.72 HD23 HG22 ' C' ' 7' ' ' THR . 64.9 tp -100.73 118.78 37.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' C' ' 8' ' ' LEU . 92.6 t -112.21 133.43 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.25 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.579 ' H ' HD11 ' C' ' 8' ' ' LEU . 18.8 mt -109.58 149.09 30.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.42 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -93.62 155.66 17.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 110.555 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 67.0 tp -101.15 122.78 44.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.556 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -63.06 -39.69 95.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.763 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.19 -163.0 54.45 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.32 166.27 54.71 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.606 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -58.13 159.84 5.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.169 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -139.69 141.4 34.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.349 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . 0.579 ' HD2' HG21 ' D' ' 12' ' ' THR . 3.9 m-85 -83.93 123.8 30.34 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.815 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.529 ' CG1' HD12 ' D' ' 69' ' ' LEU . 81.4 t -109.78 103.75 15.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.656 -0.417 . . . . 0.0 110.5 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -94.45 122.91 37.51 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.841 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -82.71 179.36 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.129 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.502 HD11 ' H ' ' D' ' 71' ' ' LEU . 79.6 mt -62.87 -35.48 80.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.085 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -67.01 -14.92 63.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.792 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.73 -14.05 59.13 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -62.55 131.01 47.66 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.275 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . 0.579 HG21 ' HD2' ' D' ' 4' ' ' PHE . 97.7 m -104.15 132.59 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.019 0.438 . . . . 0.0 110.806 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.401 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.2 mt -127.16 107.14 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.872 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -81.85 127.67 33.24 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.301 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.606 HD21 ' HD2' ' D' ' 33' ' ' LYS . 93.4 mt -123.16 126.36 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.8 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -66.1 113.88 4.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.388 0.613 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.446 HG12 ' CD ' ' D' ' 29' ' ' LYS . 20.3 m -135.62 162.63 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.131 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -106.42 152.75 40.69 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.09 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.65 -37.24 91.22 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.988 1.792 . . . . 0.0 111.956 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 83.9 p -81.16 -8.64 59.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -57.92 138.1 56.11 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.014 0.435 . . . . 0.0 110.991 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 44.8 p -80.37 162.87 24.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.12 -39.34 85.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.071 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.5 -39.89 89.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -62.45 -42.67 99.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.112 0.482 . . . . 0.0 110.477 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.28 -42.71 96.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.655 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.461 ' HG2' HD11 ' D' ' 43' ' ' LEU . 56.9 mtmt -60.23 -39.76 87.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.323 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.65 92.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.488 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.446 ' CD ' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -60.16 -38.83 84.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . 0.646 HD13 HD11 ' D' ' 69' ' ' LEU . 97.2 mt -64.71 -39.69 86.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.701 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.68 -40.94 93.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.17 -40.29 97.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.606 ' HD2' HD21 ' D' ' 15' ' ' LEU . 59.4 mttt -78.59 -71.41 0.43 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.892 0.377 . . . . 0.0 111.007 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -88.32 166.64 14.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.086 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.5 21.77 23.92 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . 0.566 HG22 ' HG3' ' D' ' 41' ' ' GLN . 27.1 mm -78.08 119.3 76.85 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.367 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.45 161.95 42.81 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.173 1.915 . . . . 0.0 111.538 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.12 -37.51 87.15 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.236 1.957 . . . . 0.0 112.479 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -62.3 -42.75 99.62 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.348 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -82.8 -12.52 57.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.185 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.566 ' HG3' HG22 ' D' ' 36' ' ' ILE . 79.4 mt-30 -80.86 80.57 7.31 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -97.8 94.59 7.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.687 ' HB2' HD12 ' D' ' 50' ' ' LEU . 11.9 mt -85.15 129.67 34.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.471 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.596 HG23 ' HA ' ' D' ' 49' ' ' GLN . 49.1 mt -129.1 130.18 68.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.376 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.644 ' HB3' HD21 ' D' ' 50' ' ' LEU . 68.2 t80 -148.45 154.75 40.3 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.832 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 70.0 22.25 5.84 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.757 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 -2.24 77.62 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.529 ' HB3' HD22 ' A' ' 73' ' ' LEU . 5.3 ptm180 -132.26 150.47 52.15 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.08 0.467 . . . . 0.0 110.47 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . 0.596 ' HA ' HG23 ' D' ' 44' ' ' ILE . 21.1 pt20 -65.13 148.5 51.56 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.566 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' D' ' 43' ' ' LEU . 81.0 mt -84.88 109.44 18.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.784 -178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.82 151.8 37.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.201 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -74.9 167.93 20.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.221 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.51 24.58 76.1 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -129.3 169.29 15.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.821 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 57.4 p -115.53 164.63 14.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.452 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.82 -39.66 95.0 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 96.7 p -62.72 -28.49 69.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.07 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.49 -35.97 79.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.025 0.441 . . . . 0.0 110.158 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -94.92 12.04 29.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.224 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 56.21 39.6 30.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.143 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -85.48 112.83 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.915 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -97.11 177.18 5.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.531 0.681 . . . . 0.0 111.133 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -61.7 142.58 57.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.121 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 65.13 18.61 11.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.334 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . 0.427 ' O ' HD12 ' D' ' 67' ' ' LEU . 32.0 m -70.55 130.79 42.78 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.605 -0.438 . . . . 0.0 109.94 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 61.4 m -82.32 126.3 31.98 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . 0.581 HD23 HD11 ' D' ' 50' ' ' LEU . 5.6 mp -117.09 142.85 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.06 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -89.19 117.67 28.34 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.232 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.646 HD11 HD13 ' D' ' 30' ' ' ILE . 0.4 OUTLIER -97.7 100.26 11.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.31 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.68 128.83 38.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.502 ' H ' HD11 ' D' ' 8' ' ' LEU . 75.6 mt -104.62 148.87 26.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.557 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -128.27 129.85 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.4 . . . . 0.0 110.949 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.526 HD13 ' CZ ' ' C' ' 59' ' ' TYR . 81.4 mt -109.2 16.51 22.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.386 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -60.08 128.07 34.98 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.946 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.12 -9.6 76.85 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.658 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -69.94 149.27 47.96 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.068 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.9 m-30 -89.28 126.94 35.72 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.366 0.603 . . . . 0.0 110.208 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' ILE . 83.4 mt -67.35 -38.46 84.87 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.878 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG11 HG22 ' A' ' 124' ' ' VAL . 0.9 OUTLIER -147.48 161.99 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 179.494 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -173.06 122.14 0.39 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.048 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -153.51 153.16 31.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.68 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.608 ' HA ' HD12 ' A' ' 46' ' ' LEU . 99.6 mtt180 -70.51 123.38 21.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.572 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.59 ' HB3' HG23 ' A' ' 47' ' ' VAL . . . -153.46 145.69 23.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.266 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.15 151.74 17.69 Favored Glycine 0 CA--C 1.519 0.33 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -89.25 172.61 8.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.979 0.419 . . . . 0.0 110.99 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' PHE . 33.3 mtp -136.41 170.47 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.632 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.9 m -120.8 121.31 37.88 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 37' ' ' THR . 22.0 tp -104.57 118.26 36.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.639 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -119.55 107.23 13.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.743 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.52 -92.88 0.61 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 19.4 p -135.13 19.84 3.43 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 122.942 -0.152 . . . . 0.0 110.972 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.551 ' O ' HD12 ' A' ' 33' ' ' LEU . 90.6 m -121.52 130.94 53.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.838 0.351 . . . . 0.0 110.369 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.476 ' CG2' HD13 ' A' ' 33' ' ' LEU . 76.8 t -112.31 124.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.194 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -116.51 136.15 23.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.267 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.55 147.18 45.46 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.956 1.771 . . . . 0.0 112.918 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -101.94 122.31 43.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.635 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -65.3 -11.34 40.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.762 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -73.8 78.79 1.58 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -55.47 137.36 48.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.143 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -133.86 -159.49 8.98 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.312 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.608 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.1 tp -139.09 124.43 19.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.59 HG23 ' HB3' ' A' ' 28' ' ' ALA . 55.4 t -96.91 109.62 23.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.454 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 39.5 p90 -132.72 154.52 50.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.905 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 23' ' ' LEU . 84.5 mt -120.8 141.77 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.625 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -142.85 140.95 31.48 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 123.75 0.657 . . . . 0.0 110.048 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -104.43 127.43 52.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.975 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.527 HG23 ' CD2' ' A' ' 58' ' ' HIS . 27.9 p -87.67 173.95 8.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.77 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.69 -11.08 22.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.822 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -86.21 -1.24 57.27 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.399 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t 69.97 19.88 6.76 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.246 0.546 . . . . 0.0 110.529 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.76 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 54.9 mt -101.96 128.79 48.22 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 131' ' ' PRO . 51.5 mm -82.21 127.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.527 ' CD2' HG23 ' A' ' 52' ' ' THR . 68.4 m-70 -104.99 114.82 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.112 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.578 ' CB ' HD13 ' A' ' 75' ' ' ILE . 59.9 t80 -89.57 107.77 19.27 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 95.0 m -119.36 140.8 49.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -121.59 114.08 20.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.187 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -105.99 147.61 28.65 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.348 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -79.8 137.19 36.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.737 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -76.55 -21.1 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 50.3 m -60.14 -45.17 93.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.674 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.7 p -116.48 -12.17 11.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.492 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.4 77.12 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -102.01 146.29 28.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.95 0.405 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.17 105.93 3.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.174 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -84.0 -31.55 25.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.832 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -128.12 147.92 50.56 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.392 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.572 ' O ' HD23 ' A' ' 73' ' ' LEU . 2.1 p-10 -158.7 99.14 1.55 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.549 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 72' ' ' ASP . 38.5 mt -126.7 134.53 50.66 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.645 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.586 ' C ' HD12 ' A' ' 75' ' ' ILE . 97.3 mt -79.12 129.22 37.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.136 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.586 HD12 ' C ' ' A' ' 74' ' ' ILE . 1.9 mp -117.28 117.14 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.841 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.76 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 52.4 m-85 -83.4 163.56 49.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.28 137.97 78.39 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.736 1.624 . . . . 0.0 111.003 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 58.25 14.29 2.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.149 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -90.02 -40.81 12.08 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.462 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -128.06 147.91 50.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.864 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 96' ' ' LEU . 10.6 tp10 -121.34 129.68 53.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.254 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -107.03 117.63 34.57 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -143.1 167.97 20.83 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.629 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -82.38 160.83 22.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.865 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.93 90.44 13.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.145 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -80.35 59.83 7.6 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.069 1.846 . . . . 0.0 112.342 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.12 -39.8 3.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.371 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 36.9 t -127.89 81.09 70.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.11 130.55 29.27 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.804 1.669 . . . . 0.0 111.528 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p 170.27 -39.52 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.887 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.7 -146.07 5.01 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.418 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.38 106.96 13.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.33 . . . . 0.0 110.43 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.6 t -126.62 129.63 71.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.22 154.14 43.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.325 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.8 p -130.19 135.99 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-O 121.127 0.489 . . . . 0.0 110.349 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 80' ' ' CYS . 62.4 tp -104.65 118.29 36.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -117.45 131.2 56.79 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.194 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' A' ' 101' ' ' GLY . 59.9 m-85 -86.84 114.81 23.81 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -31.6 70.93 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.449 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.93 -21.98 11.31 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.15 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 98' ' ' PHE . . . -71.98 -23.25 78.26 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.827 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 66.79 12.24 8.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.563 0.22 . . . . 0.0 111.186 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -118.81 155.81 30.52 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.797 0.332 . . . . 0.0 110.779 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 143.78 45.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.992 0.425 . . . . 0.0 110.747 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 95' ' ' VAL . 57.8 mt -120.21 151.98 38.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.522 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.406 ' HB2' ' HB2' ' A' ' 31' ' ' MET . 98.1 m-85 -121.28 134.23 55.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.69 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.62 158.14 44.62 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.129 0.49 . . . . 0.0 111.148 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -132.73 138.71 47.31 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.893 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.408 ' HG3' ' H ' ' A' ' 111' ' ' GLU . 52.2 tpp -70.5 132.75 46.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.766 -178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.72 1.81 14.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.426 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 109' ' ' MET . 88.6 mt-10 -66.34 146.48 99.04 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.393 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.04 -40.47 84.74 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.923 1.748 . . . . 0.0 112.659 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -122.98 146.61 47.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.883 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.3 p -96.88 11.96 33.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.551 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -59.72 -21.46 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.368 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -116.63 6.32 13.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -61.95 -46.79 87.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.938 0.399 . . . . 0.0 110.702 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.86 -40.88 97.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.042 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.06 -43.66 94.81 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.695 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.698 ' O ' HG23 ' A' ' 124' ' ' VAL . 64.2 m170 -64.65 -40.97 96.38 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.755 0.788 . . . . 0.0 109.535 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 47.5 t -63.54 -43.99 95.51 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.874 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.8 tpp85 -67.51 -42.33 83.0 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.691 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.44 -41.39 98.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.244 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.7 t -58.34 -47.77 86.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.15 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -63.93 -38.2 90.22 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.575 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -72.47 -29.46 63.67 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.219 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -83.01 -29.77 28.66 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.696 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.502 HD22 ' HB ' ' A' ' 75' ' ' ILE . 81.4 mt -89.23 -20.64 23.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.5 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -111.39 -23.99 10.45 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.154 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -134.51 72.45 69.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.164 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.434 ' HB3' HD11 ' A' ' 57' ' ' ILE . 31.4 Cg_exo -59.83 150.83 75.24 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.744 2.296 . . . . 0.0 112.081 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 N--CA 1.49 1.312 0 C-N-CA 122.402 2.068 . . . . 0.0 112.088 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 48.7 mp0 -71.18 149.38 94.37 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.692 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.02 150.32 29.63 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.564 2.176 . . . . 0.0 112.182 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -81.91 153.47 69.87 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.166 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.12 158.96 53.65 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.413 2.075 . . . . 0.0 112.144 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.31 -169.27 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.783 2.322 . . . . 0.0 112.027 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -120.06 159.83 45.52 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.349 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.53 143.98 86.19 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.638 2.225 . . . . 0.0 112.253 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -154.92 164.73 38.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.078 0.466 . . . . 0.0 110.936 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -86.22 134.95 33.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.689 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -120.29 132.62 55.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.349 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 3.8 mt -131.11 130.61 63.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -76.45 85.22 3.18 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.158 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.406 179.696 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.92 164.89 9.56 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.481 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' ILE . . . . . . . . . . . . . 15.6 pt -144.35 141.05 24.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.193 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' PHE . . . . . 0.477 ' HD2' HG21 ' C' ' 12' ' ' THR . 7.8 m-85 -86.12 123.85 31.88 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.847 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 94.2 t -109.07 116.83 53.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -95.08 121.74 37.01 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.757 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.556 HG22 HD23 ' C' ' 69' ' ' LEU . 81.9 p -83.51 172.59 12.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.22 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.647 HD11 ' H ' ' C' ' 71' ' ' LEU . 81.9 mt -61.94 -36.6 81.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.203 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 48.7 p -68.22 -11.62 59.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.801 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.28 -12.75 63.46 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -66.61 130.28 42.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' THR . . . . . 0.477 HG21 ' HD2' ' C' ' 4' ' ' PHE . 97.5 m -104.62 131.27 52.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.997 0.427 . . . . 0.0 110.643 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.43 HG21 ' HG2' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -125.66 110.2 23.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.841 -179.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' THR . . . . . . . . . . . . . 30.0 m -81.31 130.15 34.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.092 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.626 HD21 ' CD ' ' C' ' 33' ' ' LYS . 70.0 mt -122.32 131.41 53.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.701 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -71.94 116.03 11.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 110.729 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.489 HG12 ' CD ' ' C' ' 29' ' ' LYS . 20.3 m -136.08 164.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.394 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -105.33 153.22 39.82 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.223 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.41 -34.91 95.67 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.081 1.854 . . . . 0.0 112.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' SER . . . . . . . . . . . . . 68.8 m -86.53 -2.19 58.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -62.42 136.66 58.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 110.737 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 59.8 p -78.59 163.07 25.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.931 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' ILE . . . . . 1.002 HD12 HD23 ' C' ' 50' ' ' LEU . 40.3 mm -64.84 -41.27 91.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.429 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -58.16 -36.81 73.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.747 -0.381 . . . . 0.0 109.996 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -65.08 -41.76 94.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.382 0.611 . . . . 0.0 110.826 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.559 HG12 HD21 ' C' ' 43' ' ' LEU . 70.5 t -64.24 -42.27 94.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.588 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.497 ' HG2' HD13 ' C' ' 43' ' ' LEU . 56.4 mtmt -60.82 -39.72 90.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.315 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.16 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.043 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' LYS . . . . . 0.489 ' CD ' HG12 ' C' ' 17' ' ' VAL . 67.3 mttm -60.31 -39.17 86.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' ILE . . . . . 0.486 HD12 HD11 ' C' ' 43' ' ' LEU . 91.4 mt -65.15 -40.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.179 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' GLN . . . . . . . . . . . . . 26.1 tm0? -59.75 -41.11 90.27 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.326 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -64.28 -40.47 96.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.153 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.626 ' CD ' HD21 ' C' ' 15' ' ' LEU . 0.0 OUTLIER -71.88 -63.7 1.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.47 -178.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -107.05 159.66 16.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.893 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.23 55.25 3.99 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' ILE . . . . . 0.462 HG23 HD22 ' C' ' 71' ' ' LEU . 33.8 mm -107.91 121.01 45.28 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.56 159.94 47.75 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.651 1.568 . . . . 0.0 111.868 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.93 -39.08 94.07 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.186 1.924 . . . . 0.0 112.47 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -61.48 -50.22 73.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.551 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -67.63 -39.69 84.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.692 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -54.2 96.23 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.279 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' ARG . . . . . 0.594 ' NE ' HD11 ' C' ' 44' ' ' ILE . 76.9 ttt180 -104.24 110.75 23.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.559 HD21 HG12 ' C' ' 26' ' ' VAL . 7.2 mp -92.68 117.91 30.49 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.65 0.594 . . . . 0.0 110.701 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' ILE . . . . . 0.594 HD11 ' NE ' ' C' ' 42' ' ' ARG . 92.4 mt -130.06 128.36 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.417 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -127.9 128.87 45.93 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.662 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 25.62 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.527 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.28 1.63 90.12 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . 0.633 ' HE2' HD23 ' D' ' 73' ' ' LEU . 57.1 mtpt -103.17 123.14 46.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -66.95 134.08 51.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.222 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 1.002 HD23 HD12 ' C' ' 23' ' ' ILE . 9.7 mp -87.25 102.27 14.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.344 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -74.21 146.17 43.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.912 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.67 144.93 53.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.536 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.15 -15.38 63.3 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.8 mmp_? -83.22 168.09 17.08 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' THR . . . . . . . . . . . . . 56.9 p -116.45 161.76 18.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.447 HD21 HG21 ' C' ' 26' ' ' VAL . 83.0 mt -61.74 -40.36 94.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.959 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 99.5 p -63.19 -24.68 67.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.528 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -62.78 -37.78 88.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 110.145 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' TYR . . . . . 0.708 ' CE2' HD22 ' D' ' 73' ' ' LEU . 60.7 m-85 -95.59 14.15 23.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.165 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.93 41.77 27.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.979 0.419 . . . . 0.0 110.171 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ILE . . . . . 0.547 HD11 HD21 ' C' ' 50' ' ' LEU . 86.2 mt -91.87 106.16 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.667 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -92.51 -173.77 3.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.961 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -65.63 144.78 56.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.221 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 63.64 13.07 7.03 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.075 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' SER . . . . . . . . . . . . . 52.9 m -65.6 132.78 49.7 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' THR . . . . . 0.629 ' C ' HD12 ' C' ' 67' ' ' LEU . 56.6 m -85.02 127.67 34.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' LEU . . . . . 0.629 HD12 ' C ' ' C' ' 66' ' ' THR . 10.2 mp -119.39 140.38 50.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -86.15 123.72 31.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.171 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' LEU . . . . . 0.556 HD23 HG22 ' C' ' 7' ' ' THR . 66.5 tp -109.33 120.1 41.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.626 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.633 HG12 ' H ' ' C' ' 72' ' ' ARG . 87.6 t -116.83 131.74 68.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' LEU . . . . . 0.647 ' H ' HD11 ' C' ' 8' ' ' LEU . 18.9 mt -92.84 32.47 1.25 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.591 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.633 ' H ' HG12 ' C' ' 70' ' ' VAL . 40.3 mmt180 59.49 43.82 15.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.384 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' LEU . . . . . . . . . . . . . 66.4 tp -103.01 122.98 45.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.274 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -95.42 125.59 40.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.243 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.15 -40.01 97.95 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.12 90.7 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.599 -179.748 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.9 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -65.02 162.59 16.39 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.472 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' ILE . . . . . 0.472 HG22 ' HB3' ' D' ' 65' ' ' SER . 7.9 pt -141.17 146.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.942 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' PHE . . . . . . . . . . . . . 12.4 m-30 -90.58 101.14 13.88 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.686 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -87.75 101.03 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 132.65 41.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -64.45 -150.66 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.04 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.598 HD13 ' NH1' ' D' ' 74' ' ' ARG . 83.8 mt -59.85 -40.01 87.14 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.387 -0.525 . . . . 0.0 109.589 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 0.452 HG22 ' C ' ' D' ' 8' ' ' LEU . 0.0 OUTLIER 179.96 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.123 179.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.46 -89.35 0.44 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.096 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.36 139.88 14.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.887 0.375 . . . . 0.0 110.762 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' THR . . . . . . . . . . . . . 98.1 m -126.43 137.78 53.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.833 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.537 HG22 ' HD2' ' D' ' 33' ' ' LYS . 1.5 mt -121.65 111.7 32.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.28 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' THR . . . . . . . . . . . . . 33.4 m -85.78 125.78 33.51 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.126 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -122.63 130.42 52.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.514 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -73.56 115.97 13.59 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.589 HG12 ' HE3' ' D' ' 29' ' ' LYS . 21.2 m -133.65 166.3 29.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.616 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -111.46 152.66 44.1 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.893 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.7 -27.28 82.82 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.76 1.64 . . . . 0.0 111.765 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' SER . . . . . . . . . . . . . 88.1 p -87.36 -11.42 49.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.37 142.19 58.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.032 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' THR . . . . . . . . . . . . . 57.4 p -82.32 165.41 20.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.879 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' ILE . . . . . 0.567 HD12 HD13 ' D' ' 50' ' ' LEU . 49.9 mm -62.42 -38.75 82.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.8 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.29 -41.41 88.86 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.078 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -60.86 -42.82 98.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.569 . . . . 0.0 110.375 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.08 -41.39 90.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.933 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' LYS . . . . . 0.486 ' HG2' HD11 ' D' ' 43' ' ' LEU . 56.2 mtmt -60.5 -40.09 90.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.008 0.432 . . . . 0.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.36 91.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.393 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . 0.589 ' HE3' HG12 ' D' ' 17' ' ' VAL . 67.0 mttm -59.78 -38.33 81.58 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' ILE . . . . . . . . . . . . . 82.4 mt -62.79 -39.73 86.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.371 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.66 -43.95 97.03 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.53 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -71.31 -20.15 62.23 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.985 -0.447 . . . . 0.0 111.871 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.537 ' HD2' HG22 ' D' ' 13' ' ' ILE . 6.8 mttm -102.9 -7.67 21.34 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -141.32 -43.8 0.37 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.252 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.16 14.92 10.3 Favored Glycine 0 C--N 1.321 -0.268 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.038 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -88.79 117.64 68.5 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.622 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.32 172.67 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.961 1.774 . . . . 0.0 111.362 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.67 -27.13 18.87 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 122.494 2.129 . . . . 0.0 111.763 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -100.24 -176.15 3.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.837 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 64.94 16.9 10.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.539 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' D' ' 69' ' ' LEU . 14.4 pt20 -157.2 159.15 37.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.016 0.436 . . . . 0.0 110.777 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -147.27 131.32 17.26 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.703 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.486 HD11 ' HG2' ' D' ' 27' ' ' LYS . 22.4 mt -100.49 114.52 28.18 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' ILE . . . . . 0.417 HD12 ' HZ ' ' A' ' 76' ' ' PHE . 77.0 mt -118.71 130.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.61 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' PHE . . . . . 0.446 ' O ' ' HB3' ' D' ' 46' ' ' ALA . 90.1 t80 -142.38 149.23 39.1 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.984 0.421 . . . . 0.0 111.192 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' D' ' 45' ' ' PHE . . . 67.25 15.78 10.04 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -13.14 64.23 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' ARG . . . . . 0.655 ' HB3' HD22 ' A' ' 73' ' ' LEU . 38.2 ptt180 -114.62 142.34 46.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.102 0.477 . . . . 0.0 110.534 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -69.51 146.14 52.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.24 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.567 HD13 HD12 ' D' ' 23' ' ' ILE . 83.2 mt -84.32 115.66 22.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.477 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.23 138.81 42.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.487 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -60.13 147.93 37.83 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.469 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.77 68.13 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -84.08 167.77 16.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.776 0.288 . . . . 0.0 110.607 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -114.07 159.44 20.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.025 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.21 -39.89 94.27 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.714 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' SER . . . . . . . . . . . . . 91.6 p -63.61 -24.13 67.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.18 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -63.09 -38.1 89.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.079 0.466 . . . . 0.0 110.234 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' TYR . . . . . 0.407 ' CE2' HD23 ' D' ' 50' ' ' LEU . 63.5 m-85 -96.12 12.73 29.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.206 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' ASN . . . . . . . . . . . . . 63.6 t30 57.45 41.37 26.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.326 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.04 103.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -90.55 179.33 5.87 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.239 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -61.74 150.7 36.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.987 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 60.07 31.3 20.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' SER . . . . . 0.472 ' HB3' HG22 ' D' ' 3' ' ' ILE . 18.4 t -86.57 125.88 34.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.919 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 123.22 26.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.326 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' LEU . . . . . . . . . . . . . 8.5 mp -112.05 149.72 31.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.815 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -99.13 117.76 34.33 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.626 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' D' ' 41' ' ' GLN . 61.4 tp -100.69 112.73 25.17 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.904 HG11 HD11 ' A' ' 56' ' ' LEU . 66.7 t -112.6 123.52 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' LEU . . . . . 0.551 ' H ' HD21 ' D' ' 8' ' ' LEU . 61.4 mt -96.76 140.67 31.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.759 0.314 . . . . 0.0 110.534 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -62.9 -40.59 98.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.738 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' LEU . . . . . 0.708 HD22 ' CE2' ' C' ' 59' ' ' TYR . 15.9 tp -141.3 54.53 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.337 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' ARG . . . . . 0.598 ' NH1' HD13 ' D' ' 8' ' ' LEU . 2.7 mpt_? 48.6 34.43 5.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.996 0.427 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.95 -177.54 25.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.782 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -71.06 148.17 47.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.127 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -94.82 125.17 39.31 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.452 0.644 . . . . 0.0 110.419 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 51' ' ' GLN . 92.4 mt -68.87 -36.54 78.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.304 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.95 160.78 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.729 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -172.84 122.73 0.42 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.23 0.538 . . . . 0.0 110.888 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.0 158.98 38.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.218 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.511 ' HA ' HD12 ' A' ' 46' ' ' LEU . 94.1 mtm-85 -77.35 119.57 21.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.831 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -151.21 146.05 25.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.395 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -107.25 150.88 16.87 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -89.3 162.15 15.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.07 0.462 . . . . 0.0 111.031 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.496 ' HE3' HG12 ' A' ' 38' ' ' VAL . 1.2 mtm -133.23 168.54 18.36 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.5 m -121.75 134.24 54.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.653 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.706 HD13 HG22 ' A' ' 38' ' ' VAL . 25.3 tp -115.42 118.96 34.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.058 0.456 . . . . 0.0 110.553 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -123.8 120.76 33.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.926 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.0 -85.79 0.22 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.32 22.56 0.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.684 0.278 . . . . 0.0 110.752 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.569 ' O ' HD12 ' A' ' 33' ' ' LEU . 92.7 m -123.77 128.73 49.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.946 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.706 HG22 HD13 ' A' ' 33' ' ' LEU . 40.4 t -107.89 119.79 58.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.822 HG22 ' HB3' ' B' ' 947' ' ' PRO . 22.0 p -114.3 135.31 22.19 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.656 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.74 149.25 37.71 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.064 1.843 . . . . 0.0 112.856 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -105.53 142.91 34.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -80.61 -7.97 59.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.523 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -72.3 75.87 1.0 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -57.38 135.23 56.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.295 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.68 -159.15 8.45 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 27' ' ' ARG . 6.5 tp -137.3 125.71 23.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.2 t -98.53 109.14 23.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.55 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 60' ' ' CYS . 38.8 p90 -132.44 153.97 50.32 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.4 139.85 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.458 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.55 128.81 29.91 Favored 'General case' 0 C--O 1.221 -0.405 0 O-C-N 123.922 0.764 . . . . 0.0 110.736 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.667 ' HB2' HD11 ' A' ' 23' ' ' LEU . 51.1 tt0 -99.29 124.23 44.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.497 HG23 ' CD2' ' A' ' 58' ' ' HIS . 13.7 p -85.11 170.74 12.63 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.414 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.03 -10.73 15.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -87.71 0.53 55.59 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.556 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.8 t 69.81 20.45 6.77 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.225 0.536 . . . . 0.0 110.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HG11 ' D' ' 70' ' ' VAL . 75.9 mt -99.56 121.94 41.91 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.512 HG21 HD23 ' A' ' 128' ' ' LEU . 50.5 mm -79.32 124.83 38.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.495 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.497 ' CD2' HG23 ' A' ' 52' ' ' THR . 73.0 m-70 -100.32 115.42 29.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.833 -178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -95.08 108.29 20.38 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . 81.9 m -121.61 143.7 49.17 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.787 0.804 . . . . 0.0 112.836 -177.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -124.86 114.42 19.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.025 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -104.93 144.13 32.21 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.419 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -80.8 131.5 35.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -72.29 -18.43 61.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.899 0.381 . . . . 0.0 110.786 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.7 m -59.54 -45.43 91.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.649 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.7 m -117.09 -13.46 10.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.038 0.446 . . . . 0.0 110.32 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.36 23.73 74.89 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -102.15 152.16 21.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.611 0.243 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.82 102.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.678 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -76.16 -35.01 59.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.12 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -125.59 147.07 49.42 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.725 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.566 ' O ' HD23 ' A' ' 73' ' ' LEU . 65.5 t0 -157.81 98.88 1.67 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.518 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' D' ' 48' ' ' ARG . 40.1 mt -128.9 133.04 47.76 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.901 0.382 . . . . 0.0 110.907 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.09 124.75 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.913 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.525 ' HB ' HD22 ' A' ' 128' ' ' LEU . 25.5 mm -111.37 128.15 68.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.076 0.465 . . . . 0.0 110.62 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.417 ' HZ ' HD12 ' D' ' 44' ' ' ILE . 66.4 m-85 -93.04 162.17 29.3 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.364 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.56 140.2 89.3 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.931 1.754 . . . . 0.0 111.362 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 59.52 13.2 3.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.249 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -87.28 -37.79 16.87 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-O 120.872 0.368 . . . . 0.0 110.415 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.597 ' HB3' HD11 ' A' ' 96' ' ' LEU . 81.8 m -131.75 153.41 50.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.261 0.553 . . . . 0.0 111.653 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -125.5 129.49 49.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -103.57 117.45 34.44 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.04 166.39 24.83 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.602 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -83.73 160.11 21.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.987 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.93 90.26 12.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.51 60.65 7.65 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.049 1.832 . . . . 0.0 112.31 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -114.01 -37.97 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.328 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 34.0 t -132.3 76.25 72.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.72 130.57 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.278 1.985 . . . . 0.0 111.435 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 168.83 -42.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.055 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -133.27 -149.72 6.18 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.408 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.26 105.68 13.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.0 t -125.19 127.71 72.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.701 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -126.13 152.23 46.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 105' ' ' LEU . 14.2 p -128.35 137.85 56.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.457 . . . . 0.0 110.228 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 80' ' ' CYS . 59.4 tp -102.33 120.22 40.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -118.47 134.86 54.73 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.49 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -84.36 117.03 23.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -61.24 -37.54 83.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.744 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -100.42 -10.28 21.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.728 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.83 152.92 17.15 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -93.18 22.02 5.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.331 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HD3' HD21 ' A' ' 105' ' ' LEU . 1.2 tmmm? -118.33 144.85 45.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.0 110.912 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.421 ' O ' HD23 ' A' ' 105' ' ' LEU . 33.7 ptt180 -139.72 152.79 46.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.958 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 95' ' ' VAL . 36.1 mt -121.58 159.39 26.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.252 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.502 ' CZ ' HD22 ' A' ' 33' ' ' LEU . 87.9 m-85 -126.12 137.54 53.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.42 161.24 38.55 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.353 0.597 . . . . 0.0 111.088 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -137.76 140.56 40.7 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.637 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 75.9 mmm -72.77 139.1 46.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.143 0.497 . . . . 0.0 110.788 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.94 4.27 15.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.844 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.96 147.49 93.98 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.49 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -60.94 -38.93 65.25 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.812 1.674 . . . . 0.0 112.223 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -118.81 145.76 45.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.148 -179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.0 p -91.9 1.25 57.3 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.972 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.24 -19.79 48.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.364 0.415 . . . . 0.0 110.151 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -116.86 -17.42 10.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.29 -41.49 97.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.846 -0.341 . . . . 0.0 110.503 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.64 -41.06 98.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.388 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.92 -41.77 90.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.531 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.732 ' O ' HG23 ' A' ' 124' ' ' VAL . 63.5 m170 -63.82 -39.91 95.36 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.698 0.761 . . . . 0.0 109.196 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m -62.41 -42.35 99.38 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.39 -1.277 . . . . 0.0 109.641 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -65.22 -43.96 89.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.822 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -61.88 -37.72 85.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.025 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 120' ' ' HIS . 53.5 t -58.35 -48.76 84.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.24 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -79.54 -27.83 41.3 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.904 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.88 -37.99 79.39 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.482 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -80.91 -31.78 34.97 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.753 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.525 HD22 ' HB ' ' A' ' 75' ' ' ILE . 59.6 mt -82.16 -20.57 37.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -114.13 -17.36 11.93 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.116 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -146.56 72.88 12.82 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.753 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.55 160.95 45.42 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 123.03 2.487 . . . . 0.0 112.139 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.495 1.579 0 C-N-CA 122.651 2.234 . . . . 0.0 112.377 -179.556 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 940' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 941' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 50.12 71.89 1.42 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 942' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.83 144.09 99.51 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.913 2.408 . . . . 0.0 112.15 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 943' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.89 154.66 92.62 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 944' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.77 150.2 88.99 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.332 2.021 . . . . 0.0 111.824 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 945' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -55.5 -169.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.237 1.958 . . . . 0.0 112.319 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 946' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -127.04 154.86 76.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 947' ' ' PRO . . . . . 0.822 ' HB3' HG22 ' A' ' 39' ' ' THR . 33.1 Cg_endo -63.86 143.32 85.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.252 1.968 . . . . 0.0 112.124 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 948' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -156.79 164.81 37.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.701 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 949' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -88.05 133.33 34.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.4 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 950' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -121.49 125.88 47.9 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.311 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 951' ' ' ILE . . . . . . . . . . . . . 1.4 mp -129.83 120.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.506 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 952' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -81.53 83.71 6.93 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.962 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 953' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.583 179.458 . . . . . . . . 0 0 . 1 stop_ save_